PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Spitz, L; Kiely, EM				Spitz, L; Kiely, EM			Conjoined twins	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HISTORY		Inst Child Hlth, Dept Paediat Surg, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Spitz, L (corresponding author), Inst Child Hlth, Dept Paediat Surg, 30 Guilford St, London WC1N 1EH, England.	l.spitz@ich.ucl.ac.uk						BONDESON J, 1992, J ROY SOC MED, V85, P217; Cywes S, 1997, PEDIATR SURG INT, V12, P234, DOI 10.1007/BF01372142; Geroulanos S, 1993, Gesnerus, V50 ( Pt 3-4), P179; HOYLE RM, 1990, SURG GYNECOL OBSTET, V170, P549; HUNTER K, 1964, DUET LIFETIME; Kingston CA, 2001, RADIOGRAPHICS, V21, P1187, DOI 10.1148/radiographics.21.5.g01se011187; KOENIG E, 1689, EPHEMERID NATUR CURI, V2, P145; MacKenzie TC, 2002, J PEDIATR SURG, V37, P303, DOI 10.1053/jpsu.2002.30830; ONEILL JA, 1998, PEDIAT SURG, P1925; Rickham P P, 1986, Prog Pediatr Surg, V20, P94; Spencer R, 2000, CLIN ANAT, V13, P36, DOI 10.1002/(SICI)1098-2353(2000)13:1<36::AID-CA5>3.0.CO;2-3; Spencer R, 1996, J PEDIATR SURG, V31, P941, DOI 10.1016/S0022-3468(96)90417-0; Spielmann AL, 2001, J COMPUT ASSIST TOMO, V25, P88, DOI 10.1097/00004728-200101000-00015; Spitz L, 2000, LANCET, V356, P1765, DOI 10.1016/S0140-6736(00)03220-7; Spitz L, 2002, BRIT J SURG, V89, P1188, DOI 10.1046/j.1365-2168.2002.02193.x; SPITZ L, IN PRESS ANN R COLL; TURNER W, 1829, ENTERED STATIONERS H; Wilcox DT, 1998, BRIT J UROL, V81, P905	18	89	92	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1307	1310		10.1001/jama.289.10.1307	http://dx.doi.org/10.1001/jama.289.10.1307			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633195				2022-12-28	WOS:000181466500035
J	Christensen, PR				Christensen, PR			Formation of recent martian gullies through melting of extensive water-rich snow deposits	NATURE			English	Article							SURFACE GROUND ICE; LIQUID WATER; NEAR-SURFACE; HIGH OBLIQUITY; MARS ODYSSEY; HYDROGEN; SEEPAGE	The observation of gullies on Mars indicates the presence of liquid water near the surface in recent times(1,2), which is difficult to reconcile with the current cold climate. Gullies have been proposed to form through surface runoff from subsurface aquifers(1,3) or through melting of near-surface ice under warmer conditions(4). But these gullies are observed to occur preferentially in cold mid-latitudes(2), where the presence of liquid water is less likely, and on isolated surfaces where groundwater seepage would not be expected, making both potential explanations unsatisfactory. Here I show that gullies can form by the melting of water-rich snow that has been transported from the poles to midlatitudes during periods of high obliquity within the past 10(5) to 10(6) years (refs 5, 6). Melting within this snow(7) can generate sufficient water to erode gullies in about 5,000 years. My proposed model for gully formation is consistent with the age and location of the gullies, and it explains the occurrence of liquid water in the cold mid-latitudes as well as on isolated surfaces. Remnants of the snowpacks are still present on mid-latitude, pole-facing slopes, and the recent or current occurrence of liquid water within them provides a potential abode for life.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Campus Box 876305, Tempe, AZ 85287 USA.							Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Carr MH, 2001, J GEOPHYS RES-PLANET, V106, P23571, DOI 10.1029/2000JE001316; CLOW GD, 1987, ICARUS, V72, P95, DOI 10.1016/0019-1035(87)90123-0; Costard F, 2002, SCIENCE, V295, P110, DOI 10.1126/science.1064419; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Gulick VC, 1997, ICARUS, V130, P68, DOI 10.1006/icar.1997.5802; Haberle RM, 2001, J GEOPHYS RES-PLANET, V106, P23317, DOI 10.1029/2000JE001360; Hecht MH, 2002, ICARUS, V156, P373, DOI 10.1006/icar.2001.6794; HOWARD AD, 1988, WATER RESOUR RES, V24, P1659, DOI 10.1029/WR024i010p01659; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; JAKOSKY BM, 1985, NATURE, V315, P559, DOI 10.1038/315559a0; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Knauth LP, 2000, SCIENCE, V290, P711; KNAUTH LP, 2001, LUNAR PLANETARY I CO, V1095, P60; LEE P, 2001, LUNAR PLANET SCI, P1809; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MALIN MC, 2002, MALIN SPACE SCI SYST; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 2001, J GEOPHYS RES-PLANET, V106, P23165, DOI 10.1029/2000JE001424; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; TOKAR RL, 2002, J GEOPHYS RES, V29; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; WARD WR, 1979, J GEOPHYS RES, V84, P237, DOI 10.1029/JB084iB01p00237	26	264	267	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					45	48		10.1038/nature01436	http://dx.doi.org/10.1038/nature01436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12594459				2022-12-28	WOS:000181343100030
J	Barringer, TA; Kirk, JK; Santaniello, AC; Foley, KL; Michielutte, R				Barringer, TA; Kirk, JK; Santaniello, AC; Foley, KL; Michielutte, R			Effect of a multivitamin and mineral supplement on infection and quality of life - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							VITAMIN-E SUPPLEMENTATION; HEALTHY ELDERLY SUBJECTS; IMMUNITY; MICRONUTRIENTS; SUSCEPTIBILITY; NUTRITION; RESPONSES; STRESS; ZINC	Background: use of multivitamin and mineral supplements is common among U.S. adults, yet few well-designed trials have assessed the reputed benefits. Objective: To determine the effect of a daily multivitamin and mineral supplement on infection and well-being. Design: Randomized, double-blind, placebo-controlled trial. Setting: Primary care clinics at two medical centers in North Carolina. Participants: 130 community-dwelling adults stratified by age (45 to 64 years or :65 years) and presence of type 2 diabetes mellitus. Intervention: Multivitamin and mineral supplement or placebo taken daily for 1 year. Measurements: incidence of participant-reported symptoms of infection, incidence of infection-associated absenteeism, and scores on the physical and mental health subscales of the Medica Outcomes Study 12-Item Short Form. Results: More participants receiving placebo reported an infectious illness over the study year than did participants receiving multivitamin and mineral supplements (73% vs. 43%; P < 0.001). Infection-related absenteeism was also higher in the placebo group than in the treatment group (57% vs. 21 %; P < 0.001). Participants with type 2 diabetes mellitus (n = 51) accounted for this finding. Among diabetic participants receiving placebo, 93% reported an infection compared with 17% of those receiving supplements (P < 0.001). Medical Outcomes Study 12-Item Short Form scores did not differ between the treatment and placebo groups. Conclusions: A multivitamin and mineral supplement reduced the incidence of participant-reported infection and related absenteeism in a sample of participants with type 2 diabetes mellitus and a high prevalence of subclinical micronutrient deficiency. A larger clinical trial is needed to determine whether these findings can be replicated not only in diabetic persons but also in any population with a high rate of suboptimal nutrition or potential underlying disease impairment.	Carolinas Med Ctr, Dept Family Practice, Univ N Carolina, Sch Med, Charlotte, NC 28207 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA	Carolinas Medical Center; University of North Carolina; University of North Carolina Charlotte; Wake Forest University	Barringer, TA (corresponding author), Carolinas Med Ctr, Dept Family Practice, Univ N Carolina, Sch Med, CMC-MP Bldg,1350 S Kings Dr, Charlotte, NC 28207 USA.	tbarringer@carolinas.org						BAEHNER RL, 1977, BLOOD, V50, P327; Balluz LS, 2000, ARCH FAM MED, V9, P258, DOI 10.1001/archfami.9.3.258; BOGDEN JD, 1994, AM J CLIN NUTR, V60, P437, DOI 10.1093/ajcn/60.3.437; BOGDEN JD, 1990, J AM COLL NUTR, V9, P214; CHANDRA R, 1995, NUTR REV, V53, pS80; Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Chandra RK, 1997, JAMA-J AM MED ASSOC, V277, P1398, DOI 10.1001/jama.277.17.1398; CHANDRA RK, 1984, JAMA-J AM MED ASSOC, V252, P1443, DOI 10.1001/jama.252.11.1443; CHANDRA RK, 1992, LANCET, V340, P1124, DOI 10.1016/0140-6736(92)93151-C; CHAVANCE M, 1993, INT J VITAM NUTR RES, V63, P11; COHEN S, 1988, CLAR SYMP, P31; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Erickson KL, 2000, J INFECT DIS, V182, pS5, DOI 10.1086/315922; ERVIN RB, 1999, VITAL HLTH STAT, V244, P1; GALLACHER SJ, 1995, DIABETIC MED, V12, P916, DOI 10.1111/j.1464-5491.1995.tb00396.x; Glaser R, 1999, JAMA-J AM MED ASSOC, V281, P2268, DOI 10.1001/jama.281.24.2268; High KP, 1999, CLIN INFECT DIS, V28, P717, DOI 10.1086/515208; High KP, 2001, CLIN INFECT DIS, V33, P1892, DOI 10.1086/324509; Keech M, 1998, OCCUP MED-OXFORD, V48, P85, DOI 10.1093/occmed/48.2.85; MCMAHON MM, 1995, INFECT DIS CLIN N AM, V9, P1; Meydani SN, 1997, JAMA-J AM MED ASSOC, V277, P1380, DOI 10.1001/jama.277.17.1380; Muchova J, 1999, DIABETIC MED, V16, P74, DOI 10.1046/j.1464-5491.1999.00015.x; PRASAD JS, 1980, AM J CLIN NUTR, V33, P606, DOI 10.1093/ajcn/33.3.606; Rassias AJ, 1999, ANESTH ANALG, V88, P1011, DOI 10.1097/00000539-199905000-00008; SMITH AP, 1990, PHILOS T ROY SOC B, V327, P519, DOI 10.1098/rstb.1990.0095; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	28	63	66	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					365	371		10.7326/0003-4819-138-5-200303040-00005	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614088				2022-12-28	WOS:000181257300001
J	Alderson, P; Chalmers, I				Alderson, P; Chalmers, I			Survey of claims of no effect in abstracts of Cochrane reviews	BRITISH MEDICAL JOURNAL			English	Article									NHS Res & Dev Programme, UK Cochrane Ctr, Oxford OX2 7LG, England	Cochrane Centre	Alderson, P (corresponding author), NHS Res & Dev Programme, UK Cochrane Ctr, Oxford OX2 7LG, England.							ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Greene WL, 2000, ANN INTERN MED, V132, P715, DOI 10.7326/0003-4819-132-9-200005020-00006	2	34	36	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					475	475		10.1136/bmj.326.7387.475	http://dx.doi.org/10.1136/bmj.326.7387.475			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609942	Green Published, Bronze			2022-12-28	WOS:000181421400016
J	Sniderman, AD; Furberg, CD; Keech, A; van Lennep, JER; Frohlich, J; Jungner, I; Walldius, G				Sniderman, AD; Furberg, CD; Keech, A; van Lennep, JER; Frohlich, J; Jungner, I; Walldius, G			Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment	LANCET			English	Editorial Material							HEART-DISEASE; A-I; LIPOPROTEIN CHOLESTEROL; B REPLACE; FOLLOW-UP; PREVENTION; PREDICTION; PROFILE; EVENTS		McGill Univ, McGill Univ Hlth Ctr, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ, Canada; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; Leiden Univ, Med Ctr, Leiden, Netherlands; St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; St Gorans Univ Hosp, CALAB Res, Stockholm, Sweden; Karolinska Inst, Karolinska Hosp, Clin Epidemiol Unit, S-10401 Stockholm, Sweden; AstraZeneca, Molndal, Sweden; Karolinska Inst, King Gustaf V Res Inst, Stockholm, Sweden	McGill University; Wake Forest University; Wake Forest Baptist Medical Center; University of Sydney; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Saint Goran's Hospital; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; Karolinska Institutet	Sniderman, AD (corresponding author), Royal Victoria Hosp, Mike Rosenbloom Lab Cardiovasc Res, Room H7-22,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	allan.sniderman@muhc.mcgill.ca						Ballantyne CM, 2001, AM J CARDIOL, V88, P265, DOI 10.1016/S0002-9149(01)01638-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Durrington PN, 2002, CLIN CHEM, V48, P401; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Miremadi S, 2002, CLIN CHEM, V48, P484; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Otvos JD, 2002, AM J CARDIOL, V90, p22I; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; Simes RJ, 2002, CIRCULATION, V105, P1162, DOI 10.1161/hc1002.105136; Sniderman AD, 2001, ANN INTERN MED, V135, P447, DOI 10.7326/0003-4819-135-6-200109180-00014; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2	17	357	370	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					777	780		10.1016/S0140-6736(03)12663-3	http://dx.doi.org/10.1016/S0140-6736(03)12663-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620753				2022-12-28	WOS:000181232000023
J	Fowler, KB; Stagno, S; Pass, RF				Fowler, KB; Stagno, S; Pass, RF			Maternal immunity and prevention of congenital cytomegalovirus infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DAY-CARE; VIRUS INFECTION; INFANTS BORN; MOTHERS; TRANSMISSION; POPULATION; PREGNANCY; WORKERS; WOMEN	Context Vaccine development to prevent congenital cytomegalovinus (CMV) infection has been impeded by the uncertainty over whether maternal immunity protects the fetus. Objective To determine whether the presence of maternal antibodies to CMV significantly reduces the risk of congenital CMV infection in future pregnancies. Design, Setting, and Participants Cohort study of 3461 multiparous women from a population with a high rate of congenital CMV infection who delivered newborns screened for congenital CMV infection between 1993 and 1998, and whose cord serum specimen from a previous delivery could be retrieved and tested for antibody to CMV. Main Outcome Measure Congenital CMV infection according to maternal immune status, age, race, parity, and socioeconomic status. Results Of 604 newborns born to initially seronegative mothers, congenital CMV infection occurred in 18 (3.0%). In contrast, of 2857 newborns born to immune mothers, congenital CMV infection occurred in 29 (1.0%) Two factors, preconception maternal immunity (adjusted risk ratio, 0.31; 95% confidence interval, 0.17-0.58) and maternal age of 25 years or older (adjusted risk ratio, 0.19; 95% confidence interval, 0.07-0.49), were highly protective against congenital CMV infection. No other factors were associated with a reduction in the risk of congenital CMV infection. Conclusion Naturally acquired immunity results in a 69% reduction in the risk of congenital CMV infection in future pregnancies.	Univ Alabama, Dept Pediat, Birmingham, AL 35233 USA; Univ Alabama, Dept Epidemiol, Birmingham, AL 35233 USA; Univ Alabama, Dept Maternal & Child Hlth, Birmingham, AL 35233 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fowler, KB (corresponding author), Univ Alabama, Dept Pediat, 1600 7th Ave S,CHB 306, Birmingham, AL 35233 USA.			Pass, Robert/0000-0003-2029-0247	NCRR NIH HHS [M01 RR000032] Funding Source: Medline; NIAID NIH HHS [P01 AI043681, P01 AI43681] Funding Source: Medline; PHS HHS [M01 R00032] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043681] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADLER SP, 1989, NEW ENGL J MED, V321, P1290, DOI 10.1056/NEJM198911093211903; Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969; BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; CHANDLER SH, 1985, J INFECT DIS, V152, P249, DOI 10.1093/infdis/152.2.249; FOWLER KB, 1993, J INFECT DIS, V168, P552, DOI 10.1093/infdis/168.3.552; Fowler KB, 1999, J PEDIATR-US, V135, P60, DOI 10.1016/S0022-3476(99)70328-8; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; HICKS T, 1993, J PEDIATR-US, V123, P779, DOI 10.1016/S0022-3476(05)80859-5; MURPH JR, 1991, JAMA-J AM MED ASSOC, V265, P603, DOI 10.1001/jama.265.5.603; Mussi-Pinhata MM, 1998, J PEDIATR-US, V132, P285, DOI 10.1016/S0022-3476(98)70446-9; PASS RF, 1990, PEDIATR INFECT DIS J, V9, P465, DOI 10.1097/00006454-199007000-00003; Pass RF, 1996, INFECT AGENT DIS, V5, P240; PREECE PM, 1986, J EPIDEMIOL COMMUN H, V40, P205, DOI 10.1136/jech.40.3.205; SCHOPFER K, 1978, ARCH DIS CHILD, V53, P536, DOI 10.1136/adc.53.7.536; SOHN Y M, 1992, Journal of Korean Medical Science, V7, P47; SOHN YM, 1991, J INFECT DIS, V163, P460, DOI 10.1093/infdis/163.3.460; STAGNO C, 1995, INFECT DIS FETUS NEW, P312; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STAGNO S, 1977, NEW ENGL J MED, V296, P1254, DOI 10.1056/NEJM197706022962203; STRATTON K, 2001, VACCINES 21 CENTURY, P476	22	296	308	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1008	1011		10.1001/jama.289.8.1008	http://dx.doi.org/10.1001/jama.289.8.1008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597753	Bronze			2022-12-28	WOS:000181129800027
J	Law, FD; Nutt, DJ				Law, FD; Nutt, DJ			Maintenance buprenorphine for opioid users	LANCET			English	Editorial Material							METHADONE-MAINTENANCE; DEPENDENCE		Univ Bristol, Psychopharmacol Unit, Sch Med Sci, Bristol BS8 1TD, Avon, England	University of Bristol	Law, FD (corresponding author), Univ Bristol, Psychopharmacol Unit, Sch Med Sci, Bristol BS8 1TD, Avon, England.							BICKEL WK, 1988, J PHARMACOL EXP THER, V247, P47; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; DOLE VP, 1969, NEW ENGL J MED, V280, P1372, DOI 10.1056/NEJM196906192802502; GRONBLADH L, 1990, ACTA PSYCHIAT SCAND, V82, P223, DOI 10.1111/j.1600-0447.1990.tb03057.x; GUNNE LM, 1981, DRUG ALCOHOL DEPEN, V7, P248; Guseva T.V, 2002, HYDROCHEMICAL VARIAB, P148; KADDEN RM, 1992, PROJECT MATCH COGNIT; Kraft MK, 1997, AM J PSYCHIAT, V154, P1214; Ling W, 1996, ARCH GEN PSYCHIAT, V53, P401; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; NEWMAN RG, 1979, LANCET, V2, P485; TURNBALL PJ, 2000, 212 HOM OFF; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2; Zubieta JK, 2000, NEUROPSYCHOPHARMACOL, V23, P326, DOI 10.1016/S0893-133X(00)00110-X	14	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					634	635		10.1016/S0140-6736(03)12612-8	http://dx.doi.org/10.1016/S0140-6736(03)12612-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606172				2022-12-28	WOS:000181129500010
J	Lokkegaard, E; Pedersen, AT; Heitmann, BL; Jovanovic, Z; Keiding, N; Hundrup, YA; Obel, EB; Ottesen, B				Lokkegaard, E; Pedersen, AT; Heitmann, BL; Jovanovic, Z; Keiding, N; Hundrup, YA; Obel, EB; Ottesen, B			Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTMENOPAUSAL WOMEN; ESTROGEN REPLACEMENT; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; PLASMA-LIPIDS; RISK FACTOR; PREVENTION; NONUSERS; COHORT; NIDDM	Objective To investigate the risk of ischaemic heart disease and myocardial infarction among women using hormone replacement therapy, especially the potential modifying effect of cardiovascular risk factors. Design Prospective observational study. Setting Denmark. Participants 19 898 nurses aged 45 and over completing a questionnaire on lifestyle and use of hormone replacement therapy in 1993. Main outcome measures All cases of death and incident cases of ischaemic heart disease and myocardial infarction until the end of 1998. Results Current users of hormone replacement therapy smoked more, consumed more alcohol, had lower self rated health, but were slimmer and had a lower prevalence of diabetes than never users. In current users compared with never users, hormone replacement therapy had no protective effect on ischaemic heart disease (hazard ratio 1.2, 0.9 to 1.7) or myocardial infarction (1.0, 0.6 to 1.7), whereas current users with diabetes had an increased risk of death (3.2, 1.4 to 7.5), ischaemic heart disease (4.2, 1.4 to 12.5), and myocardial infarction (9.2, 2.0 to 41.4) compared with never users with diabetes. Conclusion Hormone replacement therapy showed no protective effect on ischaemic heart disease, but there was a significantly increased risk of death from all causes and ischaemic heart disease among women with diabetes.	Hvidovre Univ Hosp, Dept Obstet & Gynaecol, DK-2650 Hvidovre, Denmark; Univ Copenhagen, Rigshosp, Juliane Marie Ctr, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Panum Inst, Dept Biostat, DK-2100 Copenhagen, Denmark; Natl Inst Publ Hlth, Danish Nurse Study, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-1399 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Lokkegaard, E (corresponding author), Hvidovre Univ Hosp, Dept Obstet & Gynaecol, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	loekkegaard@dadlnet.dk	Andersen, Zorana Jovanovic/P-4983-2014	Andersen, Zorana Jovanovic/0000-0003-4138-9828; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Lokkegaard, Ellen/0000-0003-4149-5663				Andersson B, 1997, J CLIN ENDOCR METAB, V82, P638, DOI 10.1210/jc.82.2.638; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Brussaard HE, 1997, DIABETOLOGIA, V40, P843, DOI 10.1007/s001250050758; Cornu C, 2000, MATURITAS, V37, P95, DOI 10.1016/S0378-5122(00)00164-X; FALKEBORN M, 1992, BRIT J OBSTET GYNAEC, V99, P821, DOI 10.1111/j.1471-0528.1992.tb14414.x; Friday KE, 2001, J CLIN ENDOCR METAB, V86, P48, DOI 10.1210/jc.86.1.48; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRADY J, 2002, JAMA-J AM MED ASSOC, V288, P49; Grodstein F, 1999, EPIDEMIOLOGY, V10, P476, DOI 10.1097/00001648-199909000-00003; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hu FB, 2000, NEW ENGL J MED, V343, P530, DOI 10.1056/NEJM200008243430802; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hundrup YA, 2000, ACTA OBSTET GYN SCAN, V79, P194, DOI 10.1080/j.1600-0412.2000.079003194.x; Hundrup YA, 2002, SCAND J PUBLIC HEALT, V30, P47, DOI 10.1080/140349401753481583; Koh KK, 2001, J AM COLL CARDIOL, V38, P1409, DOI 10.1016/S0735-1097(01)01566-2; Manwaring P, 2000, MATURITAS, V34, P239, DOI 10.1016/S0378-5122(99)00112-7; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Rodstrom K, 1999, BMJ-BRIT MED J, V319, P890, DOI 10.1136/bmj.319.7214.890; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Troisi RJ, 2000, OBSTET GYNECOL, V96, P665, DOI 10.1097/00006250-200011000-00005	25	32	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					426	428A		10.1136/bmj.326.7386.426	http://dx.doi.org/10.1136/bmj.326.7386.426			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595383	Bronze, Green Published			2022-12-28	WOS:000181318000020
J	Ikeda, H; Heinke, B; Ruscheweyh, R; Sandkuhler, J				Ikeda, H; Heinke, B; Ruscheweyh, R; Sandkuhler, J			Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia	SCIENCE			English	Article							LONG-TERM POTENTIATION; SUBSTANCE-P RECEPTOR; DORSAL HORN; T-TYPE; NEUROPATHIC PAIN; CALCIUM CHANNELS; RAT; INVOLVEMENT; EXPRESSION; MEMORY	Inflammation, trauma, or nerve injury may cause enduring hyperalgesia, an enhanced sensitivity to painful stimuli. Neurons in lamina I of the spinal dorsal horn that express the neurokinin 1 receptor for substance P mediate this abnormal pain sensitivity by an unknown cellular mechanism. We report that in these, but not in other nociceptive lamina I cells, neurokinin 1 receptor-activated signal transduction pathways and activation of low-threshold (T-type) voltage-gated calcium channels synergistically facilitate activity- and calcium-dependent long-term potentiation at synapses from nociceptive nerve fibers. Thereby, memory traces of painful events are retained.	Univ Heidelberg, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany; Univ Vienna, Sch Med, Brain Res Inst, A-1090 Vienna, Austria	Ruprecht Karls University Heidelberg; University of Vienna	Sandkuhler, J (corresponding author), Univ Heidelberg, Inst Physiol & Pathophysiol, D-69120 Heidelberg, Germany.		Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X				Bester H, 2000, J NEUROPHYSIOL, V83, P2239, DOI 10.1152/jn.2000.83.4.2239; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; DUGGAN AW, 1988, BRAIN RES, V451, P261, DOI 10.1016/0006-8993(88)90771-8; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Honore P, 1999, J NEUROSCI, V19, P7670, DOI 10.1523/JNEUROSCI.19-17-07670.1999; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Kawamata M, 1996, PAIN, V68, P85, DOI 10.1016/S0304-3959(96)03222-8; Khasabov SG, 2002, J NEUROSCI, V22, P9086; KLEIN T, 2003, IN PRESS PROGR PAIN, V24; LITTLEWOOD NK, 1995, NEUROSCIENCE, V66, P597, DOI 10.1016/0306-4522(95)00039-L; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Matthews EA, 2001, EUR J PHARMACOL, V415, P141, DOI 10.1016/S0014-2999(01)00812-3; Neveu D, 1996, NEURON, V16, P619, DOI 10.1016/S0896-6273(00)80081-1; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; Sandkuhler J, 2000, PAIN, V88, P113, DOI 10.1016/S0304-3959(00)00424-3; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Talley EM, 1999, J NEUROSCI, V19, P1895; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Tolle TR, 1996, PROG BRAIN RES, V110, P193; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	24	419	442	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1237	1240		10.1126/science.1080659	http://dx.doi.org/10.1126/science.1080659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595694				2022-12-28	WOS:000181065500042
J	Cooper, MS; Stewart, PM				Cooper, MS; Stewart, PM			Current concepts - Corticosteroid insufficiency in acutely ill patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PITUITARY-ADRENAL AXIS; SEPTIC SHOCK; DOUBLE-BLIND; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; DEHYDROEPIANDROSTERONE REPLACEMENT; CORTISOL RESPONSE; BINDING GLOBULIN; ADDISONS-DISEASE; INTENSIVE-CARE; THERAPY		Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Stewart, PM (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Div Med Sci, Birmingham B15 2TH, W Midlands, England.		Cooper, Mark S/C-9529-2012; Annane, Djillali/R-7947-2019; Tritos, Nicholas/W-1594-2019	Tritos, Nicholas/0000-0001-8867-607X; Cooper, Mark/0000-0003-3112-7728				Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Barquist E, 1997, J TRAUMA, V42, P27, DOI 10.1097/00005373-199701000-00006; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Beishuizen A, 1999, LANCET, V353, P1675, DOI 10.1016/S0140-6736(99)01346-X; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; Beishuizen A, 2001, BEST PRACT RES CL EN, V15, P513, DOI 10.1053/beem.2001.0167; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BOUACHOUR G, 1994, INTENS CARE MED, V20, P138, DOI 10.1007/BF01707669; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Burchard K, 2001, J TRAUMA, V51, P800, DOI 10.1097/00005373-200110000-00033; CATALANO RD, 1984, ARCH SURG-CHICAGO, V119, P145; CHERNOW B, 1987, ARCH INTERN MED, V147, P1273, DOI 10.1001/archinte.147.7.1273; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Clark PM, 1998, CLIN ENDOCRINOL, V49, P287; Cooper MS, 2001, J BONE MINER RES, V16, P1037, DOI 10.1359/jbmr.2001.16.6.1037; Cooper MS, 2002, J BONE MINER RES, V17, P979, DOI 10.1359/jbmr.2002.17.6.979; Coursin DB, 2002, JAMA-J AM MED ASSOC, V287, P236, DOI 10.1001/jama.287.2.236; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Erturk E, 1998, J CLIN ENDOCR METAB, V83, P2350, DOI 10.1210/jc.83.7.2350; ESTEBAN NV, 1991, J CLIN ENDOCR METAB, V72, P39, DOI 10.1210/jcem-72-1-39; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; JACOBS HS, 1969, BRIT MED J, V2, P595, DOI 10.1136/bmj.2.5657.595; Kaiser UB, 2001, NEW ENGL J MED, V344, P1536, DOI 10.1056/NEJM200105173442008; KIDESS AI, 1993, MAYO CLIN PROC, V68, P435, DOI 10.1016/S0025-6196(12)60188-8; KNOWLTON AI, 1989, J INTENSIVE CARE MED, V4, P35, DOI DOI 10.1177/088506668900400104; Lamberts SWJ, 1997, NEW ENGL J MED, V337, P1285, DOI 10.1056/NEJM199710303371807; LEBEL MH, 1988, NEW ENGL J MED, V319, P964, DOI 10.1056/NEJM198810133191502; LEDINGHAM IM, 1983, LANCET, V1, P1270; Malik KJ, 1996, ANN CLIN BIOCHEM, V33, P187, DOI 10.1177/000456329603300302; Marik PE, 2002, CRIT CARE MED, V30, P1267, DOI 10.1097/00003246-200206000-00018; Meduri GU, 2002, AM J RESP CRIT CARE, V165, P983, DOI 10.1164/ajrccm.165.7.2106014; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; MOLIJN GJ, 1995, J CLIN ENDOCR METAB, V80, P1799, DOI 10.1210/jc.80.6.1799; NORBIATO G, 1994, BAILLIERE CLIN ENDOC, V8, P777, DOI 10.1016/S0950-351X(05)80300-3; Oelkers W, 1996, EUR J ENDOCRINOL, V135, P27, DOI 10.1530/eje.0.1350027; PERROT D, 1993, CRIT CARE MED, V21, P396, DOI 10.1097/00003246-199303000-00018; SALEM M, 1994, ANN SURG, V219, P416, DOI 10.1097/00000658-199404000-00013; SIBBALD WJ, 1977, ANN SURG, V186, P29, DOI 10.1097/00000658-197707000-00005; Stewart PM, 1999, VITAM HORM, V57, P249; Subramanian S, 1997, ARCH INTERN MED, V157, P1008, DOI 10.1001/archinte.157.9.1008; Ten S, 2001, J CLIN ENDOCR METAB, V86, P2909, DOI 10.1210/jc.86.7.2909; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; Zaloga GP, 2001, CRIT CARE CLIN, V17, P25, DOI 10.1016/S0749-0704(05)70150-0	48	660	692	1	26	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					727	734		10.1056/NEJMra020529	http://dx.doi.org/10.1056/NEJMra020529			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594318				2022-12-28	WOS:000181014400009
J	Janssen, EM; Lemmens, EE; Wolfe, T; Christen, U; von Herrath, MG; Schoenberger, SP				Janssen, EM; Lemmens, EE; Wolfe, T; Christen, U; von Herrath, MG; Schoenberger, SP			CD4(+) T cells are required for secondary expansion and memory in CD8(+) T lymphocytes	NATURE			English	Article							HELPER; DIFFERENTIATION; RESPONSES; GENERATION; INDUCTION; INVIVO; MICE; CTL	A long-standing paradox in cellular immunology concerns the conditional requirement for CD4(+) T-helper (T-H) cells in the priming of cytotoxic CD8(+) T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4(+) T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T-H cells(1-4). A clearer understanding of the contribution of T-H cells to CTL development has been hampered by the fact that most T-H-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T-H-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T-H-dependent and T-H-independent CTLs and find in both cases that CD4(+) T cells are dispensable for primary expansion of CD8(+) T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T-H cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8(+) T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.	La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology	Schoenberger, SP (corresponding author), La Jolla Inst Allergy & Immunol, Div Cellular Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Christen, Urs/A-7338-2009	Christen, Urs/0000-0003-4165-7976; janssen, edith/0000-0001-7881-6307				Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BULLER RML, 1987, NATURE, V328, P77, DOI 10.1038/328077a0; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; DI RF, 1996, J EXP MED, V183, P2153; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Mintern JD, 2002, J IMMUNOL, V168, P977, DOI 10.4049/jimmunol.168.3.977; Oehen S, 1998, J IMMUNOL, V161, P5338; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, J IMMUNOL, V161, P3808; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Suresh M, 2001, J IMMUNOL, V167, P5565, DOI 10.4049/jimmunol.167.10.5565; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730	27	1254	1304	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					852	856		10.1038/nature01441	http://dx.doi.org/10.1038/nature01441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594515				2022-12-28	WOS:000181044700050
J	Klockner, HR; Baan, WA; Garrett, MA				Klockner, HR; Baan, WA; Garrett, MA			Investigation of the obscuring circumnuclear torus in the active galaxy Mrk231	NATURE			English	Article							DISK; STARBURST; EMISSION; MASERS	Active galaxies are characterized by prominent emission from their nuclei. In the 'unified' view of active galaxies, the accretion of material onto a massive compact object-now generally believed to be a black hole-provides the fundamental power source(1). Obscuring material along the line of sight can account for the observed differences in the nuclear emission(2,3), which determine the classification of AGN (for example, as Seyfert 1 or Seyfert 2 galaxies). Although the physical processes of accretion have been confirmed observationally(4,5), the structure and extent of the obscuring material have not been determined. Here we report observations of powerful hydroxyl (OH) line emissions that trace this obscuring material within the circumnuclear environment of the galaxy Markarian 231. The hydroxyl (mega)-maser emission shows the characteristics of a rotating, dusty, molecular torus (or thick disk) located between 30 and 100 pc from the central engine. We now have a clear view of the physical conditions, the kinematics and the spatial structure of this material on intermediate size scales, confirming the main tenets of unification models.	Univ Groningen, Kapteyn Inst, NL-9700 AV Groningen, Netherlands; Westerbork Observ, ASTRON, NL-7990 AA Dwingeloo, Netherlands; Joint Inst VLBI Europe, NL-7990 AA Dwingeloo, Netherlands	University of Groningen	Klockner, HR (corresponding author), Univ Groningen, Kapteyn Inst, POB 800, NL-9700 AV Groningen, Netherlands.	hrkloeck@astro.rug.nl	Klöckner, Hans-Rainer/AAW-7015-2021	Klöckner, Hans-Rainer/0000-0002-0648-2704				BAAN WA, 1989, ASTROPHYS J, V338, P804, DOI 10.1086/167237; Baan WA, 1998, ASTROPHYS J, V509, P633, DOI 10.1086/306504; BAAN WA, 1982, ASTROPHYS J, V260, pL49, DOI 10.1086/183868; BAAN WA, 1985, NATURE, V315, P26, DOI 10.1038/315026a0; Bryant PM, 1996, ASTROPHYS J, V457, P678, DOI 10.1086/176763; Carilli CL, 1998, ASTRON J, V115, P928, DOI 10.1086/300253; Diamond PJ, 1999, ASTROPHYS J, V511, P178, DOI 10.1086/306681; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Gallimore JF, 1997, NATURE, V388, P852, DOI 10.1038/42201; GREENHILL LJ, 1995, ASTROPHYS J, V440, P619, DOI 10.1086/175301; HENKEL C, 1987, ASTRON ASTROPHYS, V185, P14; Herrnstein JR, 1998, ASTROPHYS J, V508, P243, DOI 10.1086/306398; KEIICHI W, 2002, ASTROPHYS J, V566, pL21; Krolik J. H., 1999, ACTIVE GALACTIC NUCL; KROLIK JH, 1988, ASTROPHYS J, V329, P702, DOI 10.1086/166414; Levine DA, 1998, ASTROPHYS J, V504, P64, DOI 10.1086/306065; Maloney PR, 2002, PUBL ASTRON SOC AUST, V19, P401, DOI 10.1071/AS01100; Pihlstrom YM, 2001, ASTRON ASTROPHYS, V377, P413, DOI 10.1051/0004-6361:20011107; RANDELL J, 1995, ASTRON ASTROPHYS, V300, P659; REES MJ, 1984, ANNU REV ASTRON ASTR, V22, P471, DOI 10.1146/annurev.aa.22.090184.002351; Richards AMS, 2001, IAU SYMP, P212; Schmitt HR, 2001, ASTROPHYS J, V555, P663, DOI 10.1086/321505; Taylor GB, 1999, ASTROPHYS J, V519, P185, DOI 10.1086/307362; Ulvestad JS, 1999, ASTROPHYS J, V517, pL81, DOI 10.1086/312040; Ulvestad JS, 1999, ASTROPHYS J, V516, P127, DOI 10.1086/307111; van Langevelde HJ, 2000, ASTRON ASTROPHYS, V354, pL45; WILLIAM J, 1999, NATURE, V401, P891	27	58	58	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					821	823		10.1038/nature01381	http://dx.doi.org/10.1038/nature01381			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594506	Green Submitted			2022-12-28	WOS:000181044700041
J	Morris, DG; Huang, XZ; Kaminski, N; Wang, YN; Shapiro, SD; Dolganov, G; Glick, A; Sheppard, D				Morris, DG; Huang, XZ; Kaminski, N; Wang, YN; Shapiro, SD; Dolganov, G; Glick, A; Sheppard, D			Loss of integrin alpha v beta 6-mediated TGF-beta activation causes Mmp12-dependent emphysema	NATURE			English	Article							MACROPHAGE METALLOELASTASE; CYTOPLASMIC DOMAIN; LUNG INFLAMMATION; FOCAL CONTACTS; EXPRESSION; MICE; SUBUNIT; REVEALS; LOCALIZATION; INHIBITION	Integrins are heterodimeric cell-surface proteins that regulate cell growth, migration and survival. We have shown previously that the epithelial-restricted integrin alphavbeta6 has another critical function; that is, it binds and activates latent transforming growth factor-beta (TGF-beta)(1,2). Through a global analysis of pulmonary gene expression in the lungs of mice lacking this integrin (Itgb6 null mice) we have identified a marked induction of macrophage metalloelastase (Mmp12)-a metalloproteinase that preferentially degrades elastin and has been implicated in the chronic lung disease emphysema(3). Here we report that Itgb6-null mice develop age-related emphysema that is completely abrogated either by transgenic expression of versions of the beta6 integrin subunit that support TGF-beta activation, or by the loss of Mmp12. Furthermore, we show that the effects of Itgb6 deletion are overcome by simultaneous transgenic expression of active TGF-beta1. We have uncovered a pathway in which the loss of integrin-mediated activation of latent TGF-beta causes age-dependent pulmonary emphysema through alterations of macrophage Mmp12 expression. Furthermore, we show that a functional alteration in the TGF-beta activation pathway affects susceptibility to this disease.	Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; Univ Pittsburgh, Dept Med, Div Pulm & Crit Care Med, Pittsburgh, PA 15261 USA; Brigham & Womens Hosp, Dept Med, Pulm & Crit Care Med Sect, Boston, MA 02115 USA; NCI, Cellular Carcinogenesis & Tumor Promot Lab, Bethesda, MD 20892 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sheppard, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, Dept Med, San Francisco, CA 94143 USA.			Kaminski, Naftali/0000-0001-5917-4601				AGREZ M, 1994, J CELL BIOL, V127, P547, DOI 10.1083/jcb.127.2.547; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; Clark JC, 2001, AM J PHYSIOL-LUNG C, V280, pL705, DOI 10.1152/ajplung.2001.280.4.L705; CONE RI, 1994, CELL ADHES COMMUN, V2, P101, DOI 10.3109/15419069409004430; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Feinberg MW, 2000, J BIOL CHEM, V275, P25766, DOI 10.1074/jbc.M002664200; Fujita M, 2001, AM J PHYSIOL-LUNG C, V280, pL39, DOI 10.1152/ajplung.2001.280.1.L39; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HUANG XZ, 1995, AM J RESP CELL MOL, V13, P245, DOI 10.1165/ajrcmb.13.2.7626292; Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921; Huang XZ, 1998, AM J RESP CELL MOL, V19, P636, DOI 10.1165/ajrcmb.19.4.3293; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; WERB Z, 1975, J EXP MED, V142, P361, DOI 10.1084/jem.142.2.361; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; WIKENHEISER KA, 1992, CANCER RES, V52, P5342; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	27	373	393	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					169	173		10.1038/nature01413	http://dx.doi.org/10.1038/nature01413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634787				2022-12-28	WOS:000181488900046
J	Yoshino, T; Walter, MJ; Katsura, T				Yoshino, T; Walter, MJ; Katsura, T			Core formation in planetesimals triggered by permeable flow	NATURE			English	Article							OLIVINE	The tungsten isotope composition of meteorites indicates that core formation in planetesimals occurred within a few million years of Solar System formation(1,2). But core formation requires a mechanism for segregating metal, and the 'wetting' properties of molten iron alloy in an olivine-rich matrix is thought to preclude segregation by permeable flow unless the silicate itself is partially molten(3-5). Excess liquid metal over a percolation threshold, however, can potentially create permeability in a solid matrix, thereby permitting segregation. Here we report the percolation threshold for molten iron-sulphur compounds of approximately 5 vol.% in solid olivine, based on electrical conductivity measurements made in situ at high pressure and temperature. We conclude that heating within planetesimals by decay of short-lived radionuclides can increase temperature sufficiently above the iron-sulphur melting point (similar to1,000degreesC) to trigger segregation of iron alloy by permeable flow within the short time-frame indicated by tungsten isotopes. We infer that planetesimals with radii greater than about 30 km and larger planetary embryos are expected to have formed cores very early, and these objects would have contained much of the mass in the terrestrial region of the protoplanetary nebula. The Earth and other terrestrial planets are likely therefore to have formed by accretion of previously differentiated planetesimals, and Earth's core may accordingly be viewed as a blended composite of preformed cores.	Okayama Univ, Inst Study Earths Interior, Misasa, Tottori 6820193, Japan	Okayama University	Yoshino, T (corresponding author), Okayama Univ, Inst Study Earths Interior, Yamada 827, Misasa, Tottori 6820193, Japan.	tyoshino@misasa.okayama-u.ac.jp	Katsura, Tomoo/A-7483-2010; YOSHINO, Takashi/B-1899-2011; Katsura, Tomoo/ABC-1899-2021	Katsura, Tomoo/0000-0001-7857-5101; YOSHINO, Takashi/0000-0002-5422-7396; Katsura, Tomoo/0000-0001-7857-5101				Agee CB, 1997, PHYS EARTH PLANET IN, V100, P41, DOI 10.1016/S0031-9201(96)03230-X; Ballhaus C, 1996, EARTH PLANET SC LETT, V143, P137, DOI 10.1016/0012-821X(96)00135-5; Fei YW, 1997, SCIENCE, V275, P1621, DOI 10.1126/science.275.5306.1621; Gaetani GA, 1999, EARTH PLANET SC LETT, V169, P147, DOI 10.1016/S0012-821X(99)00062-X; HUTCHEON ID, 1989, NATURE, V337, P238, DOI 10.1038/337238a0; Jurewicz S, 1995, P LUNAR PLANET SCI C, V26, P709; KATSURA T, 1998, REV HIGH PRESSURE SC, V7, P18; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Kokubo E, 2000, ICARUS, V143, P15, DOI 10.1006/icar.1999.6237; Minarik WG, 1996, SCIENCE, V272, P530, DOI 10.1126/science.272.5261.530; Scott E. R. D., 1996, CHONDRULES PROTOPLAN, P87; Shannon MC, 1996, GEOPHYS RES LETT, V23, P2717, DOI 10.1029/96GL02817; SHUKOLYUKOV A, 1993, SCIENCE, V259, P1138, DOI 10.1126/science.259.5098.1138; SHUKOLYUKOV A, 1997, METEORITICS, V31, pA129; Stevenson DJ., 1990, ORIGIN EARTH, P231; TAYLOR GJ, 1992, J GEOPHYS RES, V97, P231; Taylor SR, 1992, SOLAR SYSTEM EVOLUTI; USSELMAN TM, 1975, AM J SCI, V275, P278, DOI 10.2475/ajs.275.3.278; VONBARGEN N, 1986, J GEOPHYS RES-SOLID, V91, P9261, DOI 10.1029/JB091iB09p09261; Weidenschilling SJ, 1997, ICARUS, V127, P290, DOI 10.1006/icar.1997.5712; WETHERILL GW, 1994, GEOCHIM COSMOCHIM AC, V58, P4513, DOI 10.1016/0016-7037(94)90352-2; Xu YS, 1998, SCIENCE, V280, P1415, DOI 10.1126/science.280.5368.1415; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	23	170	173	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					154	157		10.1038/nature01459	http://dx.doi.org/10.1038/nature01459			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634783				2022-12-28	WOS:000181488900042
J	Jayaraman, KS				Jayaraman, KS			India budgets for boost in research	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					6	6		10.1038/422006b	http://dx.doi.org/10.1038/422006b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621401	Bronze			2022-12-28	WOS:000181343100008
J	Pang, T				Pang, T			Complementary strategies for efficient use of knowledge for better health	LANCET			English	Editorial Material									WHO, Res Policy & Cooperat, CH-1211 Geneva, Switzerland	World Health Organization	Pang, T (corresponding author), WHO, Res Policy & Cooperat, CH-1211 Geneva, Switzerland.							Abbasi K, 2001, BRIT MED J, V323, P886, DOI 10.1136/bmj.323.7318.886; [Anonymous], 2001, NAT HLTH RES SYST RE; [Anonymous], MON FIN FLOWS HLTH R; Ferriman A, 2002, BRIT MED J, V325, P1194, DOI 10.1136/bmj.325.7374.1194; Godlee F, 2000, BRIT MED J, V321, P776, DOI 10.1136/bmj.321.7264.776; *HERG, 2002, 28 HERG; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; HYDEN G, 1995, DEV DIALOGUE, V2, P34; Malakoff D, 2001, SCIENCE, V293, P189; MUSUVENI Y, 1995, DEV DIALOGUE, V2, P7; Organisation for Economic Co-operation and Development, 2001, MEAS EXP HLTH REL R; Pang T, 2002, BMJ-BRIT MED J, V324, P499, DOI 10.1136/bmj.324.7336.499; World Health Organization, 2001, MACR HLTH INV HLTH E	13	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 1	2003	361	9359					716	716		10.1016/S0140-6736(03)12668-2	http://dx.doi.org/10.1016/S0140-6736(03)12668-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620734				2022-12-28	WOS:000181232000005
J	Ashraf, H				Ashraf, H			The people of Iraq face a grim future with or without a war	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					626	627		10.1016/S0140-6736(03)12620-7	http://dx.doi.org/10.1016/S0140-6736(03)12620-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12611387	Bronze			2022-12-28	WOS:000181129500004
J	Conway, G; Toenniessen, G				Conway, G; Toenniessen, G			Science for African food security	SCIENCE			English	Editorial Material							SOIL		Rockefeller Fdn, Food Secur Theme, New York, NY 10018 USA		Conway, G (corresponding author), Rockefeller Fdn, Food Secur Theme, New York, NY 10018 USA.							Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; [Anonymous], 2001, STAT FOOD INS WORLD; Banziger M, 2001, EUPHYTICA, V122, P503, DOI 10.1023/A:1017510928038; Conway G, 1999, DOUBLY GREEN REVOLUT; CONWAY G, 1997, FEEDING WORLD POPULA, P249; Delgado C.L., 1998, 107 IFPRI; DeVries J, 2001, SECURING HARVEST BIO; HENNO J, 1999, ESTIMATING RATES NUT; Herren Hans R., 1996, V15, P136; ININDA J, 2000, COORDINATED ECOSYSTE; Kanampiu F, 2002, PLANT CELL TISS ORG, V69, P105, DOI 10.1023/A:1015241509808; LANGAT M, 2000, MBILI UPDATE TESTING; Legg JP, 1999, CROP PROT, V18, P627, DOI 10.1016/S0261-2194(99)00062-9; Mwangi WM, 1997, NUTR CYCL AGROECOSYS, V47, P135; Nziguheba G, 1998, PLANT SOIL, V198, P159, DOI 10.1023/A:1004389704235; Palm CA, 2001, AGR ECOSYST ENVIRON, V83, P27, DOI 10.1016/S0167-8809(00)00267-X; Sanchez PA, 2002, SCIENCE, V295, P2019, DOI 10.1126/science.1065256; SEWARD PD, 1998, METHODS DEV INFRASTR; Wambugu F, 2001, BENEFITS BIOTECHNOLO; World Bank, 1986, POVERTY HUNGER ISSUE; *WORLD FOOD PROGR, 2002, WFP GLOB FOOD AID SH	21	44	46	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1187	1188		10.1126/science.1081978	http://dx.doi.org/10.1126/science.1081978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595678				2022-12-28	WOS:000181065500024
J	Hankins, TH; Kern, JS; Weatherall, JC; Eilek, JA				Hankins, TH; Kern, JS; Weatherall, JC; Eilek, JA			Nanosecond radio bursts from strong plasma turbulence in the Crab pulsar	NATURE			English	Article							GIANT PULSES; MILLISECOND PULSAR; EMISSION; CONVERSION	The Crab pulsar was discovered(1) by the occasional exceptionally bright radio pulses it emits, subsequently dubbed 'giant' pulses. Only two other pulsars are known to emit giant pulses(2,3). There is no satisfactory explanation for the occurrence of giant pulses, nor is there a complete theory of the pulsar emission mechanism in general. Competing models for the radio emission mechanism can be distinguished by the temporal structure of their coherent emission. Here we report the discovery of isolated, highly polarized, two-nanosecond sub-pulses within the giant radio pulses from the Crab pulsar. The plasma structures responsible for these emissions must be smaller than one metre in size, making them by far the smallest objects ever detected and resolved outside the Solar System, and the brightest transient radio sources in the sky. Only one of the current models-the collapse of plasma-turbulent wave packets in the pulsar magnetosphere-can account for the nanopulses we observe.	New Mexico Inst Min & Technol, Dept Phys, Socorro, NM 87801 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA	New Mexico Institute of Mining Technology; National Radio Astronomy Observatory (NRAO)	Hankins, TH (corresponding author), New Mexico Inst Min & Technol, Dept Phys, Socorro, NM 87801 USA.		Weatherall, James/ABG-6670-2021	Kern, Jeffrey/0000-0001-5019-4104; Weatherall, James C/0000-0001-7651-2510				ARENDT PN, IN PRESS ASTROPHYS J, V581; ASSEO E, 1990, MON NOT R ASTRON SOC, V247, P529; BENFORD G, 1977, MON NOT R ASTRON SOC, V179, P311, DOI 10.1093/mnras/179.3.311; BUSCHAUER R, 1976, MON NOT R ASTRON SOC, V177, P109, DOI 10.1093/mnras/177.1.109; Cairns IH, 2001, ASTROPHYS J, V563, pL65, DOI 10.1086/338359; Cognard I, 1996, ASTROPHYS J, V457, pL81, DOI 10.1086/309894; CORDES JM, 1976, ASTROPHYS J, V210, P780, DOI 10.1086/154887; DeLaney T, 1999, ASTROPHYS J, V519, P291, DOI 10.1086/307334; ELITZUR M, 1992, ASTRONOMICAL MASERS, P68; GOLDMAN MV, 1984, REV MOD PHYS, V56, P709, DOI 10.1103/RevModPhys.56.709; GOLDREICH P, 1969, ASTROPHYS J, V157, P869, DOI 10.1086/150119; Hankins T. H., 1975, METHODS COMPUTATIONA, V14, P55; HANKINS TH, 1971, ASTROPHYS J, V169, P487, DOI 10.1086/151164; Jenet FA, 2001, ASTROPHYS J, V558, P302, DOI 10.1086/322469; LUNDGREN SC, 1995, ASTROPHYS J, V453, P433, DOI 10.1086/176404; Lyutikov M, 1999, MON NOT R ASTRON SOC, V305, P338, DOI 10.1046/j.1365-8711.1999.02443.x; MORAN JM, 1981, B AM ASTRON SOC, V13, P508; Popov MV, 2002, ASTRON REP+, V46, P206, DOI 10.1134/1.1463098; RICKETT BJ, 1975, ASTROPHYS J, V197, P185, DOI 10.1086/153501; RICKETT BJ, 1981, IAU S, V95, P107; Romani RW, 2001, ASTROPHYS J, V557, pL93, DOI 10.1086/323415; Sallmen S, 1999, ASTROPHYS J, V517, P460, DOI 10.1086/307183; STAELIN DH, 1968, SCIENCE, V162, P1481, DOI 10.1126/science.162.3861.1481; Weatherall JC, 1997, ASTROPHYS J, V483, P402, DOI 10.1086/304222; Weatherall JC, 2001, ASTROPHYS J, V559, P196, DOI 10.1086/322404; Weatherall JC, 1998, ASTROPHYS J, V506, P341, DOI 10.1086/306218; ZAKHAROV VE, 1972, ZH EKSP TEOR FIZ, V35, P908	27	256	262	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					141	143		10.1038/nature01477	http://dx.doi.org/10.1038/nature01477			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634779				2022-12-28	WOS:000181488900038
J	Hari, P; Raivonen, M; Vesala, T; Munger, JW; Pilegaard, K; Kulmala, M				Hari, P; Raivonen, M; Vesala, T; Munger, JW; Pilegaard, K; Kulmala, M			Atmospheric science - Ultraviolet light and leaf emission of NOx	NATURE			English	Article							FLUX; CHEMISTRY		Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Riso Natl Lab, Plant Res Dept, DK-4000 Roskilde, Denmark	University of Helsinki; University of Helsinki; Harvard University; Technical University of Denmark	Hari, P (corresponding author), Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland.		Kulmala, Markku T/I-7671-2016; Munger, J William/H-4502-2013; Pilegaard, Kim/H-9026-2019; Pilegaard, Kim/I-7137-2013; Vesala, Timo/C-3795-2017	Kulmala, Markku T/0000-0003-3464-7825; Munger, J William/0000-0002-1042-8452; Pilegaard, Kim/0000-0002-5169-5717; Pilegaard, Kim/0000-0002-5169-5717; Vesala, Timo/0000-0002-4852-7464; Raivonen, Maarit/0000-0002-8987-4972				Altimir N, 2002, ATMOS ENVIRON, V36, P19, DOI 10.1016/S1352-2310(01)00478-2; CONRAD R, 1994, BIOGEOCHEMISTRY, V27, P155, DOI 10.1007/BF00000582; ESALA T, 1998, TRENDS HEAT MASS MOM, V4, P17; Hari P, 1999, PLANT CELL ENVIRON, V22, P1297, DOI 10.1046/j.1365-3040.1999.00478.x; Hereid DP, 2001, ATMOS ENVIRON, V35, P975, DOI 10.1016/S1352-2310(00)00342-3; Honrath RE, 2000, J GEOPHYS RES-ATMOS, V105, P24183, DOI 10.1029/2000JD900361; Lerdau MT, 2000, SCIENCE, V289, P2291, DOI 10.1126/science.289.5488.2291; RONDON A, 1994, TELLUS B, V46, P339, DOI 10.1034/j.1600-0889.1994.t01-4-00001.x; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; Sparks JP, 2001, OECOLOGIA, V127, P214, DOI 10.1007/s004420000594; Wildt J, 1997, J GEOPHYS RES-ATMOS, V102, P5919, DOI 10.1029/96JD02968	11	42	46	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					134	134		10.1038/422134a	http://dx.doi.org/10.1038/422134a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634774	Bronze			2022-12-28	WOS:000181488900033
J	Chen, MW; McCauley, JW; Hemker, KJ				Chen, MW; McCauley, JW; Hemker, KJ			Shock-induced localized amorphization in boron carbide	SCIENCE			English	Article							PRESSURE-INDUCED AMORPHIZATION; MOLECULAR-DYNAMICS; ROOM-TEMPERATURE; ALPHA-QUARTZ; CRYSTAL; STRAIN; SILICON; DEFORMATION; NANOWIRES	High-resolution electron microscope observations of shock-loaded boron carbide have revealed the formation of nanoscale intragranular amorphous bands that occur parallel to specific crystallographic planes and contiguously with apparent cleaved fracture surfaces. This damage mechanism explains the measured, but not previously understood, decrease in the ballistic performance of boron carbide at high impact rates and pressures. The formation of these amorphous bands is also an example of how shock loading can result in the synthesis of novel structures and materials with substantially altered properties.	Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; USA, Res Lab, Aberdeen Proving Ground, MD 21005 USA	Johns Hopkins University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Hemker, KJ (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.		CHEN, Mingwei/A-4855-2010; Hemker, Kevin J/A-3315-2010; Chen, Ming/GVU-8412-2022; Chen, Mingwei/A-4855-2010	CHEN, Mingwei/0000-0002-8274-3099; Chen, Mingwei/0000-0002-2850-8872				[Anonymous], 20 INT S BALL ORL FL; Bourne NK, 2002, P ROY SOC A-MATH PHY, V458, P1999, DOI 10.1098/rspa.2002.0968; Branicio PS, 2000, PHYS REV B, V62, P16950, DOI 10.1103/PhysRevB.62.16950; CLARKE DR, 1988, PHYS REV LETT, V60, P2156, DOI 10.1103/PhysRevLett.60.2156; CORDIER P, 1993, PHYS CHEM MINER, V20, P176; Dandekar, 2001, ARLTR2456; Deb SK, 2001, NATURE, V414, P528, DOI 10.1038/35107036; Domnich V, 2002, APPL PHYS LETT, V81, P3783, DOI 10.1063/1.1521580; Gooch W. A, 2002, 13 ANN GROUND VEH SU; Grady D., 1992, Shock Compression of Condensed Matter - 1991. Proceedings of the American Physical Society Topical Conference, P455; GRADY DE, 1980, J GEOPHYS RES, V85, P913, DOI 10.1029/JB085iB02p00913; Grady DE, 1995, 943266 SAND NAT LAB; GRATZ AJ, 1993, SCIENCE, V259, P663, DOI 10.1126/science.259.5095.663; HOLMQUIST TJ, 1999, 13754 TARDEC; Ikeda H, 1999, PHYS REV LETT, V82, P2900, DOI 10.1103/PhysRevLett.82.2900; Johnson GR, 1999, J APPL PHYS, V85, P8060, DOI 10.1063/1.370643; KINGMA KJ, 1993, SCIENCE, V259, P666, DOI 10.1126/science.259.5095.666; MANGHNANI M, 2001, INT C ADV CER GLASS; Mashimo T, 1997, J APPL PHYS, V81, P7064, DOI 10.1063/1.365229; McClellan KJ, 2001, J MATER SCI, V36, P3403, DOI 10.1023/A:1017947625784; MINOWA K, 1992, PHYS REV LETT, V69, P320, DOI 10.1103/PhysRevLett.69.320; Orphal DL, 1997, INT J IMPACT ENG, V19, P15, DOI 10.1016/S0734-743X(96)00004-8; RUH R, 1992, J AM CERAM SOC, V75, P864, DOI 10.1111/j.1151-2916.1992.tb04152.x; Sharma SM, 1996, PROG MATER SCI, V40, P1, DOI 10.1016/0079-6425(95)00006-2; Struzhkin VV, 2002, SCIENCE, V298, P1213, DOI 10.1126/science.1078535; TSE JS, 1991, PHYS REV LETT, V67, P3559, DOI 10.1103/PhysRevLett.67.3559; WANG JH, 1993, PHYS REV LETT, V71, P4182, DOI 10.1103/PhysRevLett.71.4182; YAKEL HL, 1975, ACTA CRYSTALLOGR B, V31, P1797, DOI 10.1107/S0567740875006267	28	419	427	5	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1563	1566		10.1126/science.1080819	http://dx.doi.org/10.1126/science.1080819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624264				2022-12-28	WOS:000181367900034
J	Lynch, HT; de la Chapelle, A				Lynch, HT; de la Chapelle, A			Genomic medicine - Hereditary colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FAMILIAL ADENOMATOUS POLYPOSIS; REPAIR GENE-MUTATIONS; ABL TYROSINE KINASE; MICROSATELLITE INSTABILITY; APC GENE; DESMOID TUMORS; COWDEN-DISEASE; HMLH1 PROMOTER; COLON-CANCER; INSTITUTE WORKSHOP		Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA	Creighton University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lynch, HT (corresponding author), Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, 2500 Calif Plaza, Omaha, NE 68178 USA.	htlynch@creighton.edu			NATIONAL CANCER INSTITUTE [U01CA086389, R01CA067941, P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA67941, 1U01 CA86389-01, P30 CA16058] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Aktan-Collan K, 2000, INT J CANCER, V89, P44, DOI 10.1002/(SICI)1097-0215(20000120)89:1<44::AID-IJC8>3.3.CO;2-V; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alexander J, 2001, AM J PATHOL, V158, P527, DOI 10.1016/S0002-9440(10)63994-6; ANDREWS L, 1995, AM J HUM GENET, V56, P327; Bjork J, 2001, GASTROENTEROLOGY, V121, P1127, DOI 10.1053/gast.2001.28707; Boland CR, 1998, CANCER RES, V58, P5248; BOMAN BM, 1999, P ASCO, V18, pA236; BRANCH P, 1995, NAT GENET, V9, P231, DOI 10.1038/ng0395-231; Brensinger JD, 1998, GUT, V43, P548, DOI 10.1136/gut.43.4.548; Burke C, 2001, GASTROENTEROLOGY, V121, P1246, DOI 10.1053/gast.2001.29265; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; BURN J, 1995, EUR J CANCER, V31A, P1385, DOI 10.1016/0959-8049(95)00185-L; Chadwick RB, 2000, P NATL ACAD SCI USA, V97, P2662, DOI 10.1073/pnas.040579497; Chadwick RB, 2001, J MED GENET, V38, P461, DOI 10.1136/jmg.38.7.461; Cho MK, 1999, AM J MED GENET, V83, P157, DOI 10.1002/(SICI)1096-8628(19990319)83:3<157::AID-AJMG4>3.0.CO;2-G; Cunningham JM, 1998, CANCER RES, V58, P3455; de la Chapelle A, 1999, EUR J HUM GENET, V7, P407, DOI 10.1038/sj.ejhg.5200335; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2001, NEW ENGL J MED, V345, P232; Duval A, 2001, HUM MOL GENET, V10, P513, DOI 10.1093/hmg/10.5.513; Eng C, 1998, AM J HUM GENET, V62, P1020, DOI 10.1086/301847; Eng C, 2002, ANNU REV MED, V53, pXI; Eng C, 2001, ANNU REV MED, V52, P371, DOI 10.1146/annurev.med.52.1.371; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fusaro RM, 1996, J TUMOR MARKER ONCOL, V11, P19; Giardiello FM, 1997, NEW ENGL J MED, V336, P823, DOI 10.1056/NEJM199703203361202; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herrera L, 1990, FAMILIAL ADENOMATOUS; HOULSTON RS, 1992, ANN HUM GENET, V56, P99, DOI 10.1111/j.1469-1809.1992.tb01136.x; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Huang J, 1996, P NATL ACAD SCI USA, V93, P9049, DOI 10.1073/pnas.93.17.9049; Ilyas M, 1999, EUR J CANCER, V35, P335, DOI 10.1016/S0959-8049(98)00431-6; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; JASS JR, 1992, GUT, V33, P783, DOI 10.1136/gut.33.6.783; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Jemal A, 2002, CA-CANCER J CLIN, V52, P119; Jemal A, 2002, CA-CANCER J CLIN, V52, P181; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kane MF, 1997, CANCER RES, V57, P808; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Konishi M, 1996, GASTROENTEROLOGY, V111, P307, DOI 10.1053/gast.1996.v111.pm8690195; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; LOTHE RA, 1993, CANCER RES, V53, P5849; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Lynch HT, 1996, AM J HUM GENET, V59, P1184; Lynch HT, 1998, AM J HUM GENET, V62, P1288, DOI 10.1086/301890; Lynch HT, 1996, AM J GASTROENTEROL, V91, P455; Lynch HT, 1996, AM J GASTROENTEROL, V91, P2598; LYNCH HT, 1995, CANCER, V75, P936, DOI 10.1002/1097-0142(19950215)75:4<936::AID-CNCR2820750407>3.0.CO;2-Q; Lynch HT, 1999, J MED GENET, V36, P801; Lynch HT, 1997, CANCER, V80, P614; Lynch HT, 1999, DIS COLON RECTUM, V42, P310, DOI 10.1007/BF02236344; Lynch HT, 1996, DIS COLON RECTUM, V39, P109, DOI 10.1007/BF02048279; LYNCH HT, 1994, DIS COLON RECTUM, V37, P260, DOI 10.1007/BF02048164; LYNCH HT, 1991, DIS COLON RECTUM, V34, P891, DOI 10.1007/BF02049703; LYNCH HT, 1995, CANCER, V76, P2427, DOI 10.1002/1097-0142(19951215)76:12<2427::AID-CNCR2820761205>3.0.CO;2-B; Lynch HT, 2001, CANCER, V91, P625, DOI 10.1002/1097-0142(20010215)91:4<625::AID-CNCR1044>3.0.CO;2-4; LYNCH HT, 2000, PRINCIPLES PRACTICE, P29; Lynch J, 1997, Semin Oncol Nurs, V13, P91, DOI 10.1016/S0749-2081(97)80005-8; Malkhosyan S, 1996, NATURE, V382, P499, DOI 10.1038/382499a0; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Matloff ET, 2000, J CLIN ONCOL, V18, P2484, DOI 10.1200/JCO.2000.18.12.2484; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; Nakagawa H, 2002, CANCER RES, V62, P4579; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; NystromLahti M, 1996, HUM MOL GENET, V5, P763, DOI 10.1093/hmg/5.6.763; Park YJ, 2000, CLIN CANCER RES, V6, P2994; PELTOMAKI P, 1993, CANCER RES, V53, P5853; Pokorski RJ, 1997, CANCER, V80, P627, DOI 10.1002/(SICI)1097-0142(19970801)80:3+<627::AID-CNCR13>3.0.CO;2-G; Polednak A P, 1998, Conn Med, V62, P3; Prior TW, 1999, GASTROENTEROLOGY, V116, P58, DOI 10.1016/S0016-5085(99)70229-5; Ramsey SD, 2001, ANN INTERN MED, V135, P577, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00008; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Rozen P, 1999, GASTROENTEROLOGY, V116, P54, DOI 10.1016/S0016-5085(99)70228-3; Salovaara, 2000, J CLIN ONCOL, V18, P3456; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Sankila R, 1996, GASTROENTEROLOGY, V110, P682, DOI 10.1053/gast.1996.v110.pm8608876; Shashidharan M, 1999, DIS COLON RECTUM, V42, P722, DOI 10.1007/BF02236925; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Smyrk TC, 2001, CANCER, V91, P2417, DOI 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.3.CO;2-L; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Thibodeau SN, 1998, CANCER RES, V58, P1713; Tonelli F, 2000, J SURG ONCOL, V74, P15, DOI 10.1002/1096-9098(200005)74:1<15::AID-JSO4>3.0.CO;2-Z; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Vogelstein B., 1998, GENETIC BASIS HUMAN; WATSON P, 1994, ANTICANCER RES, V14, P1635; Watson P, 1998, CANCER, V83, P259, DOI 10.1002/(SICI)1097-0142(19980715)83:2<259::AID-CNCR9>3.0.CO;2-L; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Wijnen J, 1999, NAT GENET, V23, P142, DOI 10.1038/13773; Williamson SLH, 1999, CARCINOGENESIS, V20, P805, DOI 10.1093/carcin/20.5.805; Wu Y, 2001, NAT GENET, V29, P137, DOI 10.1038/ng1001-137; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	106	1438	1517	4	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					919	932		10.1056/NEJMra012242	http://dx.doi.org/10.1056/NEJMra012242			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621137	Bronze			2022-12-28	WOS:000181341100008
J	Weiner, DL; Hibberd, PL; Betit, P; Cooper, AB; Botelho, CA; Brugnara, C				Weiner, DL; Hibberd, PL; Betit, P; Cooper, AB; Botelho, CA; Brugnara, C			Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	44th Annual Meeting of the American-Society-of-Hematology	DEC 06-10, 2002	PHILADELPHIA, PA	Amer Soc Hematol			HEMOGLOBIN; ARGININE; ENDOTHELIUM; VALIDATION; ACTIVATION; THERAPY; ANEMIA	Context Vaso-occlusion is central to the painful crises and acute and chronic organ damage in sickle cell disease. Abnormal nitric oxide-dependent regulation of vascular tone, adhesion, platelet activation, and inflammation contributes to the pathophysiology of vaso-occlusion. Nitric oxide may have promise as a mechanism-of-disease-based therapy for treatment of vaso-occlusion. Objective To explore the efficacy and safety of inhaled nitric oxide (INO) for treatment of vaso-occlusive crisis in pediatric patients. Design Prospective, double-blind, placebo-controlled, randomized clinical trial with enrollment between September 1999 and October 2001. Setting Urban, tertiary care children's hospital in the United States. Participants Twenty patients aged 10 to 21 years with sickle cell disease and severe acute vaso-occlusive crisis. Intervention Patients were randomly assigned to receive INO (80 ppm with 21% final concentration of inspired oxygen; n=10), or placebo (21% inspired oxygen; n=10) for 4 hours. Main Outcome Measures Change in pain at 4 hours of inhalation compared with preinhalation pain, measured on a 10-cm visual analog scale (VAS); secondary outcome measures were pain over 6 hours, parenteral narcotic use over 24 hours, duration of hospitalization, blood pressure, oxygen saturation, and methemoglobin concentration. Results Preinhalation VAS pain scores were similar in the INO and placebo groups (P=.80). The decrease in VAS pain scores at 4 hours was 2.0 cm in the I NO group and 1.2 cm in the placebo group (P=37). Repeated-measures analysis of variance for hourly pain scores showed a 1-cm/h greater reduction in the INO group than the placebo group (P=.02). Morphine use over 6 hours was significantly less in the INO group (mean cumulative use, 0.29 vs 0.44 mg/kg; P=.03) but was not different over 4 hours (0.26 vs 0.32 mg/kg; P=.21) or 24 hours (0.63 vs 0.91 mg/kg; P=.15). Duration of hospitalization was 78 and 100 hours in the INO and placebo groups, respectively (P=.19). No INO toxicity was observed. Conclusions Results of this exploratory study suggest that INO may be beneficial for acute vaso-occlusive crisis. These preliminary results warrant further investigation.	Childrens Hosp Boston, Clin Res Program, Boston, MA 02115 USA; Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Weiner, DL (corresponding author), Childrens Hosp Boston, Clin Res Program, 300 Longwood Ave, Boston, MA 02115 USA.	weiner_d@tch.harvard.edu	Cooper, Andrew/C-1655-2010; Brugnara, Carlo/A-8041-2010	Cooper, Andrew/0000-0001-6027-8272; Brugnara, Carlo/0000-0001-8192-8713; Hibberd, Patricia/0000-0002-7455-8117	NCRR NIH HHS [RR02172] Funding Source: Medline; FDA HHS [FD-R-001686] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); FDA HHS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		*AC PAIN MAN GUID, 1992, AC PAIN MAN OP MED P; Atz AM, 1997, ANESTHESIOLOGY, V87, P988, DOI 10.1097/00000542-199710000-00037; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Belhassen L, 2001, BLOOD, V97, P1584, DOI 10.1182/blood.V97.6.1584; Benjamin L. J., 2001, DISORDERS HEMOGLOBIN, P671; Butte AJ, 2000, J AM MED INFORM ASSN, P111; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Gladwin MT, 1999, J CLIN INVEST, V104, P937, DOI 10.1172/JCI7637; Gladwin MT, 2002, BRIT J HAEMATOL, V116, P436, DOI 10.1046/j.1365-2141.2002.03274.x; Gladwin MT, 2001, SEMIN HEMATOL, V38, P333, DOI 10.1053/shem.2001.27574; Glover RE, 1999, MOL PHARMACOL, V55, P1006, DOI 10.1124/mol.55.6.1006; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Hardwick WE, 1999, PEDIATR EMERG CARE, V15, P179, DOI 10.1097/00006565-199906000-00004; Head CA, 1997, J CLIN INVEST, V100, P1193, DOI 10.1172/JCI119631; Hebbel RP, 1997, J LAB CLIN MED, V129, P288, DOI 10.1016/S0022-2143(97)90176-1; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; HOLTZMAN S, 2000, AM SOC HEM DEC 4 SAN; Hrinczenko BW, 2000, BIOCHEM BIOPH RES CO, V275, P962, DOI 10.1006/bbrc.2000.3413; Kalweit GA, 2001, J THORAC CARDIOV SUR, V122, P1011, DOI 10.1067/mtc.2001.115158; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Lopez BL, 2000, AM J HEMATOL, V64, P15, DOI 10.1002/(SICI)1096-8652(200005)64:1<15::AID-AJH3>3.0.CO;2-P; Martinez-Ruiz R, 2001, ANESTHESIOLOGY, V94, P1113, DOI 10.1097/00000542-200106000-00028; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Morris CR, 2000, BRIT J HAEMATOL, V111, P498, DOI 10.1046/j.1365-2141.2000.02403.x; Morris CR, 2000, J PEDIAT HEMATOL ONC, V22, P515, DOI 10.1097/00043426-200011000-00009; Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099; PEPKEZABA J, 1991, LANCET, V338, P1173, DOI 10.1016/0140-6736(91)92033-X; Powars Darleen R., 1994, P395; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; ROBERTS JD, 1992, LANCET, V340, P818, DOI 10.1016/0140-6736(92)92686-A; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; Shapiro Barbara S., 1994, P531; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; Stork E, 1997, NEW ENGL J MED, V336, P597; Sullivan KJ, 1999, CRIT CARE MED, V27, P2563, DOI 10.1097/00003246-199911000-00039; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; TYLER DC, 1993, PAIN, V52, P301, DOI 10.1016/0304-3959(93)90163-J; Weiner DL, 2003, ANN EMERG MED, V41, P242, DOI 10.1067/mem.2003.52; Wun T, 1997, J LAB CLIN MED, V129, P507, DOI 10.1016/S0022-2143(97)90005-6	39	114	126	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1136	1142		10.1001/jama.289.9.1136	http://dx.doi.org/10.1001/jama.289.9.1136			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	650XM	12622584	Bronze			2022-12-28	WOS:000181289400030
J	Hebert, RS; Smith, CG; Wright, SM				Hebert, RS; Smith, CG; Wright, SM			Minimal prevalence of authorship misrepresentation among internal medicine residency applicants: Do previous estimates of "misrepresentation" represent insufficient case finding?	ANNALS OF INTERNAL MEDICINE			English	Article							GASTROENTEROLOGY FELLOWSHIPS; ACADEMIC ACCOMPLISHMENTS; RESEARCH CRITERIA; PUBLICATIONS	Background: High rates of authorship misrepresentation have been documented among medical trainees. Objective: To assess misrepresentation among internal medicine residency applicants while comparing searches used by previous authors (searches 1 and 2) to a more comprehensive strategy (search 3). Design: Review of 497 residency applications. Setting: Two university-based internal medicine residency programs. Measurements: Search 1 was limited to MEDLINE. Search 2 added Current Contents, Science Citation Index, and BIOSIS and included searching journals by hand. Search 3 added seven other databases and contacts to librarians, editors, and coauthors. Results: 224 applicants reported 634 articles; 630 (99%) were verified. The number of applicants with misrepresented citations varied depending on the search used (56 applicants [25%] in search 1 vs. 34 applicants [15%] in search 2 vs. 4 applicants [1.8%] in search 3). Conclusions: Using a comprehensive search, we found substantially less misrepresentation than had been reported. Previous studies probably overestimated the magnitude of the problem.	Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Harrison Med Lib, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Hebert, RS (corresponding author), Univ Pittsburgh, Div Gen Internal Med, 933W,MUH,200 Lothrop St, Pittsburgh, PA 15213 USA.	heberts@msx.upmc.edu	Smith, Cheri/B-3268-2008					Baker DR, 2000, ACAD RADIOL, V7, P727, DOI 10.1016/S1076-6332(00)80531-0; Barthel HR, 1996, ANN INTERN MED, V124, P456, DOI 10.7326/0003-4819-124-4-199602150-00019; Bilge A, 1998, ACAD MED, V73, P532, DOI 10.1097/00001888-199805000-00022; Dale JA, 1999, J BONE JOINT SURG AM, V81A, P1679; ENGLER RL, 1987, NEW ENGL J MED, V317, P1383, DOI 10.1056/NEJM198711263172205; Gurudevan SV, 1996, ANN EMERG MED, V27, P327, DOI 10.1016/S0196-0644(96)70268-8; Hammerschmidt DE, 1996, ANN INTERN MED, V124, P456, DOI 10.7326/0003-4819-124-4-199602150-00018; KIMBALL HR, 1995, ANN INTERN MED, V123, P58, DOI 10.7326/0003-4819-123-1-199507010-00009; McAlister WP, 2000, J BONE JOINT SURG AM, V82A, P1512, DOI 10.2106/00004623-200010000-00027; Panicek DM, 1998, AM J ROENTGENOL, V170, P577, DOI 10.2214/ajr.170.3.9490934; SEKAS G, 1995, ANN INTERN MED, V123, P38, DOI 10.7326/0003-4819-123-1-199507010-00006; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Young TA, 1997, CAN MED ASSOC J, V156, P219; 2001, ULRICHS PERIODICALS	14	28	28	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					390	392		10.7326/0003-4819-138-5-200303040-00008	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614091				2022-12-28	WOS:000181257300004
J	Harnden, A; Brueggemann, A; Shepperd, S; White, J; Hayward, AC; Zambon, M; Crook, D; Mant, D				Harnden, A; Brueggemann, A; Shepperd, S; White, J; Hayward, AC; Zambon, M; Crook, D; Mant, D			Near patient testing for influenza in children in primary care: comparison with laboratory test	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England; Univ Oxford, Acad Dept Microbiol & Infect Dis, Oxford OX3 9DU, England; UCL, Ctr Infect Dis Epidemiol, London NW3 2PF, England; Cent Publ Hlth Lab, Div Virus Reference, London NW9 5HT, England	University of Oxford; University of Oxford; University of London; University College London; Public Health England	Harnden, A (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Primary Hlth Care, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009; Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232; Shepperd, Sasha/0000-0001-6384-8322; Brueggemann, Angela/0000-0002-2329-1934				Carman WF, 2000, BRIT MED J, V321, P736, DOI 10.1136/bmj.321.7263.736; Delaney BC, 1999, BMJ-BRIT MED J, V319, P824, DOI 10.1136/bmj.319.7213.824; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Rodriguez WJ, 2002, PEDIATR INFECT DIS J, V21, P193, DOI 10.1097/00006454-200203000-00006; Zambon M., 1998, TXB INFLUENZA, P291	5	22	22	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					480	480		10.1136/bmj.326.7387.480	http://dx.doi.org/10.1136/bmj.326.7387.480			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609945	Green Published, Bronze			2022-12-28	WOS:000181421400019
J	Gibbs, RA; Nelson, DL				Gibbs, RA; Nelson, DL			Primate shadow play	SCIENCE			English	Editorial Material							SEQUENCE		Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine	Gibbs, RA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA.							[Anonymous], COMMUNICATION; Ansari-Lari MA, 1998, GENOME RES, V8, P29; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	6	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1331	1333		10.1126/science.1082931	http://dx.doi.org/10.1126/science.1082931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610290				2022-12-28	WOS:000181192300035
J	Knight, J				Knight, J			NASA seeks inspiration from microscopic views of life	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					878	878		10.1038/421878b	http://dx.doi.org/10.1038/421878b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606959	Bronze			2022-12-28	WOS:000181186900005
J	Rubin, RH; King, ME; Mark, EJ; Calderon, HA; Abramson, S; Gewirtz, H; Greene, RE				Rubin, RH; King, ME; Mark, EJ; Calderon, HA; Abramson, S; Gewirtz, H; Greene, RE			Case 7-2003: A 43-year-old man with fever, rapid loss of vision in the left eye, and cardiac findings - Pneumococcal pneumonia with endocarditis and endophthalmitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AORTIC-VALVE DISEASE; INFECTIVE ENDOCARDITIS; DIAGNOSIS; ABSCESS; NECROPSY; CRITERIA; ADULTS		Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; Harvard MIT Div Hlth Sci & Technol, Ctr Expt Pharmacol & therapeut, Cambridge, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Rubin, RH (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.							ARNETT EN, 1976, CIRCULATION, V54, P140, DOI 10.1161/01.CIR.54.1.140; Aronin SI, 1998, CLIN INFECT DIS, V26, P165, DOI 10.1086/516279; BAUM J, 1998, INFECT DIS, P1355; BLUMBERG EA, 1995, CHEST, V107, P898, DOI 10.1378/chest.107.4.898; DARE AJ, 1993, HUM PATHOL, V24, P1330, DOI 10.1016/0046-8177(93)90267-K; dUdekem Y, 1996, ANN THORAC SURG, V62, P48, DOI 10.1016/0003-4975(96)00274-3; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Felson B., 1973, CHEST ROENTGENOLOGY; FLEISCHNER FG, 1948, RADIOLOGY, V50, P184, DOI 10.1148/50.2.184; FLEISCHNER FG, 1927, ROFO FORTSCHR RONTG, V36, P319; FRASER RG, 1977, DIAGNOSIS DISEASES C, P342; Karchmer AW, 2001, HEART DIS TXB CARDIO, P1723; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MARRIE TJ, 1994, CLIN INFECT DIS, V18, P501, DOI 10.1093/clinids/18.4.501; MUFSON MA, 1967, AM J EPIDEMIOL, V86, P526, DOI 10.1093/oxfordjournals.aje.a120763; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; OKADA AA, 1994, OPHTHALMOLOGY, V101, P832; SANFORD JP, 1980, PULMONARY DIS DISORD, V2, P1130; SHRADER SK, 1990, J INFECT DIS, V162, P115, DOI 10.1093/infdis/162.1.115; Silver MD, 2001, CARDIOVASC PATHOL, V3rd, P443; STEINER I, 1995, CARDIOVASC PATHOL, V4, P207, DOI 10.1016/1054-8807(95)00001-L; TURRI M, 1990, EUR J CARDIO-THORAC, V4, P556, DOI 10.1016/1010-7940(90)90145-P; VIRMANI R, 1996, ATLAS CARDIOVASCULAR, P64	23	6	7	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					834	843		10.1056/NEJMcpc020032	http://dx.doi.org/10.1056/NEJMcpc020032			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606739				2022-12-28	WOS:000181173300011
J	Sugita, Y; Suzuki, Y				Sugita, Y; Suzuki, Y			Audiovisual perception - Implicit estimation of sound-arrival time	NATURE			English	Editorial Material									Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3004201, Japan; Tohoku Univ, Grad Sch Informat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; Tohoku University	Sugita, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Teragu Hakusan 1497-1, Tsukuba, Ibaraki 3004201, Japan.							McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669	3	141	142	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					911	911		10.1038/421911a	http://dx.doi.org/10.1038/421911a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606990	Bronze			2022-12-28	WOS:000181186900037
J	Hinrichs, KU; Hmelo, LR; Sylva, SP				Hinrichs, KU; Hmelo, LR; Sylva, SP			Molecular fossil record of elevated methane levels in late pleistocene coastal waters	SCIENCE			English	Article							SANTA-BARBARA BASIN; MARINE-SEDIMENTS; SUBDUCTION ZONE; GAS HYDRATE; OXIDATION; DISSOCIATION; PALEOCENE; LIPIDS; OCEAN; SEEPS	Accumulating evidence suggests that methane has been released episodically from hydrates trapped in sea floor sediments during many intervals of rapid climate warming. Here we show that sediments from the Santa Barbara Basin deposited during warm intervals in the last glacial period contain molecular fossils that are diagnostic of aerobic and anaerobic methanotrophs. Sediment intervals with high abundances of these compounds indicate episodes of vigorous methanotrophic activity in methane-laden water masses. Signals for anaerobic methanotrophy in 44, 100-year-old sediment are evidence for particularly intense methane emissions and suggest that the basin's methane cycle can profoundly affect oxygen budgets in the water column.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Hinrichs, KU (corresponding author), Univ Bremen, DFG Res Ctr Ocean Margins, POB 330 440, D-28334 Bremen, Germany.	khinrichs@uni-bremen.de	Sylva, Sean/D-4400-2014; Hinrichs, Kai-Uwe/C-7675-2009	Sylva, Sean/0000-0002-4727-440X; Hinrichs, Kai-Uwe/0000-0002-0739-9291				Behl R. J., 1995, P OCEAN DRILL PROGRA, V146, P295; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Bohrmann G, 1998, GEOLOGY, V26, P647, DOI 10.1130/0091-7613(1998)026<0647:ACFTCS>2.3.CO;2; Clark JF, 2000, J GEOPHYS RES-OCEANS, V105, P11509, DOI 10.1029/2000JC000259; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dickens GR, 2001, ORG GEOCHEM, V32, P1179, DOI 10.1016/S0146-6380(01)00086-9; Dickens GR, 2000, B SOC GEOL FR, V171, P37; Elvert M, 2000, ORG GEOCHEM, V31, P1175, DOI 10.1016/S0146-6380(00)00111-X; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HEESCHEN K, 2002, GEOL SOC AM ABSTR, V34, P35231; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hinrichs KU, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000286; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hinrichs KU, 2000, ORG GEOCHEM, V31, P1685, DOI 10.1016/S0146-6380(00)00106-6; Hinrichs KU, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; HINRICHS KU, UNPUB; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Kennett JP, 2003, METHANE HYDRATES QUA; Kuwabara JS, 1999, GEOCHIM COSMOCHIM AC, V63, P2199, DOI 10.1016/S0016-7037(99)00084-8; LANGWORTHY TA, 1986, SYST APPL MICROBIOL, V7, P253; Pancost RD, 2001, ORG GEOCHEM, V32, P695, DOI 10.1016/S0146-6380(01)00015-8; REEBURGH WS, 1991, DEEP-SEA RES, V38, pS1189; ROHMER M, 1984, J GEN MICROBIOL, V130, P1137; Schimmelmann A, 1991, GLOBAL BIOGEOCHEM CY, V5, P173, DOI 10.1029/91GB00382; Stott LD, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000196; SUMMONS RE, 1994, GEOCHIM COSMOCHIM AC, V58, P2853, DOI 10.1016/0016-7037(94)90119-8; VANGEEN A, 1995, PALEOCEANOGRAPHY, V10, P159, DOI 10.1029/94PA03352; WAKEHAM SG, IN PRESS GEOCHIM COS; WARD BB, 1987, NATURE, V327, P226, DOI 10.1038/327226a0; WEFER G, 1994, NATURE, V369, P282, DOI 10.1038/369282a0	30	83	95	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1214	1217		10.1126/science.1079601	http://dx.doi.org/10.1126/science.1079601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595688				2022-12-28	WOS:000181065500035
J	Vale, RD				Vale, RD			The molecular motor toolbox for intracellular transport	CELL			English	Review							FAST AXONAL-TRANSPORT; KINESIN SUPERFAMILY PROTEIN; AMYLOID PRECURSOR PROTEIN; CYTOPLASMIC DYNEIN; DYNACTIN COMPLEX; MYOSIN-V; CHEMOSENSORY NEURONS; MEMBRANE-TRANSPORT; TUMOR-SUPPRESSOR; MONOMERIC MOTOR	Eukaryotic cells create internal order by using protein motors to transport molecules and organelles along cytoskeletal tracks. Recent genomic and functional studies suggest that five cargo-carrying motors emerged in primitive eukaryotes and have been widely used throughout evolution. The complexity of these "Toolbox" motors expanded in higher eukaryotes through gene duplication, alternative splicing, and the addition of associated subunits, which enabled new cargoes to be transported. Remarkably, fungi, parasites, plants, and animals have distinct subsets of Toolbox motors in their genomes, suggesting an underlying diversity of strategies for intracellular transport.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	vale@phy.ucsf.edu						ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; Anikster Y, 2002, AM J HUM GENET, V71, P407, DOI 10.1086/341606; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bloom K, 2001, CURR BIOL, V11, pR326, DOI 10.1016/S0960-9822(01)00176-2; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; CYR JL, 1991, P NATL ACAD SCI USA, V88, P10114, DOI 10.1073/pnas.88.22.10114; De Marco V, 2001, EMBO J, V20, P3370, DOI 10.1093/emboj/20.13.3370; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Erickson HP, 2001, CURR OPIN CELL BIOL, V13, P55, DOI 10.1016/S0955-0674(00)00174-5; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; Gong TWL, 1999, GENE, V239, P117, DOI 10.1016/S0378-1119(99)00370-4; Grissom PM, 2002, MOL BIOL CELL, V13, P817, DOI 10.1091/mbc.01-08-0402; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hakimi MA, 2002, J BIOL CHEM, V277, P36909, DOI 10.1074/jbc.C200434200; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hurd DD, 1996, GENETICS, V144, P1075; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 2002, TRAFFIC, V3, P930, DOI 10.1034/j.1600-0854.2002.31208.x; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; KLOPFENSTEIN DR, 2003, IN PRESS J MUSCLE RE; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Langford GM, 2002, TRAFFIC, V3, P859, DOI 10.1034/j.1600-0854.2002.31202.x; Lawrence CJ, 2001, TRAFFIC, V2, P362, DOI 10.1034/j.1600-0854.2001.25020508.x; Lehmler C, 1997, EMBO J, V16, P3464, DOI 10.1093/emboj/16.12.3464; Li JY, 2000, J NEUROSCI RES, V61, P151, DOI 10.1002/1097-4547(20000715)61:2<151::AID-JNR6>3.3.CO;2-E; Macho B, 2002, SCIENCE, V298, P2388, DOI 10.1126/science.1077265; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Morimatsu M, 2000, BIOCHEM BIOPH RES CO, V270, P147, DOI 10.1006/bbrc.2000.2391; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Neuwald AF, 1999, GENOME RES, V9, P27; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Pollock N, 1999, J CELL BIOL, V147, P493, DOI 10.1083/jcb.147.3.493; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Reddy ASN, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-7-research0024; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Seiler S, 2000, NAT CELL BIOL, V2, P333, DOI 10.1038/35014022; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Tabb JS, 1998, J CELL SCI, V111, P3221; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; TYNAN SH, 1997, ANNU REV CELL DEV BI, V13, P745; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vallee RB, 2001, TRENDS CELL BIOL, V11, P155, DOI 10.1016/S0962-8924(01)01956-0; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2001, CURR OPIN MICROBIOL, V4, P634, DOI 10.1016/S1369-5274(01)00262-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Warita H, 1999, BRAIN RES, V819, P120, DOI 10.1016/S0006-8993(98)01351-1; Wedlich-Soldner R, 2002, EMBO J, V21, P2946, DOI 10.1093/emboj/cdf296; Win TZ, 2002, CELL MOTIL CYTOSKEL, V51, P53, DOI 10.1002/cm.10021; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Xu Y, 2002, J CELL BIOL, V158, P293, DOI 10.1083/jcb.200202058; Yang ZH, 2001, MOL CELL BIOL, V21, P5306, DOI 10.1128/MCB.21.16.5306-5311.2001; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	113	1424	1472	1	347	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 21	2003	112	4					467	480		10.1016/S0092-8674(03)00111-9	http://dx.doi.org/10.1016/S0092-8674(03)00111-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600311	Bronze			2022-12-28	WOS:000181252600006
J	Studdert, DM; Gresenz, CR				Studdert, DM; Gresenz, CR			Enrollee appeals of preservice coverage denials at 2 health maintenance organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED CARE BACKLASH; MEDICAL NECESSITY; PHYSICIAN ORGANIZATIONS; PROVIDER ORGANIZATIONS; DECISION-MAKING; CALIFORNIA; IMPACT; COSTS	Context Congress and state legislatures are considering patient bills of rights that seek to strengthen opportunities for patients to have denials of coverage reconsidered by their health plans. Little is publicly known about such appeals systems. Objective To improve understanding of the sources, types, and outcomes of conflicts between patients and managed care organizations over coverage of services. Design and Setting Descriptive study of information abstracted from 1774 preservice appeals out of a larger stratified random sample of 3519 appeals lodged between January 1998 and June 2000 at 2 large US health maintenance organizations. Main Outcome Measures Classification of preservice appeals according to whether they contested access to out-of-network care, the contractual limits of coverage, or the medical necessity of services; analysis of contractual coverage and medical necessity appeals by the services in dispute and out-of-network appeals by enrollees' reasons for seeking care; and comparison of the proportions of appeals won by enrollees across types of appeals and services. Results Approximately one third (36.9%) of preservice appeals involved medical necessity determinations, another third (36.6%) centered on the scope of contractually covered benefits, and most of the remainder (19.7%) involved out-of-network care. Enrollee wins were significantly more frequent among medical necessity appeals than out-of-network or contractual coverage appeals (52.2% vs 35.4% and 33.2%, respectively; P<001). Appeals were concentrated among relatively few services and among therapies that are generally regarded as nonessential. Conclusions A majority of preservice appeals disputed choice of provider or contractual coverage issues, rather than medical necessity. Medical necessity disputes proliferate not around life-saving treatments but in areas of societal uncertainty about the legitimate boundaries of insurance coverage. Greater transparency about the coverage status of specific services, through more precise contractual language and consumer education about benefits limitations, may help to avoid a large proportion of disputes in managed care.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; RAND, Arlington, VA USA	Harvard University; Harvard T.H. Chan School of Public Health; RAND Corporation	Studdert, DM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS011285] Funding Source: NIH RePORTER; AHRQ HHS [KO2HS11285] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*ADV COMM CONS PRO, 1997, CONS BILL RIGHTS RES; *AM BAR ASS AM MED, 1998, COMM HLTH CAR DISP R; American Medical Association, 2000, MOD MAN CAR CONTR; ANNAS GJ, 1995, NEW ENGL J MED, V333, P1647, DOI 10.1056/NEJM199512143332420; BERTHGOLD LA, 1995, HLTH AFF MILLWOOD, V14, P180; Blendon RJ, 1998, HEALTH AFFAIR, V17, P80, DOI 10.1377/hlthaff.17.4.80; Charles C, 1997, MILBANK Q, V75, P365, DOI 10.1111/1468-0009.00060; COURT J, 1999, MAKING KILLING HMOS; Eddy DM, 1996, JAMA-J AM MED ASSOC, V275, P650, DOI 10.1001/jama.275.8.650; Emanuel EJ, 1998, J HEALTH POLIT POLIC, V23, P635; Enthoven AC, 1998, HEALTH AFFAIR, V17, P95, DOI 10.1377/hlthaff.17.4.95; Glassman PA, 1997, ANN INTERN MED, V126, P152, DOI 10.7326/0003-4819-126-2-199701150-00011; Gold MR, 2001, HEALTH AFFAIR, V20, P175, DOI 10.1377/hlthaff.20.2.175; Gresenz CR, 2002, HEALTH AFFAIR, V21, P189, DOI 10.1377/hlthaff.21.4.189; HALL MA, 1992, U PENN LAW REV, V140, P1636; HAVIGHURST CC, 1995, HLTH CARE CHOICES PR; HENSLER DR, 1991, PUBLICATION RAND; *HJ KAIS FAM FDN, 2002, TRENDS IND CHANG HLT; HURLEY RE, 1991, INQUIRY-J HEALTH CAR, V28, P375; HYMAN DA, 1998, VILL L REV, V43, P409; Jacobson PD, 1997, INQUIRY-J HEALTH CAR, V34, P143; KARP N, 2000, UNDERSTANDING HLTH P; Kesselheim AS, 2001, U PENN LAW REV, V149, P873, DOI 10.2307/3312872; KINNEY ED, 2002, PORTECTING AM HLTH C; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Miller TE, 1998, J LAW MED ETHICS, V26, P89, DOI 10.1111/j.1748-720X.1998.tb01665.x; MOORE SH, 1983, NEW ENGL J MED, V309, P1400, DOI 10.1056/NEJM198312013092239; *NAT ASS INS COMM, 2001, PROH US DISCR CLAUS; POLLITZ K, 2002, ASSESSING STATE EXTE; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; RICHARDSON DA, 1993, STUDY COVERAGE DENIA; ROBINSON JC, 1995, NEW ENGL J MED, V333, P1684, DOI 10.1056/NEJM199512213332506; Rosenbaum S, 1999, NEW ENGL J MED, V340, P229, DOI 10.1056/NEJM199901213400312; Rosenblatt L, 1999, AM J MANAG CARE, V5, P1525; Rosenthal MB, 2001, HEALTH AFFAIR, V20, P109, DOI 10.1377/hlthaff.20.4.109; Rosenthal MB, 2001, HEALTH AFFAIR, V20, P187, DOI 10.1377/hlthaff.20.5.187; SABIN JE, 1994, HASTINGS CENT REP, V24, P5, DOI 10.2307/3563458; Schauffler HH, 2001, MED CARE, V39, P15, DOI 10.1097/00005650-200101000-00004; Singer SJ, 2001, HEALTH AFFAIR, V20, P200, DOI 10.1377/hlthaff.20.1.200; Studdert DM, 1999, HEALTH AFFAIR, V18, P7, DOI 10.1377/hlthaff.18.6.7; Studdert DM, 2002, AM J EPIDEMIOL, V156, P219, DOI 10.1093/aje/kwf032; Tintinalli JE, 2000, ANN EMERG MED, V35, P291, DOI 10.1016/S0196-0644(00)70083-7; *US GEN ACC OFF, 1996, PUBL US GEN ACC OFF; *US GEN ACC OFF, 1998, PUBL US GEN ACC OFF; 2000, FED REG, V65, P70246	45	18	18	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					864	870		10.1001/jama.289.7.864	http://dx.doi.org/10.1001/jama.289.7.864			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647BW	12588270	Bronze			2022-12-28	WOS:000181072200030
J	Ioannidis, JPA; Trikalinos, TA; Ntzani, EE; Contopoulos-Ioannidis, DG				Ioannidis, JPA; Trikalinos, TA; Ntzani, EE; Contopoulos-Ioannidis, DG			Genetic associations in large versus small studies: an empirical assessment	LANCET			English	Article							PUBLICATION BIAS; SYSTEMATIC REVIEWS; LARGE TRIALS; METAANALYSIS; POLYMORPHISMS; DISEASES; TIME	Background Advances in human genetics could help us to assess prognosis on an individual basis and to optimise the management of complex diseases. However, different studies on the same genetic association sometimes have discrepant results. Our aim was to assess how often large studies arrive at different conclusions than smaller studies, and whether this situation arises more frequently when findings of first published studies disagree with those of subsequent research. Methods We examined the results of 55 meta-analyses (579 study comparisons) of genetic associations and tested whether the magnitude of the genetic effect differs in large versus smaller studies. Findings We noted significant between-study heterogeneity in 26 (47%) meta-analyses. The magnitude of the genetic effect differed significantly in large versus smaller studies in ten (18%), 20 (36%), and 21 (38%) meta-analyses with tests of rank correlation, regression on SE, and regression on inverse of variance, respectively. The largest studies generally yielded more conservative results than the complete meta-analyses, which included all studies (p=0.005). In 14 (26%) meta-analyses the proposed association was significantly stronger in the first studies than in subsequent research. Only in nine (16%) meta-analyses was the genetic association significant and replicated without hints of heterogeneity or bias. There was little concordance in first versus subsequent discrepancies, and large versus small discrepancies. Interpretation Genuine heterogeneity and bias could affect the results of genetic association studies. Genetic risk factors for complex diseases should be assessed cautiously and, if possible, using large scale evidence.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Univ Ioannina, Sch Med, Dept Paediat, GR-45110 Ioannina, Greece; Fdn Res & Technol Hellas, Inst Biomed Res, Ioannina, Greece; Tufts Univ New England Med Ctr, Div Clin Care Res, Boston, MA USA; George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA	University of Ioannina; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; George Washington University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011; Trikalinos, Thomas A/A-1217-2009; Ntzani, Evangelina E./K-1565-2019	Ntzani, Evangelia/0000-0003-3712-4181				BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Begg CB, 2002, J NATL CANCER I, V94, P1221; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Gambaro G, 2000, LANCET, V355, P308, DOI 10.1016/S0140-6736(99)07202-5; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Heo M, 2001, GENETICS, V159, P1163; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; JELSEY JL, 1996, METHODS OBSERVATIONA; Khoury MJ, 2000, AM J EPIDEMIOL, V151, P2; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; MANTEL N, 1959, J NATL CANCER I, V22, P719; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8	34	472	480	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					567	571		10.1016/S0140-6736(03)12516-0	http://dx.doi.org/10.1016/S0140-6736(03)12516-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598142				2022-12-28	WOS:000181033400010
J	Krasilnikov, AS; Yang, XJ; Pan, T; Mondragon, A				Krasilnikov, AS; Yang, XJ; Pan, T; Mondragon, A			Crystal structure of the specificity domain of ribonuclease P	NATURE			English	Article							SUBTILIS RNASE-P; IN-VITRO SELECTION; PRE-TRANSFER-RNA; MACROMOLECULAR STRUCTURES; TERTIARY INTERACTIONS; RIBOZYME; RECOGNITION; EVOLUTION; SUBSTRATE; SUBUNIT	RNase P is the only endonuclease responsible for processing the 5' end of transfer RNA by cleaving a precursor and leading to tRNA maturation(1,2). It contains an RNA component and a protein component and has been identified in all organisms. It was one of the first catalytic RNAs identified(3) nd the first that acts as a multiple-turnover enzyme in vivo. RNase P and the ribosome are so far the only two ribozymes known to be conserved in all kingdoms of life. The RNA component of bacterial RNase P can catalyse pre-tRNA cleavage in the absence of the RNase P protein in vitro and consists of two domains: a specificity domain and a catalytic domain(4,5). Here we report a 3.15-Angstrom resolution crystal structure of the 154-nucleotide specificity domain of Bacillus subtilis RNase P. The structure reveals the architecture of this domain, the interactions that maintain the overall fold of the molecule, a large non-helical but well-structured module that is conserved in all RNase P RNA, and the regions that are involved in interactions with the substrate.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu						Altman S., 1999, RNA WORLD, P351; Barrera A, 2002, BIOCHEMISTRY-US, V41, P12986, DOI 10.1021/bi020416k; Brown JW, 1999, NUCLEIC ACIDS RES, V27, P314, DOI 10.1093/nar/27.1.314; Brown JW, 1996, P NATL ACAD SCI USA, V93, P3001, DOI 10.1073/pnas.93.7.3001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen JL, 1997, RNA, V3, P557; Chen JL, 1998, EMBO J, V17, P1515, DOI 10.1093/emboj/17.5.1515; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 1997, EMBO J, V16, P3289, DOI 10.1093/emboj/16.11.3289; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Frank DN, 2000, RNA, V6, P1895, DOI 10.1017/S1355838200001461; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Loria A, 1997, BIOCHEMISTRY-US, V36, P6317, DOI 10.1021/bi970115o; Loria A, 1996, RNA, V2, P551; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; NOLAN JM, 1993, SCIENCE, V261, P762, DOI 10.1126/science.7688143; Odell L, 1998, NUCLEIC ACIDS RES, V26, P3717, DOI 10.1093/nar/26.16.3717; PAN T, 1995, BIOCHEMISTRY-US, V34, P8458, DOI 10.1021/bi00026a029; Pan T, 1995, P NATL ACAD SCI USA, V92, P12510, DOI 10.1073/pnas.92.26.12510; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; Qin H, 2001, BIOCHEMISTRY-US, V40, P11202, DOI 10.1021/bi010076n; TANNER MA, 1995, RNA, V1, P349	29	188	201	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					760	764		10.1038/nature01386	http://dx.doi.org/10.1038/nature01386			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610630				2022-12-28	WOS:000180938000048
J	Messenger, S; Keller, LP; Stadermann, FJ; Walker, RM; Zinner, E				Messenger, S; Keller, LP; Stadermann, FJ; Walker, RM; Zinner, E			Samples of stars beyond the solar system: Silicate grains in interplanetary dust	SCIENCE			English	Article							ISOTOPIC COMPOSITION; OXYGEN ISOTOPES; PRESOLAR; CORUNDUM; NUCLEOSYNTHESIS; IDENTIFICATION; ORIGINS; AL2O3	We have identified six circumstellar silicate grains within interplanetary dust particles (IDPs). Their extrasolar origins are demonstrated by their extremely anomalous oxygen isotopic compositions. Three O-17-rich grains appear to originate from red giant or asymptotic giant branch stars. One O-16-rich grain may be from a metal-poor star. Two O-16-poor grains have unknown stellar sources. One of the grains is forsterite, and two are amorphous silicate "GEMS" (glass with embedded metal and sulfides), which is consistent with astronomical identifications of crystalline and amorphous silicates in the outflows of evolved stars. These observations suggest cometary origins of these IDPs and underscore the perplexing absence of silicates among circumstellar dust grains from meteorites.	Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; Washington Univ, Dept Phys, St Louis, MO 63130 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Washington University (WUSTL); Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Messenger, S (corresponding author), Washington Univ, Space Sci Lab, St Louis, MO 63130 USA.							ALEXANDER CMO, 2001, LUNAR PLANET SCI, V32, P2191; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bradley J, 1996, ASTR SOC P, V104, P275; Bradley J. P., 1988, METEORITES EARLY SOL, P861; Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; BRADLEY JP, 1983, NATURE, V301, P473, DOI 10.1038/301473a0; Choi BG, 1998, SCIENCE, V282, P1284, DOI 10.1126/science.282.5392.1284; Choi BG, 1999, ASTROPHYS J, V522, pL133, DOI 10.1086/312239; ENGRAND C, 1999, LUNAR PLANET SCI, V30, pA1690; ESAT TM, 1979, SCIENCE, V206, P190, DOI 10.1126/science.206.4415.190; Harker DE, 2002, ASTROPHYS J, V565, pL109, DOI 10.1086/339363; HUSS GR, 1994, ASTROPHYS J, V430, pL81, DOI 10.1086/187443; HUTCHEON ID, 1994, ASTROPHYS J, V425, pL97, DOI 10.1086/187319; Keller LP, 2000, J GEOPHYS RES-SPACE, V105, P10397, DOI 10.1029/1999JA900395; Kemper F, 2001, ASTRON ASTROPHYS, V369, P132, DOI 10.1051/0004-6361:20010086; KRESTINA N, 2002, LUNAR PLANET SCI, V33, pA1425; Li A, 2001, ASTROPHYS J, V550, pL213, DOI 10.1086/319640; MCKEEGAN KD, 1987, SCIENCE, V237, P1468, DOI 10.1126/science.237.4821.1468; MCKEEGAN KD, 1987, THESIS WASHINGTON U; Messenger S, 2000, METEORIT PLANET SCI, V35, pA109; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2002, METEORIT PLANET SCI, V37, P1491, DOI 10.1111/j.1945-5100.2002.tb00806.x; Messenger S, 1997, AIP CONF PROC, P545, DOI 10.1063/1.53336; MOLSTER FJ, 2002, LUNAR PLANET SCI, V33, pA1471; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; NITTLER LR, 2003, LUNAR PLANET SCI, V34; Sandford S. A., 1987, Fundamentals of Cosmic Physics, V12, P1; STADERMANN FJ, 1991, THESIS U HEIDELBERG; WASSERBURG GJ, 1995, ASTROPHYS J, V447, pL37, DOI 10.1086/309555; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361; Waters LBFM, 2000, ASTR SOC P, V196, P3; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147; ZINNER E, UNPUB	34	321	327	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					105	108		10.1126/science.1080576	http://dx.doi.org/10.1126/science.1080576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12610229				2022-12-28	WOS:000181988900041
J	Abbott, A				Abbott, A			Danish biotech centre faces axe	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					105	105		10.1038/422105b	http://dx.doi.org/10.1038/422105b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634749	Bronze			2022-12-28	WOS:000181488900012
J	Mietto, P; Avanzini, M; Rolandi, G				Mietto, P; Avanzini, M; Rolandi, G			Palaeontology: Human footprints in Pleistocene volcanic ash	NATURE			English	Article									Univ Padua, Dipartimento Geol Paleontol & Geofis, I-35137 Padua, Italy; Museo Tridentino Sci Nat, I-38100 Trent, Italy; Univ Naples, Dipartimento Geofis & Vulcanol, I-80138 Naples, Italy	University of Padua; University of Naples Federico II	Mietto, P (corresponding author), Univ Padua, Dipartimento Geol Paleontol & Geofis, I-35137 Padua, Italy.							Ballini A., 1989, B GRUPPO NAZL VULCAN, V2, P533; DERITA D, 1996, J VOLCANOL GEOTHERM, V78, P2267; Kramer PA, 2000, J HUM EVOL, V38, P651, DOI 10.1006/jhev.1999.0375	3	53	57	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					133	133		10.1038/422133a	http://dx.doi.org/10.1038/422133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654HG	12634773	Bronze			2022-12-28	WOS:000181488900032
J	Treiner, E; Duban, L; Bahram, S; Radosavljevic, M; Wanner, V; Tilloy, F; Affaticati, P; Gilfillan, S; Lantz, O				Treiner, E; Duban, L; Bahram, S; Radosavljevic, M; Wanner, V; Tilloy, F; Affaticati, P; Gilfillan, S; Lantz, O			Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1	NATURE			English	Article							MHC CLASS-I; POSITIVE SELECTION; HEMATOPOIETIC-CELLS; MUTANT MICE; MU-CHAIN; GENE; MOUSE; GENERATION; EXPRESSION; BINDING	The evolutionary conservation of T lymphocyte subsets bearing T-cell receptors (TCRs) using invariant alpha-chains is indicative of unique functions. CD1d-restricted natural killer T (NK-T) cells that express an invariant Valpha14 TCRalpha chain have been implicated in microbial and tumour responses, as well as in auto-immunity(1,2) Here we show that T cells that express the canonical hValpha7.2-Jalpha33 or mValpha19-Jalpha33 TCR rearrangement' are preferentially located in the gut lamina propria of humans and mice, respectively, and are therefore genuine mucosal-associated invariant T (MAIT) cells. Selection and/or expansion of this population requires B lymphocytes, as MAIT cells are absent in B-cell-deficient patients and mice. In addition, we show that MAIT cells are selected and/or restricted by MR1, a monomorphic major histocompatibility complex class I-related molecule that is markedly conserved in diverse mammalian species'. MAIT cells are not present in germfree mice, indicating that commensal flora is required for their expansion in the gut lamina propria. This indicates that MAIT cells are probably involved in the host response at the site of pathogen entry, and may regulate intestinal B-cell activity.	Inst Curie, Immunol Lab, F-75005 Paris, France; Inst Curie, INSERM, U520, F-75005 Paris, France; Ctr Rech Immunol & Hematol, CReS, INSERM, F-67085 Strasbourg, France; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Washington University (WUSTL)	Lantz, O (corresponding author), Inst Curie, Immunol Lab, F-75005 Paris, France.		Lantz, Olivier J/J-4960-2012; Bahram, Seiamak/GZA-7150-2022	Lantz, Olivier J/0000-0003-3161-7719; Bahram, Seiamak/0000-0002-6928-9952; Radosavljevic, Mirjana/0000-0003-3925-0640				Arstila T, 2000, J EXP MED, V191, P823, DOI 10.1084/jem.191.5.823; ASARNOW DM, 1993, NATURE, V362, P158, DOI 10.1038/362158a0; Bahram S, 2000, Adv Immunol, V76, P1; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENVENISTE J, 1971, J IMMUNOL, V107, P1656; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; JAKOBOVITS A, 1993, P NATL ACAD SCI USA, V90, P2551, DOI 10.1073/pnas.90.6.2551; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lee N, 1998, J IMMUNOL, V160, P4951; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJS, 2001, NAT IMMUNOL, V2, P625, DOI 10.1038/89775; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; Riegert P, 1998, J IMMUNOL, V161, P4066; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Tourne S, 1996, P NATL ACAD SCI USA, V93, P1464, DOI 10.1073/pnas.93.4.1464; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; Ugolini S, 2001, NAT IMMUNOL, V2, P198, DOI 10.1038/85246; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3	30	737	760	3	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					164	169		10.1038/nature01433	http://dx.doi.org/10.1038/nature01433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634786				2022-12-28	WOS:000181488900045
J	Gurwitz, JH; Field, TS; Harrold, LR; Rothschild, J; Debellis, K; Seger, AC; Cadoret, C; Garber, L; Kelleher, M; Bates, DW				Gurwitz, JH; Field, TS; Harrold, LR; Rothschild, J; Debellis, K; Seger, AC; Cadoret, C; Garber, L; Kelleher, M; Bates, DW			Incidence and preventability of adverse drug events among older persons in the ambulatory setting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICATION ERRORS; ELDERLY PATIENTS; UNITED-STATES; MEDICINE; QUALITY; PRESCRIPTION; POPULATION; DEATHS; SAFETY; COSTS	Context Adverse drug events, especially those that may be preventable, are among the most serious concerns about medication use in older persons cared for in the ambulatory clinical setting. Objective To assess the incidence and preventability of adverse drug events among older persons in the ambulatory clinical setting. Design, Setting, and Patients Cohort study of all Medicare enrollees (30 397 person-years of observation) cared for by a multispecialty group practice during a 12-month study period (July 1, 1999, through June 30, 2000), in which possible drug-related incidents occurring in the ambulatory clinical setting were detected using multiple methods, including reports from health care providers; review of hospital discharge summaries; review of emergency department notes; computer-generated signals; automated free-text review of electronic clinic notes; and review of administrative incident reports concerning medication errors. Main Outcome Measures Number of adverse drug events, severity of the events (classified as significant, serious, life-threatening, or fatal), and whether the events were preventable. Results There were 1523 identified adverse drug events, of which 27.6% (421) were considered preventable. The overall rate of adverse drug events was 50.1 per 1000 person-years, with a rate of 13.8 preventable adverse drug events per 1000 person-years. Of the adverse drug events, 578 (38.0%) were categorized as serious, life-threatening, or fatal; 244 (42.2%) of these more severe events were deemed preventable compared with 177 (18.7%) of the 945 significant adverse drug events. Errors associated with preventable adverse drug events occurred most often at the stages of prescribing (n = 246, 58.4%) and monitoring (n = 256, 60.8%), and errors involving patient adherence (n = 89, 21.1%) also were common. Cardiovascular medications (24.5%), followed by diuretics (22.1%), nonopioid analgesics (15.4%), hypoglytemics (10.9%), and anticoagulants (10.2%) were the most common medication categories associated with preventable adverse drug events. Electrolyte/renal (26.6%), gastrointestinal tract (21.1%), hemorrhagic (15.9%), metabolic/endocrine (13.8%), and neuropsychiatric (8.6%) events were the most common types of preventable adverse drug events. Conclusions Adverse drug events are common and often preventable among older persons in the ambulatory Clinical setting. More serious adverse drug events are more likely to be preventable. Prevention strategies should target the prescribing and monitoring stages of. pharmaceutical care. Interventions focused on improving patient adherence with prescribed regimens and monitoring of prescribed medications also may be beneficial.	Meyers Primary Care Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Partners Healthcare Syst, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Gurwitz, JH (corresponding author), Meyers Primary Care Inst, 630 Plantat St, Worcester, MA 01605 USA.	jgurwitz@meyersprimary.org		Cadoret, Cynthia/0000-0001-6713-2823	NATIONAL INSTITUTE ON AGING [R01AG015979] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Applegate WB, 2002, JAMA-J AM MED ASSOC, V288, P495, DOI 10.1001/jama.288.4.495; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Chertow GM, 2001, JAMA-J AM MED ASSOC, V286, P2839, DOI 10.1001/jama.286.22.2839; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; *CTR MED MED SERV, MED MAN CAR CONTR PL; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Gurwitz JH, 2002, ARCH INTERN MED, V162, P1670, DOI 10.1001/archinte.162.15.1670; Hanlon JT, 2000, PHARMACOTHERAPY, V20, P575, DOI 10.1592/phco.20.6.575.35163; Hanlon JT, 2002, J AM GERIATR SOC, V50, P26, DOI 10.1046/j.1532-5415.2002.50004.x; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Honigman B, 2001, INT J MED INFORM, V61, P21, DOI 10.1016/S1386-5056(00)00131-3; Honigman B, 2001, J AM MED INFORM ASSN, V8, P254, DOI 10.1136/jamia.2001.0080254; KATZ JN, 1992, ARTHRITIS RHEUM-US, V35, P1257, DOI 10.1002/art.1780351103; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kaushal R, 2001, ARCH PEDIAT ADOL MED, V155, P1002, DOI 10.1001/archpedi.155.9.1002; Knight EL, 2001, ANN INTERN MED, V135, P703, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00009; Kohn KT, 2000, ERR IS HUMAN BUILDIN; KOZAK LJ, 2002, ADV DATA VITAL HLTH, V13; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leape LL, 1999, JAMA-J AM MED ASSOC, V282, P267, DOI 10.1001/jama.282.3.267; *LEAPFR GROUP, 2002, PAT SAF SURV RES SUM; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Matchar DB, 2002, AM J MED, V113, P42, DOI 10.1016/S0002-9343(02)01131-2; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; *NAT CTR HLTH STAT, POP AG SEX RAC NAT S; Pitkala KH, 2002, ARCH INTERN MED, V162, P1707, DOI 10.1001/archinte.162.15.1707; Rosner B., 2010, FUNDAMENTALS BIOSTAT; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; SHOJANIA K, 2001, AHRQ PUBLICATION; Sox H C Jr, 2000, Eff Clin Pract, V3, P277; Thomas EJ, 2002, ANN INTERN MED, V136, P812, DOI 10.7326/0003-4819-136-11-200206040-00009; WALTON RT, 2001, COCHRANE DB SYST REV, V1; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823	45	1080	1115	1	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1107	1116		10.1001/jama.289.9.1107	http://dx.doi.org/10.1001/jama.289.9.1107			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622580	Bronze			2022-12-28	WOS:000181289400026
J	Spodick, DH				Spodick, DH			Acute pericarditis - Current concepts and practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIAC-TAMPONADE; DIAGNOSIS; FREQUENCY; ETIOLOGY; DISEASE		Univ Massachusetts, Sch Med, Cardiovasc Med Fellowship Program, St Vincent Hosp, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Spodick, DH (corresponding author), Worcester Med Ctr, Div Cardiovasc, 20 Worcester Ctr Blvd, Worcester, MA 01608 USA.							BRUCE MA, 1980, J ELECTROCARDIOL, V13, P61, DOI 10.1016/S0022-0736(80)80011-2; FOWLER NO, 1991, JAMA-J AM MED ASSOC, V266, P99, DOI 10.1001/jama.266.1.99; FRIEDMAN PL, 1981, NEW ENGL J MED, V305, P1171, DOI 10.1056/NEJM198111123052002; LEE KS, 1993, CLEV CLIN J MED, V60, P336, DOI 10.3949/ccjm.60.4.336; Lieng LH, 1996, J AM COLL CARDIOL, V27, p32A; MAISCH B, 1994, CURR OPIN CARDIOL, V9, P379, DOI 10.1097/00001573-199405000-00017; Merce J, 1999, AM HEART J, V138, P759, DOI 10.1016/S0002-8703(99)70193-6; Myers RBH, 1999, AM HEART J, V138, P219, DOI 10.1016/S0002-8703(99)70105-5; PERMANYER G, 1988, ENFERMEDADES PERICAR, P5; PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9; REDDY PS, 1990, AM J CARDIOL, V66, P1487, DOI 10.1016/0002-9149(90)90540-H; REYDEL B, 1990, AM HEART J, V119, P1160, DOI 10.1016/S0002-8703(05)80248-0; Spodick DH, 1997, AM J CARDIOL, V80, P102, DOI 10.1016/S0002-9149(97)00296-8; SPODICK DH, 1984, AM J CARDIOL, V53, P842, DOI 10.1016/0002-9149(84)90416-8; SPODICK DH, 1973, CIRCULATION, V48, P575, DOI 10.1161/01.CIR.48.3.575; Spodick DH, 1997, PERICARDIUM COMPREHE; Spodick DH, 2001, HEART DIS, P823; SPODICK DH, 2002, EVALUATION PATIENT H, P339; SWAMI A, IN PRESS CLIN CARDIO; ZAYAS R, 1995, AM J CARDIOL, V75, P378, DOI 10.1016/S0002-9149(99)80558-X	20	117	121	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1150	1153		10.1001/jama.289.9.1150	http://dx.doi.org/10.1001/jama.289.9.1150			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622586				2022-12-28	WOS:000181289400032
J	Bose, A; Coen, P; Tully, J; Viner, R; Booy, R				Bose, A; Coen, P; Tully, J; Viner, R; Booy, R			Effectiveness of meningococcal C conjugate vaccine in teenagers in England	LANCET			English	Article							EFFICACY	Meningococcal C conjugate vaccine was introduced into clinical practice in the UK before phase 3 trials had been undertaken. We therefore did a case-control study,in teenagers to assess vaccine effectiveness. All cases (n=31) enrolled had laboratory confirmed meningococcal C disease. We also enrolled between one and three controls (n=65) per case, matched by age, sex, and general practitioner. Three patients and 23 controls had been vaccinated. The protective effectiveness of the vaccine, estimated by conditional logistic regression, was 93% (95% CI 39-99), which is similar to screening method estimates. The estimated protective effectiveness varied little when potential confounding risk factors were taken into account. Our findings indicate that the vaccine is highly protective against invasive meningococcal C disease.	Royal London Hosp, Acad Dept Child Hlth, London E1 1BB, England; Inst Child Hlth, London, England; UCL Hosp, Adolescent Res Unit, London, England; Great Ormond St Hosp Sick Children, London, England	Barts Health NHS Trust; Royal London Hospital; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Booy, R (corresponding author), Royal London Hosp, Acad Dept Child Hlth, London E1 1BB, England.	R.Booy@qmul.ac.uk	Viner, Russell M/A-1441-2009; Booy, Robert/D-4188-2011	Viner, Russell M/0000-0003-3047-2247; Tully, Joanna/0000-0002-3918-6063				MARYKRAUSE M, 1993, REV EPIDEMIOL SANTE, V41, P155; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Simondon F, 1999, INT J EPIDEMIOL, V28, P113, DOI 10.1093/ije/28.1.113; TULLY J, ARCH DIS CHILD S, V82, pA5	5	33	35	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					675	676		10.1016/S0140-6736(03)12563-9	http://dx.doi.org/10.1016/S0140-6736(03)12563-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606181				2022-12-28	WOS:000181129500019
J	Pollard, TD; Borisy, GG				Pollard, TD; Borisy, GG			Cellular motility driven by assembly and disassembly of actin filaments	CELL			English	Review							ALDRICH-SYNDROME PROTEIN; ACANTHAMOEBA ACTOPHORIN ADF/COFILIN; DEPOLYMERIZING FACTOR COFILIN; ARP2/3 COMPLEX; N-WASP; F-ACTIN; LEADING-EDGE; BARBED ENDS; DENDRITIC ORGANIZATION; DIRECTIONAL MOTILITY	Motile cells extend a leading edge by assembling a branched network of actin filaments that produces physical force, as the polymers grow beneath the plasma membrane. A core set of proteins including actin, Arp2/3 complex, profilin, capping protein, and ADF/cofilin can reconstitute the process in vitro, and mathematical models of the constituent reactions predict the rate of motion. Signaling pathways converging on WASp/Scar proteins regulate the activity of Arp2/3 complex, which mediates the initiation of new filaments as branches on preexisting filaments. After a brief spurt of growth, capping protein terminates the elongation of the filaments. After filaments have aged by hydrolysis of their bound ATP and dissociation of the gamma phosphate, ADF/cofilin proteins promote debranching and depolymerization. Profilin catalyzes the exchange of ADP for ATP, refilling the pool of ATP-actin monomers bound to profilin, ready for elongation.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Northwestern Univ, Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA	Yale University; Northwestern University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu; g-borisy@northwestern.edu		Borisy, Gary/0000-0002-0266-8018	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062431, R01GM026338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26338, GM62431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; CARLIER MF, 1988, FEBS LETT, V235, P211, DOI 10.1016/0014-5793(88)81264-X; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; EDDS KT, 1993, CELL MOTIL CYTOSKEL, V26, P262, DOI 10.1002/cm.970260309; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Evangelista M, 2000, J CELL BIOL, V148, P353, DOI 10.1083/jcb.148.2.353; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Fujiwara I, 2002, NAT CELL BIOL, V4, P666, DOI 10.1038/ncb841; Fujiwara I, 2002, BIOCHEM BIOPH RES CO, V293, P1550, DOI 10.1016/S0006-291X(02)00421-7; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Huang M, 1999, CURR BIOL, V9, P979, DOI 10.1016/S0960-9822(99)80428-X; Ichetovkin I, 2000, CELL MOTIL CYTOSKEL, V45, P293, DOI 10.1002/(SICI)1097-0169(200004)45:4<293::AID-CM5>3.0.CO;2-1; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Kaiser DA, 1999, J CELL SCI, V112, P3779; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200; Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; Maciver SK, 1998, EUR J BIOCHEM, V256, P388, DOI 10.1046/j.1432-1327.1998.2560388.x; Maly IV, 2001, P NATL ACAD SCI USA, V98, P11324, DOI 10.1073/pnas.181338798; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Nyakern-Meazza M, 2002, J BIOL CHEM, V277, P28774, DOI 10.1074/jbc.M203360200; OKADA K, 2002, IN PRESS J BIOL CHEM; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2002, CELL BIOL; POLLARD TD, 1999, GUIDEBOOK CYTOSKELET, P3; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rengan R, 2000, BLOOD, V95, P1283, DOI 10.1182/blood.V95.4.1283.004k44_1283_1292; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; ROSENBLATT J, 1995, MOL BIOL CELL, V6, P227, DOI 10.1091/mbc.6.2.227; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; SAFER D, 1994, BIOESSAYS, V16, P473, DOI 10.1002/bies.950160706; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; TILNEY LG, 1992, J CELL BIOL, V118, P71, DOI 10.1083/jcb.118.1.71; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	123	3104	3193	8	501	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 21	2003	112	4					453	465		10.1016/S0092-8674(03)00120-X	http://dx.doi.org/10.1016/S0092-8674(03)00120-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600310	Bronze			2022-12-28	WOS:000181252600005
J	Asimow, PD; Langmuir, CH				Asimow, PD; Langmuir, CH			The importance of water to oceanic mantle melting regimes	NATURE			English	Article							THERMODYNAMIC MODELS; RIDGE; TEMPERATURE; CONSTRAINTS; EXTRACTION; ANOMALIES; MINERALS; BENEATH; MAGMA	The formation of basaltic crust at mid-ocean ridges and ocean islands provides a window into the compositional and thermal state of the Earth's upper mantle. But the interpretation of geochemical and crustal-thickness data in terms of magma source parameters depends on our understanding of the melting, melt-extraction and differentiation processes that intervene between the magma source and the crust. Much of the quantitative theory developed to model these processes has neglected the role of water in the mantle and in magma, despite the observed presence of water in ocean-floor basalts. Here we extend two quantitative models of ridge melting, mixing and fractionation to show that the addition of water can cause an increase in total melt production and crustal thickness while causing a decrease in mean extent of melting. This may help to resolve several enigmatic observations in the major- and trace-element chemistry of both normal and hotspot-affected ridge basalts.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	California Institute of Technology; Harvard University	Asimow, PD (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	asimow@gps.caltech.edu	Asimow, Paul D/E-7451-2010	Asimow, Paul D/0000-0001-6025-8925				Asimow PD, 2001, J PETROL, V42, P963, DOI 10.1093/petrology/42.5.963; ASIMOW PD, 1998, EOS T AM GEOPHYS UN, V79, pF938; BONATTI E, 1990, SCIENCE, V250, P107, DOI 10.1126/science.250.4977.107; DETRICK RS, 1995, J GEOPHYS RES-SOL EA, V100, P3767, DOI 10.1029/94JB02649; Detrick RS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000350; DICK HJB, 1984, EARTH PLANET SC LETT, V69, P88, DOI 10.1016/0012-821X(84)90076-1; Dixon JE, 2002, NATURE, V420, P385, DOI 10.1038/nature01215; FORSYTH DW, 1992, GEOPH MONOG SERIES, V71, P1; Gaetani GA, 1998, CONTRIB MINERAL PETR, V131, P323, DOI 10.1007/s004100050396; Ghiorso MS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000217; Hirschmann MM, 1999, J PETROL, V40, P831, DOI 10.1093/petrology/40.5.831; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; ITO GT, 1995, J GEOPHYS RES-SOL EA, V100, P3733, DOI 10.1029/94JB02594; JOHNSON KTM, 1990, J GEOPHYS RES-SOLID, V95, P2661, DOI 10.1029/JB095iB03p02661; KATZ RF, UNPUB GEOCHEM GEOPHY; KAY RW, 1973, J GEOL, V81, P653, DOI 10.1086/627919; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; LANGMUIR CH, 1995, EOS T AM GEOPHYS U S, V76, pF694; Lehnert K, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000026; MCKENZIE D, 1985, EARTH PLANET SC LETT, V74, P81, DOI 10.1016/0012-821X(85)90168-2; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MICHAEL PJ, 1987, CONTRIB MINERAL PETR, V96, P245, DOI 10.1007/BF00375237; PLANK T, 1992, J GEOPHYS RES-SOL EA, V97, P19749, DOI 10.1029/92JB01769; PLANK T, 1995, J GEOPHYS RES-SOL EA, V100, P15045, DOI 10.1029/95JB01148; Robinson CJ, 2001, EARTH PLANET SC LETT, V188, P383, DOI 10.1016/S0012-821X(01)00329-6; SCHILLING JG, 1980, PHILOS T R SOC A, V297, P147, DOI 10.1098/rsta.1980.0208; SCHILLING JG, 1975, EARTH PLANET SC LETT, V25, P103, DOI 10.1016/0012-821X(75)90186-7; SHEN Y, 1995, J GEOPHYS RES-SOL EA, V100, P2211, DOI 10.1029/94JB02768; STOLPER E, 1994, EARTH PLANET SC LETT, V121, P293, DOI 10.1016/0012-821X(94)90074-4; SU YJ, 2002, THESIS COLUMBIA U; White RS, 2001, J PETROL, V42, P1171, DOI 10.1093/petrology/42.6.1171	32	302	321	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					815	820		10.1038/nature01429	http://dx.doi.org/10.1038/nature01429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594505				2022-12-28	WOS:000181044700040
J	Henry, G; Li, W; Garner, W; Woodley, DT				Henry, G; Li, W; Garner, W; Woodley, DT			Migration of human keratinocytes in plasma and serum and wound re-epithelialisation	LANCET			English	Article								When skin is wounded, human keratinocytes at the wound edge stop differentiating and start migrating to resurface the wound. How this change takes place is unclear. Because keratinocytes at the wound edge are for the first time surrounded by serum rather than plasma, serum could contain some migration-promoting factor or factors that is absent in plasma. We did standard computer-assisted in-vitro migration assays of human keratinocytes in the presence of either human plasma or serum. We also did a semiquantitative western blot analysis to determine if p38 mitogen-activated protein kinase (p38MAPK) was activated by either serum or plasma. Our results showed that keratinocytes migrating on collagen in the presence of serum produced migration indices in the range of 28, whereas those in the presence of plasma were about 12-the same level as control assays without either serum or plasma. We also showed that induced keratinocyte polarisation, activation of p38MAPK, and production of matrix metalloprotease 9 are possible mechanisms for promotion of re-epithelialisation of skin wounds by human serum.	Univ So Calif, Keck Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Surg, Div Plast Surg, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Woodley, DT (corresponding author), Univ So Calif, Keck Sch Med, Div Dermatol, Dept Med, Los Angeles, CA 90033 USA.				NIAMS NIH HHS [R01 AR46538] Funding Source: Medline; NIGMS NIH HHS [R01 GM/AR66193] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066193] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Johansson N, 2000, J CELL SCI, V113, P227; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; Woodley DT, 1996, MOL CELLULAR BIOL WO, P339	5	38	39	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					574	576		10.1016/S0140-6736(03)12510-X	http://dx.doi.org/10.1016/S0140-6736(03)12510-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598145				2022-12-28	WOS:000181033400013
J	Fleischer, JW; Segev, M; Efremidis, NK; Christodoulides, DN				Fleischer, JW; Segev, M; Efremidis, NK; Christodoulides, DN			Observation of two-dimensional discrete solitons in optically induced nonlinear photonic lattices	NATURE			English	Article							LOCALIZED MODES; BREATHERS; ARRAYS; BRIGHT	Nonlinear periodic lattices occur in a large variety of systems, such as biological molecules(1), nonlinear optical waveguides(2), solid-state systems(3) and Bose-Einstein condensates'. The underlying dynamics in these systems is dominated by the interplay between tunnelling between adjacent potential wells and non-linearity(1-15). A balance between these two effects can result in a self-localized state: a lattice or 'discrete' soliton(1,2). Direct observation of lattice solitons has so far been limited to one-dimensional systems, namely in arrays of nonlinear optical waveguides(2,9-17). However, many fundamental features are expected to occur in higher dimensions, such as vortex lattice solitons(18), bright lattice solitons that carry angular momentum, and three-dimensional collisions between lattice solitons. Here, we report the experimental observation of two-dimensional (2D) lattice solitons. We use optical induction, the interference of two or more plane waves in a photosensitive material, to create a 2D photonic lattice in which the solitons form(11,12). Our results pave the way for the realization of a variety of nonlinear localization phenomena in photonic lattices and crystals(19-23). Finally, our observation directly relates to the proposed lattice solitons in Bose-Einstein condensates', which can be observed in optically induced periodic potentials(24,25).	Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; Univ Cent Florida, CREOL, Sch Opt, Orlando, FL 32816 USA	Technion Israel Institute of Technology; Princeton University; State University System of Florida; University of Central Florida	Segev, M (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	msegev@tx.technion.ac.il	Efremidis, Nikolaos/E-1991-2011	Efremidis, Nikolaos/0000-0002-9830-0268				ABLOWITZ MJ, 2001, PHYS REV LETT, V87; Anderson BP, 1998, SCIENCE, V282, P1686, DOI 10.1126/science.282.5394.1686; CHEN W, 1987, PHYS REV LETT, V58, P160, DOI 10.1103/PhysRevLett.58.160; CHRISTODOULIDES DN, 1995, J OPT SOC AM B, V12, P1628, DOI 10.1364/JOSAB.12.001628; CHRISTODOULIDES DN, 1989, PHYS REV LETT, V62, P1746, DOI 10.1103/PhysRevLett.62.1746; Christodoulides DN, 2002, OPT LETT, V27, P568, DOI 10.1364/OL.27.000568; CHRISTODOULIDES DN, 1988, OPT LETT, V13, P794, DOI 10.1364/OL.13.000794; CHRISTODOULIDES DN, 2001, PHYS REV LETT, V87; DAVYDOV AS, 1973, PHYS STATUS SOLIDI B, V59, P465, DOI 10.1002/pssb.2220590212; Efremidis NK, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046602; Eisenberg HS, 2000, PHYS REV LETT, V85, P1863, DOI 10.1103/PhysRevLett.85.1863; Eisenberg HS, 1998, PHYS REV LETT, V81, P3383, DOI 10.1103/PhysRevLett.81.3383; Fleischer JW, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.023902; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; JOHN S, 1993, PHYS REV LETT, V71, P1168, DOI 10.1103/PhysRevLett.71.1168; KIVSHAR YS, 1993, OPT LETT, V18, P1147, DOI 10.1364/OL.18.001147; Lederer F., 2001, SPRINGER SERIES OPTI, P269; Malomed BA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026601; Mingaleev SF, 2001, PHYS REV LETT, V86, P5474, DOI 10.1103/PhysRevLett.86.5474; Morandotti R, 2001, PHYS REV LETT, V86, P3296, DOI 10.1103/PhysRevLett.86.3296; Schwarz UT, 1999, PHYS REV LETT, V83, P223, DOI 10.1103/PhysRevLett.83.223; SCOTT AC, 1983, PHYS LETT A, V98, P87, DOI 10.1016/0375-9601(83)90733-8; SEGEV M, 1994, PHYS REV LETT, V73, P3211, DOI 10.1103/PhysRevLett.73.3211; Shih MF, 1996, OPT LETT, V21, P931, DOI 10.1364/OL.21.000931; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; Swanson BI, 1999, PHYS REV LETT, V82, P3288, DOI 10.1103/PhysRevLett.82.3288; Trias E, 2000, PHYS REV LETT, V84, P741, DOI 10.1103/PhysRevLett.84.741; Trombettoni A, 2001, PHYS REV LETT, V86, P2353, DOI 10.1103/PhysRevLett.86.2353; Xie AH, 2000, PHYS REV LETT, V84, P5435, DOI 10.1103/PhysRevLett.84.5435	30	1133	1160	11	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					147	150		10.1038/nature01452	http://dx.doi.org/10.1038/nature01452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634781				2022-12-28	WOS:000181488900040
J	Kerner, M; Hohenberg, H; Ertl, S; Reckermann, M; Spitzy, A				Kerner, M; Hohenberg, H; Ertl, S; Reckermann, M; Spitzy, A			Self-organization of dissolved organic matter to micelle-like microparticles in river water	NATURE			English	Article							PARTICLES; COLLOIDS; CARBON; ACID	In aquatic systems, the concept of the 'microbial loop' is invoked to describe the conversion of dissolved organic matter to particulate organic matter by bacteria(1). This process mediates the transfer of energy and matter from dissolved organic matter to higher trophic levels, and therefore controls (together with primary production) the productivity of aquatic systems. Here we report experiments on laboratory incubations of sterile filtered river water in which we find that up to 25% of the dissolved organic carbon (DOC) aggregates abiotically to particles of diameter 0.4-0.8 micrometres, at rates similar to bacterial growth. Diffusion drives aggregation of low- to high-molecular-mass DOC and further to larger micelle-like microparticles. The chemical composition of these microparticles suggests their potential use as food by planktonic bacterivores. This pathway is apparent from differences in the stable carbon isotope compositions of picoplankton and the microparticles. A large fraction of dissolved organic matter might therefore be channelled through microparticles directly to higher trophic levels-bypassing the microbial loop-suggesting that current concepts of carbon conversion in aquatic systems require revision.	Univ Hamburg, Inst Hydrobiol & Fishery Sci, D-22765 Hamburg, Germany; Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; Univ Kiel, Res & Technol Ctr Westcoast, D-25761 Busum, Hafentorn, Germany	University of Hamburg; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University of Kiel	Kerner, M (corresponding author), Univ Hamburg, Inst Hydrobiol & Fishery Sci, Zeiseweg 9, D-22765 Hamburg, Germany.							AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bianchi A, 1996, APPL ENVIRON MICROB, V62, P174, DOI 10.1128/AEM.62.1.174-177.1996; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Ducklow Hugh W., 1993, P261; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; GREENSPAN P, 1985, J LIPID RES, V26, P781; HARRIS JR, 1997, NEGATIVE STAINING CR, P12; Hertkorn N, 2002, J ENVIRON QUAL, V31, P375, DOI 10.2134/jeq2002.0375; HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x; HUBER SA, 1991, ANAL CHEM, V63, P2122, DOI 10.1021/ac00019a011; Hullar MAJ, 1996, APPL ENVIRON MICROB, V62, P2489, DOI 10.1128/AEM.62.7.2489-2493.1996; KEPKAY PE, 1994, MAR ECOL PROG SER, V109, P293, DOI 10.3354/meps109293; Kerner M, 2001, MICROBIAL ECOL, V41, P69; LEPPARD GG, 1995, SCI TOTAL ENVIRON, V165, P103, DOI 10.1016/0048-9697(95)04546-D; Nagata T, 1997, ADV MICROB ECOL, V15, P81; Nanny MA, 2001, ENVIRON SCI TECHNOL, V35, P379, DOI 10.1021/es0012927; Niedergesass R., 1995, WASSERWIRTSCHAFT WAS, V7, P22; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; POLLARD TD, 2002, CELL BIOL, P277; Posch T, 1996, AQUAT MICROB ECOL, V10, P45, DOI 10.3354/ame010045; RAIMBAULT P, 1991, LIMNOL OCEANOGR, V36, P405, DOI 10.4319/lo.1991.36.2.0405; RILEY GA, 1963, LIMNOL OCEANOGR, V8, P372, DOI 10.4319/lo.1963.8.4.0372; Santschi PH, 1998, LIMNOL OCEANOGR, V43, P896, DOI 10.4319/lo.1998.43.5.0896; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Volke F, 1997, CHEM PHYS LIPIDS, V85, P115, DOI 10.1016/S0009-3084(96)02649-7	25	118	127	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					150	154		10.1038/nature01469	http://dx.doi.org/10.1038/nature01469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634782				2022-12-28	WOS:000181488900041
J	Vidal-Madjar, A; des Etangs, AL; Desert, JM; Ballester, GE; Ferlet, R; Hebrand, G; Mayor, M				Vidal-Madjar, A; des Etangs, AL; Desert, JM; Ballester, GE; Ferlet, R; Hebrand, G; Mayor, M			An extended upper atmosphere around the extrasolar planet HD209458b	NATURE			English	Article							LYMAN-ALPHA; 51 PEGASI; SEARCH; TRANSITS	The planet in the system HD209458 is the first one for which repeated transits across the stellar disk have been observed(1,2). Together with radial velocity measurements', this has led to a determination of the planet's radius and mass, confirming it to be a gas giant. But despite numerous searches for an atmospheric signature(4-6), only the dense lower atmosphere of HD209458b has been observed, through the detection of neutral sodium absorption(7). Here we report the detection of atomic hydrogen absorption in the stellar Lyman alpha line during three transits of HD209458b. An absorption of 15 +/- 4% (1sigma) is observed. Comparison with models shows that this absorption should take place beyond the Roche limit and therefore can be understood in terms of escaping hydrogen atoms.	UPMC, CNRS, Inst Astrophys Paris, F-75014 Paris, France; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Observ Geneva, CH-1290 Sauverny, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Arizona; University of Geneva	Vidal-Madjar, A (corresponding author), UPMC, CNRS, Inst Astrophys Paris, 98bis Blvd Arago, F-75014 Paris, France.	alfred@iap.fr	Lecavelier des Etangs, Alain/GLU-6503-2022	Lecavelier des Etangs, Alain/0000-0002-5637-5253				Bundy KA, 2000, PUBL ASTRON SOC PAC, V112, P1421, DOI 10.1086/317706; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; CUMMING A, 2002, ASTROPH0209199; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; Konacki M, 2003, NATURE, V421, P507, DOI 10.1038/nature01379; Lemaire P, 2002, ESA SPEC PUBL, V508, P219; Mazeh T, 2000, ASTROPHYS J, V532, pL55, DOI 10.1086/312558; Moutou C, 2001, ASTRON ASTROPHYS, V371, P260, DOI 10.1051/0004-6361:20010406; PACZYNSKI B, 1971, ANNU REV ASTRON ASTR, V9, P183, DOI 10.1146/annurev.aa.09.090171.001151; PRINZ DK, 1974, ASTROPHYS J, V187, P369, DOI 10.1086/152641; Rauer H, 2000, ASTRON ASTROPHYS, V355, P573; VIDALMADJAR A, 1975, SOL PHYS, V40, P69, DOI 10.1007/BF00183153	13	847	851	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					143	146		10.1038/nature01448	http://dx.doi.org/10.1038/nature01448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634780				2022-12-28	WOS:000181488900039
J	Esposito, L				Esposito, L			Cassini imaging at Jupiter	SCIENCE			English	Editorial Material									Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Esposito, L (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA.		ESPOSITO, LARRY W/AAB-3673-2021	ESPOSITO, LARRY W/0000-0003-3381-2016				Clarke JT, 2002, NATURE, V415, P997, DOI 10.1038/415997a; Hill TW, 2002, NATURE, V415, P965, DOI 10.1038/415965a; MCGRATH MA, 2000, B AM ASTRON SOC; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462	4	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1529	1530		10.1126/science.1081517	http://dx.doi.org/10.1126/science.1081517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624253				2022-12-28	WOS:000181367900023
J	Klein, RG				Klein, RG			Whither the Neanderthals?	SCIENCE			English	Editorial Material							EVOLUTION; DNA		Stanford Univ, Program Human Biol, Stanford, CA 94305 USA	Stanford University	Klein, RG (corresponding author), Stanford Univ, Program Human Biol, Stanford, CA 94305 USA.		Klein, Richard G/B-5910-2009	Klein, Richard/0000-0002-6180-2168				Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Duarte C, 1999, P NATL ACAD SCI USA, V96, P7604, DOI 10.1073/pnas.96.13.7604; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; HUBLIN JJ, 1995, CR ACAD SCI II A, V321, P931; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Klein R. G., 1999, HUMAN CAREER HUMAN B; Mellars P., 1996, NEANDERTHAL LEGACY, DOI [10.1515/9781400843602, DOI 10.1515/9781400843602]; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; SANTALUCA AP, 1978, J HUM EVOL, V7, P619, DOI 10.1016/S0047-2484(78)80047-5; Smith NP, 1999, COMPUT SCI ENG, V1, P96; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Trinkaus E., 1993, NEANDERTALS CHANGING; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685	17	114	117	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1525	1527		10.1126/science.1082025	http://dx.doi.org/10.1126/science.1082025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624250				2022-12-28	WOS:000181367900020
J	Sandler, RS; Halabi, S; Baron, JA; Budinger, S; Paskett, E; Keresztes, R; Petrelli, N; Pipas, JM; Karp, DD; Loprinzi, CL; Steinbach, G; Schilsky, R				Sandler, RS; Halabi, S; Baron, JA; Budinger, S; Paskett, E; Keresztes, R; Petrelli, N; Pipas, JM; Karp, DD; Loprinzi, CL; Steinbach, G; Schilsky, R			A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; REDUCED RISK; CHEMOPREVENTION; SULINDAC; POLYPS; AGENTS; FIBER; RECURRENCE; COLON; FAT	Background: Experimental studies in animals and observational studies in humans suggest that regular aspirin use may decrease the risk of colorectal adenomas, the precursors to most colorectal cancers. Methods: We conducted a randomized, double-blind trial to determine the effect of aspirin on the incidence of colorectal adenomas. We randomly assigned 635 patients with previous colorectal cancer to receive either 325 mg of aspirin per day or placebo. We determined the proportion of patients with adenomas, the number of recurrent adenomas, and the time to the development of adenoma between randomization and subsequent colonoscopic examinations. Relative risks were adjusted for age, sex, cancer stage, the number of colonoscopic examinations, and the time to a first colonoscopy. The study was terminated early by an independent data and safety monitoring board when statistically significant results were reported during a planned interim analysis. Results: A total of 517 randomized patients had at least one colonoscopic examination a median of 12.8 months after randomization. One or more adenomas were found in 17 percent of patients in the aspirin group and 27 percent of patients in the placebo group (P=0.004). The mean (+/-SD) number of adenomas was lower in the aspirin group than the placebo group (0.30+/-0.87 vs. 0.49+/-0.99, P=0.003 by the Wilcoxon test). The adjusted relative risk of any recurrent adenoma in the aspirin group, as compared with the placebo group, was 0.65 (95 percent confidence interval, 0.46 to 0.91). The time to the detection of a first adenoma was longer in the aspirin group than in the placebo group (hazard ratio for the detection of a new polyp, 0.64; 95 percent confidence interval, 0.43 to 0.94; P=0.022). Conclusions: Daily use of aspirin is associated with a significant reduction in the incidence of colorectal adenomas in patients with previous colorectal cancer.	Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Duke Univ, Med Ctr, Ctr Stat, Canc & Leukemia Grp B, Durham, NC USA; Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; Dartmouth Coll Sch Med, Dept Med, Hanover, NH USA; Dartmouth Coll Sch Med, Dept Community & Family Med, Hanover, NH USA; Wake Forest Univ, Sch Med, Winston Salem, NC USA; Cornell Univ, Weill Med Coll, New York, NY USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Univ Texas, MD Anderson Canc Ctr, Eastern Cooperat Oncol Grp, Houston, TX 77030 USA; Mayo Clin, N Cent Canc Treatment Grp, Rochester, MN USA; Cent Off Chairman, Canc & Leukemia Grp B, Chicago, IL USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Dartmouth College; Dartmouth College; Wake Forest University; Cornell University; Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic	Sandler, RS (corresponding author), Univ N Carolina, Dept Med, CB 7555,4111 Bioinformat Bldg, Chapel Hill, NC 27599 USA.	rsandler@med.unc.edu	Halabi, Susan/AAG-7938-2022; Halabi, Susan/AFL-7973-2022	Halabi, Susan/0000-0003-4135-2777; Halabi, Susan/0000-0003-4135-2777; Steinbach, Gideon/0000-0001-7597-0544	NATIONAL CANCER INSTITUTE [U10CA077658, U10CA074811, U10CA047559, U10CA067663, U10CA047555, U10CA045418, U10CA041287, U10CA008025, U10CA077298, U10CA025224, U10CA011789, U10CA012449, U10CA032291, U10CA045389, U10CA037135, U10CA047642, U10CA002599, U10CA021060, U10CA047577, U10CA035279, U10CA012046, U10CA035421, U10CA004457, U10CA077406, U10CA052784, U10CA035091, U10CA031946, U10CA016450, U10CA004326, U10CA033601, U10CA007968, U10CA031983, U10CA045564, U10CA045808, U10CA003927] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Collet JP, 1999, BRIT J CANCER, V81, P62, DOI 10.1038/sj.bjc.6690651; Cooper GS, 1999, CANCER-AM CANCER SOC, V85, P2124, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2124::AID-CNCR5>3.0.CO;2-L; Cruz-Correa M, 2002, GASTROENTEROLOGY, V122, P641, DOI 10.1053/gast.2002.31890; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Green RJ, 2002, ANN INTERN MED, V136, P261, DOI 10.7326/0003-4819-136-4-200202190-00005; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Kune GA, 2007, INT J EPIDEMIOL, V36, P951, DOI 10.1093/ije/dym193; LABAYLE D, 1991, GASTROENTEROLOGY, V101, P635, DOI 10.1016/0016-5085(91)90519-Q; Ladabaum U, 2001, ANN INTERN MED, V135, P769, DOI 10.7326/0003-4819-135-9-200111060-00007; LaVecchia C, 1997, BRIT J CANCER, V76, P675, DOI 10.1038/bjc.1997.444; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; MACLENNAN R, 1995, J NATL CANCER I, V87, P1760, DOI 10.1093/jnci/87.23.1760; MARTINEZ ME, 1995, CANCER EPIDEM BIOMAR, V4, P703; MCKEOWNEYSSEN GE, 1994, J CLIN EPIDEMIOL, V47, P525, DOI 10.1016/0895-4356(94)90299-2; MCKEOWNEYSSEN GE, 1995, J CLIN EPIDEMIOL, V48, pR1; MUSCAT JE, 1994, CANCER-AM CANCER SOC, V74, P1847, DOI 10.1002/1097-0142(19941001)74:7<1847::AID-CNCR2820740704>3.0.CO;2-#; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; O'Shaughnessy JA, 2002, CLIN CANCER RES, V8, P314; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; PELEG II, 1994, ARCH INTERN MED, V154, P394, DOI 10.1001/archinte.154.4.394; POCOCK SJ, 1989, CONTROL CLIN TRIALS, V10, pS209; POLLARD M, 1980, CANCER TREAT REP, V64, P1323; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; Sample D, 2002, CANCER EPIDEM BIOMAR, V11, P275; Sandler Robert S., 1996, P123; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; Shaheen NJ, 2002, CANCER-AM CANCER SOC, V94, P950, DOI 10.1002/cncr.10333; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; SUH O, 1993, CANCER-AM CANCER SOC, V72, P1171, DOI 10.1002/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D; Suleiman S, 2002, GASTROENTEROLOGY, V122, P78, DOI 10.1053/gast.2002.29689; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Winawer SJ, 1998, GASTROENTEROLOGY, V114, P625; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P1060; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	46	867	908	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					883	890		10.1056/NEJMoa021633	http://dx.doi.org/10.1056/NEJMoa021633			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621132				2022-12-28	WOS:000181341100003
J	Karlawish, JHT; Clark, CM				Karlawish, JHT; Clark, CM			Diagnostic evaluation of elderly patients with mild memory problems	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY STANDARDS SUBCOMMITTEE; ALZHEIMERS-DISEASE PATIENTS; PRIMARY-CARE PATIENTS; DOUBLE-BLIND PLACEBO; MINI-MENTAL-STATE; VASCULAR DEMENTIA; AMERICAN-ACADEMY; COGNITIVE IMPAIRMENT; REVERSIBLE DEMENTIAS; DEPRESSIVE SYMPTOMS	This case-based discussion focuses on the clinical presentation and diagnostic assessment of a uniquely challenging group of elderly patients: those with symptoms of mild memory problems. Such patients present a challenge to clinicians because of flux in our understandings of normal, age-related cognitive changes; of cognitive changes due to neurodegenerative illnesses; and of the relationships between depression and cognitive impairment. In addition, symptoms of memory problems may be reported by an observer rather than by the patient. These challenges warrant stepwise evaluation of elderly patients who present with symptoms of memory loss.	Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Karlawish, JHT (corresponding author), Inst Aging, 3615 Chestnut St, Philadelphia, PA 19104 USA.	jasonkar@mail.med.upenn.edu			NIA NIH HHS [AG-09215, P01-AG10124, K01-AG00931] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG009215, K01AG000931] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANESHENSEL CS, 1993, J HEALTH SOC BEHAV, V34, P54, DOI 10.2307/2137304; BASSETT SS, 1993, J GERIATR PSYCH NEUR, V6, P105, DOI 10.1177/089198879300600207; BOWLER JV, 1995, CEREBROVASC DIS, V4, P357; BROADHEAD WE, 1990, JAMA-J AM MED ASSOC, V264, P2524, DOI 10.1001/jama.264.19.2524; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; Chui H, 1997, NEUROLOGY, V49, P925, DOI 10.1212/WNL.49.4.925; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Chui HC, 2000, ARCH NEUROL-CHICAGO, V57, P191, DOI 10.1001/archneur.57.2.191; CLARFIELD AM, 1988, ANN INTERN MED, V109, P476, DOI 10.7326/0003-4819-109-6-476; COHEN CA, 1993, GERONTOLOGIST, V33, P714, DOI 10.1093/geront/33.6.714; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; ERKINJUNTTI T, 1994, ARCH NEUROL-CHICAGO, V51, P260, DOI 10.1001/archneur.1994.00540150054016; FEHER EP, 1994, J GERIATR PSYCH NEUR, V7, P58, DOI 10.1177/089198879400700111; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freter S, 1998, CAN MED ASSOC J, V159, P657; HACHINSKI VC, 1974, LANCET, V2, P207; HANNINEN T, 1994, J AM GERIATR SOC, V42, P1; HORWATH E, 1992, ARCH GEN PSYCHIAT, V49, P817; Karlawish JHT, 2000, NEUROLOGY, V55, P1008, DOI 10.1212/WNL.55.7.1008; Karlawish JHT, 2001, J AM GERIATR SOC, V49, P1066, DOI 10.1046/j.1532-5415.2001.49210.x; KIYAK HA, 1994, GERONTOLOGIST, V34, P324, DOI 10.1093/geront/34.3.324; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; KOSS E, 1993, ARCH NEUROL-CHICAGO, V50, P92, DOI 10.1001/archneur.1993.00540010086023; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LAZARUS LW, 1987, AM J PSYCHIAT, V144, P41; LIEBERMAN MA, 1991, GERONTOLOGIST, V31, P371, DOI 10.1093/geront/31.3.371; Logsdon R.G., 1999, J MENTAL HLTH AGING, V5, P21, DOI DOI 10.1037/T03352-000; Lyketsos CG, 1997, J NEUROPSYCH CLIN N, V9, P556; Lyness JM, 1999, J AM GERIATR SOC, V47, P647, DOI 10.1111/j.1532-5415.1999.tb01584.x; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; MCGLONE J, 1990, ARCH NEUROL-CHICAGO, V47, P1189, DOI 10.1001/archneur.1990.00530110043015; McGlynn S.M., 1991, AWARENESS DEFICIT BR, P84; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; O'Hara M W, 1986, Psychol Aging, V1, P208; PARNETTI L, 1993, DRUG INVEST, V6, P181, DOI 10.1007/BF03259242; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petracca G, 1996, J NEUROPSYCH CLIN N, V8, P270; POPKIN SJ, 1982, EXP AGING RES, V8, P141, DOI 10.1080/03610738208260271; REDING M, 1985, ARCH NEUROL-CHICAGO, V42, P894, DOI 10.1001/archneur.1985.04060080080019; REIFLER BV, 1989, AM J PSYCHIAT, V146, P45; REIFLER BV, 1982, J AM GERIATR SOC, V30, P665, DOI 10.1111/j.1532-5415.1982.tb05067.x; Ritchie K, 2000, LANCET, V355, P225, DOI 10.1016/S0140-6736(99)06155-3; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROYBYRNE P, 1994, J GEN INTERN MED, V9, P507, DOI 10.1007/BF02599221; SCHACTER DL, 1997, STORIES ELDERS SEARC, P280; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; Snow V, 2000, ANN INTERN MED, V132, P738, DOI 10.7326/0003-4819-132-9-200005020-00010; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; SONG FJ, 1993, BMJ-BRIT MED J, V306, P683, DOI 10.1136/bmj.306.6879.683; Squire L. R., 1987, MEMORY BRAIN; STEWART JW, 1992, AM J PSYCHIAT, V149, P615; Szegedi A, 1997, PHARMACOPSYCHIATRY, V30, P97, DOI 10.1055/s-2007-979490; Tierney MC, 1996, ARCH NEUROL-CHICAGO, V53, P423, DOI 10.1001/archneur.1996.00550050053023; Turvey CL, 2000, J AM GERIATR SOC, V48, P1435, DOI 10.1111/j.1532-5415.2000.tb02634.x; VANMOFFAERT M, 1989, NEW TRENDS EXPT CLIN, V3, P167; WEINTRAUB S, 2000, PRINCIPLES BEHAV COG, P121; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WELLS KB, 1992, ARCH GEN PSYCHIAT, V49, P788; WHO, 2012, ICD 10 CLASS MENT BE; WILLIAMS JW, 1995, J GEN INTERN MED, V10, P7, DOI 10.1007/BF02599568; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; YLIKOSKI R, 1993, ARCH NEUROL-CHICAGO, V50, P818, DOI 10.1001/archneur.1993.00540080029009; Zanetti O, 1999, J AM GERIATR SOC, V47, P196, DOI 10.1111/j.1532-5415.1999.tb04578.x	69	22	25	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					411	419		10.7326/0003-4819-138-5-200303040-00011	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614094				2022-12-28	WOS:000181257300007
J	Baba, H; Aziz, F; Kaifu, Y; Suwa, G; Kono, RT; Jacob, T				Baba, H; Aziz, F; Kaifu, Y; Suwa, G; Kono, RT; Jacob, T			Homo erectus calvarium from the Pleistocene of Java	SCIENCE			English	Article							RELATIVE BRAIN SIZE; CRANIAL VARIATION; ARCHITECTURE; EVOLUTION; REMAINS; SAPIENS; BASE	A Homo erectus calvarium [Sambungmacan 4 (Sm 4)] was recovered from Pleistocene sediments at Sambungmacan in central Java. Micro-computed tomography analysis shows a modern human-like cranial base flexion associated with a low platycephatic vault, implying that the evolution of human cranial globularity was independent of cranial base flexion. The overall morphology of Sm 4 is intermediate between that of earlier and later Javanese Homo erectus; apparent morphological specializations are more strongly expressed in the latter. This supports the hypothesis that later Pleistocene Javanese populations were substantially isolated and made minimal contributions to the ancestry of modern humans.	Museum Nat Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan; Univ Tokyo, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Geol Res & Dev Ctr, Lab Vertebrate Paleontol, Bandung 40122, Indonesia; Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; Gadjah Mada Univ, Lab Bio & Palaeomanthropol, Yogyakarta 55002, Indonesia	University of Tokyo; University of Tokyo; Gadjah Mada University	Baba, H (corresponding author), Museum Nat Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan.	baba@kahaku.go.jp		Kaifu, Yousuke/0000-0003-0483-104X				Anton SC, 2002, AM J PHYS ANTHROPOL, V118, P301, DOI 10.1002/ajpa.10091; Anton SC, 2002, J HUM EVOL, V43, P555, DOI 10.1006/jhev.2002.0577; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; BHAT M, 1985, ANGLE ORTHOD, V55, P269; Bookstein F, 1999, ANAT RECORD, V257, P217, DOI 10.1002/(SICI)1097-0185(19991215)257:6<217::AID-AR7>3.0.CO;2-W; Delson E, 2001, ANAT RECORD, V262, P380, DOI 10.1002/ar.1048; Gathorne-Hardy FJ, 2002, BIOL J LINN SOC, V75, P453, DOI 10.1046/j.1095-8312.2002.00031.x; Hawks J, 2000, J HUM EVOL, V39, P1, DOI 10.1006/jhev.1999.0384; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOLLOWAY R, 1999, HDB HUMAN SYMBOLIC E, P74; Hyodo M, 2002, J HUM EVOL, V43, P27, DOI 10.1006/jhev.2002.0555; Jacob T., 1981, HOMO ERECTUS PAPERS, P87; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Matsu'ura S, 2000, CURR ANTHROPOL, V41, P297, DOI 10.1086/300136; McCarthy RC, 2001, J HUM EVOL, V40, P41, DOI 10.1006/jhev.2000.0446; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; ROSS C, 1995, AM J PHYS ANTHROPOL, V98, P575, DOI 10.1002/ajpa.1330980413; Santa Luca A.P., 1980, NGANDONG FOSSIL HOMI; Seidler H, 1997, J HUM EVOL, V33, P691, DOI 10.1006/jhev.1997.0163; Spoor F, 2000, AM J PHYS ANTHROPOL, P288; Spoor F, 1997, S AFR J SCI, V93, P182; Spoor F, 1999, NATURE, V397, P572, DOI 10.1038/17505; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; van den Bergh G.D., 1996, B INDO PACIFIC PREHI, V14, P7, DOI [10.7152/bippa.v14i0.11583, DOI 10.7152/BIPPA.V14I0.11583]; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; Weidenreich F., 1943, Palaeontologia Sinica, VD 10, P1; Weidenreich F., 1951, ANTHROPOLOGICAL PAPE, V43, P205; Wolpoff M. H., 1999, PALEOANTHROPOLOGY	31	74	78	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1384	1388		10.1126/science.1081676	http://dx.doi.org/10.1126/science.1081676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610302				2022-12-28	WOS:000181192300049
J	Schmitt, JP; Kamisago, M; Asahi, M; Li, GH; Ahmad, F; Mende, U; Kranias, EG; MacLennan, DH; Seidman, JG; Seidman, CE				Schmitt, JP; Kamisago, M; Asahi, M; Li, GH; Ahmad, F; Mende, U; Kranias, EG; MacLennan, DH; Seidman, JG; Seidman, CE			Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban	SCIENCE			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; SARCOPLASMIC-RETICULUM; TRANSGENIC MICE; CALCIUM; CONTRACTILITY; CA2+; PHOSPHORYLATION; CA2+-ATPASES; EXPRESSION; DOMAIN	Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars annually, remain poorly understood. Here we report that an inherited human dilated cardiomyopathy with refractory congestive heart failure is caused by a dominant Arg --> Cys missense mutation at residue 9 (R9C) in phospholamban (PLN), a transmembrane phosphoprotein that inhibits the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase (SERCA2a) pump. Transgenic PLNR9C mice recapitulated human heart failure with premature death. Cellular and biochemical studies revealed that, unlike wild-type PLN, PLNR9C did not directly inhibit SERCA2a. Rather, PLNR9C trapped protein kinase A (PKA), which blocked PKA-mediated phosphorylation of wild-type PLN and in turn delayed decay of calcium transients in myocytes. These results indicate that myocellular calcium dysregulation can initiate human heart failure-a finding that may lead to therapeutic opportunities.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Cincinnati, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Toronto; University System of Ohio; University of Cincinnati	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.		Schmitt, Joachim/GQP-7068-2022	Ahmad, Ferhaan/0000-0003-2877-4641				Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Chen J, 1999, J CLIN INVEST, V103, P1483, DOI 10.1172/JCI7297; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Frank K, 2000, ANN MED, V32, P572, DOI 10.3109/07853890008998837; Haghighi K, 2001, J BIOL CHEM, V276, P24145, DOI 10.1074/jbc.M102403200; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kubo H, 2001, CIRCULATION, V104, P1012, DOI 10.1161/hc3401.095073; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Reiken S, 2001, CIRCULATION, V104, P2843, DOI 10.1161/hc4701.099578; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Solaro RJ, 1999, NAT MED, V5, P1353, DOI 10.1038/70916; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; TOYOFUKU T, 1992, J BIOL CHEM, V267, P14490; Zhai J, 2000, J BIOL CHEM, V275, P10538, DOI 10.1074/jbc.275.14.10538; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	22	438	460	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1410	1413		10.1126/science.1081578	http://dx.doi.org/10.1126/science.1081578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610310				2022-12-28	WOS:000181192300057
J	Hannonen, M; Sundstrom, L				Hannonen, M; Sundstrom, L			Sociobiology - Worker nepotism among polygynous ants	NATURE			English	Editorial Material							REPRODUCTIVE-SKEW; EVOLUTION; INSECT		Univ Helsinki, Dept Systemat & Ecol, FIN-00014 Helsinki, Finland	University of Helsinki	Hannonen, M (corresponding author), Univ Helsinki, Dept Systemat & Ecol, POB 65, FIN-00014 Helsinki, Finland.	liselotte.sundstrom@helsinki.fi	Sundstrom, Liselotte/G-5080-2010	Sundstrom, Liselotte/0000-0002-6176-8940				COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hannonen M, 2002, ETHOLOGY, V108, P961, DOI 10.1046/j.1439-0310.2002.00829.x; KELLER L, 1993, SCIENCE, V260, P1107, DOI 10.1126/science.260.5111.1107; Keller L, 1999, MG BEH ECOL, P153; PAGE RE, 1989, NATURE, V338, P576, DOI 10.1038/338576a0; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Sundstrom L, 2001, HEREDITY, V86, P515, DOI 10.1046/j.1365-2540.2001.00884.x; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197	10	73	75	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					910	910		10.1038/421910a	http://dx.doi.org/10.1038/421910a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606988				2022-12-28	WOS:000181186900036
J	Neuhauser, MM; Weinstein, RA; Rydman, R; Danziger, LH; Karam, G; Quinn, JP				Neuhauser, MM; Weinstein, RA; Rydman, R; Danziger, LH; Karam, G; Quinn, JP			Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIMICROBIAL RESISTANCE; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; SURVEILLANCE PROGRAM; STATES HOSPITALS; ESCHERICHIA-COLI; INFECTIONS; SUSCEPTIBILITY; RATES	Context Previous surveillance studies have documented increasing rates of antimicrobial resistance in US intensive care units (ICUs) in the early 1990S. Objectives To assess national rates of antimicrobial resistance among gram-negative aerobic isolates recovered from ICU patients and to compare these rates to antimicrobial use. Design and Setting Participating institutions, representing a total of 43 US states plus the District of Columbia, provided antibiotic susceptibility results for 35790 non-duplicate gram-negative aerobic isolates recovered from ICU patients between 1994 and 2000. Main Outcome Measures Each institution tested approximately 100 consecutive gram-negative aerobic isolates recovered from ICU patients. Organisms were identified to the species level. Susceptibility tests were performed, and national fluoroquinolone consumption data were obtained. Results The activity of most antimicrobial agents against gram-negative aerobic isolates showed an absolute decrease of 6% or less over the study period. The overall susceptibility to ciprofloxacin decreased steadily from 86% in 1994 to 76% in 2000 and was significantly associated with increased national use of fluoroquinolones. Conclusions This study documents the increasing incidence of ciprofloxacin resistance among gram-negative bacilli that has occurred coincident with increased use of fluoroquinolones. More judicious use of fluoroquinolones will be necessary to limit this downward trend.	Cook Cty Hosp, Div Infect Dis, Dept Med, Chicago, IL 60612 USA; Univ Houston, Coll Pharm, Dept Clin Sci & Adm, Houston, TX 77030 USA; Rush Med Coll, Dept Med, Chicago, IL 60612 USA; Cook Cty Hosp, Dept Emergency Med, Chicago, IL 60612 USA; Univ Illinois, Sch Publ Hlth, Chicago, IL USA; Univ Illinois, Dept Pharm Practice, Chicago, IL USA; Louisiana State Univ, Sch Med, Dept Med, New Orleans, LA USA	John H Stroger Junior Hospital Cook County; University of Houston System; University of Houston; Rush University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Louisiana State University System	Weinstein, RA (corresponding author), Cook Cty Hosp, Div Infect Dis, Dept Med, Suite 129 Durand,1835 W Harrison St, Chicago, IL 60612 USA.		Asadikaram, Gholamreza/AAG-4437-2021	Asadikaram, Gholamreza/0000-0002-9100-0756				Archibald L, 1997, CLIN INFECT DIS, V24, P211, DOI 10.1093/clinids/24.2.211; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; Gales AC, 2001, CLIN INFECT DIS, V32, pS146, DOI 10.1086/320186; Gerberding J, 2000, AM J INFECT CONTROL, V28, P429, DOI 10.1067/mic.2000.110544; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Hanberger H, 1999, JAMA-J AM MED ASSOC, V281, P67, DOI 10.1001/jama.281.1.67; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Itokazu GS, 1996, CLIN INFECT DIS, V23, P779, DOI 10.1093/clinids/23.4.779; Kohler T, 1999, J BACTERIOL, V181, P6300; Lautenbach E, 2001, CLIN INFECT DIS, V33, P1288, DOI 10.1086/322667; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Paterson DL, 2000, CLIN INFECT DIS, V30, P473, DOI 10.1086/313719; Tankovic J, 1999, J ANTIMICROB CHEMOTH, V43, P19, DOI 10.1093/jac/43.suppl_2.19; Walson JL, 2001, J INFECT DIS, V184, P1163, DOI 10.1086/323647; Wiener J, 1999, JAMA-J AM MED ASSOC, V281, P517, DOI 10.1001/jama.281.6.517	16	512	540	0	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					885	888		10.1001/jama.289.7.885	http://dx.doi.org/10.1001/jama.289.7.885			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588273	Bronze			2022-12-28	WOS:000181072200033
J	Rathore, SS; Curtis, JP; Wang, YF; Bristow, MR; Krumholz, HM				Rathore, SS; Curtis, JP; Wang, YF; Bristow, MR; Krumholz, HM			Association of serum digoxin concentration and outcomes in patients with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; TRIAL	Context The Digitalis Investigation Group (DIG) trial reported that digoxin provided no overall mortality benefit and only a modest reduction in hospitalizations among patients with heart failure and depressed left ventricular systolic function. The clinical outcomes associated with digoxin therapy at different serum concentrations in the DIG trial have not been assessed. Objective To assess variations in serum digoxin concentration (SDC) and their association with mortality and hospitalization in patients with heart failure. Design, Setting, and Patients Post hoc analysis of the randomized, double-blinded, place bo-controlled DIG trial, conducted from August 1991 to December 1995, with the main analysis restricted to men with a left ventricular ejection fraction of 45% or less (n = 3782). Patients randomly assigned to receive digoxin were divided into 3 groups based on SDC at 1 month (0.5-0.8 ng/mL, n=572; 0.9-1.1 ng/mL, n=322; and greater than or equal to1.2 ng/mL, n=277) And compared with patients randomly assigned to receive placebo (n = 2611). Main Outcome Measure All-cause mortality at a mean follow-up of 37 months. Results Higher SDCs were associated with increased crude all-cause mortality rates (0.5-0.8 ng/mL, 29.9%; 0.9-1.1 ng/mL, 38.8%; and greater than or equal to1.2 ng/mL, 48.0%; P=.006 for trend). Patients with SDCs of 0.5 to 0.8 ng/mL had a 6.3% (95% confidence, interval [01, 2.1%-10.5%) lower mortality rate compared with patients receiving placebo. Digoxin was not associated with a reduction in mortality among patients with SDCs of 0.9 to 1.1 ng/mL (2.6% increase; 95% CO,-3.0% to 8.3%), whereas patients with SDCs of 1.2 ng/mL and higher had an 11.8% (95% CI, 5.7%-18.0%) higher absolute mortality rate than patients receiving placebo. The association between SDC and mortality persisted after multivariable adjustment (SDC 0.5-0.8 ng/mL hazard ratio [HR] 0.80, 95% CI, 0.68-0.94; SDC 0.9-1.1 ng/mL HR 0.89, 95% CI, 0.74-1.08; SDC 1.2 ng/mL HR 1.16, 95% CI, 0.96-1.39; and HR of 1.00 [referent] for placebo). Conclusions Our findings demonstrate that higher SDCs were associated,with increased mortality and suggest that the effectiveness of digoxin therapy in men with heart failure and a left ventricular ejection fraction of 45% or less may be optimized in the SDC range of 0.5 to 0.8 ng/mL.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; Univ Colorado, Hlth Sci Ctr, Div Cardiol, Denver, CO 80262 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Room I-456 SHM,333 Cedar St,POB 208025, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; bristow, michael r/G-7850-2011					Abernathy GT, 1996, CONTROL CLIN TRIALS, V17, P77; Adams KF, 2002, J AM COLL CARDIOL, V39, P946, DOI 10.1016/S0735-1097(02)01708-4; [Anonymous], 2002, AM J KIDNEY DIS, V39, pS76, DOI DOI 10.1053/ajkd.2002.30944; BRISTOW MR, 1994, CORONARY ARTERY DIS, V5, P112, DOI 10.1097/00019501-199402000-00004; BRISTOW MW, 2001, HEART DIS; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; GHEORGHIADE M, 1991, CIRCULATION, V84, P2181, DOI 10.1161/01.CIR.84.5.2181; Gheorghiade M, 1997, AM HEART J, V134, P3, DOI 10.1016/S0002-8703(97)70100-5; GHEORGHIADE M, 1995, CIRCULATION, V92, P1801, DOI 10.1161/01.CIR.92.7.1801; Gibbs CR, 2000, BRIT MED J, V320, P495, DOI 10.1136/bmj.320.7233.495; Hauptman PJ, 1999, CIRCULATION, V99, P1265, DOI 10.1161/01.CIR.99.9.1265; HUNT SA, ACC AHA GUIDELINES E; JAHANGIR A, 2000, MAYO CLIN CARDIOLOGY; JELLIFFE RW, 1974, AM J MED, V57, P63, DOI 10.1016/0002-9343(74)90769-4; Krohn BG, 2002, J AM COLL CARDIOL, V40, P836, DOI 10.1016/S0735-1097(02)02018-1; LEJEMTEL TH, 2001, HURSTS HEART; LEOR J, 1995, CARDIOVASC DRUG THER, V9, P723, DOI 10.1007/BF00878556; Liu P, 2001, Can J Cardiol, V17 Suppl E, p5E; Lowes BD, 2000, J AM COLL CARDIOL, V36, P501, DOI 10.1016/S0735-1097(00)00759-2; MANCINI DM, 1991, CIRCULATION, V84, P243; Newton GE, 1996, J AM COLL CARDIOL, V28, P155, DOI 10.1016/0735-1097(96)00120-9; ORDOG GJ, 1987, ANN EMERG MED, V16, P32, DOI 10.1016/S0196-0644(87)80281-0; PACKER M, 1993, J AM COLL CARDIOL, V22, pA119, DOI 10.1016/0735-1097(93)90474-F; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Perry G, 1997, NEW ENGL J MED, V336, P525; Rathore SS, 2002, NEW ENGL J MED, V347, P1403, DOI 10.1056/NEJMoa021266; REMME WJ, 1994, BR HEART J S, V72, P92; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Slatton ML, 1997, J AM COLL CARDIOL, V29, P1206, DOI 10.1016/S0735-1097(97)00057-0; Soto J, 1997, NEW ENGL J MED, V337, P129; Terra SG, 1999, PHARMACOTHERAPY, V19, P1123, DOI 10.1592/phco.19.15.1123.30570; van Veldhuisen DJ, 2002, J AM COLL CARDIOL, V39, P954, DOI 10.1016/S0735-1097(02)01710-2; VANVELDHUISEN DJ, 1993, J AM COLL CARDIOL, V22, P1564, DOI 10.1016/0735-1097(93)90579-P; WARE JA, 1984, J AM GERIATR SOC, V32, P631, DOI 10.1111/j.1532-5415.1984.tb02249.x	34	445	467	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					871	878		10.1001/jama.289.7.871	http://dx.doi.org/10.1001/jama.289.7.871			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588271	Bronze			2022-12-28	WOS:000181072200031
J	Pan, JW; Gasparoni, S; Aspelmeyer, M; Jennewein, T; Zeilinger, A				Pan, JW; Gasparoni, S; Aspelmeyer, M; Jennewein, T; Zeilinger, A			Experimental realization of freely propagating teleported qubits	NATURE			English	Article							QUANTUM TELEPORTATION; COMMUNICATION; ENTANGLEMENT; COMPUTATION; OPERATIONS; STATE	Quantum teleportation(1) is central to quantum communication, and plays an important role in a number of quantum computation protocols(2,3). Most information-processing applications of quantum teleportation include the subsequent manipulation of the qubit (the teleported photon), so it is highly desirable to have a teleportation procedure resulting in high-quality, freely flying qubits. In our previous teleportation experiment(4), the teleported qubit had to be detected (and thus destroyed) to verify the success of the procedure. Here we report a teleportation experiment that results in freely propagating individual qubits. The basic idea is to suppress unwanted coincidence detection events by providing the photon to be teleported much less frequently than the auxiliary entangled pair. Therefore, a case of successful teleportation can be identified with high probability without the need actually to detect the teleported photon. The experimental fidelity of our procedure surpasses the theoretical limit required for the implementation of quantum repeaters(5,6).	Univ Vienna, Inst Expt Phys, A-1090 Vienna, Austria	University of Vienna	Pan, JW (corresponding author), Univ Vienna, Inst Expt Phys, Boltzmanngasse 5, A-1090 Vienna, Austria.	pan@ap.univie.ac.at; Zeilinger-office@exp.univie.ac.at	Aspelmeyer, Markus/C-4098-2017; Zeilinger, Anton/A-1170-2011; Pan, Jian-Wei/A-2332-2010	Aspelmeyer, Markus/0000-0003-4499-7335; Pan, Jian-Wei/0000-0002-6100-5142				Aschauer H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047902; Bennett CH, 1999, PHYS REV LETT, V83, P3081, DOI 10.1103/PhysRevLett.83.3081; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bouwmeester D, 1998, NATURE, V394, P841, DOI 10.1038/29678; Braunstein SI, 1998, NATURE, V394, P840, DOI 10.1038/29674; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Grosshans F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.010301; Howell JC, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.030401; JENNEWEIN T, 2002, PHYS REV LETT, V88; Kim YH, 2001, PHYS REV LETT, V86, P1370, DOI 10.1103/PhysRevLett.86.1370; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kok P, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.042304; Kurtsiefer C, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.023802; Pan JW, 2001, PHYS REV LETT, V86, P4435, DOI 10.1103/PhysRevLett.86.4435; Pan JW, 1998, PHYS REV A, V57, P2208, DOI 10.1103/PhysRevA.57.2208; Pan JW, 2001, NATURE, V410, P1067, DOI 10.1038/35074041; RUDOLPH T, 2001, PHYS REV LETT, V88	20	80	90	5	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					721	725		10.1038/nature01412	http://dx.doi.org/10.1038/nature01412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610619				2022-12-28	WOS:000180938000037
J	Watkins, DN; Berman, DM; Burkholder, SG; Wang, BL; Beachy, PA; Baylin, SB				Watkins, DN; Berman, DM; Burkholder, SG; Wang, BL; Beachy, PA; Baylin, SB			Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer	NATURE			English	Article							SONIC HEDGEHOG; CYCLOPAMINE; INHIBITION; GROWTH; SHH; MEDULLOBLASTOMA; DIFFERENTIATION; MORPHOGENESIS; CEREBELLUM; MUTANTS	Embryonic signalling pathways regulate progenitor cell fates in mammalian epithelial development and cancer(1,2). Prompted by the requirement for sonic hedgehog (Shh) signalling in lung development(3,4), we investigated a role for this pathway in regeneration and carcinogenesis of airway epithelium. Here we demonstrate extensive activation of the hedgehog (Hh) pathway within the airway epithelium during repair of acute airway injury. This mode of Hh signalling is characterized by the elaboration and reception of the Shh signal within the epithelial compartment, and immediately precedes neuroendocrine differentiation. We reveal a similar pattern of Hh signalling in airway development during normal differentiation of pulmonary neuroendocrine precursor cells, and in a subset of small-cell lung cancer (SCLC), a highly aggressive and frequently lethal human tumour with primitive neuroendocrine features. These tumours maintain their malignant phenotype in vitro and in vivo through ligand-dependent Hh pathway activation. We propose that some types of SCLC might recapitulate a critical, Hh-regulated event in airway epithelial differentiation. This requirement for Hh pathway activation identifies a common lethal malignancy that may respond to pharmacological blockade of the Hh signalling pathway.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Watkins, DN (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.		berman, david/HIR-4177-2022; Watkins, David N/I-6113-2013	berman, david/0000-0001-5985-3698				Bellusci S, 1997, DEVELOPMENT, V124, P53; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hogan B, 1994, MANIPULATING MOUSE E; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Johnson DH, 1999, CHEST, V116, p525S, DOI 10.1378/chest.116.suppl_3.525S; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Lee J, 1997, DEVELOPMENT, V124, P2537; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Nakakura EK, 2001, P NATL ACAD SCI USA, V98, P4010, DOI 10.1073/pnas.051014098; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Park HL, 2000, DEVELOPMENT, V127, P1593; Peake JL, 2000, AM J PATHOL, V156, P279, DOI 10.1016/S0002-9440(10)64728-1; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Weaver M, 1999, DEVELOPMENT, V126, P4005; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	30	877	974	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					313	317		10.1038/nature01493	http://dx.doi.org/10.1038/nature01493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12629553				2022-12-28	WOS:000181637300040
J	Gross, CP; Gupta, AR; Krumholz, HM				Gross, CP; Gupta, AR; Krumholz, HM			Disclosure of financial competing interests in randomised controlled trials: cross sectional review	BRITISH MEDICAL JOURNAL			English	Article									Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, 333 Cedar St, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020					Blumenthal D, 1996, ACAD MED, V71, P1291, DOI 10.1097/00001888-199612000-00010; BODENHEIMER T, 2000, NEW ENGL J MED, V342, P1621; Davidoff F, 2001, LANCET, V358, P854, DOI 10.1016/S0140-6736(01)06035-4; Hussain A, 2001, BRIT MED J, V323, P263, DOI 10.1136/bmj.323.7307.263; *INT COMM MED J, 1997, UNPUB ANN INTERN MED, V126, P36	5	24	24	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					526	527		10.1136/bmj.326.7388.526	http://dx.doi.org/10.1136/bmj.326.7388.526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623910	Green Published, Bronze			2022-12-28	WOS:000181548400016
J	Bridle, SL; Lahav, O; Ostriker, JP; Steinhardt, PJ				Bridle, SL; Lahav, O; Ostriker, JP; Steinhardt, PJ			Precision cosmology? Not just yet ...	SCIENCE			English	Editorial Material							SUPERNOVAE; OMEGA(M); UNIVERSE		Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	University of Cambridge; Princeton University	Bridle, SL (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	sarah@ast.cam.ac.uk		Steinhardt, Paul/0000-0003-3488-1603				Allen SJ, UNPUB; Bahcall NA, 2000, ASTROPHYS J, V541, P1, DOI 10.1086/309423; BENNETT CH, UNPUB; DEDEO S, UNPUB; GRAINGE K, UNPUB; HINSHAW G, UNPUB; Hoekstra H, 2002, ASTROPHYS J, V577, P595, DOI 10.1086/342120; Jarvis M.J., UNPUB; KHOURY J, UNPUB; KOGUT A, UNPUB; KOMATSU E, UNPUB; KUO CH, UNPUB; PEARSON T, UNPUB; PEIRIS H, UNPUB; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; PIERPAOLI E, UNPUB; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; SPERGEL D, UNPUB; Steinhardt PJ, 2002, SCIENCE, V296, P1436, DOI 10.1126/science.1070462; VERDE L, UNPUB	21	174	174	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1532	1533		10.1126/science.1082158	http://dx.doi.org/10.1126/science.1082158			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624255				2022-12-28	WOS:000181367900025
J	Meneghini, MD; Wu, M; Madhani, HD				Meneghini, MD; Wu, M; Madhani, HD			Conserved histone variant H2A.Z protects euchromatin from the ectopic spread of silent heterochromatin	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; GENE-EXPRESSION; ACTIVE GENES; TRANSCRIPTIONAL ACTIVATION; IN-VIVO; YEAST; CHROMATIN; H3; METHYLATION	Boundary elements hinder the spread of heterochromatin, yet these sites do not fully account for the preservation of adjacent euchromatin. Histone variant H2A.Z (Htz1 in yeast) replaces conventional H2A in many nucleosomes. Microarray analysis revealed that HTZ1-activated genes cluster near telomeres. The reduced expression of most of these genes in htz1Delta cells was reversed by the deletion of SIR2 (sir2Delta) suggesting that H2A.Z antagonizes telomeric silencing. Other Htz1-activated genes flank the silent HMR mating-type locus. Their requirement for Htz1 can be bypassed by sir2Delta or by a deletion encompassing the silencing nucleation sites in HMR. In htz1Delta cells, Sir2 and Sir3 spread into flanking euchromatic regions, producing changes in histone H4 acetylation and H3 4-methylation indicative of ectopic heterochromatin formation. Htz1 is enriched in these euchromatic regions and acts synergistically with a boundary element to prevent the spread of heterochromatin. Thus, euchromatin and heterochromatin each contains components that antagonize switching to the opposite chromatin state.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Madhani, Hiten/0000-0001-7400-6657				Abbott DW, 2001, J BIOL CHEM, V276, P41945, DOI 10.1074/jbc.M108217200; ALLIS CD, 1980, CELL, V20, P609, DOI 10.1016/0092-8674(80)90307-4; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bi X, 2001, CURR OPIN GENET DEV, V11, P199, DOI 10.1016/S0959-437X(00)00179-9; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fourel G, 2002, BIOESSAYS, V24, P828, DOI 10.1002/bies.10139; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oki M, 2002, CURR OPIN CELL BIOL, V14, P299, DOI 10.1016/S0955-0674(02)00327-7; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1998, GENETICS, V149, P1205; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	53	480	496	1	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					725	736		10.1016/S0092-8674(03)00123-5	http://dx.doi.org/10.1016/S0092-8674(03)00123-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628191	Bronze			2022-12-28	WOS:000181443600014
J	White, AR; Enever, P; Tayebi, M; Mushens, R; Linehan, J; Brandner, S; Anstee, D; Collinge, J; Hawke, S				White, AR; Enever, P; Tayebi, M; Mushens, R; Linehan, J; Brandner, S; Anstee, D; Collinge, J; Hawke, S			Monoclonal antibodies inhibit prion replication and delay the development of prion disease	NATURE			English	Article							FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; SCRAPIE AGENT; INCUBATION PERIOD; MICE LACKING; VARIANT CJD; CONGO RED; PROTEIN; PRP; ACCUMULATION	Prion diseases such as Creutzfeldt-Jakob disease (CJD) are fatal, neuro-degenerative disorders with no known therapy. A proportion of the UK population has been exposed to a bovine spongiform encephalopathy-like prion strain(1-3) and are at risk of developing variant CJD(4). A hallmark of prion disease is the transformation of normal cellular prion protein (PrP(C)) into an infectious disease-associated isoform(5), PrP(Sc). Recent in vitro studies indicate that anti-PrP monoclonal antibodies with little or no affinity for PrP(Sc) can prevent the incorporation of PrP(C) into propagating prions(6,7). We therefore investigated in a murine scrapie model whether anti-PrP monoclonal antibodies show similar inhibitory effects on prion replication in vivo. We found that peripheral PrP(Sc) levels and prion infectivity were markedly reduced, even when the antibodies were first administered at the point of near maximal accumulation of PrP(Sc) in the spleen. Furthermore, animals in which the treatment was continued remained healthy for over 300 days after equivalent untreated animals had succumbed to the disease. These findings indicate that immunotherapeutic strategies for human prion diseases are worth pursuing.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Neurosci & Psychol Med, Dept Neurogenet,CNS Infect & Immun Grp, London W2 1PG, England; Natl Blood Serv, IBGRL, Bristol BS10 5ND, Avon, England; UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	Imperial College London; University of London; University College London; University of London; University College London	Hawke, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Neurosci & Psychol Med, Dept Neurogenet,CNS Infect & Immun Grp, Norfolk Pl, London W2 1PG, England.	s.hawke@imperial.ac.uk	TAYEBI, MOURAD/F-7404-2010; Brandner, Sebastian/J-4562-2014; White, Anthony/P-5596-2016	Brandner, Sebastian/0000-0002-9821-0342; White, Anthony/0000-0003-1802-9891; TAYEBI, MOURAD/0000-0001-8664-6918				ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; AVENT ND, 1988, BIOCHEM J, V256, P1043, DOI 10.1042/bj2561043; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Beringue V, 2000, J VIROL, V74, P5432, DOI 10.1128/JVI.74.12.5432-5440.2000; BERINGUE V, UNPUB BRAIN; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Brown P, 2002, NEUROLOGY, V58, P1720, DOI 10.1212/WNL.58.12.1720; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; MCKENZIE D, 1994, J VIROL, V68, P7534, DOI 10.1128/JVI.68.11.7534-7536.1994; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Souan L, 2001, EUR J IMMUNOL, V31, P2338, DOI 10.1002/1521-4141(200108)31:8&lt;2338::AID-IMMU2338&gt;3.0.CO;2-V; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Westaway D, 2002, TRENDS BIOCHEM SCI, V27, P301, DOI 10.1016/S0968-0004(02)02106-0; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	30	382	410	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					80	83		10.1038/nature01457	http://dx.doi.org/10.1038/nature01457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621436	Green Published			2022-12-28	WOS:000181343100041
J	Drazen, JM				Drazen, JM			Inappropriate advertising of dietary supplements	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GROWTH-HORMONE						Drazen, Jeffrey M/E-5841-2012; de Lemos, Mario L./I-2462-2019	Drazen, Jeffrey/0000-0003-2715-9890				RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; VANCE ML, 1990, NEW ENGL J MED, V323, P52	2	25	29	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					777	778		10.1056/NEJMp030021	http://dx.doi.org/10.1056/NEJMp030021			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606730	Bronze			2022-12-28	WOS:000181173300002
J	Hamm, CE; Merkel, R; Springer, O; Jurkojc, P; Maier, C; Prechtel, K; Smetacek V				Hamm, CE; Merkel, R; Springer, O; Jurkojc, P; Maier, C; Prechtel, K; Smetacek, V			Architecture and material properties of diatom shells provide effective mechanical protection	NATURE			English	Article							ZOOPLANKTON; MORPHOLOGY; FRUSTULE; SILICA; CYCLE; BONE	Diatoms are the major contributors to phytoplankton blooms in lakes and in the sea and hence are central in aquatic ecosystems and the global carbon cycle(1). All free-living diatoms differ from other phytoplankton groups in having silicified cell walls in the form of two 'shells' (the frustule) of manifold shape and intricate architecture(2) whose function and role, if any, in contributing to the evolutionary success of diatoms is under debate(3-5). We explored the defence potential of the frustules as armour against predators by measuring their strength. Real and virtual loading tests (using calibrated glass microneedles and finite element analysis) were performed on centric and pennate diatom cells. Here we show that the frustules are remarkably strong by virtue of their architecture and the material properties of the diatom silica. We conclude that diatom frustules have evolved as mechanical protection for the cells because exceptional force is required to break them. The evolutionary arms race between diatoms and their specialized predators will have had considerable influence in structuring pelagic food webs and biogeochemical cycles.	Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Tech Univ Munich, Dept Phys, Biophys Grp E22, D-85748 Garching, Germany; Forschungszentrum Julich, Res Ctr, Inst Thin Films & Interfaces, D-52425 Julich, Germany; Hsch bramen Univ Appl Sci, D-28199 Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Technical University of Munich; Helmholtz Association; Research Center Julich; Bremen University of Applied Sciences	Hamm, CE (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.	chamm@awi-bremerhaven.de	Merkel, Rudolf/G-3647-2013	Merkel, Rudolf/0000-0003-3178-3282; Hamm, Christian/0000-0002-5121-9542				ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0; ATKINSON A, 1995, ICES J MAR SCI, V52, P385, DOI 10.1016/1054-3139(95)80054-9; BURKHARDT B, 1984, DIATOMS 1 SHELLS NAT; Cifuentes AO, 1992, FINITE ELEM ANAL DES, V12, P313; Crawford SA, 2001, J PHYCOL, V37, P543, DOI 10.1046/j.1529-8817.2001.037004543.x; Ehrenberg CG., 1838, INFUSIONSTHIERCHEN A, DOI [10.5962/bhl.title.58475, DOI 10.5962/BHL.TITLE.58475]; Fortin D., 2000, J AM DENT ASSOC, V131, p26S, DOI DOI 10.14219/JADA.ARCHIVE.2000.0399; FOWLER SW, 1983, DEEP-SEA RES, V30, P963, DOI 10.1016/0198-0149(83)90051-1; Gersonde R, 1990, PROC OCEAN DRILL SCI, P365, DOI DOI 10.2973/0DP.PR0C.SR.113.127.1990; HAECKEL Ernst, 2004, KUNSTFORMEN NATUR; Hale MS, 2001, AQUAT MICROB ECOL, V24, P287, DOI 10.3354/ame024287; Jacobson DM, 1999, J EUKARYOT MICROBIOL, V46, P376, DOI 10.1111/j.1550-7408.1999.tb04616.x; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; Round F. E., 1990, DIATOMS BIOL MORPHOL; Round F. E., 1972, NOVA HEDWIGIA, V23, P291; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; SMETACEK V, 1981, MAR BIOL, V63, P1, DOI 10.1007/BF00394657; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; STEUCEK G, 1989, BEITR 1 INT S SOND 2, P194; Suh HL, 1996, HYDROBIOLOGIA, V321, P235, DOI 10.1007/BF00143753; SULLIVAN BK, 1975, MAR BIOL, V30, P175, DOI 10.1007/BF00391591; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; TILMAN D, 1976, LIMNOL OCEANOGR, V21, P409; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Weis-Fogh T., 1977, SCALE EFFECTS ANIMAL, P511; WILLEMS G, 1992, DENT MATER, V8, P310, DOI 10.1016/0109-5641(92)90106-M	27	634	661	10	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					841	843		10.1038/nature01416	http://dx.doi.org/10.1038/nature01416			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594512	Green Published			2022-12-28	WOS:000181044700047
J	Filippini, G; Munari, L; Incorvaia, B; Ebers, GC; Polman, C; D'Amico, R; Rice, GPA				Filippini, G; Munari, L; Incorvaia, B; Ebers, GC; Polman, C; D'Amico, R; Rice, GPA			Interferons in relapsing remitting multiple sclerosis: a systematic review	LANCET			English	Article							QUALITY-OF-LIFE; RECOMBINANT ALPHA-2 INTERFERON; DOUBLE-BLIND; DISEASE-ACTIVITY; CLINICAL-TRIAL; BETA; DISABILITY; THERAPY; EXACERBATION; PROGRESSION	Background Recombinant interferons have been approved by many national regulatory agencies for treatment of relapsing remitting multiple sclerosis, but widespread discussion continues about their true effectiveness, benefits, side-effects, and costs. Methods With the Cochrane Collaboration methodology, we reviewed all published, randomised, placebo-controlled trials of recombinant interferons undertaken in patients with relapsing remitting multiple sclerosis between 1993 and 2002. Our primary aim was to find out whether recombinant interferons reduced the number of patients who had clinical exacerbations and disease progression, compared with placebo. Findings The seven trials that met our criteria included 1215 randomised patients: data from 667 (55%) were available for analysis at 1 year's and from 919 (76%) at 2 years' follow-up. Interferon seemed to reduce the number of patients who had exacerbations during the first year of treatment (relative risk 0.73, 95% CI 0.54-0.99), but results at 2 years' follow-up were not robust and were difficult to interpret because of the many dropouts'. Although the number of patients who had exacerbations (0.81, 0.74-0.89) or progressed (0.70, 0.55-0.88) during the first 2 years fell significantly in the protocol analysis, results were inconclusive after sensitivity analyses for exacerbations (1.11, 0.73-1.68) and disease progression (1.31, 0.60-2.89). Data were insufficient to establish whether steroid use and admissions to hospital were reduced in the interferon group. Similarly, MRI outcome data could not be analysed quantitatively. Side-effects were common, and acute toxic effects adversely affected quality of life. Interpretation Recombinant interferons slightly reduce the number of patients who have exacerbations during first year of treatment. Their clinical effect beyond 1 year is uncertain and new trials are needed to assess their long-term effectiveness and side-effects.	Natl Neurol Inst C Besta, Unit Neuroepidemiol, I-20133 Milan, Italy; Mediss Med Serv, Milan, Italy; Univ Milan, Neurol Clin, Milan, Italy; Univ Oxford, Radcliffe Infirm, Oxford OX2 6HE, England; Neurol VU Med Ctr, Amsterdam, Netherlands; Univ Studi Modena & Reggio Emilia, Dipartimento Sci Igienist Microbiol & Biostat, Modena, Italy; Univ Western Ontario, London, ON, Canada	IRCCS Istituto Neurologico Besta; University of Milan; Radcliffe Infirmary; University of Oxford; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Universita di Modena e Reggio Emilia; Western University (University of Western Ontario)	Filippini, G (corresponding author), Natl Neurol Inst C Besta, Unit Neuroepidemiol, Via Celoria 11, I-20133 Milan, Italy.		D'Amico, Roberto/I-8106-2014	D'Amico, Roberto/0000-0002-3211-6687; Ebers, George/0000-0003-4771-4177				AbdulAhad AK, 1997, CYTOKINES CELL MOL T, V3, P27; Brod SA, 2001, NEUROLOGY, V57, P845, DOI 10.1212/WNL.57.5.845; CAMENGA DL, 1986, ARCH NEUROL-CHICAGO, V43, P1239; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; DURELLI L, 1994, NEUROLOGY, V44, P406, DOI 10.1212/WNL.44.3_Part_1.406; Ebers G, 1999, NEUROLOGY, V53, P679; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Ebrahim S, 2001, SYSTEMATIC REV HLTH, P386; European Agency for the Evaluation of Medicinal Products, 2002, COMM PROPR MED PROD; Fernandez O, 1995, Mult Scler, V1 Suppl 1, pS67; Forbes RB, 1999, BMJ-BRIT MED J, V319, P1529, DOI 10.1136/bmj.319.7224.1529; FRITH JA, 1989, J NEUROL NEUROSUR PS, V52, P566; HERNDON RM, 1999, INT J MS CARE, V1, P1; HIRSCH RL, 1986, J INTERFERON RES, V6, P171, DOI 10.1089/jir.1986.6.171; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; JACOBS L, 1981, SCIENCE, V214, P1026, DOI 10.1126/science.6171035; Jacobs L D, 1995, Mult Scler, V1, P118; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Juni P, 2001, SYSTEMATIC REV HLTH, P87; KNOBLER RL, 1984, ANN NY ACAD SCI, V436, P382, DOI 10.1111/j.1749-6632.1984.tb14809.x; KNOBLER RL, 1984, NEUROLOGY, V34, P1273, DOI 10.1212/WNL.34.10.1273; KNOBLER RL, 1993, J INTERFERON RES, V13, P333, DOI 10.1089/jir.1993.13.333; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; MILANESE C, 1990, J NEUROL NEUROSUR PS, V53, P554, DOI 10.1136/jnnp.53.7.554; Myhr KM, 1999, NEUROLOGY, V52, P1049, DOI 10.1212/WNL.52.5.1049; Narayanan S, 2001, J NEUROL, V248, P979, DOI 10.1007/s004150170052; Nortvedt MW, 1999, MULT SCLER, V5, P317, DOI 10.1177/135245859900500503; Nortvedt MW, 2000, NEUROLOGY, V55, P51, DOI 10.1212/WNL.55.1.51; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POZZILLI C, 1997, J NEUROLOGY S3, V244, pS25; Rice G, 1998, ARCH NEUROL-CHICAGO, V55, P1578, DOI 10.1001/archneur.55.12.1578; RICE GP, 2000, COCHRANE LIB; RUDGE P, 1995, LANCET, V345, P580, DOI 10.1016/S0140-6736(95)90486-7; Rudick RA, 1997, NEUROLOGY, V49, P358, DOI 10.1212/WNL.49.2.358; Rudick RA, 1998, NEUROLOGY, V50, P1266, DOI 10.1212/WNL.50.5.1266; Schwartz CE, 1997, ARCH NEUROL-CHICAGO, V54, P1475, DOI 10.1001/archneur.1997.00550240029009; Simon JH, 1999, NEUROLOGY, V53, P139, DOI 10.1212/WNL.53.1.139; Smeeth L, 1999, BMJ-BRIT MED J, V318, P1548, DOI 10.1136/bmj.318.7197.1548; Tilbery CP, 2000, ARQ NEURO-PSIQUIAT, V58, P452, DOI 10.1590/S0004-282X2000000300009	45	237	247	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					545	552		10.1016/S0140-6736(03)12512-3	http://dx.doi.org/10.1016/S0140-6736(03)12512-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598138				2022-12-28	WOS:000181033400006
J	Check, E				Check, E			Biologists wary that cash up front could mean cuts later	NATURE			English	News Item																		2003, NATURE, V421, P565	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					677	677		10.1038/421677b	http://dx.doi.org/10.1038/421677b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610581	Bronze			2022-12-28	WOS:000180938000003
J	Etienne-Manneville, S; Hall, A				Etienne-Manneville, S; Hall, A			Cdc42 regulates GSK-3 beta and adenomatous polyposis coli to control cell polarity	NATURE			English	Article							BETA-CATENIN; XENOPUS EMBRYOS; PROTEIN EB1; C-ELEGANS; KINASE; PHOSPHORYLATION; MICROTUBULES; COMPLEX; BINDING; ACTIVATION	Cell polarity is a fundamental property of all cells. In higher eukaryotes, the small GTPase Cdc42, acting through a Par6-atypical protein kinase C (aPKC) complex, is required to establish cellular asymmetry during epithelial morphogenesis, asymmetric cell division and directed cell migration(1-5). However, little is known about what lies downstream of this complex. Here we show, through the use of primary rat astrocytes in a cell migration assay, that Par6-PKCzeta interacts directly with and regulates glycogen synthase kinase-3beta (GSK-3beta) to promote polarization of the centrosome and to control the direction of cell protrusion. Cdc42-dependent phosphorylation of GSK-3beta induces the interaction of adenomatous polyposis coli (Apc) protein with the plus ends of microtubules. The association of Apc with microtubules is essential for cell polarization. We conclude that Cdc42 regulates cell polarity through the spatial regulation of GSK-3beta and Apc. This role for Apc may contribute to its tumour-suppressor activity. occurs specifically at the leading edge of migrating cells, and	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Canc Res UK Oncogene & Signal Transduct Grp, Cell Biol Unit, London WC1E 6BT, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Hall, A (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	alan.hall@ucl.ac.uk	Etienne-Manneville, Sandrine/C-5879-2015	Etienne-Manneville, Sandrine/0000-0001-6651-3675				Barth AIM, 2002, J CELL SCI, V115, P1583; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Emily-Fenouil F, 1998, DEVELOPMENT, V125, P2489; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ferkey DM, 2000, DEV BIOL, V225, P471, DOI 10.1006/dbio.2000.9816; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Lucas FR, 1998, J CELL SCI, V111, P1351; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Oriente F, 2001, J BIOL CHEM, V276, P37109, DOI 10.1074/jbc.M104405200; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SU LK, 1995, CANCER RES, V55, P2972; Troussard AA, 1999, MOL CELL BIOL, V19, P7420; Wagner U, 1996, J CELL SCI, V109, P1537; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	28	682	706	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					753	756		10.1038/nature01423	http://dx.doi.org/10.1038/nature01423			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610628				2022-12-28	WOS:000180938000046
J	Gordon, J				Gordon, J			ABC of learning and teaching in medicine - One to one teaching and feedback	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Gordon, J (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.							AUSUBEL D. P., 1978, ED PSYCHOL COGNITIVE, V2; Parsell G, 2001, MED EDUC, V35, P409, DOI 10.1046/j.1365-2923.2001.00900.x; PAULMAN PM, 2000, PRECEPTING MED STUDE; Stott N C, 1979, J R Coll Gen Pract, V29, P201; Westberg J., 1993, COLLABORATIVE CLIN E; WHITEHOUSE C, 1997, TEACHING MED COMMUNI	6	50	56	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2003	326	7388					543	545		10.1136/bmj.326.7388.543	http://dx.doi.org/10.1136/bmj.326.7388.543			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623919	Green Published			2022-12-28	WOS:000181548400025
J	Samanta, J; Kendall, J; Samanta, A				Samanta, J; Kendall, J; Samanta, A			10-minute consultation - Chronic low back pain	BRITISH MEDICAL JOURNAL			English	Article									Leicester Royal Infirm, Dept Rheumatol, Leicester LE1 5WW, Leics, England	University of Leicester	Samanta, A (corresponding author), Leicester Royal Infirm, Dept Rheumatol, Leicester LE1 5WW, Leics, England.								0	27	30	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					535	535		10.1136/bmj.326.7388.535	http://dx.doi.org/10.1136/bmj.326.7388.535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623915	Bronze, Green Published			2022-12-28	WOS:000181548400021
J	Schwartz, A; Hupert, J				Schwartz, A; Hupert, J			Medical students' application of published evidence: randomised trial	BRITISH MEDICAL JOURNAL			English	Article							CRITICAL-APPRAISAL	Objectives To determine how medical students apply research evidence that varies in validity of methods and importance of results to a clinical decision. Design Students examined a standardised patient with a whiplash injury, decided whether to order a cervical spine radiograph, and rated their confidence in their decision. They then read one of four randomly assigned variants of a structured abstract from a study of a decision rule that argued against such a procedure in this patient Variants factorially combined two levels of validity of methods (prospective cohort or chart review) with two levels of importance of results (high sensitivity or high specificity rule). After reading the abstract, students repeated their choice and rated their confidence. Setting Academic medical centre in the United States. Participants 164 graduating medical students. Main outcome measures Proportion of students in each group whose beliefs shifted or stayed the same. Results When abstracts were of low importance students were more likely to shift their beliefs in favour of radiography, which was not supported by the evidence (odds ratio 3.42, 95% confidence interval 1.10 to 10.66). Neither methodological validity nor the interaction between validity and importance influenced decision shift. Few students acquired all necessary clinical data from the patient. Conclusions Although the students could apply concepts of diagnostic testing, greater focus is needed on appraisal of validity and application of evidence to a particular patient.	Univ Illinois, Dept Med Educ, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Schwartz, A (corresponding author), Univ Illinois, Dept Med Educ, MC 591,808 S Wood St,986 CME, Chicago, IL 60612 USA.		Schwartz, Alan/G-2814-2010	Schwartz, Alan/0000-0003-3809-6637				*ASS AC MED COLL, LCME ANN MED SCH QUE; Bradley P, 1999, MED EDUC, V33, P815, DOI 10.1046/j.1365-2923.1999.00466.x; Green ML, 1999, ACAD MED, V74, P686, DOI 10.1097/00001888-199906000-00017; Norman GR, 1998, CAN MED ASSOC J, V158, P177; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Schwartz Alan, 2001, Pediatric Research, V49, p74A; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841	7	10	10	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					536	538		10.1136/bmj.326.7388.536	http://dx.doi.org/10.1136/bmj.326.7388.536			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623916	Green Published, Bronze			2022-12-28	WOS:000181548400022
J	Atran, S				Atran, S			Genesis of suicide terrorism	SCIENCE			English	Review							CONFLICT	Contemporary suicide terrorists from the Middle East are publicly deemed crazed cowards bent on senseless destruction who thrive in poverty and ignorance. Recent research indicates they have no appreciable psychopathology and are as educated and economically well-off as surrounding populations. A first line of defense is to get the communities from which suicide attackers stem to stop the attacks by learning how to minimize the receptivity of mostly ordinary people to recruiting organizations.	CNRS, Inst Jean Nicod, F-75007 Paris, France; Univ Michigan, Inst Social Res, Ann Arbor, MI 48106 USA	Centre National de la Recherche Scientifique (CNRS); University of Michigan System; University of Michigan	Atran, S (corresponding author), CNRS, Inst Jean Nicod, 1 Bis Ave Lowendal, F-75007 Paris, France.							Allport GW, 1948, J PSYCHOL, V25, P3, DOI 10.1080/00223980.1948.9917361; ALQARADHAWI SY, 2001, AL AHRAM AL ARABI; ATRAN S, 1990, POLIT SOC, V18, P481, DOI 10.1177/003232929001800404; Atran Scott, 2002, GODS WE TRUST; AXELL A, 2002, KAMIKAZE; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BARBER B, IN PRESS HEART STONE; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Brooks D., 2002, ATLANTIC MONTHLY, V289, P18; Chapin DM, 2002, SCIENCE, V297, P1997, DOI 10.1126/science.1077855; Chomsky Noam, 2001, 9 11; CLARK R., 1970, CRIME AM; Eagly A. H., 1993, PSYCHOL ATTITUDES; EZEKIEL R, 1995, RACIST MIND; Friedman Thomas, 2002, LONGITUDES ATTITUDES; HASSAN N, 2001, NEW YORKER      1119; JAI JJ, 2001, CHRISTIAN SCI M 1210, P7; KRUEGER A. B., 2002, W9074 NBER; Lewis B, 2002, ASSASSINS; Lewis Bernard, 2002, WHAT WENT WRONG; LYNCH C, 2002, WASHINGTON POST 1218, pA27; Malakoff D, 2002, SCIENCE, V295, P254; MERARI A, 2002, I SOC RES SEM SER PS; MILGRAM S., 1974, OBEDIENCE AUTHORITY; *PEW RES CTR, 2002, WHAT WORLD THNKS 200; RHODE D, 2002, NY TIMES        0317, pA1; Robespierre M., 1794, PRINCIPES MORALE POL; ROSS L, 1991, NEGOTIATION J, V7, P389, DOI 10.1111/j.1571-9979.1991.tb00634.x; SCIOLINO E, 2002, NY TIMES        0127, pA8; Singapore Ministry of Home Affairs, 2003, WHIT PAP JEM ISL ARR; *UN U ASS CONGR, 2002, CONFR ANT AR ANT MUS; *US DEP JUST, 2001, AL QAED TRAIN MAN; *US DEP STAT, 2002, PATT GLOB TERR; Von Drehle David, 2002, WASH POST, pA01; [No title captured]; 2001, AL RISALA; 2002, JANES BIOSECURITY	37	373	377	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1534	1539		10.1126/science.1078854	http://dx.doi.org/10.1126/science.1078854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624256	Green Submitted			2022-12-28	WOS:000181367900026
J	Chaimanee, Y; Jolly, D; Benammi, M; Tafforeau, P; Duzer, D; Moussa, I; Jaeger, JJ				Chaimanee, Y; Jolly, D; Benammi, M; Tafforeau, P; Duzer, D; Moussa, I; Jaeger, JJ			A Middle Miocene hominoid from Thailand and orangutan origins	NATURE			English	Article							SIVAPITHECUS; PAKISTAN; NEOGENE; LUFENG; CHINA	The origin of orangutans has long been debated. Sivapithecus is considered to be the closest ancestor of orangutans because of its facial-palatal similarities(1), but its dental characteristics 2 and postcranial skeleton(2,3) do not confirm this phylogenetic position. Here we report a new Middle Miocene hominoid, cf. Lufengpithecus chiangmuanensis n. sp. from northern Thailand. Its dental morphology relates it to the Pongo clade, which includes Lufengpithecus(4,5), Sivapithecus(2), Gigantopithecus(6), Ankarapithecus(7) and possibly Griphopithecus(8). Our new species displays striking dental resemblances with living orangutans and appears as a more likely candidate to represent an ancestor of this ape. In addition, it originates from the geographic area of Pleistocene orangutans. But surprisingly, the associated flora shows strong African affinities, demonstrating the existence of a temporary floral and faunal dispersal corridor between southeast Asia and Africa during the Middle Miocene, which may have played a critical role in hominoid dispersion.	Univ Montpellier 2, ISEM, F-34095 Montpellier, France; Dept Mineral Resources, Geol Survey Div, Paleontol Sect, Bangkok 10400, Thailand; Univ Nacl Autonoma Mexico, Inst Geofis, Mexico City 04510, DF, Mexico	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Department of Mineral Resources - Thailand; Universidad Nacional Autonoma de Mexico	Jaeger, JJ (corresponding author), Univ Montpellier 2, ISEM, CC 064,Pl Eugene Bataillon, F-34095 Montpellier, France.	jaeger@isem.univ-montp2.fr		Tafforeau, Paul/0000-0002-5962-1683; chaimanee, yaowalak/0000-0002-8432-3880				ALPAGUT B, 1990, J HUM EVOL, V19, P397, DOI 10.1016/0047-2484(90)90052-D; BADGLEY C, 1988, NATL GEOGR RES, V4, P178; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Harrison T, 2002, J HUM EVOL, V43, P207, DOI 10.1006/jhev.2002.0570; Harrison Terry, 1997, P327; Hooijer D. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P175; JOHNSON NM, 1983, J GEOPHYS RES, V88, P1213, DOI 10.1029/JB088iB02p01213; KAPPELMAN J, IN PRESS GEOLOGY PAL; Kelley J, 1998, J HUM EVOL, V35, P577, DOI 10.1006/jhev.1998.0253; KELLEY J, 1995, J HUM EVOL, V28, P503, DOI 10.1006/jhev.1995.1039; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin L.B., 1983, THESIS U LONDON; MORGAN ME, 1994, NATURE, V367, P162, DOI 10.1038/367162a0; PAJUNEN H, 1985, P S INT PEAT SOC JAM, P186; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; PILBEAM D, 1990, NATURE, V348, P237, DOI 10.1038/348237a0; Remus D., 1993, J SE ASIAN EARTH SCI, V8, P321, DOI [10. 1016/0743-9547(93)90043-O, DOI 10.1016/0743-9547(93)90043-O]; Schwartz Jeffrey H., 1997, P363; SCHWARTZ JH, 1990, J HUM EVOL, V19, P591, DOI 10.1016/0047-2484(90)90001-R; Simons E. L., 1969, Postilla, VNo. 138, P1; Swarts J.D., 1988, P263; Ward Steve, 1997, P269; WU R, 1987, ACTA ANTHR SIN, V6, P263; WU RK, 1983, NATURE, V306, P258, DOI 10.1038/306258a0	25	100	104	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					61	65		10.1038/nature01449	http://dx.doi.org/10.1038/nature01449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621432				2022-12-28	WOS:000181343100036
J	Hristov, TS; Miller, SD; Friehe, CA				Hristov, TS; Miller, SD; Friehe, CA			Dynamical coupling of wind and ocean waves through wave-induced air flow	NATURE			English	Article							TURBULENT-FLOW; GENERATION; SURFACE	Understanding the physical mechanisms behind the generation of ocean waves by wind has been a longstanding challenge(1,2). Previous studies(3-6) have assumed that ocean waves induce fluctuations in velocity and pressure of the overlying air that are synchronized with the waves, and numerical models have supported this assumption(7). In a complex feedback, these fluctuations provide the energy for wave generation. The spatial and temporal structure of the wave-induced airflow therefore holds the key to the physics of wind-wave coupling, but detailed observations have proved difficult. Here we present an analysis of wind velocities and ocean surface elevations observed over the open ocean. We use a linear filter(8) to identify the wave-induced air flow from the measurements and find that its structure is in agreement with 'critical-layer' theory(3). Considering that the wave-induced momentum flux is then controlled by the wave spectrum and that it varies considerably in vertical direction, a simple parameterization of the total air-sea momentum flux is unlikely to exist.	Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92697 USA	Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Irvine	Hristov, TS (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	Tihomir.Hristov@jhu.edu						BELCHER SE, 1993, J FLUID MECH, V251, P109, DOI 10.1017/S0022112093003350; Csanady G.T., 2001, AIR SEA INTERACTION; DAVIS RE, 1970, J FLUID MECH, V42, P721, DOI 10.1017/S002211207000157X; Donelan M., 1990, SEA VOLUME 9 OCEAN E, V9, P239; HASSE L, 1986, INTRO PHYSICS ATMOSP, P101; Hristov T, 1998, PHYS REV LETT, V81, P5245, DOI 10.1103/PhysRevLett.81.5245; Janssen PAEM, 2002, ADV FLUID MECH SER, V33, P155; Jeffreys H, 1925, P R SOC LOND A-CONTA, V107, P189, DOI 10.1098/rspa.1925.0015; Kelvin Lord, 1871, PHILOS MAG, V42, P362, DOI DOI 10.1080/14786447108640585; Komen G.J., 1994, DYNAMICS MODELLING O, DOI DOI 10.1017/CBO9780511628955; LANDAU LD, 1986, FLUID MECH, P172; Li PY, 2000, BOUND-LAY METEOROL, V95, P397, DOI 10.1023/A:1002677312259; LIN CC, 1955, THEORY HYDRODYNAMICS; LONGUETH.MS, 1969, PHYS FLUIDS, V12, P737, DOI 10.1063/1.1692549; Meirink JF, 2000, J FLUID MECH, V415, P155, DOI 10.1017/S0022112000008624; MILES JW, 1957, J FLUID MECH, V3, P185, DOI 10.1017/S0022112057000567; PHILLIPS OM, 1957, J FLUID MECH, V2, P417, DOI 10.1017/S0022112057000233; Sullivan PP, 2000, J FLUID MECH, V404, P47, DOI 10.1017/S0022112099006965; THOMSON W, 1980, MATH PHYS PAP, V4	19	116	121	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					55	58		10.1038/nature01382	http://dx.doi.org/10.1038/nature01382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621430				2022-12-28	WOS:000181343100034
J	Ship, AN; Lonner, JH				Ship, AN; Lonner, JH			A 57-year-old man with osteoarthritis of the knee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROXIMAL TIBIAL OSTEOTOMY; FOLLOW-UP; LONG-TERM; GASTROINTESTINAL TOXICITY; ARTHROSCOPIC DEBRIDEMENT; RHEUMATOID-ARTHRITIS; CHONDROITIN SULFATE; ARTICULAR-CARTILAGE; RISK-FACTORS		Penn Hosp, Philadelphia, PA 19107 USA	University of Pennsylvania	Lonner, JH (corresponding author), Penn Hosp, 800 Spruce St, Philadelphia, PA 19107 USA.	lonnerj@pahosp.com						Adams ME, 1995, OSTEOARTHR CARTILAGE, V3, P213, DOI 10.1016/S1063-4584(05)80013-5; Altman RD, 1998, J RHEUMATOL, V25, P2203; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; BADLEY EM, 1995, J RHEUMATOL, V22, P19; BALCH HW, 1977, RHEUMATOL REHABIL, V16, P137, DOI 10.1093/rheumatology/16.3.137; Belmar CJ, 1999, J ARTHROPLASTY, V14, P911, DOI 10.1016/S0883-5403(99)90002-5; Bhattacharyya T, 2002, J BONE JOINT SURG AM, V84A, P562, DOI 10.2106/00004623-200204000-00009; BODEN SD, 1992, CLIN ORTHOP RELAT R, P177; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bradbury N, 1998, AM J SPORT MED, V26, P530, DOI 10.1177/03635465980260041001; BRADLEY JD, 1991, NEW ENGL J MED, V325, P87, DOI 10.1056/NEJM199107113250203; BROUGHTON NS, 1986, J BONE JOINT SURG BR, V68, P447, DOI 10.1302/0301-620X.68B3.3733813; BUCKWALTER JA, 1996, SPORTS MED ARTHROSC, V4, P276; BUECHEL FF, 1990, CLIN ORTHOP RELAT R, V260, P162; Bullens PHJ, 2001, J ARTHROPLASTY, V16, P740, DOI 10.1054/arth.2001.23922; CALLIGARO KD, 1994, J VASC SURG, V20, P927, DOI 10.1016/0741-5214(94)90229-1; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P349; Clarke HD., 2001, SURG KNEE, P90; COLWELL CW, 1995, CLIN ORTHOP RELAT R, V321, P19; COVENTRY MB, 1993, J BONE JOINT SURG AM, V75A, P196, DOI 10.2106/00004623-199302000-00006; Creamer P, 1999, Curr Opin Rheumatol, V11, P417, DOI 10.1097/00002281-199909000-00016; Crenshaw SJ, 2000, CLIN ORTHOP RELAT R, P185, DOI 10.1097/00003086-200006000-00022; Deal CL, 1999, RHEUM DIS CLIN N AM, V25, P379, DOI 10.1016/S0889-857X(05)70074-0; Diduch DR, 1997, J BONE JOINT SURG AM, V79A, P575, DOI 10.2106/00004623-199704000-00015; DONNELLY S, 1995, RHEUMATOL EUR, V23, P437; EDWARDS BG, 1986, ARCH PHYS MED REHAB, V67, P734, DOI 10.1016/0003-9993(86)90006-7; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; Felson DT, 1995, OSTEOARTHRITIC DISOR, P13; Finkelstein JA, 1996, J BONE JOINT SURG AM, V78A, P1348, DOI 10.2106/00004623-199609000-00008; FISHER NM, 1991, ARCH PHYS MED REHAB, V72, P365; FORMAN MD, 1983, J RHEUMATOL, V10, P282; Ginsberg JS, 2000, ARCH INTERN MED, V160, P669, DOI 10.1001/archinte.160.5.669; HAAS SB, 1995, J BONE JOINT SURG AM, V77A, P1700, DOI 10.2106/00004623-199511000-00009; Hanssen A D, 1997, Instr Course Lect, V46, P555; Harwin SF, 1999, ARTHROSCOPY, V15, P142, DOI 10.1053/ar.1999.v15.015014; Healy WL, 2002, J BONE JOINT SURG AM, V84A, P348, DOI 10.2106/00004623-200203000-00003; HECK DA, 1993, CLIN ORTHOP RELAT R, V286, P154; Hewett TE, 1998, ORTHOPEDICS, V21, P131; Idusuyi OB, 1996, J BONE JOINT SURG AM, V78A, P177, DOI 10.2106/00004623-199602000-00003; IVARSSON I, 1991, CLIN ORTHOP RELAT R, P139; Keating E M, 1993, Orthop Rev, V22, P921; Kirkley A, 1999, J BONE JOINT SURG AM, V81A, P539, DOI 10.2106/00004623-199904000-00012; Kraus VB, 1997, MED CLIN N AM, V81, P85, DOI 10.1016/S0025-7125(05)70506-X; Laskin RS, 1999, CLIN ORTHOP RELAT R, P43; LAURENCIN CT, 1991, CLIN ORTHOP RELAT R, V273, P151; Lefkowith James B., 1999, American Journal of Medicine, V106, p43S, DOI 10.1016/S0002-9343(99)00116-3; LIEBERMAN JR, 1994, J BONE JOINT SURG AM, V76A, P1239, DOI 10.2106/00004623-199408000-00015; Lonner J H, 1999, J Am Acad Orthop Surg, V7, P311; Lonner JH, 1999, J ARTHROPLASTY, V14, P969, DOI 10.1016/S0883-5403(99)90012-8; Lonner JH, 2000, J BONE JOINT SURG AM, V82A, P342, DOI 10.2106/00004623-200003000-00005; Lonner JH, 1999, J ARTHROPLASTY, V14, P488, DOI 10.1016/S0883-5403(99)90106-7; LONNER JH, 2002, COAGULATION THROMBOE; LONNER JH, 2000, CLIN ORTHOP RELAT R, V380, P85; Lotke PA, 2000, ARTHROSCOPY, V16, P76, DOI 10.1016/S0749-8063(00)90132-4; LOTKE PA, 2003, MASTER TECHNIQUES OR; Lussier A, 1996, J RHEUMATOL, V23, P1579; Lyu SR, 2000, CLIN ORTHOP RELAT R, P313; Mancuso CA, 2001, J BONE JOINT SURG AM, V83A, P1005, DOI 10.2106/00004623-200107000-00005; MAUERHAN DR, 1994, J BONE JOINT SURG AM, V76A, P39, DOI 10.2106/00004623-199401000-00006; McClung CD, 2000, J ORTHOP RES, V18, P35, DOI 10.1002/jor.1100180106; MCGINTY JB, 1992, J BONE JOINT SURG AM, V74A, P1563, DOI 10.2106/00004623-199274100-00019; MCGRORY BJ, 1995, MAYO CLIN PROC, V70, P342, DOI 10.4065/70.4.342; Messner K, 1996, ACTA ORTHOP SCAND, V67, P165, DOI 10.3109/17453679608994664; MINOR MA, 1989, ARTHRITIS RHEUM, V32, P1396, DOI 10.1002/anr.1780321108; MONT MA, 1994, CLIN ORTHOP RELAT R, P125; Morreale P, 1996, J RHEUMATOL, V23, P1385; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Muller-Fassbender H, 1994, Osteoarthritis Cartilage, V2, P61, DOI 10.1016/S1063-4584(05)80007-X; MURPHY SM, 1998, J MUSCULOSKELETA JUN, P26; Nagel A, 1996, J BONE JOINT SURG AM, V78A, P1353, DOI 10.2106/00004623-199609000-00009; Naudie D, 1999, CLIN ORTHOP RELAT R, P18; Newman JH, 1998, J BONE JOINT SURG BR, V80B, P862, DOI 10.1302/0301-620X.80B5.8835; Noack W, 1994, Osteoarthritis Cartilage, V2, P51, DOI 10.1016/S1063-4584(05)80006-8; NormanTaylor FH, 1996, J BONE JOINT SURG BR, V78B, P74, DOI 10.1302/0301-620X.78B1.0780074; ODENBRING S, 1992, CLIN ORTHOP RELAT R, V277, P210; OGILVIE-HARRIS D J, 1991, Arthroscopy, V7, P151, DOI 10.1016/0749-8063(91)90101-3; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; Parvizi J, 2001, J BONE JOINT SURG AM, V83A, P1157, DOI 10.2106/00004623-200108000-00004; Pope RO, 1997, J BONE JOINT SURG BR, V79B, P914, DOI 10.1302/0301-620X.79B6.7516; Potter HG, 1998, J BONE JOINT SURG AM, V80A, P1276, DOI 10.2106/00004623-199809000-00005; Praemer A, 1992, MUSCULOSKELETAL COND; Price AJ, 2001, J ARTHROPLASTY, V16, P970, DOI 10.1054/arth.2001.25552; RADIN EL, 1995, OSTEOARTHRITIC DISOR, P197; Rahme E, 2002, ARTHRITIS RHEUM-US, V46, P3046, DOI 10.1002/art.10604; RAND J A, 1991, Arthroscopy, V7, P358; Reginster JY, 2001, LANCET, V357, P251, DOI 10.1016/S0140-6736(00)03610-2; Ries MD, 1996, J BONE JOINT SURG AM, V78A, P1696, DOI 10.2106/00004623-199611000-00009; RITTER MA, 1994, CLIN ORTHOP RELAT R, V309, P136; RODRIGUEZ JA, 2001, CLIN ORTHOP RELAT R, V388, P10; Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X; Saleh KJ, 2001, J BONE JOINT SURG AM, V83A, P1144, DOI 10.2106/00004623-200108000-00002; Schai PA, 1998, J ARTHROPLASTY, V13, P365, DOI 10.1016/S0883-5403(98)90000-6; SCOTT RD, 1986, CLIN ORTHOP RELAT R, P100; SCOTT RD, 1991, CLIN ORTHOP RELAT R, P96; SCUDERI GR, 1989, J BONE JOINT SURG BR, V71, P798, DOI 10.1302/0301-620X.71B5.2584250; Seldes RM, 1999, J ARTHROPLASTY, V14, P533, DOI 10.1016/S0883-5403(99)90073-6; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon LS, 1999, RHEUM DIS CLIN N AM, V25, P345, DOI 10.1016/S0889-857X(05)70072-7; Singh BB, 2001, ALTERN THER HEALTH M, V7, P58; Smith M, 2001, CANCER PRACT, V9, P253, DOI 10.1046/j.1523-5394.2001.009005253.x; SQUIRE MW, 1999, CLIN ORTHOP RELAT R, V367, P61; Towheed TE, 1997, SEMIN ARTHRITIS RHEU, V26, P755, DOI 10.1016/S0049-0172(97)80043-1; Trousdale RT, 1999, MAYO CLIN PROC, V74, P978; Uebelhart D, 1998, OSTEOARTHR CARTILAGE, V6, P6, DOI 10.1016/S1063-4584(98)80005-8; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wai EK, 2002, J BONE JOINT SURG AM, V84A, P17, DOI 10.2106/00004623-200201000-00003; WILSON MG, 1990, J BONE JOINT SURG AM, V72A, P878, DOI 10.2106/00004623-199072060-00013	108	9	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1016	1025		10.1001/jama.289.8.1016	http://dx.doi.org/10.1001/jama.289.8.1016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597755				2022-12-28	WOS:000181129800029
J	Klausberger, T; Magill, PJ; Marton, LF; Roberts, JDB; Cobden, PM; Buzsaki, G; Somogyi, P				Klausberger, T; Magill, PJ; Marton, LF; Roberts, JDB; Cobden, PM; Buzsaki, G; Somogyi, P			Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo	NATURE			English	Article							PYRAMIDAL CELLS; RAT HIPPOCAMPUS; THETA-RHYTHM; IN-VIVO; NEURONS	Neural-network oscillations at distinct frequencies have been implicated in the encoding, consolidation and retrieval of information in the hippocampus. Some GABA (gamma-aminobutyric acid)-containing interneurons fire phase-locked to theta oscillations (4-8 Hz) or to sharp-wave-associated ripple oscillations (120-200 Hz), which represent different behavioural states(1-6). Interneurons also entrain pyramidal cells in vitro(7). The large diversity of interneurons(8-10) poses the question of whether they have specific roles in shaping distinct network activities in vivo. Here we report that three distinct interneuron types-basket, axo-axonic and oriens-lacunosum-moleculare cells-visualized and defined by synaptic connectivity as well as by neurochemical markers, contribute differentially to theta and ripple oscillations in anaesthetized rats. The firing patterns of individual cells of the same class are remarkably stereotyped and provide unique signatures for each class. We conclude that the diversity of interneurons, innervating distinct domains of pyramidal cells 11, emerged to coordinate the activity of pyramidal cells in a temporally distinct and brain-state-dependent manner.	Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	University of Oxford; Rutgers State University Newark; Rutgers State University New Brunswick	Klausberger, T (corresponding author), Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Mansfield Rd, Oxford OX1 3TH, England.	thomas.klausberger@pharm.ox.ac.uk		Buzsaki, Gyorgy/0000-0002-3100-4800; Magill, Peter/0000-0001-7141-7071				Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; FOX SE, 1989, EXP BRAIN RES, V77, P283, DOI 10.1007/BF00274985; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2001, NEURON, V32, P771, DOI 10.1016/S0896-6273(01)00528-1; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Losonczy A, 2002, J PHYSIOL-LONDON, V542, P193, DOI 10.1113/jphysiol.2002.020024; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MCBAIN CJ, 1994, J NEUROSCI, V14, P4433; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; SIK A, 1995, J NEUROSCI, V15, P6651; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Traub RD, 2002, REV NEUROSCIENCE, V13, P1; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YLINEN A, 1995, J NEUROSCI, V15, P30; Zar JH., 1999, BIOSTAT ANAL, V663rd	30	942	993	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					844	848		10.1038/nature01374	http://dx.doi.org/10.1038/nature01374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594513				2022-12-28	WOS:000181044700048
J	Aguilaniu, H; Gustafsson, L; Rigoulet, M; Nystrom, T				Aguilaniu, H; Gustafsson, L; Rigoulet, M; Nystrom, T			Asymmetric inheritance of oxidatively damaged proteins during cytokinesis	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DAUGHTER CELLS; MOTHER; YEAST; RESPIRATION; LONGEVITY; MUTATION; SIR2	Carbonylated proteins were visualized in single cells of the budding yeast Saccharomyces cerevisiae, revealing that they accumulate with replicative age. Furthermore, carbonylated proteins were not inherited by daughter cells during cytokinesis. Mother cells of a yeast strain lacking the sir2 gene, a life-span determinant, failed to retain oxidatively damaged proteins during cytokinesis. These findings suggest that a genetically determined, Sir2p-dependent asymmetric inheritance of oxidatively damaged proteins may contribute to free-radical defense and the fitness of newborn cells.	Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden; Chalmers Univ Technol, Dept Mol Biotechnol, S-41296 Gothenburg, Sweden; Univ Victor Segalen, CNRS, Inst Biochim & Genet Cellulaires, Bordeaux, France	University of Gothenburg; Chalmers University of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Nystrom, T (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden.							Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; Barker MG, 1999, FEMS MICROBIOL LETT, V177, P199, DOI 10.1016/S0378-1097(99)00308-0; Bindokas VP, 1996, J NEUROSCI, V16, P1324; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lai CY, 2002, GENETICS, V162, P73; Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Nestelbacher R, 2000, EXP GERONTOL, V35, P63, DOI 10.1016/S0531-5565(99)00087-X; Park PU, 2002, METHOD ENZYMOL, V351, P468; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616	15	490	505	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1751	1753		10.1126/science.1080418	http://dx.doi.org/10.1126/science.1080418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12610228				2022-12-28	WOS:000181519500051
J	Ose, T; Watanabe, K; Mie, T; Honma, M; Watanabe, H; Yao, M; Oikawa, H; Tanaka, I				Ose, T; Watanabe, K; Mie, T; Honma, M; Watanabe, H; Yao, M; Oikawa, H; Tanaka, I			Insight into a natural Diels-Alder reaction from the structure of macrophomate synthase	NATURE			English	Article							UNUSUAL MULTISTEP TRANSFORMATION; SHAPE COMPLEMENTARITY; ENZYMATIC-ACTIVITY; REACTION-MECHANISM; 2-PYRONES; CATALYSIS; BINDING	The Diels-Alder reaction, which forms a six-membered ring from an alkene (dienophile) and a 1,3-diene, is synthetically very useful for construction of cyclic products with high regio- and stereoselectivity under mild conditions(1). It has been applied to the synthesis of complex pharmaceutical and biologically active compounds(2). Although evidence(3-7) on natural Diels-Alderases has been accumulated in the biosynthesis of secondary metabolites(8), there has been no report on the structural details of the natural Diels-Alderases. The function and catalytic mechanism of the natural Diels-Alderase are of great interest owing to the diversity of molecular skeletons in natural Diels-Alder adducts(8). Here we present the 1.70 Angstrom resolution crystal structure of the natural Diels-Alderase, fungal macrophomate synthase (MPS)(3), in complex with pyruvate. The active site of the enzyme is large and hydrophobic, contributing amino acid residues that can hydrogen-bond to the substrate 2-pyrone. These data provide information on the catalytic mechanism of MPS, and suggest that the reaction proceeds via a large-scale structural reorganization of the product.	Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Oikawa, H (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan.	hoik@chem.agr.hokudai.ac.jp; tmaka@castor.sci.hokudai.ac.jp	Oikawa, Hideaki/F-9128-2012; yao, min/F-5287-2011; Watanabe, Kenji/N-2012-2015	Oikawa, Hideaki/0000-0002-6947-3397; yao, min/0000-0003-1687-5904; Watanabe, Kenji/0000-0002-0463-4831				AFARINKIA K, 1992, TETRAHEDRON, V48, P9111, DOI 10.1016/S0040-4020(01)85607-6; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLAKE JF, 1991, J AM CHEM SOC, V113, P7430, DOI 10.1021/ja00019a055; BRAISTED AC, 1990, J AM CHEM SOC, V112, P7430, DOI 10.1021/ja00176a073; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carruthers W., 1990, CYCLOADDITION REACTI; Chen JG, 2000, CHEMBIOCHEM, V1, P255, DOI 10.1002/1439-7633(20001117)1:4<255::AID-CBIC255>3.0.CO;2-S; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Desimoni G., 1983, NATURAL PRODUCTS SYN; GOUVERNEUR VE, 1993, SCIENCE, V262, P204, DOI 10.1126/science.8211138; Heine A, 1998, SCIENCE, V279, P1934, DOI 10.1126/science.279.5358.1934; HILVERT D, 1989, J AM CHEM SOC, V111, P9261, DOI 10.1021/ja00208a037; ICHIHARA A, 1987, TETRAHEDRON, V43, P5245, DOI 10.1016/S0040-4020(01)87700-0; ICHIHARA A, 1999, COMPREHENSIVE NATURA, V1, P367; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Katayama K, 1998, BBA-PROTEIN STRUCT M, V1384, P387, DOI 10.1016/S0167-4838(98)00040-5; Oikawa H, 1998, J ORG CHEM, V63, P8748, DOI 10.1021/jo980743r; OIKAWA H, 1995, J CHEM SOC CHEM COMM, P1321, DOI 10.1039/c39950001321; Oikawa H, 1999, TETRAHEDRON LETT, V40, P6983, DOI 10.1016/S0040-4039(99)01441-0; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; SAKURAI I, 1988, CHEM PHARM BULL, V36, P2003; SAUER J, 1980, ANGEW CHEM INT EDIT, V19, P779, DOI 10.1002/anie.198007791; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200; Watanabe K, 2000, J BIOCHEM-TOKYO, V127, P467, DOI 10.1093/oxfordjournals.jbchem.a022629; Watanabe K, 2000, BIOSCI BIOTECH BIOCH, V64, P530, DOI 10.1271/bbb.64.530; Watanabe K, 2000, TETRAHEDRON LETT, V41, P1443, DOI 10.1016/S0040-4039(99)02311-4; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345; YLIKAUHALUOMA JT, 1995, J AM CHEM SOC, V117, P7041, DOI 10.1021/ja00132a001	29	159	161	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					185	189		10.1038/nature01454	http://dx.doi.org/10.1038/nature01454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634789				2022-12-28	WOS:000181488900050
J	Violato, C; Lockyer, J; Fidler, H				Violato, C; Lockyer, J; Fidler, H			Multisource feedback: a method of assessing surgical practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN PERFORMANCE; RATINGS	New methods are needed for assessing surgeons' performance across a wide range of competencies. Violato and colleagues describe the development of a programme based on feedback from medical colleagues, coworkers, and patients for the assessment of surgeons throughout Alberta, Canada.	Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB T2N 4N1, Canada; Univ Calgary, Off Continuing Med Educ & Profess Dev, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Violato, C (corresponding author), Univ Calgary, Fac Med, Dept Community Hlth Sci, 3330 Univ Dr NW, Calgary, AB T2N 4N1, Canada.	violato@ucalgary.ca	Lockyer, Jocelyn M/J-2189-2019	Lockyer, Jocelyn M/0000-0002-3928-4827; Violato, Claudio/0000-0001-7551-5621				BRACKEN DW, 2001, HDB MULTISOURCE FEED; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Fidler M, 1999, ACAD MED, V74, P702, DOI 10.1097/00001888-199906000-00019; GRIFFIN E, 2000, HLTH INFORM J, V6, P71; Hall W, 1999, CAN MED ASSOC J, V161, P52; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Lipner RS, 2002, ACAD MED, V77, pS64, DOI 10.1097/00001888-200210001-00021; Maudsley RF, 2000, ACAD MED, V75, P113, DOI 10.1097/00001888-200002000-00005; RAMSEY PG, 1993, JAMA-J AM MED ASSOC, V269, P1655, DOI 10.1001/jama.269.13.1655; *SOC NEEDS WORK GR, 1996, ANN R COLL PHYS SURG, V29, P206; Southgate L, 2001, MED EDUC, V35, P2; Southgate L, 2001, MED EDUC, V35, P474, DOI 10.1046/j.1365-2923.2001.00897.x; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; TORNOW WW, 1998, MAXIMIZING VALUE 360; Violato C, 1997, ACAD MED, V72, pS82, DOI 10.1097/00001888-199710001-00028; WENRICH MD, 1993, ACAD MED, V68, P680, DOI 10.1097/00001888-199309000-00014; Wilson RM, 1999, MED J AUSTRALIA, V170, P411, DOI 10.5694/j.1326-5377.1999.tb127814.x	17	112	114	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2003	326	7388					546	548		10.1136/bmj.326.7388.546	http://dx.doi.org/10.1136/bmj.326.7388.546			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623920	Green Published			2022-12-28	WOS:000181548400026
J	Schmidt, B; Asztalos, EV; Roberts, RS; Robertson, CMT; Sauve, RS; Whitfield, MF				Schmidt, B; Asztalos, EV; Roberts, RS; Robertson, CMT; Sauve, RS; Whitfield, MF		TIPP Investigators	Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months - Results from the trial of indomethacin prophylaxis in preterms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN; AGE; PREDICTION; DISABILITY	Context Despite more than 2 decades of outcomes research after very preterm birth, clinicians remain uncertain about the extent to which neonatal morbidities predict poor long-term outcomes of extremely low-birth-weight (ELBW) infants. Objective To determine the individual and combined prognostic effects of bronchopulmonary dysplasia (BPD), ultrasonographic signs of brain injury, and severe retinopathy of prematurity (ROP) on 18-month outcomes of ELBW infants. Design Inception cohort assembled for the Trial of Indomethacin Prophylaxis in Preterms (TIPP). Setting and Participants A total of 910 infants with birth weights of 500 to 999 g who were admitted to 1 of 32 neonatal intensive care units in Canada, the United States, Australia, New Zealand, and Hong Kong between 1996 and 1998 and who survived to a postmenstrual age of 36 weeks. Main Outcome Measures Combined end point of death or survival to 18 months with 1 or more of cerebral palsy, cognitive delay, severe hearing loss, and bilateral blindness. Results Each of the neonatal morbidities was similarly and independently correlated with a poor 18-month outcome. Odds ratios were 2.4 (95% confidence interval [CI], 1.8-3.2) for BPD, 3.7 (95% CI, 2.6-5.3) for brain injury, and 3.1 (95% CI, 1.9-5.0) for severe ROP. In children who were free of BPD, brain injury and severe ROP the rate of poor long-term outcomes was 18% (95% CI, 14%-22%). Corresponding rates with any 1, any 2, and all 3 neonatal morbidities were 42% (95% CI, 37%-47%), 62% (95% CI, 53%-70%), and 88% (64%-99%), respectively. Conclusion In ELBW infants who survive to a postmenstrual age of 36 weeks, a simple count of 3 common neonatal morbidities strongly predicts the risk of later death or neurosensory impairment.	McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Glenrose Rehabil Hosp, Child Hlth Outcomes Unit, Edmonton, AB, Canada; Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	McMaster University; McMaster University; University of Toronto; University of Calgary; University of Calgary; University of British Columbia	Schmidt, B (corresponding author), McMaster Univ, Dept Pediat, HSC 3N11E,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	schmidt@mcmaster.ca	Asztalos, Elizabeth/L-8834-2019; Pritchard, Margo A/G-5188-2010; Colditz, Paul B/F-6772-2010	Asztalos, Elizabeth/0000-0002-9468-2860; Pritchard, Margo A/0000-0002-1058-9117; Colditz, Paul B/0000-0002-6408-8238	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027851, U10HD034216, U10HD027904, U10HD021373, U10HD027880, U10HD021364, U10HD021385] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD027881] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000997, M01RR000070] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR 00070, M01 RR 00997] Funding Source: Medline; NICHD NIH HHS [U10 HD27881, U10 HD27880, U10 HD27851, U10 HD21385, U10 HD21373, U10 HD21364, U10 HD27904, U10 HD34216] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1987, Arch Ophthalmol, V105, P906; [Anonymous], 1997, Arch Dis Child Fetal Neonatal Ed, V77, pF91; AZIZ K, 1995, PEDIATRICS, V95, P837; Bayley N, 1993, BAYLEY SCALES INFANT; Butler C, 1999, DEV MED CHILD NEUROL, V41, P55, DOI 10.1017/S0012162299000110; Davis PG, 2002, J PEDIATR-US, V140, P555, DOI 10.1067/mpd.2002.123291; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Finnstrom O, 1998, ACTA PAEDIATR, V87, P1055, DOI 10.1080/080352598750031374; GARNER A, 1984, PEDIATRICS, V74, P127; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; HOSMER DW, 2000, WILEY PS TX, P1; Msall ME, 2000, PEDIATRICS, V106, P998, DOI 10.1542/peds.106.5.998; O'Connor AR, 2002, PEDIATRICS, V109, P12, DOI 10.1542/peds.109.1.12; Palta M, 2000, ARCH PEDIAT ADOL MED, V154, P23; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; PINTOMARTIN JA, 1995, PEDIATRICS, V95, P249; Schmidt B, 2001, NEW ENGL J MED, V344, P1966, DOI 10.1056/NEJM200106283442602; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Singer L, 1997, PEDIATRICS, V100, P987, DOI 10.1542/peds.100.6.987; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Waugh J, 1996, J PAEDIATR CHILD H, V32, P120, DOI 10.1111/j.1440-1754.1996.tb00907.x; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	22	424	436	3	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1124	1129		10.1001/jama.289.9.1124	http://dx.doi.org/10.1001/jama.289.9.1124			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622582	Bronze			2022-12-28	WOS:000181289400028
J	Jonas, WB; Kaptchuk, TJ; Linde, K				Jonas, WB; Kaptchuk, TJ; Linde, K			A critical overview of homeopathy	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN BASOPHIL DEGRANULATION; DILUTE ANTISERUM; CLINICAL-TRIALS; PLACEBO; METAANALYSIS; GLUTAMATE; EFFICACY; MEDICINE; ARNICA	Homeopathy is a 200-year-old therapeutic system that uses small doses of various substances to stimulate autoregulatory and self-healing processes. Homeopathy selects substances by matching a patient's symptoms with symptoms produced by these substances in healthy individuals. Medicines are prepared by serial dilution and shaking, which proponents claim imprints information into water. Although many conventional physicians find such notions implausible, homeopathy had a prominent place in 19th-century health care and has recently undergone a worldwide revival. In the United States, patients who seek homeopathic care are more affluent and younger and more often seek treatment for subjective symptoms than those who seek conventional care. Homeopathic remedies were allowed by the 1939 Pure Food and Drug Act and are available over the counter. Some data-both from randomized, controlled trials and laboratory research-show effects from homeopathic remedies that contradict the contemporary rational basis of medicine. Three independent systematic reviews of placebo-controlled trials on homeopathy reported that its effects seem to be more than placebo, and one review found its effects consistent with placebo. There is also evidence from randomized, controlled trials that homeopathy may be effective for the treatment of influenza, allergies, postoperative ileus, and childhood diarrhea. Evidence suggests that homeopathy is ineffective for migraine, delayed-onset muscle soreness, and influenza prevention. There is a lack of conclusive evidence on the effectiveness of homeopathy for most conditions. Homeopathy deserves an open-minded opportunity to demonstrate its value by using evidence-based principles, but it should not be substituted for proven therapies.	Samueli Inst Informat Biol, Bethesda, MD USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Tech Univ Munich, Ctr Complementary Med Res, D-8000 Munich, Germany	Uniformed Services University of the Health Sciences - USA; Harvard University; Harvard Medical School; Technical University of Munich	Jonas, WB (corresponding author), Samueli Inst, 121 S St Asaph St,Suite 200, Alexandria, VA 22314 USA.	wjonas@siib.org		Linde, Klaus/0000-0002-2902-970X	NCCIH NIH HHS [AT00178-01, AT00270-01] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT000178, R21AT000270] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Barnes J, 1997, J CLIN GASTROENTEROL, V25, P628, DOI 10.1097/00004836-199712000-00016; Belon P, 1999, INFLAMM RES, V48, pS17; Cassedy James H., 1984, AM MED STAT THINKING; COULTER HL, 1981, CONFLICT HOMEOPATHY, V3; Cucherat M, 2000, EUR J CLIN PHARMACOL, V56, P27, DOI 10.1007/s002280050716; DAVENAS E, 1988, NATURE, V333, P816, DOI 10.1038/333816a0; EGGER M, 2001, ARE CLIN EFFECTS HOM; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 1999, J PAIN SYMPTOM MANAG, V18, P353, DOI 10.1016/S0885-3924(99)00095-0; Ernst E, 1996, ARCH INTERN MED, V156, P2162, DOI 10.1001/archinte.156.19.2162; Ernst E, 1999, PERFUSION, V12, P13; Ernst E, 1998, ARCH SURG-CHICAGO, V133, P1187, DOI 10.1001/archsurg.133.11.1187; Ernst E, 1997, PERFUSION, V10, P293; FYE WB, 1986, CIRCULATION, V73, P21, DOI 10.1161/01.CIR.73.1.21; HAEHL R, 1922, S HAHNEMANN HIS LIFE; HAHNEMANN S, 1982, ORGANON MED; HIRST SJ, 1993, NATURE, V366, P525, DOI 10.1038/366525a0; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Jacobs J, 1998, ARCH FAM MED, V7, P537, DOI 10.1001/archfami.7.6.537; JACOBS J, 1994, PEDIATRICS, V93, P719; JACOBS J, 2003, IN PRESS PEDIAT INFE; Jacobs J W, 1991, Ned Tijdschr Geneeskd, V135, P317; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Jonas W, 1999, PERFUSION-GERMANY, V12, P452; Jonas W, 2001, NEUROREPORT, V12, P335, DOI 10.1097/00001756-200102120-00031; Jonas W B, 2001, BMC Complement Altern Med, V1, P12, DOI 10.1186/1472-6882-1-12; Jonas WB, 2000, J ALTERN COMPLEM MED, V6, P213, DOI 10.1089/acm.2000.6.213; Jonas WB, 2000, RHEUM DIS CLIN N AM, V26, P117, DOI 10.1016/S0889-857X(05)70125-3; JONAS WB, 1996, HEALING HOMEOPATHY C; Jonas WB, 2000, J SCI EXPLOR, V14, P35; JONAS WB, 1999, ESSENTIALS COMPLEMEN, P167; JOSLIN BF, 1849, ECLECTIC MED J, V8, P363; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; KAPTCHUK TJ, 1996, BRIT HOMEOPATHIC J, V85, P237; KENT JT, 1885, HOMOEOPATHIC PHYSICI, V5, P346; KLEIJNEN J, 1991, BRIT MED J, V302, P316, DOI 10.1136/bmj.302.6772.316; LEARY B, 1994, BRIT HOMEOPATHIC J, V83, P117; LELAND PW, 1852, BOSTON MED SURG J, V47, P283; LEWIN DI, 1996, J NIH RES, V8, P30; Lewith GT, 2002, BMJ-BRIT MED J, V324, P520, DOI 10.1136/bmj.324.7336.520; LINDE K, 1994, HUM EXP TOXICOL, V13, P481, DOI 10.1177/096032719401300706; Linde K, 1998, J ALTERN COMPLEM MED, V4, P371, DOI 10.1089/acm.1998.4.371; Linde K, 2003, J ROY SOC MED, V96, P17, DOI 10.1258/jrsm.96.1.17; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; Linde K., 1999, ESSENTIALS COMPLEMEN, P57; Linde K, 2000, COCHRANE DB SYST REV; LUDTKE R, 1999, JB K V CARSTENSSTIFT, V5, P97; MADDOX J, 1988, NATURE, V334, P287, DOI 10.1038/334287a0; MUKHERJEE JK, 1964, HAHN GLEAN, V31, P163; Nicholls Phillip A., 1988, HOMEOPATHY MED PROFE; OVELGONNE JH, 1992, EXPERIENTIA, V48, P504, DOI 10.1007/BF01928175; PARKER WW, 1886, JHAMA, P7; PERSONS S, 1991, B HIST MED, V65, P74; ROBERTS WH, 1986, B HIST MED, V60, P73; Rogers Naomi, 1998, ALTERNATIVE PATH MAK; ROTHSTEIN WG, 1992, AM PHYSICIANS 19 CEN; Taylor MA, 2000, BMJ-BRIT MED J, V321, P471, DOI 10.1136/bmj.321.7259.471; Vickers AJ, 1999, FORSCH KOMPLEMENTMED, V6, P311, DOI 10.1159/000021286; VICKERS AJ, 2000, COCHRANE DB SYST REV; WALACH H, 1997, THESIS A LUDWIGS U F; Wiesenauer M, 1996, FORSCH KOMPLEMENTMED, V3, P230; 1882, HOMOEOPATHIC PHYSICI, V2, P73	62	115	145	2	61	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					393	399		10.7326/0003-4819-138-5-200303040-00009	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614092				2022-12-28	WOS:000181257300005
J	Foote, J				Foote, J			Isomeric antibodies	SCIENCE			English	Editorial Material							ANTIGEN; FAB		Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Foote, J (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.							BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; LANCET D, 1976, P NATL ACAD SCI USA, V73, P3549, DOI 10.1073/pnas.73.10.3549; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; METZGER H, 1992, J IMMUNOL, V149, P1477; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; PECHT I, 1982, ANTIGENS, V6, P1; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; STEVENS FJ, 1988, P NATL ACAD SCI USA, V85, P6895, DOI 10.1073/pnas.85.18.6895	12	31	31	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1327	1328		10.1126/science.1082717	http://dx.doi.org/10.1126/science.1082717			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610286				2022-12-28	WOS:000181192300031
J	Brown, RS; Russo, MW; Lai, M; Shiffman, ML; Richardson, MC; Everhart, JE; Hoofnagle, JH				Brown, RS; Russo, MW; Lai, M; Shiffman, ML; Richardson, MC; Everhart, JE; Hoofnagle, JH			A survey of liver transplantation from living adult donors in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRAFTS; UNINEPHRECTOMY; MORTALITY; SURVIVAL; PATIENT; LOBE	BACKGROUND The transplantation of the right lobe of a liver from a living adult donor into an adult recipient has been performed increasingly frequently in the United States. Although the use of grafts from living donors is standard practice in transplantation in children, their use in adults remains controversial. METHODS To study the use of liver transplantation from a living donor, we sent a 24-item questionnaire to all liver-transplantation programs in the United States. Data on indications, evaluation, and outcomes were analyzed with the use of univariate and multivariate methods. Data on recent transplantations were gathered from the Scientific Registry of Transplant Recipients and directly from the transplantation programs. RESULTS Questionnaires were returned by 84 of the 122 programs (69 percent) describing the results of 449 adult-to-adult transplantations of partial livers from living donors that were performed in 42 centers. Fourteen centers had performed more than 10 such transplantations each and together accounted for 80 percent of such transplantations. Centers that performed such transplantations also performed more transplantations of livers from cadaveric donors and more transplantations from living donors in children than centers that did not perform the adult-to-adult procedure (P=0.002 and P=0.001, respectively). A total of 45 percent of potential donors who were evaluated eventually donated a lobe of their liver; 99 percent of these donors were genetically or emotionally related to the recipient. Complications in the donor were more frequent in the centers performing the fewest transplantations from living donors in adults and included biliary complications requiring intervention (in 6.0 percent), reoperation (in 4.5 percent), and death (in one donor [0.2 percent]). Among the recipients, 1.6 percent did not meet criteria for receipt of a cadaveric transplant; cancer, retransplantation, and acute liver failure were uncommon indications for transplantation from a living donor. Biliary complications occurred in 22.0 percent of recipients, and vascular complications occurred in 9.8 percent. CONCLUSIONS Adult-to-adult liver transplantation from a living donor is increasingly performed in the United States but is concentrated in a few large-volume centers. Mortality among donors is low, but complications in the donor are relatively common.	Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA; New York Presbyterian Hosp, Ctr Liver Dis & Transplantat, New York, NY USA; Virginia Commonwealth Univ Hlth Syst, Dept Med, Richmond, VA USA; NIDDKD, Div Digest Dis & Nutr, Bethesda, MD 20892 USA	Columbia University; NewYork-Presbyterian Hospital; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Brown, RS (corresponding author), Columbia Presbyterian Med Ctr, Ctr Liver Dis & Transplantat, 622 W 168th St,PH 14, New York, NY 10036 USA.		Russo, Mark/AAI-1438-2021					BAUDOIN P, 1993, AM J KIDNEY DIS, V21, P603, DOI 10.1016/S0272-6386(12)80032-1; Broelsch CE, 2000, LIVER TRANSPLANT, V6, pS64, DOI 10.1053/jlts.2000.19015; BROELSCH CE, 1991, ANN SURG, V214, P428, DOI 10.1097/00000658-199110000-00007; BROELSCH CE, 1990, ANN SURG, V212, P368, DOI 10.1097/00000658-199009000-00015; Busquets J, 2001, TRANSPLANTATION, V71, P1765, DOI 10.1097/00007890-200106270-00011; Cronin DC, 2001, NEW ENGL J MED, V344, P1633, DOI 10.1056/NEJM200105243442112; EMOND JC, 1993, TRANSPLANTATION, V55, P835, DOI 10.1097/00007890-199304000-00029; Everhart JE, 1997, TRANSPLANTATION, V64, P1300, DOI 10.1097/00007890-199711150-00012; Gruenberger T, 1994, Transpl Int, V7 Suppl 1, pS672; HAKIM RM, 1984, KIDNEY INT, V25, P930, DOI 10.1038/ki.1984.112; Marcos A, 1999, TRANSPLANTATION, V68, P798, DOI 10.1097/00007890-199909270-00012; NARKUNBURGESS DM, 1993, KIDNEY INT, V43, P1110, DOI 10.1038/ki.1993.156; Reding R, 1999, J PEDIATR-US, V134, P280, DOI 10.1016/S0022-3476(99)70450-6; Rizzetto M, 2001, LIVER TRANSPLANT, V7, P518, DOI 10.1053/jlts.2001.25880; RYCKMAN FC, 1991, J PEDIATR SURG, V26, P422, DOI 10.1016/0022-3468(91)90989-7; Shiffman ML, 2002, LIVER TRANSPLANT, V8, P174, DOI 10.1053/jlts.2002.30981; SINGER PA, 1989, NEW ENGL J MED, V321, P620, DOI 10.1056/NEJM198908313210919; SMITH S, 1985, AM J KIDNEY DIS, V6, P143, DOI 10.1016/S0272-6386(85)80017-2; Surman OS, 2002, NEW ENGL J MED, V346, P1038, DOI 10.1056/NEJM200204043461402; Todo S, 2000, LIVER TRANSPLANT, V6, pS66, DOI 10.1053/jlts.2000.19009; Trotter JF, 2002, NEW ENGL J MED, V346, P1074, DOI 10.1056/NEJMra011629; *UN NETW ORG SHAR, 2000, ANN REP US SCI REG O; Vargas HE, 1999, GASTROENTEROLOGY, V117, P149, DOI 10.1016/S0016-5085(99)70561-5; Wachs ME, 1998, TRANSPLANTATION, V66, P1313, DOI 10.1097/00007890-199811270-00008; YAMAOKA Y, 1994, TRANSPLANTATION, V57, P1127, DOI 10.1097/00007890-199404150-00024	25	368	390	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					818	825		10.1056/NEJMsa021345	http://dx.doi.org/10.1056/NEJMsa021345			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606737	Bronze			2022-12-28	WOS:000181173300009
J	Mauk, BH; Mitchell, DG; Krimigis, SM; Roelof, EC; Paranicas, CP				Mauk, BH; Mitchell, DG; Krimigis, SM; Roelof, EC; Paranicas, CP			Energetic neutral atoms from a trans-Europa gas torus at Jupiter	NATURE			English	Article							JOVIAN MAGNETOSPHERE; PLASMA TORUS; ION; SATURN; OXYGEN; IMAGE	The space environments-or magnetospheres-of magnetized planets emit copious quantities of energetic neutral atoms (ENAs) at energies between tens of electron volts to hundreds of kiloelectron volts (keV)(1,2). These energetic atoms result from charge exchange between magnetically trapped energetic ions and cold neutral atoms, and they carry significant amounts of energy and mass from the magnetospheres. Imaging their distribution allows us to investigate the structure of planetary magnetospheres(1,3-6). Here we report the analysis of 50-80 keV ENA images of Jupiter's magnetosphere(7), where two distinct emission regions dominate: the upper atmosphere of Jupiter itself, and a torus of emission residing just outside the orbit of Jupiter's satellite Europa. The trans-Europa component shows that, unexpectedly, Europa generates a gas cloud comparable in gas content to that associated with the volcanic moon Io. The quantity of gas found indicates that Europa has a much greater impact than hitherto believed on the structure of, and the energy flow within, Jupiter's magnetosphere.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Mauk, BH (corresponding author), Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.		Paranicas, Christopher/B-1470-2016; Mauk, Barry H/E-8420-2017; Roelof, Edmond/G-6654-2019; Mitchell, Donald G/H-4601-2016; Krimigis, Stamatios/G-4591-2019	Paranicas, Christopher/0000-0002-4391-8255; Mauk, Barry H/0000-0001-9789-3797; Roelof, Edmond/0000-0002-2270-0652; Mitchell, Donald G/0000-0003-1960-2119; Krimigis, Stamatios/0000-0003-2781-2386				BAGENAL F, 1992, ANNU REV EARTH PL SC, V20, P289, DOI 10.1146/annurev.ea.20.050192.001445; BARNUN A, 1985, SURF SCI, V150, P143, DOI 10.1016/0039-6028(85)90215-8; Brandt PC, 2001, J GEOPHYS RES-SPACE, V106, P24663, DOI 10.1029/2000JA900119; BRANDT PC, IN PRESS J GEOPHYS R; BROWN RA, 1981, ASTROPHYS J, V244, P1072, DOI 10.1086/158777; Burch JL, 2001, SCIENCE, V291, P619, DOI 10.1126/science.291.5504.619; CHENG AF, 1986, J GEOPHYS RES, V91, P4524, DOI 10.1029/JA091iA04p04524; Clarke JT, 1996, SCIENCE, V274, P404, DOI 10.1126/science.274.5286.404; Cooper JF, 2001, ICARUS, V149, P133, DOI 10.1006/icar.2000.6498; Henderson MG, 1997, GEOPHYS RES LETT, V24, P1167, DOI 10.1029/97GL01162; Ip WH, 1998, GEOPHYS RES LETT, V25, P829, DOI 10.1029/98GL00472; KIRSCH E, 1981, GEOPHYS RES LETT, V8, P169, DOI 10.1029/GL008i002p00169; Krimigis SM, 2002, NATURE, V415, P994, DOI 10.1038/415994a; KRIMIGIS SM, IN PRESS SPACE SCI R; KURANA KK, IN PRESS JUPITER; Mauk BH, 1998, ADV SPACE RES, V21, P1483, DOI 10.1016/S0273-1177(98)00021-0; MENDILLO M, 1990, NATURE, V348, P312, DOI 10.1038/348312a0; Mitchell DG, 1996, P SOC PHOTO-OPT INS, V2803, P154, DOI 10.1117/12.253415; Mitchell DG, 2001, GEOPHYS RES LETT, V28, P1151, DOI 10.1029/2000GL012395; RAIRDEN RL, 1986, J GEOPHYS RES, V91, P3613, DOI 10.1029/JA091iA12p13613; ROELOF EC, 1987, GEOPHYS RES LETT, V14, P652, DOI 10.1029/GL014i006p00652; Rosenfeld A., 1982, DIGITAL PICTURE PROC; Saur J, 1998, J GEOPHYS RES-PLANET, V103, P19947, DOI 10.1029/97JE03556; Schreier R, 1998, J GEOPHYS RES-PLANET, V103, P19901, DOI 10.1029/98JE00697; SKINNER TE, 1986, ASTROPHYS J, V310, P966, DOI 10.1086/164747; Smyth WH, 2000, J GEOPHYS RES-SPACE, V105, P7783, DOI 10.1029/1999JA000308; Williams DJ, 1996, SCIENCE, V274, P401, DOI 10.1126/science.274.5286.401	27	97	97	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					920	922		10.1038/nature01431	http://dx.doi.org/10.1038/nature01431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606993				2022-12-28	WOS:000181186900041
J	Bentley, SD; Maiwald, M; Murphy, LD; Pallen, MJ; Yeats, CA; Dover, LG; Norbertczak, HT; Besra, GS; Quail, MA; Harris, DE; von Herbay, A; Goble, A; Rutter, S; Squares, R; Squares, S; Barrell, BG; Parkhill, J; Relman, DA				Bentley, SD; Maiwald, M; Murphy, LD; Pallen, MJ; Yeats, CA; Dover, LG; Norbertczak, HT; Besra, GS; Quail, MA; Harris, DE; von Herbay, A; Goble, A; Rutter, S; Squares, R; Squares, S; Barrell, BG; Parkhill, J; Relman, DA			Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei	LANCET			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACILLUS; ORIGIN; ADHERENCE; WHIPPELII; PROTEIN; DIVERSE	Background Whipple's disease is a rare multisystem chronic infection, involving the intestinal tract as well as various other organs. The causative agent, Tropheryma whipplei, is a Gram-positive bacterium about which little is known. Our aim was to investigate the biology of this organism by generating and analysing the complete DNA sequence of its genome. Methods We isolated and propagated T whipplei strain TWO8/27 from the cerebrospinal fluid of a patient diagnosed with Whipple's disease. We generated the complete sequence of the genome by the whole genome shotgun method, and analysed it with a combination of automatic and manual bioinformatic techniques. Findings Sequencing revealed a condensed 925 938 bp genome with a lack of key biosynthetic pathways and a reduced capacity for energy metabolism. A family of large surface proteins was identified, some associated with large amounts of non-coding repetitive DNA, and an unexpected degree of sequence variation. Interpretation The genome reduction and lack of metabolic capabilities point to a host-restricted lifestyle for the organism. The sequence variation indicates both known and novel mechanisms for the elaboration and variation of surface structures, and suggests that immune evasion and host interaction play an important part in the lifestyle of this persistent bacterial pathogen.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Birmingham, Birmingham, W Midlands, England; Heidelberg Univ, Dept Pathol, D-6900 Heidelberg, Germany	Wellcome Trust Sanger Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Birmingham; Ruprecht Karls University Heidelberg	Parkhill, J (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	Parkhill@sanger.ac.uk	Pallen, Mark J./E-7619-2011; Dover, Lynn G/F-3021-2010; Dover, Lynn George/Q-6778-2019; Quail, michael/ABE-6131-2020; Parkhill, Julian/G-4703-2011	Dover, Lynn G/0000-0002-4776-2665; Dover, Lynn George/0000-0002-4776-2665; Parkhill, Julian/0000-0002-7069-5958; Relman, David A./0000-0001-8331-1354; Besra, Gurdyal/0000-0002-5605-0395; Maiwald, Matthias/0000-0001-5448-8417; Pallen, Mark/0000-0003-1807-3657; Murphy, Lee/0000-0001-6467-7449	NIDDK NIH HHS [DK56339] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bansal AK, 2002, J BACTERIOL, V184, P2260, DOI 10.1128/JB.184.8.2260-2272.2002; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bhattacharjee MK, 2001, J BACTERIOL, V183, P5927, DOI 10.1128/JB.183.20.5927-5936.2001; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; Casjens S, 1998, ANNU REV GENET, V32, P339, DOI 10.1146/annurev.genet.32.1.339; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Dobbins 3rd WO, 1987, WHIPPLES DIS; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Fredricks DN, 2001, J INFECT DIS, V183, P1229, DOI 10.1086/319684; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kachlany SC, 2001, TRENDS MICROBIOL, V9, P429, DOI 10.1016/S0966-842X(01)02161-8; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Maiwald M, 1996, INT J SYST BACTERIOL, V46, P1078, DOI 10.1099/00207713-46-4-1078; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; MAIWALD M, 2002, SLEISENGER FORDTRANS, P1854; MARTH T, 1994, CLIN IMMUNOL IMMUNOP, V72, P217, DOI 10.1006/clin.1994.1134; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Salazar L, 1996, MOL MICROBIOL, V20, P283, DOI 10.1111/j.1365-2958.1996.tb02617.x; SILVA MT, 1985, J GEN MICROBIOL, V131, P1001; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; vonHerbay A, 1996, GASTROENTEROLOGY, V110, P1735, DOI 10.1053/gast.1996.v110.pm8964398; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z	30	174	392	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2003	361	9358					637	644		10.1016/S0140-6736(03)12597-4	http://dx.doi.org/10.1016/S0140-6736(03)12597-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606174				2022-12-28	WOS:000181129500012
J	Sander, HW; Hedley-Whyte, ET				Sander, HW; Hedley-Whyte, ET			Case 6-2003: A nine-year-old girl with progressive weakness and areflexia - Chronic inflammatory demyelinating polyradiculoneuropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; INTRAVENOUS IMMUNOGLOBULIN; CLINICAL-FEATURES; PLASMA-EXCHANGE; DOUBLE-BLIND; CROSS-OVER; POLYNEUROPATHY; CHILDHOOD; THERAPY		Weill Cornell Med Coll, Peripheral Neuropathy Ctr, New York, NY 10021 USA; Weill Cornell Med Coll, Dept Neurol, New York, NY USA; NYU, Sch Med, Dept Neurol, New York, NY USA; New York Med Coll, Dept Neurol, Valhalla, NY 10595 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Cornell University; Cornell University; New York University; New York Medical College; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sander, HW (corresponding author), Weill Cornell Med Coll, Peripheral Neuropathy Ctr, New York, NY 10021 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Sander, Howard/0000-0002-9654-7849				Alaedini A, 2003, ARCH NEUROL-CHICAGO, V60, P42, DOI 10.1001/archneur.60.1.42; Barnett MH, 1998, MUSCLE NERVE, V21, P454, DOI 10.1002/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8; Bouchard C, 1999, NEUROLOGY, V52, P498, DOI 10.1212/WNL.52.3.498; Brannagan TH, 2002, NEUROLOGY, V58, P1856, DOI 10.1212/WNL.58.12.1856; CASSIDY JT, 1995, TXB PEDIAT RHEUMATOL, P368; Comi G, 1998, ITAL J NEUROL SCI, V19, P261, DOI 10.1007/BF00713851; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; DYCK PJ, 1994, ANN NEUROL, V36, P838, DOI 10.1002/ana.410360607; DYCK PJ, 1993, PERIPHERAL NEUROPATH, V2, P1498; FORD MD, 1998, GOLDFRANKS TOXICOLOG, P1261; Good JL, 1998, NEUROLOGY, V51, P1735, DOI 10.1212/WNL.51.6.1735; Gorson KC, 1997, NEUROLOGY, V48, P321, DOI 10.1212/WNL.48.2.321; Gorson KC, 1998, NEUROLOGY, V50, P84, DOI 10.1212/WNL.50.1.84; Hahn AF, 1996, BRAIN, V119, P1055, DOI 10.1093/brain/119.4.1055; Hahn AF, 1996, BRAIN, V119, P1067, DOI 10.1093/brain/119.4.1067; Haq RU, 2000, ARCH NEUROL-CHICAGO, V57, P1745, DOI 10.1001/archneur.57.12.1745; Hattori N, 1998, J NEUROL SCI, V154, P66, DOI 10.1016/S0022-510X(97)00216-5; Hughes R, 2001, ANN NEUROL, V50, P195, DOI 10.1002/ana.1088; LUCIANO CA, 1995, MUSCLE NERVE, V18, P85, DOI 10.1002/mus.880180112; MATTHEWS WB, 1993, PERIPHERAL NEUROPATH, V2, P1418; MCCOMBE PA, 1987, BRAIN, V110, P1617; Mendell JR, 2001, NEUROLOGY, V56, P445, DOI 10.1212/WNL.56.4.445; Midroni G, 1999, J NEUROL SCI, V170, P36, DOI 10.1016/S0022-510X(99)00195-1; Nevo Y, 1996, NEUROLOGY, V47, P98, DOI 10.1212/WNL.47.1.98; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; Ryan MM, 2000, NEUROMUSCULAR DISORD, V10, P398, DOI 10.1016/S0960-8966(00)00119-X; Sander HW, 1999, MUSCLE NERVE, V22, P88, DOI 10.1002/(SICI)1097-4598(199901)22:1<88::AID-MUS13>3.3.CO;2-3; Schmidt B, 1996, MUSCLE NERVE, V19, P474, DOI 10.1002/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9; SLADKY JT, 1999, PEDIAT NEUROLOGY PRI, V2, P1202; SUMI SM, 1983, ARCH NEUROL-CHICAGO, V40, P577, DOI 10.1001/archneur.1983.04050080077016; SWAIMAN KF, 1999, PEDIAT NEUROLOGY PRI, V1, P115; VEDANARAYANAN VV, 1991, NEUROLOGY, V41, P828, DOI 10.1212/WNL.41.6.828	32	12	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					735	743		10.1056/NEJMcpc020031	http://dx.doi.org/10.1056/NEJMcpc020031			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594319				2022-12-28	WOS:000181014400010
J	Schiermeier, Q				Schiermeier, Q			Nobel laureate slams misconduct smear	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					773	773		10.1038/421773b	http://dx.doi.org/10.1038/421773b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594464	Bronze			2022-12-28	WOS:000181044700005
J	MacDonald, TM; Wei, L				MacDonald, TM; Wei, L			Effect of ibuprofen on cardioprotective effect of aspirin	LANCET			English	Article								Treatment with ibuprofen might limit the cardioprotective effects of aspirin. We aimed to assess whether patients with known cardiovascular disease who take low-dose aspirin and ibuprofen have increased risk of cardiovascular mortality. We studied 7107 patients who were discharged after first admission for cardiovascular disease between April, 1989, and April, 1997, and who were prescribed low-dose aspirin (<325 mg/day) and survived for at least I month. Compared with those who used aspirin alone, patients taking aspirin plus ibuprofen had an increased risk of all-cause mortality (adjusted hazard ratio 1.93, 95% CI 1.30-2.87, p=0.0011) and cardiovascular mortality (1.73, 1.05-2.84, p=0.0305). Our finding lends support to the hypothesis that ibuproen may interact with the cardioprotective effects of aspirin, at least in patients with established cardiovascular disease.	Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Med Monitoring Unit, Dundee DD1 9SY, Scotland	University of Dundee	MacDonald, TM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Med Monitoring Unit, Dundee DD1 9SY, Scotland.			MacDonald, Thomas/0000-0001-5189-6669				Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Evans JMM, 1999, BRIT J CLIN PHARMACO, V47, P105, DOI 10.1046/j.1365-2125.1999.00853.x; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1	4	321	334	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					573	574		10.1016/S0140-6736(03)12509-3	http://dx.doi.org/10.1016/S0140-6736(03)12509-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598144				2022-12-28	WOS:000181033400012
J	Check, E				Check, E			Cancer fears cast doubts on future of gene therapy	NATURE			English	News Item																		2003, NATURE, V421, P305	1	31	38	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					678	678		10.1038/421678b	http://dx.doi.org/10.1038/421678b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610583	Bronze			2022-12-28	WOS:000180938000005
J	Hamilton, VE; Christensen, PR; Bandfield, JL				Hamilton, VE; Christensen, PR; Bandfield, JL			Volcanism or aqueous alteration on Mars?	NATURE			English	Article									Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Hamilton, VE (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96828 USA.	hamilton@higp.hawaii.edu		Bandfield, Joshua/0000-0003-3571-3716				Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bandfield JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001469; BELL JF, 1996, MINERAL SPECTROSCOPY, P359; Christensen, 1992, MARS, P686; Foley CN, 2000, METEORIT PLANET SCI, V35, pA55; Marsh BD, 2002, GEOCHIM COSMOCHIM AC, V66, P2211, DOI 10.1016/S0016-7037(02)00905-5; Thompson G., 1983, HYDROTHERMAL PROCESS, P225; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356	10	13	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					711	712		10.1038/421711b	http://dx.doi.org/10.1038/421711b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610612				2022-12-28	WOS:000180938000030
J	Libby, RT; Smith, RS; Savinova, OV; Zabaleta, A; Martin, JE; Gonzalez, FJ; John, SWM				Libby, RT; Smith, RS; Savinova, OV; Zabaleta, A; Martin, JE; Gonzalez, FJ; John, SWM			Modification of ocular defects in mouse developmental glaucoma models by tyrosinase	SCIENCE			English	Article							PRIMARY CONGENITAL GLAUCOMA; TRANSCRIPTION FACTOR GENE; FETAL DEVELOPMENT; ADRENERGIC CELLS; RETINOIC ACID; NEURAL CREST; PHENOTYPES; PROMOTER; NEURONS; CYP1B1	Mutations in the cytochrome P450 family 1, subfamily B, polypeptide 1 (CYP1B1) gene are a common cause of human primary congenital glaucoma (PCG). Here we show that Cyp1b1(-/-) mice have ocular drainage structure abnormalities resembling those reported in human PCG patients. Using Cyp1b1(-/-) mice, we identified the tyrosinase gene (Tyr) as a modifier of the drainage structure phenotype, with Tyr deficiency increasing the magnitude of dysgenesis. The severe dysgenesis in eyes lacking both CYP1B1 and TYR was alleviated by administration of the tyrosinase product dihydroxyphenylalanine (L-dopa). Tyr also modified the drainage structure dysgenesis in mice with a mutant Foxc1 gene, which is also involved in PCG. These experiments raise the possibility that a tyrosinase/L-dopa pathway modifies human PCG, which could open new therapeutic avenues.	Jackson Lab, Bar Harbor, ME 04609 USA; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; NCI, Lab Metab, Bethesda, MD 20892 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Jackson Laboratory; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University	John, SWM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.		Libby, Richard/Q-6720-2019	Libby, Richard/0000-0003-2844-7632	NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NCI NIH HHS [CA34196] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN L, 1955, ARCH OPHTHALMOL-CHIC, V53, P783, DOI 10.1001/archopht.1955.00930010791002; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Boissy RE, 1997, PIGM CELL RES, V10, P12, DOI 10.1111/j.1600-0749.1997.tb00461.x; CATALANO RA, 1988, OPHTHALMIC PAED GEN, V9, P5, DOI 10.3109/13816818809031473; Cazorla P, 2000, J NEUROCHEM, V74, P1829, DOI 10.1046/j.1471-4159.2000.0741829.x; Chen H, 2000, DRUG METAB DISPOS, V28, P315; Dellovade TL, 1998, J COMP NEUROL, V402, P402; GENCIK A, 1980, CLIN GENET, V17, P241; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Ilia M, 1999, J COMP NEUROL, V405, P394, DOI 10.1002/(SICI)1096-9861(19990315)405:3<394::AID-CNE9>3.0.CO;2-Y; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lebel M, 2001, J NEUROCHEM, V77, P558, DOI 10.1046/j.1471-4159.2001.00257.x; MAUMENEE EA, 1958, T AM OPHTHAL SOC, V56, P507; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; RITCH R, 1996, GLAUCOMAS CLIN SCI, V2; Rockwood JM, 1996, EXP CELL RES, V223, P250, DOI 10.1006/excr.1996.0079; Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126; SAVINOVA OV, UNPUB; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Smith R S, 2001, BMC Dev Biol, V1, P3, DOI 10.1186/1471-213X-1-3; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; VANDORP DB, 1984, CLIN GENET, V26, P440; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Vitalis T, 2000, J NEUROSCI, V20, P6501, DOI 10.1523/JNEUROSCI.20-17-06501.2000; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	28	160	173	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1578	1581		10.1126/science.1080095	http://dx.doi.org/10.1126/science.1080095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624268				2022-12-28	WOS:000181367900039
J	Takahashi, T; Svoboda, K; Malinow, R				Takahashi, T; Svoboda, K; Malinow, R			Experience strengthening transmission by driving AMPA receptors into synapses	SCIENCE			English	Article							BARREL FIELD CORTEX; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; IN-VIVO; TRAFFICKING; RAT; POTENTIATION; EXPRESSION; MECHANISM	The mechanisms underlying experience-dependent plasticity in the brain may depend on the AMPA subclass of glutamate receptors (AMPA-Rs). We examined the trafficking of AMPA-Rs into synapses in the developing rat barrel cortex. In vivo gene delivery was combined with in vitro recordings to show that experience drives recombinant GluR1, an AMPA-R subunit, into synapses formed between layer 4 and layer 2/3 neurons. Moreover, expression of the GluR1 cytoplasmic tail, a construct that inhibits synaptic delivery of endogenous AMPA-Rs during long-term potentiation, blocked experience-driven synaptic potentiation. In general, synaptic incorporation of AMPA-Rs in vivo conforms to rules identified in vitro and contributes to plasticity driven by natural stimuli in the mammalian brain.	Cold Spring Harbor Lab, Jones Lab, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Malinow, R (corresponding author), Cold Spring Harbor Lab, Jones Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032827, R01NS038259] Funding Source: NIH RePORTER; NINDS NIH HHS [NS032827, NS038259] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; DURHAM D, 1984, J COMP NEUROL, V223, P424, DOI 10.1002/cne.902230308; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Frolov I, 1996, P NATL ACAD SCI USA, V93, P11371, DOI 10.1073/pnas.93.21.11371; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; LI XR, 1995, J COMP NEUROL, V357, P465, DOI 10.1002/cne.903570310; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1999, IMAGING LIVING NEURO; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Vees AM, 1998, J COMP NEUROL, V400, P110; WINFIELD DA, 1981, BRAIN RES, V206, P166, DOI 10.1016/0006-8993(81)90110-4; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	29	229	234	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1585	1588		10.1126/science.1079886	http://dx.doi.org/10.1126/science.1079886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624270				2022-12-28	WOS:000181367900041
J	Rortveit, G; Daltveit, AK; Hannestad, YS; Hunskaar, S				Rortveit, G; Daltveit, AK; Hannestad, YS; Hunskaar, S		Norwegian EPINCONT Study	Urinary incontinence after vaginal delivery or cesarean section	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDEMIOLOGIC SURVEY; SEVERITY INDEX; RISK-FACTORS; STRESS-INCONTINENCE; NORWEGIAN EPINCONT; WOMEN; PREVALENCE; PRIMIPARAS; COMMUNITY; VALIDITY	Background: It is uncertain whether women who deliver by cesarean section have an increased risk of urinary incontinence as compared with nulliparous women and whether women who deliver vaginally have an even higher risk. Methods: We studied 15,307 women enrolled in the Epidemiology of Incontinence in the County of Nord-Trondelag (EPINCONT) study, which involved a community-based cohort. The data base for this study was linked to data from the Medical Birth Registry of Norway. We included women who answered questions related to urinary incontinence, were younger than 65 years of age, and had had no deliveries, cesarean sections only, or vaginal deliveries only. Results: The prevalence of any incontinence was 10.1 percent in the nulliparous group; age-standardized prevalences were 15.9 percent in the cesarean-section group and 21.0 percent in the vaginal-delivery group. Corresponding figures for moderate or severe incontinence were 3.7 percent, 6.2 percent, and 8.7 percent, respectively; figures for stress incontinence were 4.7 percent, 6.9 percent, and 12.2 percent, respectively; figures for urge incontinence were 1.6 percent, 2.2 percent, and 1.8 percent, respectively; and figures for mixed-type incontinence were 3.1 percent, 5.3 percent, and 6.1 percent, respectively. As compared with nulliparous women, women who had cesarean sections had an adjusted odds ratio for any incontinence of 1.5 (95 percent confidence interval, 1.2 to 1.9) and an adjusted odds ratio for moderate or severe incontinence of 1.4 (95 percent confidence interval, 1.0 to 2.1). Only stress and mixed-type incontinence were significantly associated with cesarean sections. The adjusted odds ratio for any incontinence associated with vaginal deliveries as compared with cesarean sections was 1.7 (95 percent confidence interval, 1.3 to 2.1), and the adjusted odds ratio for moderate or severe incontinence was 2.2 (95 percent confidence interval, 1.5 to 3.1). Only stress incontinence (adjusted odds ratio, 2.4; 95 percent confidence interval, 1.7 to 3.2) was associated with the mode of delivery. Conclusions: The risk of urinary incontinence is higher among women who have had cesarean sections than among nulliparous women and is even higher among women who have had vaginal deliveries. However, these findings should not be used to justify an increase in the use of cesarean sections.	Univ Bergen, Sect Gen Practice, Dept Publ Hlth & Primary Hlth Care, N-5009 Bergen, Norway; Univ Bergen, Dept Publ Hlth & Primary Hlth Care, EPINCONT, Bergen, Norway; Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Prevent Med, Bergen, Norway; Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Rortveit, G (corresponding author), Univ Bergen, Sect Gen Practice, Dept Publ Hlth & Primary Hlth Care, Ulriksdal 8C, N-5009 Bergen, Norway.							Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Chiarelli P, 1999, NEUROUROL URODYNAM, V18, P567, DOI 10.1002/(SICI)1520-6777(1999)18:6<567::AID-NAU7>3.0.CO;2-F; Farrell SA, 2001, OBSTET GYNECOL, V97, P350, DOI 10.1016/S0029-7844(00)01164-9; Hanley J, 2001, BRIT MED J, V322, P1096, DOI 10.1136/bmj.322.7294.1096; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; HOLMEN J, 1990, Tidsskrift for den Norske Laegeforening, V110, P1973; Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021; IOSIF CS, 1982, INT J GYNECOL OBSTET, V20, P87, DOI 10.1016/0020-7292(82)90017-0; JOLLEYS JV, 1988, BRIT MED J, V296, P1300, DOI 10.1136/bmj.296.6632.1300; King JK, 1998, BRIT J OBSTET GYNAEC, V105, P1300, DOI 10.1111/j.1471-0528.1998.tb10009.x; Kuh D, 1999, J EPIDEMIOL COMMUN H, V53, P453, DOI 10.1136/jech.53.8.453; Persson J, 2000, OBSTET GYNECOL, V96, P440, DOI 10.1016/S0029-7844(00)00950-9; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; SANDVIK H, 1995, J CLIN EPIDEMIOL, V48, P339, DOI 10.1016/0895-4356(94)00147-I; SEIM A, 1995, FAM PRACT, V12, P18, DOI 10.1093/fampra/12.1.18; SNOOKS SJ, 1990, BRIT J SURG, V77, P1358, DOI 10.1002/bjs.1800771213; Thom DH, 1998, J AM GERIATR SOC, V46, P1411; VIKTRUP L, 1992, OBSTET GYNECOL, V79, P945; Wilson PD, 1996, BRIT J OBSTET GYNAEC, V103, P154, DOI 10.1111/j.1471-0528.1996.tb09668.x	21	501	518	2	15	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					900	907		10.1056/NEJMoa021788	http://dx.doi.org/10.1056/NEJMoa021788			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621134	Bronze			2022-12-28	WOS:000181341100005
J	Yanovski, JA; Rose, SR; Municchi, G; Pescovitz, OH; Hill, SC; Cassorla, FG; Cutler, GB				Yanovski, JA; Rose, SR; Municchi, G; Pescovitz, OH; Hill, SC; Cassorla, FG; Cutler, GB			Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL PRECOCIOUS PUBERTY; BONE-MINERAL DENSITY; IDIOPATHIC SHORT STATURE; GROWTH-HORMONE; FINAL HEIGHT; ADULT HEIGHT; NORMAL GIRLS; GNRH ANALOG; CHILDREN; DEFICIENCY	Background: Treatment with a luteinizing hormone-releasing hormone (LHRH) agonist increases adult height in children with LHRH-dependent precocious puberty and is prescribed by some practitioners to augment height in short adolescents. We performed a randomized clinical trial to determine whether treatment with an LHRH agonist increases adult height in short adolescents with normally timed puberty. Methods: Fifty short adolescents (18 boys and 32 girls) with low predicted adult height (mean [+/-SD], 3.3+/-1.2 SD below the population mean) received either placebo (24 subjects) or an LHRH agonist (26 subjects). The mean (+/-SD) duration of treatment was 3.5+/-0.9 years in the LHRH-agonist group and 2.1+/-1.2 years in the placebo group (P<0.001). Adult height was measured when bone age exceeded 16 years in girls and 17 years in boys and when the rate of growth was less than 1.5 cm per year. Results: Forty-seven adolescents (94 percent) were followed until they attained adult height. At the time adult height was achieved, the subjects who had been treated with an LHRH agonist were older than those who had received placebo (20.5+/-2.1 years vs. 18.0+/-2.5 years, P=0.01) and were taller (standard-deviation score, -2.2+/-1.1 vs. -3.0+/-1.2; P=0.01). Analysis of covariance showed that LHRH-agonist treatment resulted in an increase of 0.6 (95 percent confidence interval, 0.2 to 0.9) in the standard-deviation score for height, or an increase of 4.2 cm (95 percent confidence interval, 1.7 to 6.7), over the initially predicted adult height (P=0.01). Treatment with an LHRH agonist resulted in significantly greater adult height than did placebo in boys and girls, in adolescents with idiopathic short stature, and in those who had a growth-limiting syndrome. The principal adverse event in the LHRH-agonist group was decreased accretion of bone mineral density (mean lumbar vertebral bone mineral density at the time adult height was achieved, 1.6+/-1.2 SD below the population mean, vs. 0.3+/-1.2 SD below the population mean in the placebo group; P<0.001). Conclusions: Treatment with an LHRH agonist for 3.5 years increases adult height by 0.6 SD in adolescents with very short stature but substantially decreases bone mineral density. Such treatment cannot be routinely recommended to augment height in adolescents with normally timed puberty.	NICHHD, Unit Growth & Obes, Dev Endocrinol Branch, Bethesda, MD 20892 USA; NICHHD, Sect Dev Endocrinol, Dev Endocrinol Branch, Bethesda, MD 20892 USA; NIH, Diagnost Radiol Div, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA	Yanovski, JA (corresponding author), NIH, 10 Ctr Dr,Bldg 10,Rm 10N262,MSC 1862, Bethesda, MD 20892 USA.	yanovskj@mail.nih.gov		Yanovski, Jack/0000-0001-8542-1637	NCRR NIH HHS [5M01 RR00997] Funding Source: Medline; NICHD NIH HHS [Z01 HD-00610, Z01 HD-00641] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000641, Z01HD000610] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000997] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Antoniazzi F, 2000, J PEDIATR ENDOCR MET, V13, P773; BALDUCCI R, 1995, J CLIN ENDOCR METAB, V80, P3596, DOI 10.1210/jc.80.12.3596; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Bouvattier C, 1999, J CLIN ENDOCR METAB, V84, P3575, DOI 10.1210/jc.84.10.3575; BRAUNER R, 1994, J CLIN ENDOCR METAB, V79, P415, DOI 10.1210/jc.79.2.415; Carel JC, 1996, J CLIN ENDOCR METAB, V81, P3318, DOI 10.1210/jc.81.9.3318; Cutler GB, 1997, J STEROID BIOCHEM, V61, P141; Finkelstein BS, 2002, ARCH PEDIAT ADOL MED, V156, P230, DOI 10.1001/archpedi.156.3.230; Finkelstein JS, 1996, J CLIN ENDOCR METAB, V81, P1152, DOI 10.1210/jc.81.3.1152; FINKELSTEIN JS, 1992, NEW ENGL J MED, V326, P600, DOI 10.1056/NEJM199202273260904; Finkelstein JS, 1999, J CLIN ENDOCR METAB, V84, P3400; Frisancho AR, 1990, ANTHROPOMETRIC STAND, P189, DOI [10.3998/mpub.12198, DOI 10.3998/MPUB.12198]; Greulich WW., 1959, RADIOGRAPHIC ATLAS S, V2nd ed, P256, DOI DOI 10.1097/00000441-195909000-00030; GRYFE CI, 1971, LANCET, V1, P523; Heger S, 1999, J CLIN ENDOCR METAB, V84, P4583, DOI 10.1210/jc.84.12.4583; Heger S, 2000, J CLIN ENDOCR METAB, V85, P657; HIBI I, 1989, J CLIN ENDOCR METAB, V69, P221, DOI 10.1210/jcem-69-2-221; Hibi I, 1988, Acta Paediatr Jpn, V30 Suppl, P39; Hintz RL, 1999, NEW ENGL J MED, V340, P502, DOI 10.1056/NEJM199902183400702; JOB JC, 1994, HORM RES, V41, P177, DOI 10.1159/000183889; Kamp GA, 2001, J CLIN ENDOCR METAB, V86, P2969, DOI 10.1210/jc.86.7.2969; Kauli R, 1997, HORM RES, V47, P54, DOI 10.1159/000185432; Klein KO, 2001, J CLIN ENDOCR METAB, V86, P4711, DOI 10.1210/jc.86.10.4711; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Lanes R, 1998, CLIN ENDOCRINOL, V49, P197, DOI 10.1046/j.1365-2265.1998.00499.x; LESCHEK EW, 2001, PEDIAT RES S, V49, pA17; LINDNER D, 1993, EUR J PEDIATR, V152, P393, DOI 10.1007/BF01955894; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mericq MV, 2000, J CLIN ENDOCR METAB, V85, P569, DOI 10.1210/jc.85.2.569; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Mul D, 2001, J CLIN ENDOCR METAB, V86, P4655, DOI 10.1210/jc.86.10.4655; MUNICCHI G, 1993, J CLIN ENDOCR METAB, V77, P1334, DOI 10.1210/jc.77.5.1334; OERTER KE, 1990, J CLIN ENDOCR METAB, V71, P1251, DOI 10.1210/jcem-71-5-1251; Pasquino AM, 2000, J CLIN ENDOCR METAB, V85, P619, DOI 10.1210/jc.85.2.619; PAUL D, 1995, J CLIN ENDOCR METAB, V80, P546, DOI 10.1210/jc.80.2.546; ROSE SR, 1990, J CLIN ENDOCR METAB, V70, P1750, DOI 10.1210/jcem-70-6-1750; ROSE SR, 1988, NEW ENGL J MED, V319, P201, DOI 10.1056/NEJM198807283190403; SAGGESE G, 1995, J PEDIATR-US, V126, P468, DOI 10.1016/S0022-3476(95)70473-6; Sato T, 1996, PSYCHOPATHOLOGY, V29, P154, DOI 10.1159/000284985; SMITH EP, 1995, NEW ENGL J MED, V332, P131; Soyka LA, 2002, J CLIN ENDOCR METAB, V87, P4177, DOI 10.1210/jc.2001-011889; STANHOPE R, 1988, EUR J PEDIATR, V148, P200, DOI 10.1007/BF00441401; Tanaka T, 1999, ACTA PAEDIATR, V88, P85, DOI 10.1111/j.1651-2227.1999.tb14359.x; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; URIARTE MM, 1992, J CLIN ENDOCR METAB, V75, P1009; URIARTE MM, 1992, J CLIN ENDOCR METAB, V74, P436, DOI 10.1210/jc.74.2.436; Vizmanos B, 2001, AM J HUM BIOL, V13, P409, DOI 10.1002/ajhb.1065.abs; Weise M, 2001, P NATL ACAD SCI USA, V98, P6871, DOI 10.1073/pnas.121180498; ZACHMANN M, 1974, HELV PAEDIATR ACTA, V29, P61	51	90	96	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					908	917		10.1056/NEJMoa013555	http://dx.doi.org/10.1056/NEJMoa013555			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621135				2022-12-28	WOS:000181341100006
J	Brammah, A; Robertson, S; Tait, G; Isles, C				Brammah, A; Robertson, S; Tait, G; Isles, C			Bilateral renovascular disease causing cardiorenal failure	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FLASH PULMONARY-EDEMA; RENAL-ARTERY STENOSIS; HEART-FAILURE; HYPERTENSION; REVASCULARIZATION; MANAGEMENT		Dumfries & Galloway Royal Infirm, Renal Unit, Dumfries DG1 4AP, Scotland; Dumfries & Galloway Royal Infirm, Dept Cardiol, Dumfries DG1 4AP, Scotland		Brammah, A (corresponding author), Dumfries & Galloway Royal Infirm, Renal Unit, Dumfries DG1 4AP, Scotland.	abrammah@hotmail.com						Bloch MJ, 1999, AM J HYPERTENS, V12, P1, DOI 10.1016/S0895-7061(98)00201-5; DIAMOND JR, 1993, AM J KIDNEY DIS, V21, P328, DOI 10.1016/S0272-6386(12)80756-6; Farmer CKT, 1999, NEPHROL DIAL TRANSPL, V14, P1310, DOI 10.1093/ndt/14.5.1310; Isles C, 2002, CLIN MED, V2, P195, DOI 10.7861/clinmedicine.2-3-195; Isles CG, 1999, QJM-INT J MED, V92, P159, DOI 10.1093/qjmed/92.3.159; Khosla S, 1997, AM J CARDIOL, V80, P363, DOI 10.1016/S0002-9149(97)00368-8; Kwan T, 1997, ANGIOLOGY, V48, P1079, DOI 10.1177/000331979704801210; Luft FC, 2000, NEPHROL DIAL TRANSPL, V15, P1515, DOI 10.1093/ndt/15.10.1515; MacDowall P, 1998, LANCET, V352, P13, DOI 10.1016/S0140-6736(97)11060-1; MESSINA LM, 1992, J VASC SURG, V15, P73, DOI 10.1016/0741-5214(92)70015-D; Missouris CG, 2000, HEART, V83, P152, DOI 10.1136/heart.83.2.152; Modi KS, 2001, J AM SOC NEPHROL, V12, P1781, DOI 10.1681/ASN.V1281781; PICKERING TG, 1988, LANCET, V2, P551; Planken IIL, 1998, NETH J MED, V52, P116, DOI 10.1016/S0300-2977(97)00094-6; Schoolwerth AC, 2001, CIRCULATION, V104, P1985, DOI 10.1161/hc4101.096153; Shah SMA, 2001, NEPHROL DIAL TRANSPL, V16, P1311, DOI 10.1093/ndt/16.7.1311; Walker F, 2001, LANCET, V358, P556, DOI 10.1016/S0140-6736(01)05708-7; Weatherford DA, 1997, AM J SURG, V174, P160, DOI 10.1016/S0002-9610(97)00092-5	18	17	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2003	326	7387					489	491		10.1136/bmj.326.7387.489	http://dx.doi.org/10.1136/bmj.326.7387.489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609948	Green Published			2022-12-28	WOS:000181421400024
J	Kapp, C				Kapp, C			United Nations reveals aid plans for war in Iraq	LANCET			English	Editorial Material																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					622	622		10.1016/S0140-6736(03)12618-9	http://dx.doi.org/10.1016/S0140-6736(03)12618-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606216	Bronze			2022-12-28	WOS:000181129500002
J	McCarthy, M				McCarthy, M			US military plans to lead relief efforts in Iraq	LANCET			English	Editorial Material																			0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					629	629		10.1016/S0140-6736(03)12622-0	http://dx.doi.org/10.1016/S0140-6736(03)12622-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12611389				2022-12-28	WOS:000181129500006
J	Ojoo, JC; Kastelik, JA; Morice, AH				Ojoo, JC; Kastelik, JA; Morice, AH			A boy with a disabling cough	LANCET			English	Editorial Material									Univ Hull, Castle Hill Hosp, Acad Dept Med, Kingston Upon Hull HU16 5JQ, N Humberside, England	University of Hull	Morice, AH (corresponding author), Univ Hull, Castle Hill Hosp, Acad Dept Med, Kingston Upon Hull HU16 5JQ, N Humberside, England.							Bush A, 2002, PULM PHARMACOL THER, V15, P309, DOI 10.1006/pupt.2002.0340; French CL, 1998, ARCH INTERN MED, V158, P1657, DOI 10.1001/archinte.158.15.1657; Jankovic J, 2001, NEW ENGL J MED, V345, P1184, DOI 10.1056/NEJMra010032; Morice AH, 2002, PULM PHARMACOL THER, V15, P253, DOI 10.1006/pupt.2002.0352	4	15	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					674	674		10.1016/S0140-6736(03)12603-7	http://dx.doi.org/10.1016/S0140-6736(03)12603-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606180				2022-12-28	WOS:000181129500018
J	Bowler, JM; Johnston, H; Olley, JM; Prescott, JR; Roberts, RG; Shawcross, W; Spooner, NA				Bowler, JM; Johnston, H; Olley, JM; Prescott, JR; Roberts, RG; Shawcross, W; Spooner, NA			New ages for human occupation and climatic change at Lake Mungo, Australia	NATURE			English	Article							OLDEST HUMAN REMAINS; EXTINCTION; MEGAFAUNA; SKELETON; DATES; SITE	Australia's oldest human remains, found at Lake Mungo, include the world's oldest ritual ochre burial (Mungo III)(1) and the first recorded cremation (Mungo I)(2). Until now, the importance of these finds has been constrained by limited chronologies and palaeoenvironmental information(3). Mungo III, the source of the world's oldest human mitochondrial DNA(4), has been variously estimated at 30 thousand years (kyr) old(1), 42-45 kyr old(5,6) and 62 +/- 6 kyr old(7,8), while radiocarbon estimates placed the Mungo I cremation near 20-26 kyr ago(2,9,10). Here we report a new series of 25 optical ages showing that both burials occurred at 40 +/- 2 kyr ago and that humans were present at Lake Mungo by 50-46 kyr ago, synchronously with, or soon after, initial occupation of northern(11,12) and western Australia(13). Stratigraphic evidence indicates fluctuations between lake-full and drier conditions from 50 to 40 kyr ago, simultaneously with increased dust deposition, human arrival and continent-wide extinction of the megafauna(14),(15). This was followed by sustained aridity between 40 and 30 kyr ago. This new chronology corrects previous estimates for human burials at this important site and provides a new picture of Homo sapiens adapting to deteriorating climate in the world's driest inhabited continent.	Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; NSW Natl Parks & Wildlife Serv, Buronga, NSW 2739, Australia; CSIRO Land & Water, Canberra, ACT 2601, Australia; Univ Adelaide, Dept Phys & Math Phys, Adelaide, SA 5005, Australia; Univ Wollongong, Sch Geosci, Wollongong, NSW 2522, Australia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; University of Wollongong; Australian National University	Bowler, JM (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia.	j.bowler@earthsci.unimelb.edu.au	Roberts, Richard Graham/B-8245-2013	Roberts, Richard Graham/0000-0002-0128-4119				Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Aitken M.J., 1998, INTRO OPTICAL DATING; BARBETTI M, 1972, NATURE, V239, P327, DOI 10.1038/239327a0; Barrows TT, 2001, QUATERNARY RES, V55, P179, DOI 10.1006/qres.2001.2216; BELL WT, 1991, ARCHAEOMETRY, V33, P43, DOI 10.1111/j.1475-4754.1991.tb00684.x; Bowler J.M., 1998, ARCHAEOL OCEAN, V33, P120, DOI DOI 10.1002/J.1834-4453.1998.TB00414.X; Bowler J. M., 1998, ARCHAEOL OCEAN, V33, P156; Bowler J.M., 1976, ORIGIN AUSTR, P127; BOWLER JM, 1970, WORLD ARCHAEOL, V2, P39, DOI 10.1080/00438243.1970.9979463; BOWLER JM, 1972, NATURE, V240, P48, DOI 10.1038/240048a0; Bowler JM, 2000, J HUM EVOL, V38, P719, DOI 10.1006/jhev.1999.0397; Burnett W.C., 1992, URANIUM SERIES DISEQ, P486; Gillespie R, 2000, J HUM EVOL, V38, P727, DOI 10.1006/jhev.1999.0398; Gillespie R, 1997, RADIOCARBON, V39, P239, DOI 10.1017/S0033822200053236; Grun R, 2000, J HUM EVOL, V38, P733, DOI 10.1006/jhev.2000.0399; Hope JH, 1978, ALCHERINGA, V2, P65, DOI 10.1080/03115517808619080; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; HUXTABLE J, 1977, NATURE, V265, P40, DOI 10.1038/265040a0; Laj C, 2000, PHILOS T ROY SOC A, V358, P1009, DOI 10.1098/rsta.2000.0571; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Oyston B, 1996, QUATERNARY SCI REV, V15, P739, DOI 10.1016/0277-3791(96)00025-X; RADCZEWSKI OE, 1960, SPECIAL PUBLICATION, V4, P496; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Shawcross W., 1998, ARCHAEOL OCEAN, V33, P183; Simpson JJ, 1998, QUATERNARY SCI REV, V17, P1009, DOI 10.1016/S0277-3791(97)00088-7; Thorne A, 1999, J HUM EVOL, V36, P591, DOI 10.1006/jhev.1999.0305; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195	29	455	473	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					837	840		10.1038/nature01383	http://dx.doi.org/10.1038/nature01383			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	646QA	12594511				2022-12-28	WOS:000181044700046
J	Giles, J; Knight, J				Giles, J; Knight, J			Dolly's death leaves researchers woolly on clone ageing issue	NATURE			English	News Item																		Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262	2	4	6	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					776	776		10.1038/421776a	http://dx.doi.org/10.1038/421776a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594470	Bronze			2022-12-28	WOS:000181044700010
J	Muller, CD; Falcou, A; Reckefuss, N; Rojahn, M; Wiederhirn, V; Rudati, P; Frohne, H; Nuyken, O; Becker, H; Meerholz, K				Muller, CD; Falcou, A; Reckefuss, N; Rojahn, M; Wiederhirn, V; Rudati, P; Frohne, H; Nuyken, O; Becker, H; Meerholz, K			Multi-colour organic light-emitting displays by solution processing	NATURE			English	Article							HOLE-TRANSPORT MATERIALS; POLYMERS; DIODES; ELECTROLUMINESCENCE; EFFICIENT; DEVICES; LAYERS	Organic light-emitting diodes (OLEDs) show promise for applications as high-quality self-emissive displays for portable devices such as cellular phones and personal organizers(1-4). Although monochrome operation is sufficient for some applications, the extension to multi-colour devices-such as RGB (red, green, blue) matrix displays-could greatly enhance their technological impact. Multi-colour OLEDs have been successfully fabricated by vacuum deposition of small electroluminescent molecules, but solution processing of larger molecules (electroluminescent polymers) would result in a cheaper and simpler manufacturing process. However, it has proved difficult to combine the solution processing approach with the high-resolution patterning techniques required to produce a pixelated display. Recent attempts have focused on the modification of standard printing techniques, such as screen printing(5-7) and ink jetting(8), but those still have technical drawbacks. Here we report a class of electroluminescent polymers that can be patterned in a way similar to standard photoresist materials-soluble polymers with oxetane sidegroups that can be crosslinked photochemically to produce insoluble polymer networks in desired areas. The resolution of the process is sufficient to fabricate pixelated matrix displays. Consecutive deposition of polymers that are luminescent in each of the three RGB colours yielded a device with efficiencies comparable to state-of-the-art OLEDs and even slightly reduced onset voltages.	Covion Org Semcond GmbH, D-69526 Frankfurt, Germany; Tech Univ Munich, Lehrstuhl Makromol Stoffe, D-85747 Garching, Germany; Univ Munich, Dept Chem, D-81377 Munich, Germany	Technical University of Munich; University of Munich	Meerholz, K (corresponding author), Univ Cologne, Inst Phys Chem, Luxemburgerstr 116, D-50939 Cologne, Germany.	klaus.meerholz@uni-koeln.de	Meerholz, Klaus -/A-7819-2017; Rudati, Paula Santi/AAC-6010-2021	Meerholz, Klaus -/0000-0001-7450-4672; 				Bacher A, 1999, MACROMOLECULES, V32, P4551, DOI 10.1021/ma981595+; Bayerl MS, 1999, MACROMOL RAPID COMM, V20, P224; BECKER H, 2002, SID, V33, P780; Bellmann E, 1998, CHEM MATER, V10, P1668, DOI 10.1021/cm980030p; Birnstock J, 2001, APPL PHYS LETT, V78, P3905, DOI 10.1063/1.1379594; BIRNSTOCK J, 2001, P SOC PHOTO-OPT INS, V4464, P68; Chen JP, 1999, SYNTHETIC MET, V107, P129, DOI 10.1016/S0379-6779(99)00145-9; FOUASSIER JP, 1995, PHOTOINITIATION PHOT, P102; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; Haskal E. I., 2002, SID, V33, P776; Heeger AJ, 1998, SOLID STATE COMMUN, V107, P673, DOI 10.1016/S0038-1098(98)00215-4; Jiang XZ, 2000, APPL PHYS LETT, V76, P1813, DOI 10.1063/1.126174; Kraft A, 1998, ANGEW CHEM INT EDIT, V37, P402, DOI 10.1002/(SICI)1521-3773(19980302)37:4<402::AID-ANIE402>3.0.CO;2-9; Le Barny P, 1997, P SOC PHOTO-OPT INS, V3148, P160, DOI 10.1117/12.284172; Li WJ, 1999, ADV MATER, V11, P730, DOI 10.1002/(SICI)1521-4095(199906)11:9<730::AID-ADMA730>3.0.CO;2-T; Li XC, 1997, SYNTHETIC MET, V84, P437, DOI 10.1016/S0379-6779(97)80820-X; Muller DC, 2000, CHEMPHYSCHEM, V1, P207, DOI 10.1002/1439-7641(20001215)1:4<207::AID-CPHC207>3.0.CO;2-Z; Pardo DA, 2000, ADV MATER, V12, P1249, DOI 10.1002/1521-4095(200009)12:17<1249::AID-ADMA1249>3.0.CO;2-Y; Penczek S., 1989, COMPREHENSIVE POLYM, V3, P751; Salbeck J, 1996, BER BUNSEN PHYS CHEM, V100, P1667, DOI 10.1002/bbpc.19961001002; SASAKI H, 1992, J MACROMOL SCI PURE, V29, P915, DOI 10.1080/10601329208054128; SEONG TL, 2002, SID, V33, P784; Trattnig G, 2002, APPL PHYS LETT, V81, P4269, DOI 10.1063/1.1524703; TREACHER K, Patent No. 077060; TREACHER K, 2001, Patent No. 1011447	25	1030	1069	9	539	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					829	833		10.1038/nature01390	http://dx.doi.org/10.1038/nature01390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594509				2022-12-28	WOS:000181044700044
J	Paasche-Orlow, MK; Taylor, HA; Brancati, FL				Paasche-Orlow, MK; Taylor, HA; Brancati, FL			Readability standards for informed-consent forms as compared with actual readability	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; LITERACY; CARE; COMPREHENSION; INFORMATION	BACKGROUND: Institutional review boards (IRBs) are charged with safeguarding potential research subjects with limited literacy but may have an inadvertent role in promulgating unreadable consent forms. We hypothesized that text provided by IRBs in informed-consent forms falls short of the IRBs' own readability standards and that readability is influenced by the level of research activity, local literacy rates, and federal oversight. METHODS: To test these hypotheses, we conducted a cross-sectional study linking data from several public-use sources. A total of 114 Web sites of U.S. medical schools were surveyed for IRB readability standards and informed-consent-form templates. Actual readability was measured with the Flesch-Kincaid scale, which assigns a score on the basis of the minimal grade level required to read and understand English text (range, 0 to 12). Data on the level of research activity, local literacy rates, and federal oversight were obtained from organizational Web sites. RESULTS: The average readability score for text provided by IRBs was 10.6 (95 percent confidence interval, 10.3 to 10.8) on the Flesch-Kincaid scale. Specific readability standards, found on 61 Web sites (54 percent), ranged from a 5th-grade reading level to a 10th-grade reading level. The mean Flesch-Kincaid scores for the readability of sample text provided by IRBs exceeded the stated standard by 2.8 grade levels (95 percent confidence interval, 2.4 to 3.2; P<0.001). Readability was not associated with either the level of research funding (P=0.89) or local rates of literacy (P=0.92). However, the 52 schools that had been made subject to oversight by the Office for Human Research Protections (46 percent) had lower Flesch-Kincaid scores than the other schools (10.2 vs. 10.9, P=0.005). CONCLUSIONS: IRBs commonly provide text for informed-consent forms that falls short of their own readability standards. Federal oversight is associated with better readability.	Johns Hopkins Univ, Dept Med, Baltimore, MD USA; Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Paasche-Orlow, MK (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.		Paasche-Orlow, Michael/ABF-7919-2020	Paasche-Orlow, Michael/0000-0002-9276-7190	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062222] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32HL007180] Funding Source: Medline; NIDDK NIH HHS [K24DK62222] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrus MR, 2002, PHARMACOTHERAPY, V22, P282, DOI 10.1592/phco.22.5.282.33191; [Anonymous], 1986, HIST THEORY INFORM C; BAKER DW, 1995, JAMA-J AM MED ASSOC, V274, P1759, DOI 10.1001/jama.1995.03530220025016; BARBOUR GL, 1978, JAMA-J AM MED ASSOC, V240, P2741, DOI 10.1001/jama.240.25.2741; Bjorn E, 1999, J MED ETHICS, V25, P263, DOI 10.1136/jme.25.3.263; Davis TC, 1998, JNCI-J NATL CANCER I, V90, P668, DOI 10.1093/jnci/90.9.668; *DEP HLTH HUM SERV, 1993, I REV BOARD GUID; Doak CC, 1998, CA-CANCER J CLIN, V48, P151, DOI 10.3322/canjclin.48.3.151; Doak CC, 1996, TEACHING PATIENTS LO; Fitzmaurice DA, 2000, J HUM HYPERTENS, V14, P259, DOI 10.1038/sj.jhh.1001003; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; HAMMERSCHMIDT DE, 1992, AM J MED SCI, V304, P348, DOI 10.1097/00000441-199212000-00003; Heinze-Lacey Beverly, 1993, IRB, V15, P10, DOI 10.2307/3563834; *HLTH LIT PROJ, 1996, LIT HLTH LAW; Jimison HB, 1998, J AM MED INFORM ASSN, V5, P245, DOI 10.1136/jamia.1998.0050245; Kickbusch I, 2001, J HEALTH COMMUN, V6, P87, DOI 10.1080/108107301750254439; Kincaid J., 1975, NAVAL TECHNICAL TRAI; Kirsch I, 1993, ADULT LITERACY AM 1; Lehmann LS, 1997, NEW ENGL J MED, V336, P1150, DOI 10.1056/NEJM199704173361606; Meade C D, 1992, Oncol Nurs Forum, V19, P1523; *NAT I LIT, 2003, STAT LIT AM; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; *NIH, 2002, NIH AW MED SCH RANK; *OFF HUM RES PROT, 2002, OHRP COMPL ACT DET L; Padberg R M, 1999, Semin Oncol Nurs, V15, P138, DOI 10.1016/S0749-2081(99)80071-0; Pape T, 1997, AORN J, V65, P1122, DOI 10.1016/S0001-2092(06)62955-4; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Peterson Barry T, 1992, IRB, V14, P6, DOI 10.2307/3563853; PHILIPSON SJ, 1995, J INVEST MED, V43, P459; Raich PC, 2001, CANCER INVEST, V19, P437, DOI 10.1081/CNV-100103137; RUDD R, 1999, HLTH LITERACY; Sugarman J, 1999, Hastings Cent Rep, V29, pS1, DOI 10.2307/3528546; Taylor KM, 1998, J NATL CANCER I, V90, P644, DOI 10.1093/jnci/90.9.644; Taylor MP, 1999, OXFORD REV ECON POL, V15, P95, DOI 10.1093/oxrep/15.2.95; Weiss BD, 1998, J FAM PRACTICE, V46, P168; White LJ, 1996, ACAD EMERG MED, V3, P745, DOI 10.1111/j.1553-2712.1996.tb03509.x; Williams MV, 1998, CHEST, V114, P1008, DOI 10.1378/chest.114.4.1008; Young Daniel R, 1990, IRB, V12, P1, DOI 10.2307/3564107	38	458	464	0	25	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					721	726		10.1056/NEJMsa021212	http://dx.doi.org/10.1056/NEJMsa021212			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594317				2022-12-28	WOS:000181014400008
J	Noth, I; Strek, ME; Leff, AR				Noth, I; Strek, ME; Leff, AR			Churg-Strauss syndrome	LANCET			English	Review							TERM FOLLOW-UP; SYSTEMIC VASCULITIS; POLYARTERITIS-NODOSA; CYCLOPHOSPHAMIDE THERAPY; CORTICOSTEROID WITHDRAWAL; MICROSCOPIC POLYANGIITIS; ALLERGIC GRANULOMATOSIS; EOSINOPHILIA; ANGIITIS; INVOLVEMENT	Churg-Strauss syndrome is a rare diffuse vasculitis that is almost invariably accompanied by severe asthma. Although overall prognosis is good, and treatment with prednisone alone or in combination with immunosuppressive drugs is usually successful, severe asthma typically persists. Diffuse organ involvement of Churg-Strauss syndrome, especially cardiovascular and rare involvement of the CNS and renal system, suggests a poorer prognosis than usual, and can be fatal. The cause of Churg-Strauss syndrome is unknown, but its characteristic histological findings and association with asthma distinguish it from other vasculitides. Controversy surrounds the use of asthma drugs-especially antileukotrienes-and development of the disorder. We review the epidemiological evidence for an association of drug treatment with Churg-Strauss syndrome, the diverse diagnostic and pathological criteria for this syndrome, and treatment options.	Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, Chicago, IL 60637 USA; Univ Chicago, Comm Clin Pharmacol, Chicago, IL 60637 USA; Univ Chicago, Comm Pharmacogenet & Mol Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Leff, AR (corresponding author), Univ Chicago, Dept Med, Pulm & Crit Care Med Sect, MC6076,5841 S Maryland Ave, Chicago, IL 60637 USA.	aleff@medicine.bsd.uchicago.edu						ABUSHAKRA M, 1994, ARTHRITIS RHEUM, V37, P1798, DOI 10.1002/art.1780371214; ALLEN JN, 1994, AM J RESP CRIT CARE, V150, P1423, DOI 10.1164/ajrccm.150.5.7952571; ANSELL ID, 1975, BRIT J UROL, V47, P413, DOI 10.1111/j.1464-410X.1975.tb03998.x; APTEKAR RG, 1973, ARTHRITIS RHEUM, V16, P461, DOI 10.1002/art.1780160405; BRADLEY JD, 1989, ARTHRITIS RHEUM, V32, P45, DOI 10.1002/anr.1780320108; CHEN K-R, 1992, Journal of Dermatology (Tokyo), V19, P40; Choi YH, 2000, CHEST, V117, P117, DOI 10.1378/chest.117.1.117; CHUMBLEY LC, 1977, MAYO CLIN PROC, V52, P477; CHURG J, 1951, AM J PATHOL, V27, P277; CLUTTERBUCK EJ, 1990, NEPHROL DIAL TRANSPL, V5, P161, DOI 10.1093/ndt/5.3.161; Conron M, 2000, THORAX, V55, P870, DOI 10.1136/thorax.55.10.870; COOPER BJ, 1978, ARCH INTERN MED, V138, P367, DOI 10.1001/archinte.138.3.367; Eastell R, 1998, J INTERN MED, V244, P271, DOI 10.1046/j.1365-2796.1998.00408.x; FAIRCHILD WV, 1979, J UROLOGY, V122, P163, DOI 10.1016/S0022-5347(17)56306-5; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; FAUCI AS, 1979, NEW ENGL J MED, V301, P235, DOI 10.1056/NEJM197908023010503; FERGONI V, 1995, RECENTI PROG MED, V86, P353; FRAIOLI P, 1994, SARCOIDOSIS, V11, P42; Franco J, 1999, THORAX, V54, P558, DOI 10.1136/thx.54.6.558; FROHNERT PP, 1967, AM J MED, V43, P8, DOI 10.1016/0002-9343(67)90144-1; Gayraud M, 2001, ARTHRITIS RHEUM, V44, P666, DOI 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A; Gayraud M, 1997, BRIT J RHEUMATOL, V36, P1290; GOLIN AL, 1977, J UROLOGY, V118, P110, DOI 10.1016/S0022-5347(17)57911-2; Guillevin L, 1996, MEDICINE, V75, P17, DOI 10.1097/00005792-199601000-00003; Guillevin L, 1997, ANN MED INTERNE, V148, P198; GUILLEVIN L, 1991, CHEST, V100, P1472, DOI 10.1378/chest.100.5.1472; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-00003; Hagen EC, 1998, KIDNEY INT, V53, P743, DOI 10.1046/j.1523-1755.1998.00807.x; HAMILOS DL, 1991, J ALLERGY CLIN IMMUN, V88, P823, DOI 10.1016/0091-6749(91)90195-T; Harper L, 2000, J PATHOL, V190, P349, DOI 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A; Hattori N, 1999, BRAIN, V122, P427, DOI 10.1093/brain/122.3.427; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; JAYNE DRW, 1991, LANCET, V337, P1137, DOI 10.1016/0140-6736(91)92797-6; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kinoshita M, 1999, J ALLERGY CLIN IMMUN, V103, P534, DOI 10.1016/S0091-6749(99)70483-5; LANHAM JG, 1984, MEDICINE, V63, P65, DOI 10.1097/00005792-198403000-00001; LANHAM JG, 1992, BRIT J HOSP MED, V47, P667; Le Gall C, 2000, EUR RESPIR J, V15, P978, DOI 10.1034/j.1399-3003.2000.15e29.x; LEIB ES, 1979, AM J MED, V67, P941, DOI 10.1016/0002-9343(79)90634-X; Levy Y, 1999, SOUTHERN MED J, V92, P412, DOI 10.1097/00007611-199904000-00012; Martin RM, 1999, PHARMACOEPIDEM DR S, V8, P179, DOI 10.1002/(SICI)1099-1557(199905/06)8:3<179::AID-PDS414>3.3.CO;2-B; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Meziane H, 2001, RESP MED, V95, P799, DOI 10.1053/rmed.2001.1163; MORGAN JM, 1989, BRIT HEART J, V62, P462; Muschen M, 1999, AM J PATHOL, V155, P915, DOI 10.1016/S0002-9440(10)65191-7; PLOTZ PH, 1979, ANN INTERN MED, V91, P221, DOI 10.7326/0003-4819-91-2-221; Prechtl S, 2000, J IMMUNOL, V164, P754, DOI 10.4049/jimmunol.164.2.754; Ramakrishna G, 2001, ANN ALLERG ASTHMA IM, V86, P603, DOI 10.1016/S1081-1206(10)62286-7; Reid AJC, 1998, QJM-MON J ASSOC PHYS, V91, P219, DOI 10.1093/qjmed/91.3.219; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Rychlik I, 1997, NEPHROL DIAL TRANSPL, V12, P837, DOI 10.1093/ndt/12.4.837; SARTORI M, 1995, EUR J CLIN INVEST, V25, P68, DOI 10.1111/j.1365-2362.1995.tb01528.x; SASAKI A, 1998, ACTA PATHOL JPN, V38, P761; Schmitt WH, 1998, ARTHRITIS RHEUM, V41, P445, DOI 10.1002/1529-0131(199803)41:3<445::AID-ART10>3.3.CO;2-V; SHARMA A, 1993, CAN J CARDIOL, V9, P329; Solans R, 2001, RHEUMATOLOGY, V40, P763, DOI 10.1093/rheumatology/40.7.763; STILLWELL TJ, 1988, ARTHRITIS RHEUM, V31, P465, DOI 10.1002/art.1780310402; Stirling RG, 1999, THORAX, V54, P865, DOI 10.1136/thx.54.10.865; Tatsis E, 1998, ANN INTERN MED, V129, P370, DOI 10.7326/0003-4819-129-5-199809010-00004; Watts RA, 2000, ARTHRITIS RHEUM, V43, P414, DOI 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0; Watts RA, 2001, ANN RHEUM DIS, V60, P170, DOI 10.1136/ard.60.2.170; Wechsler ME, 1998, JAMA-J AM MED ASSOC, V279, P455, DOI 10.1001/jama.279.6.455; Wechsler ME, 2000, CHEST, V117, P708, DOI 10.1378/chest.117.3.708; WELLER PF, 2001, NIH WORKSHOP SUMM RE, V108, P175; WITHERS NJ, 1996, PULMONARY CRITICAL C, P583; Yamashita Y, 1998, INTERNAL MED, V37, P561, DOI 10.2169/internalmedicine.37.561	67	267	285	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					587	594		10.1016/S0140-6736(03)12518-4	http://dx.doi.org/10.1016/S0140-6736(03)12518-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598156				2022-12-28	WOS:000181033400023
J	Masur, H; Kaplan, JE; Holmes, KK				Masur, H; Kaplan, JE; Holmes, KK			Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 - Recommendations of the US Public Health Service and the Infectious Diseases Society of America	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; PNEUMOCYSTIS-CARINII-PNEUMONIA; MYCOBACTERIUM-AVIUM COMPLEX; MOTHER-TO-CHILD; PLACEBO-CONTROLLED TRIAL; PRIMARY PROPHYLAXIS; DOUBLE-BLIND; CYTOMEGALOVIRUS RETINITIS; TRIMETHOPRIM-SULFAMETHOXAZOLE; MAINTENANCE THERAPY	In 1995, the U.S. Public Health Service (USPHS) and the Infectious Diseases Society of America (IDSA) developed guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV); these guidelines were updated in 1997 and 1999. This fourth edition of the guidelines, made available on the Internet in 2001, is intended for clinicians and other health-care providers who care for HIV-infected persons. The goal of these guidelines is to provide evidence-based guidelines for preventing OIs among HIV-infected adults and adolescents, including pregnant women, and HIV-exposed or infected children. Nineteen OIs, or groups of OIs, are addressed, and recommendations are included for preventing exposure to opportunistic pathogens, preventing first episodes of disease by chemoprophylaxis or vaccination (primary prophylaxis), and preventing disease recurrence (secondary prophylaxis). Major changes since the last edition of the guidelines include 1) updated recommendations for discontinuing primary and secondary OI prophylaxis among persons whose CD4(+) T lymphocyte counts have increased in response to antiretroviral therapy; 2) emphasis on screening all HIV-infected persons for infection with hepatitis C virus; 3) new information regarding transmission of human herpesvirus 8 infection; 4) new information regarding drug interactions, chiefly related to rifamycins and antiretroviral drugs; and 5) revised recommendations for immunizing HIV-infected adults and adolescents and HIV-exposed or infected children.	NIH, Bethesda, MD 20892 USA; CDC, Atlanta, GA 30333 USA; Univ Washington, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle	Masur, H (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.		, Holmes/K-6215-2019	Kovacs, Joseph/0000-0002-5191-9880; Polis, Michael/0000-0002-9151-2268; Mofenson, Lynne/0000-0002-2818-9808; Pellett, Philip/0000-0002-8536-8343; Holtgrave, David/0000-0002-4321-7395; Fukuda, Keiji/0000-0002-9598-9565; Lundgren, Jens/0000-0001-8901-7850				Aberg JA, 1998, J INFECT DIS, V178, P1446, DOI 10.1086/314469; ABERG JA, 2000, 7 C RETR OPP INF SAN; Abramson JS, 2000, PEDIATRICS, V106, P362; Adair CD, 1998, OBSTET GYNECOL, V91, P165, DOI 10.1016/S0029-7844(97)00586-3; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Alter MJ, 1998, INFECT DIS CLIN N AM, V12, P13, DOI 10.1016/S0891-5520(05)70405-0; [Anonymous], 1996, Arch Ophthalmol, V114, P23; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; [Anonymous], 1997, Ann Intern Med, V126, P264; [Anonymous], 1995, Clin Infect Dis, V21 Suppl 1, pS32; Belfort R, 2002, AM J OPHTHALMOL, V133, P467; BENSON C, 1999, 6 C RETR OPP INF CHI; Benson CA, 2000, J INFECT DIS, V181, P1289, DOI 10.1086/315380; Bourboulia D, 1998, JAMA-J AM MED ASSOC, V280, P31, DOI 10.1001/jama.280.1.31-a; BOZZETTE SA, 1991, NEW ENGL J MED, V324, P580, DOI 10.1056/NEJM199102283240902; BOZZETTE SA, 1995, NEW ENGL J MED, V332, P693, DOI 10.1056/NEJM199503163321101; Breiman RF, 2000, ARCH INTERN MED, V160, P2633, DOI 10.1001/archinte.160.17.2633; Brosgart CL, 1998, AIDS, V12, P269, DOI 10.1097/00002030-199803000-00004; Cannon MJ, 2001, NEW ENGL J MED, V344, P637, DOI 10.1056/NEJM200103013440904; CARR A, 1992, ANN INTERN MED, V117, P106, DOI 10.7326/0003-4819-117-2-106; *CDC, 1999, HLTH INF INT TRAV 19, P202; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P185; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P733; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Chaisson RE, 1997, AIDS, V11, P311, DOI 10.1097/00002030-199703110-00008; CHAISSON RE, 1994, ANN INTERN MED, V121, P905, DOI 10.7326/0003-4819-121-12-199412150-00001; Chan C, 1999, J INFECT DIS, V180, P369, DOI 10.1086/314893; Chemello L, 1996, ANN INTERN MED, V124, P1058, DOI 10.7326/0003-4819-124-12-199606150-00005; Cohn DL, 1999, CLIN INFECT DIS, V29, P125, DOI 10.1086/520141; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Currier JS, 2000, ANN INTERN MED, V133, P493, DOI 10.7326/0003-4819-133-7-200010030-00008; DANNEMANN B, 1992, ANN INTERN MED, V116, P33, DOI 10.7326/0003-4819-116-1-33; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; de Smet MD, 1999, OCUL IMMUNOL INFLAMM, V7, P189, DOI 10.1076/ocii.7.3.189.4007; DIAZLLOPIS M, 1994, BRIT J OPHTHALMOL, V78, P120, DOI 10.1136/bjo.78.2.120; DREW WL, 1995, NEW ENGL J MED, V333, P615, DOI 10.1056/NEJM199509073331002; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Dworkin MS, 2000, J INFECT DIS, V182, P611, DOI 10.1086/315734; El-Sadr WM, 1999, CLIN INFECT DIS, V29, P775, DOI 10.1086/520433; El-Sadr WM, 2000, NEW ENGL J MED, V342, P1085, DOI 10.1056/NEJM200004133421503; El-Sadr WM, 1998, NEW ENGL J MED, V339, P1889, DOI 10.1056/NEJM199812243392604; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Feinberg JE, 1998, J INFECT DIS, V177, P48, DOI 10.1086/513804; Fichtenbaum CJ, 2000, AIDS, V14, P2889, DOI 10.1097/00002030-200012220-00010; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Furrer H, 2000, LANCET, V355, P2217, DOI 10.1016/S0140-6736(00)02407-7; Furrer H, 1999, NEW ENGL J MED, V340, P1301, DOI 10.1056/NEJM199904293401701; Furrer H, 2001, AIDS, V15, P501, DOI 10.1097/00002030-200103090-00009; Furrer H, 2000, AIDS, V14, P1409, DOI 10.1097/00002030-200007070-00014; Galgiani JN, 2000, ANN INTERN MED, V133, P676, DOI 10.7326/0003-4819-133-9-200011070-00009; Gebo KA, 1996, J INFECT DIS, V173, P857, DOI 10.1093/infdis/173.4.857; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822; Gordin FM, 1999, CLIN INFECT DIS, V28, P1080, DOI 10.1086/514748; GROSS PA, 1994, CLIN INFECT DIS, V18, P421, DOI 10.1093/clinids/18.3.421; Guerrero M, 1999, AIDS, V13, P1971, DOI 10.1097/00002030-199910010-00021; HARDY WD, 1992, NEW ENGL J MED, V327, P1842, DOI 10.1056/NEJM199212243272604; Havlir DV, 1998, CLIN INFECT DIS, V27, P1369, DOI 10.1086/515018; Havlir DV, 1996, NEW ENGL J MED, V335, P392, DOI 10.1056/NEJM199608083350604; He J, 1998, J INFECT DIS, V178, P1787, DOI 10.1086/314512; Holmberg SD, 1998, JAMA-J AM MED ASSOC, V279, P384, DOI 10.1001/jama.279.5.384; Human rabies-New York, 1993, MMWR MORB MORTAL WKL, V42, P806; Jabs DA, 1998, AM J OPHTHALMOL, V126, P817, DOI 10.1016/S0002-9394(98)00285-2; Jacobson LP, 2000, J INFECT DIS, V181, P1940, DOI 10.1086/315503; *JANSS PHARM CO, 1999, MED EC CO INC PHYS D, P1441; Jouan M, 2001, AIDS, V15, P23, DOI 10.1097/00002030-200101050-00006; Kaplan JE, 1998, J INFECT DIS, V178, P1126, DOI 10.1086/515658; KAPLAN JE, 1995, JAMA-J AM MED ASSOC, V274, P347, DOI 10.1001/jama.274.4.347; Kaplan JE, 1997, JAMA-J AM MED ASSOC, V278, P337; Katlama C, 1996, CLIN INFECT DIS, V22, P268, DOI 10.1093/clinids/22.2.268; Kirk O, 1999, AIDS, V13, P1647, DOI 10.1097/00002030-199909100-00007; Kirk O, 2002, ANN INTERN MED, V137, P239, DOI 10.7326/0003-4819-137-4-200208200-00008; KIRSCH LS, 1995, OPHTHALMOLOGY, V102, P533, DOI 10.1016/S0161-6420(95)30985-2; KURMAN RJ, 1994, JAMA-J AM MED ASSOC, V271, P1866, DOI 10.1001/jama.271.23.1866; Lalezari J, 2002, J ACQ IMMUN DEF SYND, V30, P392, DOI [10.1097/00042560-200208010-00004, 10.1097/01.QAI.0000018570.35064.1D]; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Ledergerber B, 2001, NEW ENGL J MED, V344, P168, DOI 10.1056/NEJM200101183440302; LEOUNG G, 1997, 37 INT C ANT AG CHEM; Lopez J R, 2001, Aten Primaria, V27, P159; Macdonald JC, 1998, J INFECT DIS, V177, P1182, DOI 10.1086/515281; Maiman M, 1999, OBSTET GYNECOL, V94, P954, DOI 10.1016/S0029-7844(99)00407-X; Martin DF, 2002, NEW ENGL J MED, V346, P1119, DOI 10.1056/NEJMoa011759; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; MASUR H, 1993, NEW ENGL J MED, V329, P898, DOI 10.1056/NEJM199309163291228; Masur H, 2000, CLIN INFECT DIS, V30, pS29; McKinsey DS, 1999, CLIN INFECT DIS, V28, P1049, DOI 10.1086/514744; McNaghten AD, 1999, AIDS, V13, P1687, DOI 10.1097/00002030-199909100-00012; *MED EC CO INC, 2001, PHYS DESK REF; MIRO JM, 2000, 39 INT C ANT AG CHEM; Mussini C, 2000, J INFECT DIS, V181, P1635, DOI 10.1086/315471; MUSSINI C, 2001, 8 C RETR OPP INF CHI; OPRAVIL M, 1995, CLIN INFECT DIS, V20, P531, DOI 10.1093/clinids/20.3.531; PALESTINE AG, 1991, ANN INTERN MED, V115, P665, DOI 10.7326/0003-4819-115-9-665; Para MF, 2000, J ACQ IMMUN DEF SYND, V24, P337, DOI 10.1097/00126334-200008010-00007; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; PHAIR J, 1990, NEW ENGL J MED, V322, P161, DOI 10.1056/NEJM199001183220304; Pierce M, 1996, NEW ENGL J MED, V335, P384, DOI 10.1056/NEJM199608083350603; Plancoulaine S, 2000, LANCET, V356, P1062, DOI 10.1016/S0140-6736(00)02729-X; PODZAMCZER D, 1995, ANN INTERN MED, V122, P755, DOI 10.7326/0003-4819-122-10-199505150-00004; POWDERLY WG, 1992, NEW ENGL J MED, V326, P793, DOI 10.1056/NEJM199203193261203; POWDERLY WG, 1995, NEW ENGL J MED, V332, P700, DOI 10.1056/NEJM199503163321102; Pursley TJ, 1996, CLIN INFECT DIS, V22, P336, DOI 10.1093/clinids/22.2.336; RABAUD C, 2000, 7 C RETR OPP INF SAN; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Renwick N, 1998, AIDS, V12, P2481, DOI 10.1097/00002030-199818000-00018; Rodriguez-Rosado R, 1998, AIDS, V12, P1256, DOI 10.1097/00002030-199810000-00025; Saag MS, 1999, CLIN INFECT DIS, V28, P291, DOI 10.1086/515110; Salmon-Ceron D, 2000, AIDS, V14, P1041, DOI 10.1097/00002030-200005260-00017; Saves M, 2000, ANTIMICROB AGENTS CH, V44, P3451, DOI 10.1128/AAC.44.12.3451-3455.2000; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Schacker T, 1998, ANN INTERN MED, V128, P21, DOI 10.7326/0003-4819-128-1-199801010-00004; SCHNEIDER MME, 1995, J INFECT DIS, V171, P1632, DOI 10.1093/infdis/171.6.1632; Schneider MME, 1999, LANCET, V353, P201, DOI 10.1016/S0140-6736(98)07204-3; SCHNEIDER MME, 1992, NEW ENGL J MED, V327, P1836, DOI 10.1056/NEJM199212243272603; Schuman P, 1997, ANN INTERN MED, V126, P689, DOI 10.7326/0003-4819-126-9-199705010-00003; SHAFRAN SD, 2001, 8 C RETR OPP INF CHI; Sitas F, 1999, NEW ENGL J MED, V340, P1923, DOI 10.1056/NEJM199906173402414; Soriano V, 2000, AIDS, V14, P383, DOI 10.1097/00002030-200003100-00011; SPECTOR SA, 1994, NEW ENGL J MED, V331, P1181, DOI 10.1056/NEJM199411033311802; Spector SA, 1996, NEW ENGL J MED, V334, P1491, DOI 10.1056/NEJM199606063342302; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; SPECTOR SA, 1993, J INFECT DIS, V168, P557, DOI 10.1093/infdis/168.3.557; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; THOMSEN J, 1990, AM J OTOL, V11, P12; Torriani FJ, 2000, AIDS, V14, P173, DOI 10.1097/00002030-200001280-00013; Tural C, 1998, J INFECT DIS, V177, P1080, DOI 10.1086/517399; *US PHS, 1997, HIV PREV B MED ADV P; *USDA, 2002, FOODS GOV GAT GOV FO; *USPHS, 2000, AM FAM PHYSICIAN, V61, P163; *USPHS IDSA, 1996, ANN INTERN MED, V124, P349; *USPHS IDSA PREV O, 1998, PEDIATRICS, V102, P1064; *USPHS IDSA PREV O, 1997, ANN INTERN MED, V127, P922; *USPHSIDSA PREV OP, 1997, AM FAM PHYSICIAN, V56, P823; Vrabec TR, 1998, OPHTHALMOLOGY, V105, P1259, DOI 10.1016/S0161-6420(98)97031-2; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0; WHEAT J, 1993, ANN INTERN MED, V118, P610, DOI 10.7326/0003-4819-118-8-199304150-00006; Whitby D, 1999, J INFECT DIS, V179, P234, DOI 10.1086/314563; Whitcup SM, 1999, JAMA-J AM MED ASSOC, V282, P1633, DOI 10.1001/jama.282.17.1633; Yangco BG, 2000, ANN INTERN MED, V132, P201, DOI 10.7326/0003-4819-132-3-200002010-00005; Young S, 1998, OPHTHALMOLOGY, V105, P1404, DOI 10.1016/S0161-6420(98)98020-4; 2001, MMWR MORB MORTAL WKL, V50, P19; 2001, MMWR MORB MORTAL WKL, V56, P7	145	160	172	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	2				435	477		10.7326/0003-4819-137-5_Part_2-200209031-00002	http://dx.doi.org/10.7326/0003-4819-137-5_Part_2-200209031-00002			43	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592TJ	12617574				2022-12-28	WOS:000177952700002
J	Langmore, NE; Hunt, S; Kilner, RM				Langmore, NE; Hunt, S; Kilner, RM			Escalation of a coevolutionary arms race through host rejection of brood parasitic young	NATURE			English	Article							CUCULUS-CANORUS; REED WARBLERS; CUCKOO; DISCRIMINATION; CONSTRAINTS; EVOLUTION; MODEL; EGGS	Cuckoo nestlings that evict all other young from the nest soon after hatching impose a high reproductive cost on their hosts(1). In defence, hosts have coevolved strategies to prevent brood parasitism. Puzzlingly, they do not extend beyond the egg stage(2-5). Thus, hosts adept at recognizing foreign eggs remain vulnerable to exploitation by cuckoo nestlings(6,7). Here we show that the breach of host egg defences by cuckoos creates a new stage in the coevolutionary cycle. We found that defences used during the egg-laying period by host superb fairy-wrens (Malurus cyaneus) are easily evaded by the Horsfield's bronze-cuckoo (Chrysococcyx basalis), a specialist fairy-wren brood parasite. However, although hosts never deserted their own broods, they later abandoned 40% of nests containing a lone Horsfield's bronze-cuckoo nestling, and 100% of nests with a lone shining bronze-cuckoo nestling (Chrysococcyx lucidus), an occasional fairy-wren brood parasite. Our experiments demonstrate that host discrimination against evictor-cuckoo nestlings is possible, and suggest that it has selected for the evolution of nestling mimicry in bronze-cuckoos.	Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Australian National University; University of Bristol; University of Cambridge	Langmore, NE (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia.	naomi.langmore@anu.edu.au	Langmore, Naomi E/C-9302-2009; Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758				BIBBY CJ, 1978, BIRD STUDY, V25, P207, DOI 10.1080/00063657809476599; BROOKE MD, 1988, NATURE, V335, P630; BROOKER MG, 1989, IBIS, V131, P528, DOI 10.1111/j.1474-919X.1989.tb04789.x; BROOKER MG, 1989, AUSTR ZOOLOGICAL REV, V2, P1; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; DAVIDSON LS, 1989, J MACROECON, V11, P1, DOI 10.1016/0164-0704(89)90014-1; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Fraga RM, 1998, OX ORN SER, V9, P173; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Kruger O, 2002, P ROY SOC B-BIOL SCI, V269, P375, DOI 10.1098/rspb.2001.1887; Lichtenstein G, 2001, ANIM BEHAV, V61, P401, DOI 10.1006/anbe.2000.1595; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; Lotem A, 1998, OX ORN SER, V9, P223; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; Marchetti K, 2000, ANIM BEHAV, V59, P877, DOI 10.1006/anbe.1999.1388; MASON P, 1986, EVOLUTION, V40, P1207, DOI 10.1111/j.1558-5646.1986.tb05745.x; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; MULDER RA, 1992, EVOLUTIONARY ECOLOGY; NIAS RC, 1987, COOPERATIVE BREEDING; OGILVIE MA, 1992, HDB BIRDS EUROPE MID, V6, P193; Payne RB, 1998, OX ORN SER, V9, P152; Payne RB, 2001, ANIM BEHAV, V62, P473, DOI 10.1006/anbe.2001.1773; Rowley I., 1997, FAIRY WRENS GRASSWRE; Rowley Ian, 1965, Emu, V64, P251; TIDEMANN SC, 1983, BEHAV ECOLOGY TREE C	27	249	265	2	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					157	160		10.1038/nature01460	http://dx.doi.org/10.1038/nature01460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634784				2022-12-28	WOS:000181488900043
J	Falush, D; Wirth, T; Linz, B; Pritchard, JK; Stephens, M; Kidd, M; Blaser, MJ; Graham, DY; Vacher, S; Perez-Perez, GI; Yamaoka, Y; Megraud, F; Otto, K; Reichard, U; Katzowitsch, E; Wang, XY; Achtman, M; Suerbaum, S				Falush, D; Wirth, T; Linz, B; Pritchard, JK; Stephens, M; Kidd, M; Blaser, MJ; Graham, DY; Vacher, S; Perez-Perez, GI; Yamaoka, Y; Megraud, F; Otto, K; Reichard, U; Katzowitsch, E; Wang, XY; Achtman, M; Suerbaum, S			Traces of human migrations in Helicobacter pylori populations	SCIENCE			English	Article							GENETIC-STRUCTURE; ASIAN GENOTYPES; RECOMBINATION; STRAINS; MARKERS	Helicobacter pylori, a chronic gastric pathogen of human beings, can be divided into seven populations and subpopulations with distinct geographical distributions. These modern populations derive their gene pools from ancestral populations that arose in Africa, Central Asia, and East Asia. Subsequent spread can be attributed to human migratory fluxes such as the prehistoric colonization of Polynesia and the Americas, the neolithic introduction of farming to Europe, the Bantu expansion within Africa, and the stave trade.	Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA; Univ Bordeaux 2, F-33076 Bordeaux, France; Univ Wurzburg, Inst Hyg & Mikrobiol, D-97080 Wurzburg, Germany	Max Planck Society; University of Chicago; University of Washington; University of Washington Seattle; Yale University; New York University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); UDICE-French Research Universities; Universite de Bordeaux; University of Wurzburg	Achtman, M (corresponding author), Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany.	achtman@mpiib-berlin.mpg.de	Wirth, Thierry/B-4915-2008; Graham, David/AAL-2165-2021; Perez, Guillermo Perez/AAJ-3761-2020	Wirth, Thierry/0000-0002-7371-0172; Yamaoka, Yoshio/0000-0002-1222-5819; Achtman, Mark/0000-0001-6815-0070; Perez Perez, Guillermo/0000-0002-0131-5798	NIGMS NIH HHS [R02GM63270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Agostini HT, 1997, P NATL ACAD SCI USA, V94, P14542, DOI 10.1073/pnas.94.26.14542; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Diamond JM, 2000, NATURE, V403, P709, DOI 10.1038/35001685; Ehret C, 2001, INT J AFR HIST STUD, V34, P5, DOI 10.2307/3097285; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; FALUSH D, UNPUB; Feldman RA, 2001, HELICOBACTER PYLORI: MOLECULAR AND CELLULAR BIOLOGY, P29; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; Graham DY, 2000, HELICOBACTER, V5, pS3; Kersulyte D, 1999, MOL MICROBIOL, V31, P31, DOI 10.1046/j.1365-2958.1999.01140.x; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; LI WH, 1991, GENETICS, V129, P513; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; MUSSER JM, 1990, REV INFECT DIS, V12, P75; Oppenheimer Stephen, 2001, Science Progress, V84, P157, DOI 10.3184/003685001783238989; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; Pritchard JK, 2000, GENETICS, V155, P945; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0	25	705	740	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1582	1585		10.1126/science.1080857	http://dx.doi.org/10.1126/science.1080857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624269				2022-12-28	WOS:000181367900040
J	Baron, JA; Cole, BF; Sandler, RS; Haile, RW; Ahnen, D; Bresalier, R; McKeown-Eyssen, G; Summers, RW; Rothstein, R; Burke, CA; Snover, DC; Church, TR; Allen, JI; Beach, M; Beck, GJ; Bond, JH; Byers, T; Greenberg, ER; Mandel, JS; Marcon, N; Mott, LA; Pearson, L; Saibil, F; van Stolk, RU				Baron, JA; Cole, BF; Sandler, RS; Haile, RW; Ahnen, D; Bresalier, R; McKeown-Eyssen, G; Summers, RW; Rothstein, R; Burke, CA; Snover, DC; Church, TR; Allen, JI; Beach, M; Beck, GJ; Bond, JH; Byers, T; Greenberg, ER; Mandel, JS; Marcon, N; Mott, LA; Pearson, L; Saibil, F; van Stolk, RU			A randomized trial of aspirin to prevent colorectal adenomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COST-EFFECTIVENESS; CANCER; SULINDAC; RISK; CHEMOPREVENTION; EPIDEMIOLOGY; SUPPRESSION; INHIBITION; POLYPS	Background: Laboratory and epidemiologic data suggest that aspirin has an antineoplastic effect in the large bowel. Methods: We performed a randomized, double-blind trial of aspirin as a chemopreventive agent against colorectal adenomas. We randomly assigned 1121 patients with a recent history of histologically documented adenomas to receive placebo (372 patients), 81 mg of aspirin (377 patients), or 325 mg of aspirin (372 patients) daily. According to the protocol, follow-up colonoscopy was to be performed approximately three years after the qualifying endoscopy. We compared the groups with respect to the risk of one or more neoplasms (adenomas or colorectal cancer) at least one year after randomization using generalized linear models to compute risk ratios and 95 percent confidence intervals. Results: Reported adherence to study medications and avoidance of nonsteroidal antiinflammatory drugs were excellent. Follow-up colonoscopy was performed at least one year after randomization in 1084 patients (97 percent). The incidence of one or more adenomas was 47 percent in the placebo group, 38 percent in the group given 81 mg of aspirin per day, and 45 percent in the group given 325 mg of aspirin per day (global P=0.04). Unadjusted relative risks of any adenoma (as compared with the placebo group) were 0.81 in the 81-mg group (95 percent confidence interval, 0.69 to 0.96) and 0.96 in the 325-mg group (95 percent confidence interval, 0.81 to 1.13). For advanced neoplasms (adenomas measuring at least 1 cm in diameter or with tubulovillous or villous features, severe dysplasia, or invasive cancer), the respective relative risks were 0.59 (95 percent confidence interval, 0.38 to 0.92) and 0.83 (95 percent confidence interval, 0.55 to 1.23). Conclusions: Low-dose aspirin has a moderate chemopreventive effect on adenomas in the large bowel.	Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA; Dartmouth Coll Sch Med, Hanover, NH USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Univ So Calif, Sch Med, Los Angeles, CA USA; Vet Affairs Med Ctr, Denver, CO USA; Univ Colorado, Sch Med, Denver, CO USA; Henry Ford Hlth Sci Ctr, Detroit, MI USA; Univ Toronto, Toronto, ON, Canada; Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Fairview Southdale Hosp, Minneapolis, MN USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Vet Affairs Med Ctr, Minneapolis, MN USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Henry Ford Health System; Henry Ford Hospital; University of Toronto; University of Iowa; Cleveland Clinic Foundation; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Emory University; Rollins School Public Health	Baron, JA (corresponding author), Evergreen Ctr, 46 Centerra Pkwy, Lebanon, NH 03766 USA.	john.a.baron@dartmouth.edu	Church, Timothy/AAH-7017-2020	Church, Timothy/0000-0003-3292-5035; Bresalier, Robert/0000-0002-9740-281X	NATIONAL CANCER INSTITUTE [R01CA059005] Funding Source: NIH RePORTER; NCI NIH HHS [CA 59005] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1994, BMJ-BRIT MED J, V308, P81, DOI DOI 10.1136/BMJ.308.6921.81; Arber N, 2000, CAN J GASTROENTEROL, V14, P299, DOI 10.1155/2000/245964; Barnes CJ, 1999, CANCER EPIDEM BIOMAR, V8, P311; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; GANN PH, 1993, JNCI-J NATL CANCER I, V85, P1220, DOI 10.1093/jnci/85.15.1220; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hawkey CJ, 2000, GASTROENTEROLOGY, V119, P521, DOI 10.1053/gast.2000.9561; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; *INT AG RES CANC, 1997, IARC HDB CANC PREV, V1; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Krause W, 2000, PROSTAG OTH LIPID M, V61, P145, DOI 10.1016/S0090-6980(00)00069-1; LABAYLE D, 1991, GASTROENTEROLOGY, V101, P635, DOI 10.1016/0016-5085(91)90519-Q; Ladabaum U, 2001, ANN INTERN MED, V135, P769, DOI 10.7326/0003-4819-135-9-200111060-00007; LADENHEIM J, 1995, GASTROENTEROLOGY, V108, P1083, DOI 10.1016/0016-5085(95)90206-6; NEUGUT AI, 1993, CANCER EPIDEM BIOMAR, V2, P159; PEIPINS LA, 1994, EPIDEMIOL REV, V16, P273, DOI 10.1093/oxfordjournals.epirev.a036154; Provenzale D, 2002, GASTROENTEROLOGY, V122, P230, DOI 10.1053/gast.2002.30618; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; Ruffin MT, 1997, JNCI-J NATL CANCER I, V89, P1152, DOI 10.1093/jnci/89.15.1152; Sample D, 2002, CANCER EPIDEM BIOMAR, V11, P275; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Shiff SJ, 1999, J EXP MED, V190, P445, DOI 10.1084/jem.190.4.445; Shureiqi I, 2001, CANCER RES, V61, P6307; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292	31	1093	1129	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					891	899		10.1056/NEJMoa021735	http://dx.doi.org/10.1056/NEJMoa021735			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621133				2022-12-28	WOS:000181341100004
J	Reynen, K; Strasser, RH				Reynen, K; Strasser, RH			Impending rupture of the myocardial wall	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Dresden Univ Technol, D-01307 Dresden, Germany	Technische Universitat Dresden	Reynen, K (corresponding author), Dresden Univ Technol, D-01307 Dresden, Germany.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					E3	E3		10.1056/ENEJMicm020410	http://dx.doi.org/10.1056/ENEJMicm020410			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621147				2022-12-28	WOS:000181341100036
J	Carr, A; Emery, S; Law, I; Puls, R; Lundgren, JD; Powderly, WG; Carr, B; Cooper, DA; Grinspoon, S; Ioannidis, J; Lewis, R; Law, M; Lichtenstein, K; Murray, J; Pizzuti, D; Rozenbaum, W; Schambelan, M; Moore, A; Miller, J				Carr, A; Emery, S; Law, I; Puls, R; Lundgren, JD; Powderly, WG; Carr, B; Cooper, DA; Grinspoon, S; Ioannidis, J; Lewis, R; Law, M; Lichtenstein, K; Murray, J; Pizzuti, D; Rozenbaum, W; Schambelan, M; Moore, A; Miller, J		HIV Lipodystrophy Case Definition	An objective case definition of lipodystrophy in HIV-infected adults: a case-control study	LANCET			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; IMMUNODEFICIENCY-VIRUS INFECTION; PREADIPOCYTE DIFFERENTIATION; METABOLIC ABNORMALITIES; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS; RISK; PREVALENCE	Background Lipodystrophy (peripheral lipoatrophy, central fat accumulation, and lipomatosis) is a common and disfiguring problem in adult patients with HIV-1 infection on antiretrovirals. However, an objective, validated definition of the disorder does not exist. We aimed to develop an objective, sensitive, specific, and broadly applicable case definition of HIV lipodystrophy. Methods In a case-control study, 1081 consecutive, HIV-infected, adult outpatients (261 [15%] women) without active AIDS were recruited from 32 sites worldwide. We classed patients with at least one moderate or severe subjective lipodystrophic feature, identified by lipodystrophy-specific physical examination and patient questionnaire, and apparent to both doctor and patient as cases (n=417). We classed patients with no such feature as controls (n=371), and patients without a clear diagnosis as non-assigned. We used objective clinical, metabolic, and body composition measurements to construct a logistic regression model with a subset of randomly selected cases and controls. The model was validated in the remaining patients. Findings A model including age, sex, duration of HIV infection, HIV disease stage, waist to hip ratio, anion gap, serum HDL cholesterol concentration, trunk to peripheral fat ratio, percentage leg fat, and intra-abdominal to extra-abdominal fat ratio had 79% (95% CI 70-85) sensitivity and 80% (95% Cl 71-87) specificity for diagnosis of lipodystrophy. Models that incorporated only clinical, or only clinical and metabolic variables had lower sensitivity and specificity than the inclusive model. Models for lipoatrophy, fat accumulation, and lipomatosis could not be developed since pure phenotypes occurred in fewer than 10% of patients with clinical diagnoses of these disorders. Interpretation Our objective case definition of HIV-associated lipodystrophy should improve assessment of lipodystrophy prevalence, risk factors, and pathogenesis; prevention and treatment approaches; and assist in diagnosis.	St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia; Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; Hvidovre Univ Hosp, Copenhagen, Denmark; Washington Univ, Sch Med, St Louis, MO USA; Forum Collaborat HIV Res, Baltimore, MD USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Ioannina, GR-45110 Ioannina, Greece; Agouron Pharmaceut, San Diego, CA USA; HIV Outpatient Study Ctr Dis Control & Prevent, Denver, CO USA; US FDA, US Dept HHS, Washington, DC 20204 USA; Bristol Myers Squibb Co, Princeton, NJ USA; Hop Rothschild, F-75571 Paris, France; Agence Natl Res SIDA, Paris, France; Univ Calif San Francisco, San Francisco, CA 94143 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; Kirby Institute; University of Copenhagen; Washington University (WUSTL); Harvard University; Massachusetts General Hospital; University of Ioannina; Pfizer; US Food & Drug Administration (FDA); Bristol-Myers Squibb; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California San Francisco	Carr, A (corresponding author), St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia.	acarr@stvincents.com.au	Ioannidis, John P. A./G-9836-2011; Puls, Rebekah/A-3992-2013; Emery, Sean/O-9122-2019; Emery, Sean/J-3825-2017; Lundgren, Jens/AAE-6876-2019	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Rozenbaum, Willy/0000-0003-1975-3566; Lundgren, Jens/0000-0001-8901-7850; Law, Matthew/0000-0002-3540-8837; Powderly, William/0000-0001-7808-3086				Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Belloso WH, 2003, JAIDS-J ACQ IMM DEF, V32, P104, DOI 10.1097/00126334-200301010-00015; Caron M, 2001, DIABETES, V50, P1378, DOI 10.2337/diabetes.50.6.1378; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Carr A, 2002, LANCET, V360, P81, DOI 10.1016/S0140-6736(02)09341-8; Dowell P, 2000, J BIOL CHEM, V275, P41325, DOI 10.1074/jbc.M006474200; Duran S, 2001, AIDS, V15, P2441, DOI 10.1097/00002030-200112070-00012; Egger M, 2001, AIDS, V15, pS193, DOI 10.1097/00002030-200100005-00023; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grunfeld C., 2002, 14 INT AIDS C BARC S; Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541; Hyams KC, 1998, EPIDEMIOL REV, V20, P148, DOI 10.1093/oxfordjournals.epirev.a017977; KINGSLEY L, 2001, 8 C RETR OPP INF CHI; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Marcos MA, 2001, LANCET, V357, P1499, DOI 10.1016/S0140-6736(00)04658-4; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; *NAT CHOL ED PROGR, FRAM CARD RISK EQ; Roche R, 2002, AIDS, V16, P13, DOI 10.1097/00002030-200201040-00003; Saint-Marc T, 2000, AIDS, V14, P37, DOI 10.1097/00002030-200001070-00005; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thiebaut R, 2000, CLIN INFECT DIS, V31, P1482, DOI 10.1086/317477; van der Valk M, 2001, AIDS, V15, P847, DOI 10.1097/00002030-200105040-00005; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; Yarasheski KE, 1999, J ACQ IMMUN DEF SYND, V21, P209, DOI 10.1097/00126334-199907010-00005	32	337	347	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					726	735		10.1016/S0140-6736(03)12656-6	http://dx.doi.org/10.1016/S0140-6736(03)12656-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620736				2022-12-28	WOS:000181232000007
J	Ong, ACM; Wheatley, DN				Ong, ACM; Wheatley, DN			Polycystic kidney disease - the ciliary connection	LANCET			English	Review							TRANSGENIC MICE; GENE HOMOLOG; C-ELEGANS	Context "Cystic degeneration" of the kidneys was first described pathologically in 1841 and "polycystic kidneys" as a clinical syndrome in 1888. The heritable nature in some families was noted in 1899, and autosomal dominant and, recessive patterns of inheritance of polycystic kidney disease (PKD) were later recognised. Autosomal dominant PKD is one, of the most common human genetic diseases and results, from mutations in PKD1 or PKD2. These genes encode two proteins, polycystin-1 and polycystin-2. Starting point Primary cilia are cellular organelles previously,thought by some to be vestigial. New findings from several, species, including algae, nematodes, and mice, implicate, defects in structure or function of primary cilia as a possible common mechanism central to the development of some forms of recessive PKD. Two recent reports propose a causal link between ciliary dysfunction and autosomal dominant PKD. B Yoder and colleagues (J Am Soc Nephrol 2002; 13:, 2508-16) show that polycystin-1 and polycystin-2 are localised to primary cilia in cultured renal epithelial cells. S Nauli and colleagues (Nat Genet 2003; 33: 129-37) show that polycystin-1 and polycystin-2 function as flow-sensitive mechanosensors in the same signal-transduction pathway. Where next? Cystic epithelial cells show many altered cellular properties, including changes in proliferation, apoptosis, adhesion, differentiation, polarity, extracellular matrix synthesis, and fluid transport. The next important steps in PKD research will be to define the physiological roles: of primary renal cilia and how defects in ciliary structure and function lead to the development of a cystic phenotype in: different forms of PKD.	Univ Sheffield, Div Clin Sci N, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England; Univ Aberdeen, Dept Cell Pathol, Aberdeen, Scotland	University of Sheffield; University of Aberdeen	Ong, ACM (corresponding author), Univ Sheffield, Div Clin Sci N, Sheffield Kidney Inst, Sheffield S5 7AU, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; ARCHER FL, 1971, J ANAT, V109, P277; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; SCHAFFNER DL, 1993, AM J PATHOL, V142, P1051; Streets AJ, 2002, J AM SOC NEPHROL, V13, p46A; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zimmerman K., 1898, ARCH MIKROSK ANAT, V52, P552, DOI [10.1007/BF02975837, DOI 10.1007/BF02975837]	28	103	107	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					774	776		10.1016/S0140-6736(03)12662-1	http://dx.doi.org/10.1016/S0140-6736(03)12662-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620752				2022-12-28	WOS:000181232000022
J	Murray, M; Berwick, DM				Murray, M; Berwick, DM			Advanced access - Reducing waiting and delays in primary care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Delay of care is a persistent and undesirable feature of current health care systems. Although delay seems to be inevitable and linked to resource limitations, it often is neither.. Rather, it is usually the result of unplanned, irrational scheduling and resource allocation. Application of queuing theory and principles of industrial engineering, adapted appropriately to clinical settings, can reduce delay substantially, even in small practices, without requiring additional resources. One model, sometimes referred to as advanced access, has increasingly been shown to reduce waiting times in primary care. The core principle of advanced access is that patients calling to schedule a physician visit are offered an appointment the same day. Advanced access is not sustainable if patient demand for appointments is permanently greater than physician capacity to offer appointments. Six elements of advanced access are important in its application: balancing supply and demand, reducing backlog, reducing the variety of appointment types, developing contingency plans for unusual circumstances, working to adjust demand profiles, and increasing the availability of bottleneck resources. Although these principles are powerful, they are counter to deeply held beliefs and established practices in health care organizations. Adopting these principles requires strong leadership investment and support.	Inst Healthcare Improvement, Boston, MA 02215 USA; Mark Murray & Associates, Sacramento, CA USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 375 Longwood Ave, Boston, MA 02215 USA.							*AM COLL PHYS, 1999, COMPL HOM MED GUID; Cunningham PJ, 1995, MED CARE RES REV, V52, P453, DOI 10.1177/107755879505200402; GOITEIN M, 1990, NEW ENGL J MED, V323, P604, DOI 10.1056/NEJM199008303230911; Goldratt E., 1992, GOAL PROCESS ONGOING; GREENBLATT J, 2002, 08 AG HEALTHC RES QU; Hall R., 1991, QUEUEING METHODS SER; Institute of Medicine, 2001, CROSSING QUALITY CHA; *KAIS FAM FDN, 2002, WOM HLTH US HLTH COV; Kaiser Family Foundation, 2000, NAT SURV CONS EXP HL; LIPPMAN H, 2000, HIPPOCRATES      FEB, P49; Murray M, 2000, Fam Pract Manag, V7, P45; NOFFSINGER EB, 2000, GROUP PRACT J, V49, P48; Nolan T.W., 1996, REDUCING DELAYS WAIT; Ohno T., 2019, TOYOTA PRODUCTION SY, V1st ed., DOI [10.4324/9780429273018, DOI 10.4324/9780429273018]; Patel VL, 2000, TEACH LEARN MED, V12, P117, DOI 10.1207/S15328015TLM1203_2; Schwartz LM, 1999, J GEN INTERN MED, V14, P230, DOI 10.1046/j.1525-1497.1999.00322.x; SINGER I, 2001, ADV ACCESS NEW PARAD; Spear S, 1999, HARVARD BUS REV, V77, P96; STARFIELD B, 1998, PRIMARY CARE; STRUNK BC, 2002, TREADING WATER AM AC; TEMIANKA D, 1991, NEW ENGL J MED, V324, P335; WOMACK J, 1991, MACH CHANGED WORLD; Womack J.P., 1996, LEAN THINKING	23	362	367	0	42	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1035	1040		10.1001/jama.289.8.1035	http://dx.doi.org/10.1001/jama.289.8.1035			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597760				2022-12-28	WOS:000181129800034
J	Bridle, KR; Frazer, DM; Wilkins, SJ; Dixon, JL; Purdie, DM; Crawford, DHG; Subramaniam, VN; Powell, LW; Anderson, GJ; Ramm, GA				Bridle, KR; Frazer, DM; Wilkins, SJ; Dixon, JL; Purdie, DM; Crawford, DHG; Subramaniam, VN; Powell, LW; Anderson, GJ; Ramm, GA			Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis	LANCET			English	Article							AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; GENE; OVERLOAD; PROTEIN; EXPRESSION; MUTATIONS; CLONING; SLC11A3	Background The mechanisms responsible for disturbed iron homoeostasis in hereditary haemochromatosis are poorly understood. However, results of some studies indicate a link between hepcidin, a liver-derived peptide, and intestinal iron absorption, suggesting that this molecule could play a part in hepatic iron overload. To investigate this possible association, we studied the hepatic expression of the gene for hepcidin (HAMP) and a gene important in iron transport (IREG1) in patients with haemochromatosis, in normal controls, and in Hfe-knockout mice. Methods We extracted total RNA from the liver tissue of 27 patients with HFE-associated haemochromatosis, seven transplant donors (controls), and Hfe-knockout mice. HAMP and IREG1 mRNA concentrations were examined by ribonuclease protection assays and expressed relative to the housekeeping gene GAPD. Findings There was a significant decrease in HAMP expression in untreated patients compared with controls (5.4-fold, 95% CI 3.3-7.5; p<0.0001) despite significantly increased iron loading. Similarly, we noted a decrease in Hamp expression in iron-loaded Hfe-knockout mice. Hepatic IREG1 expression was greatly upregulated in patients with haemochromatosis (1.8-fold, 95% CI 1.5-2.2; p=0.002). There was a significant correlation between hepatic iron concentration and expression of HAMP (r=0.59, p=0.02) and IREG1 (r=0.67, p=0.007) in untreated patients. Interpretation Lack of HAMP upregulation in HFE-associated haemochromatosis despite significant hepatic iron loading indicates that HFE plays an important part in the regulation of hepcidin expression in response to iron overload. Our results imply that the liver is important in the pathophysiology of HFE-associated haemochromatosis. Furthermore, the increase in hepatic IREG1 expression in haemochromatosis suggests that IREG1 could function to facilitate the removal of excess iron from the liver.	Royal Brisbane Hosp, Queensland Inst Med Res, Lab Iron Metab, Iron Metab Grp, Herston, Qld 4029, Australia; Royal Brisbane Hosp, Queensland Inst Med Res, Hepat Fibrosis Grp, Herston, Qld 4029, Australia; Royal Brisbane Hosp, Queensland Inst Med Res, Membrane Transport Grp, Herston, Qld 4029, Australia; Univ Queensland, Dept Med, St Lucia, Qld 4067, Australia; Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Anderson, GJ (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Lab Iron Metab, Iron Metab Grp, Herston, Qld 4029, Australia.		Crawford, Darrell HG/F-2157-2010; Ramm, Grant A/G-2669-2013; Frazer, David M/L-3570-2014; Anderson, Gregory J/G-4148-2013; Subramaniam, V. Nathan/A-1901-2010; Bridle, Kim/F-6266-2010	Ramm, Grant A/0000-0001-7058-6201; Frazer, David M/0000-0003-4098-1379; Anderson, Gregory J/0000-0002-8814-5866; Subramaniam, V. Nathan/0000-0002-4583-7790; Bridle, Kim/0000-0002-7090-1387; Crawford, Darrell/0000-0001-8480-5954	NIDDK NIH HHS [R01 DK57648-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057648] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; ANDERSON GJ, 2002, MOL CELLULAR IRON TR, P559; BASSETT ML, 1984, SEMIN LIVER DIS, V4, P217, DOI 10.1055/s-2008-1041772; BASSETT ML, 1986, HEPATOLOGY, V6, P24, DOI 10.1002/hep.1840060106; Cardoso EM, 2002, BLOOD, V100, P4239, DOI 10.1182/blood-2002-05-1565; Crawford D, 2002, HEPATOLOGY, V36, p194A; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Frazer DM, 2002, GASTROENTEROLOGY, V123, P835, DOI 10.1053/gast.2002.35353; Frazer DM, 2001, AM J PHYSIOL-GASTR L, V281, pG931, DOI 10.1152/ajpgi.2001.281.4.G931; Jackson HA, 2001, BRIT J HAEMATOL, V114, P474, DOI 10.1046/j.1365-2141.2001.02949.x; Jouanolle AM, 1997, HUM GENET, V100, P544, DOI 10.1007/s004390050549; Kendall M, 1977, ADV THEORY STAT; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MCLAREN GD, 1991, J LAB CLIN MED, V117, P390; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; NIEDERAU C, 1994, BAILLIERE CLIN HAEM, V7, P881, DOI 10.1016/S0950-3536(05)80129-5; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; OLYNYK JK, 1994, POSTGRAD MED, V96, P151, DOI 10.1080/00325481.1994.11945914; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; POWELL LW, 1980, GASTROENTEROLOGY, V78, P374; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Waheed A, 1999, P NATL ACAD SCI USA, V96, P1579, DOI 10.1073/pnas.96.4.1579; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260	30	484	499	4	40	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					669	673		10.1016/S0140-6736(03)12602-5	http://dx.doi.org/10.1016/S0140-6736(03)12602-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606179				2022-12-28	WOS:000181129500017
J	Garattini, S; Bertele', V; Bassi, LL				Garattini, S; Bertele', V; Bassi, LL			Light and shade in proposed revision of EU drug-regulatory legislation	LANCET			English	Editorial Material									Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.		Bertele, Vittorio/AAA-6461-2020; Garattini, Silvio/AAA-6390-2020	Bertele, Vittorio/0000-0002-0032-7033; Garattini, Silvio/0000-0003-0647-9297				CORREA CM, 2002, WHOEDMPAR20023; *EUR MED EV AG, 2002, COMM PROPR MED PROD; Ottawa Charter for Health Promotion, 1986, 1 INT C HLTH PROM OT; Rogers A, 2002, LANCET, V360, P1397, DOI 10.1016/S0140-6736(02)11421-8; *WORLD TRAD ORG, 2001, MIN C 4 SESS DOH NOV; 2002, REV PRESCRIRE   1101	6	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					635	636		10.1016/S0140-6736(03)12615-3	http://dx.doi.org/10.1016/S0140-6736(03)12615-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606173				2022-12-28	WOS:000181129500011
J	Christensen, JH; Christensen, OB				Christensen, JH; Christensen, OB			Climate modelling: Severe summertime flooding in Europe	NATURE			English	Article							SIMULATIONS		Danish Meteorol Inst, DK-2100 Copenhagen O, Denmark	Danish Meteorological Institute DMI	Christensen, JH (corresponding author), Danish Meteorol Inst, Lyngbyvej 100, DK-2100 Copenhagen O, Denmark.		Christensen, Jens Hesselbjerg/C-4162-2013; Christensen, Ole B/E-4417-2013	Christensen, Jens Hesselbjerg/0000-0002-9908-8203; 				Christensen JH, 2002, EOS, V83, P147, DOI DOI 10.1029/2002E0000094; Christensen OB, 1998, J CLIMATE, V11, P3204, DOI 10.1175/1520-0442(1998)011<3204:VHRRCS>2.0.CO;2; CHRISTENSEN OB, 2001, IMPLICATIONS CLIMATI, P101; Frei C, 1998, GEOPHYS RES LETT, V25, P1431, DOI 10.1029/98GL51099; FREI C, IN PRESS J GEOPHYS R; Houghton J. T., 2001, CLIMATE CHANGE 2001; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Roeckner E, 1999, J CLIMATE, V12, P3004, DOI 10.1175/1520-0442(1999)012<3004:TCCSWA>2.0.CO;2; ROECKNER EK, 1996, 218 MPI; Voss R, 2002, INT J CLIMATOL, V22, P755, DOI 10.1002/joc.757	10	517	535	0	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					805	806		10.1038/421805a	http://dx.doi.org/10.1038/421805a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594501				2022-12-28	WOS:000181044700036
J	Studdert, DM; Mello, MM; Brennan, TA				Studdert, DM; Mello, MM; Brennan, TA			Medical monitoring for pharmaceutical injuries - Tort law for the public's health?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBESE-PATIENTS; DEXFENFLURAMINE; TROGLITAZONE; HEPATOTOXICITY; ABNORMALITIES; LITIGATION; AGGREGATE	A remarkable development in personal injury litigation in recent years involves attempts to expand legal claims beyond existing injuries to anticipated future harms. Attorneys have begun to sue on behalf of individuals exposed to defective pharmaceutical products who have no current injury, but who may be at risk for developing one after a latency period. This strategy seeks to make drug manufacturers pay for medical monitoring, a court-ordered program that provides diagnostic tests to exposed individuals to facilitate early detection of adverse health effects. Because medical monitoring does not depend on the existence of an actual injury and large populations may be exposed, some commentators have warned that it has the potential to spiral out of control. We examine medical monitoring in the context of 2 major cases involving diet drugs and an oral hypoglycemic drug. We conclude that this expansion of tort law should be applied sparingly, but that the performance of courts to date in these cases gives cause for optimism. Judges appear to be paying close attention to sophisticated epidemiological, clinical, and cost-effectiveness considerations. Medical monitoring arms the courts with a new mechanism for addressing harms proactively rather than reactively, which could yield new victories for public health.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Studdert, DM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	studdert@hsph.harvard.edu	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270				ABRAHAM KS, 1988, COLUMBIA LAW REV, V88, P942, DOI 10.2307/1122695; Aithal PG, 1999, GUT, V44, P731, DOI 10.1136/gut.44.5.731; *AM LAW I, 1991, ENT RESP PERS INJ RE; Angell Marcia, 1996, SCI TRIAL CLASH MED; Brenner J., 1991, International Journal of Wildland Fire, V1, P73, DOI 10.1071/WF9910073; Calabresi G, 1970, COST ACCIDENTS LEGAL; COFFEE JC, 1987, U CHICAGO LAW REV, V54, P877, DOI 10.2307/1599829; COFFEE JC, 1999, COLUMBIA LAW REV, V95, P1343; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Connolly HM, 1999, CURR PROB CARDIOLOGY, V24, P751; Cranor C. F., 2001, LAW CONTEMP PROBL, V64, P5; Cutler DM, 2002, J POLICY ANAL MANAG, V21, P1, DOI 10.1002/pam.1037; *FDA, FDA AN CARD VALV DYS; Fee Elizabeth, 1987, DIS DISCOVERY HIST J; Gardin JM, 2000, JAMA-J AM MED ASSOC, V283, P1703, DOI 10.1001/jama.283.13.1703; Gardin JM, 2001, JAMA-J AM MED ASSOC, V286, P2011, DOI 10.1001/jama.286.16.2011; Geyelin Milo, 2002, WALL ST J, pB1; Gitlin N, 1998, ANN INTERN MED, V129, P36, DOI 10.7326/0003-4819-129-1-199807010-00008; Gold MR, 1996, COST EFFECTIVENESS H; GOSTIN LO, 2000, PUBIC HLTH LAW POWER; HENDERSON JA, 2002, SC L REV, V53, P815; Hensler D. R., 2000, CLASS ACTION DILEMMA; Issacharoff S, 2002, TEX LAW REV, V80, P1925; Issacharoff S, 2002, NOTRE DAME LAW REV, V77, P1057; Jick H, 2000, JAMA-J AM MED ASSOC, V283, P1738, DOI 10.1001/jama.283.13.1738; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Keeton W., 1984, PROSSER KEETON LAW T; Khan MA, 1998, NEW ENGL J MED, V339, P713, DOI 10.1056/NEJM199809103391101; KLEIN AR, 1998, BROOK L REV, V64, P1; KNOPPER M, 2002, CHICAGO TRIBUNE 0911, pC1; Kohlroser J, 2000, AM J GASTROENTEROL, V95, P272; MARTIN SL, 1995, COLUM J ENV L, V20, P121; Maskin Arvin, 2000, W MITCHELL L REV, V27, P521; Mello MM, 2002, TEX LAW REV, V80, P1595; MILLER AR, 1979, HARVARD LAW REV, V92, P664, DOI 10.2307/1340397; Parmet WE, 2000, ANNU REV PUBL HEALTH, V21, P437, DOI 10.1146/annurev.publhealth.21.1.437; Resnik J, 1996, NEW YORK U LAW REV, V71, P296; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; RUBIN R, 2002, US TODAY        0722, pD1; SAYRE A, 2003, ADVOCATE        0120, pB3; Schiano T, 2000, DIGEST DIS SCI, V45, P1039, DOI 10.1023/A:1005510132625; Schwartz S, 1998, NEW ENGL J MED, V338, P861, DOI 10.1056/NEJM199803263381302; Shibuya A, 1998, DIABETES CARE, V21, P2140, DOI 10.2337/diacare.21.12.2140; SLAGEL AT, 1988, INDIANA LAW J, V63, P849; Venugopal P, 2002, COLUMBIA LAW REV, V102, P1659, DOI 10.2307/1123794; VOGELSHORT M, 2002, NJ LAW          1223, P1; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; DIET DRUG SETTLEMENT	49	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					889	894		10.1001/jama.289.7.889	http://dx.doi.org/10.1001/jama.289.7.889			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647BW	12588274				2022-12-28	WOS:000181072200034
J	Saul, J; Vinnik, L				Saul, J; Vinnik, L			Earth science - Mantle deformation or processing artefact?	NATURE			English	Article							BASE		Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Inst Earth Phys, Moscow 123995, Russia	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Saul, J (corresponding author), Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany.			Wookey, James/0000-0002-7403-4380; Kendall, John Michael/0000-0002-1486-3945				BARH M, 1966, ANN GEOFIS, V19, P119; Bostock MG, 1998, J GEOPHYS RES-SOL EA, V103, P21183, DOI 10.1029/98JB01069; GAHERTY JB, 1995, SCIENCE, V268, P1468, DOI 10.1126/science.268.5216.1468; Vinnik L, 1998, NATURE, V393, P564, DOI 10.1038/31208; Wookey J, 2002, NATURE, V415, P777, DOI 10.1038/415777a; ZANDT G, 1985, GEOPHYS RES LETT, V12, P565, DOI 10.1029/GL012i009p00565	6	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					136	136		10.1038/422136a	http://dx.doi.org/10.1038/422136a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634776	Bronze			2022-12-28	WOS:000181488900035
J	Vasan, RS; Beiser, A; D'Agostino, RB; Levy, D; Selhub, J; Jacques, PF; Rosenberg, IH; Wilson, PWF				Vasan, RS; Beiser, A; D'Agostino, RB; Levy, D; Selhub, J; Jacques, PF; Rosenberg, IH; Wilson, PWF			Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; FOLIC-ACID; CORONARY; HYPERHOMOCYSTEINEMIA; POPULATION; CLASSIFICATION; DETERMINANTS; FOLATE; SERUM	Context Elevated plasma homocysteine levels are associated with increased risk of vascular disease. It is unclear whether elevated homocysteine levels are a risk factor for congestive heart failure (CHF). Objective To study prospectively the-association between nonfasting plasma homocysteine and incidence of CHF. Design, Setting, and Participants Community-based prospective cohort study of 2491 adults (mean age 72 years, 1547 women) who participated in the Framingham Heart Study during the 1979-1982 and 1986-1990 examinations and were free of CHIF or prior myocardial infarction (recognized or unrecognized) at baseline. Main Outcome Measure incidence of a first episode of CHIF during an 8-year follow-up period. Results During follow-up, 156 subjects (88 women) developed CHF. In multivariable analyses controlling for established risk factors for CHF including the occurrence of myocardial infarction (recognized or unrecognized) during follow-up, plasma homocysteine levels higher than the sex-specific median value were associated with an adjusted hazards ratio,for heart failure of 1.93 in women (95% confidence interval, 1.19-3.14)and 1.84 in men (95% confidence interval, 1.06-3.17). The relation of plasma homocysteine levels to CHF risk was more continuous in women than in men. In analyses restricted to participants without any manifestation of coronary heart disease at baseline, the association of plasma homocysteine levels with risk of CHF was maintained in men and women. Conclusions An increased plasma homocysteine level independently predicts risk of the development of CHF in adults without prior myocardial infarction. Additional investigations are warranted to confirm these findings.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Clin Epidemiol, Boston, MA 02215 USA; NHLBI, Bethesda, MD 20892 USA; Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Site 2, Framingham, MA 01702 USA.	vasan@fram.nhlbi.nih.gov	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Wilson, Peter W.F./J-2455-2016	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Beiser, Alexa/0000-0001-8551-7778	NHLBI NIH HHS [1K24 HL04334, N01-HC-25195, R01 HL71039] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, R01HL071039] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Obaidi MK, 2000, J AM COLL CARDIOL, V36, P1217, DOI 10.1016/S0735-1097(00)00820-2; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; *AM HEART ASS, 2000, 2001 HEART STROK STA, P19; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Blacher J, 1999, J NEPHROL, V12, P248; Bostom AG, 1999, CIRCULATION, V99, P2361, DOI 10.1161/01.CIR.99.18.2361; Chao CL, 1999, ATHEROSCLEROSIS, V147, P379, DOI 10.1016/S0021-9150(99)00208-7; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Chilian WM, 1997, CIRCULATION, V95, P522; Clarke R, 2001, J CARDIOVASC RISK, V8, P363, DOI 10.1097/00043798-200112000-00005; Cooke GE, 2000, J AM COLL CARDIOL, V36, P509, DOI 10.1016/S0735-1097(00)00756-7; Cowie MR, 1997, EUR HEART J, V18, P208; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kannel W., 1987, FRAMINGHAM HEART STU; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lentz SR, 1997, LIFE SCI, V61, P1205, DOI 10.1016/S0024-3205(97)00392-5; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McMurray JJV, 1998, EUR HEART J, V19, pP9; Miller A, 2002, AM J HYPERTENS, V15, P157, DOI 10.1016/S0895-7061(01)02286-5; Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491; Nurk E, 2001, J NUTR, V131, P1214, DOI 10.1093/jn/131.4.1214; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; *SAS I INC, 1997, PHREG PROC CHANG ENH; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Symons JD, 2002, ARTERIOSCL THROM VAS, V22, P772, DOI 10.1161/01.ATV.0000014588.71807.0A; UELAND PM, 1993, CLIN CHEM, V39, P1764; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Ventura P, 2001, METABOLISM, V50, P1466, DOI 10.1053/meta.2001.28079; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Whincup PH, 1999, HEART, V82, P448, DOI 10.1136/hrt.82.4.448; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; 1997, ARCH INTERN MED, V157, P2413; 1996, FED REG, V61, P8781	41	161	177	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1251	1257		10.1001/jama.289.10.1251	http://dx.doi.org/10.1001/jama.289.10.1251			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633186	Bronze			2022-12-28	WOS:000181466500026
J	Porco, CC; West, RA; McEwen, A; Del Genio, AD; Ingersoll, AP; Thomas, P; Squyres, S; Dones, L; Murray, CD; Johnson, TV; Burns, JA; Brahic, A; Neukum, G; Veverka, J; Barbara, JM; Denk, T; Evans, M; Ferrier, JJ; Geissler, P; Helfenstein, P; Roatsch, T; Throop, H; Tiscareno, M; Vasavada, AR				Porco, CC; West, RA; McEwen, A; Del Genio, AD; Ingersoll, AP; Thomas, P; Squyres, S; Dones, L; Murray, CD; Johnson, TV; Burns, JA; Brahic, A; Neukum, G; Veverka, J; Barbara, JM; Denk, T; Evans, M; Ferrier, JJ; Geissler, P; Helfenstein, P; Roatsch, T; Throop, H; Tiscareno, M; Vasavada, AR			Cassini imaging of Jupiter's atmosphere, satellites, and rings	SCIENCE			English	Article							GREAT RED SPOT; MOIST CONVECTION; CLOUD STRUCTURE; EQUATORIAL REGION; GIANT PLANETS; ZONAL WINDS; SYSTEM; IMAGES; IO; ULTRAVIOLET	The Cassini Imaging Science Subsystem acquired about 26,000 images of the Jupiter system as the spacecraft encountered the giant planet en route to Saturn. We report findings on Jupiter's zonal winds, convective storms, low-latitude upper troposphere, polar stratosphere, and northern aurora. We also describe previously unseen emissions arising from lo and Europa in eclipse, a giant volcanic plume over lo's north pole, disk-resolved images of the satellite Himalia, circumstantial evidence for a causal relation between the satellites Metis and Adrastea and the main jovian ring, and information on the nature of the ring particles.	SW Res Inst, Dept Space Sci, Boulder, CO 80302 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Univ London, Queen Mary, Astron Unit, London E1 4NS, England; Univ Paris, Ctr Etud Saclay, F-91191 Gif Sur Yvette, France; Free Univ Berlin, Dept Earth Sci, D-12249 Berlin, Germany; German Aerosp Ctr, Inst Space Sensor Technol & Planetary Explorat, D-12489 Berlin, Germany; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; Cornell University; University of London; Queen Mary University London; UDICE-French Research Universities; Universite Paris Cite; Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); University of California System; University of California Los Angeles	Porco, CC (corresponding author), SW Res Inst, Dept Space Sci, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.		Evans, Michael W/AAG-4117-2020; Tiscareno, Matthew/D-6963-2011; Del Genio, Anthony/D-4663-2012	Del Genio, Anthony/0000-0001-7450-1359; Barbara, John/0000-0002-2190-4290				ALBRECHT BA, 1995, B AM METEOROL SOC, V76, P889, DOI 10.1175/1520-0477(1995)076<0889:TASTE>2.0.CO;2; Allison M, 2000, PLANET SPACE SCI, V48, P753, DOI 10.1016/S0032-0633(00)00032-5; Banfield D, 1998, ICARUS, V135, P230, DOI 10.1006/icar.1998.5985; BORUCKI WJ, 1992, ICARUS, V96, P1, DOI 10.1016/0019-1035(92)90002-O; Brooks S. T., UNPUB; Brown ME, 1996, NATURE, V380, P229, DOI 10.1038/380229a0; BURNS JA, 1980, ICARUS, V44, P339, DOI 10.1016/0019-1035(80)90029-9; BUSSE FH, 1976, ICARUS, V29, P255, DOI 10.1016/0019-1035(76)90053-1; CARLSON BE, 1994, J GEOPHYS RES-PLANET, V99, P14623, DOI 10.1029/94JE01222; Connerney JEP, 1998, J GEOPHYS RES-SPACE, V103, P11929, DOI 10.1029/97JA03726; Cowley SWH, 2001, PLANET SPACE SCI, V49, P1067, DOI 10.1016/S0032-0633(00)00167-7; CRUIKSHANK DP, 1977, ICARUS, V30, P224, DOI 10.1016/0019-1035(77)90136-1; DEGEWIJ J, 1980, ICARUS, V44, P520, DOI 10.1016/0019-1035(80)90042-1; Del Genio AD, 2002, J CLIMATE, V15, P2597, DOI 10.1175/1520-0442(2002)015<2597:CPOTPC>2.0.CO;2; DELGENIO AD, 1990, ICARUS, V84, P29, DOI 10.1016/0019-1035(90)90156-4; DENK T, 2001, C JUP PLAN SAT MAGN; FLASAR FM, UNPUB; FU R, 1994, J CLIMATE, V7, P1092, DOI 10.1175/1520-0442(1994)007<1092:IOOSCO>2.0.CO;2; Garcia-Melendo E, 2001, ICARUS, V152, P316, DOI 10.1006/icar.2001.6646; GRUEN E, 1980, ICARUS, V44, P326; Gurnett DA, 2002, NATURE, V415, P985, DOI 10.1038/415985a; HALL DT, 1995, NATURE, V373, P677, DOI 10.1038/373677a0; Hamilton D. P., 2001, B AM ASTRON SOC, V33, P1085; HANSEN C, UNPUB; Hueso R, 2001, ICARUS, V151, P257, DOI 10.1006/icar.2000.6606; INGERSOLL AP, 1982, ICARUS, V52, P62, DOI 10.1016/0019-1035(82)90169-5; Ingersoll AP, 1998, ICARUS, V135, P251, DOI 10.1006/icar.1998.5971; INGERSOLL AP, 1979, NATURE, V280, P773, DOI 10.1038/280773a0; Irwin PGJ, 2002, ICARUS, V156, P52, DOI 10.1006/icar.2001.6773; JACOBSON RA, COMMUNICATION; KIRK RL, 1987, ASTROPHYS J, V316, P836, DOI 10.1086/165248; Kurth WS, 2002, NATURE, V415, P991, DOI 10.1038/415991a; LIMAYE SS, 1986, ICARUS, V65, P335, DOI 10.1016/0019-1035(86)90142-9; Little B, 1999, ICARUS, V142, P306, DOI 10.1006/icar.1999.6195; MCEWEN AS, 1983, ICARUS, V55, P191, DOI 10.1016/0019-1035(83)90075-1; MCGRATH M, 2000, 32 ANN M DIV PLAN SC; Mishchenko MI, 1998, J QUANT SPECTROSC RA, V60, P309, DOI 10.1016/S0022-4073(98)00008-9; Ockert-Bell ME, 1999, ICARUS, V138, P188, DOI 10.1006/icar.1998.6072; ORTON GS, 1994, SCIENCE, V265, P625, DOI 10.1126/science.265.5172.625; PIRRAGLIA JA, 1981, NATURE, V292, P677, DOI 10.1038/292677a0; PORCO CC, UNPUB; Roesler FL, 1999, SCIENCE, V283, P353, DOI 10.1126/science.283.5400.353; Sanchez-Lavega A, 1998, GEOPHYS RES LETT, V25, P4043, DOI 10.1029/1998GL900059; SHOWALTER MR, 1987, ICARUS, V69, P458, DOI 10.1016/0019-1035(87)90018-2; SHOWALTER MR, 2001, C JUP PLAN SAT MAGN; Simon AA, 1999, ICARUS, V141, P29, DOI 10.1006/icar.1999.6163; SMITH BA, 1979, SCIENCE, V204, P951, DOI 10.1126/science.204.4396.951; Spencer JR, 1997, GEOPHYS RES LETT, V24, P2471, DOI 10.1029/97GL02592; STROBEL DF, COMMUNICATION; Thomas PC, 1998, ICARUS, V135, P360, DOI 10.1006/icar.1998.5976; Vasavada AR, 1998, ICARUS, V135, P265, DOI 10.1006/icar.1998.5984; Vasavada AR, 1999, J GEOPHYS RES-PLANET, V104, P27133, DOI 10.1029/1999JE001055; Vincent MB, 2000, ICARUS, V143, P205, DOI 10.1006/icar.1999.6233; Vincent MB, 2000, ICARUS, V143, P189, DOI 10.1006/icar.1999.6232; WAITE JH, UNPUB; WEST RA, 1979, ICARUS, V38, P12, DOI 10.1016/0019-1035(79)90082-4; ZIPSER EJ, 1994, MON WEATHER REV, V122, P1751, DOI 10.1175/1520-0493(1994)122<1751:TVPORR>2.0.CO;2	60	326	328	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1541	1547		10.1126/science.1079462	http://dx.doi.org/10.1126/science.1079462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624258				2022-12-28	WOS:000181367900028
J	Acevedo-Whitehouse, K; Gulland, F; Greig, D; Amos, W				Acevedo-Whitehouse, K; Gulland, F; Greig, D; Amos, W			Disease susceptibility in California sea lions	NATURE			English	Article							ZALOPHUS-CALIFORNIANUS; MICROSATELLITES		Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Marine Mammal Ctr, Sausalito, CA 94965 USA	University of Cambridge	Acevedo-Whitehouse, K (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	w.amos@zoo.cam.ac.uk		Greig, Denise/0000-0003-0783-1002				Allen PJ, 1995, MOL ECOL, V4, P653, DOI 10.1111/j.1365-294X.1995.tb00266.x; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Buchanan FC, 1998, MOL ECOL, V7, P1083; Coltman DW, 1996, MOL ECOL, V5, P161, DOI 10.1111/j.1365-294X.1996.tb00303.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; GAGE LJ, 1993, J ZOO WILDLIFE MED, V24, P41; Goldstein T., 1999, Aquatic Mammals, V25, P43; Gulland FMD, 2002, VET REC, V150, P475; Hoelzel AR, 2001, P ROY SOC B-BIOL SCI, V268, P325; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lipscomb TP, 2000, VET PATHOL, V37, P609, DOI 10.1354/vp.37-6-609; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499	13	267	273	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					35	35		10.1038/422035a	http://dx.doi.org/10.1038/422035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621424	Bronze			2022-12-28	WOS:000181343100027
J	Harrell, J; Carrasquillo, O				Harrell, J; Carrasquillo, O			The Latino disparity in health coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Harrell, J (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.							Brown R, 2000, RACIAL ETHNIC DISPAR; GUYER J, 1999, EMPLOYED NOT INSURED; LUCHON L, 2000, PUBLICATION COMMONWE, V362; QUINN K, 2000, PUBLICATION COMMONWE, V370; SCHUR C, 2001, PUBLICATION COMMONWE, V453; *US CENS BUR, 2003, NAT POP EST; *US CENS BUR, 2001, HLTH INSUR COV; *US GEN ACC OFF, MED DEM NON CHILDR S	8	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1167	1167		10.1001/jama.289.9.1167	http://dx.doi.org/10.1001/jama.289.9.1167			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622594	Bronze			2022-12-28	WOS:000181289400039
J	Reaven, GM				Reaven, GM			Importance of identifying the overweight patient who will benefit the most by losing weight	ANNALS OF INTERNAL MEDICINE			English	Article							DEPENDENT DIABETES-MELLITUS; HIGH-DENSITY-LIPOPROTEIN; ISCHEMIC-HEART-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; HIGH BLOOD-PRESSURE; INSULIN-RESISTANCE; OBESE INDIVIDUALS; HDL-CHOLESTEROL; LIFE-STYLE; RISK	Because being overweight increases the risk for type 2 diabetes, hypertension, and coronary heart disease, the rapid increase in the prevalence of overweight and obesity in the United States represents a major health problem. The relationship between overweight and obesity and these conditions is probably due to insulin resistance and compensatory hyperinsulinemia. However, although it is known that weight loss in insulin-resistant and hyperinsulinemic persons will be of substantial metabolic benefit, it is equally well established that many overweight and obese persons are not insulin resistant. In the absence of insulin resistance and its manifestations, the risk for type 2 diabetes, hypertension, and coronary heart disease is reduced and the metabolic benefit of weight loss in the substantial number of overweight persons who are insulin sensitive is relatively minimal. Consequently, it is important to identify which overweight persons are most likely to be insulin resistant by considering their family history; blood pressure; and plasma glucose, triglyceride, and high-density lipoprotein cholesterol concentrations. Thoughtful use of this information will help identify the subset of persons who will benefit the most from intense therapeutic efforts to lose weight.	Stanford Univ, Ctr Med, CV Med Falk CVRC, Stanford, CA 94305 USA	Stanford University	Reaven, GM (corresponding author), Stanford Univ, Ctr Med, CV Med Falk CVRC, 300 Pasteur Dr, Stanford, CA 94305 USA.	greaven@cvmed.stanford.edu						BOGARDUS C, 1985, AM J PHYSIOL, V248, pE286, DOI 10.1152/ajpendo.1985.248.3.E286; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; JEPPESEN J, 1995, ARTERIOSCL THROM VAS, V15, P320, DOI 10.1161/01.ATV.15.3.320; Jeppesen J, 2001, ARCH INTERN MED, V161, P361, DOI 10.1001/archinte.161.3.361; Jeppesen J, 2000, HYPERTENSION, V36, P226, DOI 10.1161/01.HYP.36.2.226; Jones CNO, 2000, AM J PHYSIOL-ENDOC M, V278, pE501, DOI 10.1152/ajpendo.2000.278.3.E501; Kim HS, 2001, AM J CLIN NUTR, V74, P592; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krauss Ronald M., 1994, Current Opinion in Lipidology, V5, P339, DOI 10.1097/00041433-199410000-00005; LAWS A, 1992, J INTERN MED, V231, P25, DOI 10.1111/j.1365-2796.1992.tb00494.x; LONG SD, 1994, DIABETES CARE, V17, P372, DOI 10.2337/diacare.17.5.372; McLaughlin T, 2001, METABOLISM, V50, P819, DOI 10.1053/meta.2001.24220; McLaughlin T, 2001, METABOLISM, V50, P795, DOI 10.1053/meta.2001.24210; McLaughlin T, 1999, J CLIN ENDOCR METAB, V84, P578, DOI 10.1210/jc.84.2.578; MILLER GJ, 1975, LANCET, V1, P16; OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Reaven G, 2001, AM J CARDIOL, V87, P827, DOI 10.1016/S0002-9149(00)01521-6; REAVEN GM, 1993, J CLIN INVEST, V92, P141, DOI 10.1172/JCI116541; REAVEN GM, 1983, AM J MED, V75, P8, DOI 10.1016/0002-9343(83)90248-6; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REAVEN GM, 2001, HDB PHYSL 7, V2, P1169; REISIN E, 1978, NEW ENGL J MED, V298, P1, DOI 10.1056/NEJM197801052980101; ROCCHINI AP, 1987, HYPERTENSION, V10, P267, DOI 10.1161/01.HYP.10.3.267; SHEU WHH, 1992, AM J HYPERTENS, V5, P444, DOI 10.1093/ajh/5.7.444; SU HY, 1995, AM J HYPERTENS, V8, P1067, DOI 10.1016/0895-7061(95)00330-R; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Williams KV, 2000, DIABETES OBES METAB, V2, P121, DOI 10.1046/j.1463-1326.2000.00049.x; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773; ZAVARONI I, 1992, J INTERN MED, V231, P235, DOI 10.1111/j.1365-2796.1992.tb00529.x; Zavaroni I, 1999, METABOLISM, V48, P989, DOI 10.1016/S0026-0495(99)90195-6; 2001, DIABETES CARE S1, V24, pS5	39	72	72	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					420	423		10.7326/0003-4819-138-5-200303040-00012	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614095				2022-12-28	WOS:000181257300008
J	Cochrane, MA				Cochrane, MA			Fire science for rainforests	NATURE			English	Review							EAST KALIMANTAN; HABITAT FRAGMENTATION; DIPTEROCARP FOREST; POSITIVE FEEDBACKS; AMAZONIAN FORESTS; NATURAL-RESOURCE; TROPICAL FORESTS; BURNED FORESTS; CENTRAL-AFRICA; SATELLITE DATA	Forest fires are growing in size and frequency across the tropics. Continually eroding fragmented forest edges, they are unintended ecological disturbances that transcend deforestation to degrade vast regions of standing forest, diminishing ecosystem services and the economic potential of these natural resources. Affecting the health of millions, net forest fire emissions may have released carbon equivalent to 41% of worldwide fossil fuel use in 1997-98. Episodically more severe during El Nino events, pan-tropical forest fires will increase as more damaged, less fire-resistant, forests cover the landscape. Here I discuss the current state of tropical fire science and make recommendations for advancement.	Michigan State Univ, Ctr Global Change & Earth Observ, E Lansing, MI 48823 USA; IMAZON, BR-66017000 Belem, Para, Brazil	Michigan State University	Cochrane, MA (corresponding author), Michigan State Univ, Ctr Global Change & Earth Observ, 1405 S Harrison Rd,Room 101, E Lansing, MI 48823 USA.	cochrane@globalchange.msu.edu	Cochrane, Mark A/A-1735-2018	Cochrane, Mark A/0000-0002-4573-568X				Ackerman AS, 2000, SCIENCE, V288, P1042, DOI 10.1126/science.288.5468.1042; Agee, 1993, FIRE ECOLOGY PACIFIC; Anderson H. A., 1982, INT122 US FOR SERV; AUBREVELLE A. M. A., 1947, UNASYLVA, V1, P5; BAILEY WO, 1882, REPORT MICHIGAN FORE; Barber C, 2000, TRIAL FIRE FOREST FI; Barbosa Reinaldo Imbrozio, 1999, Acta Amazonica, V29, P513; Barlow J, 2002, BIOL CONSERV, V105, P157, DOI 10.1016/S0006-3207(01)00177-X; Bucini G, 2002, APPL GEOGR, V22, P27, DOI 10.1016/S0143-6228(01)00020-0; CAIRNS MA, 2000, P JOINT FIR SCI C WO, V1, P242; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 2001, ENVIRONMENT, V43, P28, DOI 10.1080/00139150109604505; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x; Cochrane MA, 1998, INT J REMOTE SENS, V19, P3433, DOI 10.1080/014311698214109; COCHRANE MA, 2002, SPREADING LIKE WILDL; COCHRANE MA, IN PRESS WORKING FOR; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; DeFries RS, 2002, GLOBAL CHANGE BIOL, V8, P438, DOI 10.1046/j.1365-2486.2002.00483.x; Eltahir EAB, 1996, REV GEOPHYS, V34, P367, DOI 10.1029/96RG01927; Elvidge C. D., 1999, REMOTE SENSING CHANG, P74; Eva H, 1998, INT J REMOTE SENS, V19, P3473, DOI 10.1080/014311698213768; Finney M.A., 1998, FARSITE FIRE AREA SI; Fredericksen NJ, 2002, BIODIVERS CONSERV, V11, P27, DOI 10.1023/A:1014065510554; Fuller DO, 2000, INT J REMOTE SENS, V21, P181, DOI 10.1080/014311600211073; Fuller DO, 2000, PROG PHYS GEOG, V24, P543, DOI 10.1177/030913330002400404; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gerwing JJ, 2002, FOREST ECOL MANAG, V157, P131, DOI 10.1016/S0378-1127(00)00644-7; Gerwing JJ, 2001, J APPL ECOL, V38, P1264, DOI 10.1046/j.0021-8901.2001.00677.x; Giglio L, 1999, INT J REMOTE SENS, V20, P1947, DOI 10.1080/014311699212290; Giglio L, 2000, INT J REMOTE SENS, V21, P203, DOI 10.1080/014311600211109; Goldammer J.G., 1999, HLTH GUIDELINES VEGE, P9; GOLDAMMER JG, 1990, ECOL STU AN, V84, P11; GOLDAMMER JG, 1989, NATURWISSENSCHAFTEN, V76, P518, DOI 10.1007/BF00374124; GOLDAMMER JG, 1990, FIRE TROPICAL BIOTA, P487; Goldammer JG, 1996, DIPTEROCARP FOREST E, P155; Gould KA, 2002, FOREST ECOL MANAG, V165, P225, DOI 10.1016/S0378-1127(01)00620-X; Hammond DS, 1998, CONSERV BIOL, V12, P944, DOI 10.1046/j.1523-1739.1998.012005944.x; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Houghton J. T., 2001, CLIMATE CHANGE 2001; HUBER O, 1984, BRITTONIA, V36, P104, DOI 10.2307/2806619; Jackson SM, 2002, FOREST ECOL MANAG, V166, P271, DOI 10.1016/S0378-1127(01)00681-8; KAUFFMAN JB, 1990, ECOL STU AN, V84, P117; Kauffman JB, 1998, OECOLOGIA, V113, P415, DOI 10.1007/s004420050394; Kaufman YJ, 2002, NATURE, V419, P215, DOI 10.1038/nature01091; Kellman M, 1997, J BIOGEOGR, V24, P23, DOI 10.1111/j.1365-2699.1997.tb00047.x; Kinnaird MF, 1998, CONSERV BIOL, V12, P954, DOI 10.1046/j.1523-1739.1998.012005954.x; Kleidon A, 2001, GEOPHYS RES LETT, V28, P2425, DOI 10.1029/2000GL012750; KUNII O, 1999, HLTH GUIDELINES VEGE, P299; Latham D., 2001, FOREST FIRES BEHAV E, DOI 10.1016/B978-012386660-8/50013-1; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2001, CONSERV BIOL, V15, P1529, DOI 10.1046/j.1523-1739.2001.01093.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Lawton RO, 2001, SCIENCE, V294, P584; LINDEN E, 2000, TIME LATINA     0920; Lyons WA, 1998, SCIENCE, V282, P77, DOI 10.1126/science.282.5386.77; Matricardi E.A.T., 2001, MULTITEMPORAL DETECT; MEGGERS BJ, 1994, CLIMATIC CHANGE, V28, P321, DOI 10.1007/BF01104077; Moreira MZ, 1997, GLOB CHANGE BIOL, V3, P439, DOI 10.1046/j.1365-2486.1997.00082.x; MUELLERDOMBOIS M, 1981, P C FIR REG EC PROP, P137; Nascimento HEM, 2002, FOREST ECOL MANAG, V168, P311, DOI 10.1016/S0378-1127(01)00749-6; Nepstad D., 1999, FLAMES RAIN FOREST O; Nepstad D.C., 1995, EVALUATING MONITORIN, P333; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; OERTEL D, 2000, FOREST FIRE MONITORI, P224; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Pereira AC, 1996, INT J REMOTE SENS, V17, P1925, DOI 10.1080/01431169608948748; Phulpin T, 2002, INT J REMOTE SENS, V23, P1943, DOI 10.1080/01431160110076135; Pyne S.J., 1997, WORLD FIRE CULTURE F; Quintiere J.G., 1993, J FIRE PROT ENG, V5, P67, DOI DOI 10.1177/104239159300500203; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Rosenfeld D, 1999, GEOPHYS RES LETT, V26, P3105, DOI 10.1029/1999GL006066; RUITENBEEK J, 1999, INDONESIAS FIRE HAZE, P88; SANFORD RL, 1985, SCIENCE, V227, P53, DOI 10.1126/science.227.4682.53; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Siegert F, 2000, INT J REMOTE SENS, V21, P831, DOI 10.1080/014311600210632; Sist P, 2002, FOREST ECOL MANAG, V165, P85, DOI 10.1016/S0378-1127(01)00649-1; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Slik JWF, 2002, BIODIVERS CONSERV, V11, P85, DOI 10.1023/A:1014036129075; Stone TA, 1998, INT J REMOTE SENS, V19, P2517, DOI 10.1080/014311698214604; Stott P, 2000, PROG PHYS GEOG, V24, P355, DOI 10.1177/030913330002400303; SWAINE MD, 1992, J VEG SCI, V3, P365, DOI 10.2307/3235762; Tate GHH, 1932, ECOLOGY, V13, P235, DOI 10.2307/1931551; Tutin CEG, 1996, GLOBAL ECOL BIOGEOGR, V5, P36, DOI 10.2307/2997469; UHL C, 1985, BIOTROPICA, V17, P265, DOI 10.2307/2388588; UHL C, 1988, OIKOS, V53, P176, DOI 10.2307/3566060; Uhl C, 1997, BIOSCIENCE, V47, P160, DOI 10.2307/1313035; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; *UN ENV PROGR, 2000, GEO LAT AM CAR ENV O; Van Nieuwstadt MGL, 2001, CONSERV BIOL, V15, P1183, DOI 10.1046/j.1523-1739.2001.0150041183.x; VAYDA AP, 1999, FINDING CAUSES 1997; VERISSIMO A, 1995, FOREST ECOL MANAG, V72, P39, DOI 10.1016/0378-1127(94)03432-V; Verissimo A, 2002, SCIENCE, V297, P1478, DOI 10.1126/science.1072807; WARD DE, 1999, HLTH GUIDELINES VEGE, P71; WOODS P, 1989, BIOTROPICA, V21, P290, DOI 10.2307/2388278	97	685	727	15	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					913	919		10.1038/nature01437	http://dx.doi.org/10.1038/nature01437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606992				2022-12-28	WOS:000181186900040
J	Hadziyannis, SJ; Tassopoulos, NC; Heathcote, EJ; Chang, TT; Kitis, G; Rizzetto, M; Marcellin, P; Lim, SG; Goodman, Z; Wulfsohn, MS; Xiong, S; Fry, J; Brosgart, CL				Hadziyannis, SJ; Tassopoulos, NC; Heathcote, EJ; Chang, TT; Kitis, G; Rizzetto, M; Marcellin, P; Lim, SG; Goodman, Z; Wulfsohn, MS; Xiong, S; Fry, J; Brosgart, CL		Adefovir Dipivoxil 438 Study Grp	Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LAMIVUDINE; VIRUS; CARRIERS; DNA	BACKGROUND Adefovir dipivoxil, a nucleotide analogue, demonstrated clinically significant antiviral activity in patients with chronic hepatitis B in phase 1 and 2 clinical trials. METHODS We randomly assigned 185 patients with chronic hepatitis B who were negative for hepatitis B e antigen (HBeAg) to receive either 10 mg of adefovir dipivoxil or placebo once daily for 48 weeks in a 2:1 ratio and a double-blind manner. The primary end point was histologic improvement. RESULTS At week 48, 64 percent of patients who had base-line liver-biopsy specimens available in the adefovir dipivoxil group had improvement in histologic liver abnormalities (77 of 121), as compared with 33 percent of patients in the placebo group (19 of 57, P<0.001). Serum hepatitis B virus (HBV) DNA levels were reduced to fewer than 400 copies per milliliter in 51 percent of patients in the adefovir dipivoxil group (63 of 123) and in 0 percent of those in the placebo group (0 of 61, P<0.001). The median decrease in log-transformed HBV DNA levels was greater with adefovir dipivoxil treatment than with placebo (3.91 vs. 1.35 log copies per milliliter, P<0.001). Alanine aminotransferase levels had normalized at week 48 in 72 percent of patients receiving adefovir dipivoxil (84 of 116), as compared with 29 percent of those receiving placebo (17 of 59, P<0.001). No HBV polymerase mutations associated with resistance to adefovir were identified. The safety profile of adefovir dipivoxil was similar to that of placebo. CONCLUSIONS In patients with HBeAg-negative chronic hepatitis B, 48 weeks of adefovir dipivoxil treatment resulted in significant histologic, virologic, and biochemical improvement, with an adverse-event profile similar to that of placebo. There was no evidence of the emergence of adefovir-resistant HBV polymerase mutations.	Henry Dunant Hosp, Dept Med & Hepatol, Athens 11526, Greece; Western Attica Gen Hosp, Athens, Greece; Univ Toronto, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; Georgios Papanikolaou Hosp, Thessaloniki, Greece; Azienda Osped San Giovanni Battista, Turin, Italy; INSERM, U481, Serv Hepatol, Clichy, France; Hop Beaujon, Ctr Rech Claude Bernard Hepatites Virales, Clichy, France; Natl Univ Singapore Hosp, Div Gastroenterol, Singapore 117548, Singapore; Armed Forces Inst Pathol, Washington, DC 20306 USA; Gilead Sci Inc, Foster City, CA 94404 USA	Henry Dunant Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Cheng Kung University; National Cheng Kung University Hospital; George Papanikolaou General Hospital of Thessaloniki; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; National University of Singapore; United States Department of Defense; Gilead Sciences	Hadziyannis, SJ (corresponding author), Henry Dunant Hosp, Dept Med, 107 Mesogion Ave, Athens 11526, Greece.	hadziyannis@ath.forthnet.gr	Chang, Ting-Tsung/B-4306-2009; LIM, Seng Gee/AAD-9040-2020	LIM, Seng Gee/0000-0003-0994-4932				Benhamou Y, 2001, LANCET, V358, P718, DOI 10.1016/S0140-6736(01)05840-8; BONINO F, 1986, GASTROENTEROLOGY, V90, P1268, DOI 10.1016/0016-5085(86)90395-1; BRUNETTO MR, 1991, J HEPATOL, V13, pS8, DOI 10.1016/0168-8278(91)91713-Q; DECLERCQ E, 1994, NUCLEOS NUCLEOT NUCL, V13, P1271, DOI 10.1080/15257779408012151; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Funk ML, 2002, J VIRAL HEPATITIS, V9, P52, DOI 10.1046/j.1365-2893.2002.00304.x; Ghany MG, 2000, HEPATOLOGY, V32, p376A, DOI 10.1053/jhep.2000.17912; HADZIYANNIS S, 1990, J HEPATOL, V11, pS133, DOI 10.1016/0168-8278(90)90180-Y; Hadziyannis SJ, 2001, HEPATOLOGY, V34, P617, DOI 10.1053/jhep.2001.27834; HADZIYANNIS SJ, 1995, VIRAL HEPATITIS REV, V1, P7; Heathcote EJ, 1998, HEPATOLOGY, V28, p317A; Heathcote EJ, 2001, HEPATOLOGY, V34, p316A; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Lin SM, 1999, HEPATOLOGY, V29, P971, DOI 10.1002/hep.510290312; Lindh M, 1996, HEPATOLOGY, V24, P494, DOI 10.1053/jhep.1996.v24.pm0008781313; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Manesis EK, 2001, GASTROENTEROLOGY, V121, P101, DOI 10.1053/gast.2001.25524; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; National Cancer Institute, 1999, COMM TOX CRIT VERS 2; Perrillo R, 2001, HEPATOLOGY, V34, p349A; Perrillo R, 2000, HEPATOLOGY, V32, P129, DOI 10.1053/jhep.2000.8626; Santantonio T, 2000, J HEPATOL, V32, P300, DOI 10.1016/S0168-8278(00)80076-8; Schiff ER, 2001, HEPATOLOGY, V34, p446A; Tassopoulos N. C., 1999, Journal of Hepatology, V30, P117; *WHO, 2000, WHO204; Yang HL, 2001, HEPATOLOGY, V34, p316A	27	757	817	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					800	807		10.1056/NEJMoa021812	http://dx.doi.org/10.1056/NEJMoa021812			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606734				2022-12-28	WOS:000181173300006
J	Spurgeon, D				Spurgeon, D			Canada boosts spending on science	NATURE			English	News Item																		2003, NATURE, V421, P464	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					880	880		10.1038/421880b	http://dx.doi.org/10.1038/421880b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606963	Bronze			2022-12-28	WOS:000181186900009
J	Volpp, KGM; Grande, D				Volpp, KGM; Grande, D			Patient safety - Residents' suggestions for reducing errors in teaching hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVERSE EVENTS; PERFORMANCE; PHYSICIANS; DEPRIVATION; FATIGUE; SYSTEMS; SLEEP; CARE		Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Dept Hlth Care Syst, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Volpp, KGM (corresponding author), Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735; Volpp, Kevin/0000-0003-1423-4599				ALTMAN LK, 2002, NY TIMES        0613, pA1; *AM BOARD INT MED, 2002, PROC LOG BOOK INT ME; Arnstein F, 1997, BRIT J ANAESTH, V79, P645, DOI 10.1093/bja/79.5.645; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BLUM NJ, 1992, AM J DIS CHILD, V146, P806, DOI 10.1001/archpedi.1992.02160190038016; Bogner MS, 1994, HUMAN ERROR MED; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Casarett D, 1999, ACAD MED, V74, P19, DOI 10.1097/00001888-199901001-00011; Chassin MR, 2002, ANN INTERN MED, V136, P826, DOI 10.7326/0003-4819-136-11-200206040-00012; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Drazen JM, 2002, NEW ENGL J MED, V347, P1271, DOI 10.1056/NEJMe020110; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; HAWKINS MR, 1985, J MED EDUC, V60, P530; Hofer T P, 2000, Eff Clin Pract, V3, P261; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Kasuya RT, 2001, ACAD MED, V76, P554, DOI 10.1097/00001888-200105000-00099; KATZ MH, 1988, NEW ENGL J MED, V319, P1585, DOI 10.1056/NEJM198812153192406; Kohn KT, 2000, ERR IS HUMAN BUILDIN; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Leape LL, 2002, NEW ENGL J MED, V347, P1633, DOI 10.1056/NEJMNEJMhpr011493; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; McDonald CJ, 2000, JAMA-J AM MED ASSOC, V284, P93, DOI 10.1001/jama.284.1.93; Nadel FM, 2000, ARCH PEDIAT ADOL MED, V154, P1049, DOI 10.1001/archpedi.154.10.1049; Reason J., 1990, HUMAN ERROR; Richardson WC, 2000, NEW ENGL J MED, V343, P663; ROBBINS J, 1990, WESTERN J MED, V152, P82; Sox H C Jr, 2000, Eff Clin Pract, V3, P277; Steinbrook R, 2002, NEW ENGL J MED, V347, P1296, DOI 10.1056/NEJMhpr022383; Tenore JL, 2001, FAM MED, V33, P28; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Weinstein DF, 2002, NEW ENGL J MED, V347, P1275, DOI 10.1056/NEJMsb022065; Winslow, 1997, HEART LUNG, V26, P203; Winslow EH, 1997, HEART LUNG, V26, P158, DOI 10.1016/S0147-9563(97)90076-5; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089	35	199	206	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					851	855		10.1056/NEJMsb021667	http://dx.doi.org/10.1056/NEJMsb021667			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606742				2022-12-28	WOS:000181173300014
J	Palleroni, A; Hauser, M				Palleroni, A; Hauser, M			Experience-dependent plasticity for auditory processing in a raptor	SCIENCE			English	Article							ADULT		Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Harvard Univ, Program Neurosci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Palleroni, A (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.							GILDACOSTA R, IN PRESS P R SOC LON; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; Holowka S, 2002, SCIENCE, V297, P1515, DOI 10.1126/science.1074941; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; RECANZONE GH, 2000, NEW COGNITIVE NEUROS, P237; Touchton Janeene M., 2002, Ornitologia Neotropical, V13, P365	6	35	36	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1195	1195		10.1126/science.1078813	http://dx.doi.org/10.1126/science.1078813			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595683				2022-12-28	WOS:000181065500029
J	Herridge, MS; Cheung, AM; Tansey, CM; Matte-Martyn, A; Diaz-Granados, N; Al-Saidi, F; Cooper, AB; Guest, CB; Mazer, CD; Mehta, S; Stewart, TE; Barr, A; Cook, D; Slutsky, AS				Herridge, MS; Cheung, AM; Tansey, CM; Matte-Martyn, A; Diaz-Granados, N; Al-Saidi, F; Cooper, AB; Guest, CB; Mazer, CD; Mehta, S; Stewart, TE; Barr, A; Cook, D; Slutsky, AS		Canadian Critical Care Trials Grp	One-year outcomes in survivors of the acute respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; ACUTE LUNG INJURY; TERM-FOLLOW-UP; PULMONARY-FUNCTION; RECOVERY; ABNORMALITIES; DYSFUNCTION; SF-36; ARDS	BACKGROUND: As more patients survive the acute respiratory distress syndrome, an understanding of the long-term outcomes of this condition is needed. METHODS: We evaluated 109 survivors of the acute respiratory distress syndrome 3, 6, and 12 months after discharge from the intensive care unit. At each visit, patients were interviewed and underwent a physical examination, pulmonary-function testing, a six-minute-walk test, and a quality-of-life evaluation. RESULTS: Patients who survived the acute respiratory distress syndrome were young (median age, 45 years) and severely ill (median Acute Physiology, Age, and Chronic Health Evaluation score, 23) and had a long stay in the intensive care unit (median, 25 days). Patients had lost 18 percent of their base-line body weight by the time they were discharged from the intensive care unit and stated that muscle weakness and fatigue were the reasons for their functional limitation. Lung volume and spirometric measurements were normal by 6 months, but carbon monoxide diffusion capacity remained low throughout the 12-month follow-up. No patients required supplemental oxygen at 12 months, but 6 percent of patients had arterial oxygen saturation values below 88 percent during exercise. The median score for the physical role domain of the Medical Outcomes Study 36-item Short-Form General Health Survey (a health-related quality-of-life measure) increased from 0 at 3 months to 25 at 12 months (score in the normal population, 84). The distance walked in six minutes increased from a median of 281 m at 3 months to 422 m at 12 months; all values were lower than predicted. The absence of systemic corticosteroid treatment, the absence of illness acquired during the intensive care unit stay, and rapid resolution of lung injury and multiorgan dysfunction were associated with better functional status during the one-year follow-up. CONCLUSIONS: Survivors of the acute respiratory distress syndrome have persistent functional disability one year after discharge from the intensive care unit. Most patients have extrapulmonary conditions, with muscle wasting and weakness being most prominent.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Univ Hlth Network, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Interdept Div Crit Care Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Publ Hlth Sci, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Anaesthesia, Toronto, ON, Canada; St Michaels Hosp, Dept Anesthesia & Crit Care Med, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Dept Med & Crit Care Med, Toronto, ON M5B 1W8, Canada; Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Anesthesia, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University Health Network Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; McMaster University; McMaster University	Herridge, MS (corresponding author), Toronto Gen Hosp, EN 10-212,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	margaret.herridge@uhn.on.ca	Slutsky, Arthur S/A-6013-2008; Slutsky, Arthur/M-3325-2019; Mehta, Sangeeta/C-4623-2015	Slutsky, Arthur S/0000-0002-6063-3876; Herridge, Margaret/0000-0002-2903-1631; Mazer, Cyril David/0000-0003-2566-4308; Cheung, Angela M./0000-0001-8332-0744	Canadian Institutes of Health Research [44917] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; ALBERTS WM, 1983, CHEST, V84, P272, DOI 10.1378/chest.84.3.272; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Anzueto A, 1999, CLIN CHEST MED, V20, P435, DOI 10.1016/S0272-5231(05)70151-9; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; CLEMENTS NC, 1993, CHEST, V104, P1526, DOI 10.1378/chest.104.5.1526; Cooper AB, 1999, CRIT CARE MED, V27, P2616, DOI 10.1097/00003246-199912000-00002; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; DOWNS JB, 1974, CHEST, V65, P92, DOI 10.1378/chest.65.1.92; ELLIOTT CG, 1987, AM REV RESPIR DIS, V135, P634; ELLIOTT CG, 1981, AM REV RESPIR DIS, V123, P492; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; GHIO AJ, 1989, AM REV RESPIR DIS, V140, P862; GHIO AJ, 1989, AM REV RESPIR DIS, V139, P1158, DOI 10.1164/ajrccm/139.5.1158; HALEVY A, 1984, RESPIR CARE, V29, P132; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hupcey J E, 2000, Am J Crit Care, V9, P192; Jacobs JWG, 1999, RHEUMATOLOGY, V38, P1145, DOI 10.1093/rheumatology/38.11.1145; Jones C, 2001, CRIT CARE MED, V29, P573, DOI 10.1097/00003246-200103000-00019; KLEIN JJ, 1976, CHEST, V69, P350, DOI 10.1378/chest.69.3.350; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; LAKSHMINARAYAN S, 1978, CHEST, V74, P489, DOI 10.1378/chest.74.5.489; LAKSHMINARAYAN S, 1976, AM REV RESPIR DIS, V113, P7; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MCHUGH LG, 1994, AM J RESP CRIT CARE, V150, P90, DOI 10.1164/ajrccm.150.1.8025779; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; MONTGOMERY AB, 1989, AM REV RESPIR DIS, V139, P1548, DOI 10.1164/ajrccm/139.6.1548; PETERS JI, 1989, AM REV RESPIR DIS, V139, P1163, DOI 10.1164/ajrccm/139.5.1163; Redelmeier DA, 1997, AM J RESP CRIT CARE, V155, P1278, DOI 10.1164/ajrccm.155.4.9105067; RICHARDSON JV, 1976, SOUTH MED J, V69, P735, DOI 10.1097/00007611-197606000-00022; RICHARDSON JV, 1976, SOUTH MED J, V69, P740; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; ROTMAN HH, 1977, CHEST, V72, P190, DOI 10.1378/chest.72.2.190; Schelling G, 2000, INTENS CARE MED, V26, P1304, DOI 10.1007/s001340051342; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; SHAW RA, 1981, ARCH INTERN MED, V141, P741, DOI 10.1001/archinte.141.6.741; SIMPSON DL, 1978, AM REV RESPIR DIS, V117, P449; Weinert CR, 1997, AM J RESP CRIT CARE, V156, P1120, DOI 10.1164/ajrccm.156.4.9611047; Weisman IM, 2001, CLIN CHEST MED, V22, P679, DOI 10.1016/S0272-5231(05)70060-5; YAHAV J, 1978, CHEST, V74, P247, DOI 10.1378/chest.74.3.247; YERNAULT JC, 1975, THORAX, V30, P252, DOI 10.1136/thx.30.3.252	45	1465	1535	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					683	693		10.1056/NEJMoa022450	http://dx.doi.org/10.1056/NEJMoa022450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594312				2022-12-28	WOS:000181014400003
J	Wik, L; Hansen, TB; Fylling, F; Steen, T; Vaagenes, P; Auestad, BH; Steen, PA				Wik, L; Hansen, TB; Fylling, F; Steen, T; Vaagenes, P; Auestad, BH; Steen, PA			Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREHOSPITAL CARDIAC-ARREST; IMMEDIATE COUNTERSHOCK; SURVIVAL; MODEL; QUALITY; LIFE; STATEMENT; THERAPY; SUCCESS; TIME	Context Defibrillation as soon as possible is standard treatment for patients with ventricular fibrillation. A nonrandomized study indicates that after a few minutes of ventricular fibrillation, delaying defibrillation to give cardiopulmonary resuscitation (CPR) first might improve the outcome. Objective To determine the effects of CPR before defibrillation on outcome in patients with ventricular fibrillation and with response times either up to or longer than 5 minutes. Design, Setting, and Patients Randomized trial of 200 patients with out-of-hospital ventricular fibrillation in Oslo, Norway, between June 1998 and May 2001. Patients received either standard care with immediate defibrillation (n = 96) or CPR first with 3 minutes of basic CPR by ambulance personnel prior to defibrillation (n = 104). If initial defibrillation was unsuccessful, the standard group received 1 minute of CPR, before additional defibrillation attempts compared with 3 minutes in the CPR first group. Main Outcome Measure Primary end point was survival to hospital discharge. Secondary end points were hospital admission with return of spontaneous circulation (ROSC), 1-year survival, and neurological outcome. A prespecified analysis examined subgroups with response times either up to or longer than 5 minutes. Results In the standard group, 14 (15%) of 96 patients survived to hospital discharge vs 23 (22%) of 104 in the CPR first group (P=.17). There were no differences in ROSC rates between the standard group (56% [58/104]) and the CPR first group (46% [44/96]; P=.16); or in 1-year survival (20% [21/104] and 15% [14/96], respectively ; P=.30). In subgroup analysis or patients with ambulance response times of either up to 5 minutes or shorter, there were no differences in any outcome variables between the CPR first group (n=40) and the standard group (n=41). For patients with response intervals of longer than 5 minutes, more patients achieved ROSC in the CPR first group (58% [37/64]) compared with the standard group (38% [21/55]; odds ratio [OR], 2.22; 95% confidence interval [CI], 1.06-4.63; P=.04); survival to hospital discharge (22% [14/64] vs 4% [2/55]; OR, 7.42; 95% CI, 1.61-34.3; P=.006); and 1-year survival (20% [13/64] vs 4% [2/55]; OR, 6.76; 95% CI, 1.42-31.4; P=.01). Thirty-three (89%) of 37 patients Who survived to hospital discharge had no or minor reductions in neurological status with no difference between the groups. Conclusions Compared with standard care for ventricular fibrillation, CPR first prior to defibrillation offered no advantage in improving outcomes for this entire study population or for patients with ambulance response times shorter than 5 minutes. However, the patients with ventricular fibrillation and ambulance response intervals longer than 5 minutes had better outcomes with CPR first before defibrillation was attempted. These results require confirmation in additional randomized trials.	Ullevaal Univ Hosp, Expt Med Res Inst, Div Surg, N-0407 Oslo, Norway; Norwegian Competence Ctr Emergency Med, Expt Med Res Inst, Oslo, Norway; Norwegian Def Res Estab, Div Protect & Mat, N-2007 Kjeller, Norway; Stavanger Univ Coll, Dept Technol & Nat Sci, Stavanger, Norway	University of Oslo; Norwegian Defence Research Establishment; Equinor; Universitetet i Stavanger	Wik, L (corresponding author), Ullevaal Univ Hosp, Expt Med Res Inst, Div Surg, N-0407 Oslo, Norway.							[Anonymous], 2000, Resuscitation, V46, P73; *AUT EXT DEF ACLS, 1991, AM J EMERG MED, V9, P91; Brown CG, 1996, ANN EMERG MED, V27, P184, DOI 10.1016/S0196-0644(96)70346-3; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; DYBVIK T, 1995, RESUSCITATION, V29, P89, DOI 10.1016/0300-9572(95)00850-S; Eftestol T, 2002, CIRCULATION, V105, P2270, DOI 10.1161/01.CIR.0000016362.42586.FE; Graves JR, 1997, RESUSCITATION, V35, P117; Holmberg M, 1998, RESUSCITATION, V36, P29, DOI 10.1016/S0300-9572(97)00089-0; Hsu JWY, 1996, ANN EMERG MED, V28, P597, DOI 10.1016/S0196-0644(96)70080-X; IDRIS AH, 1994, CIRCULATION, V90, P3063, DOI 10.1161/01.CIR.90.6.3063; KERN KB, 1990, RESUSCITATION, V20, P221, DOI 10.1016/0300-9572(90)90005-Y; Kloeck W, 1997, CIRCULATION, V95, P2180, DOI 10.1161/01.CIR.95.8.2180; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; MALDONADO FA, 1993, ANESTHESIOLOGY, V78, P343, DOI 10.1097/00000542-199302000-00019; Niemann JT, 2000, ANN EMERG MED, V36, P543, DOI 10.1067/mem.2000.109441; NIEMANN JT, 1992, CIRCULATION, V85, P281, DOI 10.1161/01.CIR.85.1.281; Robertson C, 1998, RESUSCITATION, V37, P81, DOI 10.1016/S0300-9572(98)00035-5; Robinson JS, 1998, EUR J ANAESTH, V15, P702, DOI 10.1097/00003643-199811000-00012; SAFAR P, 1988, BASIC ADV CARDIAC TR, P267; SAKLAYEN M, 1995, MEDICINE, V74, P163, DOI 10.1097/00005792-199507000-00001; STUEVEN HA, 1989, RESUSCITATION, V17, P251, DOI 10.1016/0300-9572(89)90041-5; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; Sunde K, 1999, RESUSCITATION, V41, P237, DOI 10.1016/S0300-9572(99)00059-3; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; WEAVER WD, 1986, ANN EMERG MED, V15, P1181; WEAVER WD, 1986, J AM COLL CARDIOL, V7, P752, DOI 10.1016/S0735-1097(86)80332-1; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; WIK L, 1994, RESUSCITATION, V28, P195, DOI 10.1016/0300-9572(94)90064-7; World Medical Association, 1964, DECL HELS; YAKAITIS RW, 1980, CRIT CARE MED, V8, P157, DOI 10.1097/00003246-198003000-00014	32	457	484	1	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1389	1395		10.1001/jama.289.11.1389	http://dx.doi.org/10.1001/jama.289.11.1389			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656PM	12636461	Bronze			2022-12-28	WOS:000181616200030
J	Ruta, V; Jiang, YX; Lee, A; Chen, JY; MacKinnon, R				Ruta, V; Jiang, YX; Lee, A; Chen, JY; MacKinnon, R			Functional analysis of an archaebacterial voltage-dependent K+ channel	NATURE			English	Article							SHAKER POTASSIUM CHANNELS; GATING MODIFIER; ION CHANNELS; WILD-TYPE; CHARYBDOTOXIN; ACTIVATION; PEPTIDE; INACTIVATION; HANATOXIN; SEQUENCE	All living organisms use ion channels to regulate the transport of ions across cellular membranes'. Certain ion channels are classed as voltage-dependent because they have a voltage-sensing structure that induces their pores to open in response to changes in the cell membrane voltage. Until recently, the voltage-dependent K+, Ca2+ and Na+ channels were regarded as a unique development of eukaryotic cells, adapted to accomplish specialized electrical signalling, as exemplified in neurons. Here we present the functional characterization of a voltage-dependent K+ (K-V) channel from a hyperthermophilic archaebacterium from an oceanic thermal vent. This channel possesses all the functional attributes of classical neuronal K-V channels. The conservation of function reflects structural conservation in the voltage sensor as revealed by specific, high-affinity interactions with tarantula venom toxins, which evolved to inhibit eukaryotic K-V channels.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Ruta, Vanessa/0000-0002-4963-2768				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	30	205	216	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					180	185		10.1038/nature01473	http://dx.doi.org/10.1038/nature01473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12629550				2022-12-28	WOS:000181488900049
J	Sali, A; Glaeser, R; Earnest, T; Baumeister, W				Sali, A; Glaeser, R; Earnest, T; Baumeister, W			From words to literature in structural proteomics	NATURE			English	Review							PROTEIN-PROTEIN INTERACTIONS; LARGE RIBOSOMAL-SUBUNIT; ALPHA-BETA-TUBULIN; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; ELECTRON CRYSTALLOGRAPHY; SACCHAROMYCES-CEREVISIAE; CRYOELECTRON MICROSCOPY; INTERACTION NETWORKS; STRUCTURE PREDICTION		Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Stanley Donner ASU, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Max Planck Society	Sali, A (corresponding author), Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA.	baumeist@biochem.mpg.de						Abbott A, 2002, NATURE, V417, P894, DOI 10.1038/417894a; Abola E, 2000, NAT STRUCT BIOL, V7, P973, DOI 10.1038/80754; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2002, TRENDS BIOCHEM SCI, V27, P633, DOI 10.1016/S0968-0004(02)02204-1; Aloy P, 2002, FEBS LETT, V530, P253, DOI 10.1016/S0014-5793(02)03427-0; Aloy P, 2002, EMBO REP, V3, P628, DOI 10.1093/embo-reports/kvf135; Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Baumeister W, 2000, TRENDS BIOCHEM SCI, V25, P624, DOI 10.1016/S0968-0004(00)01720-5; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Burley SK, 1999, NAT GENET, V23, P151, DOI 10.1038/13783; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Domingues FS, 2000, J MOL BIOL, V297, P1003, DOI 10.1006/jmbi.2000.3615; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Glaeser RM, 1999, J STRUCT BIOL, V128, P3, DOI 10.1006/jsbi.1999.4172; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Grimm R, 1998, BIOPHYS J, V74, P1031, DOI 10.1016/S0006-3495(98)74028-7; GRUNEWALD K, IN PRESS BIOPHYS CHE; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; JIN L, 1994, P NATL ACAD SCI USA, V91, P113, DOI 10.1073/pnas.91.1.113; Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Kumar A, 2002, NATURE, V415, P123, DOI 10.1038/415123a; Lappe M, 2001, Bioinformatics, V17 Suppl 1, pS149; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MALHOTRA A, 1990, P NATL ACAD SCI USA, V87, P1950, DOI 10.1073/pnas.87.5.1950; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Miras I, 2002, BIOCHEMISTRY-US, V41, P2115, DOI 10.1021/bi011854e; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Orengo CA, 2002, PROTEOMICS, V2, P11; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Pieper U, 2002, NUCLEIC ACIDS RES, V30, P255, DOI 10.1093/nar/30.1.255; Plitzko JM, 2002, TRENDS BIOTECHNOL, V20, pS40, DOI 10.1016/S0167-7799(02)02017-6; Rappsilber J, 2000, ANAL CHEM, V72, P267, DOI 10.1021/ac991081o; Rockel B, 2002, EMBO J, V21, P5979, DOI 10.1093/emboj/cdf601; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sali A, 1999, TRENDS CELL BIOL, V9, pM20, DOI 10.1016/S0962-8924(99)01685-2; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; SNELL G, IN PRESS J SYNCHROTR; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P233, DOI 10.1038/nsb0396-233; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; Volkmann N, 2002, J STRUCT BIOL, V138, P123, DOI 10.1016/S1047-8477(02)00009-6; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Westbrook J, 2002, NUCLEIC ACIDS RES, V30, P245, DOI 10.1093/nar/30.1.245; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang PJ, 2001, J STRUCT BIOL, V135, P251, DOI 10.1006/jsbi.2001.4404; Zhu YX, 2001, J STRUCT BIOL, V135, P302, DOI 10.1006/jsbi.2001.4415; 2000, NATURE STRUCT BIOL S, V7, P927	99	357	410	1	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					216	225		10.1038/nature01513	http://dx.doi.org/10.1038/nature01513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634795				2022-12-28	WOS:000181488900056
J	De Angelis, H; Skvarca, P				De Angelis, H; Skvarca, P			Glacier surge after ice shelf collapse	SCIENCE			English	Article							RETREAT; SHEET; ANTARCTICA	The possibility that the West Antarctic Ice Sheet will collapse as a consequence of ice shelf disintegration has been debated for many years. This matter is of concern because such an event would imply a sudden increase in sea level. Evidence is presented here showing drastic dynamic perturbations on former tributary glaciers that fed sections of the Larsen Ice Shelf on the Antarctic Peninsula before its collapse in 1995. Satellite images and airborne surveys allowed unambiguous identification of active surging phases of Boydell, Sjogren, Edgeworth, Bombardier, and Drygalski glaciers. This discovery calls for a reconsideration of former hypotheses about the stabilizing role of ice shelves.	Inst Antartico Argentino, Buenos Aires, DF, Argentina	Instituto Antartico Argentino	De Angelis, H (corresponding author), Inst Antartico Argentino, Cerrito 1248,C1010AAZ, Buenos Aires, DF, Argentina.		De Angelis, Hernán/E-1352-2012; De Angelis, Hernán/AAD-9020-2019	De Angelis, Hernán/0000-0002-8584-272X; De Angelis, Hernán/0000-0002-8584-272X				DOAKE CSM, 1975, NATURE, V257, P780, DOI 10.1038/257780a0; HERTERICH K, 1987, DYNAMICS W ANTARCTIC, P185; Hindmarsh RCA, 2001, J GLACIOL, V47, P271, DOI 10.3189/172756501781832269; HUGHES T, 1973, J GEOPHYS RES, V78, P7884, DOI 10.1029/JC078i033p07884; Huybrechts P., 1990, ANN GLACIOL, V14, P115; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Patterson W.S.B, 1994, PHYS GLACIERS, Vthird, P496; Posts A., 1999, GLACIER ICE; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Rott H, 2002, ANN GLACIOL-SER, V34, P277, DOI 10.3189/172756402781817716; Rott H, 1996, SCIENCE, V271, P788, DOI 10.1126/science.271.5250.788; Skvarca P, 1999, POLAR RES, V18, P151, DOI 10.1111/j.1751-8369.1999.tb00287.x; Thomas R., 1979, J GLACIOL, V24, P167, DOI DOI 10.3189/S0022143000014726; VAUGHAN DG, 1996, NATURE, V379, P6563; VAUGHAN DG, 1992, CONTRIBUTION ANTARCT, P35; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	17	287	290	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1560	1562		10.1126/science.1077987	http://dx.doi.org/10.1126/science.1077987			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624263				2022-12-28	WOS:000181367900033
J	Fan, ZS; Beresford, PJ; Oh, DY; Zhang, D; Lieberman, J				Fan, ZS; Beresford, PJ; Oh, DY; Zhang, D; Lieberman, J			Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor	CELL			English	Article							DIPHOSPHATE KINASE; HISTONE ACETYLATION; CELL-DEATH; FRAGMENTATION; REPAIR; CLEAVAGE; TARGET; TRANSCRIPTION; NUCLEASE; GENE	Granzyme A (GzmA) induces a caspase-independent cell death pathway characterized by single-stranded DNA nicks and other features of apoptosis. A GzmA-activated DNase (GAAD) is in an ER associated complex containing pp32 and the GzmA substrates SET, HMG-2, and Ape1. We show that GAAD is NM23-H1, a nucleoside diphosphate kinase implicated in suppression of tumor metastasis, and its specific inhibitor (IGAAD) is SET. NM23-H1 binds to SET and is released from inhibition by GzmA cleavage of SET. After GzmA loading or CTL attack, SET and NM23-H1 translocate to the nucleus and SET is degraded, allowing NM23-H1 to nick chromosomal DNA. GzmA-treated cells with silenced NM23-H1 expression are resistant to GzmA-mediated DNA damage and cytolysis, while cells over-expressing NM23-H1 are more sensitive.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015	ZHANG, DONG/0000-0002-1068-8334	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045587, R56AI045587] Funding Source: NIH RePORTER; NIAID NIH HHS [AI45587] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1997, P NATL ACAD SCI USA, V94, P9285, DOI 10.1073/pnas.94.17.9285; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Gaiddon C, 1999, EMBO J, V18, P5609, DOI 10.1093/emboj/18.20.5609; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; IZUMIYA H, 1995, J BIOL CHEM, V270, P27859, DOI 10.1074/jbc.270.46.27859; Jans DA, 1999, J BIOL CHEM, V274, P3953, DOI 10.1074/jbc.274.7.3953; KOKILEVA L, 1994, INT ARCH ALLERGY IMM, V105, P339, DOI 10.1159/000236779; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Krystosek A, 1999, HISTOCHEM CELL BIOL, V111, P265, DOI 10.1007/s004180050357; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; LAGARKOVA MA, 1995, J BIOL CHEM, V270, P20239, DOI 10.1074/jbc.270.35.20239; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P213; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Ma DQ, 2002, J BIOL CHEM, V277, P1560, DOI 10.1074/jbc.M108359200; Monteiro ANA, 2000, TRENDS BIOCHEM SCI, V25, P469, DOI 10.1016/S0968-0004(00)01632-7; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; Postel EH, 2002, BIOCHEMISTRY-US, V41, P6330, DOI 10.1021/bi025606+; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Postel EH, 1999, J BIOL CHEM, V274, P22821, DOI 10.1074/jbc.274.32.22821; Postel EH, 1996, P NATL ACAD SCI USA, V93, P6892, DOI 10.1073/pnas.93.14.6892; Postel EH, 2000, P NATL ACAD SCI USA, V97, P14194, DOI 10.1073/pnas.97.26.14194; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sarin A, 1997, IMMUNITY, V6, P209, DOI 10.1016/S1074-7613(00)80427-6; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099; Thomas DA, 2000, IMMUNITY, V12, P621, DOI 10.1016/S1074-7613(00)80213-7; Toh SY, 1998, BIOCHEM BIOPH RES CO, V250, P598, DOI 10.1006/bbrc.1998.9369; WEAVER VM, 1993, BIOCHEM CELL BIOL, V71, P488, DOI 10.1139/o93-071; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Zhang D, 2001, P NATL ACAD SCI USA, V98, P5746, DOI 10.1073/pnas.101329598; Zhang D, 2001, J BIOL CHEM, V276, P3683, DOI 10.1074/jbc.M005390200	50	435	470	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					659	672		10.1016/S0092-8674(03)00150-8	http://dx.doi.org/10.1016/S0092-8674(03)00150-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628186	Bronze			2022-12-28	WOS:000181443600009
J	Schulz, M; Moshammer, R; Fischer, D; Kollmus, H; Madison, DH; Jones, S; Ullrich, J				Schulz, M; Moshammer, R; Fischer, D; Kollmus, H; Madison, DH; Jones, S; Ullrich, J			Three-dimensional imaging of atomic four-body processes	NATURE			English	Article							ELECTRON-IMPACT IONIZATION; DISTORTED WAVES; CROSS-SECTIONS; E,2E; COLLISIONS; HELIUM; STATE	To understand the physical processes that occur in nature we need to obtain a solid concept about the 'fundamental' forces acting between pairs of elementary particles. It is also necessary to describe the temporal and spatial evolution of many mutually interacting particles under the influence of these forces. This latter step, known as the few-body problem, remains an important unsolved problem in physics. Experiments involving atomic collisions represent a useful testing ground for studying the few-body problem. For the single ionization of a helium atom by charged particle impact, kinematically complete experiments have been performed(1-6) since 1969 (ref. 7). The theoretical analysis of such experiments was thought to yield a complete picture of the basic features of the collision process, at least for large collision energies(8-14). These conclusions are, however, almost exclusively based on studies of restricted electron-emission geometries(1-3). Here, we report three-dimensional images of the complete electron emission pattern for the single ionization of helium by the impact of C6+ ions of energy 100 MeV per a.m.u. (a four-body system) and observe features that have not been predicted by any published theoretical model. We propose a higher-order ionization mechanism, involving the interaction between the projectile and the target nucleus, to explain these features.	Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; Univ Missouri, Dept Phys, Rolla, MO 65409 USA; Univ Missouri, Lab Atom Mol & Opt Res, Rolla, MO 65409 USA	Max Planck Society; University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology	Schulz, M (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.		Fischer, Daniel/I-5573-2014	Fischer, Daniel/0000-0003-3870-9843				BELKIC D, 1978, J PHYS B-AT MOL OPT, V11, P3529, DOI 10.1088/0022-3700/11/20/015; BRAY I, 1992, PHYS REV LETT, V69, P53, DOI 10.1103/PhysRevLett.69.53; Crothers DSF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.053201; CROTHERS DSF, 1983, J PHYS B-AT MOL OPT, V16, P3229, DOI 10.1088/0022-3700/16/17/015; EHRHARDT H, 1986, Z PHYS D ATOM MOL CL, V1, P3, DOI 10.1007/BF01384654; EHRHARDT H, 1969, PHYS REV LETT, V22, P82; Jones S, 1998, PHYS REV LETT, V81, P2886, DOI 10.1103/PhysRevLett.81.2886; LAHMAMBENNANI A, 1991, J PHYS B-AT MOL OPT, V24, P2401, DOI 10.1088/0953-4075/24/10/001; MADISON D, 2002, J PHYS B ATOM MOL PH, V15, P3297; Marchalant PJ, 1998, J PHYS B-AT MOL OPT, V31, P1141, DOI 10.1088/0953-4075/31/6/005; MURRAY AJ, 1992, J PHYS B-AT MOL OPT, V25, P3021, DOI 10.1088/0953-4075/25/13/011; Rescigno TN, 1999, SCIENCE, V286, P2474, DOI 10.1126/science.286.5449.2474; Roder J, 1996, J PHYS B-AT MOL OPT, V29, P2103, DOI 10.1088/0953-4075/29/10/018; Schulz M, 2001, J PHYS B-AT MOL OPT, V34, pL305, DOI 10.1088/0953-4075/34/9/104; STEFANI G, 1990, J PHYS B-AT MOL OPT, V23, pL227, DOI 10.1088/0953-4075/23/11/007; Ullrich J, 1997, J PHYS B-AT MOL OPT, V30, P2917, DOI 10.1088/0953-4075/30/13/006; WHELAN CT, 1993, MATH PHYSICAL SCI C, V414, P1	17	264	270	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					48	50		10.1038/nature01415	http://dx.doi.org/10.1038/nature01415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621427	Green Submitted			2022-12-28	WOS:000181343100031
J	Cohen, JJ				Cohen, JJ			The consequences of premature abandonment of affirmative action in medical school admissions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The US Supreme Court recently accepted on appeal 2 cases from the University of Michigan regarding the constitutionality of race-conscious decision making in higher education admissions. The consequences of the Court's decision will directly affect the future of medicine in the United States. Medical schools have a societal obligation to select and educate the physician workforce of the future. To outlaw the use of affirmative action in the admissions process would cripple the profession's ability to achieve racial and ethnic diversity. Preserving this diversity in medical school admissions programs is important for 4 major reasons: (1) adequate representation among students and faculty of the-diversity in US society is indispensable for quality medical education; (2) increasing the diversity of the physician workforce will improve access to health care for underserved populations; (3) increasing the diversity of the research workforce can accelerate advances in medical and public health research; and (4) diversity among managers of health care organizations makes good business sense. This article explores these reasons in detail, reviews the history and effectiveness of affirmative action in medical school admissions programs, and explains why alternatives to affirmative action are unworkable.	Assoc Amer Med Coll, Washington, DC 20037 USA	Association of American Medical Colleges	Cohen, JJ (corresponding author), Assoc Amer Med Coll, 2450 N St NW, Washington, DC 20037 USA.							*ASS AM MED COLL, 1993, MIN STUD MED ED FACT, V7; Cantor JC, 1996, INQUIRY-J HEALTH CAR, V33, P167; CLEGG R, 1998, WASHINGTON TIME 0603, pA18; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; HERIOT G, 2001, NEXUS, V6, P163; Huff KL, 1999, ACAD MED, V74, P454, DOI 10.1097/00001888-199904000-00047; Jencks C., 1998, BLACK WHITE TEST SCO; KEITH SN, 1985, NEW ENGL J MED, V313, P1519, DOI 10.1056/NEJM198512123132406; KINGTON R, 2001, RIGHT THING DO SMART, V64, P68; KOENIG J, 2002, MCAT MONOGRAPH, V8; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; NICKENS HW, 1994, NEW ENGL J MED, V331, P472, DOI 10.1056/NEJM199408183310712; ORFIELD G, 2001, CHILLING ADM AFFIRMA, P1; Perez TE, 2001, RIGHT THING TO DO, THE SMART THING TO DO, P91; Rudenstine N. L., 2001, DIVERSITY CHALLENGED, P31; SHELBY S, 1990, CONTENT OUR CHARACTE, P120; SHUSHOK F, 2001, PECENTAGE PLANS COLL; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; *US COMM CIV RIGHT, 2002, PERC PALNS CHALL EQ; WIGHTMAN L. F., 1997, NEW YORK U LAW REV, V72, P1	20	104	104	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1143	1149		10.1001/jama.289.9.1143	http://dx.doi.org/10.1001/jama.289.9.1143			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650XM	12622585				2022-12-28	WOS:000181289400031
J	Etheredge, J; Uhlig, P				Etheredge, J; Uhlig, P			Incremental approaches to increasing health care coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPANDING COVERAGE		Texas A&M Univ, Hlth Sci Ctr, College Stn, TX 77843 USA; Dartmouth Coll Sch Med, Hanover, NH USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Dartmouth College	Etheredge, J (corresponding author), Texas A&M Univ, Hlth Sci Ctr, College Stn, TX 77843 USA.							Bilheimer LT, 2001, HEALTH AFFAIR, V20, P83, DOI 10.1377/hlthaff.20.1.83; Blake CH, 2001, J HEALTH POLIT POLIC, V26, P679, DOI 10.1215/03616878-26-4-679; Davis K, 2001, J URBAN HEALTH, V78, P46, DOI 10.1093/jurban/78.1.46; Feder J, 2001, HEALTH AFFAIR, V20, P27, DOI 10.1377/hlthaff.20.1.27; Glied S, 2002, MILBANK Q, V80, P603, DOI 10.1111/1468-0009.00026; Pauly M, 2001, HEALTH AFFAIR, V20, P9, DOI 10.1377/hlthaff.20.1.9; Pauly M.V., 2002, PUBLIC FINANC REV, V30, P349, DOI [10.1177/109114210203000502, DOI 10.1177/109114210203000502]; Young Donald, 2002, Mod Healthc, V32, P20; 2002, LANCET, V359, P1871	9	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1166	1166		10.1001/jama.289.9.1166	http://dx.doi.org/10.1001/jama.289.9.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650XM	12622593				2022-12-28	WOS:000181289400038
J	Jaques, D				Jaques, D			ABC of learning and teaching in medicine - Teaching small groups	BMJ-BRITISH MEDICAL JOURNAL			English	Review																		Brookfield S.D., 2012, DISCUSSION WAY TEACH; FORSTER F, 1995, TUTORING DEMONSTRATI; HABESHAW T, 1992, 53 INTERESTING THING; Jaques D, 2000, LEARNING GROUPS; TIBERIUS RG, 1999, SMALL GROUP TEACHING	5	86	87	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2003	326	7387					492	494		10.1136/bmj.326.7387.492	http://dx.doi.org/10.1136/bmj.326.7387.492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609949	Green Published			2022-12-28	WOS:000181421400025
J	Murray, CJL; Lauer, JA; Hutubessy, RCW; Niessen, L; Tomijima, N; Rodgers, A; Lawes, CMM; Evans, DB				Murray, CJL; Lauer, JA; Hutubessy, RCW; Niessen, L; Tomijima, N; Rodgers, A; Lawes, CMM; Evans, DB			Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk	LANCET			English	Article							CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL; PREVENTION; HYPERTENSION; GUIDELINES; MORBIDITY; SMOKING; STROKE; SALT	Background Cardiovascular disease accounts for much morbidity and mortality in developed countries and is becoming increasingly important in less developed regions. Systolic blood pressure above 115 mm Hg accounts for two-thirds of strokes and almost half of ischaemic heart disease cases, and cholesterol concentrations exceeding 3.8 mmol/L for 18% and 55%, respectively. We report estimates of the population health effects, and costs of selected interventions to reduce the risks associated with high cholesterol concentrations and blood pressure in areas of the world with differing epidemiological profiles. Methods Effect sizes were derived from systematic reviews or meta-analyses, and the effect on health outcomes projected over time for populations with differing age, sex, and epidemiological profiles. Incidence data from estimates of burden of disease were used in a four-state longitudinal population model to calculate disability-adjusted life years (DALYs) averted and patients treated. Costs were taken from previous publications, or estimated by local experts, in 14 regions. Findings Non-personal health interventions, including government action to stimulate a reduction in the salt content of processed foods, are cost-effective ways to limit cardiovascular disease and could avert over 21 million DALYs per year worldwide. Combination treatment for people whose risk of a cardiovascular event over the next 10 years is above 35% is also cost effective leading to substantial additional health benefits by averting an additional 63 million DALYs per year worldwide. Interpretation The combination of personal and non-personal health interventions evaluated here could lower the global incidence of cardiovascular events by as much as 50%.	WHO, Evidence & Informat Policy, Geneva 27, Switzerland; Univ Med Ctr Rotterdam, Erasmus MC, Inst Med Technol Assessment, Rotterdam, Netherlands; Univ Med Ctr Rotterdam, Erasmus MC, Inst Hlth Policy Management, Rotterdam, Netherlands; Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand	World Health Organization; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Auckland	Evans, DB (corresponding author), WHO, Evidence & Informat Policy, Geneva 27, Switzerland.	Evansd@who.int	Niessen, Louis/F-6254-2015	Niessen, Louis/0000-0002-8639-5191; Rodgers, Anthony/0000-0003-1282-1896; Lauer, Jeremy A/0000-0003-0652-0691				ADAM T, IN PRESS ECONOMETRIC; ADAM T, IN PRESS INT J TECHN; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; *AS PAC COH STUD C, IN PRESS J HYPERTENS; Baltussen R, 2002, GEN COST EFFECTIVENE; Baltussen RMPM, 2002, INT J TECHNOL ASSESS, V18, P112; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cooper RS, 1998, BMJ-BRIT MED J, V316, P614, DOI 10.1136/bmj.316.7131.614; Ebrahim S, 2001, INT J EPIDEMIOL, V30, P201, DOI 10.1093/ije/30.2.201; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Fortmann SP, 2000, AM J EPIDEMIOL, V152, P316, DOI 10.1093/aje/152.4.316; Gold MR, 1996, COST EFFECTIVENESS H; Haynes RB, 1996, LANCET, V348, P383; Hooper L, 2002, BMJ-BRIT MED J, V325, P628, DOI 10.1136/bmj.325.7365.628; Hutubessy Raymond C, 2002, Appl Health Econ Health Policy, V1, P89; Hutubessy RCW, 2001, HEALTH ECON, V10, P473, DOI 10.1002/hec.614; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Jamison D.T., 1993, DIS CONTROL PRIORITI; Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149; JOHNS B, IN PRESS PROGRAMME C; Lambert J.D., 1991, NUMERICAL METHODS OR; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; LAW MR, IN PRESS BMJ; LAWES C, IN PRESS COMP QUANTI; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Marmot M, 2001, J EPIDEMIOL COMMUN H, V55, P301, DOI 10.1136/jech.55.5.301; Marshall T, 2002, BMJ-BRIT MED J, V325, P197, DOI 10.1136/bmj.325.7357.197; Martin I, 1999, CLIN EXP HYPERTENS, V21, P659, DOI 10.3109/10641969909060997; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Neal B, 2000, LANCET, V356, P1955; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; *PROGRESS COLL GRO, IN PRESS ARCH INTERN; Puska P, 1996, CARDIOVASC RISK FACT, V6, P203; Qizilbash N, 1995, LANCET, V346, P1647; Richard F, 2001, NEUROLOGY, V56, P1593, DOI 10.1212/WNL.56.11.1593; Rodgers A, 1998, LANCET, V352, P1801; Rodgers A, 1999, LANCET, V353, P1332, DOI 10.1016/S0140-6736(99)01198-8; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; Sellers DE, 1997, SOC SCI MED, V44, P1325, DOI 10.1016/S0277-9536(96)00263-8; Vartiainen E, 1999, PREV MED, V29, pS124, DOI 10.1006/pmed.1999.0403; WHO, 2002, RED RISKS PROM HLTH; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; World Health Organization, 2002, IN CAR CHRON COND BU	47	399	405	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					717	725		10.1016/S0140-6736(03)12655-4	http://dx.doi.org/10.1016/S0140-6736(03)12655-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620735				2022-12-28	WOS:000181232000006
J	Olesen, AW; Basso, O				Olesen, AW; Basso, O			Risk of recurrence of prolonged pregnancy	BRITISH MEDICAL JOURNAL			English	Article							POSTTERM		Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University	Olesen, AW (corresponding author), Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark.		Basso, Olga/E-5384-2010	Basso, Olga/0000-0001-9298-4921; Olesen, Annette Wind/0000-0002-0586-4815				Campbell MK, 1997, OBSTET GYNECOL, V89, P543; Mackie J., 1974, CEMENT UNIVERSE STUD; Olsen J, 1997, EPIDEMIOLOGY, V8, P6, DOI 10.1097/00001648-199701000-00001; Shea KM, 1998, EPIDEMIOLOGY, V9, P199, DOI 10.1097/00001648-199803000-00017; Stornes I, 1996, Ugeskr Laeger, V158, P422	5	33	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					476	476		10.1136/bmj.326.7387.476	http://dx.doi.org/10.1136/bmj.326.7387.476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609943	Bronze, Green Published			2022-12-28	WOS:000181421400017
J	Song, F; Altman, DG; Glenny, AM; Deeks, JJ				Song, F; Altman, DG; Glenny, AM; Deeks, JJ			Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRIALS; PLACEBO	Objective To determine the validity of adjusted indirect comparisons by using data from published meta-analyses of randomised trials. Design Direct comparison of different interventions in randomised trials and adjusted indirect comparison in which two interventions were compared through their relative effect versus a common comparator. ne discrepancy between the direct and adjusted indirect comparison was measured by the difference between the two estimates. Data sources Database of abstracts of reviews of effectiveness (1994-8), the Cochrane database of systematic reviews, Medline, and references of retrieved articles. Results 44 published meta-analyses (from 28 systematic reviews) provided sufficient data. In most cases, results of adjusted indirect comparisons were not significantly different from those of direct comparisons. A significant discrepancy (P < 0.05) was observed in three of the 44 comparisons between the direct and the adjusted indirect estimates. There was a moderate agreement between the statistical conclusions from the direct and adjusted indirect comparisons (kappa 0.51). The direction of discrepancy between the two estimates was inconsistent. Conclusions Adjusted indirect comparisons usually but not always agree with the results of head to head randomised trials. When there is no or insufficient direct evidence from randomised trials, the adjusted indirect comparison may provide useful or supplementary information on the relative efficacy of competing interventions. The validity of the adjusted indirect comparisons depends on the internal validity and similarity of the included trials.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Inst Hlth Sci, Ctr Stat Med, Oxford OX3 7LF, England; Univ Dent Hosp Manchester, Cochrane Oral Hlth Grp, Manchester M15 6FH, Lancs, England	University of Birmingham; University of Oxford; University of Manchester	Song, F (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	f.song@bham.ac.uk	Song, Fujian/B-3516-2013; Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971; Glenny, Anne-Marie/0000-0003-4037-2899				Abel U, 1999, J CLIN EPIDEMIOL, V52, P487; Altman D.G., 1991, PRACTICAL STAT MED R; Black N, 1996, BRIT MED J, V312, P1215; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fisher LD, 2001, AM HEART J, V141, P26, DOI 10.1067/mhj.2001.111262; Hasselblad V, 2001, DRUG INF J, V35, P435, DOI 10.1177/009286150103500212; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; McAlister FA, 1999, JAMA-J AM MED ASSOC, V282, P1371, DOI 10.1001/jama.282.14.1371; Pocock S, 1996, CLIN TRIALS PRACTICA; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Song FJ, 2000, CONTROL CLIN TRIALS, V21, P488, DOI 10.1016/S0197-2456(00)00055-6	14	682	700	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2003	326	7387					472	475		10.1136/bmj.326.7387.472	http://dx.doi.org/10.1136/bmj.326.7387.472			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609941	Green Published, Bronze			2022-12-28	WOS:000181421400015
J	Hekimi, S; Guarente, L				Hekimi, S; Guarente, L			Genetics and the specificity of the aging process	SCIENCE			English	Review							CAENORHABDITIS-ELEGANS; LIFE-SPAN; OXIDATIVE DAMAGE; C-ELEGANS; SACCHAROMYCES-CEREVISIAE; CLK-1 MUTANTS; FREE-RADICALS; PROTEIN SIR2; COENZYME-Q; LONGEVITY	The identification and study of long-lived mutant animals has provided valuable insights into the mechanisms that limit the life-span of organisms. Findings with the gene SIR2 suggest that the rate of aging can be regulated under certain conditions. Indeed, increased expression of SIR2 lengthens life-span by acting on biological processes that promote survival under conditions of scarcity. In addition, studies of mutant strains of Caenorhabditis elegans, in particular daf-2, clk-1, and isp-1 mutants, suggest that the biology of reactive oxygen species in the mitochondria and elsewhere might be the main determinant of life-span in this organism. Thus, the aging process may be more specific than previously anticipated on evolutionary grounds.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; MIT, Dept Biol, Cambridge, MA 02139 USA	McGill University; Massachusetts Institute of Technology (MIT)	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Gimenez, Luis E Diaz/D-9291-2011					BABLOR BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P34; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Borges F, 2002, CURR MED CHEM, V9, P195, DOI 10.2174/0929867023371229; Braeckman BP, 2002, MECH AGEING DEV, V123, P1447, DOI 10.1016/S0047-6374(02)00085-4; Braeckman BP, 1999, CURR BIOL, V9, P493, DOI 10.1016/S0960-9822(99)80216-4; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; BURGESS J, UNPUB; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; D'Angelo S, 2001, FREE RADICAL BIO MED, V31, P1, DOI 10.1016/S0891-5849(01)00518-4; Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5; DAVENPORT RJ, 2003, SCI SAGE KE     0226; Davydov DR, 2001, TRENDS BIOCHEM SCI, V26, P155, DOI 10.1016/S0968-0004(00)01749-7; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; FEIG DI, 1994, CANCER RES, V54, pS1890; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Flanagan SW, 1998, FEBS LETT, V431, P285, DOI 10.1016/S0014-5793(98)00779-0; Garigan D, 2002, GENETICS, V161, P1101; Guarente L, 2003, AGELESS QUEST; Hekimi S, 2001, TRENDS GENET, V17, P712, DOI 10.1016/S0168-9525(01)02523-9; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hihi AK, 2002, J BIOL CHEM, V277, P2202, DOI 10.1074/jbc.M109034200; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOPKIN K, 2003, SCI SAGE KE     0226; HOSOKAWA H, 1994, MECH AGEING DEV, V74, P161, DOI 10.1016/0047-6374(94)90087-6; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; LEE SS, 2002, NAT GENET, V25, P25; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MASORO EJ, 2003, SCI SAGE KE     0226; Miyadera H, 2002, FEBS LETT, V512, P33, DOI 10.1016/S0014-5793(02)02282-2; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; MORTIMER RK, 1959, NATURE, V183, P1742; Murakami S, 1996, GENETICS, V143, P1207; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Riddle DL, 1997, C ELEGANS, P739; RINE J, 1987, GENETICS, V116, P9; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3; TUMA R, 2001, SCI SAGE KE     1003; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887; WEINDRUCH R, 1988, RETARDATION AGING DI; WONG A, 1995, GENETICS, V139, P1247; C ELEGANS SIR2 1 SCI; S CEREVISIAE SIR2 SC	70	341	376	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1351	1354		10.1126/science.1082358	http://dx.doi.org/10.1126/science.1082358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610295				2022-12-28	WOS:000181192300040
J	Theise, ND; Krause, DS; Sharkis, S				Theise, ND; Krause, DS; Sharkis, S			Comment on "Little evidence for developmental plasticity of adult hematopoietic stem cells"	SCIENCE			English	Editorial Material									Beth Israel Med Ctr, Dept Med, Div Digest Dis, New York, NY 10003 USA; Beth Israel Med Ctr, Dept Pathol, Div Digest Dis, New York, NY 10003 USA; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Yale University; Johns Hopkins University; Johns Hopkins Medicine	Theise, ND (corresponding author), Beth Israel Med Ctr, Dept Med, Div Digest Dis, 1st Ave & 16th St, New York, NY 10003 USA.							Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Ogawa M, 2002, EXP HEMATOL, V30, P3, DOI 10.1016/S0301-472X(01)00770-6; THEISE ND, UNPUB; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807	5	74	76	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1317A	1317A		10.1126/science.1078412	http://dx.doi.org/10.1126/science.1078412			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610282				2022-12-28	WOS:000181192300025
J	Johnson, DDP; Stopka, P; Knights, S				Johnson, DDP; Stopka, P; Knights, S			Sociology - The puzzle of human cooperation	NATURE			English	Editorial Material							PUNISHMENT; EVOLUTION		Harvard Univ, Olin Inst Strateg Studies, Cambridge, MA 02138 USA; Charles Univ Prague, Dept Zool, CR-12844 Prague 2, Czech Republic; Univ Oxford, Dept Econ, Oxford OX1 3QU, England	Harvard University; Charles University Prague; University of Oxford	Johnson, DDP (corresponding author), Harvard Univ, Olin Inst Strateg Studies, Cambridge, MA 02138 USA.	dominic@post.harvard.edu	Johnson, Dominic/C-6948-2009; Stopka, Pavel/A-6193-2008	Stopka, Pavel/0000-0002-1104-1655; Gaechter, Simon/0000-0002-7182-8505				Alexander R., 1987, BIOL MORAL SYSTEMS; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Sober E., 1998, OTHERS EVOLUTION PSY; Sosis R, 2000, CROSS-CULT RES, V34, P70, DOI 10.1177/106939710003400105; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	10	91	92	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					911	912		10.1038/421912a	http://dx.doi.org/10.1038/421912a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649BK	12606989	Bronze			2022-12-28	WOS:000181186900038
J	Marcellin, P; Chang, T; Lim, SG; Tong, MJ; Sievert, W; Shiffman, ML; Jeffers, L; Goodman, Z; Wulfsohn, MS; Xiong, S; Fry, J; Brosgart, CL; Afdhal, N; O'Conner, C; Andreone, P; Cursaro, C; Angus, P; Vaughan, R; Bain, V; Gutfreund, K; Barange, K; Duffant, M; Barnes, E; Bennett, M; Pressman, J; Bernstein, D; Bonino, F; Coco, B; Borum, M; Schuck, S; Bourliere, M; Benali, S; Boyer, N; Castelnau, C; Brown, R; Scales, S; Buggisch, P; Peterson, J; Cooksley, G; MacDonald, G; Couzigou, P; Foucner, D; Crawford, D; Der, A; Desmond, P; Boussioutas, A; DiBisceglie, A; Bacon, B; Dieterich, D; Goldman, D; Dusheiko, G; Enriquez, J; Gallego, A; Esposito, S; Lemieszewski, J; Esteban, R; Buti, M; Faust, T; Wherity, K; Francavilla, A; Malcangi, F; Fried, M; Nakayama, C; Gilson, R; Lascar, M; Gish, R; Trinh, H; Gordon, S; Colar, S; Gregor, M; Kaiser, S; Heathcote, J; Imagawa, D; Jacobson, I; Rooney, J; James, C; Fallis, R; Jain, A; Chen, S; Ma, J; Hsing, A; Nonaka-Wong, S; Kraus, M; Jen, CM; Kaita, K; Koval, G; Parrish, H; Kowdley, K; Kronborg, I; Nicoll, A; Kullavanijaya, P; Amonrattanakosol, J; Lao-Tan, J; Garcia, L; Liaw, YF; Chien, RN; Lok, A; Richtmyer, P; Luengrojanakul, P; Tanwandee, T; Manns, M; Schueler, A; Martin, P; Peacock, V; McCaughan, G; Strasser, S; McHutchison, J; Pockros, P; Merican, I; Lachmanan, S; Mohamed, R; Naccarato, R; Fagiuoli, S; Nelson, M; Higgs, C; Pastore, G; Perrillo, R; Denham, C; Pol, S; Fontaine, H; Riely, C; Litley, D; Rizzetto, M; Lagget, M; Rodriguez, M; Espiga, M; Rustgi, V; Lee, P; Sacks, S; Farley, J; Samuel, D; Feray, C; Sasadeusz, J; Gioupouki, M; Shaw, D; Le Mire, M; Shelton, D; Sherman, M; Bartolucci, A; Schiff, E; Siebert, A; Sollano, J; Dy, F; Thuluvath, P; Tong, L; Trepo, C; Maynard, M; Trinchet, JC; Carrie, N; Vetter, D; Metzger, S; Vierling, J; Clarke-Platt, J; Wakil, E; Bzowej, N; Warnes, T; Wright, T; Kwong, A; Young, YY; Zarski, JP; Leroy, V				Marcellin, P; Chang, T; Lim, SG; Tong, MJ; Sievert, W; Shiffman, ML; Jeffers, L; Goodman, Z; Wulfsohn, MS; Xiong, S; Fry, J; Brosgart, CL; Afdhal, N; O'Conner, C; Andreone, P; Cursaro, C; Angus, P; Vaughan, R; Bain, V; Gutfreund, K; Barange, K; Duffant, M; Barnes, E; Bennett, M; Pressman, J; Bernstein, D; Bonino, F; Coco, B; Borum, M; Schuck, S; Bourliere, M; Benali, S; Boyer, N; Castelnau, C; Brown, R; Scales, S; Buggisch, P; Peterson, J; Cooksley, G; MacDonald, G; Couzigou, P; Foucner, D; Crawford, D; Der, A; Desmond, P; Boussioutas, A; DiBisceglie, A; Bacon, B; Dieterich, D; Goldman, D; Dusheiko, G; Enriquez, J; Gallego, A; Esposito, S; Lemieszewski, J; Esteban, R; Buti, M; Faust, T; Wherity, K; Francavilla, A; Malcangi, F; Fried, M; Nakayama, C; Gilson, R; Lascar, M; Gish, R; Trinh, H; Gordon, S; Colar, S; Gregor, M; Kaiser, S; Heathcote, J; Imagawa, D; Jacobson, I; Rooney, J; James, C; Fallis, R; Jain, A; Chen, S; Ma, J; Hsing, A; Nonaka-Wong, S; Kraus, M; Jen, CM; Kaita, K; Koval, G; Parrish, H; Kowdley, K; Kronborg, I; Nicoll, A; Kullavanijaya, P; Amonrattanakosol, J; Lao-Tan, J; Garcia, L; Liaw, YF; Chien, RN; Lok, A; Richtmyer, P; Luengrojanakul, P; Tanwandee, T; Manns, M; Schueler, A; Martin, P; Peacock, V; McCaughan, G; Strasser, S; McHutchison, J; Pockros, P; Merican, I; Lachmanan, S; Mohamed, R; Naccarato, R; Fagiuoli, S; Nelson, M; Higgs, C; Pastore, G; Perrillo, R; Denham, C; Pol, S; Fontaine, H; Riely, C; Litley, D; Rizzetto, M; Lagget, M; Rodriguez, M; Espiga, M; Rustgi, V; Lee, P; Sacks, S; Farley, J; Samuel, D; Feray, C; Sasadeusz, J; Gioupouki, M; Shaw, D; Le Mire, M; Shelton, D; Sherman, M; Bartolucci, A; Schiff, E; Siebert, A; Sollano, J; Dy, F; Thuluvath, P; Tong, L; Trepo, C; Maynard, M; Trinchet, JC; Carrie, N; Vetter, D; Metzger, S; Vierling, J; Clarke-Platt, J; Wakil, E; Bzowej, N; Warnes, T; Wright, T; Kwong, A; Young, YY; Zarski, JP; Leroy, V		Adefovir Dipivoxil 437 Study Grp; Royal Free Viral Hepatitis Grp	Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LAMIVUDINE THERAPY; VIRUS	BACKGROUND In preclinical and phase 2 studies, adefovir dipivoxil demonstrated potent activity against hepatitis B virus (HBV), including lamivudine-resistant strains. METHODS We randomly assigned 515 patients with chronic hepatitis B who were positive for hepatitis B e antigen (HBeAg) to receive 10 mg of adefovir dipivoxil (172 patients), 30 mg of adefovir dipivoxil (173), or placebo (170) daily for 48 weeks. The primary end point was histologic improvement in the 10-mg group as compared with the placebo group. RESULTS After 48 weeks of treatment, significantly more patients who received 10 mg or 30 mg of adefovir dipivoxil per day than who received placebo had histologic improvement (53 percent [P<0.001], 59 percent [P<0.001], and 25 percent, respectively), a reduction in serum HBV DNA levels (by a median of 3.52 [P<0.001], 4.76 [P<0.001], and 0.55 log copies per milliliter, respectively), undetectable levels (fewer than 400 copies per milliliter) of serum HBV DNA (21 percent [P<0.001], 39 percent [P<0.001], and 0 percent, respectively), normalization of alanine aminotransferase levels (48 percent [P<0.001], 55 percent [P<0.001], and 16 percent, respectively), and HBeAg seroconversion (12 percent [P=0.049], 14 percent [P=0.01], and 6 percent, respectively). No adefovir-associated resistance mutations were identified in the HBV DNA polymerase gene. The safety profile of the 10-mg dose of adefovir dipivoxil was similar to that of placebo; however, there was a higher frequency of adverse events and renal laboratory abnormalities in the group given 30 mg of adefovir dipivoxil per day. CONCLUSIONS In patients with HBeAg-positive chronic hepatitis B, 48 weeks of 10 mg or 30 mg of adefovir dipivoxil per day resulted in histologic liver improvement, reduced serum HBV DNA and alanine aminotransferase levels, and increased the rates of HBeAg seroconversion. The 10-mg dose has a favorable risk-benefit profile for long-term treatment. No adefovir-associated resistance mutations were identified in the HBV DNA polymerase gene.	Hop Beaujon, INSERM, U481, Serv Hepatol, 100 Blvd gen Leclerc, F-92110 Clichy, France; Hop Beaujon, Ctr Rech Claude Bernard Hepatites Virales, F-92110 Clichy, France; Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; Natl Univ Singapore Hosp, Div Gastroenterol, Singapore 117548, Singapore; Huntington Med Res Inst, Ctr Liver, Pasadena, CA USA; Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; Monash Med Ctr, Melbourne, Vic, Australia; Virginia Commonwealth Univ Hlth Syst, Div Gastroenterol, Richmond, VA USA; Univ Miami, Sch Med, Ctr Liver Dis, Miami, FL USA; Miami Vet Affairs Med Ctr, Miami, FL USA; Armed Forces Inst Pathol, Washington, DC 20306 USA; Gilead Sci Inc, Foster City, CA 94404 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Policlin S Orsola, Bologna, Italy; Austin & Repatriat Med Ctr, Melbourne, Vic, Australia; Univ Alberta, Edmonton, AB, Canada; Hop Purpan, Toulouse, France; Royal Free Hosp, London, England; Med Assoc Res Grp, San Diego, CA USA; North Shore Univ Hosp, Manhasset, NY USA; Azienda Osped Pisana, Pisa, Italy; George Washington Univ, Med Ctr, Washington, DC 20037 USA; Hop St Joseph, Marseilles, France; Hop Beaujon, Clichy, France; Columbia Presbyterian Med Ctr, New York, NY 10032 USA; Univ Krankenhaus Eppendorf, Hamburg, Germany; Royal Brisbane Hosp, Brisbane, Qld, Australia; Hop Haut Leveque, Pessac, France; Princess Alexandra Hosp, Brisbane, Qld, Australia; Monash Med Ctr, Melbourne, Vic, Australia; St Vincents Hosp, Melbourne, Vic, Australia; St Louis Univ, Med Ctr, St Louis, MO USA; Liberty Med Grp, New York, NY USA; NYU, Sch Med, New York, NY USA; Hosp Santa Creu & Sant Pau, Barcelona, Spain; Hepatobiliary Associates New York, Bayside, NY USA; Hosp Valle De Hebron, Barcelona, Spain; Univ Chicago Hosp, Med Ctr, Chicago, IL 60637 USA; Azienda Osped Consorziale Policlin, Bari, Italy; Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; UCL, Med Ctr, London, England; Calif Pacific Med Ctr, San Francisco, CA USA; William Beaumont Hosp, Royal Oak, MI 48072 USA; Eberhard Karl Univ, Tubingen, Germany; Toronto Western Hosp, Toronto, ON, Canada; Univ Calif Irvine, Irvine, CA USA; Cornell Univ, Sch Med, New York, NY 10021 USA; Gilead Sci, Foster City, CA USA; Natl Cheng Kung Univ Hosp, Tainan, Taiwan; Univ Manitoba, Hlth Sci Ctr, Winnipeg, MB, Canada; West Hills Gastroenterol Associates, Portland, OR USA; Univ Washington, Hepatol Ctr, Seattle, WA 98195 USA; Western Hosp, Melbourne, Vic, Australia; Chulalongkorn Univ Hosp, Bangkok, Thailand; Cebu Doctors Hosp, Cebu, Philippines; Chang Gung Mem Hosp, Taipei, Taiwan; Univ Michigan, Med Ctr, Ann Arbor, MI USA; Siriraj Hosp, Bangkok, Thailand; Hannover Med Sch, Hannover, Germany; UCLA Med Ctr, Los Angeles, CA USA; Royal Prince Alfred Hosp, Sydney, NSW, Australia; Scripps Clin, La Jolla, CA 92037 USA; Hosp Kuala Lumpur, Kuala Lumpur, Malaysia; Univ Malaya, Kuala Lumpur, Malaysia; Azienda Osped Padova, Padua, Italy; Chelsea & Westminster Hosp, London, England; Azienda Osped Consorziale, Bari, Italy; Alton Ochsner Med Clin, New Orleans, LA USA; Hop Necker Enfants Malad, Paris, France; Univ Tennessee, Med Grp, Memphis, TN USA; Azienda Osped San Giovanni Battista, Turin, Italy; Hosp Cent Asturias, Oviedo, Spain; Metro Clin Trials, Fairfax, VA USA; Viridae Clin Sci, Vancouver, BC, Canada; Hop Paul Brousse, Villejuif, France; Royal Melbourne Hosp, Melbourne, Vic, Australia; Royal Adelaide Hosp, Adelaide, SA, Australia; Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; Toronto Gen Hosp, Toronto, ON, Canada; Univ Miami, Miami, FL USA; Santo Tomas Univ Hosp, Manila, Philippines; Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; Huntington Med Res Inst, Pasadena, CA USA; Hop Hotel Dieu, Lyon, France; Hop Jean Verdier, Bondy, France; Hospices Civils Strasbourg, Strasbourg, France; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Sutter Inst Med Res, Sacramento, CA USA; Manchester Royal Infirm, Manchester, Lancs, England; San Francisco VA Med Ctr, San Francisco, CA USA; Natl Univ Singapore Hosp, Singapore, Singapore; Hop Albert Michallon, CHU Grenoble, Grenoble, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; National Cheng Kung University; National Cheng Kung University Hospital; National University of Singapore; Huntington Medical Research Institutes; Monash University; Monash University; Virginia Commonwealth University; University of Miami; United States Department of Defense; Gilead Sciences; Harvard University; Beth Israel Deaconess Medical Center; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Alberta; CHU de Toulouse; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Northwell Health; North Shore University Hospital; University of Pisa; Azienda Ospedaliero Universitaria Pisana; George Washington University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Columbia University; NewYork-Presbyterian Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Royal Brisbane & Women's Hospital; CHU Bordeaux; Monash University; St Vincent's Hospital Melbourne; Saint Louis University; New York University; Hospital of Santa Creu i Sant Pau; Hospital Universitari Vall d'Hebron; University of Chicago; University of Illinois System; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of London; University College London; California Pacific Medical Center; Beaumont Health; Eberhard Karls University of Tubingen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California Irvine; Cornell University; Gilead Sciences; National Cheng Kung University; National Cheng Kung University Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Washington; University of Washington Seattle; Western Hospital; Chulalongkorn University; Cebu Doctors University; Chang Gung Memorial Hospital; University of Michigan System; University of Michigan; Mahidol University; Hannover Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Sydney; Scripps Research Institute; Universiti Malaya; University of Padua; Azienda Ospedaliera - Universita di Padova; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Tennessee System; University of Tennessee Health Science Center; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Central University Hospital Asturias; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Royal Melbourne Hospital; Royal Adelaide Hospital; Hunter Holmes McGuire Veterinary Affairs Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Miami; University of Santo Tomas; Johns Hopkins University; Johns Hopkins Medicine; Huntington Medical Research Institutes; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cedars Sinai Medical Center; University of Manchester; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; National University of Singapore; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Marcellin, P (corresponding author), Hop Beaujon, INSERM, U481, Serv Hepatol, 100 Blvd gen Leclerc, F-92110 Clichy, France.	marcellin@bichat.inserm.fr	Esposito, Susanna/AAA-8275-2022; Andreone, Pietro/K-8050-2016; Kowdley, Kris/AAF-5202-2019; Tanwandee, Tawesak/AAR-6459-2020; LIM, Seng Gee/AAD-9040-2020; Crawford, Darrell HG/F-2157-2010	Andreone, Pietro/0000-0002-4794-9809; LIM, Seng Gee/0000-0003-0994-4932; 				Benhamou Y, 2001, LANCET, V358, P718, DOI 10.1016/S0140-6736(01)05840-8; Chien RN, 1999, HEPATOLOGY, V30, P770, DOI 10.1002/hep.510300313; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Heathcote EJ, 1998, HEPATOLOGY, V28, p317A; Kim JW, 2001, CLIN INFECT DIS, V33, P403, DOI 10.1086/321879; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; LEUNG NW, 2001, HEPATOLOGY, V34, pA348; National Cancer Institute, 1999, COMM TOX CRIT VERS 2; Schiff ER, 2001, HEPATOLOGY, V34, p446A; *WHO, 2000, WHO204; Yang HL, 2002, HEPATOLOGY, V36, P464, DOI 10.1053/jhep.2002.34740	12	1026	1131	0	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					808	816		10.1056/NEJMoa020681	http://dx.doi.org/10.1056/NEJMoa020681			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606735	Green Published			2022-12-28	WOS:000181173300007
J	Moreno, MA				Moreno, MA			The cross-cover resident	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					956	957		10.1001/jama.289.8.956	http://dx.doi.org/10.1001/jama.289.8.956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597732				2022-12-28	WOS:000181129800001
J	Sehgal, AR				Sehgal, AR			Impact of quality improvement efforts on race and sex disparities in hemodialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALBUMIN CONCENTRATION; ETHNIC DISPARITIES; OF-LIFE; HEALTH; PREDICTORS; CARE; INEQUALITY; MORTALITY; SURVIVAL; DIALYSIS	Context By improving the process of care, quality improvement efforts have the potential to reduce race and sex disparities. However, little is known about whether reductions actually occur. National quality improvement activities targeting hemodialysis patients provide an opportunity to examine this issue. Objective To determine the effect of quality improvement efforts on race and sex disparities among hemodialysis patients. Design, Setting, and Subjects Longitudinal study of 58700 randomly selected hemodialysis patients from throughout the United States in 1993 through 2000. Intervention Medicare-funded quality improvement project involving monitoring of patient outcomes, feedback of performance data, and education of clinicians at dialysis centers. Main Outcome Measures Changes in hemodialysis dose (Kt/V), anemia management (hemoglobin level), and nutritional status (albumin level). Results The proportion of all patients with an adequate hemodialysis dose increased 2-fold. In 1993, 46% of white patients and 36% of black patients received an adequate hemodialysis dose compared with 2000 when the proportions were 87% and 84%, respectively. Thus, the gap between white and black patients decreased from 10% to 3% (P<.001). The gap between female and male patients decreased from 23% to 9% over the same period (P=.008). The proportion of all patients with adequate hemoglobin levels increased 3-fold. The proportion of all patients with adequate albumin levels remained unchanged. Race and sex disparities in anemia management and nutritional status did not change significantly. Conclusions Quality improvement efforts have a variable impact on race and sex disparities in health outcomes. Further work is needed to determine how quality improvement methods can be targeted to reduce health disparities.	Case Western Reserve Univ, Metrohlth Med Ctr, Div Nephrol, 2500 Metrohlth Dr, Cleveland, OH 44109 USA; Case Western Reserve Univ, Metrohlth Med Ctr, Ctr Hlth Care Res & Policy, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Biomed Eth, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Sehgal, AR (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr, Div Nephrol, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	axs81@po.cwru.edu			NIDDK NIH HHS [DK54178, DK51472] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051472, P50DK054178] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; [Anonymous], 1997, Am J Kidney Dis, V30, pS15; [Anonymous], 1997, Am J Kidney Dis, V30, pS192; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Bierman A S, 2001, J Am Med Womens Assoc (1972), V56, P155; COLLINS AJ, 1994, AM J KIDNEY DIS, V23, P272, DOI 10.1016/S0272-6386(12)80984-X; Cooper LA, 2002, J GEN INTERN MED, V17, P477, DOI 10.1046/j.1525-1497.2002.10633.x; EVANS RW, 1990, JAMA-J AM MED ASSOC, V263, P825; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Hakim RM, 2001, HDB DIALYSIS, V3rd, P236; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; *HLTH CAR FIN ADM, 1994, ANN REP END STAG REN; IGLEHART JK, 1993, NEW ENGL J MED, V328, P366, DOI 10.1056/NEJM199302043280528; Kaysen GA, 1997, AM J KIDNEY DIS, V29, P658, DOI 10.1016/S0272-6386(97)90117-7; KEPPEL KG, 2002, HLTH PEOPLE 2000 STA, V23, P1; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; Leon JB, 2001, AM J NEPHROL, V21, P200, DOI 10.1159/000046248; Leon JB, 2001, J RENAL NUTR, V11, P9, DOI 10.1016/S1051-2276(01)79890-1; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; McClellan WM, 1999, AM J KIDNEY DIS, V34, P1075, DOI 10.1016/S0272-6386(99)70013-2; McClellan WM, 1998, AM J KIDNEY DIS, V31, P584, DOI 10.1053/ajkd.1998.v31.pm9531173; *NAT KIDN FDN, 2000, AM J KIDNEY DIS S, V35, pS1, DOI DOI 10.1053/KD.2000.6671; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; SCHOENBACH VJ, 2002, AM PUBL HLTH ASS ANN; Sehgal A R, 1998, J Ren Nutr, V8, P179, DOI 10.1016/S1051-2276(98)90016-4; Sehgal AR, 2002, JAMA-J AM MED ASSOC, V287, P1961, DOI 10.1001/jama.287.15.1961; Sehgal AR, 2001, AM J KIDNEY DIS, V37, P1223, DOI 10.1053/ajkd.2001.24526; Smith JL, 2001, MED CARE, V39, P910, DOI 10.1097/00005650-200109000-00002; Stamler R, 1987, HYPERTENSION, V9, P641; *US DEPT HHS, 1998, 1998 ANN REP END STA; *US DEPT HHS, 1996, 1995 ANN REP END STA; *US DEPT HHS, 1999, 1999 ANN REP END STA; *US DEPT HHS, 1997, 1997 ANN REP END STA; *US DEPT HHS, 2000, 2000 ANN REP END STA; *US DEPT HHS, 1997, 1996 ANN REP END STA; *US DHHS, 2001, 2001 ANN REP END STA; *USRDS, 2002, 2002 ANN DAT REP; Williams DR, 2000, HEALTH CARE FINANC R, V21, P75	40	143	145	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					996	1000		10.1001/jama.289.8.996	http://dx.doi.org/10.1001/jama.289.8.996			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597751	Bronze			2022-12-28	WOS:000181129800025
J	Sporer, KA				Sporer, KA			Strategies for preventing heroin overdose	BMJ-BRITISH MEDICAL JOURNAL			English	Article							METHADONE-MAINTENANCE TREATMENT; TAKE-HOME NALOXONE; NONFATAL OVERDOSE; OPIATE OVERDOSE; OPIOID OVERDOSE; USERS; AUSTRALIA; DEATHS; MORTALITY; RISK	Making naloxone available in addicts' homes is one of several official or unofficial ways that are being tried out to reduce the rising toll of fatalities from heroin overdose.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sporer, KA (corresponding author), San Francisco Gen Hosp, Emergency Serv, San Francisco, CA 94110 USA.	ksporer@itsa.ucsf.edu						Abbasi K, 1998, BRIT MED J, V316, P331; Bammer G, 2000, AUST NZ J PUBL HEAL, V24, P214, DOI 10.1111/j.1467-842X.2000.tb00147.x; Bigg D, 2002, BRIT MED J, V324, P678, DOI 10.1136/bmj.324.7338.678; Burris S., 2001, INT J DRUG POLICY, V12, P237, DOI [10.1016/S0955-3959(01)00080-9, DOI 10.1016/S0955-3959(01)00080-9]; Caplehorn JRM, 1996, SUBST USE MISUSE, V31, P177, DOI 10.3109/10826089609045806; CHAMBERLAIN JM, 1994, AM J EMERG MED, V12, P650, DOI 10.1016/0735-6757(94)90033-7; Christenson J, 2000, ACAD EMERG MED, V7, P1110, DOI 10.1111/j.1553-2712.2000.tb01260.x; CUSHMAN P, 1977, AM J DRUG ALCOHOL AB, V4, P543, DOI 10.3109/00952997709007010; Darke S, 1997, ADDICTION, V92, P1195; Darke S, 1996, ADDICTION, V91, P413, DOI 10.1046/j.1360-0443.1996.91341310.x; Darke S, 2002, ADDICTION, V97, P977, DOI 10.1046/j.1360-0443.2002.00148.x; Darke S, 1996, ADDICTION, V91, P405, DOI 10.1111/j.1360-0443.1996.tb02289.x; DAVOLI M, 1993, INT J EPIDEMIOL, V22, P273, DOI 10.1093/ije/22.2.273; Dettmer K, 2001, BRIT MED J, V322, P895, DOI 10.1136/bmj.322.7291.895; Fry C, 2000, ADDICTION, V95, P1865; GEARING FR, 1974, AM J EPIDEMIOL, V100, P101, DOI 10.1093/oxfordjournals.aje.a112012; Gerostamoulos J, 2001, DRUG ALCOHOL DEPEN, V61, P123, DOI 10.1016/S0376-8716(00)00128-9; GRONBLADH L, 1990, ACTA PSYCHIAT SCAND, V82, P223, DOI 10.1111/j.1600-0447.1990.tb03057.x; GUNNE LM, 1981, DRUG ALCOHOL DEPEN, V7, P249, DOI 10.1016/0376-8716(81)90096-X; Hall W, 2000, LANCET, V356, P7, DOI 10.1016/S0140-6736(00)02423-5; Hall WD, 1996, MED J AUSTRALIA, V164, P197, DOI 10.5694/j.1326-5377.1996.tb94132.x; Hall WD, 1999, MED J AUSTRALIA, V171, P34, DOI 10.5694/j.1326-5377.1999.tb123495.x; Lenton SR, 2000, MED J AUSTRALIA, V173, P260, DOI 10.5694/j.1326-5377.2000.tb125633.x; Ling W, 2002, J SUBST ABUSE TREAT, V23, P87, DOI 10.1016/S0740-5472(02)00257-X; McGregor C, 1998, ADDICTION, V93, P701, DOI 10.1046/j.1360-0443.1998.9357016.x; Osterwalder JJ, 1996, J TOXICOL-CLIN TOXIC, V34, P409, DOI 10.3109/15563659609013811; OXMAN G, 2000, MMWR-MORBID MORTAL W, V49, P633; POSER W, 1995, BMJ-BRIT MED J, V310, P463, DOI 10.1136/bmj.310.6977.463a; Seal KH, 2001, AM J PUBLIC HEALTH, V91, P1842, DOI 10.2105/AJPH.91.11.1842; Simini B, 1998, LANCET, V352, P967, DOI 10.1016/S0140-6736(05)61528-0; SOLET D, 2000, MMWR-MORBID MORTAL W, V49, P636; Sporer KA, 1996, ACAD EMERG MED, V3, P660, DOI 10.1111/j.1553-2712.1996.tb03487.x; Sporer KA, 1999, ANN INTERN MED, V130, P584, DOI 10.7326/0003-4819-130-7-199904060-00019; Strang J, 1996, BRIT MED J, V312, P1435, DOI 10.1136/bmj.312.7044.1435; Strang J, 1999, ADDICTION, V94, P199, DOI 10.1046/j.1360-0443.1999.9421993.x; Tagliaro F, 1998, LANCET, V351, P1923, DOI 10.1016/S0140-6736(97)10101-5; Wanger K, 1998, ACAD EMERG MED, V5, P293, DOI 10.1111/j.1553-2712.1998.tb02707.x; White JM, 1999, ADDICTION, V94, P961, DOI 10.1046/j.1360-0443.1999.9479612.x; Yamey G, 2000, BRIT MED J, V320, P667; Zador D, 1996, MED J AUSTRALIA, V164, P204, DOI 10.5694/j.1326-5377.1996.tb94136.x	40	88	91	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					442	444		10.1136/bmj.326.7386.442	http://dx.doi.org/10.1136/bmj.326.7386.442			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	651KA	12595388	Green Submitted, Green Published			2022-12-28	WOS:000181318000027
J	Catteruccia, F; Godfray, HCJ; Crisanti, A				Catteruccia, F; Godfray, HCJ; Crisanti, A			Impact of genetic manipulation on the fitness of Anopheles stephensi mosquitoes	SCIENCE			English	Article							GERMLINE TRANSFORMATION; MALARIA; VECTOR	Genetic modification of mosquitoes offers exciting possibilities for controlling malaria, but success will depend on how transformation affects the fitness of modified insects. The expression of an exogenous gene, the mutations caused by its insertion, and inbreeding while transformed lines are established can all lead to reductions in fitness. Factors influencing fitness were investigated in cage experiments with four lines of transgenic Anopheles stephensi, a vector species of human malaria. The results indicate direct costs of the introduced transgene in at least three out of the four lines, as well as an apparent cost of the inbreeding involved in making transgenic homozygotes.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Perugia, I-06100 Perugia, Italy	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Perugia	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, SAF Bldg,S Kensington Campus, London SW7 2AZ, England.	acrs@ic.ac.uk		Catteruccia, Flaminia/0000-0003-3295-6683; Crisanti, Andrea/0000-0002-2406-4426	Biotechnology and Biological Sciences Research Council [S19551] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alphey L, 2002, MOL BIOCHEM PARASIT, V121, P173, DOI 10.1016/S0166-6851(02)00040-3; Arca B, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P483; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Nolan T, 2002, J BIOL CHEM, V277, P8759, DOI 10.1074/jbc.C100766200; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117	14	156	165	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1225	1227		10.1126/science.1081453	http://dx.doi.org/10.1126/science.1081453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595691				2022-12-28	WOS:000181065500038
J	Bates, SH; Stearns, WH; Dundon, TA; Schubert, M; Tso, AWK; Wang, YP; Banks, AS; Lavery, HJ; Haq, AK; Maratos-Flier, E; Neel, BG; Schwartz, MW; Myers, MG				Bates, SH; Stearns, WH; Dundon, TA; Schubert, M; Tso, AWK; Wang, YP; Banks, AS; Lavery, HJ; Haq, AK; Maratos-Flier, E; Neel, BG; Schwartz, MW; Myers, MG			STAT3 signalling is required for leptin regulation of energy balance but not reproduction	NATURE			English	Article							HYPOTHALAMIC NEURONS; CYTOKINE RECEPTORS; NEUROPEPTIDE-Y; POMC NEURONS; FEMALE MICE; EARLY-ONSET; OB-R; ACTIVATION; OBESITY; MOUSE	Secretion of leptin from adipocytes communicates body energy status to the brain by activating the leptin receptor long form (LRb). LRb regulates energy homeostasis and neuroendocrine function; the absence of LRb in db/db mice results in obesity, impaired growth, infertility and diabetes(1-4). Tyr 1138 of LRb mediates activation of the transcription factor STAT3 during leptin action(5-8). To investigate the contribution of STAT3 signalling to leptin action in vivo, we replaced the gene encoding the leptin receptor (lepr) in mice with an allele coding for a replacement of Tyr 1138 in LRb with a serine residue (lepr(S1138)) that specifically disrupts the LRb-STAT3 signal. Here we show that, like db/db mice, lepr(S1138) homozygotes (s/s) are hyperphagic and obese. However, whereas db/db mice are infertile, short and diabetic, s/s mice are fertile, long and less hyperglycaemic. Furthermore, hypothalamic expression of neuropeptide Y (NPY) is elevated in db/db mice but not s/s mice, whereas the hypothalamic melanocortin system is suppressed in both db/db and s/s mice. LRb-STAT3 signalling thus mediates the effects of leptin on melanocortin production and body energy homeostasis, whereas distinct LRb signals regulate NPY and the control of fertility, growth and glucose homeostasis.	Beth Israel Deaconess Med Ctr, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98122 USA	Harvard University; Beth Israel Deaconess Medical Center; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harborview Medical Center; University of Washington; University of Washington Seattle	Myers, MG (corresponding author), Beth Israel Deaconess Med Ctr, Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.		Schwartz, Michael W/H-9950-2012; Banks, Alexander/B-4832-2012; Schubert, Markus/F-5150-2010	Banks, Alexander/0000-0003-1787-6925; 				Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; CATZEFLIS C, 1993, ENDOCRINOLOGY, V132, P224, DOI 10.1210/en.132.1.224; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chehab FF, 1997, SCIENCE, V275, P88, DOI 10.1126/science.275.5296.88; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Malik NM, 2001, ENDOCRINOLOGY, V142, P5198, DOI 10.1210/en.142.12.5198; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; White DW, 1997, J BIOL CHEM, V272, P4065, DOI 10.1074/jbc.272.7.4065	25	763	794	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					856	859		10.1038/nature01388	http://dx.doi.org/10.1038/nature01388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594516				2022-12-28	WOS:000181044700051
J	Genty, D; Blamart, D; Ouahdi, R; Gilmour, M; Baker, A; Jouzel, J; Van-Exter, S				Genty, D; Blamart, D; Ouahdi, R; Gilmour, M; Baker, A; Jouzel, J; Van-Exter, S			Precise dating of Dansgaard-Oeschger climate oscillations in western Europe from stalagmite data	NATURE			English	Article							LAST GLACIAL PERIOD; GREENLAND ICE-CORE; OXYGEN-ISOTOPE; SPELEOTHEMS; CAVE; RECORDS; PAST; TEMPERATURE; INSTABILITY; ANTARCTICA	The signature of Dansgaard-Oeschger events-millennial-scale abrupt climate oscillations during the last glacial period-is well established in ice cores and marine records(1-3). But the effects of such events in continental settings are not as clear, and their absolute chronology is uncertain beyond the limit of C-14 dating and annual layer counting for marine records and ice cores, respectively. Here we present carbon and oxygen isotope records from a stalagmite collected in southwest France which have been precisely dated using U-234/Th-230 ratios. We find rapid climate oscillations coincident with the established Dansgaard-Oeschger events between 83,000 and 32,000 years ago in both isotope records. The oxygen isotope signature is similar to a record from Soreq cave, Israel(4), and deep-sea records(5,6), indicating the large spatial scale of the climate oscillations. The signal in the carbon isotopes gives evidence of drastic and rapid vegetation changes in western Europe, an important site in human cultural evolution. We also find evidence for a long phase of extremely cold climate in southwest France between 61.2 6 +/- 0.6 and 67.4 +/- 0.9 kyr ago.	CEA, CNRS, UMR 1572, IPSL Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Open Univ, Dept Earth Sci, Uranium Series Facil, Milton Keynes MK7 6AA, Bucks, England; Univ Newcastle Upon Tyne, Ctr Land Use & Water Resouces Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Montpellier 2, Lab Hydrosci, CNRS,UMR 5569, IRD, F-34095 Montpellier 5, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Open University - UK; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Genty, D (corresponding author), CEA, CNRS, UMR 1572, IPSL Lab Sci Climat & Environm, Bat 709,Lorme Merisiers CEA Saclay, F-91191 Gif Sur Yvette, France.		Baker, Andy/O-5362-2019	Baker, Andy/0000-0002-1552-6166				Allen JRM, 1999, NATURE, V400, P740, DOI 10.1038/23432; BAKER A, 1993, NATURE, V364, P518, DOI 10.1038/364518a0; Bar-Matthews M, 2000, CHEM GEOL, V169, P145, DOI 10.1016/S0009-2541(99)00232-6; Beck JW, 2001, SCIENCE, V292, P2453, DOI 10.1126/science.1056649; BENDER M, 1994, NATURE, V372, P663, DOI 10.1038/372663a0; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Cayre O, 1999, PALEOCEANOGRAPHY, V14, P384, DOI 10.1029/1998PA900027; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Dennis PF, 2001, GEOCHIM COSMOCHIM AC, V65, P871, DOI 10.1016/S0016-7037(00)00576-7; Dorale JA, 1998, SCIENCE, V282, P1871, DOI 10.1126/science.282.5395.1871; Genty D, 1996, J SEDIMENT RES, V66, P275; Genty D, 2001, GEOCHIM COSMOCHIM AC, V65, P3443, DOI 10.1016/S0016-7037(01)00697-4; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; GUIOT J, 1993, PALAEOGEOGR PALAEOCL, V103, P73, DOI 10.1016/0031-0182(93)90053-L; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; JOHNSEN SJ, 1992, NATURE, V359, P311, DOI 10.1038/359311a0; Johnsen SJ, 2001, J QUATERNARY SCI, V16, P299, DOI 10.1002/jqs.622; Labeyrie L, 2000, SCIENCE, V290, P1905, DOI 10.1126/science.290.5498.1905; Lang C, 1999, SCIENCE, V286, P934, DOI 10.1126/science.286.5441.934; Mook W.G., 1980, HDB ENV ISOTOPE GEOC, P49, DOI DOI 10.1016/B978-0-444-41780-0.50008-0; ONEIL JR, 1969, J CHEM PHYS, V51, P5547, DOI 10.1063/1.1671982; ROZANSKI K, 1985, CHEM GEOL, V52, P349, DOI 10.1016/0168-9622(85)90045-4; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Stringer C, 2001, NATURE, V413, P791, DOI 10.1038/35101688; Urbanc J., 1985, ACTA CARSOLOGICA, V13, P99; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Yiou F, 1997, J GEOPHYS RES-OCEANS, V102, P26783, DOI 10.1029/97JC01265	30	457	502	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					833	837		10.1038/nature01391	http://dx.doi.org/10.1038/nature01391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594510				2022-12-28	WOS:000181044700045
J	Kuritzkes, DR; Currier, J				Kuritzkes, DR; Currier, J			Cardiovascular risk factors and antiretroviral therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Div Infect Dis, Sect Retroviral Therapeut, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Aids, Boston, MA USA; Univ Calif Los Angeles, Ctr Clin AIDS Res & Educ, Div Infect Dis, Los Angeles, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles	Kuritzkes, DR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, Sect Retroviral Therapeut, 75 Francis St, Boston, MA 02115 USA.								0	16	19	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					679	680		10.1056/NEJMp020182	http://dx.doi.org/10.1056/NEJMp020182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594310				2022-12-28	WOS:000181014400001
J	Cho, HS; Mason, K; Ramyar, KX; Stanley, AM; Gabelli, SB; Denney, DW; Leahy, DJ				Cho, HS; Mason, K; Ramyar, KX; Stanley, AM; Gabelli, SB; Denney, DW; Leahy, DJ			Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab	NATURE			English	Article							ERBB SIGNALING NETWORK; BREAST-CANCER; TRASTUZUMAB HERCEPTIN; MOLECULAR REPLACEMENT; MONOCLONAL-ANTIBODY; RECEPTORS; ONCOGENE; PROGRAM; DOMAIN; CELLS	HER2 (also known as Neu, ErbB2) is a member of the epidermal growth factor receptor (EGFR; also known as ErbB) family of receptor tyrosine kinases, which in humans includes HER1 (EGFR, ERBB1), HER2, HER3 (ERBB3) and HER4 (ERBB4)(1). ErbB receptors are essential mediators of cell proliferation and differentiation in the developing embryo and in adult tissues(2), and their inappropriate activation is associated with the development and severity of many cancers(3). Overexpression of HER2 is found in 20-30% of human breast cancers, and correlates with more aggressive tumours and a poorer prognosis(4). Anticancer therapies targeting ErbB receptors have shown promise, and a monoclonal antibody against HER2, Herceptin (also known as trastuzumab), is currently in use as a treatment for breast cancer(5). Here we report crystal structures of the entire extracellular regions of rat HER2 at 2.4 Angstrom and human HER2 complexed with the Herceptin antigen-binding fragment (Fab) at 2.5 Angstrom. These structures reveal a fixed conformation for HER2 that resembles a ligand-activated state, and show HER2 poised to interact with other ErbB receptors in the absence of direct ligand binding. Herceptin binds to the juxtamembrane region of HER2, identifying this site as a target for anticancer therapies.	Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Genitope Corp, Redwood City, CA 94063 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.		Gabelli, Sandra B/A-3705-2008; Mieszkowska, Magdalena/O-6753-2017	Gabelli, Sandra B/0000-0003-1205-5204; 				Banfield MJ, 1997, PROTEINS, V29, P161, DOI 10.1002/(SICI)1097-0134(199710)29:2<161::AID-PROT4>3.0.CO;2-G; Berezov A, 2002, J BIOL CHEM, V277, P28330, DOI 10.1074/jbc.M202880200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke CL, 1997, ONCOGENE, V14, P687, DOI 10.1038/sj.onc.1200873; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; DENNEY DW, 1998, Patent No. 5776746; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; FERGUSON KM, IN PRESS MOL CELL; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; Molina MA, 2001, CANCER RES, V61, P4744; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Tang CK, 1998, HORMONES SIGNALING, P113; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	30	1122	1292	6	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					756	760		10.1038/nature01392	http://dx.doi.org/10.1038/nature01392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610629				2022-12-28	WOS:000180938000047
J	Cua, DJ; Sherlock, J; Chen, Y; Murphy, CA; Joyce, B; Seymour, B; Lucian, L; To, W; Kwan, S; Churakova, T; Zurawski, S; Wiekowski, M; Lira, SA; Gorman, D; Kastelein, RA; Sedgwick, JD				Cua, DJ; Sherlock, J; Chen, Y; Murphy, CA; Joyce, B; Seymour, B; Lucian, L; To, W; Kwan, S; Churakova, T; Zurawski, S; Wiekowski, M; Lira, SA; Gorman, D; Kastelein, RA; Sedgwick, JD			Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; IFN-GAMMA; ENCEPHALOMYELITIS; EXPRESSION; DISEASE; IL-12; MICE; ANTIBODIES; RESPONSES; IL-23	Interleukin-12 (IL-12) is a heterodimeric molecule composed of p35 and p40 subunits. Analyses in vitro have defined IL-12 as an important factor for the differentiation of naive T cells into T-helper type 1 CD4(+) lymphocytes secreting interferon-gamma (refs 1, 2). Similarly, numerous studies(3-7) have concluded that IL-12 is essential for T-cell-dependent immune and inflammatory responses in vivo, primarily through the use of IL-12 p40 gene-targeted mice and neutralizing antibodies against p40. The cytokine IL-23, which comprises the p40 subunit of IL-12 but a different p19 subunit(8), is produced predominantly by macrophages and dendritic cells, and shows activity on memory T cells. Evidence from studies of IL-23 receptor expression(9) and IL-23 overexpression in transgenic mice(10) suggest, however, that IL-23 may also affect macrophage function directly. Here we show, by using gene-targeted mice lacking only IL-23 and cytokine replacement studies, that the perceived central role for IL-12 in autoimmune inflammation, specifically in the brain, has been misinterpreted and that IL-23, and not IL-12, is the critical factor in this response. In addition, we show that IL-23, unlike IL-12, acts more broadly as an end-stage effector cytokine through direct actions on macrophages.	DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, Palo Alto, CA 94304 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Genom, Palo Alto, CA 94304 USA; DNAX Res Inst Mol & Cellular Biol Inc, Dept Prot & Antibody Technol, Palo Alto, CA 94304 USA; Schering Plough Corp, Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Merck & Company; Schering Plough Corporation	Cua, DJ (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunol, 901 Calif Ave, Palo Alto, CA 94304 USA.							Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Caspi NR, 1998, CLIN IMMUNOL IMMUNOP, V88, P4, DOI 10.1006/clin.1998.4540; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Chen SC, 2001, J IMMUNOL, V166, P3362, DOI 10.4049/jimmunol.166.5.3362; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Constantinescu CS, 1998, J IMMUNOL, V161, P5097; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Falcone M, 1999, CURR OPIN IMMUNOL, V11, P670, DOI 10.1016/S0952-7915(99)00035-7; FRUCHT DM, 2002, SCI STKE, V114; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; ISSAZADEH S, 1995, J NEUROIMMUNOL, V61, P205, DOI 10.1016/0165-5728(95)00100-G; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Leonard JP, 1996, ANN NY ACAD SCI, V795, P216, DOI 10.1111/j.1749-6632.1996.tb52671.x; LEONARD JP, 1995, J EXP MED, V181, P381, DOI 10.1084/jem.181.1.381; Matthys P, 2001, TRENDS IMMUNOL, V22, P367, DOI 10.1016/S1471-4906(01)01937-8; Nguyen KB, 2002, SCIENCE, V297, P2063, DOI 10.1126/science.1074900; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Piccotti JR, 1998, J IMMUNOL, V160, P1132; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Willenborg DO, 1996, J IMMUNOL, V157, P3223	29	2160	2383	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					744	748		10.1038/nature01355	http://dx.doi.org/10.1038/nature01355			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610626				2022-12-28	WOS:000180938000044
J	Mougeot, F; Redpath, SM; Leckie, F; Hudson, PJ				Mougeot, F; Redpath, SM; Leckie, F; Hudson, PJ			The effect of aggressiveness on the population dynamics of a territorial bird	NATURE			English	Article							HOST-PARASITE SYSTEM; RED GROUSE; TRICHOSTRONGYLUS-TENUIS; CYCLES; KIN; PREDATION; DENSITY; FLUCTUATIONS; PREVENTION; STABILITY	A central issue in ecology lies in identifying the importance of resources, natural enemies and behaviour in the regulation of animal populations. Much of the debate on this subject has focused on animals that show cyclic fluctuations in abundance(1-7). However, there is still disagreement about the role of extrinsic (food, parasites or predators) and intrinsic (behaviour) factors in causing cycles(2,8-10). Recent studies have examined the impact of natural enemies(1,3,4,7), although spatial patterns resulting from restricted dispersal or recruitment are increasingly recognized as having the potential to influence unstable population dynamics(5,6,11-13). We tested the hypothesis that population cycles in a territorial bird, red grouse Lagopus lagopus scoticus, are caused by delayed density-dependent changes in the aggressiveness and spacing behaviour of males. Here we show that increasing aggressiveness experimentally for a short period in autumn reduced recruitment and subsequent breeding density by 50%, and changed population trajectories from increasing to declining. Intrinsic processes can therefore have fundamental effects on population dynamics.	CEH Banchory, Banchory AB31 4BW, Aberdeen, Scotland; Univ Stirling, Dept Biol & Mol Sci, Stirling FK9 4LA, Scotland	UK Centre for Ecology & Hydrology (UKCEH); University of Stirling	Mougeot, F (corresponding author), CEH Banchory, Hills Brathens, Banchory AB31 4BW, Aberdeen, Scotland.		Hudson, Peter/AAB-8080-2020; Mougeot, Francois/B-1894-2009; Mougeot, Francois/Y-9569-2019; Redpath, Stephen/B-4640-2012	Hudson, Peter/0000-0003-0468-3403; Mougeot, Francois/0000-0002-5819-6275; Mougeot, Francois/0000-0002-5819-6275; Redpath, Stephen/0000-0001-5399-9477				Berryman AA, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P3; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; CHARNOV EL, 1980, OECOLOGIA, V45, P1, DOI 10.1007/BF00346698; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Fox A, 2001, ECOL LETT, V4, P139, DOI 10.1046/j.1461-0248.2001.00207.x; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hudson P. J., 1985, Ecology and genetics of host-parasite interactions. International symposium, Keele University, 12-13 July 1984, P77; Hudson PJ, 1997, WILDLIFE BIOL, V3, P79, DOI 10.2981/wlb.1997.010; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUDSON PJ, 1992, J ANIM ECOL, V61, P477, DOI 10.2307/5338; Hudson PJ, 2002, PHILOS T R SOC B, V357, P1259, DOI 10.1098/rstb.2002.1126; Korpimaki E, 2002, P ROY SOC B-BIOL SCI, V269, P991, DOI 10.1098/rspb.2002.1972; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Lambin X, 1998, J ANIM ECOL, V67, P1, DOI 10.1046/j.1365-2656.1998.00181.x; Lambin X, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P155; Matthiopoulos J, 2000, ECOL MODEL, V127, P53, DOI 10.1016/S0304-3800(99)00199-4; Moss R, 2001, ADV ECOL RES, V32, P53, DOI 10.1016/S0065-2504(01)32011-1; Moss R, 1996, ECOLOGY, V77, P1512, DOI 10.2307/2265548; MOSS R, 1994, P ROY SOC B-BIOL SCI, V258, P175, DOI 10.1098/rspb.1994.0159; Mountford M.D., 1990, P78; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; Stenseth NC, 1996, P ROY SOC B-BIOL SCI, V263, P1423, DOI 10.1098/rspb.1996.0208; Thirgood SJ, 2000, J ANIM ECOL, V69, P504, DOI 10.1046/j.1365-2656.2000.00413.x; Turchin P, 1999, SCIENCE, V285, P1068, DOI 10.1126/science.285.5430.1068; WATSON A, 1994, J ANIM ECOL, V63, P39, DOI 10.2307/5581	27	88	92	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					737	739		10.1038/nature01395	http://dx.doi.org/10.1038/nature01395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610624				2022-12-28	WOS:000180938000042
J	Huang, CY; Ayliffe, MA; Timmis, JN				Huang, CY; Ayliffe, MA; Timmis, JN			Direct measurement of the transfer rate of chloroplast DNA into the nucleus	NATURE			English	Article							PLASTID GENOME; GENE; TOBACCO; PLANTS; ARABIDOPSIS; EXPRESSION; REVEALS; INSERTION	Gene transfer from the chloroplast to the nucleus has occurred over evolutionary time(1). Functional gene establishment in the nucleus is rare, but DNA transfer without functionality is presumably more frequent. Here, we measured directly the transfer rate of chloroplast DNA (cpDNA) into the nucleus of tobacco plants (Nicotiana tabacum). To visualize this process, a nucleus-specific neomycin phosphotransferase gene (neoSTLS2) was integrated into the chloroplast genome, and the transfer of cpDNA to the nucleus was detected by screening for kanamycin-resistant seedlings in progeny. A screen for kanamycin-resistant seedlings was conducted with about 250,000 progeny produced by fertilization of wild-type females with pollen from plants containing cp-neoSTLS2. Sixteen plants of independent origin were identified and their progenies showed stable inheritance of neoSTLS2, characteristic of nuclear genes. Thus, we provide a quantitative estimate of one transposition event in about 16,000 pollen grains for the frequency of transfer of cpDNA to the nucleus. In addition to its evident role in organellar evolution, transposition of cpDNA to the nucleus in tobacco occurs at a rate that must have significant consequences for existing nuclear genes.	Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia; CSIRO Plant Ind, Canberra, ACT 2601, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Timmis, JN (corresponding author), Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia.	jeremy.timmis@adelaide.edu.au	Ayliffe, Michael A/A-2089-2010					Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Babiychuk E, 1997, P NATL ACAD SCI USA, V94, P12722, DOI 10.1073/pnas.94.23.12722; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Daniell H, 2002, TRENDS PLANT SCI, V7, P84, DOI 10.1016/S1360-1385(01)02193-8; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; ECKES P, 1986, MOL GEN GENET, V205, P14, DOI 10.1007/BF02428027; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Horser C, 2002, GENET ENG P, V24, P239; Huang CY, 2000, PLANT PHYSIOL, V124, P415, DOI 10.1104/pp.124.1.415; Kaneko T, 1996, DNA Res, V3, P109; Maas C, 1997, MOL BREEDING, V3, P15, DOI 10.1023/A:1009602923403; Maliga P, 2002, CURR OPIN PLANT BIOL, V5, P164, DOI 10.1016/S1369-5266(02)00248-0; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ricchetti M, 1999, NATURE, V402, P96, DOI 10.1038/47076; Scott SE, 1999, NAT BIOTECHNOL, V17, P390, DOI 10.1038/7952; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; TIMMIS JN, 1983, NATURE, V305, P65, DOI 10.1038/305065a0; Whitney SM, 2001, PLANT CELL, V13, P193, DOI 10.1105/tpc.13.1.193; Yuan Q, 2002, MOL GENET GENOMICS, V267, P713, DOI 10.1007/s00438-002-0706-1; ZOUBENKO OV, 1994, NUCLEIC ACIDS RES, V22, P3819, DOI 10.1093/nar/22.19.3819	26	217	234	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					72	76		10.1038/nature01435	http://dx.doi.org/10.1038/nature01435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12594458				2022-12-28	WOS:000181343100039
J	Pinnock, H; Bawden, R; Proctor, S; Wolfe, S; Scullion, J; Price, D; Sheikh, A				Pinnock, H; Bawden, R; Proctor, S; Wolfe, S; Scullion, J; Price, D; Sheikh, A			Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; PATIENTS SATISFACTION; CONSULTATIONS; QUALITY; QUESTIONNAIRE; PRACTITIONERS; ACCESS	Objective To determine whether routine review by telephone of patients with asthma improves access and is a good alternative to face to face reviews in general practices. Design Pragmatic, randomised controlled trial. Setting Four general practices in England. Participants 278 adults who had not been reviewed in the previous 11 months. Intervention Participants were randomised to either telephone review or face to face consultation with the asthma nurse. Main outcome measures Primary outcome measures Were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire. Secondary outcome measures included the validated "short Q" asthma morbidity score, nursing care satisfaction questionnaire score, and length of consultation. Results Of 137 people randomised to telephone consultation, 101 (74%) were reviewed, compared with 68 reviewed (48%) of the 141 people in the surgery group, a difference of 26% (95% confidence interval 14% to 37%; P < 0.001; number needed to treat 3.8). Three months after randomisation the two groups did not differ in the Juniper score (risk difference - 0.07 (95% confidence interval - 0.40 to 0.27) or in satisfaction with the consultation (risk difference - 0.07 (- 0.27 to 0.13)). Telephone consultations were on average 10 minutes shorter than reviews held in the surgery (mean difference 10.7 minutes (12.6 to 8.8; P < 0.001)). Conclusions Compared with face to face consultations in the surgery, telephone consultations enable more people with asthma to be reviewed, without clinical disadvantage or loss of satisfaction. A shorter duration means that telephone consultations are likely to be an efficient option in primary care for routine review of asthma.	Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Gen Practice Airways Grp, Aberdeen AB25 2AY, Scotland; Botesdale Hlth Ctr, Diss IP22 1DU, Norfolk, England; Clarendon Med Ctr, Hyde SK14 2AQ, Cheshire, England; Thorpewood Surg, Norwich NR7 9QL, Norfolk, England; Glenfield Gen Hosp, Resp Unit, Leicester LE3 9QP, Leics, England; St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England	University of Aberdeen; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; St Georges University London	Pinnock, H (corresponding author), Whitstable Hlth Ctr, Whitstable CT5 1BZ, Kent, England.	hpinnock@gpiag-asthma.org	Sheikh, Aziz/D-2818-2009; Price, David/H-2837-2019	Sheikh, Aziz/0000-0001-7022-3056; Price, David/0000-0002-9728-9992				BAKER R, 1990, BRIT J GEN PRACT, V40, P487; CHARLTON I, 1991, BRIT J GEN PRACT, V41, P227; *DEP HLTH, 2000, NHS PLAN; Freeman GK, 2002, BRIT MED J, V324, P880, DOI 10.1136/bmj.324.7342.880; Garratt AN, 2002, BMJ-BRIT MED J, V324, P1417, DOI 10.1136/bmj.324.7351.1417; Gruffydd-Jones K, 1999, ASTHMA GEN PRACT, V7, P36; HALLAM L, 1991, BRIT MED J, V302, P629, DOI 10.1136/bmj.302.6777.629; HALLAM L, 1993, BRIT J GEN PRACT, V43, P331; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; MARKLUND B, 1991, BRIT J GEN PRACT, V41, P462; McKinstry B, 2002, BRIT J GEN PRACT, V52, P306; National Asthma Campaign, 2001, ASTHMA J S, V6, P3; PARTRIDGE M, 1999, ASTHMA J, V4, P103; Pearson M, 1999, MEASURING CLIN OUTCO; Pearson MG, 1997, THORAX, V52, pS1; Poulton BC, 1996, BRIT J GEN PRACT, V46, P26; Rimmington L. D., 1997, European Respiratory Journal Supplement, V10, p194S; Rutter D.R., 1987, COMMUNICATING TELEPH; Toon PD, 2002, BRIT MED J, V324, P1230, DOI 10.1136/bmj.324.7348.1230; Walters JAE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub3; WASSON J, 1992, JAMA-J AM MED ASSOC, V267, P1788, DOI 10.1001/jama.267.13.1788	24	91	93	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2003	326	7387					477	479		10.1136/bmj.326.7387.477	http://dx.doi.org/10.1136/bmj.326.7387.477			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609944	Green Published, Bronze			2022-12-28	WOS:000181421400018
J	Allen, M				Allen, M			Liability for climate change	NATURE			English	Editorial Material									Univ Oxford, Dept Phys, Oxford OX1 3PU, England	University of Oxford	Allen, M (corresponding author), Univ Oxford, Dept Phys, Oxford OX1 3PU, England.	myles.allen@physics.ox.ac.uk							0	286	287	4	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					891	892		10.1038/421891a	http://dx.doi.org/10.1038/421891a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606972				2022-12-28	WOS:000181186900017
J	Kelsen, J; Obel, A				Kelsen, J; Obel, A			Fatal cerebral hypoxemia after cardiac arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Aarhus Univ Hosp, DK-8000 Aarhus C, Denmark	Aarhus University	Kelsen, J (corresponding author), Aarhus Univ Hosp, DK-8000 Aarhus C, Denmark.								0	6	6	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					817	817		10.1056/NEJMicm020544	http://dx.doi.org/10.1056/NEJMicm020544			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606736				2022-12-28	WOS:000181173300008
J	Lou, ZK; Minter-Dykhouse, K; Wu, XL; Chen, JJ				Lou, ZK; Minter-Dykhouse, K; Wu, XL; Chen, JJ			MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways	NATURE			English	Article							ATAXIA-TELANGIECTASIA; FHA DOMAIN; CHECKPOINT; PHOSPHORYLATION; PROTEIN; THREONINE-68; KINASE; ATM; REPAIR; BRCA1	Forkhead-homology-associated (FHA) domains function as protein-protein modules that recognize phosphorylated serine/threonine motifs(1-5). Interactions between FHA domains and phosphorylated proteins are thought to have essential roles in the transduction of DNA damage signals; however, it is unclear how FHA-domain-containing proteins participate in mammalian DNA damage responses. Here we report that a FHA-domain-containing protein-mediator of DNA damage checkpoint protein 1 (MDC1; previously known as KIAA0170)-is involved in DNA damage responses. MDC1 localizes to sites of DNA breaks and associates with CHK2 after DNA damage. This association is mediated by the MDC1 FHA domain and the phosphorylated Thr 68 of CHK2. Furthermore, MDC1 is phosphorylated in an ATM/CHK2-dependent manner after DNA damage, suggesting that MDC1 may function in the ATM-CHK2 pathway. Consistent with this hypothesis, suppression of MDC1 expression results in defective S-phase checkpoint and reduced apoptosis in response to DNA damage, which can be restored by the expression of wildtype MDC1 but not MDC1 with a deleted FHA domain. Suppression of MDC1 expression results in decreased p53 stabilization in response to DNA damage. These results suggest that MDC1 is recruited through its FHA domain to the activated CHK2, and has a critical role in CHK2-mediated DNA damage responses.	Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA	Mayo Clinic	Chen, JJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Oncol, 200 1st St SW, Rochester, MN 55905 USA.	chen.junjie@mayo.edu	Minter Dykhouse, Katherine/L-4573-2013	Minter Dykhouse, Katherine/0000-0003-4363-5826				Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Jack MT, 2002, P NATL ACAD SCI USA, V99, P9825, DOI 10.1073/pnas.152053599; Li J, 1999, P NATL ACAD SCI USA, V96, P7821, DOI 10.1073/pnas.96.14.7821; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shieh SY, 2000, GENE DEV, V14, P289; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Wang P, 2000, J MOL BIOL, V302, P927, DOI 10.1006/jmbi.2000.4095; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	30	272	293	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					957	961		10.1038/nature01447	http://dx.doi.org/10.1038/nature01447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607004				2022-12-28	WOS:000181186900052
J	Grier, HE; Krailo, MD; Tarbell, NJ; Link, MP; Fryer, CJH; Pritchard, DJ; Gebhardt, MC; Dickman, PS; Perlman, EJ; Meyers, PA; Donaldson, SS; Moore, S; Rausen, AR; Vietti, TJ; Miser, JS				Grier, HE; Krailo, MD; Tarbell, NJ; Link, MP; Fryer, CJH; Pritchard, DJ; Gebhardt, MC; Dickman, PS; Perlman, EJ; Meyers, PA; Donaldson, SS; Moore, S; Rausen, AR; Vietti, TJ; Miser, JS			Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG-ADULTS; PEDIATRIC ONCOLOGY; NO BENEFIT; CHILDREN; CYCLOPHOSPHAMIDE; VINCRISTINE; DOXORUBICIN; COMBINATION; EXPERIENCE; CHILDHOOD	BACKGROUND: Ewing's sarcoma and primitive neuroectodermal tumor of bone are closely related, highly malignant tumors of children, adolescents, and young adults. A new drug combination, ifosfamide and etoposide, was highly effective in patients with Ewing's sarcoma or primitive neuroectodermal tumor of bone who had a relapse after standard therapy. We designed a study to test whether the addition of these drugs to a standard regimen would improve the survival of patients with newly diagnosed disease. METHODS: Patients 30 years old or younger with Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sarcoma of bone were eligible. The patients were randomly assigned to receive 49 weeks of standard chemotherapy with doxorubicin, vincristine, cyclophosphamide, and dactinomycin or experimental therapy with these four drugs alternating with courses of ifosfamide and etoposide. RESULTS: A total of 518 patients met the eligibility requirements. Of 120 patients with metastatic disease, 62 were randomly assigned to the standard-therapy group and 58 to the experimental-therapy group. There was no significant difference in five-year event-free survival between the treatment groups (P=0.81). Among the 398 patients with nonmetastatic disease, the mean (+/-SE) five-year event-free survival among the 198 patients in the experimental-therapy group was 69+/-3 percent, as compared with 54+/-4 percent among the 200 patients in the standard-therapy group (P=0.005). Overall survival was also significantly better among patients in the experimental-therapy group (72+/-3.4 percent vs. 61+/-3.6 percent in the standard-therapy group, P=0.01). CONCLUSIONS: The addition of ifosfamide and etoposide to a standard regimen does not affect the outcome for patients with metastatic disease, but it significantly improves the outcome for patients with nonmetastatic Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sarcoma of bone.	Dana Farber Canc Inst, Dept Pediat Hematol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; King Khalid Natl Hosp, Dept Pediat, Jeddah, Saudi Arabia; Mayo Clin, Rochester, MN USA; Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Childrens Hosp, Dept Radiol, Los Angeles, CA 90027 USA; NYU Med Ctr, Dept Pediat, New York, NY 10016 USA; Washington Univ, Med Ctr, Div Pediat Hematol & Oncol, St Louis, MO USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; City Hope Natl Med Ctr, Dept Pediat, Duarte, CA 91010 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; University of Southern California; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; Stanford University; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Children's Hospital Los Angeles; New York University; Washington University (WUSTL); Washington University (WUSTL); City of Hope	Grier, HE (corresponding author), Dana Farber Canc Inst, Dept Pediat Hematol, 44 Binney St, Boston, MA 02115 USA.			Perlman, Elizabeth/0000-0001-6853-6221; Donaldson, Sarah/0000-0001-7125-3118; Meyers, Paul/0000-0001-6146-6101				ANTMAN KH, 1989, J CLIN ONCOL, V7, P126, DOI 10.1200/JCO.1989.7.1.126; ANTMAN KH, 1989, J CLIN ONCOL, V7, P1369; Bacci G, 1998, CANCER-AM CANCER SOC, V82, P1174, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1174::AID-CNCR24>3.0.CO;2-2; Craft A, 1998, J CLIN ONCOL, V16, P3628, DOI 10.1200/JCO.1998.16.11.3628; DEHNER LP, 1994, ARCH PATHOL LAB MED, V118, P606; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; HUSTU HO, 1972, CANCER, V30, P1522, DOI 10.1002/1097-0142(197212)30:6<1522::AID-CNCR2820300617>3.0.CO;2-J; JURGENS H, 1988, CANCER, V61, P23, DOI 10.1002/1097-0142(19880101)61:1<23::AID-CNCR2820610106>3.0.CO;2-M; Jurgens H, 1989, Cancer Chemother Pharmacol, V24 Suppl 1, pS40; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KAMEN BA, 1995, J CLIN ONCOL, V13, P307, DOI 10.1200/JCO.1995.13.2.307; KUNG FH, 1993, CANCER-AM CANCER SOC, V71, P1898, DOI 10.1002/1097-0142(19930301)71:5<1898::AID-CNCR2820710529>3.0.CO;2-Q; KUSHNER BH, 1995, J CLIN ONCOL, V13, P2796, DOI 10.1200/JCO.1995.13.11.2796; MAGRATH I, 1986, CANCER CHEMOTH PHARM, V18, pS25, DOI 10.1007/BF00647446; MEYER WH, 1992, J CLIN ONCOL, V10, P1737, DOI 10.1200/JCO.1992.10.11.1737; MISER JS, 1987, J CLIN ONCOL, V5, P1191, DOI 10.1200/JCO.1987.5.8.1191; Nesbit M E, 1976, CA Cancer J Clin, V26, P174, DOI 10.3322/canjclin.26.3.174; NESBIT ME, 1990, J CLIN ONCOL, V8, P1664, DOI 10.1200/JCO.1990.8.10.1664; OBERLIN O, 1992, J CLIN ONCOL, V10, P1407, DOI 10.1200/JCO.1992.10.9.1407; Paulussen M, 2001, J CLIN ONCOL, V19, P1818, DOI 10.1200/JCO.2001.19.6.1818; Rosito P, 1999, CANCER-AM CANCER SOC, V86, P421, DOI 10.1002/(SICI)1097-0142(19990801)86:3<421::AID-CNCR10>3.0.CO;2-O; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; Wexler LH, 1996, CANCER, V78, P901; Wexler LH, 1997, CANCER, V79, P867; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4	26	822	895	0	56	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					694	701		10.1056/NEJMoa020890	http://dx.doi.org/10.1056/NEJMoa020890			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594313				2022-12-28	WOS:000181014400004
J	Abbott, A				Abbott, A			Social scientists call for abolition of dishonesty committee	NATURE			English	News Item																		Abbott A, 2003, NATURE, V421, P201, DOI 10.1038/421201a; 2003, NATURE, V421, P195	2	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					681	681		10.1038/421681b	http://dx.doi.org/10.1038/421681b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610589	Bronze			2022-12-28	WOS:000180938000011
J	Aebersold, R				Aebersold, R			Constellations in a cellular universe	NATURE			English	Editorial Material									Univ Washington, Dept Biol Mol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Aebersold, R (corresponding author), Univ Washington, Dept Biol Mol, Seattle, WA 98195 USA.								0	74	83	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					115	116		10.1038/422115a	http://dx.doi.org/10.1038/422115a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634755				2022-12-28	WOS:000181488900017
J	Tyers, M; Mann, M				Tyers, M; Mann, M			From genomics to proteomics	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; IDENTIFICATION; MICROARRAYS; PROTEINS; YEAST		Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5G 1X5, Canada; Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, DK-5230 Odense, Denmark	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Southern Denmark	Tyers, M (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Mann, Matthias/A-3454-2013; Tyers, Michael/ABE-3194-2021	Mann, Matthias/0000-0003-1292-4799; 				Aebersold R, 2002, NAT BIOTECHNOL, V20, P651, DOI 10.1038/nbt0702-651; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BADER GD, 2001, GENOMICS BIOINFORMAT, P399; Ball P, 2002, NATURE, V418, P11, DOI 10.1038/418011a; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gerlai R, 2002, TRENDS NEUROSCI, V25, P506, DOI 10.1016/S0166-2236(02)02250-6; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Liu HB, 2002, BIOTECHNIQUES, V32, P898, DOI 10.2144/02324pt01; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; MANN M, IN PRESS NATURE BIOT; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Marshall E, 2001, SCIENCE, V291, P1192, DOI 10.1126/science.291.5507.1192; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Shoemaker DD, 2002, CURR OPIN MICROBIOL, V5, P334, DOI 10.1016/S1369-5274(02)00327-2; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4; Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yoon HJ, 2002, CURR BIOL, V12, P2048, DOI 10.1016/S0960-9822(02)01331-3	28	660	789	14	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					193	197		10.1038/nature01510	http://dx.doi.org/10.1038/nature01510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634792				2022-12-28	WOS:000181488900053
J	Delneri, D; Colson, I; Grammenoudi, S; Roberts, IN; Louis, EJ; Oliver, SG				Delneri, D; Colson, I; Grammenoudi, S; Roberts, IN; Louis, EJ; Oliver, SG			Engineering evolution to study speciation in yeasts	NATURE			English	Article							SENSU-STRICTO COMPLEX; SACCHAROMYCES-CEREVISIAE; REDUNDANCY; GENOME; TRANSLOCATION; STERILITY; BAYANUS; SYSTEM; HYBRID; CELLS	The Saccharomyces 'sensu stricto' yeasts are a group of species that will mate with one another, but interspecific pairings produce sterile hybrids. A retrospective analysis of their genomes revealed that translocations between the chromosomes of these species do not correlate with the group's sequence-based phylogeny(1) (that is, translocations do not drive the process of speciation). However, that analysis was unable to infer what contribution such rearrangements make to reproductive isolation between these organisms. Here, we report experiments that take an interventionist, rather than a retrospective approach to studying speciation, by reconfiguring the Saccharomyces cerevisiae genome so that it is collinear with that of Saccharomyces mikatae. We demonstrate that this imposed genomic collinearity allows the generation of interspecific hybrids that produce a large proportion of spores that are viable, but extensively aneuploid. We obtained similar results in crosses between wild-type S. cerevisiae and the naturally collinear species Saccharomyces paradoxus, but not with non-collinear crosses. This controlled comparison of the effect of chromosomal translocation on species barriers suggests a mechanism for the generation of redundancy in the S. cerevisiae genome(2).	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Inst Food Res, Natl Collect Yeast Cultures, Norwich NR4 7UA, Norfolk, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Manchester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Leicester	Oliver, SG (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	steve.oliver@man.ac.uk	Oliver, Stephen/AAQ-5992-2021; Louis, Edward/B-7920-2008; Roberts, Ian N/B-9743-2008	Oliver, Stephen/0000-0003-3410-6439; Louis, Edward/0000-0003-1157-3608; Delneri, Daniela/0000-0001-8070-411X				ADAMS A, 1997, METHODS YEAST GENETI, P145; [Anonymous], SACCHAROMYCES GENOME; BENGTSSON BO, 1976, ANN HUM GENET, V40, P253, DOI 10.1111/j.1469-1809.1976.tb00188.x; Delneri D, 2000, GENE, V252, P127, DOI 10.1016/S0378-1119(00)00217-1; Delneri D, 1999, GENETICS, V153, P1591; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Fischer G, 2001, GENOME RES, V11, P2009, DOI 10.1101/gr.212701; GARDNER DCJ, 1993, YEAST, V9, P1053, DOI 10.1002/yea.320091003; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kielland-Brandt MC, 1983, YEAST GENETICS FUNDA, P421; Llorente B, 2000, FEBS LETT, V487, P122, DOI 10.1016/S0014-5793(00)02291-2; Loidl J, 1998, CHROMOSOMA, V107, P247, DOI 10.1007/s004120050304; Lynch M, 2001, GENETICS, V159, P1789; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Naumov GI, 1997, SYST APPL MICROBIOL, V20, P595, DOI 10.1016/S0723-2020(97)80031-8; Naumov GI, 2000, INT J SYST EVOL MICR, V50, P1931, DOI 10.1099/00207713-50-5-1931; NAUMOV GI, 1987, EXPANDING REALM YEAS; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ryu SL, 1998, CURR GENET, V33, P345, DOI 10.1007/s002940050346; Sebastiani F, 2002, RES MICROBIOL, V153, P53, DOI 10.1016/S0923-2508(01)01286-4; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Tamai Y, 1998, YEAST, V14, P923, DOI 10.1002/(SICI)1097-0061(199807)14:10<923::AID-YEA298>3.3.CO;2-9; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	26	181	187	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					68	72		10.1038/nature01418	http://dx.doi.org/10.1038/nature01418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621434				2022-12-28	WOS:000181343100038
J	Takada, K; Sakurai, H; Takayama-Muromachi, E; Izumi, F; Dilanian, RA; Sasaki, T				Takada, K; Sakurai, H; Takayama-Muromachi, E; Izumi, F; Dilanian, RA; Sasaki, T			Superconductivity in two-dimensional CoO2 layers	NATURE			English	Article							SYSTEM	Since the discovery of high-transition-temperature (high-T-c) superconductivity in layered copper oxides(1), many researchers have searched for similar behaviour in other layered metal oxides involving 3d-transition metals, such as cobalt and nickel. Such attempts have so far failed, with the result that the copper oxide layer is thought to be essential for superconductivity. Here we report that NaxCoO2.yH(2)O (x approximate to 0.35, y approximate to 1.3) is a superconductor with a T-c of about 5 K. This compound consists of two-dimensional CoO2 layers separated by a thick insulating layer of Na+ ions and H2O molecules. There is a marked resemblance in superconducting properties between the present material and high-T-c copper oxides, suggesting that the two systems have similar underlying physics.	Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; Natl Inst Mat Sci, Superconducting Mat Ctr, Tsukuba, Ibaraki 3050044, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan	National Institute for Materials Science; National Institute for Materials Science; Japan Science & Technology Agency (JST)	Takada, K (corresponding author), Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan.	takada.kazunori@nims.go.jp	SASAKI, Takayoshi/H-2956-2011; Takada, Kazunori/H-2842-2011	TAKAYAMA-MUROMACHI, Eiji/0000-0001-7819-4317				Balsys RJ, 1997, SOLID STATE IONICS, V93, P279, DOI 10.1016/S0167-2738(96)00557-7; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; FOUASSIER C, 1973, J SOLID STATE CHEM, V6, P532, DOI 10.1016/S0022-4596(73)80011-8; Izumi F, 2000, MATER SCI FORUM, V321-3, P198, DOI 10.4028/www.scientific.net/MSF.321-324.198; TANAKA T, 1994, JPN J APPL PHYS 2, V33, pL581, DOI 10.1143/JJAP.33.L581	5	1622	1656	19	456	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					53	55		10.1038/nature01450	http://dx.doi.org/10.1038/nature01450			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621429				2022-12-28	WOS:000181343100033
J	Bitton, A; Kahn, JG				Bitton, A; Kahn, JG			Government share of health care expenditures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bitton, A (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							*CTR MED MED SERV, NAT HLTH CAR TRENDS; Fox DM, 2000, HEALTH AFFAIR, V19, P271, DOI 10.1377/hlthaff.19.2.271-a; Himmelstein DU, 2003, AM J PUBLIC HEALTH, V93, P102, DOI 10.2105/AJPH.93.1.102; Himmelstein DU, 2002, INT J HEALTH SERV, V32, P657, DOI 10.2190/JK74-14MB-YT5T-KUXQ; Sheils J, 1999, HEALTH AFFAIR, V18, P176, DOI 10.1377/hlthaff.18.2.176; Woolhandler S, 1997, NEW ENGL J MED, V336, P769, DOI 10.1056/NEJM199703133361106; Woolhandler S, 2002, HEALTH AFFAIR, V21, P88, DOI 10.1377/hlthaff.21.4.88	7	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1165	1165		10.1001/jama.289.9.1165	http://dx.doi.org/10.1001/jama.289.9.1165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650XM	12622592	Bronze			2022-12-28	WOS:000181289400037
J	Boffelli, D; McAuliffe, J; Ovcharenko, D; Lewis, KD; Ovcharenko, I; Pachter, L; Rubin, EM				Boffelli, D; McAuliffe, J; Ovcharenko, D; Lewis, KD; Ovcharenko, I; Pachter, L; Rubin, EM			Phylogenetic shadowing of primate sequences to find functional regions of the human genome	SCIENCE			English	Article							CORONARY-HEART-DISEASE; EPSILON-GLOBIN; LIPOPROTEIN(A); APOLIPOPROTEIN(A); GENES; GAMMA	Nonhuman primates represent the most relevant model organisms to understand the biology of Homo sapiens. The recent divergence and associated overall sequence conservation between individual members of this taxon have nonetheless largely precluded the use of primates in comparative sequence studies. We used sequence comparisons of an extensive set of Old World and New World monkeys and hominoids to identify functional regions in the human genome. Analysis of these data enabled the discovery of primate-specific gene regulatory elements and the demarcation of the exons of multiple genes. Much of the information content of the comprehensive primate sequence comparisons could be captured with a small subset of phylogenetically close primates. These results demonstrate the utility of intraprimate sequence comparisons to discover common mammalian as well as primate-specific functional elements in the human genome, which are unattainable through the evaluation of more evolutionarily distant species.	USDA, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	United States Department of Agriculture (USDA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rubin, EM (corresponding author), USDA, Joint Genome Inst, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov		Pachter, Lior/0000-0002-9164-6231; Ovcharenko, Dmitriy/0000-0003-1271-1099	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066728] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002362] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01-HG02362-01] Funding Source: Medline; NHLBI NIH HHS [HL66728] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAWN RM, 1995, J BIOL CHEM, V270, P24004, DOI 10.1074/jbc.270.41.24004; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; Notredame C, 2001, BIOINFORMATICS, V17, P373, DOI 10.1093/bioinformatics/17.4.373; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; WADE DP, 1994, J BIOL CHEM, V269, P19757; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	14	392	423	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1391	1394		10.1126/science.1081331	http://dx.doi.org/10.1126/science.1081331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610304	Green Submitted			2022-12-28	WOS:000181192300051
J	Erbil, HY; Demirel, AL; Avci, Y; Mert, O				Erbil, HY; Demirel, AL; Avci, Y; Mert, O			Transformation of a simple plastic into a superhydrophobic surface	SCIENCE			English	Article							REPELLENT; CONTAMINATION; WETTABILITY; DROPS; FILMS; GEL	Superhydrophobic surfaces are generally made by controlling the surface chemistry and surface roughness of various expensive materials, which are then applied by means of complex time-consuming processes. We describe a simple and inexpensive method for forming a superhydrophobic coating using polypropylene (a simple polymer) and a suitable selection of solvents and temperature to control the surface roughness. The resulting get-like porous coating has a water contact angle of 160degrees. The method can be applied to a variety of surfaces as long as the solvent mixture does not dissolve the underlying material.	Kocaeli Univ, Fac Sci & Arts, Dept Chem, TR-41300 Izmit, Kocaeli, Turkey; Koc Univ, Coll Arts & Sci, Dept Chem, TR-34450 Istanbul, Turkey	Kocaeli University; Koc University	Erbil, HY (corresponding author), Kocaeli Univ, Fac Sci & Arts, Dept Chem, TR-41300 Izmit, Kocaeli, Turkey.	yerbil@kou.edu.tr; ldemirel@ku.edu.tr	Duman, Yonca/F-5785-2018; Gentleman, Molly M/A-7137-2010; mert, olcay/F-5252-2018; Erbil, H. Yildirim/C-9246-2009	Duman, Yonca/0000-0001-6881-018X; Erbil, H. Yildirim/0000-0001-9204-3806				Andrianova GP, 1997, POLYM ENG SCI, V37, P1367, DOI 10.1002/pen.11783; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bico J, 1999, EUROPHYS LETT, V47, P220, DOI 10.1209/epl/i1999-00548-y; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Chen W, 1999, LANGMUIR, V15, P3395, DOI 10.1021/la990074s; Coulson SR, 2000, J PHYS CHEM B, V104, P8836, DOI 10.1021/jp0000174; Erbil H. Y., 1997, HDB SURFACE COLLOID; Erbil HY, 2002, LANGMUIR, V18, P2636, DOI 10.1021/la011470p; Fujimatsu H, 2001, POLYM J, V33, P543, DOI 10.1295/polymj.33.543; Hozumi A, 1998, THIN SOLID FILMS, V334, P54, DOI 10.1016/S0040-6090(98)01116-X; Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142; Neinhuis C, 1998, NEW PHYTOL, V138, P91, DOI 10.1046/j.1469-8137.1998.00882.x; Nishino T, 1999, LANGMUIR, V15, P4321, DOI 10.1021/la981727s; Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o; Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o; Richard D, 1999, EUROPHYS LETT, V48, P286, DOI 10.1209/epl/i1999-00479-1; Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728; SPERLING LH, 1997, POLYM MULTICOMPONENT, pCH6; TADNAGA T, 1997, J AM CERAM SOC, V80, P1040; VARGA J, 1995, POLYPROPYLENE STRUCT, V1, pCH3; Veeramasuneni S, 1997, PROG ORG COAT, V31, P265, DOI 10.1016/S0300-9440(97)00085-4; VESELOVSKY RA, 2002, ADHESION POLYM, pCH2; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024	23	1558	1691	41	1204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1377	1380		10.1126/science.1078365	http://dx.doi.org/10.1126/science.1078365			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610300				2022-12-28	WOS:000181192300047
J	Murray, M; Bodenheimer, T; Rittenhouse, D; Grumbach, K				Murray, M; Bodenheimer, T; Rittenhouse, D; Grumbach, K			Improving timely access to primary cre - Case studies of the advanced access model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The advanced access model of patient scheduling is based on the core principle that if the capacity to provide patient appointments balances the demand for appointments, patients calling to see their physician are offered an appointment the same day. The accompanying article in the series "Innovations in Primary Care" presents the theory behind advanced access scheduling. In this article we describe 4 case studies of primary care practices that successfully implemented advanced access and 3 examples of practices that were unable to achieve advanced access despite considerable efforts. The lessons of these case studies should be useful for primary care practices desiring to improve timely access to care and wishing to avoid the pitfalls that can derail this innovation.	Mark Murray & Associates, Sacramento, CA USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), San Francisco Gen Hosp, Bldg 80-83,1001 Potrero Ave, San Francisco, CA 94110 USA.		Grumbach, Kevin/L-9222-2016					Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Langley GJ, 1996, IMPROVEMENT GUIDE; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; Murray M, 2000, Fam Pract Manag, V7, P45; SINGER I, 2001, ADV ACCESS NEW PARAD	6	133	135	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1042	1046		10.1001/jama.289.8.1042	http://dx.doi.org/10.1001/jama.289.8.1042			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597761				2022-12-28	WOS:000181129800035
J	Mayor, U; Guydosh, NR; Johnson, CM; Grossmann, JG; Sato, S; Jas, GS; Freund, SMV; Alonso, DOV; Daggett, V; Fersht, AR				Mayor, U; Guydosh, NR; Johnson, CM; Grossmann, JG; Sato, S; Jas, GS; Freund, SMV; Alonso, DOV; Daggett, V; Fersht, AR			The complete folding pathway of a protein from nanoseconds to microseconds	NATURE			English	Article							DIFFUSION-COLLISION MODEL; DENATURED STATE; ENERGY; DOMAIN; HELIX	Combining experimental and simulation data to describe all of the structures and the pathways involved in folding a protein is problematical. Transition states can be mapped experimentally by phi values(1,2), but the denatured state(3) is very difficult to analyse under conditions that favour folding. Also computer simulation at atomic resolution is currently limited to about a microsecond or less. Ultrafast-folding proteins fold and unfold on timescales accessible by both approaches(4,5), so here we study the folding pathway of the three-helix bundle protein Engrailed homeodomain(6). Experimentally, the protein collapses in a microsecond to give an intermediate with much native alpha-helical secondary structure, which is the major component of the denatured state under conditions that favour folding. A mutant protein shows this state to be compact and contain dynamic, native-like helices with unstructured side chains. In the transition state between this and the native state, the structure of the helices is nearly fully formed and their docking is in progress, approximating to a classical diffusion-collision model. Molecular dynamics simulations give rate constants and structural details highly consistent with experiment, thereby completing the description of folding at atomic resolution.	MRC, Ctr Prot Engn, Cambridge CB2 2QH, England; CLRC Daresbury Lab, Warrington WA4 4AD, Cheshire, England; NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Cambridge; STFC Daresbury Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Washington; University of Washington Seattle	Fersht, AR (corresponding author), MRC, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008; Mayor, Ugo/F-5890-2011	Mayor, Ugo/0000-0003-2812-8287				BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Blanco FJ, 1998, J MOL BIOL, V284, P1153, DOI 10.1006/jmbi.1998.2229; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13008, DOI 10.1073/pnas.221467398; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grossmann JG, 2002, BIOCHEMISTRY-US, V41, P3613, DOI 10.1021/bi015955o; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; HUANG GS, 1995, P NATL ACAD SCI USA, V92, P6878, DOI 10.1073/pnas.92.15.6878; Islam SA, 2002, J MOL BIOL, V318, P199, DOI 10.1016/S0022-2836(02)00029-3; Itzhaki LS, 1997, J MOL BIOL, V270, P89, DOI 10.1006/jmbi.1997.1049; KARPLUS M, 1994, PROTEIN SCI, V3, P650; KIPPEN AD, 1994, BIOCHEMISTRY-US, V33, P10013, DOI 10.1021/bi00199a027; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; Mayor U, 2000, P NATL ACAD SCI USA, V97, P13518, DOI 10.1073/pnas.250473497; Oliveberg M, 1996, BIOCHEMISTRY-US, V35, P2738, DOI 10.1021/bi950967t; Sandstrom J., 1982, DYNAMIC NMR SPECTROS; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Spector S, 1999, BIOPOLYMERS, V49, P29, DOI 10.1002/(SICI)1097-0282(199901)49:1<29::AID-BIP4>3.0.CO;2-7; Thompson PA, 1997, BIOCHEMISTRY-US, V36, P9200, DOI 10.1021/bi9704764; Witty M, 2002, EMBO J, V21, P4207, DOI 10.1093/emboj/cdf417; Zhang Y.Z., 1995, THESIS U PENNSYLVANI	29	414	421	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					863	867		10.1038/nature01428	http://dx.doi.org/10.1038/nature01428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594518				2022-12-28	WOS:000181044700053
J	Scholtz, G; Braband, A; Tolley, L; Reimann, A; Mittmann, B; Lukhaup, C; Steuerwald, F; Vogt, G				Scholtz, G; Braband, A; Tolley, L; Reimann, A; Mittmann, B; Lukhaup, C; Steuerwald, F; Vogt, G			Ecology - Parthenogenesis in an outsider crayfish	NATURE			English	Article							FISH		Humboldt Univ, Inst Biol Vergleichende Zool, D-10115 Berlin, Germany; Heidelberg Univ, Inst Zool, INF 230, D-69120 Heidelberg, Germany	Humboldt University of Berlin; Ruprecht Karls University Heidelberg	Scholtz, G (corresponding author), Humboldt Univ, Inst Biol Vergleichende Zool, D-10115 Berlin, Germany.	gerhard.scholtz@rz.hu-berlin.de						Bauer RT, 1998, MAR BIOL, V132, P223, DOI 10.1007/s002270050388; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Gruner H-E, 1993, LEHRBUCH SPEZIELLEN, VI; Lukhaup C., 2001, AQUARISTIK AKTUELL, V7-8, P48; Nam YK, 2000, TRANSGENIC RES, V9, P463, DOI 10.1023/A:1026596422225; Reynolds JD, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P152; Scholtz G, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P30; Soderhall Kenneth, 1999, Freshwater Crayfish, V12, P11; Vogt G, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P53; VRIJENHOEK RC, 1994, ANNU REV ECOL SYST, V25, P71, DOI 10.1146/annurev.es.25.110194.000443	10	152	157	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					806	806		10.1038/421806a	http://dx.doi.org/10.1038/421806a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594502				2022-12-28	WOS:000181044700037
J	Harrod, HL				Harrod, HL			An essay on desire	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					813	814		10.1001/jama.289.7.813	http://dx.doi.org/10.1001/jama.289.7.813			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588245				2022-12-28	WOS:000181072200001
J	FitzGerald, GA				FitzGerald, GA			Parsing an enigma: the pharmacodynamics of aspirin resistance	LANCET			English	Editorial Material							THROMBOXANE; INHIBITORS; SYNTHASE; THERAPY; DRUGS		Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	FitzGerald, GA (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.		FitzGerald, Garret A/A-4222-2010					Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; FUNK CD, 1991, FASEB J, V5, P2304, DOI 10.1096/fasebj.5.9.1907252; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Juni P, 2002, BRIT MED J, V324, P1287, DOI 10.1136/bmj.324.7349.1287; Kimmel SE, 2002, J AM COLL CARDIOL, V39, p318A; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; REILLY IAG, 1987, BLOOD, V69, P180; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P382, DOI 10.1097/00001648-200007000-00004	14	54	60	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					542	544		10.1016/S0140-6736(03)12560-3	http://dx.doi.org/10.1016/S0140-6736(03)12560-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598136				2022-12-28	WOS:000181033400004
J	Rolland-Lagan, AG; Bangham, JA; Coen, E				Rolland-Lagan, AG; Bangham, JA; Coen, E			Growth dynamics underlying petal shape and asymmetry	NATURE			English	Article							CELL LINEAGE PATTERNS; LEAF DEVELOPMENT; CLONAL ANALYSIS; TOBACCO; PARAMETERS	Development commonly involves the generation of complex shapes from simpler ones. One way of following this process is to use landmarks to track the fate of particular points in a developing organ(1-7), but this is limited by the time over which it can be monitored. Here we use an alternative method, clonal analysis', whereby dividing cells are genetically marked and their descendants identified visually, to observe the development of Antirrhinum (snapdragon) petals. Clonal analysis has previously been used to estimate growth parameters of leaves(9-11) and Drosophila wings(12-14) but these results were not integrated within a dynamic growth model. Here we develop such a model and use it to show that a key aspect of shape-petal asymmetry-in the petal lobe of Antirrhinum depends on the direction of growth rather than regional differences in growth rate. The direction of growth is maintained parallel to the proximodistal axis of the flower, irrespective of changes in shape, implying that long-range signals orient growth along the petal as a whole. Such signals may provide a general mechanism for orienting growth in other growing structures.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Informat Syst, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk Colney, Norwich NR4 7UH, Norfolk, England.	Enrico.Coen@bbsrc.ac.uk						Almeida J, 1997, DEVELOPMENT, V124, P1387; Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Dolan L, 1998, AM J BOT, V85, P315, DOI 10.2307/2446322; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; Efremova N, 2001, DEVELOPMENT, V128, P2661; ERICKSON RO, 1976, ANNU REV PLANT PHYS, V27, P407, DOI 10.1146/annurev.pp.27.060176.002203; ERICKSON RO, 1966, J EXP BOT, V17, P390, DOI 10.1093/jxb/17.2.390; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1; HARRISON BJ, 1964, HEREDITY, V19, P237, DOI 10.1038/hdy.1964.28; HERNANDEZ LF, 1991, PLANTA, V185, P139, DOI 10.1007/BF00194054; LLOYD CW, 1988, DEVELOPMENT, V102, P211; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; MAKSYMOWYCH R, 1973, DEV CELL BIOL SERIES, V1; Perbal MC, 1996, DEVELOPMENT, V122, P3433; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1987, AM J BOT, V74, P581, DOI 10.2307/2443838; POETHIG RS, 1995, MAYDICA, V40, P67; Resino J, 2002, P NATL ACAD SCI USA, V99, P7502, DOI 10.1073/pnas.072208199; Richards OW, 1943, AM NAT, V77, P385, DOI 10.1086/281140; Sachs T., 1991, PATTERN FORMATION PL, P101; SUBTELNY S, 1978, CLONAL BASIS DEV; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Thompson DW, 1942, GROWTH FORM, V2; TILNEYBASSET RAE, 1986, PLANT CHIMERAS; Vincent CA, 2003, PLANT J, V33, P765, DOI 10.1046/j.1365-313X.2003.01666.x; Vincent CA, 1995, CURR BIOL, V5, P1449, DOI 10.1016/S0960-9822(95)00282-X; WOLF S, 1986, SILICON PROCESSING V, V1, P73	30	123	128	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					161	163		10.1038/nature01443	http://dx.doi.org/10.1038/nature01443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634785				2022-12-28	WOS:000181488900044
J	Dunham, EM; Favreau, P; Carlson, JM				Dunham, EM; Favreau, P; Carlson, JM			A supershear transition mechanism for cracks	SCIENCE			English	Article							1992 LANDERS EARTHQUAKE; SHEAR CRACKS; RUPTURE; FAULT; PLANE; PROPAGATION; RADIATION; FRICTION; MODEL; SLIP	Seismic data indicate that fault ruptures follow complicated paths with variable velocity because of inhomogeneities in initial stress or fracture energy. We report a phenomenon unique to three-dimensional cracks: Locally stronger fault sections, rather than slowing ruptures, drive them forward at velocities exceeding the shear wave speed. This supershear mechanism differentiates barrier and asperity models of fault heterogeneity, which previously have been regarded as indistinguishable. High strength barriers concentrate energy, producing potentially destructive pulses of strong ground motion.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Inst Phys Globe, F-75252 Paris, France	University of California System; University of California Santa Barbara; UDICE-French Research Universities; Universite Paris Cite	Dunham, EM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.			Dunham, Eric/0000-0003-0804-7746				Aki K., 2002, QUANTITATIVE SEISMOL, Vsecond; ANDREWS DJ, 1976, J GEOPHYS RES, V81, P5679, DOI 10.1029/JB081i032p05679; ARCHULETA RJ, 1984, J GEOPHYS RES, V89, P4559, DOI 10.1029/JB089iB06p04559; BEROZA GC, 1988, J GEOPHYS RES-SOLID, V93, P6275, DOI 10.1029/JB093iB06p06275; Bouchon M, 2000, GEOPHYS RES LETT, V27, P3013, DOI 10.1029/2000GL011761; Bouchon M, 2001, GEOPHYS RES LETT, V28, P2723, DOI 10.1029/2001GL013112; Broberg K. B., 1995, ARCH MECH, V47, P859; BROBERG KB, 1994, GEOPHYS J INT, V119, P706, DOI 10.1111/j.1365-246X.1994.tb04010.x; BRUNE JN, 1970, J GEOPHYS RES, V75, P4997, DOI 10.1029/JB075i026p04997; BURRIDGE R, 1973, GEOPHYS J ROY ASTR S, V35, P439, DOI 10.1111/j.1365-246X.1973.tb00608.x; BURRIDGE R, 1979, J GEOPHYS RES, V85, P2210; DAS S, 1977, J GEOPHYS RES, V82, P5658, DOI 10.1029/JB082i036p05658; DAS S, 1983, J GEOPHYS RES, V88, P4277, DOI 10.1029/JB088iB05p04277; Freund L., 1989, DYNAMIC FRACTURE MEC; FREUND LB, 1979, J GEOPHYS RES, V84, P2199, DOI 10.1029/JB084iB05p02199; Fukuyama E, 2000, PURE APPL GEOPHYS, V157, P1959, DOI 10.1007/PL00001070; Guatteri M, 2000, B SEISMOL SOC AM, V90, P98, DOI 10.1785/0119990053; HATZELL S, 1986, B SEISMOL SOC AM, V76, P649; IDA Y, 1972, J GEOPHYS RES, V77, P3796, DOI 10.1029/JB077i020p03796; KANAMORI H, 1978, J GEOPHYS RES, V83, P3427, DOI 10.1029/JB083iB07p03427; MADARIAGA R, 1983, ANN GEOPHYS, V1, P17; Madariaga R, 2000, PROBLEMS IN GEOPHYSICS FOR THE NEW MILLENNIUM, P89; Madariaga R, 2000, PURE APPL GEOPHYS, V157, P1981, DOI 10.1007/PL00001071; Olsen KB, 1997, SCIENCE, V278, P834, DOI 10.1126/science.278.5339.834; Peyrat S, 2001, J GEOPHYS RES-SOL EA, V106, P26467, DOI 10.1029/2001JB000205; Rosakis AJ, 1999, SCIENCE, V284, P1337, DOI 10.1126/science.284.5418.1337	26	102	106	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1557	1559		10.1126/science.1080650	http://dx.doi.org/10.1126/science.1080650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624262				2022-12-28	WOS:000181367900032
J	Jimenez, R; Flynn, C; MacDonald, J; Gibson, BK				Jimenez, R; Flynn, C; MacDonald, J; Gibson, BK			The cosmic production of helium	SCIENCE			English	Article							SMALL-MAGELLANIC-CLOUD; LOWER MAIN-SEQUENCE; DELTA-Y/DELTA-Z; ABUNDANCE DETERMINATION; HIPPARCOS PARALLAXES; CHEMICAL-COMPOSITION; EVOLUTIONARY TRACKS; SOLAR NEIGHBORHOOD; GLOBULAR-CLUSTERS; HE-4 ABUNDANCE	We estimate the cosmic production rate of helium relative to metals (DeltaY/DeltaZ) using K dwarf stars in the Hipparcos catalog with accurate spectroscopic metallicities. The best fitting value is DeltaY/DeltaZ = 2.1 +/- 0.4 at the 68% confidence level. Our derived value agrees with determinations from H II regions and with theoretical predictions from stellar yields with standard assumptions for the initial mass function. The amount of helium in stars determines how long they live and therefore how fast they will enrich the interstellar medium with fresh material.	Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; Tuorla Observ, FIN-21500 Piikio, Finland; Swinburne Univ, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA	University of Pennsylvania; University of Turku; Swinburne University of Technology; University of Delaware	Jimenez, R (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.		Gibson, Brad/M-3592-2015; MacDonald, James/AAJ-5124-2020	Gibson, Brad/0000-0003-4446-3130; MacDonald, James/0000-0002-0506-5124; Jimenez, Raul/0000-0002-3370-3103				ALEXANDER DR, 1994, ASTROPHYS J, V437, P879, DOI 10.1086/175039; BESSEL MS, 1990, ASTRON ASTROPHYS SUP, V83, P357; Bessell MS, 1998, ASTRON ASTROPHYS, V333, P231; Castellani V, 2001, MON NOT R ASTRON SOC, V320, P66, DOI 10.1046/j.1365-8711.2001.03958.x; Chaboyer B, 1998, ASTROPHYS J, V494, P96, DOI 10.1086/305201; Feltzing S, 2001, ASTRON ASTROPHYS, V367, P253, DOI 10.1051/0004-6361:20000477; Fernandes J, 1996, ASTRON ASTROPHYS, V311, P127; Flynn C, 1997, MON NOT R ASTRON SOC, V286, P617, DOI 10.1093/mnras/286.3.617; Gruenwald R, 2002, ASTROPHYS J, V567, P931, DOI 10.1086/338493; Izotov YI, 1997, ASTROPHYS J SUPPL S, V108, P1, DOI 10.1086/312956; Izotov YI, 2001, ASTROPHYS J, V562, P727, DOI 10.1086/323864; Jimenez R, 2002, ASTROPHYS J, V573, P37, DOI 10.1086/340549; Kotoneva E, 2002, MON NOT R ASTRON SOC, V335, P1147, DOI 10.1046/j.1365-8711.2002.05690.x; LAWLOR T, 2003, ASTROPHYS J, V583; Lebreton Y, 2001, ASTRON ASTROPHYS, V374, P540, DOI 10.1051/0004-6361:20010757; MAEDER A, 1992, ASTRON ASTROPHYS, V264, P105; MARIGO P, IN PRESS ASTRON ASTR; Mullan DJ, 2001, ASTROPHYS J, V559, P353, DOI 10.1086/322336; Pagel BEJ, 1998, MON NOT R ASTRON SOC, V298, P747, DOI 10.1046/j.1365-8711.1998.01637.x; Peimbert A, 2002, ASTROPHYS J, V565, P668, DOI 10.1086/324601; Peimbert M, 2000, ASTROPHYS J, V541, P688, DOI 10.1086/309485; PEIMBERT M, 1976, ASTROPHYS J, V203, P581, DOI 10.1086/154114; PERRIN MN, 1977, ASTRON ASTROPHYS, V54, P779; Salasnich B, 2000, ASTRON ASTROPHYS, V361, P1023; TAYLOR BJ, 1970, ASTROPHYS J SUPPL S, V22, P177, DOI 10.1086/190222; Thoren P, 2000, ASTRON ASTROPHYS, V363, P692; Thuan TX, 2002, SPACE SCI REV, V100, P263, DOI 10.1023/A:1015838716176; Tomkin J, 1999, ASTROPHYS J, V523, P234, DOI 10.1086/307735; Tsujimoto T, 1997, ASTROPHYS J, V483, P228, DOI 10.1086/304215	31	74	74	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1552	1555		10.1126/science.1080866	http://dx.doi.org/10.1126/science.1080866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624260	Green Submitted			2022-12-28	WOS:000181367900030
J	Karst, SM; Wobus, CE; Lay, M; Davidson, J; Virgin, HW				Karst, SM; Wobus, CE; Lay, M; Davidson, J; Virgin, HW			STAT1-dependent innate immunity to a Norwalk-like virus	SCIENCE			English	Article							MICE; GASTROENTERITIS	Norwalk-like caliciviruses (Noroviruses) cause over 90% of nonbacterial epidemic gastroenteritis worldwide, but the pathogenesis of norovirus infection is poorly understood because these viruses do not grow in cultured cells and there is no small animal model. Here, we report a previously unknown murine norovirus. Analysis of Murine Norovirus 1 infection revealed that signal transducer and activator of transcription 1-dependent innate immunity, but not T and B cell-dependent adaptive immunity, is essential for norovirus resistance. The identification of host molecules essential for murine norovirus resistance may provide targets for prevention or control of an important human disease.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Virgin@immunology.wustl.edu	Lay, Margarita/AAW-6352-2021	Lay, Margarita/0000-0002-4081-7977	NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049286] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA09547] Funding Source: Medline; NIAID NIH HHS [R01 AI49286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; GREEN KY, 2001, FIELDS VIROLOGY, V1, pCH27; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Inouye S, 2000, J INFECT DIS, V181, pS270, DOI 10.1086/315593; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; KARST S, UNPUB; MACMICKING, 1995, CELL, V81, pU17; Matsui SM, 2000, J INFECT DIS, V181, pS331, DOI 10.1086/315587; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Pastorian K, 2000, ANAL BIOCHEM, V283, P89, DOI 10.1006/abio.2000.4622; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TREANOR J, 1995, PRINCIPLES PRACTICE, pCH153; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	19	604	639	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1575	1578		10.1126/science.1077905	http://dx.doi.org/10.1126/science.1077905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624267				2022-12-28	WOS:000181367900038
J	Pfisterer, M; Buser, P; Osswald, S; Allemann, U; Amann, W; Angehrn, W; Eeckhout, E; Erne, P; Estlinbaum, W; Kuster, G; Moccetti, T; Naegeli, B; Rickenbacher, P				Pfisterer, M; Buser, P; Osswald, S; Allemann, U; Amann, W; Angehrn, W; Eeckhout, E; Erne, P; Estlinbaum, W; Kuster, G; Moccetti, T; Naegeli, B; Rickenbacher, P		TIME Investigators	Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy - One-year results of the randomized TIME trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting oft the European-Society-of-Cardiology	SEP   02, 2002	BERLIN, GERMANY	European Soc Cardiol			QUALITY-OF-LIFE; BYPASS GRAFT-SURGERY; EARLY REVASCULARIZATION; CARDIOGENIC-SHOCK; FOLLOW-UP; ANGIOPLASTY; THERAPY; SURVIVAL; ANGINA	Context The risk-benefit ratio of invasive vs medical management of elderly patients with symptomatic chronic coronary artery disease (CAD) is unclear. The Trial of Invasive versus Medical therapy in Elderly patients (TIME) recently showed early benefits in quality of life from invasive therapy in patients aged 75 years or older, although with a certain excess in mortality. Objective To assess the long-term value of invasive vs medical management of chronic CAD in elderly adults in terms of quality of life and prevention of major adverse cardiac events. Design One-year follow-up analysis of TIME, a prospective randomized trial with enrollment between February 1996 and November 2000. Setting and Participants A total of 282 patients with Canadian Cardiac Society class 2 or higher angina despite treatment with 2 or more anti-anginal drugs who survived for the first 6 months after enrollment in TIME (mean age, 80 years [range, 75-91 years]; 42% women), enrolled at 14 centers in Switzerland. Interventions Participants were randomly assigned to undergo coronary angiography followed by revascularization (if feasible) (n=140 surviving 6 months) or to receive optimized medical therapy (n=142 surviving 6 months). Main Outcome Measures Quality of life, assessed by standardized questionnaire; major adverse cardiac events (death, nonfatal myocardial infarction, or hospitalization for acute coronary syndrome) after 1 year. Results After 1 year, improvements in angina and quality of life persisted for both therapies compared with baseline, but the early difference favoring invasive therapy disappeared. Among invasive therapy patients, later hospitalization with revascularization was much less likely (10% vs 46%; hazard ratio [HR], 0.19; 95% confidence interval [CI], 0.11-0.32; P<001). However, 1-year mortality (111.1% for invasive; 8.1% for medical; HR, 1.51; 95% CI, 0.72-3.16; P=.28) and death or nonfatal myocardial infarction rates (17.0%. for invasive; 19.6% for medical; HR, 0.90; 95% CI, 0.53-1.5 3; P=.71) were not significantly different. Overall major adverse cardiac event rates were higher for medical patients after 6 months (49.3% vs 19.0% for invasive; P<.001), a difference which increased to 64.2% vs 25.5% after 12 months (P<.001). Conclusions in contrast with. differences in early results, 1-year outcomes in elderly patients with chronic angina are similar with regard to symptoms, quality of life, and death or nonfatal infarction with invasive vs optimized medical strategies based on this intention-to-treat analysis. The invasive approach carries an early intervention risk, while medical management poses an almost 50% chance of later hospitalization and revascularization.	Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland; Univ Lausanne Hosp, Dept Cardiol, Lausanne, Switzerland; State Hosp, St Gallen, Switzerland; State Hosp, Triemli Zurich, Switzerland; State Hosp, Luzern, Switzerland; State Hosp, Liestal, Switzerland; State Hosp, Lugano, Switzerland; State Hosp, Bruderholz, Switzerland; Claraspital Basel, Basel, Switzerland	University of Basel; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Triemli Hospital	Pfisterer, M (corresponding author), Univ Basel Hosp, Dept Cardiol, Petersgraben 4, CH-4031 Basel, Switzerland.		Kuster, Gabriela M/AAB-5478-2022; Osswald, Stefan/A-6904-2018	Kuster, Gabriela M/0000-0002-8209-4631; Osswald, Stefan/0000-0002-9240-6731				Alexander KP, 2000, J AM COLL CARDIOL, V35, P731, DOI 10.1016/S0735-1097(99)00606-3; Batchelor WB, 2000, J AM COLL CARDIOL, V36, P723, DOI 10.1016/S0735-1097(00)00777-4; Blumenthal RS, 2000, J AM COLL CARDIOL, V36, P668, DOI 10.1016/S0735-1097(00)00791-9; BULLINGER M, 1995, SOC SCI MED, V41, P1359, DOI 10.1016/0277-9536(95)00115-N; Chamberlain DA, 1997, LANCET, V350, P461; Graham MM, 2002, CIRCULATION, V105, P2378, DOI 10.1161/01.CIR.0000016640.99114.3D; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; PARISI AF, 1992, NEW ENGL J MED, V326, P10, DOI 10.1056/NEJM199201023260102; Pfisterer M, 2001, LANCET, V358, P951; Pocock SJ, 2000, J AM COLL CARDIOL, V35, P907, DOI 10.1016/S0735-1097(99)00637-3; RIHAL CS, 1999, EVIDENCE BASED CARDI, P368; ROGERS WJ, 1990, CIRCULATION, V82, P1647, DOI 10.1161/01.CIR.82.5.1647; Rose GA, 1982, WHO MONOGRAPH SERIES, V56; STRAUSS WE, 1995, CIRCULATION, V92, P1710, DOI 10.1161/01.CIR.92.7.1710; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	19	174	189	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1117	1123		10.1001/jama.289.9.1117	http://dx.doi.org/10.1001/jama.289.9.1117			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622581	Bronze			2022-12-28	WOS:000181289400027
J	Rosenfeld, S; Follmann, D; Nunez, O; Young, NS				Rosenfeld, S; Follmann, D; Nunez, O; Young, NS			Antithymocyte globulin and cyclosporine for severe aplastic anemia - Association between hematologic response and long-term outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MARROW TRANSPLANTATION; COLONY-STIMULATING FACTOR; SAA WORKING PARTY; IMMUNOSUPPRESSIVE THERAPY; ANTILYMPHOCYTE GLOBULIN; PATHOPHYSIOLOGY; DISEASES; CHILDREN; FAILURE	Context In most patients, aplastic anemia results from T-cell-mediated immune destruction of bone marrow. Aplastic anemia can be effectively treated by stem cell transplantation or immunosuppression. Objective To assess long-term outcomes after immunosuppressive therapy. Design, Setting, and Patients Cohort of 122 patients (31 were less than or equal to18 years and 91 were > 18 years) with severe aplastic anemia, as determined by bone marrow cellularity and blood cell count criteria, were enrolled in a single-arm interventional research protocol from 1991 to 1999 at a federal government research hospital. Interventions A dose of 40 mg/kg per day of antithymocyte globulin administered for 4 days, 10 to 12 mg/kg per day of cyclosporine for 6 months (adjusted for blood levels), and a short course of corticosteroids (1 mg/d of m ethyl prednisolone for about 2 weeks). Main Outcome Measures Survival, improvement of pancytopenia and transfusion-independence, relapse, and evolution to other hematologic diseases. Results Response rates were 60% at 3 months after initiation of treatment, 61% at 6 months, and 58% at 1 year. The blood cell counts of patients who responded no longer satisfied severity criteria and they were transfusion-independent. Overall actuarial survival at 7 years was 55%. Survival was associated with early satisfaction of response criteria (86% vs 40% at 5 years; P<.001) and by blood counts at 3 months (reticulocyte count or platelet count of >50 x 10(3)/muL predicted survival at 5 years of 90% [64/71] vs 42% [12/34] for patients with less robust recovery [P<.001 by log-rank test]). There were no deaths among responders more than 3 years after treatment. Relapse was common, but severe pancytopenia usually did not recur. Relapse did not influence survival. Thirteen patients showed evolution to other hematologic diseases, including monosomy 7. Conclusions Approximately half of patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine have durable recovery and excellent long-term survival. These outcomes were related to the quality of hematologic recovery.	NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Young, NS (corresponding author), NHLBI, Hematol Branch, NIH, Bldg 10,Room 7C103,9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL002315, ZIAHL002315] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bacigalupo A, 2000, SEMIN HEMATOL, V37, P69, DOI 10.1016/S0037-1963(00)90031-3; Bacigalupo A, 2000, BLOOD, V95, P1931, DOI 10.1182/blood.V95.6.1931; BACIGALUPO A, 1995, BLOOD, V85, P1348, DOI 10.1182/blood.V85.5.1348.bloodjournal8551348; Barrett J, 2000, SEMIN HEMATOL, V37, P15; Brodsky RA, 2001, ANN INTERN MED, V135, P477, DOI 10.7326/0003-4819-135-7-200110020-00006; CAMITTA BM, 1979, BLOOD, V53, P504; Deeg H J, 1999, Biol Blood Marrow Transplant, V5, P243, DOI 10.1053/bbmt.1999.v5.pm10465104; Di Bona E, 1999, BRIT J HAEMATOL, V107, P330, DOI 10.1046/j.1365-2141.1999.01693.x; FRICKHOFEN N, 1991, NEW ENGL J MED, V324, P1297, DOI 10.1056/NEJM199105093241901; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; HINTERBERGERFISCHER M, 1989, EUR J HAEMATOL, V43, P136; Horowitz MM, 2000, SEMIN HEMATOL, V37, P30; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kojima S, 2000, BLOOD, V96, P2049; KOOK H, IN PRESS EXP HEMATOL; LEONARD EM, 1989, BRIT J HAEMATOL, V72, P278, DOI 10.1111/j.1365-2141.1989.tb07695.x; Maciejewski JP, 2002, BLOOD, V99, P3129, DOI 10.1182/blood.V99.9.3129; Maciejewski JP, 2001, BRIT J HAEMATOL, V115, P1015, DOI 10.1046/j.1365-2141.2001.03191.x; Margolis D, 1996, BRIT J HAEMATOL, V94, P65, DOI 10.1046/j.1365-2141.1996.d01-1772.x; Margolis DA, 2000, SEMIN HEMATOL, V37, P43; MOORE MAS, 1991, NEW ENGL J MED, V324, P1358, DOI 10.1056/NEJM199105093241909; ROSENFELD SJ, 1995, BLOOD, V85, P3058, DOI 10.1182/blood.V85.11.3058.bloodjournal85113058; SCHREZENMEIER H, 1993, BRIT J HAEMATOL, V85, P371, DOI 10.1111/j.1365-2141.1993.tb03181.x; Socie G, 2000, SEMIN HEMATOL, V37, P91; SPECK B, 1977, LANCET, V2, P1145; TICHELLI A, 1994, LEUKEMIA LYMPHOMA, V12, P167, DOI 10.3109/10428199409059587; Tichelli A, 1999, ANN INTERN MED, V130, P193, DOI 10.7326/0003-4819-130-3-199902020-00004; WILLIAMS DM, 1978, CLIN HAEMATOL, V7, P467; Young NS, 1997, NEW ENGL J MED, V336, P1365, DOI 10.1056/NEJM199705083361906; Young NS, 2002, ANN INTERN MED, V136, P534, DOI 10.7326/0003-4819-136-7-200204020-00011; Young NS, 2002, INT J HEMATOL, V75, P129, DOI 10.1007/BF02982017; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687	32	279	318	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1130	1135		10.1001/jama.289.9.1130	http://dx.doi.org/10.1001/jama.289.9.1130			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650XM	12622583				2022-12-28	WOS:000181289400029
J	Fabry, U; Lammert, F; Osieka, R				Fabry, U; Lammert, F; Osieka, R			Thrombocytopenia or giant platelets?	LANCET			English	Editorial Material									Rhein Westfal TH Aachen, Fac Med, Dept Internal Med, D-52074 Aachen, Germany	RWTH Aachen University	Fabry, U (corresponding author), Rhein Westfal TH Aachen, Fac Med, Dept Internal Med, D-52074 Aachen, Germany.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 1	2003	361	9359					735	735		10.1016/S0140-6736(03)12657-8	http://dx.doi.org/10.1016/S0140-6736(03)12657-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620737				2022-12-28	WOS:000181232000008
J	Gangui, A				Gangui, A			A preposterous universe	SCIENCE			English	Editorial Material									Univ Buenos Aires, Dept Phys, RA-1428 Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, Inst Astron & Space Phys, RA-1428 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto de Astronomia y Fisica del Espacio (IAFE)	Gangui, A (corresponding author), Univ Buenos Aires, Dept Phys, Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.							BENNETT CH, UNPUB; Hivon E, 2002, SCIENCE, V298, P1349, DOI 10.1126/science.1078736; Hu W, 2002, ANNU REV ASTRON ASTR, V40, P171, DOI 10.1146/annurev.astro.40.060401.093926; Kovac JM, 2002, NATURE, V420, P772, DOI 10.1038/nature01269; Leitch EM, 2002, NATURE, V420, P763, DOI 10.1038/nature01271; REES MJ, 1968, ASTROPHYS J, V153, pL1, DOI 10.1086/180208; Smoot G.F., 1992, APJ, V396, pL1	8	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1333	1334		10.1126/science.1082423	http://dx.doi.org/10.1126/science.1082423			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610291	Green Submitted, Green Published			2022-12-28	WOS:000181192300036
J	Huneycutt, AJ; Saykally, RJ				Huneycutt, AJ; Saykally, RJ			Building solutions - One molecule at a time	SCIENCE			English	Editorial Material							GAS-PHASE REACTION; WATER; SPECTROSCOPY; CHLORINE; CLUSTERS		Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Huneycutt, AJ (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	ajhuneyc@uclink4.berkeley.edu; saykally@uclink.berkeley.edu		SAYKALLY, RICHARD/0000-0001-8942-3656				Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; Barbour LJ, 1998, NATURE, V393, P671, DOI 10.1038/31441; Blanton WB, 1999, J AM CHEM SOC, V121, P3551, DOI 10.1021/ja982100z; Bondybey VE, 2002, INT REV PHYS CHEM, V21, P277, DOI 10.1080/01442350210132741; FRANCISCO JS, 1995, J AM CHEM SOC, V117, P9917, DOI 10.1021/ja00144a021; Goldman N, 2001, J PHYS CHEM A, V105, P515, DOI 10.1021/jp003567a; Huneycutt AJ, 2003, J CHEM PHYS, V118, P1221, DOI 10.1063/1.1529177; Hurley SM, 2002, SCIENCE, V298, P202, DOI 10.1126/science.1075307; Keutsch FN, 2001, J CHEM PHYS, V114, P4005, DOI 10.1063/1.1337052; Kim NJ, 2002, INT J MASS SPECTROM, V219, P11, DOI 10.1016/S1387-3806(02)00547-X; KOLB CE, 1994, J AM CHEM SOC, V116, P10314, DOI 10.1021/ja00101a067; Leforestier C, 2002, J CHEM PHYS, V117, P8710, DOI 10.1063/1.1514977; Mitsui T, 2002, SCIENCE, V297, P1850, DOI 10.1126/science.1075095; MOLINA MJ, 1987, SCIENCE, V238, P1253, DOI 10.1126/science.238.4831.1253; MOROKUMA K, 1994, J AM CHEM SOC, V116, P10316, DOI 10.1021/ja00101a068; PFEILSTICKER K, UNPUB; Robertson WH, 2003, SCIENCE, V299, P1367, DOI 10.1126/science.1080695; Saykally RJ, 2001, NOBEL SYMP, V117, P206	18	45	47	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1329	1330		10.1126/science.1082269	http://dx.doi.org/10.1126/science.1082269			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610288				2022-12-28	WOS:000181192300033
J	Kondoh, M				Kondoh, M			Foraging adaptation and the relationship between food-web complexity and stability	SCIENCE			English	Article							CAPITA INTERACTION STRENGTH; TEMPORAL VARIATION; RAPID EVOLUTION; COMMUNITIES; RESOLUTION; NETWORKS; STREAM; MODEL; FISH	Ecological theory suggests that complex food webs should not persist because of their inherent instability. "Real" ecosystems often support a large number of interacting species. A mathematical model shows that fluctuating short-term selection on trophic links, arising from a consumer's adaptive food choice, is a key to the long-term stability of complex communities. Without adaptive foragers, food-web complexity destabilizes community composition; whereas in their presence, complexity may enhance community persistence through facilitation of dynamical food-web reconstruction that buffers environmental fluctuations. The model predicts a linkage pattern consistent with field observations.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Kyoto University	Kondoh, M (corresponding author), Cardiff Univ, Cardiff Business Sch, POB 915, Cardiff CF10 3TL, S Glam, Wales.	kondohm@cf.ac.uk	rahim, sharul kamal abdul/K-6346-2012; rahim, sharul kamal abdul/I-1584-2014; Seman, Norhudah/L-9662-2016; Kondoh, Michio/AAE-4332-2019	rahim, sharul kamal abdul/0000-0003-4511-1989; rahim, sharul kamal abdul/0000-0003-4511-1989; Seman, Norhudah/0000-0003-3881-271X; 				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Abrams Peter A., 1996, P113; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Bernays EA, 1999, P ROY SOC B-BIOL SCI, V266, P151, DOI 10.1098/rspb.1999.0615; Chen X, 2001, P ROY SOC B-BIOL SCI, V268, P869, DOI 10.1098/rspb.2001.1596; Chen X, 2001, J THEOR BIOL, V212, P223, DOI 10.1006/jtbi.2001.2370; CLOSS GP, 1994, ECOL MONOGR, V64, P1, DOI 10.2307/2937053; Cohen J.E., 1990, COMMUNITY FOOD WEBS; DEANGELIS DL, 1975, ECOLOGY, V56, P238; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Egas M, 2001, ECOL LETT, V4, P190, DOI 10.1046/j.1461-0248.2001.00219.x; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; HUMPHREYS WF, 1979, J ANIM ECOL, V48, P427, DOI 10.2307/4171; Joshi A, 1997, EVOLUTION, V51, P846, DOI 10.1111/j.1558-5646.1997.tb03666.x; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Matsuda H, 1996, EVOL ECOL, V10, P13, DOI 10.1007/BF01239343; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Pimm S.L., 1991, BALANCE NATURE; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis Gary A., 1996, P275; Raffaelli David G., 1996, P185; Robbins C.T., 1983, WILDLIFE FEEDING NUT; SCHOENLY K, 1991, ECOL MONOGR, V61, P267, DOI 10.2307/2937109; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Stephens DW, 1987, FORAGING THEORY; TavaresCromar AF, 1996, ECOL MONOGR, V66, P91, DOI 10.2307/2963482; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2	34	431	447	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1388	1391		10.1126/science.1079154	http://dx.doi.org/10.1126/science.1079154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610303				2022-12-28	WOS:000181192300050
J	Curfman, GD; Hillis, LD				Curfman, GD; Hillis, LD			A new look at cardiac exercise testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Curfman, GD (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Cardiovasc, Dallas, TX 75235 USA.							Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858	3	12	14	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					775	776		10.1056/NEJMp030004	http://dx.doi.org/10.1056/NEJMp030004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606729				2022-12-28	WOS:000181173300001
J	Geddes, JR; Carney, SM; Davies, C; Furukawa, TA; Kupfer, DJ; Frank, E; Goodwin, GM				Geddes, JR; Carney, SM; Davies, C; Furukawa, TA; Kupfer, DJ; Frank, E; Goodwin, GM			Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review	LANCET			English	Article							LONG-TERM; CONTINUATION THERAPY; DOUBLE-BLIND; MAINTENANCE THERAPIES; RECURRENT DEPRESSION; LITHIUM-CARBONATE; MAJOR DEPRESSION; GLOBAL BURDEN; PLACEBO; UNIPOLAR	Background Antidepressant drugs can promote remission from acute depressive episodes. Our aim was to establish how long such treatments should be continued to prevent relapse. Method We did a systematic overview of evidence from randomised trials of continuing treatment with antidepressants in patients with depressive disorders who have responded to acute treatment. Medline, Embase, Cinahl, PsycLIT, Psyndex, and Lilacs were searched. Findings Data were pooled from 31 randomised trials (4410 participants). Continuing treatment with antidepressants reduced the odds of relapse by 70% (95% CI 62-78; 2p<0.00001) compared with treatment discontinuation. The average rate of relapse on placebo was 41% compared with 18% on active treatment. The treatment effect seemed to persist for up to 36 months, although most trials were of 12 months' duration, and so the evidence on longer-term treatment requires confirmation. Significantly more participants allocated antidepressants withdrew from the trials than did those allocated to placebo (18% vs 15%, respectively; odds ratio 1.30, 95% CI 1.07-1.59): the treatment effect could be even greater in adherent patients. The two-thirds reduction in risk of depressive relapse seemed to be largely independent of the underlying risk of relapse, the duration of treatment before randomisation, or the duration of the randomly allocated therapy. Interpretation Antidepressants reduce the risk of relapse in depressive disorder, and continued treatment with antidepressants would benefit many patients with recurrent depressive disorder. The treatment benefit for an individual patient will depend on their absolute risk of relapse with greater absolute benefits in those at higher risk. Further trials are needed to establish the optimum length of therapy and should include patients who were not well represented in these trials, including those at low risk of relapse.	Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; Univ Oxford, Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX1 2JD, England; Nagoya City Univ, Sch Med, Dept Psychiat, Mizuho Ku, Nagoya, Aichi 467, Japan; Western Psychiat Inst & Clin, UPMC Hlth Syst, Dept Psychiat, Pittsburgh, PA USA	University of Oxford; Radcliffe Infirmary; University of Oxford; Nagoya City University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Geddes, JR (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	john.geddes@psych.ox.ac.uk	Furukawa, Toshi A./B-9259-2011	Furukawa, Toshi A./0000-0003-2159-3776; Geddes, John/0000-0002-5281-5960				Alexopoulos GS, 2000, ARCH GEN PSYCHIAT, V57, P285, DOI 10.1001/archpsyc.57.3.285; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Anderson IM, 2000, J PSYCHOPHARMACOL, V14, P3, DOI 10.1177/026988110001400101; [Anonymous], 2000, Am J Psychiatry, V157, P1; BIALOS D, 1982, AM J PSYCHIAT, V139, P325; Burgess S.S.A., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003013, DOI 10.1002/14651858.CD003013]; CLARKE MJ, 1994, BRIT MED J, V309, P1007, DOI 10.1136/bmj.309.6960.1007; COOK BL, 1986, J AFFECT DISORDERS, V10, P91, DOI 10.1016/0165-0327(86)90031-5; COPPEN A, 1978, BRIT J PSYCHIAT, V133, P28, DOI 10.1192/bjp.133.1.28; DAVIDSON J, 1984, NEUROPSYCHOBIOLOGY, V11, P191, DOI 10.1159/000118076; Depression Guideline Panel, 1993, DEPR PRIM CAR, DOI [10.1002/depr.3050020202, DOI 10.1002/DEPR.3050020202]; DOOGAN DP, 1992, BRIT J PSYCHIAT, V160, P217, DOI 10.1192/bjp.160.2.217; ERIC L, 1991, BIOL PSYCHIAT, V29, P11; Feiger AD, 1999, INT CLIN PSYCHOPHARM, V14, P19, DOI 10.1097/00004850-199901000-00002; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; FRANK E, 1990, ARCH GEN PSYCHIAT, V47, P1093; Furukawa TA, 2002, INT J EPIDEMIOL, V31, P72, DOI 10.1093/ije/31.1.72; GEDDES JR, 2002, DEPRESSIVE DISORDERS; GEORGOTAS A, 1989, ARCH GEN PSYCHIAT, V46, P783; GLEN AIM, 1984, PSYCHOL MED, V14, P37, DOI 10.1017/S0033291700003068; GOODWIN GM, 1994, BRIT J PSYCHIAT, V164, P149, DOI 10.1192/bjp.164.2.149; HARRISON W, 1986, J CLIN PSYCHIAT, V47, P346; Hirschfield RMA, 1997, JAMA-J AM MED ASSOC, V277, P333, DOI 10.1001/jama.277.4.333; Hochstrasser B, 2001, BRIT J PSYCHIAT, V178, P304, DOI 10.1192/bjp.178.4.304; JACOBY R, 1993, BRIT J PSYCHIAT, V162, P175; JENKINS SW, 1991, J CLIN PSYCHOPHARM, V10, P77; KANE JM, 1982, ARCH GEN PSYCHIAT, V39, P1065; Keller MB, 1998, JAMA-J AM MED ASSOC, V280, P1665, DOI 10.1001/jama.280.19.1665; KISHIMOTO A, 1994, ACTA PSYCHIAT SCAND, V89, P46, DOI 10.1111/j.1600-0447.1994.tb01484.x; KLERMAN GL, 1974, AM J PSYCHIAT, V131, P186, DOI 10.1176/ajp.131.2.186; Klysner R, 2002, BRIT J PSYCHIAT, V181, P29, DOI 10.1192/bjp.181.1.29; Kocsis JH, 1996, ARCH GEN PSYCHIAT, V53, P769; KUPFER DJ, 1992, ARCH GEN PSYCHIAT, V49, P769; LENDRESSE PH, 1985, PSYCHIAT FRANCAISE, V16, P156; MANDER AJ, 1988, LANCET, V2, P15; MINDHAM RHS, 1972, LANCET, V2, P854; MONTGOMERY SA, 1993, INT CLIN PSYCHOPHARM, V8, P189, DOI 10.1097/00004850-199300830-00009; MONTGOMERY SA, 1988, BRIT J PSYCHIAT, V153, P69; MONTGOMERY SA, 1992, INT CLIN PSYCHOPHARM, V6, P71, DOI 10.1097/00004850-199206005-00008; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; PAYKEL ES, 1992, BRIT MED J, V305, P1198, DOI 10.1136/bmj.305.6863.1198; PRIEN RF, 1984, ARCH GEN PSYCHIAT, V41, P1096; Reimherr FW, 1998, AM J PSYCHIAT, V155, P1247, DOI 10.1176/ajp.155.9.1247; Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39; ROBERTS JM, 1995, J PIDGIN CREOLE LANG, V10, P1, DOI 10.1075/jpcl.10.1.02rob; ROBINSON DS, 1991, PSYCHOPHARMACOL BULL, V27, P31; ROUILLON F, 1989, Encephale, V15, P527; Rouillon F, 2000, J AFFECT DISORDERS, V58, P171, DOI 10.1016/S0165-0327(99)00109-3; STEIN MK, 1980, AM J PSYCHIAT, V137, P370; SUPPES T, 1991, ARCH GEN PSYCHIAT, V48, P1082; Terra JL, 1998, INT CLIN PSYCHOPHARM, V13, P55, DOI 10.1097/00004850-199803000-00001; Versiani M, 1999, J CLIN PSYCHIAT, V60, P400, DOI 10.4088/JCP.v60n0610; Viguera AC, 1998, HARVARD REV PSYCHIAT, V5, P293, DOI 10.3109/10673229809003578; YUSUF S, 1985, EUR HEART J, V6, P556, DOI 10.1093/oxfordjournals.eurheartj.a061905	55	597	612	0	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2003	361	9358					653	661		10.1016/S0140-6736(03)12599-8	http://dx.doi.org/10.1016/S0140-6736(03)12599-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606176				2022-12-28	WOS:000181129500014
J	McCarthy, M				McCarthy, M			US military prepares for Iraq to use chemical and biological weapons	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					628	628		10.1016/S0140-6736(03)12621-9	http://dx.doi.org/10.1016/S0140-6736(03)12621-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12611388				2022-12-28	WOS:000181129500005
J	Yosipovitch, G; Greaves, MW; Schmelz, M				Yosipovitch, G; Greaves, MW; Schmelz, M			Itch	LANCET			English	Review							HISTAMINE-INDUCED ITCH; TOPICALLY APPLIED ASPIRIN; HUMAN CEREBRAL-CORTEX; ATOPIC-DERMATITIS; SUBSTANCE-P; NEUROGENIC INFLAMMATION; UREMIC PRURITUS; RECEPTOR ANTAGONIST; SCRATCHING BEHAVIOR; NEURAL PATHWAY	Itch is a common skin sensation, with substantial effects on behaviour. Neurophysiological research has permitted accurate definition of neural pathways of itch, and has confirmed the distinctiveness of itch pathways in comparison with pain. A clinical classification of itch, based on such improved understanding, describes the difference between peripheral (pruritoceptive) and central (neurogenic or neuropathic) itch. New specific and sensitive investigational methods in people and animals enable us to better understand this bothersome symptom, and have important clinical implications. We describe the clinical classification of itch, new findings on neuropathophysiology of itch, methods for assessment, and improved treatments.	Wake Forest Univ, Dept Dermatol, Winston Salem, NC 27517 USA; Hosp Univ Kebangsaan Malaysia, Fac Med, Dept Dermatol, Kuala Lumpur, Malaysia; Univ Mannheim, Dept Anaesthesiol, Heidelberg, Germany	Wake Forest University; Universiti Kebangsaan Malaysia; Ruprecht Karls University Heidelberg; University of Mannheim	Yosipovitch, G (corresponding author), Wake Forest Univ, Dept Dermatol, Med Ctr Blvd, Winston Salem, NC 27517 USA.	gyosipov@wfubmc.edu	Schmelz, Martin/A-9327-2013; Yosipovitch, Gil/K-3517-2019	Schmelz, Martin/0000-0002-9736-7241; 				Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; BERGASA NV, 1992, GASTROENTEROLOGY, V102, P544, DOI 10.1016/0016-5085(92)90102-5; Bergasa NV, 1999, J AM ACAD DERMATOL, V41, P431, DOI 10.1016/S0190-9622(99)70117-9; Bernhard JD, 1994, ITCH MECH MANAGEMENT, P185; Bickford RG, 1938, CLIN SCI, V3, P377; Bueller HA, 1999, J EUR ACAD DERMATOL, V13, P227, DOI 10.1111/j.1468-3083.1999.tb00890.x; Chan LS, 2001, J INVEST DERMATOL, V117, P977, DOI 10.1046/j.0022-202x.2001.01484.x; Chia SC, 1998, DIGEST DIS SCI, V43, P2177, DOI 10.1023/A:1026646017851; Cocchiara R, 1999, J NEUROIMMUNOL, V101, P128, DOI 10.1016/S0165-5728(99)00138-1; DALY BM, 1986, BRIT MED J, V293, P907, DOI 10.1136/bmj.293.6552.907; Darsow U, 2001, INT ARCH ALLERGY IMM, V124, P326, DOI 10.1159/000053748; Darsow U, 2000, J INVEST DERMATOL, V115, P1029, DOI 10.1046/j.1523-1747.2000.00193.x; DRAKE LA, 1994, J AM ACAD DERMATOL, V31, P613, DOI 10.1016/S0190-9622(94)70225-X; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Ebata T, 1999, BRIT J DERMATOL, V141, P82; Ebata T, 2001, BRIT J DERMATOL, V144, P305, DOI 10.1046/j.1365-2133.2001.04019.x; Endo K, 1997, ACTA DERM-VENEREOL, V77, P432; Fishman SM, 1997, AM J MED, V102, P584; FolsterHolst R, 1996, J DERMATOL TREAT, V7, P13, DOI 10.3109/09546639609086862; Grant AD, 2001, BRIT MED J, V322, P1475, DOI 10.1136/bmj.322.7300.1475; Greaves MW, 1996, LANCET, V348, P938, DOI 10.1016/S0140-6736(96)04328-0; GREAVES MW, 1973, BRIT MED J, V3, P608, DOI 10.1136/bmj.3.5881.608; GREAVES MW, 1998, DERMATOLOGY GEN MED, P487; Herzberg U, 2001, J NEUROIMMUNOL, V116, P29, DOI 10.1016/S0165-5728(01)00288-0; HEYER G, 1995, ACTA DERM-VENEREOL, V75, P348; HSIEH JC, 1994, J NEUROPHYSIOL, V72, P3004, DOI 10.1152/jn.1994.72.6.3004; JANCSO N, 1967, BRIT J PHARM CHEMOTH, V31, P138, DOI 10.1111/j.1476-5381.1967.tb01984.x; Jinks SL, 2002, J NEUROPHYSIOL, V87, P1280, DOI 10.1152/jn.00431.2001; Jones EA, 1999, HEPATOLOGY, V29, P1003, DOI 10.1002/hep.510290450; Kamei J, 2001, EUR J PHARMACOL, V418, P141, DOI 10.1016/S0014-2999(01)00941-4; Kirchner A, 2002, NEUROLOGY, V59, P108, DOI 10.1212/WNL.59.1.108; KRAUSE L, 1983, BRIT MED J, V287, P1199, DOI 10.1136/bmj.287.6400.1199; Krueger G, 2001, ARCH DERMATOL, V137, P280; KUMAGAI H, 2001, INT WORKSH STUD ITCH, P59; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Lear JT, 1996, J AM ACAD DERMATOL, V35, P642, DOI 10.1016/S0190-9622(96)90701-X; LYNN B, 1992, SKIN PHARMACOL, V5, P9; MCGLONE F, 2001, INT WORKSH STUD ITCH, P22; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Metze D, 1999, J AM ACAD DERMATOL, V41, P533, DOI 10.1016/S0190-9622(99)80048-6; Miller MJS, 2001, J INVEST DERMATOL, V117, P725, DOI 10.1046/j.0022-202x.2001.01446.x; MONROE EW, 1989, J AM ACAD DERMATOL, V21, P135, DOI 10.1016/S0190-9622(89)80353-6; MONTI JM, 1989, SLEEP, V12, P309, DOI 10.1093/sleep/12.4.309; Murphy M, 2000, CLIN EXP DERMATOL, V25, P103; NAUKKARINEN A, 1989, J INVEST DERMATOL, V92, P126, DOI 10.1111/1523-1747.ep13071340; Nilsson HJ, 1997, PAIN, V71, P49, DOI 10.1016/S0304-3959(97)03339-3; NILSSON HJ, 1999, THESIS U LUND; Oaklander AL, 2002, PAIN, V96, P9, DOI 10.1016/S0304-3959(01)00400-6; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Pauli-Magnus C, 2000, J AM SOC NEPHROL, V11, P514, DOI 10.1681/ASN.V113514; Peer G, 1996, LANCET, V348, P1552, DOI 10.1016/S0140-6736(96)04176-1; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Pincelli C, 2000, EUR J DERMATOL, V10, P85; Rodwell GEL, 2000, CLIN DERMATOL, V18, P479, DOI 10.1016/S0738-081X(99)00143-1; Rukwied R, 2000, BRIT J DERMATOL, V142, P1114, DOI 10.1046/j.1365-2133.2000.03535.x; Ruzicka T, 1997, NEW ENGL J MED, V337, P816, DOI 10.1056/NEJM199709183371203; Sandyk R, 1994, Int J Neurosci, V75, P65; Schmelz M, 1999, CLIN EXP ALLERGY, V29, P695; Schmelz M, 1997, J NEUROSCI, V17, P8003; Schmelz M, 2001, NAT NEUROSCI, V4, P9, DOI 10.1038/82956; Schwartz IF, 1999, NEPHROL DIAL TRANSPL, V14, P834, DOI 10.1093/ndt/14.4.834; SOWDEN JM, 1991, LANCET, V338, P137, DOI 10.1016/0140-6736(91)90134-B; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Suzuki R, 1999, J IMMUNOL, V163, P2410; TALBOT T L, 1991, Biomedical Instrumentation and Technology, V25, P400; Togashi Y, 2002, EUR J PHARMACOL, V435, P259, DOI 10.1016/S0014-2999(01)01588-6; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; WAHLGREN CF, 1995, SEMIN DERMATOL, V14, P277, DOI 10.1016/S1085-5629(05)80048-3; Weidner C, 2000, J INVEST DERMATOL, V115, P1015, DOI 10.1046/j.1523-1747.2000.00142.x; Yagi R, 2002, J IMMUNOL, V168, P2020, DOI 10.4049/jimmunol.168.4.2020; YAMAGIWA K, 1998, RRD BIOTECH BIOENG 1, V1, P19; Yosipovitch G, 2000, BRIT J DERMATOL, V143, P969, DOI 10.1046/j.1365-2133.2000.03829.x; Yosipovitch G, 1997, ACTA DERM-VENEREOL, V77, P46; Yosipovitch G, 2001, ACTA DERM-VENEREOL, V81, P108; Yosipovitch G, 2001, J AM ACAD DERMATOL, V45, P910, DOI 10.1067/mjd.2001.117399; Yosipovitch G, 1999, ACTA DERM-VENEREOL, V79, P118	76	302	323	1	50	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2003	361	9358					690	694		10.1016/S0140-6736(03)12570-6	http://dx.doi.org/10.1016/S0140-6736(03)12570-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606187				2022-12-28	WOS:000181129500025
J	Roth, AE				Roth, AE			The origins, history, and design of the resident match	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATURAL EXPERIMENT; MARKET; PHYSICIANS; ORGANIZATION	In the early 1900s, competition among hospitals for interns and among medical students for good internships led to increasingly early offers of internships to students. By the 1940s, appointments were often made as early as the beginning of the junior year of medical school.. Hospitals thus had little information about students' performance, and students frequently had to make a final decision to accept or reject an offer without knowing which other offers might be forthcoming. From 1945 through 1951, efforts were made to enforce a uniform date for accepting offers. However, students were still faced with offers having very short deadlines, compelling them to accept or reject offers without knowing what other offers might be forthcoming. Hospitals often had to scramble for available students, since if an offer,was rejected, it was often too late for them to reach their next preferred candidate. A centralized clearinghouse was thus developed as a way of alleviating this chaos and allowing a larger role to the preferences of both students and hospitals. This evolved into the current matching program, whose algorithm continues to be updated to take account of changing needs of applicants, such as growth in the number of couples who seek 2 positions in the same vicinity.	Harvard Univ, Dept Econ, Baker Lib 183, Boston, MA 02163 USA	Harvard University	Roth, AE (corresponding author), Harvard Univ, Dept Econ, Baker Lib 183, Boston, MA 02163 USA.			Roth, Alvin/0000-0002-8834-6481				Darrach W, 1927, BULL ASSOC AM MED CO, V2, P68; Fitz R, 1939, J ASSOC AM MED COLL, V14, P101; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; HATFIELD JN, 1935, NATL HOSP FORUM  FEB; Ludmerer K., 1999, TIME HEAL AM MED ED; Mullin FJ, 1951, J MED EDUC, V26, P341; Mullin FJ, 1952, J MED EDUC, V27, P193; MULLIN F J, 1950, J Assoc Am Med Coll, V25, P437; Roth A.E., 1990, 2 SIDED MATCHING STU, V18; ROTH AE, 1994, AM ECON REV, V84, P992; ROTH AE, 1991, AM ECON REV, V81, P415; ROTH AE, 1984, J POLIT ECON, V92, P991, DOI 10.1086/261272; Roth AE, 2002, ECONOMETRICA, V70, P1341, DOI 10.1111/1468-0262.00335; Roth AE, 1999, AM ECON REV, V89, P748, DOI 10.1257/aer.89.4.748; Roth AE, 1997, JAMA-J AM MED ASSOC, V278, P729, DOI 10.1001/jama.278.9.729; ROTH AE, 1990, SCIENCE, V250, P1524, DOI 10.1126/science.2274783; Starr P, 1982, SOCIAL TRANSFORMATIO; Turner J, 1945, J ASSOC AM MED COLL, V20, P26	18	83	86	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					909	912		10.1001/jama.289.7.909	http://dx.doi.org/10.1001/jama.289.7.909			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647BW	12588278	Bronze			2022-12-28	WOS:000181072200038
J	Kumagai, H; Miyakawa, K; Negishi, H; Inoue, H; Obara, K; Suetsugu, D				Kumagai, H; Miyakawa, K; Negishi, H; Inoue, H; Obara, K; Suetsugu, D			Magmatic dike resonances inferred from very-long-period seismic signals	SCIENCE			English	Article							FLUID-DRIVEN CRACK; ACOUSTIC PROPERTIES; VOLCANO; JAPAN; DIMENSIONS; EVENTS	Very-long-period (VLP) signals showing simple decaying harmonic oscillations with periods near 10 seconds and lasting for about 300 seconds were observed in association with an earthquake swarm that occurred beneath Hachijo Island, Japan. Results from the source-mechanism analysis and waveform simulation based on a fluid-filled crack model consistently point to the resonance of a dike filled with a basaltic magma as the source of the VLP signals. Thus, VLP signals can be used to probe the state of the fluid and dynamic processes within a volcanic system.	Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 305, Japan; Japan Marine Sci & Technol Ctr, Inst Frontier Res Earth Evolut, Yokosuka, Kanagawa, Japan	National Research Institute for Earth Science & Disaster Resilience; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Kumagai, H (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 305, Japan.	kumagai@bosai.go.jp						BOUCHON M, 1979, J GEOPHYS RES, V84, P3609, DOI 10.1029/JB084iB07p03609; Chouet B, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001919; CHOUET B, 1982, J GEOPHYS RES, V87, P3868, DOI 10.1029/JB087iB05p03868; CHOUET B, 1988, J GEOPHYS RES-SOLID, V93, P4375, DOI 10.1029/JB093iB05p04375; CHOUET B, 1986, J GEOPHYS RES-SOLID, V91, P13967, DOI 10.1029/JB091iB14p13967; Chouet B, 1992, VOLCANIC SEISMOLOGY, V3, P133; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; Garces MA, 1997, J GEOPHYS RES-SOL EA, V102, P22547, DOI 10.1029/97JB01799; KAWAKATSU H, 1992, GEOPHYS RES LETT, V19, P1959, DOI 10.1029/92GL01964; Kawakatsu H, 2000, J VOLCANOL GEOTH RES, V101, P129, DOI 10.1016/S0377-0273(00)00166-9; Kumagai H, 2000, J GEOPHYS RES-SOL EA, V105, P25493, DOI 10.1029/2000JB900273; Kumagai H, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001704; Kumagai H, 2001, GEOPHYS RES LETT, V28, P3325, DOI 10.1029/2001GL013025; Kumagai H, 2001, SCIENCE, V293, P687, DOI 10.1126/science.1062136; KUMAZAWA M, 1990, GEOPHYS J INT, V101, P613, DOI 10.1111/j.1365-246X.1990.tb05574.x; Nakano M, 2003, J VOLCANOL GEOTH RES, V122, P149, DOI 10.1016/S0377-0273(02)00499-7; NEUBERG J, 1994, GEOPHYS RES LETT, V21, P749, DOI 10.1029/94GL00377; Nishimura T, 2000, J GEOPHYS RES-SOL EA, V105, P19135, DOI 10.1029/2000JB900155; Ohminato T, 1998, J GEOPHYS RES-SOL EA, V103, P23839, DOI 10.1029/98JB01122; The Japan Society of Mechanical Engineers, 1999, JSME STEAM TABL; UENO H, 2002, NEWSLETT SEISMOL SOC, V14, P3; Yamamoto M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013996	22	36	36	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 28	2003	299	5615					2058	2061		10.1126/science.1081195	http://dx.doi.org/10.1126/science.1081195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LG	12589005				2022-12-28	WOS:000181834200052
J	Hanash, S				Hanash, S			Disease proteomics	NATURE			English	Review							2-DIMENSIONAL GEL-ELECTROPHORESIS; HELICOBACTER-PYLORI; BACILLUS-SUBTILIS; IMMUNE-RESPONSE; BREAST-CANCER; EXPRESSION; HEART; PH; MICROARRAYS; CARDIOMYOCYTES		Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hanash, S (corresponding author), Univ Michigan, Dept Pediat, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	shanash@umich.edu						[Anonymous], 2002, Nature, V419, P323; Antelmann H, 2002, PROTEOMICS, V2, P591, DOI 10.1002/1615-9861(200205)2:5<591::AID-PROT591>3.0.CO;2-8; Arrell DK, 2001, CIRC RES, V89, P480, DOI 10.1161/hh1801.097240; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Brenton JD, 2001, BREAST CANCER RES, V3, P77, DOI 10.1186/bcr274; Brichory FM, 2001, P NATL ACAD SCI USA, V98, P9824, DOI 10.1073/pnas.171320598; Brivio M, 2002, ANAL CHEM, V74, P3972, DOI 10.1021/ac020185n; Chen GA, 2002, CLIN CANCER RES, V8, P2298; Evans G, 1997, ELECTROPHORESIS, V18, P471, DOI 10.1002/elps.1150180322; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; GOUREVITCH MM, 1995, BRIT J CANCER, V72, P934, DOI 10.1038/bjc.1995.436; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Gruvberger S, 2001, CANCER RES, V61, P5979; Gure AO, 1998, CANCER RES, V58, P1034; Haas G, 2002, PROTEOMICS, V2, P313, DOI 10.1002/1615-9861(200203)2:3<313::AID-PROT313>3.0.CO;2-7; Hanash S, 2003, NAT BIOTECHNOL, V21, P37, DOI 10.1038/nbt0103-37; Hanash S, 2001, Proteomics, V1, P635; Hanash SM, 2002, LEUKEMIA, V16, P478, DOI 10.1038/sj.leu.2402412; Heinke MY, 1998, ELECTROPHORESIS, V19, P2021, DOI 10.1002/elps.1150191122; Hoving S, 2002, PROTEOMICS, V2, P127, DOI 10.1002/1615-9861(200202)2:2<127::AID-PROT127>3.0.CO;2-Y; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Knezevic V, 2001, PROTEOMICS, V1, P1271, DOI 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6; Langen H, 2000, ELECTROPHORESIS, V21, P411, DOI 10.1002/(SICI)1522-2683(20000101)21:2<411::AID-ELPS411>3.3.CO;2-W; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Naour F, 2001, PROTEOMICS, V1, P1295; Lewis L, 2000, J TELEMED TELECARE, V6, P43, DOI 10.1258/1357633001935527; Li XP, 1999, ELECTROPHORESIS, V20, P891, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<891::AID-ELPS891>3.0.CO;2-2; Madoz-Gurpide J, 2001, PROTEOMICS, V1, P1279, DOI 10.1002/1615-9861(200110)1:10<1279::AID-PROT1279>3.3.CO;2-N; McKerrow JH, 2000, MOL MED, V6, P450, DOI 10.1007/BF03401787; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Nilsson Carol L, 2002, Am J Pharmacogenomics, V2, P59, DOI 10.2165/00129785-200202010-00005; Old LJ, 1998, J EXP MED, V187, P1163, DOI 10.1084/jem.187.8.1163; Patton WF, 2002, J CHROMATOGR B, V771, P3, DOI 10.1016/S1570-0232(02)00043-0; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; Reid SD, 2002, J BACTERIOL, V184, P6316, DOI 10.1128/JB.184.22.6316-6324.2002; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Rubenwolf S, 2002, PROTEOMICS, V2, P241, DOI 10.1002/1615-9861(200203)2:3<241::AID-PROT241>3.0.CO;2-7; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soussi T, 1996, IMMUNOL TODAY, V17, P354, DOI 10.1016/0167-5699(96)30019-4; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van der Velden J, 2001, CIRCULATION, V104, P1140, DOI 10.1161/hc3501.095485; Van Eyk JE, 2001, CURR OPIN MOL THER, V3, P546; VanBogelen RA, 1999, ELECTROPHORESIS, V20, P2149, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2149::AID-ELPS2149>3.3.CO;2-E; Vondriska Thomas M, 2002, Expert Opin Ther Targets, V6, P563; Westbrook JA, 2001, ELECTROPHORESIS, V22, P2865, DOI 10.1002/1522-2683(200108)22:14<2865::AID-ELPS2865>3.0.CO;2-Y; Yamamoto A, 1996, INT J CANCER, V69, P283, DOI 10.1002/(SICI)1097-0215(19960822)69:4<283::AID-IJC8>3.3.CO;2-D; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185; Zhou G, 2002, MOL CELL PROTEOMICS, V1, P117, DOI 10.1074/mcp.M100015-MCP200; Zuo X, 2002, PROTEOMICS, V2, P58, DOI 10.1002/1615-9861(200201)2:1<58::AID-PROT58>3.3.CO;2-7	59	754	869	4	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					226	232		10.1038/nature01514	http://dx.doi.org/10.1038/nature01514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634796	Green Published			2022-12-28	WOS:000181488900057
J	Chase-Lansdale, PL; Moffitt, RA; Lohman, BJ; Cherlin, AJ; Coley, RL; Pittman, LD; Roff, J; Votruba-Drzal, E				Chase-Lansdale, PL; Moffitt, RA; Lohman, BJ; Cherlin, AJ; Coley, RL; Pittman, LD; Roff, J; Votruba-Drzal, E			Mothers transitions from welfare to work and the well-being of preschoolers and adolescents	SCIENCE			English	Article							COGNITIVE-DEVELOPMENT; MATERNAL EMPLOYMENT; SINGLE MOTHERS; CHILDREN; BEHAVIOR	Results from a longitudinal study of 2402 low-income families during the recent unprecedented era of welfare reform suggest that mothers' transitions off welfare and into employment are not associated with negative outcomes for preschoolers (ages 2 to 4 years) or young adolescents (ages 10 to 14 years). Indeed, no significant associations with mothers' welfare and employment transitions were found for preschoolers, and the dominant pattern was also of few statistically significant associations for adolescents. The associations that did occur provided slight evidence that mothers' entry into the labor force was related to improvements in adolescents' mental health, whereas exits from employment were linked with teenagers' increased behavior problems.	Northwestern Univ, Evanston, IL 60208 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA; Boston Coll, Boston, MA 02467 USA; No Illinois Univ, De Kalb, IL 60115 USA	Northwestern University; Johns Hopkins University; Boston College; Northern Illinois University	Chase-Lansdale, PL (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.							Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; Bianchi SM, 2000, DEMOGRAPHY, V37, P401, DOI 10.1353/dem.2000.0001; BLANK R, 2002, NEW WORLD WELFARE; Chase-Lansdale PL, 2002, FUTURE CHILD, V12, P167; Coley RL, 2000, SOC SERV REV, V74, P380, DOI 10.1086/516410; Duncan G.J., 2001, BETTER WORSE WELFARE, P103; Gennetian LA, 2002, WELFARE WORK POLICIE; Graber JA, 1996, DEV PSYCHOL, V32, P768, DOI 10.1037/0012-1649.32.4.768; Hofferth SL, 2000, J SOC ISSUES, V56, P747, DOI 10.1111/0022-4537.00194; Kalil A., 2001, BETTER WORSE WELFARE, P154; KU I, 2000, I RES POV MAD WI DEC; Maccoby EE, 2000, ANNU REV PSYCHOL, V51, P1, DOI 10.1146/annurev.psych.51.1.1; MCLOYD VC, 1994, CHILD DEV, V65, P562, DOI 10.1111/j.1467-8624.1994.tb00769.x; MOFFITT R, 2002, EVALUATING WELFARE R; MOFFITT R, 2000, 0001 JOHNS HOPK U; Morris PA., 2001, WELFARE WORK POLICIE; PETERS EH, 1997, CONSEQUENCES GROWING, P340; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Smith JR, 2001, CHILD DEV, V72, P1512, DOI 10.1111/1467-8624.00363; Smith JR, 2000, J MARRIAGE FAM, V62, P808, DOI 10.1111/j.1741-3737.2000.00808.x; Waldfogel J, 2002, DEMOGRAPHY, V39, P369, DOI 10.1353/dem.2002.0021; WINSTON, 1999, WELFARE CHILDREN FAM	22	156	157	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1548	1552		10.1126/science.1076921	http://dx.doi.org/10.1126/science.1076921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	652EY	12624259				2022-12-28	WOS:000181367900029
J	Dubrovinsky, L; Dubrovinskaia, N; Langenhorst, F; Dobson, D; Rubie, D; Gessmann, C; Abrikosov, IA; Johansson, B; Baykov, VI; Vitos, L; Le Bihan, T; Crichton, WA; Dmitriev, V; Weber, HP				Dubrovinsky, L; Dubrovinskaia, N; Langenhorst, F; Dobson, D; Rubie, D; Gessmann, C; Abrikosov, IA; Johansson, B; Baykov, VI; Vitos, L; Le Bihan, T; Crichton, WA; Dmitriev, V; Weber, HP			Iron-silica interaction at extreme conditions and the electrically conducting layer at the base of Earth's mantle	NATURE			English	Article							HIGH-PRESSURE; LIQUID-IRON; INNER-CORE; X-RAY; BOUNDARY; TEMPERATURES; METAL; HETEROGENEITY	The boundary between the Earth's metallic core and its silicate mantle is characterized by strong lateral heterogeneity and sharp changes in density, seismic wave velocities, electrical conductivity and chemical composition(1-7). To investigate the composition and properties of the lowermost mantle, an understanding of the chemical reactions that take place between liquid iron and the complex Mg-Fe-Si-Al-oxides of the Earth's lower mantle is first required(8-15). Here we present a study of the interaction between iron and silica (SiO(2)) in electrically and laser-heated diamond anvil cells. In a multianvil apparatus at pressures up to 140 GPa and temperatures over 3,800 K we simulate conditions down to the core-mantle boundary. At high temperature and pressures below 40 GPa, iron and silica react to form iron oxide and an iron-silicon alloy, with up to 5 wt% silicon. At pressures of 85-140 GPa, however, iron and SiO(2) do not react and iron-silicon alloys dissociate into almost pure iron and a CsCl-structured (B2) FeSi compound. Our experiments suggest that a metallic silicon-rich B2 phase, produced at the core-mantle boundary (owing to reactions between iron and silicate(2,9,10,13)), could accumulate at the boundary between the mantle and core and explain the anomalously high electrical conductivity of this region(6).	Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany; Max Planck Inst Chem, D-55128 Mainz, Germany; Uppsala Univ, Dept Phys, Condensed Matter Theory Grp, S-75121 Uppsala, Sweden; Royal Inst Technol, Dept Mat Sci & Engn, SE-10044 Stockholm, Sweden; Moscow Steel & Alloys Inst, Dept Theoret Phys, Moscow 117936, Russia; European Synchrotron Radiat Facil, Swiss Norwegian Beam Lines, F-38043 Grenoble, France; Hungarian Acad Sci, Solid State Phys Res Inst, H-1525 Budapest, Hungary	University of Bayreuth; Max Planck Society; Uppsala University; Royal Institute of Technology; National University of Science & Technology (MISIS); European Synchrotron Radiation Facility (ESRF); Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics	Dubrovinsky, L (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.	Leonid.Dubrovinsky@uni-bayreuth.de	Vitos, Levente/AAW-5606-2021; Abrikosov, Igor A/I-7328-2013; LE BIHAN, Tristan/I-5063-2013; Dmitriev, Vladimir/A-3235-2011; Dubrovinskaia, Natalia/A-8013-2015	Dubrovinskaia, Natalia/0000-0002-8256-5675; Langenhorst, Falko/0000-0003-4892-7713; Crichton, Wilson/0000-0001-6823-5509; Dobson, David/0000-0002-0890-0121; Dubrovinsky, Leonid/0000-0002-3717-7585				Alfe D, 2000, GEOPHYS RES LETT, V27, P2417, DOI 10.1029/2000GL011567; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; Buffett BA, 2000, SCIENCE, V290, P1338, DOI 10.1126/science.290.5495.1338; BUFFETT BA, 1992, J GEOPHYS RES-SOL EA, V97, P19581, DOI 10.1029/92JB00977; CARNERO EJ, 2000, GEOPHYS RES LETT, V27, P2777; DOBSON DP, IN PRESS AM MINERAL; Dubrovinsky L, 2001, NATURE, V412, P527, DOI 10.1038/35087559; Dubrovinsky LS, 2000, PHYS REV LETT, V84, P1720, DOI 10.1103/PhysRevLett.84.1720; Gessmann CK, 2001, EARTH PLANET SC LETT, V184, P367, DOI 10.1016/S0012-821X(00)00325-3; GOARANT F, 1992, J GEOPHYS RES-SOL EA, V97, P4477, DOI 10.1029/92JB00018; GURNIS M, 1998, CORE MANTLE BOUNDARY; Guyot F, 1997, EUR J MINERAL, V9, P277; Jeanloz R, 1998, REV MINERAL, V37, P241; KNITTLE E, 1991, SCIENCE, V251, P1438, DOI 10.1126/science.251.5000.1438; KNITTLE E, 1989, GEOPHYS RES LETT, V16, P609, DOI 10.1029/GL016i007p00609; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; Lin JF, 2002, SCIENCE, V295, P313, DOI 10.1126/science.1066932; Poirier JP, 1998, GEODYNAMICS, V28, P131; Prokopenko VB, 2001, J ALLOY COMPD, V327, P87, DOI 10.1016/S0925-8388(01)01402-5; Shen GY, 1998, GEOPHYS RES LETT, V25, P373, DOI 10.1029/97GL03776; SONG X, 1994, GEOPHYS RES LETT, V21, P153, DOI 10.1029/93GL03262; Steinle-Neumann G, 2001, NATURE, V413, P57, DOI 10.1038/35092536; Tschauner O, 1999, NATURE, V398, P604, DOI 10.1038/19287; Vidale JE, 2000, NATURE, V404, P273, DOI 10.1038/35005059	24	94	98	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					58	61		10.1038/nature01422	http://dx.doi.org/10.1038/nature01422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621431				2022-12-28	WOS:000181343100035
J	Lee, BK; Atwood, JE				Lee, BK; Atwood, JE			Calcified left ventricular aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Calif San Francisco, San Francisco, CA 94143 USA; Walter Reed Army Med Ctr, Washington, DC 20307 USA	University of California System; University of California San Francisco; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Lee, BK (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.		Mahajan, Rajiv/Q-3033-2019	Mahajan, Rajiv/0000-0003-3375-5568					0	8	8	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					918	918		10.1056/NEJMicm010137	http://dx.doi.org/10.1056/NEJMicm010137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621136				2022-12-28	WOS:000181341100007
J	Fassin, D; Schneider, H				Fassin, D; Schneider, H			The politics of AIDS in South Africa: beyond the controversies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VIOLENCE	At the beginning of 2000 Thabo Mbeki sent a letter to world leaders expressing his doubt that HIV was the exclusive cause of AIDS and arguing for a consideration of socioeconomic causes. He subsequently invited scientists who shared his view to sit with orthodox experts on AIDS on a presidential panel to advise him on appropriate responses to the epidemic in South Africa. Until April 2002, when Mbeki formally distanced himself from the AIDS "dissidents," the international scientific community's interest in South African policies on AIDS was almost exclusively focused on the polemic raised by the president. His statements questioning the AIDS statistics, on poverty as a cause of immune deficiency, and on the dangers of antiretrovirals, together with government stalling on the roll out of nevirapine to prevent transmission of HIV from pregnant mothers to their babies, dominated the debate.(1-3) However, the July 2002 Constitutional Court judgment ordering the government to make nevirapine universally available to pregnant women infected with HIV, followed in October by a cabinet statement supporting wider access to antiretrovirals, may have finally ushered in a new era. It should now be possible to discuss the reality of AIDS in South Africa without reducing the argument to simple dualisms (such as being for or against a viral cause of AIDS, for or against the president). We propose an approach to discussing AIDS in South Africa that is rooted in political economy and political anthropology. Such an approach will shed light not only on the objective determinants of the epidemic, especially social inequalities, but also on subjective responses, such as those of Mbeki.	Univ Paris 13, INSERM, Ctr Rech Enjeux Contemporains Sante Publ, F-93017 Bobigny, France; Univ Witwatersrand, Sch Publ Hlth, Ctr Hlth Policy, ZA-2000 Johannesburg, South Africa	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; University of Witwatersrand	Fassin, D (corresponding author), Univ Paris 13, INSERM, Ctr Rech Enjeux Contemporains Sante Publ, 74 Rue Marcel Cachin, F-93017 Bobigny, France.	dfassin@ehess.fr						Bloom SS, 2002, SEX TRANSM INFECT, V78, P261, DOI 10.1136/sti.78.4.261; Campbell C, 1997, SOC SCI MED, V45, P273, DOI 10.1016/S0277-9536(96)00343-7; Cottereau Alain., 1999, EXPERIENCE DENI, P159; *DEP HLTH, 2000, NAT HIV SYPH SER PRE; Dorrington R. E., 2001, IMPACT HIV AIDS ADUL; Farmer P., 1999, INFECT INEQUALITIES; FARMER Paul, 1992, AIDS ACCUSATION HAIT; FASSIN D., 2002, TEMPS MODERNES, V620, P429; Fassin Didier, 2002, Afr J AIDS Res, V1, P63, DOI 10.2989/16085906.2002.9626545; GOULD C, 2000, SUNDAY INDEPEND 1008, P7; JOHNSON L, 2002, HIV RISK FACTORS REV; Lurie M, 2000, S AFR J SCI, V96, P343; Makgoba MW, 2000, SCIENCE, V288, P1171, DOI 10.1126/science.288.5469.1171; Packard Randall M., 1990, WHITE PLAGUE BLACK L; Schneider H, 2002, AIDS, V16, pS45, DOI 10.1097/00002030-200216004-00007; Schneider H, 2002, AFRICAN STUDIES, V61, P145, DOI DOI 10.1080/00020180220140118; Seidman G, 1999, ANNU REV SOCIOL, V25, P419, DOI 10.1146/annurev.soc.25.1.419; Sidley, 2000, BMJ, V320, P1016, DOI 10.1136/bmj.320.7240.1016; SWANSON MW, 1977, J AFR HIST, V18, P387, DOI 10.1017/S0021853700027328; Taylor Charles, 1992, POLITICS RECOGNITION; van der Vliet V, 2001, DAEDALUS, V130, P151; WILLIAMS BG, 2000, NATURAL HIST HIV AID; Wojcicki JM, 2002, MED ANTHROPOL Q, V16, P267, DOI 10.1525/maq.2002.16.3.267; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4	24	83	84	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2003	326	7387					495	497		10.1136/bmj.326.7387.495	http://dx.doi.org/10.1136/bmj.326.7387.495			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653EC	12609950	Green Published			2022-12-28	WOS:000181421400026
J	James, LC; Roversi, P; Tawfik, DS				James, LC; Roversi, P; Tawfik, DS			Antibody multispecificity mediated by conformational diversity	SCIENCE			English	Article							PEPTIDE LIBRARIES; MOLECULAR-BASIS; ANTIGEN; BINDING; SITE; TRANSITION; CATALYSIS; INSIGHTS; LIGANDS; MIMICRY	A single antibody was shown to adopt different binding-site conformations and thereby bind unrelated antigens. Analysis by both x-ray crystallography and pre-steady-state kinetics revealed an equilibrium between different preexisting isomers, one of which possessed a promiscuous, low-affinity binding site for aromatic ligands, including the immunizing hapten. A subsequent induced-fit isomerization led to high-affinity complexes with a deep and narrow binding site. A protein antigen identified by repertoire selection made use of an unrelated antibody isomer with a wide, shallow binding site. Conformational diversity, whereby one sequence adopts multiple structures and multiple functions, can increase the effective size of the antibody repertoire but may also lead to autoimmunity and allergy.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; MRC, Ctr Prot Engn, Cambridge CB2 2HQ, England; Global Phasing Ltd, Cambridge, England	Weizmann Institute of Science; University of Cambridge; Global Phasing Limited	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	Roversi, Pietro/F-8925-2011; Roversi, Pietro/AAK-4241-2021	Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437				AREVALO JH, 1994, J MOL BIOL, V241, P663, DOI 10.1006/jmbi.1994.1543; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; CHRISTIAN RB, 1992, J MOL BIOL, V227, P711, DOI 10.1016/0022-2836(92)90219-A; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Corper AL, 1997, NAT STRUCT BIOL, V4, P374, DOI 10.1038/nsb0597-374; EHRLICH P, 1901, BERL KLIN WOCHENSCHR, V38, P569; ESHHAR Z, 1980, J IMMUNOL, V124, P775; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Hitchens TK, 2001, BIOCHEMISTRY-US, V40, P11660, DOI 10.1021/bi010909+; JAMES L, UNPUB; Joyce GF, 1997, SCIENCE, V276, P1658, DOI 10.1126/science.276.5319.1658; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; KAPLAN MH, 1962, LANCET, V1, P706; Kramer A, 1997, CELL, V91, P799, DOI 10.1016/S0092-8674(00)80468-7; LANCET D, 1976, P NATL ACAD SCI USA, V73, P3549, DOI 10.1073/pnas.73.10.3549; LANDSTEINER K, 1897, WIEN KLIN WOCHENSCHR, V10, P439; Lindner AB, 1999, J MOL BIOL, V285, P421, DOI 10.1006/jmbi.1998.2309; LU ZJ, 1995, BIO-TECHNOL, V13, P366, DOI 10.1038/nbt0495-366; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; NOBLE MEM, UNPUB; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929; Santiago ML, 1998, INT ARCH ALLERGY IMM, V117, P94, DOI 10.1159/000023995; Trinh CH, 1997, STRUCTURE, V5, P937, DOI 10.1016/S0969-2126(97)00247-5; VARGA JM, 1991, MOL IMMUNOL, V28, P641, DOI 10.1016/0161-5890(91)90133-5; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	37	590	611	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1362	1367		10.1126/science.1079731	http://dx.doi.org/10.1126/science.1079731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610298				2022-12-28	WOS:000181192300043
J	Shu, DG; Morris, SC; Zhang, ZF; Liu, JN; Han, J; Chen, L; Zhang, XL; Yasui, K; Li, Y				Shu, DG; Morris, SC; Zhang, ZF; Liu, JN; Han, J; Chen, L; Zhang, XL; Yasui, K; Li, Y			A new species of yunnanozoan with implications for deuterostome evolution	SCIENCE			English	Article							CHORDATE; VERTEBRATES; INSIGHTS; CHINA	Yunnanozoans are a distinctive clade of Lower Cambrian metazoans. Although widely accepted as deuterostomes, their exact placement within this super-phylum is controversial. Here we describe a new species of Haikouella (H. jianshanensis) from the Chengjiang Lagerstatte (Yunnan, China) with exceptional preservation of a number of features. These include external gills, which suggest that the origin of the pharyngeal clefts was independent of the gills. The diagnostic branchial arches of chordates may, therefore, be composite structures. No evidence was found for the chorwdate-like structures that have been described in other yunnanozoans. We propose that yunnanozoans are stem-group deuterostomes, allied to the vetulicolians.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Kumamoto Univ, Dept Dev & Biohist, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Changan Univ, Coll Earth Sci & Land Resources, Xian 710054, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; China University of Geosciences; University of Cambridge; Kumamoto University; Chang'an University	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.		Zhang, Zhifei/F-2532-2011	Zhang, Zhifei/0000-0003-0325-5116				BABCOCK L. E., 2001, GSA TODAY, V11, P4, DOI DOI 10.1130/1052-5173(2001)011<0004:TCBROT>2.0.CO;2; BRIGGS DEG, 1994, LETHAIA, V26, P275, DOI DOI 10.1111/J.1502-3931.1993.TB01532.X); Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; Dzik Jerzy, 1995, Acta Palaeontologica Polonica, V40, P341; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; HOU XG, 1991, ZOOL SCR, V20, P395; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Shu DG, 2001, NATURE, V414, P419, DOI 10.1038/35106514; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762, DOI 10.1093/oxfordjournals.molbev.a004134; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	15	80	95	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1380	1384		10.1126/science.1079846	http://dx.doi.org/10.1126/science.1079846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610301				2022-12-28	WOS:000181192300048
J	Kramer, C; Loros, JJ; Dunlap, JC; Crosthwaite, SK				Kramer, C; Loros, JJ; Dunlap, JC; Crosthwaite, SK			Role for antisense RNA in regulating circadian clock function in Neurospora crassa	NATURE			English	Article							GENE-FREQUENCY; ANTHERAEA-PERNYI; FEEDBACK LOOP; LIGHT INPUT; PERIOD; RHYTHMICITY; INITIATION; SILKMOTH; DEFINES; WC-2	The prevalence of antisense RNA in eukaryotes is not known and only a few naturally occurring antisense transcripts have been assigned a function(1-4). However, the recent identification of a large number of putative antisense transcripts(5) strengthens the view that antisense RNAs might affect a wider variety of processes than previously thought. Here we show that in the model organism Neurospora crassa entrainment of the circadian clock, which is critical for the correct temporal expression of genes and their products, is controlled partly by an antisense RNA arising from a clock component locus. In a wild-type strain, levels of antisense frequency (frq) transcripts cycle in antiphase to sense frq transcripts in the dark, and are inducible by light. In mutant strains in which the induction of antisense frq RNA by light is abolished, the time of the internal clock is delayed relative to the wild-type strain, and resetting of the clock by light is altered. These data provide an unexpected link between antisense RNA and circadian timing and provide a new example of a eukaryotic cellular process regulated by naturally occurring antisense RNA.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA; Dartmouth Coll Sch Med, Dept Genet, Hanover, NH 03755 USA	University of Manchester; Dartmouth College; Dartmouth College	Crosthwaite, SK (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.		Loros, Jennifer/B-6293-2014; Dunlap, Jay/L-6232-2013	Dunlap, Jay/0000-0003-1577-0457				Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BELLPEDERSEN D, 1992, GENE DEV, V6, P2382, DOI 10.1101/gad.6.12a.2382; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Collett MA, 2001, MOL CELL BIOL, V21, P2619, DOI 10.1128/MCB.21.8.2619-2628.2001; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gotter AL, 1999, NEURON, V24, P953, DOI 10.1016/S0896-6273(00)81042-9; Hastings MH, 2000, NAT REV NEUROSCI, V1, P143, DOI 10.1038/35039080; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; JOHNSON KA, 1993, THESIS DARTMOUTH COL; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; MERROW MW, 1994, EMBO J, V13, P2257, DOI 10.1002/j.1460-2075.1994.tb06507.x; Roenneberg T, 2000, METHOD ENZYMOL, V305, P104; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a	30	127	137	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					948	952		10.1038/nature01427	http://dx.doi.org/10.1038/nature01427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607002				2022-12-28	WOS:000181186900050
J	Stewart, GS; Wang, B; Bignell, CR; Taylor, AMR; Elledge, SJ				Stewart, GS; Wang, B; Bignell, CR; Taylor, AMR; Elledge, SJ			MDC1 is a mediator of the mammalian DNA damage checkpoint	NATURE			English	Article							DOUBLE-STRAND BREAKS; BUDDING YEAST RAD9; BRCT DOMAIN; IN-VIVO; PROTEIN; REPAIR; KINASE; 53BP1; ATM	To counteract the continuous exposure of cells to agents that damage DNA, cells have evolved complex regulatory networks called checkpoints to sense DNA damage and coordinate DNA replication, cell-cycle arrest and DNA repair(1). It has recently been shown that the histone H2A variant H2AX specifically controls the recruitment of DNA repair proteins to the sites of DNA damage(2-4). Here we identify a novel BRCA1 carboxy-terminal (BRCT) and forkhead-associated (FHA) domain-containing protein, MDC1 (mediator of DNA damage checkpoint protein 1), which works with H2AX to promote recruitment of repair proteins to the sites of DNA breaks and which, in addition, controls damage-induced cell-cycle arrest checkpoints. MDC1 forms foci that co-localize extensively with gamma-H2AX foci within minutes after exposure to ionizing radiation. H2AX is required for MDC1 foci formation, and MDC1 forms complexes with phosphorylated H2AX. Furthermore, this interaction is phosphorylation dependent as peptides containing the phosphorylated site on H2AX bind MDC1 in a phosphorylation-dependent manner. We have shown by using small interfering RNA (siRNA) that cells lacking MDC1 are sensitive to ionizing radiation, and that MDC1 controls the formation of damage-induced 53BP1, BRCA1 and MRN foci, in part by promoting efficient H2AX phosphorylation. In addition, cells lacking MDC1 also fail to activate the intra-S phase and G2/M phase cell-cycle checkpoints properly after exposure to ionizing radiation, which was associated with an inability to regulate Chk1 properly. These results highlight a crucial role for MDC1 in mediating transduction of the DNA damage signal.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Birmingham, CRC Inst Canc Studies, Birmingham B15 2TT, W Midlands, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Birmingham	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.			Stewart, Grant/0000-0002-0960-3241				Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HUANG M, 2000, COLD SPRING HARB SYM, V65, P1; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Liu QH, 2000, GENE DEV, V14, P1448; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Takai H, 2000, GENE DEV, V14, P1439; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Venkitaraman AR, 2001, J CELL SCI, V114, P3591; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang Y, 2000, GENE DEV, V14, P927; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	28	664	707	4	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					961	966		10.1038/nature01446	http://dx.doi.org/10.1038/nature01446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607005				2022-12-28	WOS:000181186900053
J	Lankisch, PG				Lankisch, PG			What you want to see	LANCET			English	Editorial Material									Municipal Clin Luneberg, Dept Internal Med, D-21339 Luneburg, Germany		Lankisch, PG (corresponding author), Municipal Clin Luneberg, Dept Internal Med, D-21339 Luneburg, Germany.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					668	668		10.1016/S0140-6736(03)12601-3	http://dx.doi.org/10.1016/S0140-6736(03)12601-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606178				2022-12-28	WOS:000181129500016
J	Tong, P; Ozaki, R				Tong, P; Ozaki, R			Roth spots in diabetes mellitus	LANCET			English	Editorial Material									Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Endocrinol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Tong, P (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Endocrinol, Shatin, Hong Kong, Peoples R China.								0	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					689	689		10.1016/S0140-6736(03)12568-8	http://dx.doi.org/10.1016/S0140-6736(03)12568-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606186				2022-12-28	WOS:000181129500024
J	Newmeyer, DD; Ferguson-Miller, S				Newmeyer, DD; Ferguson-Miller, S			Mitochondria: Releasing power for life and unleashing the machineries of death	CELL			English	Review							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; BCL-2 FAMILY MEMBERS; ADENINE-NUCLEOTIDE TRANSLOCATOR; APOPTOSIS-INDUCING FACTOR; ELECTRON-TRANSPORT CHAIN; PROGRAMMED CELL-DEATH; UV-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; LIPID-MEMBRANES	The mitochondrion has long been known both as a chemical powerplant and as a cellular compartment housing various biosynthetic pathways. However, studies on the function of mitochondria in apoptotic cell death have revealed a versatility and complexity of these organelles previously unsuspected. The mechanisms proposed for mitochondrial involvement in cell death are diverse and highly controversial. In one model, mitochondria are seen as passive containers that can be made to leak out cytotoxic proteins. In other scenarios, however, certain more or less familiar aspects of mitochondrial physiology, such as oxidative phosphorylation, generation of oxygen radicals, dynamic morphological rearrangements, calcium overload, and permeability transition, are proposed to play crucial roles. In this review, we examine a few promising mechanisms that have been gaining attention recently.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	La Jolla Institute for Immunology; Michigan State University	Newmeyer, DD (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	don@liai.org						Annis MG, 2001, ONCOGENE, V20, P1939, DOI 10.1038/sj.onc.1204288; Asumendi A, 2002, BRIT J CANCER, V86, P1951, DOI 10.1038/sj.bjc.6600356; BAFFY G, 1993, J BIOL CHEM, V268, P6511; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Csordas G, 2002, EMBO J, V21, P2198, DOI 10.1093/emboj/21.9.2198; D'Herde K, 2000, CELL DEATH DIFFER, V7, P331, DOI 10.1038/sj.cdd.4400655; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; DEGLIESPOSTI M, 2002, CELL DEATH DIFFER, V9, P234; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Epand RF, 2002, BIOCHEM J, V367, P849, DOI 10.1042/BJ20020986; Epand RF, 2002, BIOCHEM BIOPH RES CO, V298, P744, DOI 10.1016/S0006-291X(02)02544-5; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; EPAND RF, 2002, J BIOL CHEM, V24, P24; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Esposti MD, 2002, BBA-BIOENERGETICS, V1553, P331, DOI 10.1016/S0005-2728(02)00187-1; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gao WH, 2001, J CELL SCI, V114, P2855; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Krysko DV, 2001, J HISTOCHEM CYTOCHEM, V49, P1277, DOI 10.1177/002215540104901010; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee ST, 1999, ONCOGENE, V18, P3520, DOI 10.1038/sj.onc.1202716; Lemasters JJ, 1999, BIOCHEM SOC SYMP, V66, P205, DOI 10.1042/bss0660205; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Magalhaes PJ, 2001, LUMINESCENCE, V16, P67, DOI 10.1002/bio.614; Marchetti P, 1996, CANCER RES, V56, P2033; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; Nutt LK, 2002, J BIOL CHEM, V277, P9219, DOI 10.1074/jbc.M106817200; Osteryoung KW, 2001, CURR OPIN MICROBIOL, V4, P639, DOI 10.1016/S1369-5274(01)00263-6; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Pozzan T, 2000, CELL CALCIUM, V28, P279, DOI 10.1054/ceca.2000.0166; Pu YM, 2001, BIOCHEM BIOPH RES CO, V282, P84, DOI 10.1006/bbrc.2001.4532; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Roucou X, 2002, BIOCHEM J, V363, P547, DOI 10.1042/0264-6021:3630547; ROUCOU X, 2002, BIOCH J; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Staniek K, 2002, FREE RADICAL RES, V36, P381, DOI 10.1080/10715760290021225; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Tang D G, 1998, Pathol Oncol Res, V4, P179; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Vanden Abeele F, 2002, CANCER CELL, V1, P169; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace Douglas C., 1999, P751; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	93	1003	1075	6	142	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 21	2003	112	4					481	490		10.1016/S0092-8674(03)00116-8	http://dx.doi.org/10.1016/S0092-8674(03)00116-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600312	Bronze			2022-12-28	WOS:000181252600007
J	Schnell, DJ; Hebert, DN				Schnell, DJ; Hebert, DN			Protein translocons: Multifunctional mediators of protein translocation across membranes	CELL			English	Review							SIGNAL-RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; MITOCHONDRIAL PREPROTEIN TRANSLOCASE; ER-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; SECRETORY PATHWAY; INFLUENZA HEMAGGLUTININ; CONDUCTING CHANNEL; PRECURSOR PROTEINS; PEROXISOMAL MATRIX	Protein translocation systems consist of complex molecular machines whose activities are not limited to unidirectional protein targeting. Protein translocons and their associated receptor systems can be viewed as dynamic modular units whose interactions, and therefore functions, are regulated in response to specific signals. This flexibility allows translocons to interact with multiple signal receptor systems to manage the targeting of topologically distinct classes of proteins, to mediate targeting to different suborganellar compartments, and to respond to stress and developmental cues. Furthermore, the activities of translocons are tightly coordinated with downstream events, thereby providing a direct link between targeting and protein maturation.	Univ Massachusetts, Program Plant Biol, Amherst, MA 01003 USA; Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA; Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Schnell, DJ (corresponding author), Univ Massachusetts, Program Plant Biol, Amherst, MA 01003 USA.	dschnell@biochem.umass.edu; dhebert@biochem.umass.edu			NIGMS NIH HHS [GM61893] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061893] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Bauer J, 2001, CELL MOL LIFE SCI, V58, P420, DOI 10.1007/PL00000867; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen W, 2000, MOL BIOL CELL, V11, P765, DOI 10.1091/mbc.11.2.765; Chen XJ, 2002, PLANT CELL, V14, P641, DOI 10.1105/tpc.010336; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Davis AJ, 1998, MOL BIOL CELL, V9, P2577, DOI 10.1091/mbc.9.9.2577; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Gillece P, 2000, P NATL ACAD SCI USA, V97, P4609, DOI 10.1073/pnas.090083497; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hampton RY, 2002, ANNU REV CELL DEV BI, V18, P345, DOI 10.1146/annurev.cellbio.18.032002.131219; Hardesty Boyd, 1999, Current Opinion in Structural Biology, V9, P111, DOI 10.1016/S0959-440X(99)80014-1; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hegde RS, 1999, TRENDS CELL BIOL, V9, P132, DOI 10.1016/S0962-8924(99)01504-4; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Holroyd C, 2001, FEBS LETT, V501, P6, DOI 10.1016/S0014-5793(01)02617-5; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Jensen RE, 2002, BBA-MOL CELL RES, V1592, P25, DOI 10.1016/S0167-4889(02)00261-6; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 2001, BBA-MOL CELL RES, V1541, P80, DOI 10.1016/S0167-4889(01)00150-1; Nicchitta CV, 2002, CURR OPIN CELL BIOL, V14, P412, DOI 10.1016/S0955-0674(02)00353-8; Nouwen N, 1996, P NATL ACAD SCI USA, V93, P5953, DOI 10.1073/pnas.93.12.5953; Pfanner N, 2002, BBA-MOL CELL RES, V1592, P15, DOI 10.1016/S0167-4889(02)00260-4; Pilon M, 1999, CELL, V97, P679, DOI 10.1016/S0092-8674(00)80780-1; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; REHLING P, 2002, CELL, V111, P507; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; van den Wijngaard PWJ, 2000, EUR J BIOCHEM, V267, P3812, DOI 10.1046/j.1432-1327.2000.01419.x; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; VESTWEBER D, 1989, NATURE, V341, P205, DOI 10.1038/341205a0; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zheng N, 1996, CELL, V86, P849, DOI 10.1016/S0092-8674(00)80159-2	86	184	192	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 21	2003	112	4					491	505		10.1016/S0092-8674(03)00110-7	http://dx.doi.org/10.1016/S0092-8674(03)00110-7			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600313	Bronze			2022-12-28	WOS:000181252600008
J	Bozzette, SA; Ake, CF; Tam, HK; Chang, SW; Louis, TA				Bozzette, SA; Ake, CF; Tam, HK; Chang, SW; Louis, TA			Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL-CELL CULTURES; HIV PROTEASE INHIBITORS; INSULIN-RESISTANCE; PERIPHERAL LIPODYSTROPHY; HYPERLIPIDEMIA; CLEARANCE; APOPTOSIS; MORTALITY	BACKGROUND: Metabolic abnormalities associated with human immunodeficiency virus (HIV) infection, including dysglycemia and hyperlipidemia, are increasingly prevalent, and there is concern about the possibility of an association with accelerated cardiovascular and cerebrovascular disease. METHODS: We conducted a retrospective study of the risk of cardiovascular and cerebrovascular disease among the 36,766 patients who received care for HIV infection at Veterans Affairs facilities between January 1993 and June 2001. RESULTS: For antiretroviral therapy, 70.2 percent of the patients received nucleoside analogues, 41.6 percent received protease inhibitors, and 25.6 percent received nonnucleoside reverse-transcriptase inhibitors for a median of 17 months, 16 months, and 9 months, respectively. Approximately 1000 patients received combination therapy with a protease inhibitor for at least 48 months, and approximately 1000 patients received combination therapy with a nonnucleoside reverse-transcriptase inhibitor for at least 24 months. Between 1995 and 2001, the rate of admissions for cardiovascular or cerebrovascular disease decreased from 1.7 to 0.9 per 100 patient-years, and the rate of death from any cause decreased from 21.3 to 5.0 deaths per 100 patient-years. Patient-level regression analyses indicated that there was no relation between the use of nucleoside analogues, protease inhibitors, or nonnucleoside reverse-transcriptase inhibitors and the hazard of cardiovascular or cerebrovascular events, but the use of antiretroviral drugs was associated with a decreased hazard of death from any cause. CONCLUSIONS: Use of newer therapies for HIV was associated with a large benefit in terms of mortality that was not diminished by any increase in the rate of cardiovascular or cerebrovascular events or related mortality. Fear of accelerated vascular disease need not compromise antiretroviral therapy over the short term. However, prolonged survival among HIVinfected patients means that longer-term observation and analysis are required.	Vet Affairs San Diego Hlth Care Syst, Vet Affairs Qual Enhancement Res Initiat HIV, San Diego, CA USA; Vet Affairs San Diego Hlth Care Syst, Ctr Res Patient Oriented Care, San Diego, CA USA; Univ Calif San Diego, La Jolla, CA 92093 USA; RAND Hlth, Santa Monica, CA USA; Vet Affairs Ctr Qual Management Publ Hlth, Palo Alto, CA USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; RAND Corporation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bozzette, SA (corresponding author), San Diego Vet Affairs Med Ctr, Dept Med, 3350 La Jolla Village Dr, La Jolla, CA 92161 USA.							Backus L, 2001, J CLIN EPIDEMIOL, V54, pS12, DOI 10.1016/S0895-4356(01)00442-5; Behrens G, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(98)26026-0; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; CURRIER J, 2001, ANTIVIR THER, V6, P36; Dube M, 2002, POSTCOLONIALISM FEMI, P100; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; FISHER A, 1998, 12 WORLD AIDS C GEN, P575; Gallet B, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(05)78643-8; GEFFNER ME, 1993, PEDIATR RES, V34, P66, DOI 10.1203/00006450-199307000-00016; GRUNFELD C, 1989, AM J MED, V86, P27, DOI 10.1016/0002-9343(89)90225-8; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Heath KV, 2001, AIDS, V15, P231, DOI 10.1097/00002030-200101260-00013; HOMMES MJT, 1991, METABOLISM, V40, P651, DOI 10.1016/0026-0495(91)90059-6; Huang MB, 1999, AIDS RES HUM RETROV, V15, P1265, DOI 10.1089/088922299310160; Huang MB, 2001, J ACQ IMMUN DEF SYND, V27, P213; Jia HY, 2001, BIOCHEM BIOPH RES CO, V283, P469, DOI 10.1006/bbrc.2001.4790; Jia HY, 2001, BIOCHEM BIOPH RES CO, V284, P245, DOI 10.1006/bbrc.2001.4930; Lenert LA, 2002, AM J MED, V113, P229, DOI 10.1016/S0002-9343(02)01156-7; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; *NAT CTR HLTH STAT, 2002, CLASS DIS FUNCT DIS; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Park IW, 2001, J IMMUNOL, V167, P2766, DOI 10.4049/jimmunol.167.5.2766; Vittecoq D, 1998, LANCET, V351, P1959, DOI 10.1016/S0140-6736(05)78644-X; [No title captured]	26	451	475	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					702	710		10.1056/NEJMoa022048	http://dx.doi.org/10.1056/NEJMoa022048			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594314	Bronze			2022-12-28	WOS:000181014400005
J	Antoine, C; Muller, S; Cant, A; Cavazzana-Calvo, M; Veys, P; Vossen, J; Fasth, A; Heilmann, C; Wulffraat, N; Seger, R; Blanche, S; Friedrich, W; Abinun, M; Davies, G; Bredius, R; Schulz, A; Landais, P; Fischer, A				Antoine, C; Muller, S; Cant, A; Cavazzana-Calvo, M; Veys, P; Vossen, J; Fasth, A; Heilmann, C; Wulffraat, N; Seger, R; Blanche, S; Friedrich, W; Abinun, M; Davies, G; Bredius, R; Schulz, A; Landais, P; Fischer, A		European Grp Blood Marrow Transpla	Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99	LANCET			English	Article							BONE-MARROW TRANSPLANTATION; T-CELL; DEFICIENCY	Background Transplantation of allogeneic haemopoietic stem cells can cure several primary immunodeficiencies. This European report focuses on the long-term results of such procedures done between 1968 and December, 1999, for primary immunodeficiencies. Methods The report includes data from 37 centres in 18 countries, which participated in a European registry for stem-cell transplantation in severe combined immunodeficiencies (SCID) and in other immunodeficiency disorders (non-SCID). 1082 transplants in 919 patients were studied (566 in 475 SCID patients, 512 in 444 non-SCID patients; four procedures excluded owing to insufficient data). Minimum follow-up of 6 months was required. Findings In SCID, 3-year survival with sustained engraftment was significantly better after HLA-identical than after mismatched transplantation (77% vs 54%; p=0.002) and survival improved over time. In HLA-mismatched stem-cell transplantation, B(-) SCID had poorer prognosis than B(+) SCID. However, improvement with time occurred in both SCID phenotypes. In non-SCID, 3-year survival after genotypically HLA-matched, phenotypically HLA-matched, HLA-mismatched related, and unrelated-donor transplantation was 71%, 42%, 42%, and 59%, respectively (p=0.0006). Acute graft versus host disease predicted poor prognosis whatever the donor origin except in related HLA-identical transplantation in SCID. Interpretation The improvement in survival over time indicates more effective prevention and treatment of disease-related and procedure-related complications-eg, infections and graft versus host disease. An important factor is better prevention of graft versus host disease in the HLA-non-identical setting by use of more efficient methods of T-cell depletion. For non-SCID, stem-cell transplantation can provide a cure, and grafts from unrelated donors are almost as beneficial as those from genetically HLA-identical relatives.	Hop Necker Enfants Malad, Serv Immunol & Hematol Pediat, F-75743 Paris, France; Hop Necker Enfants Malad, Serv Biostat, Paris, France; Univ Ulm, Kinderklin, Ulm, Germany; Newcastle Gen Hosp, Dept Paediat Immunol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Great Ormond St Hosp Sick Children, Dept Immunol, London, England; Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplant, London, England; Acad Hosp Leiden, Dept Paediat, Leiden, Netherlands; Queen Silvia Childrens Hosp, Gothenburg, Sweden; Rigshosp, Dept Paediat, DK-2100 Copenhagen, Denmark; Wilhelmina Childrens Hosp, Utrecht, Netherlands; Univ Childrens Hosp, Div Immunol Haematol, Zurich, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Ulm University; Newcastle General Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Leiden University; Leiden University Medical Center (LUMC); Queen Silvia Children's Hospital; Rigshospitalet; University of Copenhagen; Wilhelmina Kinderziekenhuis; University Children's Hospital Zurich	Fischer, A (corresponding author), Hop Necker Enfants Malad, Serv Immunol & Hematol Pediat, 149 Rue Sevres, F-75743 Paris, France.		Bredius, Robbert/AAF-2592-2019; Wulffraat, Nico M/AAE-8929-2020; Fasth, Anders/I-1109-2019	Wulffraat, Nico M/0000-0001-9548-5562; Cavazzana, Marina/0000-0002-0264-0891; Bredius, Robbert/0000-0001-8151-1539; Fasth, Anders/0000-0002-0033-740X				Bertrand Y, 1999, J PEDIATR-US, V134, P740, DOI 10.1016/S0022-3476(99)70291-X; Buckley RH, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P459; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Filipovich AH, 2001, BLOOD, V97, P1598, DOI 10.1182/blood.V97.6.1598; FISCHER A, 1986, LANCET, V2, P1080; FISCHER A, 1990, LANCET, V336, P850, DOI 10.1016/0140-6736(90)92348-L; Fischer A, 2001, LANCET, V357, P1863, DOI 10.1016/S0140-6736(00)04959-X; FISCHER A, 1994, BLOOD, V83, P1149; GENTLEMAN R, 1997, INTERFACE FDN N AM; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Haddad E, 1998, BLOOD, V91, P3646; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; KLEIN C, 1995, BLOOD, V85, P580; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; PETER HH, 1983, J IMMUNOL, V131, P2332; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; REISNER Y, 1983, BLOOD, V61, P341	19	399	415	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					553	560		10.1016/S0140-6736(03)12513-5	http://dx.doi.org/10.1016/S0140-6736(03)12513-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598139				2022-12-28	WOS:000181033400007
J	Yoder, CF; Konopliv, AS; Yuan, DN; Standish, EM; Folkner, WM				Yoder, CF; Konopliv, AS; Yuan, DN; Standish, EM; Folkner, WM			Fluid core size of mars from detection of the solar tide	SCIENCE			English	Article							INTERIOR STRUCTURE; GRAVITY-FIELD; MODEL; PATHFINDER; TRACKING	The solar tidal deformation of Mars, measured by its k(2) potential Love number, has been obtained from an analysis of Mars Global Surveyor radio tracking. The observed k(2) of 0.153 +/- 0.017 is large enough to rule out a solid iron core and so indicates that at least the outer part of the core is liquid. The inferred core radius is between 1520 and 1840 kilometers and is independent of many interior properties, although partial melt of the mantle is one factor that could reduce core size. Ice-cap mass changes can be deduced from the seasonal variations in air pressure and the odd gravity harmonic J(3), given knowledge of cap mass distribution with latitude. The south cap seasonal mass change is about 30 to 40% larger than that of the north cap.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Yoder, CF (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Charles.F.Yoder@jpl.nasa.gov; Alex.Konopliv@jpl.nasa.gov						Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; DICKEY JO, 1994, SCIENCE, V265, P482, DOI 10.1126/science.265.5171.482; Folkner WM, 1997, SCIENCE, V278, P1749, DOI 10.1126/science.278.5344.1749; Groten E, 1996, ASTRON J, V111, P1388, DOI 10.1086/117885; Haberle RM, 1999, J GEOPHYS RES-PLANET, V104, P8957, DOI 10.1029/1998JE900040; JUSTUS CJ, 1996, 108513 NASA; Konopliv AS, 1996, GEOPHYS RES LETT, V23, P1857, DOI 10.1029/96GL01589; Konopliv AS, 2001, ICARUS, V150, P1, DOI 10.1006/icar.2000.6573; Ray RD, 1996, NATURE, V381, P595, DOI 10.1038/381595a0; REASENBERG RD, 1977, J GEOPHYS RES, V82, P369, DOI 10.1029/JB082i002p00369; Smith DE, 1999, J GEOPHYS RES-PLANET, V104, P1885, DOI 10.1029/1998JE900024; Smith DE, 2001, SCIENCE, V294, P2141, DOI 10.1126/science.1066556; Sohl F, 1997, J GEOPHYS RES-PLANET, V102, P1613, DOI 10.1029/96JE03419; Turcotte DL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001594; WAHR J, 1995, HDB PHYSICAL CONSTAN, V1, P40; YODER CF, 1983, NATURE, V303, P757, DOI 10.1038/303757a0; Yoder CF, 1997, J GEOPHYS RES-PLANET, V102, P4065, DOI 10.1029/96JE03642; YODER CF, 1995, ICARUS, V117, P250, DOI 10.1006/icar.1995.1156; YODER CF, 1995, HDB PHYSICAL CONSTAN, V1, P1; Yuan DN, 2001, J GEOPHYS RES-PLANET, V106, P23377, DOI 10.1029/2000JE001302; Zharkov VN, 2000, PHYS EARTH PLANET IN, V117, P407, DOI 10.1016/S0031-9201(99)00110-7; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	22	227	235	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 11	2003	300	5617					299	303		10.1126/science.1079645	http://dx.doi.org/10.1126/science.1079645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665RQ	12624177				2022-12-28	WOS:000182135400048
J	Betschinger, J; Mechtler, K; Knoblich, JA				Betschinger, J; Mechtler, K; Knoblich, JA			The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl	NATURE			English	Article							II HEAVY-CHAIN; TUMOR-SUPPRESSOR PROTEIN; DROSOPHILA NEUROBLASTS; PLASMA-MEMBRANE; PROSPERO; POLARITY; BAZOOKA; MYOSIN; LOCALIZATION; MITOSIS	To generate different cell types, some cells can segregate protein determinants into one of their two daughter cells during mitosis. In Drosophila neuroblasts, the Par protein complex localizes apically(1-5) and directs localization of the cell fate determinants Prospero(6-8) and Numb(9) and the adaptor proteins Miranda(10,11) and Pon(12) to the basal cell cortex, to ensure their segregation into the basal daughter cell. The Par protein complex has a conserved function in establishing cell polarity(13) but how it directs proteins to the opposite side is unknown. We show here that a principal function of this complex is to phosphorylate the cytoskeletal protein Lethal (2) giant larvae (Lgl; also known as L(2)gl). Phosphorylation by Drosophila atypical protein kinase C (aPKC), a member of the Par protein complex, releases Lgl from its association with membranes and the actin cytoskeleton. Genetic and biochemical experiments show that Lgl phosphorylation prevents the localization of cell fate determinants to the apical cell cortex. Lgl promotes cortical localization of Miranda(14,15),, and we propose that phosphorylation of Lgl by aPKC at the apical neuroblast cortex restricts Lgl activity and Miranda localization to the opposite, basal side of the cell.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Knoblich, JA (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Knoblich, Juergen A/C-2974-2015; Mechtler, Karl/AAF-2717-2019	Knoblich, Juergen A/0000-0002-6751-3404; Mechtler, Karl/0000-0002-3392-9946; Betschinger, Joerg/0000-0002-2627-8479				BRAND AH, 1993, DEVELOPMENT, V118, P401; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kagami M, 1998, GENETICS, V149, P1717; Kalmes A, 1996, J CELL SCI, V109, P1359; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schulze KL, 1996, GENETICS, V144, P1713; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAND D, 1994, J CELL BIOL, V127, P1345, DOI 10.1083/jcb.127.5.1345; STRAND D, 1995, ONCOGENE, V11, P291; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	30	447	457	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 20	2003	422	6929					326	330		10.1038/nature01486	http://dx.doi.org/10.1038/nature01486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656XX	12629552				2022-12-28	WOS:000181637300043
J	Hoag, H				Hoag, H			Tougher rules aim to prevent gene flow into crops	NATURE			English	News Item																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					103	103		10.1038/422103b	http://dx.doi.org/10.1038/422103b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634744	Bronze			2022-12-28	WOS:000181488900008
J	Margarit, SM; Sondermann, H; Hall, BE; Nagar, B; Hoelz, A; Pirruccello, M; Bar-Sagi, D; Kuriyan, J				Margarit, SM; Sondermann, H; Hall, BE; Nagar, B; Hoelz, A; Pirruccello, M; Bar-Sagi, D; Kuriyan, J			Structural evidence for feedback activation by Ras-GTP of the Ras-specific nucleotide exchange factor SOS	CELL			English	Article							SIGNAL-TRANSDUCTION; GENE-PRODUCT; BINDING; SWITCH	Growth factor receptors activate Ras by recruiting the nucleotide exchange factor son of sevenless (SOS) to the cell membrane, thereby triggering the production of GTP-loaded Ras. Crystallographic analyses of Ras bound to the catalytic module of SOS have led to the unexpected discovery of a highly conserved Ras binding site on SOS that is located distal to the active site and is specific for Ras-GTP. The crystal structures suggest that Ras-GTP stabilizes the active site of SOS allosterically, and we show that Ras-GTP forms ternary complexes with SOScat in solution and increases significantly the rate of SOScat-stimulated nucleotide release from Ras. These results demonstrate the existence of a positive feedback mechanism for the spatial and temporal regulation of Ras.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Rockefeller Univ, New York, NY 10021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rockefeller University	Bar-Sagi, D (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	barsagi@pharm.sunysb.edu; kuriyan@uclink.berkeley.edu	Nagar, Bhushan/C-1297-2010; Hoelz, Andre/AAB-6978-2021	Bar-Sagi, Dafna/0000-0003-2597-8948; Pirruccello-Straub, Michelle/0000-0002-7996-857X				Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARSAGI D, 1994, TRENDS ENDOCRIN MET, V5, P165, DOI 10.1016/1043-2760(94)90014-0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang C, 2000, EMBO J, V19, P3283, DOI 10.1093/emboj/19.13.3283; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kuhn K, 2001, J AM CHEM SOC, V123, P1023, DOI 10.1021/ja002723o; LAI SHY, 1993, COMPUT IND ENG, V25, P13, DOI 10.1016/0360-8352(93)90209-G; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MARGARIT SM, 2002, THESIS STATE U NEW Y; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wyatt PJ, 1997, INSTRUM SCI TECHNOL, V25, P1, DOI 10.1080/10739149709351443	32	327	361	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					685	695		10.1016/S0092-8674(03)00149-1	http://dx.doi.org/10.1016/S0092-8674(03)00149-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628188	Bronze			2022-12-28	WOS:000181443600011
J	Wang, YC; Shirogane, T; Liu, D; Harper, JW; Elledge, SJ				Wang, YC; Shirogane, T; Liu, D; Harper, JW; Elledge, SJ			Exit from exit: Resetting the cell cycle through Amn1 inhibition of G protein signaling	CELL			English	Article							SPINDLE POLE BODIES; SACCHAROMYCES-CEREVISIAE; MITOTIC EXIT; BUDDING YEAST; TRANSCRIPTION FACTOR; PHOSPHATASE CDC14; KINASE COMPLEX; TEM1 GTPASE; CHECKPOINT; MITOSIS	In S. cerevisiae cells undergoing anaphase, a ras-related GTPase, Tem1, is located on the spindle pole body that enters the daughter cell and activates a signal transduction pathway, MEN, to allow mitotic exit. MEN activation must be reversed after mitotic exit to reset the cell cycle in G1. We find that daughter cells activate an Antagonist of MEN pathway (AMEN) in part through induction of the Amn1 protein that binds directly to Tem1 and prevents its association with its target kinase Cdc15. Failure of Amn1 function results in defects of both the spindle assembly and nuclear orientation checkpoints and delays turning off Cdc14 in G1. Thus Amn1 is part of a daughter-specific switch that helps cells exit from mitotic exit and reset the cell cycle.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Human Mol Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Elledge, SJ (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.			Wang, Yanchang/0000-0001-6782-0570; Harper, Jeffrey/0000-0002-6944-7236	NIA NIH HHS [T32 AG00183] Funding Source: Medline; NIGMS NIH HHS [GM44664, GM54137] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM054137, R01GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Asakawa K, 2001, GENETICS, V157, P1437; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Geymonat M, 2002, J BIOL CHEM, V277, P28439, DOI 10.1074/jbc.M202540200; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lee SE, 2001, J CELL SCI, V114, P2345; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LIU HP, 1992, GENETICS, V132, P665; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Ro HS, 2002, P NATL ACAD SCI USA, V99, P5436, DOI 10.1073/pnas.062059999; ROSE M, 1995, YEAST, V11, P865, DOI 10.1002/yea.320110908; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Yoshida S, 2002, CURR BIOL, V12, P944, DOI 10.1016/S0960-9822(02)00870-9	42	66	70	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					697	709		10.1016/S0092-8674(03)00121-1	http://dx.doi.org/10.1016/S0092-8674(03)00121-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628189	Bronze			2022-12-28	WOS:000181443600012
J	Yajnik, V; Paulding, C; Sordella, R; McClatchey, AI; Saito, M; Wahrer, DCR; Reynolds, P; Bell, DW; Lake, R; van den Heuvel, S; Settleman, J; Haber, DA				Yajnik, V; Paulding, C; Sordella, R; McClatchey, AI; Saito, M; Wahrer, DCR; Reynolds, P; Bell, DW; Lake, R; van den Heuvel, S; Settleman, J; Haber, DA			DOCK4, a GTPase activator, is disrupted during tumorigenesis	CELL			English	Article							REPRESENTATIONAL DIFFERENCE ANALYSIS; TUMOR-SUPPRESSOR GENE; E-CADHERIN; LYMPHOCYTE MIGRATION; BINDING-PROTEIN; PROSTATE-CANCER; CELL-MIGRATION; FREQUENT LOSS; ADHESION; COMPLEX	We used representational difference analysis to identify homozygous genomic deletions selected during tumor progression in the mouse NF2 and TP53 tumor model. We describe a deletion targeting DOCK4, a member of the CDM gene family encoding regulators of small GTPases. DOCK4 specifically activates Rap GTPase, enhancing the formation of adherens junctions. DOCK4 mutations are present in a subset of human cancer cell lines; a recurrent missense mutant identified in human prostate and ovarian cancers encodes a protein that is defective in Rap1 activation. The engulfment defect of C. elegans mutants lacking the CDM gene ced-5 is rescued by wild-type DOCK4, but not by the mutant allele. Expression of wild-type, but not mutant, DOCK4 in mouse osteosarcoma cells with a deletion of the endogenous gene suppresses growth in soft agar and tumor invasion in vivo. DOCK4 therefore encodes a CDM family member that regulates intercellular junctions and is disrupted during tumorigenesis.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Med Sch, Gastrointestinal Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.		van den Heuvel, Sander J.L./B-8892-2011	van den Heuvel, Sander J.L./0000-0001-9015-7463; Reynolds, Paul/0000-0001-8738-1245	NCI NIH HHS [CA58596] Funding Source: Medline; NIDDK NIH HHS [5T32DK07191] Funding Source: Medline; NIGMS NIH HHS [GM63081] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA058596, R01CA058596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063081] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chen Q, 2002, J CELL BIOL, V158, P79, DOI 10.1083/jcb.200110151; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Jain AN, 2001, P NATL ACAD SCI USA, V98, P7952, DOI 10.1073/pnas.151241198; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kashiwa A, 2000, J NEUROCHEM, V75, P109, DOI 10.1046/j.1471-4159.2000.0750109.x; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Koike M, 1997, GENE CHROMOSOME CANC, V19, P1, DOI 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO;2-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang H, 2000, GENOMICS, V66, P226, DOI 10.1006/geno.2000.6198; LISITSYN N, 1995, METHOD ENZYMOL, V254, P291; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; LISITSYN NA, 1994, COLD SPRING HARB SYM, V59, P585, DOI 10.1101/SQB.1994.059.01.066; LISITSYN NA, 1995, TRENDS GENET, V11, P303, DOI 10.1016/S0168-9525(00)89087-3; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McClatchey AI, 1998, CURR OPIN GENET DEV, V8, P304, DOI 10.1016/S0959-437X(98)80086-5; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Perego C, 2002, J CELL SCI, V115, P3331; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; SEKIDO Y, 1995, CANCER RES, V55, P1227; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; TAKAHASHI S, 1995, CANCER RES, V55, P4114; Thomas DM, 1996, J BONE MINER RES, V11, P1312; Thomas NA, 2001, NAT GENET, V29, P379, DOI 10.1038/ng784; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zenklusen JC, 2001, NAT GENET, V27, P392, DOI 10.1038/86891	59	186	193	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					673	684		10.1016/S0092-8674(03)00155-7	http://dx.doi.org/10.1016/S0092-8674(03)00155-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628187	Bronze			2022-12-28	WOS:000181443600010
J	Tang, FS; Kauffman, EJ; Novak, JL; Nau, JJ; Catlett, NL; Weisman, LS				Tang, FS; Kauffman, EJ; Novak, JL; Nau, JJ; Catlett, NL; Weisman, LS			Regulated degradation of a class V myosin receptor directs movement of the yeast vacuole	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; CELL-CYCLE; ACTIN; INHERITANCE; MYO2P; LOCALIZATION; PROTEIN; COMPLEX; MOTOR	Normal cellular function requires that organelles be positioned in specific locations. The direction in which molecular motors move organelles is based in part on the polarity of microtubules and actin filaments(1-3). However, this alone does not determine the intracellular destination of organelles. For example, the yeast class V myosin, Myo2p, moves several organelles to distinct locations during the cell cycle(4-8). Thus the movement of each type of Myo2p cargo must be regulated uniquely. Here we report a regulatory mechanism that specifically provides directionality to vacuole movement. The vacuole-specific Myo2p receptor, Vac17p, has a key function in this process. Vac17p binds simultaneously to Myo2p and to Vac8p, a vacuolar membrane protein. The transport complex, Myo2p-Vac17p-Vac8p, moves the vacuole to the bud, and is then disrupted through the degradation of Vac17p. The vacuole is ultimately deposited near the centre of the bud. Removal of a PEST sequence (a potential signal for rapid protein degradation) within Vac17p causes its stabilization and the subsequent 'backward' movement of vacuoles, which mistargets them to the neck between the mother cell and the bud. Thus the regulated disruption of this transport complex places the vacuole in its proper location. This may be a general mechanism whereby organelles are deposited at their terminal destination.	Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Weisman, LS (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.							Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Catlett NL, 2000, CURR OPIN CELL BIOL, V12, P509, DOI 10.1016/S0955-0674(00)00124-1; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; deMesquita DSG, 1996, EUR J CELL BIOL, V71, P237; DEMESQUITA DSG, 1991, J GEN MICROBIOL, V137, P2447, DOI 10.1099/00221287-137-10-2447; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; ISHIKAWA K, IN PRESS J CELL BIOL; James P, 1996, GENETICS, V144, P1425; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reck-Peterson SL, 1999, MOL BIOL CELL, V10, P1001, DOI 10.1091/mbc.10.4.1001; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yang ZQ, 1998, CHINESE CHEM LETT, V9, P261; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	29	93	96	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					87	92		10.1038/nature01453	http://dx.doi.org/10.1038/nature01453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12594460				2022-12-28	WOS:000181343100043
J	Colton, RJ; Russell, JN				Colton, RJ; Russell, JN			Making the world a safer place	SCIENCE			English	Editorial Material									USN, Res Lab, Div Chem, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Colton, RJ (corresponding author), USN, Res Lab, Div Chem, Washington, DC 20375 USA.		Russell, John N/A-3621-2009					Boris J, 2002, COMPUT SCI ENG, V4, P22, DOI 10.1109/5992.988644; Eiceman G.A., 1994, ION MOBILITY SPECTRO; Epstein JR, 2002, ANAL CHEM, V74, P1836, DOI 10.1021/ac0156619; Garroway AN, 2001, IEEE T GEOSCI REMOTE, V39, P1108, DOI 10.1109/36.927420; MCGUIRE RE, 2001, UCRLAR143212 L LIV N; *NAT RES COUNC COM, MAK NAT SAF ROL SCI; Raber E, 2002, RISK ANAL, V22, P195, DOI 10.1111/0272-4332.00026; Raber E, 2001, INT J ENVIRON HEAL R, V11, P128, DOI 10.1080/09603120020047519; *SAND NAT LAB, 2002, SAN20021554P SAND NA; Schmedake TA, 2002, ADV MATER, V14, P1270, DOI 10.1002/1521-4095(20020916)14:18<1270::AID-ADMA1270>3.0.CO;2-R; Tamanaha CR, 2002, J MICROMECH MICROENG, V12, pN7, DOI 10.1088/0960-1317/12/2/401	11	46	58	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1324	1325		10.1126/science.1080688	http://dx.doi.org/10.1126/science.1080688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610285				2022-12-28	WOS:000181192300030
J	Armani, DK; Kippenberg, TJ; Spillane, SM; Vahala, KJ				Armani, DK; Kippenberg, TJ; Spillane, SM; Vahala, KJ			Ultra-high-Q toroid microcavity on a chip	NATURE			English	Article							GALLERY-MODE RESONANCES; FUSED-SILICA; MICROSPHERES; EXCITATION	The circulation of light within dielectric volumes enables storage of optical power near specific resonant frequencies and is important in a wide range of fields including cavity quantum electrodynamics(1,2), photonics(3,4), biosensing(5,6) and nonlinear optics(7-9). Optical trajectories occur near the interface of the volume with its surroundings, making their performance strongly dependent upon interface quality. With a nearly atomic-scale surface finish, surface-tension-induced microcavities such as liquid droplets or spheres(10-13) are superior to all other dielectric microresonant structures when comparing photon lifetime or, equivalently, cavity Q factor. Despite these advantageous properties, the physical characteristics of such systems are not easily controlled during fabrication. It is known that wafer-based processing(14) of resonators can achieve parallel processing and control, as well as integration with other functions. However, such resonators-on-a-chip suffer from Q factors that are many orders of magnitude lower than for surface-tension-induced microcavities, making them unsuitable for ultra-high-Q experiments. Here we demonstrate a process for producing silica toroid-shaped microresonators-on-a-chip with Q factors in excess of 100 million using a combination of lithography, dry etching and a selective reflow process. Such a high Q value was previously attainable only by droplets or microspheres and represents an improvement of nearly four orders of magnitude over previous chip-based resonators.	CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology	Vahala, KJ (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	vahala@caltech.edu	Kippenberg, T. J./B-3133-2013	Kippenberg, T. J./0000-0002-3408-886X				BRAGINSKY VB, 1989, PHYS LETT A, V137, P393, DOI 10.1016/0375-9601(89)90912-2; Cai M, 2000, PHYS REV LETT, V85, P74, DOI 10.1103/PhysRevLett.85.74; CAMPILLO AJ, 1991, PHYS REV LETT, V67, P437, DOI 10.1103/PhysRevLett.67.437; Chang R.K., 1996, OPTICAL PROCESSES MI, VVolume 3; COLLOT L, 1993, EUROPHYS LETT, V23, P327, DOI 10.1209/0295-5075/23/5/005; DELFINO M, 1982, ELECTRON DEVIC LETT, V3, P116, DOI 10.1109/EDL.1982.25504; Gayral B, 1999, APPL PHYS LETT, V75, P1908, DOI 10.1063/1.124894; Hansel W, 2001, NATURE, V413, P498, DOI 10.1038/35097032; Himeno A, 1998, IEEE J SEL TOP QUANT, V4, P913, DOI 10.1109/2944.736076; Kippenberg TJ, 2002, OPT LETT, V27, P1669, DOI 10.1364/OL.27.001669; Knight JC, 1997, OPT LETT, V22, P1129, DOI 10.1364/OL.22.001129; LefevreSeguin V, 1997, MAT SCI ENG B-SOLID, V48, P53, DOI 10.1016/S0921-5107(97)00080-9; MCCALL SL, 1992, APPL PHYS LETT, V60, P289, DOI 10.1063/1.106688; MCLACHLAN AD, 1987, APPL OPTICS, V26, P1728, DOI 10.1364/AO.26.001728; Michler P, 2000, APPL PHYS LETT, V77, P184, DOI 10.1063/1.126918; Sandoghdar V, 1996, PHYS REV A, V54, pR1777, DOI 10.1103/PhysRevA.54.R1777; SERPENGUZEL A, 1995, OPT LETT, V20, P654, DOI 10.1364/OL.20.000654; SHEIKBAHAE M, 1988, J APPL PHYS, V63, P518, DOI 10.1063/1.340080; Spillane SM, 2002, NATURE, V415, P621, DOI 10.1038/415621a; Treussart F, 1998, EUR PHYS J D, V1, P235, DOI 10.1007/s100530050087; Vernooy DW, 1998, PHYS REV A, V57, pR2293, DOI 10.1103/PhysRevA.57.R2293; Vernooy DW, 1998, OPT LETT, V23, P247, DOI 10.1364/OL.23.000247; Vollmer F, 2002, APPL PHYS LETT, V80, P4057, DOI 10.1063/1.1482797	23	1700	1785	24	685	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					925	928		10.1038/nature01371	http://dx.doi.org/10.1038/nature01371			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606995				2022-12-28	WOS:000181186900043
J	Elia, AEH; Cantley, LC; Yaffe, MB				Elia, AEH; Cantley, LC; Yaffe, MB			Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates	SCIENCE			English	Article							MAMMALIAN POLO KINASE; CELL-CYCLE; PROTEIN; SPECIFICITY; EXTRACTS; CLONING; PEPTIDE; SRC	We have developed a proteomic approach for identifying phosphopeptide binding domains that modulate kinase-dependent signaling pathways. An immobilized library of partially degenerate phosphopeptides biased toward a particular protein kinase phosphorylation motif is used to isolate phospho-binding domains that bind to proteins phosphorylated by that kinase. Applying this approach to cyclin-dependent kinases (Cdks), we identified the polo-box domain (PBD) of the mitotic kinase polo-like kinase 1 (Plk1) as a specific phosphoserine (pSer) or phosphothreonine (pThr) binding domain and determined its optimal binding motif. This motif is present in known Plk1 substrates such as Cdc25, and an optimal phosphopeptide containing the motif disrupted PBD-substrate binding and localization of the PBD to centrosomes. This finding reveals how Plk1 can localize to specific sites within cells in response to Cdk phosphorylation at those sites and provides a structural mechanism for targeting the Plk1 kinase domain to its substrates.	MIT, Dept Biol, Ctr Canc Res, Cambridge, MA 02139 USA; Beth Israel Deaconess Hosp, Div Signal Transduct, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Dept Biol, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52981, GM56203, R01 GM056203] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lee KS, 1999, P NATL ACAD SCI USA, V96, P14360, DOI 10.1073/pnas.96.25.14360; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Pawson T, 2000, GENE DEV, V14, P1027; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7	22	556	570	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1228	1231		10.1126/science.1079079	http://dx.doi.org/10.1126/science.1079079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595692				2022-12-28	WOS:000181065500039
J	Zanusso, G; Ferrari, S; Cardone, F; Zampieri, P; Gelati, M; Fiorini, M; Farinazzo, A; Gardiman, M; Cavallaro, T; Bentivoglio, M; Righetti, PG; Pocchiari, M; Rizzuto, N; Monaco, S				Zanusso, G; Ferrari, S; Cardone, F; Zampieri, P; Gelati, M; Fiorini, M; Farinazzo, A; Gardiman, M; Cavallaro, T; Bentivoglio, M; Righetti, PG; Pocchiari, M; Rizzuto, N; Monaco, S			Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; NEURODEGENERATIVE DISEASES; DIAGNOSTIC-CRITERIA; CEREBROSPINAL-FLUID; CLINICAL-DIAGNOSIS; MOLECULAR-BASIS; SCRAPIE; MUCOSA; EXPRESSION; ACCURACY	BACKGROUND: Olfactory cortexes and the olfactory tracts are involved in sporadic Creutzfeldt-Jakob disease. We examined peripheral regions of the olfactory sensory pathway, including the olfactory mucosa, to assess whether pathologic infectious prion protein (PrP(sup Sc)) is deposited in the epithelium lining the nasal cavity. METHODS: We studied nine patients with neuropathologically confirmed sporadic Creutzfeldt-Jakob disease. We obtained the brain, the cribriform plate with the attached olfactory mucosa, and the surrounding respiratory epithelium at autopsy. Control samples of nasal mucosa were obtained post mortem or at biopsy from age-matched control subjects and from control patients with other neurodegenerative diseases. The olfactory and respiratory mucosa and the intracranial olfactory system were analyzed by light microscopy, immunohistochemistry, and Western blotting for pathological changes and for deposition of PrP(sup Sc). RESULTS: In all nine patients with sporadic Creutzfeldt-Jakob disease, PrP(sup Sc) was found in the olfactory cilia and central olfactory pathway but not in the respiratory mucosa. No PrP(sup Sc) was detected in any of the tissue samples from the 11 controls. CONCLUSIONS: Our pathological and biochemical studies show that PrP(sup Sc) is deposited in the neuroepithelium of the olfactory mucosa in patients with sporadic Creutzfeldt-Jakob disease, indicating that olfactory biopsy may provide diagnostic information in living patients. The olfactory pathway may represent a route of infection and a means of spreading prions.	Univ Verona, Policlin GB Rossi, Dept Neurol & Visual Sci, Sect Clin Neurol, I-37134 Verona, Italy; Univ Verona, Dept Ear Nose & Throat, I-37134 Verona, Italy; Univ Verona, Dept Morphol & Biomed Sci, I-37134 Verona, Italy; Univ Verona, Dept Agr & Ind Biotechnol, I-37134 Verona, Italy; Ist Super Sanita, Virol Lab, I-00161 Rome, Italy; Univ Padua, Dept Pathol, I-35100 Padua, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; University of Verona; Istituto Superiore di Sanita (ISS); University of Padua	Monaco, S (corresponding author), Univ Verona, Policlin GB Rossi, Dept Neurol & Visual Sci, Sect Clin Neurol, Piazzale LA Scuro 10, I-37134 Verona, Italy.	salvatore.monaco@mail.univr.it	Pocchiari, Maurizio/J-8443-2018; Monaco, Salvatore/K-4659-2018; Bentivoglio, Marina/K-1008-2016; Ferrari, Sergio/AAE-5649-2019; Zanusso, Gianluigi/K-2823-2018; Gelati, Matteo/AAR-1692-2020; Cardone, Franco/D-1724-2009	Pocchiari, Maurizio/0000-0002-7269-2486; Monaco, Salvatore/0000-0003-3191-8597; Bentivoglio, Marina/0000-0003-4958-9795; Zanusso, Gianluigi/0000-0001-5199-6264; Cardone, Franco/0000-0002-2376-0470; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716				BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Castellani R, 1996, NEUROLOGY, V46, P1690, DOI 10.1212/WNL.46.6.1690; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; DeArmond SJ, 1999, COLD SPRING HARBOR M, V38, P585; Duda JE, 1999, EXP NEUROL, V160, P515, DOI 10.1006/exnr.1999.7228; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Haywood AM, 1997, NEW ENGL J MED, V337, P1821, DOI 10.1056/NEJM199712183372508; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ingrosso L, 1999, J GEN VIROL, V80, P3043, DOI 10.1099/0022-1317-80-11-3043; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kern RC, 2000, LARYNGOSCOPE, V110, P1071, DOI 10.1097/00005537-200007000-00001; KITAMOTO T, 1987, LAB INVEST, V57, P230; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Kovacs GG, 2002, BRAIN PATHOL, V12, P1; Kretzschmar HA, 1996, ARCH NEUROL-CHICAGO, V53, P913, DOI 10.1001/archneur.1996.00550090125018; MASTERS CL, 1979, ANN NEUROL, V5, P177, DOI 10.1002/ana.410050212; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reuber M, 2001, J NEUROL NEUROSUR PS, V71, P412, DOI 10.1136/jnnp.71.3.412; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SALVATORE M, 1994, HUM GENET, V94, P375, DOI 10.1007/BF00201596; SALVATORE M, 1995, HUM GENET, V95, P605; SHIPLEY MT, 1996, HAND CHEM N, V12, P469; Steinhoff BJ, 1996, ARCH NEUROL-CHICAGO, V53, P162, DOI 10.1001/archneur.1996.00550020074017; TABATON M, 1991, NEUROLOGY, V41, P391, DOI 10.1212/WNL.41.3.391; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Zanusso G, 2001, BRAIN PATHOL, V11, P182; Zanusso G, 2001, J BIOL CHEM, V276, P40377, DOI 10.1074/jbc.C100458200; Zerr I, 2000, ANN NEUROL, V48, P323, DOI 10.1002/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	38	117	120	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					711	719		10.1056/NEJMoa022043	http://dx.doi.org/10.1056/NEJMoa022043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594315				2022-12-28	WOS:000181014400006
J	Dybul, M; Fauci, AS; Bartlett, JG; Kaplan, JE; Pau, AK				Dybul, M; Fauci, AS; Bartlett, JG; Kaplan, JE; Pau, AK			Guidelines for using antiretroviral agents among HIV-infected adults and adolescents - The panel on clinical practices for treatment of HIV	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE INHIBITOR; PNEUMOCYSTIS-CARINII-PNEUMONIA; PLACEBO-CONTROLLED TRIAL; TYPE-1 RNA LEVELS; CD4 CELL COUNTS; BONE-MINERAL LOSS; VIRAL LOAD; PROTEASE-INHIBITOR; RISK-FACTORS	The availability of an increasing number of antiretroviral agents and the rapid evolution of new information have introduced substantial complexity into treatment regimens for persons infected with human immunodeficiency virus (HIV). In 1996, the Department of Health and Human Services and the Henry J. Kaiser Family Foundation convened the Panel on Clinical Practices for the Treatment of HIV to develop guidelines for clinical management of HIV-infected adults and adolescents (CDC. Report of the NIH Panel To Define Principles of Therapy of HIV Infection and Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR. 1998;47[RR-5]:1-41). This report, which updates the 1998 guidelines, addresses 1) using testing for plasma HIV ribonucleic acid levels (i.e., viral load) and CD4(+) T cell count; 2) using testing for antiretroviral drug resistance; 3) considerations for when to initiate therapy; 4) adherence to antiretroviral therapy; 5) considerations for therapy among patients with advanced disease; 6) therapy-related adverse events; 7) interruption of therapy, 8) considerations for changing therapy and available therapeutic options; 9) treatment for acute HIV infection; 10) considerations for antiretroviral therapy among adolescents; 11) considerations for antiretroviral therapy among pregnant women; and 12) concerns related to transmission of HIV to others. Antiretroviral regimens are complex, have serious side effects, pose difficulty with adherence, and carry serious potential consequences from the development of viral resistance because of non-adherence to the drug regimen or suboptimal levels of antiretroviral agents. Patient education and involvement in therapeutic decisions are critical. Treatment should usually be offered to all patients with symptoms ascribed to HIV infection. Recommendations for offering antiretroviral therapy among asymptomatic patients require analysis of real and potential risks and benefits. In general, treatment should be offered to persons who have <350 CD4(+) T cells/mm(3) or plasma HIV ribonucleic acid (RNA) levels of >55,000 copies/mL (by b-deoxyribonucleic acid [bDNA] or reverse transcriptase-polymerase chain reaction [RT-PCR] assays). The recommendation to treat asymptomatic patients should be based on the willingness and readiness of the pet-son to begin therapy; the degree of existing immunodeficiency as determined by the CD4(+) T cell count; the risk for disease progression as determined by the CD4(+) T cell count and level of plasma HIV RNA; the potential benefits and risks of initiating therapy in an asymptomatic person; and the likelihood, after counseling and education, of adherence to the prescribed treatment regimen. Treatment goals should be maximal and durable suppression of viral load, restoration and preservation of immunologic function, improvement of quality of life, and reduction of HIV-related morbidity and mortality. Results of therapy are evaluated through plasma HIV RNA levels, which are expected to indicate a 1.0 log(10) decrease at 2-8 weeks and no detectable virus (<50 copies/mL) at 4-6 months after treatment initiation. Failure of therapy at 4-6 months might be ascribed to nonadherence, inadequate potency of drugs or suboptimal levels of antiretroviral agents, viral resistance, and other factors that are poorly understood. Patients whose therapy fails in spite of a high level of adherence to the regimen should have their regimen changed; this change should be guided by a thorough drug treatment history and the results of drug-resistance testing. Because of limitations in Me available alternative antiretroviral regimens Mat have documented efficacy optimal changes in therapy might be difficult to achieve for patients in whom the preferred regimen has failed. These decisions are further confounded by problems with adherence, toxicity, and resistance. For certain patients, participating in a clinical trial with or without access to new drugs or using a regimen that might not achieve complete suppression of viral replication might be preferable. Because concepts regarding HIV management are evolving rapidly, readers should check regularly for additional information and updates at the HIV/AIDS Treatment Information Service website (http://www.hivatis.org).	NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Baltimore, MD USA; CDC, Atlanta, GA 30333 USA	National Institutes of Health (NIH) - USA; Johns Hopkins University; Centers for Disease Control & Prevention - USA	Dybul, M (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							Acosta EP, 1999, PHARMACOTHERAPY, V19, P708, DOI 10.1592/phco.19.9.708.31544; AHDIEH L, 2000, 13 INT AIDS C DURB S; ANASTOS K, 1999, 6 C RETR OPP INF CHI, P1208; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Antinori A, 2001, AIDS, V15, P1579, DOI 10.1097/00002030-200108170-00018; ARNSTEN J, 2000, 7 C RETR OPP INF, P88; Aukrust P, 1999, J CLIN ENDOCR METAB, V84, P145, DOI 10.1210/jc.84.1.145; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BAETEN J, 2000, 13 INT AIDS C DURB S; Bailey A, 1999, AIDS, V13, P1377, DOI 10.1097/00002030-199907300-00016; BAILEY R, 2001, 8 C RETR OPP INF CHI; Bangsberg D, 1997, JAMA-J AM MED ASSOC, V278, P63, DOI 10.1001/jama.278.1.63; BANGSBERG DR, 2000, 7 C RETR OPP INF SAN, P88; Barry MG, 1996, AIDS, V10, P1361, DOI 10.1097/00002030-199610000-00008; Bartlett J, 2001, 8 C RETR OPP INF CHI; BARTLETT J, 2000, 13 INT AIDS C DURB S; BAXTER JD, 1999, 6 C RETR OPP INF CHI, P206; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Bersoff-Matcha SJ, 2001, CLIN INFECT DIS, V32, P124, DOI 10.1086/317536; BINGHAM T, 2001, 8 C RETR OPP INF CHI; BLAIR J, 2000, 7 C RETR OPP INF SAN, P112; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Boden D, 1999, JAMA-J AM MED ASSOC, V282, P1135, DOI 10.1001/jama.282.12.1135; *BOEHR ING ROX LAB, 2000, DEAR HLTH CAR PROF L; Bonfanti P, 2001, J ACQ IMMUN DEF SYND, V27, P316; Bossi P, 2000, CLIN INFECT DIS, V30, P227, DOI 10.1086/313629; BOUBAKER K, 2000, 7 C RETR OPP INF SAN; Bourezane Y, 1998, CLIN INFECT DIS, V27, P1321, DOI 10.1086/517713; BOXWELL DE, 1999, 39 INT C ANT AG CHEM, P496; Brinkman K, 2000, CLIN INFECT DIS, V31, P167, DOI 10.1086/313921; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; *BRIST MYERS SQUIB, 2001, HEALTHC PROV IMP DRU; BUKUSI E, 2000, 13 INT AIDS C DURB S; Bush CE, 1996, J CLIN MICROBIOL, V34, P970, DOI 10.1128/JCM.34.4.970-972.1996; BUVE A, 2000, 13 INT AIDS C DURB S; CAHN P, 2000, 40 INT C ANT AG CHEM; Cameron DW, 1999, AIDS, V13, P213, DOI 10.1097/00002030-199902040-00009; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carmona A, 2000, 13 INT AIDS C DURB S; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P185; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; CHEEVER L, 1999, ADHERENCE HIV THERAP, P10; Chen R, 2001, 8 C RETR OPP INF CHI; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Chodock R, 1999, NEPHROL DIAL TRANSPL, V14, P2484, DOI 10.1093/ndt/14.10.2484; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Clarke S, 2000, CLIN INFECT DIS, V31, P806, DOI 10.1086/314026; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COHEN C, 2000, 7 C RETR OPP INF SAN, P120; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; COODLEY GO, 1994, J ACQ IMMUN DEF SYND, V7, P681; COOPER DA, 1993, NEW ENGL J MED, V329, P297, DOI 10.1056/NEJM199307293290501; Crespo-Fierro M, 1997, J Assoc Nurses AIDS Care, V8, P43, DOI 10.1016/S1055-3290(97)80012-X; CUNNEY RJ, 1999, 37 INF DIS SOC AM M; DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Deeks SG, 1999, J INFECT DIS, V179, P1375, DOI 10.1086/314775; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dube M P, 1998, AIDS Clin Care, V10, P41; Dube MP, 2000, CLIN INFECT DIS, V31, P1216; Dunlop MBV, 1999, B RHEUM DIS, V48, P1; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; DYBUL M, 2001, 8 C RETR OPP INF CHI; Eastman PS, 1998, J INFECT DIS, V177, P557, DOI 10.1086/514228; Eastone JA, 1997, ANN INTERN MED, V127, P948, DOI 10.7326/0003-4819-127-10-199711150-00017; EGGER M, 2001, 41 INT C ANT AG CHEM; Evans JS, 1997, J INFECT DIS, V175, P795, DOI 10.1086/513973; FAGARD C, 2001, 8 C RETR OPP INF CHI; Fagot JP, 2001, AIDS, V15, P1843, DOI 10.1097/00002030-200109280-00014; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FISCHL M, 2000, 7 C RETR OPP INF SAN; FLAKS R, 2001, 8 C RETR OPP INF CHI; FLANIGAN T, 1999, ADHERENCE HIV THERAP, P21; FORTGANG IS, 1995, AM J GASTROENTEROL, V90, P1433; Fowler M E, 1998, J Assoc Nurses AIDS Care, V9, P72, DOI 10.1016/S1055-3290(98)80021-6; Furrer H, 1999, NEW ENGL J MED, V340, P1301, DOI 10.1056/NEJM199904293401701; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; GAUGHAN DM, 2001, 8 C RETR OPP INF CHI; Gervasoni C, 1999, AIDS, V13, P465, DOI 10.1097/00002030-199903110-00004; Gisolf EH, 2000, CLIN INFECT DIS, V31, P1234, DOI 10.1086/317449; GLESBY M, 2000, ANTIVIR THER, V5, P21; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; GRAY R, 2000, 13 INT AIDS C DURB S; GREENBERG RN, 1984, CLIN THER, V6, P592; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HARRIS M, 2000, ANTIVIR THER S, V5, P31; Hart CE, 1999, J INFECT DIS, V179, P871, DOI 10.1086/314656; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hoen B, 1999, J INFECT DIS, V180, P1342, DOI 10.1086/315002; HOFFMAN I, 2000, 13 INT AIDS C DURB S; Hogg R, 2000, 13 INT AIDS C DURB S; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; HOY J, 2000, 7 C RETR OPP INF SAN; Hsu A, 1998, CLIN PHARMACOL THER, V63, P453, DOI 10.1016/S0009-9236(98)90041-8; Human rabies-New York, 1993, MMWR MORB MORTAL WKL, V42, P806; Ibdah JA, 1999, NEW ENGL J MED, V340, P1723, DOI 10.1056/NEJM199906033402204; Ibdah JA, 2000, MOL GENET METAB, V71, P182, DOI 10.1006/mgme.2000.3065; Ickovics JR, 1997, J CLIN EPIDEMIOL, V50, P385, DOI 10.1016/S0895-4356(97)00041-3; Ioannidis JPA, 2001, J INFECT DIS, V183, P539, DOI 10.1086/318530; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; Joffe BI, 2001, LANCET, V357, P1379, DOI 10.1016/S0140-6736(00)04616-X; John M, 2001, AIDS, V15, P717, DOI 10.1097/00002030-200104130-00007; Junghans C, 1999, LANCET, V353, P589, DOI 10.1016/S0140-6736(05)75645-2; Kakuda TN, 1999, AIDS, V13, P2311, DOI 10.1097/00002030-199911120-00019; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; KALISH LA, 1999, 39 INT C ANT AG CHEM, P532; Kaplan J, 2000, 13 INT AIDS C DURB S; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4; KILBY M, 2000, 40 INT C ANT AG CHEM, P336; KINLOCHDELOES S, 1995, NEW ENGL J MED, V333, P408, DOI 10.1056/NEJM199508173330702; Knobel H, 2001, J ACQ IMMUN DEF SYND, V28, P14, DOI 10.1097/00042560-200109010-00003; KNOBEL H, 1998, 12 INT AIDS C GEN SW; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; Kotler DP, 1999, J ACQ IMMUN DEF SYND, V20, P228, DOI 10.1097/00042560-199903010-00003; Kourtis AP, 2001, JAMA-J AM MED ASSOC, V285, P709, DOI 10.1001/jama.285.6.709; Kovacs A, 2001, LANCET, V358, P1593, DOI 10.1016/S0140-6736(01)06653-3; KUROWSKI M, 2000, 40 INT C ANT AG CHEM, P333; Lafeuillade A, 1997, J INFECT DIS, V175, P1051, DOI 10.1086/516442; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; LIBMAN H, 2000, HIV; LICHTENSTEIN K, 2000, 13 INT AIDS C DURB S; Lillo FB, 1999, AIDS, V13, P791, DOI 10.1097/00002030-199905070-00007; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; LOES SKD, 1993, CLIN INFECT DIS, V17, P59, DOI 10.1093/clinids/17.1.59; Lonergan JT, 2000, CLIN INFECT DIS, V31, P162, DOI 10.1086/313912; LUBER AD, 2000, 40 INT C ANT AG CHEM, P297; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Luzzati R, 1999, LANCET, V353, P901, DOI 10.1016/S0140-6736(99)00523-1; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; MALLAL S, 1999, 1 INT WORKSH ADV DRU; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; MANNHERHEIMER S, 2000, 13 INT AIDS C DURB S; MANNUCCI PM, 1994, BRIT J HAEMATOL, V86, P174, DOI 10.1111/j.1365-2141.1994.tb03270.x; Martinez E, 2000, CLIN INFECT DIS, V31, P1266, DOI 10.1086/317426; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; MARX P, 2000, 13 INT AIDS C DURB S; Masur H, 2002, ANN INTERN MED, V137, P435, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00002; MASUR H, 2000, 38 INF DIS SOC AM M; McCune JM, 1998, J CLIN INVEST, V101, P2301, DOI 10.1172/JCI2834; McPherson-Baker S., 2000, AIDS Care, V12, P399, DOI 10.1080/09540120050123792; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MILLER J, 2001, 8 C RETR OPP INF CHI; Miller KD, 2000, ANN INTERN MED, V133, P192, DOI 10.7326/0003-4819-133-3-200008010-00010; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; Miller V, 1999, J INFECT DIS, V180, P530, DOI 10.1086/314890; Minkoff H, 1997, AM J OBSTET GYNECOL, V176, P478, DOI 10.1016/S0002-9378(97)70519-2; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mokrzycki MH, 2000, CLIN INFECT DIS, V30, P198, DOI 10.1086/313594; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; MOORE R, 2000, 7 C RETR OPP INF SAN; Moore RD, 1999, LANCET, V353, P463, DOI 10.1016/S0140-6736(98)05379-3; Mora S, 2001, AIDS, V15, P1823, DOI 10.1097/00002030-200109280-00011; Moroni M, 1999, LANCET, V353, P589, DOI 10.1016/S0140-6736(05)75646-4; MOYLE GJ, 2000, 40 INT C ANT AG CHEM; MULDER JW, 1994, AIDS, V8, P313, DOI 10.1097/00002030-199403000-00004; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Mulligan K, 2001, J ACQ IMMUN DEF SYND, V26, P443, DOI 10.1097/00126334-200104150-00006; MURATA H, 2001, 3 INT WORKSH ADV DRU; Murphy RL, 2001, AIDS, V15, pF1, DOI 10.1097/00002030-200101050-00002; NIEUWKERK P, 2000, 13 INT AIDS C DURB S; NIU MT, 1993, J INFECT DIS, V168, P1490, DOI 10.1093/infdis/168.6.1490; Nunez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; OPRAVIL M, 2001, 8 C RETR OPP INF CHI; Overbaugh J, 1996, AIDS RES HUM RETROV, V12, P107, DOI 10.1089/aid.1996.12.107; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PALUMBO R, 1999, GLOB STRAT PREV HIV; Pantaleo G, 1998, NAT MED, V4, P341, DOI 10.1038/nm0398-341; PARIENTI JJ, 2000, 40 INT C ANT AG CHEM; Parkin NT, 1999, J INFECT DIS, V180, P865, DOI 10.1086/314928; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Paton NIJ, 1997, CALCIFIED TISSUE INT, V61, P30, DOI 10.1007/s002239900288; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; PISCITELLI S, 2000, 7 C RETR OPP INF SAN; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; POWDERLY WG, 2000, 40 INT C ANT AG CHEM; Prins M, 1999, AIDS, V13, P2361, DOI 10.1097/00002030-199912030-00007; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 1996, J INFECT DIS, V174, P191, DOI 10.1093/infdis/174.1.191; Racoosin JA, 1999, HAEMOPHILIA, V5, P266; Raffi F, 2000, CLIN INFECT DIS, V31, P1274, DOI 10.1086/317424; RAPPAPORT E, 1999, ADHERENCE HIV THERAP, P31; Rodman JH, 1996, J INFECT DIS, V174, P490, DOI 10.1093/infdis/174.3.490; ROGERS A, 1999, ADHERENCE HIV THERAP, P16; ROMEAU J, 1999, 39 INT C ANT AG CHEM; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Ruiz L, 2001, J ACQ IMMUN DEF SYND, V27, P229, DOI 10.1097/00126334-200107010-00003; SAAH A, 1999, 6 C RETR OPP INF CHI; Saint-Marc T, 2000, AIDS, V14, P37, DOI 10.1097/00002030-200001070-00005; Saves M, 2000, ANTIMICROB AGENTS CH, V44, P3451, DOI 10.1128/AAC.44.12.3451-3455.2000; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schneider MME, 1999, LANCET, V353, P201, DOI 10.1016/S0140-6736(98)07204-3; Schramm C, 1999, EUR J ANAESTH, V16, P733; Scribner AN, 2000, J ACQ IMMUN DEF SYND, V25, P19, DOI 10.1097/00126334-200009010-00003; Sellmeyer DE, 1996, ENDOCR REV, V17, P518, DOI 10.1210/er.17.5.518; Shaheen F, 1999, J HUMAN VIROL, V2, P154; Sham HL, 1998, ANTIMICROB AGENTS CH, V42, P3218, DOI 10.1128/AAC.42.12.3218; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Sherer R, 1998, JAMA-J AM MED ASSOC, V280, P567, DOI 10.1001/jama.280.6.567; Singh N, 1996, AIDS CARE, V8, P261, DOI 10.1080/09540129650125696; Soriano V, 2000, AIDS, V14, P1672, DOI 10.1097/00002030-200007280-00032; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; SQUIRES K, 2001, 8 C RETR OPP INF CHI; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Staszewski S, 2001, JAMA-J AM MED ASSOC, V285, P1155, DOI 10.1001/jama.285.9.1155; STEIN DS, 1992, J INFECT DIS, V165, P352, DOI 10.1093/infdis/165.2.352; STENZEL MS, 2000, 13 INT AIDS C DURB S; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; STERLING TR, 2001, 8 C RETR OPP INF CHI; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; TEBAS P, 2000, ANTIVIR THER, V5, P18; ter Hofstede HJM, 2000, INT J STD AIDS, V11, P611; Thiebaut R, 2000, CLIN INFECT DIS, V31, P1482, DOI 10.1086/317477; TINDALL B, 1991, AIDS, V5, P1, DOI 10.1097/00002030-199101000-00001; TOFFALETTI JG, 1991, CRIT REV CL LAB SCI, V28, P253, DOI 10.3109/10408369109106865; Tsiodras S, 2000, ARCH INTERN MED, V160, P2050, DOI 10.1001/archinte.160.13.2050; TYNDALL M, 2000, 13 INT AIDS C DURB S; *US DEP HHS, 2002, PHS TASK FORC REC US; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Visnegarwala F, 1997, ANN INTERN MED, V127, P947, DOI 10.7326/0003-4819-127-10-199711150-00016; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; WABWIREMANGEN F, 2000, 13 INT AIDS C DURB S; WALSH JC, 2000, 40 INT C ANT AG CHEM, P294; Webber MP, 1999, AIDS, V13, P257, DOI 10.1097/00002030-199902040-00014; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0; Williams A, 1997, AIDS Clin Care, V9, P51; Williams A, 1997, AIDS CLIN CARE, V9, P58; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; YARASHESKI K, 2001, 3 INT WORKSH ADV DRU; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; 1996, MMWR MORB MORTAL WKL, V45, P468; 1998, MMWR MORB MORTAL WKL, V47, P1521	252	249	267	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2002	137	5	2				381	433		10.7326/0003-4819-137-5_Part_2-200209031-00001	http://dx.doi.org/10.7326/0003-4819-137-5_Part_2-200209031-00001			53	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	592TJ	12617573				2022-12-28	WOS:000177952700001
J	Aebersold, R; Mann, M				Aebersold, R; Mann, M			Mass spectrometry-based proteomics	NATURE			English	Review							2-DIMENSIONAL GEL-ELECTROPHORESIS; PROTEIN COMPLEXES; ACCURATE MASS; QUANTITATIVE-ANALYSIS; SEQUENCE DATABASES; GENE-EXPRESSION; YEAST PROTEOME; SPECTRAL DATA; IDENTIFICATION; PEPTIDES		Inst Syst Biol, Seattle, WA 98103 USA; Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark	Institute for Systems Biology (ISB); University of Southern Denmark	Aebersold, R (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	raebersold@systemsbiology.org; mann@bmb.sdu.dk	Mann, Matthias/A-3454-2013	Mann, Matthias/0000-0003-1292-4799				Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Aebersold R, 2002, NAT BIOTECHNOL, V20, P651, DOI 10.1038/nbt0702-651; Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; ANDERSON NL, 1984, CLIN CHEM, V30, P2031; ASHMAN K, CELL SIGNALLING PROT; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Cohen SL, 2001, ANNU REV BIOPH BIOM, V30, P67, DOI 10.1146/annurev.biophys.30.1.67; Conrads TP, 2002, BIOCHEM BIOPH RES CO, V290, P885, DOI 10.1006/bbrc.2001.6275; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Gauss C, 1999, ELECTROPHORESIS, V20, P575, DOI 10.1002/(SICI)1522-2683(19990301)20:3<575::AID-ELPS575>3.0.CO;2-3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goodlett DR, 2000, ANAL CHEM, V72, P1112, DOI 10.1021/ac9913210; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; GUINA T, IN PRESS P NATL ACAD; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Gygi SP, 2002, J PROTEOME RES, V1, P47, DOI 10.1021/pr015509n; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hager JW, 2002, RAPID COMMUN MASS SP, V16, P512, DOI 10.1002/rcm.607; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hanson CL, 2003, J BIOL CHEM, V278, P1259, DOI 10.1074/jbc.M208966200; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Kuster B, 2001, PROTEOMICS, V1, P641; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Leung AKL, 2002, J CELL BIOL, V157, P615, DOI 10.1083/jcb.200201120; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Loboda AV, 2000, RAPID COMMUN MASS SP, V14, P1047, DOI 10.1002/1097-0231(20000630)14:12<1047::AID-RCM990>3.0.CO;2-E; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; MacDonald JA, 2002, MOL CELL PROTEOMICS, V1, P314, DOI 10.1074/mcp.M200002-MCP200; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; MANN M, IN PRESS NATURE BIOT; MANN M, 2002, NATURE, V420, P21; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; Medzihradszky KF, 2000, ANAL CHEM, V72, P552, DOI 10.1021/ac990809y; Mirgorodskaya OA, 2000, RAPID COMMUN MASS SP, V14, P1226, DOI 10.1002/1097-0231(20000730)14:14<1226::AID-RCM14>3.0.CO;2-V; Mortz E, 1996, P NATL ACAD SCI USA, V93, P8264, DOI 10.1073/pnas.93.16.8264; Munchbach M, 2000, ANAL CHEM, V72, P4047, DOI 10.1021/ac000265w; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783; Oh H, 2002, P NATL ACAD SCI USA, V99, P15863, DOI 10.1073/pnas.212643599; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; RANISH JA, IN PRESS NATURE GENE; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rappsilber J, 2000, ANAL CHEM, V72, P267, DOI 10.1021/ac991081o; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schwartz JC, 2002, J AM SOC MASS SPECTR, V13, P659, DOI 10.1016/S1044-0305(02)00384-7; Shevchenko A, 2002, MOL CELL PROTEOMICS, V1, P204, DOI 10.1074/mcp.M200005-MCP200; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Steen H, 2002, J BIOL CHEM, V277, P1031, DOI 10.1074/jbc.M109992200; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Taylor SW, 2003, TRENDS BIOTECHNOL, V21, P82, DOI 10.1016/S0167-7799(02)00037-9; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Valaskovic GA, 1996, SCIENCE, V273, P1199, DOI 10.1126/science.273.5279.1199; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; ZHANG H, UNPUB QUANTITATIVE A; Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777; Zhou HL, 2002, NAT BIOTECHNOL, V20, P512, DOI 10.1038/nbt0502-512; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	91	5028	5362	62	2532	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					198	207		10.1038/nature01511	http://dx.doi.org/10.1038/nature01511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634793				2022-12-28	WOS:000181488900054
J	Duncan, RR; Greaves, J; Wiegand, UK; Matskovich, I; Bodammer, G; Apps, DK; Shipston, MJ; Chow, RH				Duncan, RR; Greaves, J; Wiegand, UK; Matskovich, I; Bodammer, G; Apps, DK; Shipston, MJ; Chow, RH			Functional and spatial segregation of secretory vesicle pools according to vesicle age	NATURE			English	Article							ADRENAL CHROMAFFIN CELLS; EXOCYTOSIS; GRANULES; CALCIUM; BARIUM; SYNAPTOTAGMINS; BIOSYNTHESIS; MICROSCOPY; TRANSPORT; DYNAMICS	Synaptic terminals and neuroendocrine cells are packed with secretory vesicles, only a few of which are docked at the plasma membrane and readily releasable. The remainder are thought to constitute a large cytoplasmic reserve pool awaiting recruitment into the readily releasable pool (RRP) for exocytosis'. How vesicles are prioritized in recruitment is still unknown: the choice could be random, or else the oldest or the newest ones might be favoured. Here we show, using a fluorescent cargo protein(2) that changes colour with time(3), that vesicles in bovine adrenal chromaffin cells segregate into distinct populations, based on age. Newly assembled vesicles are immobile (morphologically docked) at the plasma membrane shortly after biogenesis, whereas older vesicles are mobile and located deeper in the cell. Different secretagogues selectively release vesicles from the RRP or, surprisingly, selectively from the deeper cytoplasmic pool. Thus, far from being equal, vesicles are segregated functionally and spatially according to age.	Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; Univ Edinburgh, Membrane Biol Grp, Edinburgh EH8 9XD, Midlothian, Scotland	University of Southern California; University of Edinburgh	Chow, RH (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA.		Shipston, Mike/C-7309-2013; Chow, Robert/B-8155-2013	Shipston, Mike/0000-0001-7544-582X; Duncan, Rory/0000-0003-0693-910X; Greaves, Jennifer/0000-0001-8445-789X				Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; CHEN TT, 1989, ENDOCRINOLOGY, V125, P1904, DOI 10.1210/endo-125-4-1904; CORCORAN JJ, 1984, J BIOL CHEM, V259, P6208; Cuchillo-Ibanez I, 1999, FEBS LETT, V459, P22, DOI 10.1016/S0014-5793(99)01115-1; Duncan RR, 1999, BIOCHEM J, V342, P497, DOI 10.1042/0264-6021:3420497; FREESTONE S, 1989, BRIT J CLIN PHARMACO, V27, P13, DOI 10.1111/j.1365-2125.1989.tb05329.x; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; HELDMAN E, 1989, J BIOL CHEM, V264, P7914; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Lundstrom K, 2001, HISTOCHEM CELL BIOL, V115, P83, DOI 10.1007/s004180000223; Morgan A, 1997, SEMIN CELL DEV BIOL, V8, P141, DOI 10.1006/scdb.1996.0133; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; NGUYEN TT, 1988, FEBS LETT, V231, P393, DOI 10.1016/0014-5793(88)80857-3; Ogawa T, 1999, AM J PHYSIOL-HEART C, V276, pH1977, DOI 10.1152/ajpheart.1999.276.6.H1977; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; PHILLIPS JH, 1982, NEUROSCIENCE, V7, P1595, DOI 10.1016/0306-4522(82)90017-3; Rudolf R, 2001, MOL BIOL CELL, V12, P1353, DOI 10.1091/mbc.12.5.1353; Seward EP, 1996, J NEUROSCI, V16, P1370; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; TERBUSH DR, 1992, J NEUROCHEM, V58, P680, DOI 10.1111/j.1471-4159.1992.tb09771.x; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Winkler H, 1998, CELL MOL NEUROBIOL, V18, P193, DOI 10.1023/A:1022516919932	27	174	178	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					176	180		10.1038/nature01389	http://dx.doi.org/10.1038/nature01389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634788				2022-12-28	WOS:000181488900048
J	Gami, AS; Montori, VM; Erwin, PJ; Khan, MA; Smith, SA				Gami, AS; Montori, VM; Erwin, PJ; Khan, MA; Smith, SA		EVIDENS Res Grp	Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Mayo Clin & Mayo Fdn, Div Endocrinol Diabet Metab Nutr & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Med Lib, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Smith, SA (corresponding author), Mayo Clin & Mayo Fdn, Div Endocrinol Diabet Metab Nutr & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	smith.steven@mayo.edu		Montori, Victor/0000-0003-0595-2898				*BRIT HEART FDN HE, 2002, LANCET, V360, P7; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486	2	12	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2003	326	7388					528	529		10.1136/bmj.326.7388.528	http://dx.doi.org/10.1136/bmj.326.7388.528			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623912	Bronze, Green Published			2022-12-28	WOS:000181548400018
J	Depege, N; Bellafiore, S; Rochaix, JD				Depege, N; Bellafiore, S; Rochaix, JD			Role of chloroplast protein kinase Stt7 in LHCII phosphorylation and state transition in Chlamydomonas	SCIENCE			English	Article							LIGHT ENERGY-DISTRIBUTION; REINHARDTII; PHOTOSYNTHESIS; MUTANTS; POLYPEPTIDE; ACTIVATION; SUBUNIT	Photosynthetic organisms adapt to changes in light quality by redistributing light excitation energy between two photosystems through state transition. This reorganization of antenna systems leads to an enhanced photosynthetic yield. Using a genetic approach in Chlamydomonas reinhardtii to dissect the signal transduction pathway of state transition, we identified a chloroplast thylakoid-associated serine-threonine protein kinase, Stt7, that has homologs in land plants. Stt7 is required for the phosphorylation of the major light-harvesting protein (LHCII) and for state transition.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Rochaix, JD (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean-david.rochaix@molbio.unige.ch	Bellafiore, stephane/J-4756-2014; Bellafiore, stephane/AFS-1835-2022; Rochaix, Jean-David/ABC-5243-2020	Bellafiore, stephane/0000-0002-4394-0866; Bellafiore, stephane/0000-0002-4394-0866; Fargeix, Nathalie/0000-0003-4591-1791				ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; DEPEGE N, UNPUB; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Kruse O, 1999, PHOTOSYNTH RES, V61, P43, DOI 10.1023/A:1006229308606; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; PURTON S, 1994, PLANT MOL BIOL, V24, P533, DOI 10.1007/BF00024121; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; Ruelland E, 1999, TRENDS PLANT SCI, V4, P136, DOI 10.1016/S1360-1385(99)01391-6; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Snyders S, 1999, J BIOL CHEM, V274, P9137, DOI 10.1074/jbc.274.14.9137; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	19	394	413	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1572	1575		10.1126/science.1081397	http://dx.doi.org/10.1126/science.1081397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624266				2022-12-28	WOS:000181367900037
J	Conner, SD; Schmid, SL				Conner, SD; Schmid, SL			Regulated portals of entry into the cell	NATURE			English	Review							COATED VESICLE FORMATION; ENDOCYTOSIS IN-VITRO; MEDIATED ENDOCYTOSIS; TYROSINE PHOSPHORYLATION; DYNAMIN RECRUITMENT; EPS15 HOMOLOGY; CLATHRIN; PROTEIN; ACTIN; CAVEOLAE	The plasma membrane is the interface between cells and their harsh environment. Uptake of nutrients and all communication among cells and between cells and their environment occurs through this interface. 'Endocytosis' encompasses several diverse mechanisms by which cells internalize macromolecules and particles into transport vesicles derived from the plasma membrane. It controls entry into the cell and has a crucial role in development, the immune response, neurotransmission, intercellular communication, signal transduction, and cellular and organismal homeostasis. As the complexity of molecular interactions governing endocytosis are revealed, it has become increasingly clear that it is tightly coordinated and coupled with overall cell physiology and thus, must be viewed in a broader context than simple vesicular trafficking.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	slschmid@scripps.edu		Schmid, Sandra/0000-0002-1690-7024				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benmerah A, 1999, J CELL SCI, V112, P1303; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Burger KNJ, 2000, BIOCHEMISTRY-US, V39, P12485, DOI 10.1021/bi000971r; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Confalonieri S, 2000, J CELL BIOL, V150, P905, DOI 10.1083/jcb.150.4.905; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Cremona O, 2001, J CELL SCI, V114, P1041; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; de Duve C, 1991, BLUEPRINT CELL NATUR; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Doria M, 1999, J CELL BIOL, V147, P1379, DOI 10.1083/jcb.147.7.1379; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Edidin M, 2001, TRENDS CELL BIOL, V11, P492, DOI 10.1016/S0962-8924(01)02139-0; Fadok VA, 2001, SEMIN IMMUNOL, V13, P365, DOI 10.1006/smim.2001.0333; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fingerhut A, 2001, J BIOL CHEM, V276, P5476, DOI 10.1074/jbc.M009516200; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gilbert A, 1997, J CELL SCI, V110, P3105; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Korolchuk VI, 2002, TRAFFIC, V3, P428, DOI 10.1034/j.1600-0854.2002.30606.x; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; LIN HC, 1991, J CELL BIOL, V114, P881, DOI 10.1083/jcb.114.5.881; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; McMahon HT, 1999, CURR BIOL, V9, pR332, DOI 10.1016/S0960-9822(99)80206-1; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; SMYTHE E, 1992, J CELL BIOL, V119, P1163, DOI 10.1083/jcb.119.5.1163; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; Steele-Mortimer O, 2000, TRAFFIC, V1, P107, DOI 10.1034/j.1600-0854.2000.010203.x; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x	98	2878	2970	17	758	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2003	422	6927					37	44		10.1038/nature01451	http://dx.doi.org/10.1038/nature01451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621426				2022-12-28	WOS:000181343100029
J	Parthasarathi, A				Parthasarathi, A			India - A champion of new technologies	NATURE			English	Editorial Material									Jawaharlal Nehru Univ, Ctr Studies Sci Policy, Delhi, India; Jawaharlal Nehru Univ, Sch Social Sci, Delhi, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Parthasarathi, A (corresponding author), Jawaharlal Nehru Univ, Ctr Studies Sci Policy, Delhi, India.								0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					17	18		10.1038/422017a	http://dx.doi.org/10.1038/422017a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621409				2022-12-28	WOS:000181343100015
J	Vanhamme, L; Paturiaux-Hanocq, F; Poelvoorde, P; Nolan, DP; Lins, L; Van den Abbeele, J; Pays, A; Tebabi, P; Van Xong, H; Jacquet, A; Moguilevsky, N; Dieu, M; Kane, JP; De Baetselier, P; Brasseur, R; Pays, E				Vanhamme, L; Paturiaux-Hanocq, F; Poelvoorde, P; Nolan, DP; Lins, L; Van den Abbeele, J; Pays, A; Tebabi, P; Van Xong, H; Jacquet, A; Moguilevsky, N; Dieu, M; Kane, JP; De Baetselier, P; Brasseur, R; Pays, E			Apolipoprotein L-I is the trypanosome lytic factor of human serum	NATURE			English	Article							HAPTOGLOBIN-RELATED PROTEIN; L GENE-CLUSTER; BRUCEI; EXPRESSION; IDENTIFICATION; GLYCOPROTEIN; RHODESIENSE; ENDOCYTOSIS; RESISTANCE; CLONING	Human sleeping sickness in east Africa is caused by the parasite Trypanosoma brucei rhodesiense. The basis of this pathology is the resistance of these parasites to lysis by normal human serum (NHS)(1,2). Resistance to NHS is conferred by a gene that encodes a truncated form of the variant surface glycoprotein termed serum resistance associated protein (SRA)(3,4). We show that SRA is a lysosomal protein, and that the amino-terminal alpha-helix of SRA is responsible for resistance to NHS. This domain interacts strongly with a carboxy-terminal alpha-helix of the human-specific serum protein apolipoprotein L-I (apoL-I). Depleting NHS of apoL-I, by incubation with SRA or anti-apoL-I, led to the complete loss of trypanolytic activity. Addition of native or recombinant apoL-I either to apoL-I-depleted NHS or to fetal calf serum induced lysis of NHS-sensitive, but not NHS-resistant, trypanosomes. Confocal microscopy demonstrated that apoL-I is taken up through the endocytic pathway into the lysosome. We propose that apoL-I is the trypanosome lytic factor of NHS, and that SRA confers resistance to lysis by interaction with apoL-I in the lysosome.	Univ Brussels, IBMM, Mol Parasitol Lab, B-6041 Gosselies, Belgium; Univ Gembloux, Ctr Biophys Mol Numer, B-5030 Gembloux, Belgium; Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; Free Univ Brussels, Cellular Immunol Lab, B-1640 Rhode St Genese, Belgium; Univ Brussels, IBMM, Lab Appl Genet, B-6041 Brussels, Belgium; Univ Namur, Unit Cellular Biochem & Biol, B-5000 Namur, Belgium; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	Universite Libre de Bruxelles; University of Liege; Institute of Tropical Medicine (ITM); University of Namur; University of California System; University of California San Francisco	Pays, E (corresponding author), Univ Brussels, IBMM, Mol Parasitol Lab, 12 Rue Prof Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	LINS, LAURENCE/Y-1661-2019; Jacquet, Alain/GQI-0546-2022; De Baetselier, Patrick/D-3866-2014; Jacquet, Alain/T-8611-2019	LINS, LAURENCE/0000-0001-7772-6748; Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741; Nolan, Derek/0000-0002-3742-4304; Van Den Abbeele, Jan/0000-0002-4533-4480; Dieu, Marc/0000-0002-3902-542X				BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; BRASSEUR R, 1994, J MOL GRAPHICS, V12, P212; DEGREEF C, 1994, MOL BIOCHEM PARASIT, V68, P277, DOI 10.1016/0166-6851(94)90172-4; DOTHI CD, 1991, MOL BIOCHEM PARASIT, V48, P199; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; GUEX N, 1997, ELECTROPHORESIS, V18, P14; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Hatada S, 2002, MOL BIOCHEM PARASIT, V119, P291, DOI 10.1016/S0166-6851(01)00420-0; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lins L, 2001, PROTEINS, V44, P435, DOI 10.1002/prot.1109; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Raper J, 2001, CURR OPIN MICROBIOL, V4, P402, DOI 10.1016/S1369-5274(00)00226-5; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Shimamura M, 2001, MOL BIOCHEM PARASIT, V115, P227, DOI 10.1016/S0166-6851(01)00292-4; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	21	351	365	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					83	87		10.1038/nature01461	http://dx.doi.org/10.1038/nature01461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621437				2022-12-28	WOS:000181343100042
J	Nath, U; Crawford, BCW; Carpenter, R; Coen, E				Nath, U; Crawford, BCW; Carpenter, R; Coen, E			Genetic control of surface curvature	SCIENCE			English	Article							LEAF DEVELOPMENT; GROWTH; ARABIDOPSIS; ANTIRRHINUM; EXPRESSION; ASYMMETRY; PATTERNS; DIVISION; TOBACCO; PLANTS	Although curvature of biological surfaces has been considered from mathematical and biophysical perspectives, its molecular and developmental basis is unclear. We have studied the cin mutant of Antirrhinum, which has crinkly rather than flat leaves. Leaves of cin display excess growth in marginal regions, resulting in a gradual introduction of negative curvature during development. This reflects a change in the shape and the progression of a cell-cycle arrest front moving from the leaf tip toward the base. CIN encodes a TCP protein and is expressed downstream of the arrest front. We propose that CIN promotes zero curvature (flatness) by making cells more sensitive to an arrest signal, particularly in marginal regions.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Coen, E (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk						Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; BALL P, 2002, NATURE SCI UPDATE; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; DOONAN JH, COMMUNICATION; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; FOBERT PR, 1994, EMBO J, V13, P616, DOI 10.1002/j.1460-2075.1994.tb06299.x; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Gaudin V, 2000, PLANT PHYSIOL, V122, P1137, DOI 10.1104/pp.122.4.1137; Green PB, 1999, AM J BOT, V86, P1059, DOI 10.2307/2656967; Green PB, 1996, ANN BOT-LONDON, V78, P269, DOI 10.1006/anbo.1996.0121; Kosugi S, 1997, PLANT CELL, V9, P1607, DOI 10.1105/tpc.9.9.1607; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; KRSEK P., 1998, MATH SURFACES 8, P1; Lawrence A.D, UNPUB; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Luo D, 1999, CELL, V99, P367, DOI 10.1016/S0092-8674(00)81523-8; MARDER M, IN PRESS COND MAT; POETHIG RS, 1985, PLANTA, V165, P170, DOI 10.1007/BF00395039; POETHIG RS, 1985, PLANTA, V165, P158, DOI 10.1007/BF00395038; PYKE KA, 1991, J EXP BOT, V42, P1407, DOI 10.1093/jxb/42.11.1407; Stubbe H, 1966, GENETIK ZYTOLOGIE AN; SYLVESTER AW, 1990, DEVELOPMENT, V110, P985; TODD PH, 1985, J THEOR BIOL, V113, P63, DOI 10.1016/S0022-5193(85)80075-8; Waddington CH, 1940, J GENET, V41, P75, DOI 10.1007/BF02982977; WOLF SD, 1986, AM J BOT, V73, P832, DOI 10.2307/2444294	27	524	568	11	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1404	1407		10.1126/science.1079354	http://dx.doi.org/10.1126/science.1079354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610308				2022-12-28	WOS:000181192300055
J	Gaunt, MW; Yeo, M; Frame, IA; Stothard, JR; Carrasco, HJ; Taylor, MC; Mena, SS; Veazey, P; Miles, GAJ; Acosta, N; de Arias, AR; Miles, MA				Gaunt, MW; Yeo, M; Frame, IA; Stothard, JR; Carrasco, HJ; Taylor, MC; Mena, SS; Veazey, P; Miles, GAJ; Acosta, N; de Arias, AR; Miles, MA			Mechanism of genetic exchange in American trypanosomes	NATURE			English	Article							CRUZI; IDENTIFICATION; EVOLUTION; LINEAGES; STRAINS	The kinetoplastid Protozoa are responsible for devastating diseases(1). In the Americas, Trypanosoma cruzi is the agent of Chagas' disease-a widespread disease transmissible from animals to humans (zoonosis)-which is transmitted by exposure to infected faeces of blood-sucking triatomine bugs(2). The presence of genetic exchange in T. cruzi and in Leishmania is much debated(3,4). Here, by producing hybrid clones, we show that T. cruzi has an extant capacity for genetic exchange. The mechanism is unusual and distinct from that proposed for the African trypanosome, Trypanosoma brucei(5). Two biological clones(6) of T. cruzi were transfected to carry different drug-resistance markers(7,8), and were passaged together through the entire life cycle. Six double-drug-resistant progeny clones, recovered from the mammalian stage of the life cycle, show fusion of parental genotypes, loss of alleles, homologous recombination, and uniparental inheritance of kinetoplast maxicircle DNA. There are strong genetic parallels between these experimental hybrids and the genotypes among natural isolates of T. cruzi. In this instance, aneuploidy through nuclear hybridization results in recombination across far greater genetic distances than mendelian genetic exchange. This mechanism also parallels genome duplication(9,10).	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England; Cent Univ Venezuela, Fac Med, Caracas, Venezuela; Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Trop Med, Asuncion, Paraguay	University of London; London School of Hygiene & Tropical Medicine; Natural History Museum London; University of Central Venezuela; Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion	Miles, MA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.		Stothard, John Russell/AAK-4829-2021; Carrasco, Hernan Jose/AAU-6492-2020	Stothard, John Russell/0000-0002-9370-3420; Carrasco, Hernan Jose/0000-0001-7500-0927; Rojas de Arias, Antonieta/0000-0002-6207-1870; Taylor, Martin/0000-0003-4147-0693; Acosta, Nidia/0000-0003-2652-354X				[Anonymous], 2003, MANSONS TROPICAL DIS; Bingle LEH, 2001, MICROBIOL-SGM, V147, P3231, DOI 10.1099/00221287-147-12-3231; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Carrasco HJ, 1996, AM J TROP MED HYG, V54, P418, DOI 10.4269/ajtmh.1996.54.418; Chamnanpunt J, 2001, P NATL ACAD SCI USA, V98, P14530, DOI 10.1073/pnas.251464498; CRUZ AK, 1993, P NATL ACAD SCI USA, V90, P1599, DOI 10.1073/pnas.90.4.1599; DOPAZO J, 1993, P NATL ACAD SCI USA, V90, P10320, DOI 10.1073/pnas.90.21.10320; Gaunt M, 2000, MEM I OSWALDO CRUZ, V95, P557, DOI 10.1590/S0074-02762000000400019; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; GIBSON WC, 1996, MOL BIOCHEM PARASIT, V64, P241; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Kelly JM, 1997, ADV PARASIT, V39, P227, DOI 10.1016/S0065-308X(08)60047-0; Knight J, 2002, NATURE, V417, P374, DOI 10.1038/417374a; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; MacLeod A, 2000, P NATL ACAD SCI USA, V97, P13442, DOI 10.1073/pnas.230434097; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Mendonca MBA, 2002, PARASITOLOGY, V124, P177, DOI 10.1017/S0031182001001172; MILES MA, 1981, LANCET, V1, P1338; MILES MA, 1992, PROTOCOLS MOL PARASI, P15; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; Robello C, 2000, GENE, V246, P331, DOI 10.1016/S0378-1119(00)00074-3; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Stothard JR, 1999, MEM I OSWALDO CRUZ, V94, P189, DOI 10.1590/S0074-02761999000700027; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200	30	277	283	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					936	939		10.1038/nature01438	http://dx.doi.org/10.1038/nature01438			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606999				2022-12-28	WOS:000181186900047
J	Meharg, AA; Killham, K				Meharg, AA; Killham, K			Environment - A pre-industrial source of dioxins and furans	NATURE			English	Editorial Material									Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland	University of Aberdeen	Meharg, AA (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland.	a.meharg@abdn.ac.uk	Meharg, Andrew Alexander/F-8182-2014	Meharg, Andrew Alexander/0000-0003-2019-0449				Alcock RE, 1998, ENVIRON SCI TECHNOL, V32, P1580, DOI 10.1021/es9705046; Alcock RE, 1996, ENVIRON SCI TECHNOL, V30, P3133, DOI 10.1021/es960306z; EMERY N, 1996, EXCAVATIONS HIRTA; HARMAN M, 1997, ISLE CALLED HIRTE; HARRAD SJ, 1992, SCI TOTAL ENVIRON, V126, P89, DOI 10.1016/0048-9697(92)90486-C; LYNCH M, 2002, OXFORD COMPANION SCO; Martinez M, 2000, CHEMOSPHERE, V41, P1927, DOI 10.1016/S0045-6535(00)00008-4; MEHARG AA, 1995, NATURE, V375, P353, DOI 10.1038/375353a0; THUSS U, 1995, CHEMOSPHERE, V31, P2591; 1963, MEMOIRS SOIL SURVEY	10	31	32	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					909	910		10.1038/421909a	http://dx.doi.org/10.1038/421909a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606987				2022-12-28	WOS:000181186900035
J	Busch, MP; Kleinman, SH; Nemo, GJ				Busch, MP; Kleinman, SH; Nemo, GJ			Current and emerging infectious risks of blood transfusions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; SAFETY; CONTAMINATION; BACK; NAT		Blood Ctr Pacific, San Francisco, CA 94118 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Blood Syst Inc, Scottsdale, AZ USA; Westat Corp, Rockville, MD USA; Univ British Columbia, Victoria, BC, Canada; NHLBI, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; Vitalant; Westat; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Busch, MP (corresponding author), Blood Ctr Pacific, 270 Masonic Ave, San Francisco, CA 94118 USA.	mpbusch@itsa.ucsf.edu			NHLBI NIH HHS [N01-HB-97077] Funding Source: Medline; PHS HHS [47114-97082, 47114-77078, 47114-97081, 47114-97079, 47114-97080] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097077] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AuBuchon JP, 1997, TRANSFUSION, V37, P1211, DOI 10.1046/j.1537-2995.1997.37111298088055.x; Blajchman Morris A., 2001, Transfusion Medicine Reviews, V15, P108, DOI 10.1053/tm.2001.22614; Busch M, 1999, VOX SANG, V77, P67, DOI 10.1159/000031079; Busch MP, 2000, TRANSFUSION, V40, P1157, DOI 10.1046/j.1537-2995.2000.40101157.x; Busch MP, 2001, BLOOD SAFETY IN THE NEW MILLENNIUM, P33; Cannon MJ, 2001, NEW ENGL J MED, V344, P637, DOI 10.1056/NEJM200103013440904; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P879; Chamberland ME, 2002, CLIN INFECT DIS, V34, P797, DOI 10.1086/338787; CHAMBERLAND ME, 2001, AIDS REV, V3, P24; DELWART EL, IN PRESS TRANSFUSION; *DEP HLTH, CREUTZF J DIS CJD BO; Dodd RY, 2002, TRANSFUSION, V42, P509, DOI 10.1046/j.1537-2995.2002.00143.x; JACKSON BR, IN PRESS TRANSFUSION; Jacobs MR, 2001, TRANSFUSION, V41, P1331, DOI 10.1046/j.1537-2995.2001.41111331.x; Klein HG, 2000, JAMA-J AM MED ASSOC, V284, P238, DOI 10.1001/jama.284.2.238; Kleinman S, 2001, TRANSFUS MED REV, V15, P201, DOI 10.1053/tmrv.2001.24589; Kleinman SH, 2000, BEST PRACT RES CL HA, V13, P631, DOI 10.1053/beha.2000.0104; Kleinman SH, 2001, TRANSFUSION, V41, P1081, DOI 10.1046/j.1537-2995.2001.41091081.x; Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968; Leiby DA, 1997, J INFECT DIS, V176, P1047, DOI 10.1086/516534; Leiby DA, 2001, BLOOD SAFETY IN THE NEW MILLENNIUM, P55; Mungai M, 2001, NEW ENGL J MED, V344, P1973, DOI 10.1056/NEJM200106283442603; Popovsky MA, 2000, CURR OPIN HEMATOL, V7, P402, DOI 10.1097/00062752-200011000-00014; Schmidt I, 2001, VOX SANG, V81, P228, DOI 10.1046/j.1423-0410.2001.00120.x; Sibinga CTS, 2000, TRANSFUS MED REV, V14, P269, DOI 10.1053/tm.2000.7396; Stramer SL, 2000, TRANSFUSION, V40, P1165, DOI 10.1046/j.1537-2995.2000.40101165.x; Turner ML, 2000, TRANSFUS MED REV, V14, P216, DOI 10.1053/tm.2000.7357; Weinberg PD, 2002, ANN INTERN MED, V136, P312, DOI 10.7326/0003-4819-136-4-200202190-00011	28	206	217	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					959	962		10.1001/jama.289.8.959	http://dx.doi.org/10.1001/jama.289.8.959			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597733				2022-12-28	WOS:000181129800002
J	Frankish, H				Frankish, H			Health of the Iraqi people hangs in the balance	LANCET			English	Editorial Material																			0	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					623	625		10.1016/S0140-6736(03)12619-0	http://dx.doi.org/10.1016/S0140-6736(03)12619-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12611386				2022-12-28	WOS:000181129500003
J	Johal, SS; Austin, AS; Ryder, SD				Johal, SS; Austin, AS; Ryder, SD			Lesson of the week - Epistaxis: an overlooked cause of massive haematemesis in cirrhosis	BRITISH MEDICAL JOURNAL			English	Article							WHITE NIPPLE SIGN; VARICEAL HEMORRHAGE; MORTALITY		Univ Nottingham Hosp, Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England	University of Nottingham	Ryder, SD (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England.			Ryder, Stephen David/0000-0001-9649-4444				Afessa B, 2000, AM J GASTROENTEROL, V95, P484; BOSCH J, 2001, PORTAL HYPERTENSION, V3, P168; BURROUGHS AK, 1989, HEPATOLOGY, V9, P801, DOI 10.1002/hep.1840090602; del Olmo JA, 2000, J HEPATOL, V32, P19; FARKAS PS, 1982, J CLIN GASTROENTEROL, V4, P49, DOI 10.1097/00004836-198202000-00009; Hou MC, 1996, AM J GASTROENTEROL, V91, P2103; HUTCHISON SMW, 1987, J CLIN GASTROENTEROL, V9, P283, DOI 10.1097/00004836-198706000-00008; MITCHELL P, 1982, VARICEAL BLEEDING, P62; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; SIRINGO S, 1991, GASTROINTEST ENDOSC, V37, P51, DOI 10.1016/S0016-5107(91)70621-4; VLAVIANOS P, 1989, BRIT MED J, V298, P1158, DOI 10.1136/bmj.298.6681.1158	11	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					440	441		10.1136/bmj.326.7386.440	http://dx.doi.org/10.1136/bmj.326.7386.440			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595387	Green Published			2022-12-28	WOS:000181318000026
J	Kaye, JA; Jick, H				Kaye, JA; Jick, H			Incidence of erectile dysfunction and characteristics of patients before and after the introduction of sildenafil in the United Kingdom: cross sectional study with comparison patients	BRITISH MEDICAL JOURNAL			English	Article									Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA 02421 USA	Boston University	Kaye, JA (corresponding author), Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, 11 Muzzey St, Lexington, MA 02421 USA.			Kaye, James A./0000-0002-9357-4227; Jick, Hershel/0000-0003-4270-5992				JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Ralph D, 2000, BRIT MED J, V321, P499, DOI 10.1136/bmj.321.7259.499; Shakir SAW, 2001, BRIT MED J, V322, P651, DOI 10.1136/bmj.322.7287.651	5	25	25	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					424	425		10.1136/bmj.326.7386.424	http://dx.doi.org/10.1136/bmj.326.7386.424			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595382	Bronze, Green Published			2022-12-28	WOS:000181318000019
J	Wisborg, K; Kesmodel, L; Bech, BH; Hedegaard, M; Henriksen, TB				Wisborg, K; Kesmodel, L; Bech, BH; Hedegaard, M; Henriksen, TB			Maternal consumption of coffee during pregnancy and stillbirth and infant death in first year of life: prospective study	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; CAFFEINE INTAKE; FETAL GROWTH; BIRTH; RISK; REPRODUCTION; POPULATION; EXPOSURE; TOBACCO	Objective To study the association between coffee consumption during pregnancy and the risk of stillbirth and infant death in the first year of life. Design Prospective follow up study. Setting Aarhus University Hospital, Denmark, 1989-96. Participants 18 478 singleton pregnancies in women with valid information about coffee consumption during pregnancy. Main outcome measures Stillbirth (delivery of a dead fetus at greater than or equal to 28 weeks' gestation) and infant death (death of a liveborn infant during the first year of life). Results Pregnant women who drank eight or more cups of coffee per day during pregnancy had an increased risk of stillbirth compared with women who did not drink coffee (odds ratio=3.0,95% confidence interval 1.5 to 5.9). After adjustment for smoking habits and alcohol intake during pregnancy, the relative risk of stillbirth decreased slightly. Adjustment for parity, maternal age, marital status, years of education, occupational status, and body mass index did not substantially change the estimates of association. There was no significant association between coffee consumption and death in the first year of life after adjustment for smoking habits during pregnancy. Conclusion Drinking coffee during pregnancy is associated with an increased risk of stillbirth but not with infant death.	Aarhus Univ Hosp, Dept Obstet & Gynaecol, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark; Aarhus Univ Hosp, Dept Paediat, DK-8200 Aarhus, Denmark; Aarhus Univ, Dept Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Aarhus Univ, Danish Epidemiol Sci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Wisborg, K (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynaecol, Perinatal Epidemiol Res Unit, DK-8200 Aarhus N, Denmark.		Bech, Bodil Hammer/B-9646-2016	Bech, Bodil Hammer/0000-0002-0287-3687				BUNKER ML, 1979, J AM DIET ASSOC, V74, P28; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; DOMINGUEZROJAS V, 1994, EUR J EPIDEMIOL, V10, P665, DOI 10.1007/BF01719278; Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; GILBERT SG, 1988, J PHARMACOL EXP THER, V245, P1048; GOLDING J, 1995, EARLY HUM DEV, V43, P1, DOI 10.1016/0378-3782(95)01660-U; Juel K, 1999, DAN MED BULL, V46, P354; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0; WATKINSON B, 1985, NEUROBEH TOXICOL TER, V7, P9; WEATHERSBEE PS, 1977, J REPROD MED, V19, P55; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322	16	59	63	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					420	422		10.1136/bmj.326.7386.420	http://dx.doi.org/10.1136/bmj.326.7386.420			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595379	Bronze, Green Published			2022-12-28	WOS:000181318000016
J	Aizenberg, J; Muller, DA; Grazul, JL; Hamann, DR				Aizenberg, J; Muller, DA; Grazul, JL; Hamann, DR			Direct fabrication of large micropatterned single crystals	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; AMORPHOUS CALCIUM-CARBONATE; BIOMIMETIC SYNTHESIS; CRYSTALLIZATION; PRECURSOR; GROWTH; TRANSFORMATION; FILMS; PHASE	Micropatterning of single crystals for technological applications is a complex, multistep process. Nature provides alternative fabrication strategies, when crystals with exquisite micro-ornamentation directly develop within preorganized frameworks. We report a bio-inspired approach to growing large micropatterned single crystals. Micropatterned templates organically modified to induce the formation of metastable amorphous calcium carbonate were imprinted with calcite nucleation sites. The template-directed deposition and crystallization of the amorphous phase resulted in the fabrication of millimeter-sized single calcite crystals with sub-10-mum patterns and controlled crystallographic orientation. We suggest that in addition to regulating the shape, micropatterned frameworks act as sites for stress and impurity release during the amorphous-to-crystalline transition. The proposed mechanisms may have direct biological relevance and broad implications in materials synthesis.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; Mat Sim Res, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Aizenberg, J (corresponding author), Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA.		Sanguansri, Luz/B-6630-2011; Muller, David/A-7745-2010	Sanguansri, Luz/0000-0003-1908-7604; Muller, David/0000-0003-4129-0473				ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; ALPER M, 1991, MAT SYNTHESIS BASED; Belcher AM, 1998, ACTA MATER, V46, P733, DOI 10.1016/S1359-6454(97)00253-X; Beniash E, 1999, J STRUCT BIOL, V125, P50, DOI 10.1006/jsbi.1998.4081; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54; Fendler JH, 1996, CHEM MATER, V8, P1616, DOI 10.1021/cm960116n; GONIS A, 2000, NUCLEATION GROWTH PR; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; Koga N, 1998, THERMOCHIM ACTA, V318, P239, DOI 10.1016/S0040-6031(98)00348-7; KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003; Loste E, 2001, CHEM COMMUN, P901, DOI 10.1039/b101563j; Lowenstam HA, 1989, BIOMINERALIZATION; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Merten H.L., 1980, Patent version, Patent No. [4237147, 4,237,147, 431,002]; Pedersen TPL, 2001, APPL PHYS LETT, V79, P3597, DOI 10.1063/1.1415419; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Sawada K, 1997, PURE APPL CHEM, V69, P921, DOI 10.1351/pac199769050921; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Vere A. W., 1988, CRYSTAL GROWTH PRINC; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wilt FH, 1999, J STRUCT BIOL, V126, P216, DOI 10.1006/jsbi.1999.4105; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108	30	429	445	15	299	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1205	1208		10.1126/science.1079204	http://dx.doi.org/10.1126/science.1079204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595685				2022-12-28	WOS:000181065500032
J	Kriebel, PW; Barr, VA; Parent, CA				Kriebel, PW; Barr, VA; Parent, CA			Adenylyl cyclase localization regulates streaming during chemotaxis	CELL			English	Article							DEPENDENT PROTEIN-KINASE; MYOSIN HEAVY-CHAIN; DICTYOSTELIUM-DISCOIDEUM; CHEMOATTRACTANT RECEPTOR; MEDIATED ACTIVATION; CELL POLARITY; NEUTROPHIL CHEMOTAXIS; LIVING CELLS; CAMP; MORPHOGENESIS	We studied the role of the adenylyl cyclase ACA in Dictyostelium discoideum chemotaxis and streaming. In this process, cells orient themselves in a head to tail fashion as they are migrating to form aggregates. We show that cells lacking ACA are capable of moving up a chemoattractant gradient, but are unable to stream. Imaging of ACA-YFP reveals plasma membrane labeling highly enriched at the uropod of polarized cells. This localization requires the actin cytoskeleton but is independent of the regulator CRAC and the effector PKA. A constitutively active mutant of ACA shows dramatically reduced uropod enrichment and has severe streaming defects. We propose that the asymmetric distribution of ACA provides a compartment from which cAMP is secreted to locally act as a chemoattractant, thereby providing a unique mechanism to amplify chemical gradients. This could represent a general mechanism that cells use to amplify chemotactic responses.	NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37 Room 1E24, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [Z01BC010418, ZIABC010418] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anjard C, 1997, DIFFERENTIATION, V62, P43, DOI 10.1046/j.1432-0436.1997.6210043.x; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; BRICKEY DA, 1990, MOL CELL BIOCHEM, V97, P17; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DEVREOTES P, 1987, METHOD CELL BIOL, V28, P299; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; HARVATH L, 1991, J IMMUNOL, V146, P224; HAUERT AB, 2002, INT J BIOCHEM CELL B, V34, P1467; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; INSALL R, 1994, J CELL BIOL, V126, P1537, DOI 10.1083/jcb.126.6.1537; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; JOHNSON RL, 1991, BIOCHEMISTRY-US, V30, P6982, DOI 10.1021/bi00242a025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILLY PJ, 1995, J CELL BIOL, V129, P1659, DOI 10.1083/jcb.129.6.1659; Mann SKO, 1997, DEV BIOL, V183, P208, DOI 10.1006/dbio.1996.8499; MANN SKO, 1992, P NATL ACAD SCI USA, V89, P10701, DOI 10.1073/pnas.89.22.10701; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; Parent CA, 1996, J BIOL CHEM, V271, P18333, DOI 10.1074/jbc.271.31.18333; Parent CA, 1996, ANNU REV BIOCHEM, V65, P411; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; SEGALL JE, 1995, J CELL BIOL, V128, P405, DOI 10.1083/jcb.128.3.405; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SHELDEN E, 1995, J CELL SCI, V108, P1105; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; VANMENTSCOHEN M, 1989, J BIOL CHEM, V264, P8717; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	45	120	122	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					549	560		10.1016/S0092-8674(03)00081-3	http://dx.doi.org/10.1016/S0092-8674(03)00081-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600317	Bronze			2022-12-28	WOS:000181252600012
J	Liakopoulos, D; Kusch, J; Grava, S; Vogel, J; Barral, Y				Liakopoulos, D; Kusch, J; Grava, S; Vogel, J; Barral, Y			Asymmetric loading of Kar9 onto spindle poles and microtubules ensures proper spindle alignment	CELL			English	Article							CYCLIN-DEPENDENT KINASE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CYTOPLASMIC MICROTUBULES; NUCLEAR MIGRATION; MITOTIC SPINDLE; PROTEIN COMPLEX; CELL-CYCLE; ORIENTATION; PHOSPHORYLATION	Spindle alignment is the process in which the two spindle poles are directed toward preselected and opposite cell ends. In budding yeast, the APC-related molecule Kar9 is required for proper alignment of the spindle with the mother-bud axis. We find that Kar9 localizes to the prospective daughter cell spindle pole. Kar9 is transferred from the pole to cytoplasmic microtubules, which are then guided in a myosin-dependent manner to the bud. Clb4/Cdc28 kinase phosphorylates Kar9 and accumulates on the pole destined to the mother cell. Mutations that block phosphorylation at Cdc28 consensus sites result in localization of Kar9 to both poles and target them both to the bud. Thus, Clb4/Cdc28 prevents Kar9 loading on the mother bound pole. In turn, asymmetric distribution of Kar9 ensures that only one pole orients toward the bud. Our results indicate that Cdk1-dependent spindle asymmetry ensures proper alignment of the mitotic spindle with the cell division axis.	ETH Honggerberg, HPM, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; McGill Univ, Montreal, PQ H3A 1B1, Canada	Swiss Federal Institutes of Technology Domain; ETH Zurich; McGill University	Barral, Y (corresponding author), ETH Honggerberg, HPM, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland.			Barral, Yves/0000-0002-0989-3373				Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Bienz M, 2001, NAT CELL BIOL, V3, pE67, DOI 10.1038/35060140; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Dikovskaya D, 2001, TRENDS CELL BIOL, V11, P378, DOI 10.1016/S0962-8924(01)02069-4; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Guthrie C, 1991, GUIDE YEAST GENETICS; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Kaltschmidt JA, 2002, J CELL SCI, V115, P2257; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rehberg M, 2002, MOL BIOL CELL, V13, P2301, DOI 10.1091/mbc.E02-01-0054; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Segal M, 1998, J CELL BIOL, V143, P135, DOI 10.1083/jcb.143.1.135; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Sia RAL, 1996, MOL BIOL CELL, V7, P1657, DOI 10.1091/mbc.7.11.1657; SIKORSKI RS, 1989, GENETICS, V122, P19; SU LK, 1995, CANCER RES, V55, P2972; Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; Trzepacz C, 1997, J BIOL CHEM, V272, P21681, DOI 10.1074/jbc.272.35.21681; TYERS M, 1991, COLD SH Q B, V56, P21; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	38	206	207	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					561	574		10.1016/S0092-8674(03)00119-3	http://dx.doi.org/10.1016/S0092-8674(03)00119-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600318	Bronze			2022-12-28	WOS:000181252600013
J	Annas, GJ				Annas, GJ			The right to health and the nevirapine case in South Africa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Baleta A, 2002, LANCET, V360, P467, DOI 10.1016/S0140-6736(02)09697-6; Barnard D, 2002, KENNEDY INST ETHIC J, V12, P159, DOI 10.1353/ken.2002.0008; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; Farmer P, 2001, NEW ENGL J MED, V345, P208, DOI 10.1056/NEJM200107193450310; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; INNOCENTI NG, 2002, FINANCIAL TIMES 1018, P29; Makgoba MW, 2000, SCIENCE, V288, P1171, DOI 10.1126/science.288.5469.1171; MANDELA N, 2002, 14 INT AIDS C BARC S; Mann JM., 1999, HLTH HUMAN RIGHTS RE, P216; MCGREAL C, 2002, GUARDIAN LONDON 1101, P2; Ngwena C, 2000, Health Hum Rights, V5, P26, DOI 10.2307/4065221; STEINER HJ, 2000, INT HUMAN RIGHTS CON, P1395; SWARNS RL, 2002, NY TIMES        0331, P4; Tarantola Daniel, 1998, Health Hum Rights, V3, P60, DOI 10.2307/4065285; Torres Mary Ann, 2002, Chic J Int Law, V3, P105; *UN EC SOC COUNC C, 2000, GEN COMM 14 RIGHT HI	16	25	25	1	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					750	754		10.1056/NEJMlim022737	http://dx.doi.org/10.1056/NEJMlim022737			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594322	Green Published			2022-12-28	WOS:000181014400013
J	Check, E				Check, E			Journals tighten up on biosecurity	NATURE			English	News Item																		Check E, 2003, NATURE, V421, P197, DOI 10.1038/421197a	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					774	774		10.1038/421774b	http://dx.doi.org/10.1038/421774b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594467	Bronze			2022-12-28	WOS:000181044700007
J	Ebel, BE; Koepsell, TD; Bennett, EE; Rivara, FP				Ebel, BE; Koepsell, TD; Bennett, EE; Rivara, FP			Use of child booster seats in motor vehicles following a community campaign - A controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BICYCLE HELMET CAMPAIGN	Context Once children have outgrown car seats, booster seats protect from injury better than lap and shoulder belts alone. However, the majority of children aged 4 to 8 years use only an adult seat belt. Objective To evaluate the effectiveness of a multifaceted community booster seat campaign in increasing observed booster seat use among child passengers in motor vehicles. Design Prospective, nonrandomized, controlled community intervention trial. Setting and Participants The campaign was initiated in 4 communities in the greater Seattle, Wash, area between January 2000 and March 2001. Eight communities in Portland, Ore, and Spokane, Wash, served as control sites. We observed 3609 booster-eligible children (those Aged 4 8 years and weighing 18-36 kg [40-80 lb]). Main Outcome Measure Observed booster seat use 15 months after the start of the campaign. Results Before the campaign began, 13.3% of eligible children in the intervention communities and 17.3% in the control communities were using booster seats, adjusting for child age, driver seat belt use, and sex of driver. Fifteen months after the start of the campaign, adjusted booster seat use had increased to 26.1% in the intervention communities and 20.2% in the control communities (P=.008 for the difference in time trends between intervention and control communities). Conclusion These data suggest that a multifaceted community education campaign can significantly increase the use of child booster seats.	Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Pediat, Div Gen Pediat, Seattle, WA 98104 USA; Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Epidemiol, Seattle, WA 98104 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Ebel, BE (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Pediat, Div Gen Pediat, 325 9th Ave,Box 359960, Seattle, WA 98104 USA.		Ebel, Beth/F-4544-2014	Ebel, Beth/0000-0001-9310-8325				*AM AC PED, 2002, CAR SAF SEATS GUID F; [Anonymous], PAR GUID BUYING US B; BANDURA A, 1986, SOCIAL FDN THOUGHT A; BERGMAN AB, 1990, AM J DIS CHILD, V144, P727, DOI 10.1001/archpedi.1990.02150300127033; BIDEZ MW, 2001, SAE TECHNICAL PAPER; *CDCP NAT CTR HLTH, 2000, CDC GROWTH CHARTS US; *CDCP NAT CTR INJ, 2002, NAT CHILD PASS SAF W; Centers for Disease Control and Prevention (CDC), 2000, WORK PREV CONTR INJ; Cody BE., 2002, CHILD PASSENGERS RIS; EBEL BE, IN PRESS PEDIATRICS; GLANZ K, 1997, HLTH BEHAV HLTH ED T; Green L. W., 1999, HLTH PROMOTION PLANN; GREENLAND S, 1991, STAT MED, V10, P1069, DOI 10.1002/sim.4780100707; KLINICH K, 1994, STUDY OLDER CHILD RE; KORNER J, 2001, ASS ADV AUT MED C BO; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Murray D., 1998, DESIGN ANAL GROUP RA, V27; *NAT ASS REALT, SAL CALC; RABEHESKETH S, 2001, 200101 GLLAMM U LOND; Ramsey A, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e20; Rivara F P, 2001, Inj Prev, V7, P210, DOI 10.1136/ip.7.3.210; RIVARA FP, 1994, PEDIATRICS, V93, P567; *US BUR CENS, 2000, AM FACTF PROF SEL SO; Winston FK, 2000, PEDIATRICS, V105, P1179, DOI 10.1542/peds.105.6.1179; WASHINGTON STATE BOO	25	83	85	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					879	884		10.1001/jama.289.7.879	http://dx.doi.org/10.1001/jama.289.7.879			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588272	Bronze			2022-12-28	WOS:000181072200032
J	Eastwood, DM				Eastwood, DM			Neonatal hip screening	LANCET			English	Review							CONGENITAL DISLOCATION; DEVELOPMENTAL DYSPLASIA; ULTRASOUND; INSTABILITY; RISK; DIAGNOSIS; NEWBORN	Context A "missed" case of congenital hip dislocation (CDH) can be a disaster for the patient and the outcome may be poor. Considerable resources are expended on screening programmes to identify appropriate cases early but a recent change in terminology to developmental dysplasia of the hip (DDH) and a realisation that neonatal hip maturation is poorly understood has made it difficult to know who should be screened and why. Starting point Neonatal hip screenings is well established although some experts feel that the effectiveness of clinical let alone ultrasound screening programmes is unproven. Several European countries undertake population screening while selective screening occurs in 93% of UK units. K Holen and colleagues recently reported (J Bone Joint Surg 2002; 84-B: 886-90) a prospective randomised trial of just over 15 500 newborn babies in which they compare universal and selective screening programmes. With a follow-up of 6-11 years, one late-detected hip dysplasia was seen in the universal group compared with six in the selective group (not statistically significant). These investigators found, on the background of an excellent clinical programme, no additional benefit from universal screening and thus advocate selective screening. Where next The aims of a screening programme must be defined, then evaluated. A consideration of costs can never take into account family pain and distress. The results of the universal screening programme in Coventry, UK, are impressive and significantly better than results from other UK centres. If the Coventry results are the gold standard, then it is necessary to work out how this can be achieve elsewhere rather than worry about whether it is unachievable.	Royal Natl Orthopaed Hosp, London NW3 2QG, England; Royal Free Hosp, London NW3 2QG, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Eastwood, DM (corresponding author), Royal Natl Orthopaed Hosp, London NW3 2QG, England.	deborah_eastwood@lineone.net						ANDERSSON JE, 1995, J PEDIATR ORTHOPED, V15, P736, DOI 10.1097/01241398-199511000-00004; Bache CE, 2002, J PEDIATR ORTHOP B, V11, P212, DOI 10.1097/00009957-200207000-00004; BIALIK V, 1986, J PEDIATR ORTHOPED, V6, P703, DOI 10.1097/01241398-198611000-00010; BOEREE NR, 1994, J BONE JOINT SURG BR, V76B, P525, DOI 10.1302/0301-620X.76B4.8027133; CLARKE NMP, 1985, J BONE JOINT SURG BR, V67, P406, DOI 10.1302/0301-620X.67B3.3889008; CLARKE NMP, 1989, J BONE JOINT SURG BR, V71, P9, DOI 10.1302/0301-620X.71B1.2644290; Clegg J, 1999, J BONE JOINT SURG BR, V81B, P852, DOI 10.1302/0301-620X.81B5.9746; Dezateux C, 1996, ARCH DIS CHILD, V74, P445, DOI 10.1136/adc.74.5.445; Duppe H, 2002, J BONE JOINT SURG BR, V84B, P878, DOI 10.1302/0301-620X.84B6.12326; Godward S, 1998, LANCET, V351, P1149, DOI 10.1016/S0140-6736(97)10466-4; GRAF R, 1983, J PEDIATR ORTHOPED, V3, P354, DOI 10.1097/01241398-198307000-00015; HERNANDEZ RJ, 1994, J BONE JOINT SURG BR, V76B, P539, DOI 10.1302/0301-620X.76B4.8027135; Holen KJ, 2002, J BONE JOINT SURG BR, V84B, P886, DOI 10.1302/0301-620X.84B6.12093; Jones D, 1998, J BONE JOINT SURG BR, V80B, P943, DOI 10.1302/0301-620X.80B6.0800943; Jones D, 2000, J BONE JOINT SURG BR, V82B, P160, DOI 10.1302/0301-620X.82B2 .10761; KRIKLER SJ, 1992, J BONE JOINT SURG BR, V74, P701, DOI 10.1302/0301-620X.74B5.1527116; Lewis K, 1999, J PEDIATR ORTHOPED, V19, P760, DOI 10.1097/00004694-199911000-00013; MACNICOL MF, 1990, J BONE JOINT SURG BR, V72, P1057, DOI 10.1302/0301-620X.72B6.2246288; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; Paton RW, 1999, J BONE JOINT SURG BR, V81B, P255, DOI 10.1302/0301-620X.81B2.8972; Standing Medical Advisory Committee and the Standing Nursing and Midwifery Advisory Committee, 1986, SCREEN DET CONG DISL; TERJESEN T, 1989, J BONE JOINT SURG BR, V71, P767, DOI 10.1302/0301-620X.71B5.2684989; Wood MK, 2000, J PEDIATR ORTHOPED, V20, P302, DOI 10.1097/00004694-200005000-00006; Zenios M, 2000, J PEDIATR ORTHOP B, V9, P244, DOI 10.1097/01202412-200010000-00006	24	52	53	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					595	597		10.1016/S0140-6736(03)12519-6	http://dx.doi.org/10.1016/S0140-6736(03)12519-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598157				2022-12-28	WOS:000181033400024
J	Banavar, JR; Damuth, J; Maritan, A; Rinaldo, A				Banavar, JR; Damuth, J; Maritan, A; Rinaldo, A			Allometric cascades	NATURE			English	Article									Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy; INFM, I-34014 Trieste, Italy; Abdus Salam Int Ctr Theoret Phys, I-34014 Trieste, Italy; Univ Padua, Dipartimento Ingn Idraul Marittima & Geotecn, I-35131 Padua, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Santa Barbara; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Abdus Salam International Centre for Theoretical Physics (ICTP); University of Padua	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.			Damuth, John/0000-0002-1635-9726; Maritan, Amos/0000-0002-3535-7873				Burness GP, 2002, SCIENCE, V296, P1245, DOI 10.1126/science.1072300; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Hochachka P. W., 2001, BIOCH ADAPTATION MEC; Weibel ER, 2002, NATURE, V417, P131, DOI 10.1038/417131a	4	31	31	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					713	714		10.1038/421713b	http://dx.doi.org/10.1038/421713b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610615				2022-12-28	WOS:000180938000033
J	Calabrese, EJ; Baldwin, LA				Calabrese, EJ; Baldwin, LA			Toxicology rethinks its central belief - Hormesis demands a reappraisal of the way risks are assessed.	NATURE			English	Editorial Material							HYPOTHESIS		Univ Massachusetts, Dept Environm Hlth Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Calabrese, EJ (corresponding author), Univ Massachusetts, Dept Environm Hlth Sci, Amherst, MA 01003 USA.							Calabrese EJ, 2003, TOXICOL SCI, V71, P246, DOI 10.1093/toxsci/71.2.246; Calabrese EJ, 2000, HUM EXP TOXICOL, V19, P2, DOI 10.1191/096032700678815585; Calabrese EJ, 2001, CRIT REV TOXICOL, V31, P349; Callahan BG, 2001, HUM ECOL RISK ASSESS, V7, P779, DOI 10.1080/20018091094646; Luckey TD, 1991, RAD HORMESIS; Renn O, 1998, HUM EXP TOXICOL, V17, P431, DOI 10.1191/096032798678909034; Stebbing ARD, 1998, MUTAT RES-FUND MOL M, V403, P249, DOI 10.1016/S0027-5107(98)00014-1	7	480	539	8	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					691	692		10.1038/421691a	http://dx.doi.org/10.1038/421691a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610596				2022-12-28	WOS:000180938000017
J	Park, A; Edwards, M; Donaldson, M; Ghatei, M; Meeran, K				Park, A; Edwards, M; Donaldson, M; Ghatei, M; Meeran, K			Lesson of the week - Interfering antibodies affecting immunoassays in woman with pet rabbits	BRITISH MEDICAL JOURNAL			English	Review									Hammersmith Hosp, Dept Metab Med, London W12 0NN, England; Hammersmith Hosp, Dept Clin Biochem, London W12 0HS, England	Imperial College London; Imperial College London	Meeran, K (corresponding author), Hammersmith Hosp, Dept Metab Med, London W12 0NN, England.							Ismail AAA, 2001, BMJ-BRIT MED J, V323, P705, DOI 10.1136/bmj.323.7315.705; Kricka LJ, 1999, CLIN CHEM, V45, P942; OShea D, 1996, J CLIN ENDOCR METAB, V81, P1623, DOI 10.1210/jc.81.4.1623	3	7	9	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					541	542		10.1136/bmj.326.7388.541	http://dx.doi.org/10.1136/bmj.326.7388.541			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623918	Green Published			2022-12-28	WOS:000181548400024
J	Hilgenkamp, H; Ariando; Smilde, HJH; Blank, DHA; Rijnders, G; Rogalla, H; Kirtley, JR; Tsuei, CC				Hilgenkamp, H; Ariando; Smilde, HJH; Blank, DHA; Rijnders, G; Rogalla, H; Kirtley, JR; Tsuei, CC			Ordering and manipulation of the magnetic moments in large-scale superconducting pi-loop arrays	NATURE			English	Article							QUANTUM INTERFERENCE DEVICE; JOSEPHSON-JUNCTIONS; FRUSTRATION; STATE; SUPERPOSITION; SYMMETRY; FLUX	The phase of the macroscopic electron-pair wavefunction in a superconductor can vary only by multiples of 2pi when going around a closed contour. This results in quantization of magnetic flux, one of the most striking demonstrations of quantum phase coherence in superconductors(1-3). By using superconductors with unconventional pairing symmetry(4-7), or by incorporating pi-Josephson junctions(8), a phase shift of pi can be introduced in such loops(7,9,10). Under appropriate conditions, this phase shift results in doubly degenerate time-reversed ground states, which are characterized by the spontaneous generation of half quanta of magnetic flux, with magnitude 1/2 Phi(0)(Phi(0) = h/2e 5 2.07 x 10(-15) Wb) (ref. 7). Until now, it has only been possible to generate individual half flux quanta. Here we report the realization of large-scale coupled pi-loop arrays based on YBa2Cu3O7-Au-Nb Josephson contacts(11,12). Scanning SQUID (superconducting quantum interference device) microscopy has been used to study the ordering of half flux quanta in these structures. The possibility of manipulating the polarities of individual half flux quanta is also demonstrated. These pi-loop arrays are of interest as model systems for studying magnetic phenomena-including frustration effects-in Ising antiferromagnets(13-18). Furthermore, studies of coupled pi-loops can be useful for designing quantum computers based on flux-qubits(19-23) with viable quantum error correction capabilities(24,25).	Univ Twente, Fac Sci & Technol, NL-7500 AE Enschede, Netherlands; Univ Twente, MESA Res Inst, NL-7500 AE Enschede, Netherlands; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	University of Twente; University of Twente; International Business Machines (IBM)	Hilgenkamp, H (corresponding author), Univ Twente, Fac Sci & Technol, POB 217, NL-7500 AE Enschede, Netherlands.		, Ariando/F-8953-2012	, Ariando/0000-0002-0598-426X; Hilgenkamp, Hans/0000-0001-6109-8804; ROGALLA, HORST/0000-0003-3946-0891				Aeppli G, 1997, SCIENCE, V275, P177, DOI 10.1126/science.275.5297.177; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; BLACK RC, 1993, APPL PHYS LETT, V62, P2128, DOI 10.1063/1.109448; Blais A, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.042308; BULAEVSKII LN, 1977, JETP LETT+, V25, P290; CHANDRA P, 1988, PHYS REV B, V38, P9335, DOI 10.1103/PhysRevB.38.9335; COWLEY JM, 1950, PHYS REV, V77, P669, DOI 10.1103/PhysRev.77.669; Davidovic D, 1997, PHYS REV B, V55, P6518, DOI 10.1103/PhysRevB.55.6518; DEAVER BS, 1961, PHYS REV LETT, V7, P43, DOI 10.1103/PhysRevLett.7.43; DOLL R, 1961, PHYS REV LETT, V7, P51, DOI 10.1103/PhysRevLett.7.51; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Gardner BW, 2001, REV SCI INSTRUM, V72, P2361, DOI 10.1063/1.1364668; GESHKENBEIN VB, 1986, JETP LETT+, V43, P395; GESHKENBEIN VB, 1987, PHYS REV B, V36, P235, DOI 10.1103/PhysRevB.36.235; Ioffe LB, 1999, NATURE, V398, P679, DOI 10.1038/19464; KIRTLEY JR, 1995, APPL PHYS LETT, V66, P1138, DOI 10.1063/1.113838; Kirtley JR, 1997, PHYS REV B, V56, P886, DOI 10.1103/PhysRevB.56.886; LERCH P, 1990, PHYS REV B, V41, P11579, DOI 10.1103/PhysRevB.41.11579; Moessner R, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224401; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; PANNETIER B, 1984, PHYS REV LETT, V53, P1845, DOI 10.1103/PhysRevLett.53.1845; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; ROGERS FP, 1983, THESIS MIT BOSTON; Schulz RR, 2000, APPL PHYS LETT, V76, P912, DOI 10.1063/1.125627; SIGRIST M, 1992, J PHYS SOC JPN, V61, P4283, DOI 10.1143/JPSJ.61.4283; Smilde HJH, 2002, APPL PHYS LETT, V80, P4579, DOI 10.1063/1.1485305; Smilde HJH, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.057004; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; VANHARLINGEN DJ, 1995, REV MOD PHYS, V67, P515, DOI 10.1103/RevModPhys.67.515; Vu LN, 1993, IEEE T APPL SUPERCON, V3, P1918, DOI 10.1109/77.233586	32	208	208	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					50	53		10.1038/nature01442	http://dx.doi.org/10.1038/nature01442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621428				2022-12-28	WOS:000181343100032
J	Hoag, H				Hoag, H			Coal-fired power plant to bury issue of emissions	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					7	7		10.1038/422007b	http://dx.doi.org/10.1038/422007b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621403	Bronze			2022-12-28	WOS:000181343100010
J	Duke, T; Mgone, CS				Duke, T; Mgone, CS			Measles: not just another viral exanthem	LANCET			English	Review							SUBACUTE SCLEROSING PANENCEPHALITIS; VITAMIN-A SUPPLEMENTATION; PAPUA-NEW-GUINEA; RUBELLA VACCINE; ANTIBODY-RESPONSE; CELLULAR RECEPTOR; CASE-FATALITY; LUNG-DISEASE; VIRUS; CHILDREN	Measles is the most frequent cause of vaccine-preventable childhood deaths. Infants younger than the recommended age for vaccination are susceptible to the disease, and in developing countries they have a high risk of complications and mortality. Vaccine coverage in excess of 95% interrupts endemic transmission of measles in many countries, but achievement of such coverage almost always requires coordinated supplementary mass vaccination campaigns. There are substantial health gains if countries improve measles vaccine coverage, irrespective of whether or not high coverage is achieved; these gains include much lower measles complication and case fatality rates, long-term interepidemic duration, and possibly non-specific improvements in survival of children. Investigation into the cost-effectiveness of different strategies for measles control, including mass campaigns, two-dose schedules, and young-infant doses, would help countries to formulate control policies appropriate to. their setting. Pneumonia is the most common fatal complication associated with measles, and at least 50% of measles-related pneumonias are due to bacterial superinfection. WHO has developed standard case management programmes for measles, but there are several unresolved clinical issues, including optimum indications for antibiotic treatment, the importance of intravenous immunoglobulin, the role of viral coinfection, and the risk of tuberculosis after measles. The priority in worldwide efforts to control measles is to lend support to poor countries, helping them to increase vaccine coverage and sustain improvements to vaccination infrastructure, and to address technical issues with respect to optimum vaccination schedules. Measles represents a specific challenge, whereby partnerships between high-income and developing nations would reduce child mortality in developing countries; such partnerships are not without incentive for high-income countries, since without them imported measles cannot be prevented.	Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia; Papua New Guinea Inst Med Res, Goroka, Papua N Guinea	Royal Children's Hospital Melbourne; PNG Institute Of Medical Research	Duke, T (corresponding author), Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Flemington Rd, Parkville, Vic 3052, Australia.	trevor.duke@rch.org.au						AABY P, 1986, J PEDIATR-US, V109, P40, DOI 10.1016/S0022-3476(86)80569-8; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Afzal MA, 2000, B WORLD HEALTH ORGAN, V78, P199; Alejandria M. M., 2002, COCHRANE LIB; Anderson T, 1939, Br Med J, V1, P716; Anlar B, 2001, INFECTION, V29, P192, DOI 10.1007/s15010-001-1115-9; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; [Anonymous], 1982, B WORLD HEALTH ORGAN, V60, P43; Arpadi SM, 1996, PEDIATRICS, V97, P653; Bahl R, 1999, J NUTR, V129, P1569, DOI 10.1093/jn/129.8.1569; BARCLAY AJG, 1987, BMJ-BRIT MED J, V294, P296; Bellini WJ, 1998, EMERG INFECT DIS, V4, P29, DOI 10.3201/eid0401.980105; Benn CS, 1997, LANCET, V350, P101, DOI 10.1016/S0140-6736(96)12019-5; Bennett J, 1999, INT J EPIDEMIOL, V28, P147, DOI 10.1093/ije/28.1.147; Biellik R, 2002, LANCET, V359, P1564, DOI 10.1016/S0140-6736(02)08517-3; BLACK FL, 1962, J IMMUNOL, V88, P725; Carmena J, 1996, Enferm Infecc Microbiol Clin, V14, P456; CERNESCU C, 1998, VIROLOGIE, V39, P247; COAKLEY KJ, 1991, PAPUA NEW GUINEA MED, V34, P6; COETZEE N, 1994, S AFR MED J, V84, P145; CUNDALL DB, 1986, ANN TROP PAEDIATR, V6, P249, DOI 10.1080/02724936.1986.11748450; CUTTS FT, 1994, VACCINE, V12, P1311, DOI 10.1016/S0264-410X(94)80057-7; CUTTS FT, 1995, BIOLOGICALS, V23, P95; DEFRANCISCO A, 1994, INT J EPIDEMIOL, V23, P393, DOI 10.1093/ije/23.2.393; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; DOVER AS, 2002, JAMA-J AM MED ASSOC, V234, P612; DSOUZA RM, 2001, COCHRANE LIB; Duke T, 2002, B WORLD HEALTH ORGAN, V80, P16; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; Duke T, 2002, ARCH DIS CHILD, V86, P108, DOI 10.1136/adc.86.2.108; Ellison J B, 1931, Arch Dis Child, V6, P37; Engelking O, 1999, J GEN VIROL, V80, P1599, DOI 10.1099/0022-1317-80-7-1599; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; ESOLEN LM, 1993, J INFECT DIS, V168, P47, DOI 10.1093/infdis/168.1.47; *EXP PROGR IMM, 1992, WKLY EPIDEMIOL REC, V67, P357; *EXP PROGR IMM, 1990, WKLY EPIDEMIOL REC, V65, P5; FLICK JA, 1976, AM REV RESPIR DIS, V114, P257; FOMBONNE E, 2001, PEDIATRICS, V109, P991; FORTENBERRY JD, 1992, AM J DIS CHILD, V146, P1040, DOI 10.1001/archpedi.1992.02160210042018; GARENNE M, 1990, J INFECT DIS, V161, P1088, DOI 10.1093/infdis/161.6.1088; GENDELMAN HE, 1984, ANN NEUROL, V15, P353, DOI 10.1002/ana.410150409; Gibel H, 1942, J PEDIATR-US, V21, P315, DOI 10.1016/S0022-3476(42)80023-2; Gocmen A, 1997, TURKISH J PEDIATR, V39, P149; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; GRAVES M, 1984, J VIROL, V38, P224; GREMILLION DH, 1981, AM J MED, V71, P539, DOI 10.1016/0002-9343(81)90203-5; GRIFFIN DE, 1987, CLIN IMMUNOL IMMUNOP, V45, P375, DOI 10.1016/0090-1229(87)90090-0; GRIFFIN DE, 1990, FIELDS VIROLOGY, P1401; Gurkan F, 1998, SCAND J INFECT DIS, V30, P359; Hirose M, 1997, SCAND J INFECT DIS, V29, P187, DOI 10.3109/00365549709035882; Hogarth J C, 1939, Br Med J, V1, P718; HUSSEY G, 2002, PEDIATR INFECT DIS J, V9, P715; HUSSEY GD, 1992, NEW ENGL J MED, V323, P160; *IMM SAF REV COMM, 2001, IMM SAF REV MEASL MU; JOHNSON RT, 1964, NEW ENGL J MED, V310, P137; JOHNSON RT, CONCEPTS VIRAL PATHO, V20, P203; KAMBARAMI RA, 1991, B WORLD HEALTH ORGAN, V69, P213; KAPLAN LJ, 1992, JAMA-J AM MED ASSOC, V267, P1237, DOI 10.1001/jama.267.9.1237; KARELITZ S, 1951, PEDIATRICS, V7, P193; KARELITZ S, 1954, J PEDIATR-US, V44, P357, DOI 10.1016/S0022-3476(54)80208-3; Karp CL, 1999, IMMUNOL REV, V168, P91, DOI 10.1111/j.1600-065X.1999.tb01285.x; KASCHULA ROC, 1983, REV INFECT DIS, V5, P395; KATZ M, 1995, CURR TOP MICROBIOL, V191, P1; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; KINGSBURY DW, 1978, INTERVIROLOGY, V10, P137, DOI 10.1159/000148979; KIPPS A, 1977, S AFR MED J, V52, P1038; KIPPS A, 1976, S AFR MED J, V50, P1083; LAMB WH, 1988, REV INFECT DIS, V10, P457; Lee MS, 2001, B WORLD HEALTH ORGAN, V79, P615; LIEBERT UG, 2002, INTERVIROLOGY, V40, P175; LOENING WEK, 1983, LANCET, V2, P324; Maniar B M, 1994, Indian Pediatr, V31, P181; MATHIAS RG, 1989, AM J PUBLIC HEALTH, V79, P475, DOI 10.2105/AJPH.79.4.475; Metintas S, 2002, PUBLIC HEALTH, V116, P50, DOI 10.1038/sj/ph/1900818; MGONE J, 2000, PAPUA NEW GUINEA MED, V43, P90; Miki K, 2002, J MED VIROL, V68, P105, DOI 10.1002/jmv.10176; MORTON R, 1986, ANN TROP PAEDIATR, V6, P41, DOI 10.1080/02724936.1986.11748409; Moss WJ, 1999, CLIN INFECT DIS, V29, P106, DOI 10.1086/520136; Moss WJ, 2002, CLIN INFECT DIS, V35, P189, DOI 10.1086/341248; MULHOLLAND K, 1995, LANCET, V345, P305, DOI 10.1016/S0140-6736(95)90282-1; MUSTAFA MM, 1993, CLIN INFECT DIS, V16, P654, DOI 10.1093/clind/16.5.654; NAHMIAS AJ, 1967, J AMER MED ASSOC, V201, P729, DOI 10.1001/jama.201.10.729; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; NEMIR RL, 1991, PEDIATRICS, V88, P236; Nicoll A, 1998, BMJ-BRIT MED J, V316, P715, DOI 10.1136/bmj.316.7133.715; NUSSBAUM O, 1995, J VIROL, V69, P3341, DOI 10.1128/JVI.69.6.3341-3349.1995; OLSEN RW, 2002, JAMA-J AM MED ASSOC, V232, P363; Oshitani H, 1996, LANCET, V348, P415, DOI 10.1016/S0140-6736(05)65044-1; Panagiotopoulos T, 1999, BRIT MED J, V319, P1462, DOI 10.1136/bmj.319.7223.1462; PANUA P, 1992, MED CLASSICS, V11, P525; Paunio M, 2000, EPIDEMIOL INFECT, V124, P263, DOI 10.1017/S0950268899003222; PEDERSEN IR, 1986, VACCINE, V4, P173, DOI 10.1016/0264-410X(86)90006-X; Peltola H, 1998, LANCET, V351, P1327, DOI 10.1016/S0140-6736(98)24018-9; PELTOLA H, 1994, NEW ENGL J MED, V331, P1397, DOI 10.1056/NEJM199411243312101; Permar SR, 2001, J INFECT DIS, V183, P532, DOI 10.1086/318533; Perry RT, 2000, ANN NY ACAD SCI, V918, P377; Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1; Prasad R, 1967, Indian Pediatr, V4, P243; Quiambao BP, 1998, PEDIATR INFECT DIS J, V17, P89, DOI 10.1097/00006454-199802000-00002; Rahajoe N N, 1990, Paediatr Indones, V30, P233; RAOTE G J, 1992, Indian Pediatrics, V29, P45; ROOS RP, 1981, NEUROLOGY, V31, P1263, DOI 10.1212/WNL.31.10.1263; Rosales FJ, 1996, AM J EPIDEMIOL, V143, P413, DOI 10.1093/oxfordjournals.aje.a008761; ROSS LA, 1990, AM J MED, V88, P313, DOI 10.1016/0002-9343(90)90162-7; SAHA V, 1990, EPIDEMIOL INFECT, V104, P151, DOI 10.1017/S0950268800054637; Salleras L, 2001, EUROSURVEILLANCE, V6, P113; SAMB B, 1995, PEDIATR INFECT DIS J, V14, P203, DOI 10.1097/00006454-199503000-00007; Samb B, 1997, AM J EPIDEMIOL, V145, P51, DOI 10.1093/oxfordjournals.aje.a009031; SCHNEIDERSCHAUL.S, 2002, EXP REV MOL MED; Schnorr JJ, 2001, VACCINE, V19, P1503, DOI 10.1016/S0264-410X(00)00349-2; Semba RD, 1997, PUBLIC HEALTH, V111, P245, DOI 10.1016/S0033-3506(97)00042-5; SEMBA RD, 1995, LANCET, V345, P1330; SENSION MG, 1988, AM J DIS CHILD, V142, P1271, DOI 10.1001/archpedi.1988.02150120025021; Shann F, 1997, BRIT MED J, V314, P334, DOI 10.1136/bmj.314.7077.334; Shann F, 2001, LANCET, V357, P2070, DOI 10.1016/S0140-6736(00)05226-0; SHANN F, 2002, BMJ-BRIT MED J, V321, P1423; SHANN F, 2002, COCHRANE LIB; Slater P E, 1999, Public Health Rev, V27, P235; SLY PD, 1984, ARCH DIS CHILD, V59, P935, DOI 10.1136/adc.59.10.935; STIEHM ER, 1987, ANN INTERN MED, V107, P367, DOI 10.7326/0003-4819-107-2-367; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Thomas D R, 1998, Commun Dis Public Health, V1, P44; Turnbull FM, 2001, B WORLD HEALTH ORGAN, V79, P882; Usen S, 1999, BMJ-BRIT MED J, V318, P86, DOI 10.1136/bmj.318.7176.86; VANBINNENDIJK RS, 1990, J IMMUNOL, V144, P2394; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; WARNER JO, 1976, BRIT J DIS CHEST, V70, P89, DOI 10.1016/0007-0971(76)90012-7; WEINSTEIN L, 1949, AM J MED SCI, V217, P314, DOI 10.1097/00000441-194903000-00011; WESLEY A G, 1971, South African Medical Journal, V45, P1402; *WHO, VACC BIOL WHO VACC P; WHO, 1996, EP DYS, P1; WHO, 2001, WKLY EPIDEMIOL REC, V76, P242; WHO Scientific Group on the Prevention and Management of Osteoporosis (2000: Geneva Switzerland), 2003, PUBL HLTH EXP PER CA, P192; WILD TF, 1991, J GEN VIROL, V72, P439, DOI 10.1099/0022-1317-72-2-439; World Health Organization, 1998, WKLY EPIDEMIOL REC, V73, P265; World Health Organization, 2000, MAN CHILD SER INF SE; World Health Organization, 2001, WKLY EPIDEMIOL REC, V76, P249; WU VH, 1993, J CLIN MICROBIOL, V31, P118, DOI 10.1128/JCM.31.1.118-122.1993; 2000, MMWR, V49, P986; 2000, STANDARD TREATMENT C	141	111	113	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					763	773		10.1016/S0140-6736(03)12661-X	http://dx.doi.org/10.1016/S0140-6736(03)12661-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620751				2022-12-28	WOS:000181232000021
J	Tschopp, S; Brucker, R				Tschopp, S; Brucker, R			Aching joints and jaundice	LANCET			English	Editorial Material									Cantonal Hosp Sursee Wolhuden, Dept Internal Med, CH-6110 Wolhusen, Switzerland		Brucker, R (corresponding author), KSSW Sursee Wolhusen, CH-6110 Wolhusen, Switzerland.							ALARCON GS, 1973, JOHNS HOPKINS MED J, V132, P1; DLESK A, 1987, Comprehensive Therapy, V13, P13; PEASE C, 1985, POSTGRAD MED J, V61, P545, DOI 10.1136/pgmj.61.716.545; SJOGREN MH, 1987, HEPATOLOGY, V7, P582, DOI 10.1002/hep.1840070328	4	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 1	2003	361	9359					750	750		10.1016/S0140-6736(03)12660-8	http://dx.doi.org/10.1016/S0140-6736(03)12660-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620740				2022-12-28	WOS:000181232000011
J	Hasty, P; Campisi, J; Hoeijmakers, J; van Steeg, H; Vijg, J				Hasty, P; Campisi, J; Hoeijmakers, J; van Steeg, H; Vijg, J			Aging and genome maintenance: Lessons from the mouse?	SCIENCE			English	Review							EXCISION-REPAIR GENE; WERNER-SYNDROME; MICE LACKING; OXIDATIVE STRESS; DNA-REPAIR; LIFE-SPAN; DEFICIENT; P53; PROTEIN; CANCER	Recent progress in the science of aging is driven largely by the use of model systems, ranging from yeast and nematodes to mice. These models have revealed conservation in genetic pathways that balance energy production and its damaging by-products with pathways that preserve somatic maintenance. Maintaining genome integrity has emerged as a major factor in longevity and cell viability. Here we discuss the use of mouse models with defects in genome maintenance for understanding the molecular basis of aging in humans.	Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78245 USA; Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; Buck Inst Age Res, Novato, CA USA; Erasmus Univ, Dept Cell Biol & Genet, CBG, NL-3000 DR Rotterdam, Netherlands; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Buck Institute for Research on Aging; Erasmus University Rotterdam; Netherlands National Institute for Public Health & the Environment; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Hasty, P (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX 78245 USA.	hastye@uthscsa.edu; vijg@uthscsa.edu	Hoeijmakers, Jan/AAX-6972-2021	Hasty, Paul/0000-0003-3046-0131	NIA NIH HHS [AG17242] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; CAMPISI J, UNPUB; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Cooper MP, 2000, GENE DEV, V14, P907; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; FULLER J, 2002, SCI SAGE KE     1004; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebel M, 2001, CANCER RES, V61, P1816; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; LIM CS, 2003, SCI SAGE KE     0226; LIM CS, 2002, SCI SAGE KE     0515; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Lithgow GJ, 2003, NATURE, V421, P125, DOI 10.1038/421125a; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; Masoro EJ, 1996, J GERONTOL A-BIOL, V51, pB387, DOI 10.1093/gerona/51A.6.B387; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MORGAN K, 2003, SCI SAGE KE     0402; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; MULLER J, 2003, SCI SAGE KE     0226, pTG4; Murai M, 2001, P NATL ACAD SCI USA, V98, P13379, DOI 10.1073/pnas.231329598; NIEDERNHOFER LJ, UNPUB; Reed John C., 1999, Current Opinion in Oncology, V11, P68, DOI 10.1097/00001622-199901000-00014; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SEYDEL C, 2003, SCI SAGE KE     0320; Shcherbakova PV, 2003, SCI SAGE KE     0226; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Van Remmen Holly, 1995, P171; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; WALTER CA, 2003, SCI SAGE KE     0226; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; H SAPIENS WRN SCI SA	55	449	461	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1355	1359		10.1126/science.1079161	http://dx.doi.org/10.1126/science.1079161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610296				2022-12-28	WOS:000181192300041
J	Kirkham, M; Muller-Reichert, T; Oegema, K; Grill, S; Hyman, AA				Kirkham, M; Muller-Reichert, T; Oegema, K; Grill, S; Hyman, AA			SAS-4 is a C-elegans centriolar protein that controls centrosome size	CELL			English	Article							HAMSTER OVARY CELLS; CAENORHABDITIS-ELEGANS; GAMMA-TUBULIN; SPINDLE POLES; CYCLE; MATURATION; DUPLICATION; NEMATODE; EMBRYO; ORGANIZATION	Centrosomes consist of a centriole pair surrounded by pericentriolar material (PCM). Previous work suggested that centrioles are required to organize PCM to form a structurally stable organelle. Here, we characterize SAS-4, a centriole component in Caenorhabditis elegans. Like tubulin, SAS-4 is incorporated into centrioles during their duplication and remains stably associated thereafter. In the absence of SAS-4, centriole duplication falls. Partial depletion of SAS-4 results in structurally defective centrioles that contain reduced levels of SAS-4 and organize proportionally less PCM. Thus, SAS-4 is a centriole-associated component whose amount dictates centrosome size. These results provide novel insight into the poorly understood role of centrioles as centrosomal organizers.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Oegema, K (corresponding author), CMM-E 3080,9500 Gilman Dr, La Jolla, CA 92093 USA.		Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Kirkham, Matthew/I-5458-2012; Grill, Stephan/D-9427-2012	Hyman, Anthony A/0000-0003-3664-154X; Kirkham, Matthew/0000-0003-0920-5355				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; CALLAINI G, 1990, J CELL SCI, V97, P539; Chapman MJ, 2000, Q REV BIOL, V75, P409, DOI 10.1086/393621; Fry AM, 2000, CURR TOP DEV BIOL, V49, P291; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; GOULD RR, 1977, J CELL BIOL, V73, P601, DOI 10.1083/jcb.73.3.601; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lange BMH, 2000, CURR TOP DEV BIOL, V49, P235; Lonsdale JE, 2001, MICROWAVE TECHNIQUES AND PROTOCOLS, P139, DOI 10.1007/978-1-59259-128-2_11; Marshall WF, 2001, CURR BIOL, V11, pR487, DOI 10.1016/S0960-9822(01)00289-5; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; Mignot JP, 1996, BIOL CELL, V86, P81, DOI 10.1016/0248-4900(96)84770-8; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Palazzo RE, 2000, CURR TOP DEV BIOL, V49, P449; Praitis V, 2001, GENETICS, V157, P1217; Preble AM, 2000, CURR TOP DEV BIOL, V49, P207; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; RIEDER CL, 1982, BIOL CELL, V44, P117; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Schnackenberg BJ, 1998, P NATL ACAD SCI USA, V95, P9295, DOI 10.1073/pnas.95.16.9295; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; VOROBJEV IA, 1987, INT REV CYTOL, V106, P227, DOI 10.1016/S0074-7696(08)61714-3; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	39	238	241	2	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					575	587		10.1016/S0092-8674(03)00117-X	http://dx.doi.org/10.1016/S0092-8674(03)00117-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600319	Bronze			2022-12-28	WOS:000181252600014
J	Pfeffer, S				Pfeffer, S			Membrane domains in the secretory and endocytic pathways	CELL			English	Review							TRANS-GOLGI NETWORK; GDP-DISSOCIATION INHIBITOR; NUCLEOTIDE EXCHANGE FACTOR; ENDOPLASMIC-RETICULUM; MATRIX PROTEIN; RAB-GTPASES; COMPARTMENTAL ORGANIZATION; BINDING DOMAINS; RECEPTOR; COMPLEX	Progress in identifying, characterizing, and localizing the constituents,of distinct membrane bound compartments has revealed a new level of intracellular subcompartmentation. Proteins and lipids are not uniformly distributed in a given organelle, and subdomains are formed by a combination of hierarchical assembly processes and protein exclusion. Thus, functionally distinct specializations of a given organelle are physically segregated to a greater extent than previously believed.	Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Pfeffer, S (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@stanford.edu						Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Ayad N, 1997, EMBO J, V16, P4497, DOI 10.1093/emboj/16.15.4497; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Christiansen OB, 1999, HUM REPROD UPDATE, V5, P249, DOI 10.1093/humupd/5.3.249; Conibear E, 2002, MOL CELL, V10, P215, DOI 10.1016/S1097-2765(02)00601-9; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; GEUZE HJ, 1987, J CELL BIOL, V104, P1715, DOI 10.1083/jcb.104.6.1715; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; GHOSH P, 2003, IN PRESS NAT REV MOL; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hanna J, 2002, P NATL ACAD SCI USA, V99, P7450, DOI 10.1073/pnas.112198799; HAURI HP, 1997, HDB PHYSIOL 14, P605; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Krise JP, 2000, J BIOL CHEM, V275, P25188, DOI 10.1074/jbc.M001138200; LADINSKY MS, 1994, J CELL BIOL, V127, P29, DOI 10.1083/jcb.127.1.29; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2001, J CELL SCI, V114, P2255; RIDOR M, 2002, TRAFFIC, V3, P537; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SITIA R, 1992, MOL BIOL CELL, V3, P1067, DOI 10.1091/mbc.3.10.1067; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420	71	157	162	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 21	2003	112	4					507	517		10.1016/S0092-8674(03)00118-1	http://dx.doi.org/10.1016/S0092-8674(03)00118-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600314	Bronze			2022-12-28	WOS:000181252600009
J	Pashkin, YA; Yamamoto, T; Astafiev, O; Nakamura, Y; Averin, DV; Tsai, JS				Pashkin, YA; Yamamoto, T; Astafiev, O; Nakamura, Y; Averin, DV; Tsai, JS			Quantum oscillations in two coupled charge qubits	NATURE			English	Article							SINGLE-COOPER-PAIR; JOSEPHSON-JUNCTION; STATES; SUPERPOSITION	A practical quantum computer(1), if built, would consist of a set of coupled two-level quantum systems (qubits). Among the variety of qubits implemented(2), solid-state qubits are of particular interest because of their potential suitability for integrated devices. A variety of qubits based on Josephson junctions(3,4) have been implemented(5-8); these exploit the coherence of Cooper-pair tunnelling in the superconducting state(5-10). Despite apparent progress in the implementation of individual solid-state qubits, there have been no experimental reports of multiple qubit gates-a basic requirement for building a real quantum computer. Here we demonstrate a Josephson circuit consisting of two coupled charge qubits. Using a pulse technique, we coherently mix quantum states and observe quantum oscillations, the spectrum of which reflects interaction between the qubits. Our results demonstrate the feasibility of coupling multiple solid-state qubits, and indicate the existence of entangled two-qubit states.	RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; NEC Fundamental Res Labs, Tsukuba, Ibaraki 3058501, Japan; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; PN Lebedev Phys Inst, Moscow 117924, Russia	RIKEN; NEC Corporation; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Tsai, JS (corresponding author), RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan.	tsai@frl.cl.nec.co.jp	Nakamura, Yasunobu/H-1300-2012; Averin, Dmitri/I-4860-2013; Tsai, Jaw-Shen/I-7813-2012; Pashkin, Yuri/M-8540-2015; Astafiev, Oleg/L-9771-2013	Nakamura, Yasunobu/0000-0003-0424-630X; Pashkin, Yuri/0000-0003-4767-8217; 				Averin DV, 2000, FORTSCHR PHYS, V48, P1055, DOI 10.1002/1521-3978(200009)48:9/11<1055::AID-PROP1055>3.0.CO;2-1; Bennett CH, 1996, PHYS REV A, V53, P2046, DOI 10.1103/PhysRevA.53.2046; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; CLARK RG, 2001, EXPT IMPLEMENTATION; ESTEVE D, 1992, NATO ADV SCI I B-PHY, V294, P109; Flees DJ, 1997, PHYS REV LETT, V78, P4817, DOI 10.1103/PhysRevLett.78.4817; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; FULTON TA, 1989, PHYS REV LETT, V63, P1307, DOI 10.1103/PhysRevLett.63.1307; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Nakamura Y, 1997, PHYS REV LETT, V79, P2328, DOI 10.1103/PhysRevLett.79.2328; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen Michael A., 2002, QUANTUM COMPUTATION; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Yu Y, 2002, SCIENCE, V296, P889, DOI 10.1126/science.1069452	16	630	640	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					823	826		10.1038/nature01365	http://dx.doi.org/10.1038/nature01365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594507	Green Submitted			2022-12-28	WOS:000181044700042
J	Tyler, KL				Tyler, KL			Creutzfeldt-Jakob disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA; Denver Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Tyler, KL (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Neurol, Denver, CO 80262 USA.		crow, timothy J/M-8327-2014; Wood, James/A-1626-2008; Narayan, sunil K/H-4848-2013; Tyler, Kenneth L./J-2420-2019; Micheli, Federico E/A-8358-2012	crow, timothy J/0000-0002-5482-6655; Wood, James/0000-0002-0258-3188; Narayan, sunil K/0000-0001-9866-2894; Tyler, Kenneth L./0000-0003-3294-5888; 					0	15	15	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					681	682		10.1056/NEJMp020187	http://dx.doi.org/10.1056/NEJMp020187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594311				2022-12-28	WOS:000181014400002
J	Ishida, S; Iwamoto, T; Kabuto, C; Kira, M				Ishida, S; Iwamoto, T; Kabuto, C; Kira, M			A stable silicon-based allene analogue with a formally sp-hybridized silicon atom	NATURE			English	Article							DOUBLE-BONDS; HOMOLOGS; ALKYNE	Carbon chemistry exhibits a rich variety in bonding patterns, with homo- or heteronuclear multiple bonds involving sp-hybridized carbon atoms as found in molecules such as acetylenes, nitriles, allenes and carbon dioxide. Carbon's heavier homologues in group 14 of the periodic table-including silicon, germanium and tin-were long thought incapable of forming multiple bonds because of the less effective ppi-ppi orbital overlap involved in the multiple bonds. However, bulky substituents can protect unsaturated bonds and stabilize compounds with formally sp-hybridized heavy group-14 atoms(1,2) : stable germanium(2), tin(3) and lead(4) analogues of acetylene derivatives and a marginally stable tristannaallene(5) have now been reported. However, no stable silicon compounds with formal sp-silicon atoms have been isolated. Evidence for the existence of a persistent disilaacetylene(6) and trapping(7) of transient 2-silaallenes and other X=Si=X' type compounds (X,X' = O, CR(2), NR, and so on) are also known, but stable silicon compounds with formally sp-hybridized silicon atoms have not yet been isolated. Here we report the synthesis of a thermally stable, crystalline trisilaallene derivative containing a formally sp-hybridized silicon atom. We find that, in contrast to linear carbon allenes, the trisilaallene is significantly bent. The central silicon in the molecule is dynamically disordered, which we ascribe to ready rotation of the central silicon atom around the molecular axis.	Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Kira, M (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan.	mkira@si.chem.tohoku.ac.jp	Ishida, Shintaro/M-3342-2015; Iwamoto, Takeaki/C-5131-2009	Ishida, Shintaro/0000-0001-7832-912X; Iwamoto, Takeaki/0000-0002-8556-5785				Escudie J, 2000, CHEM REV, V100, P3639, DOI 10.1021/cr990013z; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Harada J, 2001, J AM CHEM SOC, V123, P10884, DOI 10.1021/ja011197d; Iwamoto T, 2000, SCIENCE, V290, P504, DOI 10.1126/science.290.5491.504; Jutzi P, 2000, ANGEW CHEM INT EDIT, V39, P3797, DOI 10.1002/1521-3773(20001103)39:21<3797::AID-ANIE3797>3.0.CO;2-8; Kira M, 1999, J AM CHEM SOC, V121, P9722, DOI 10.1021/ja9925305; Phillips AD, 2002, J AM CHEM SOC, V124, P5930, DOI 10.1021/ja0257164; Pu LH, 2000, J AM CHEM SOC, V122, P3524, DOI 10.1021/ja993346m; SEKIGUCHI A, 1991, J CHEM SOC CHEM COMM, P341, DOI 10.1039/c39910000341; Stender M, 2002, ANGEW CHEM INT EDIT, V41, P1785, DOI 10.1002/1521-3773(20020517)41:10<1785::AID-ANIE1785>3.0.CO;2-6; Wiberg N, 2002, EUR J INORG CHEM, P1066; Wiberg N, 1999, EUR J INORG CHEM, P1211	12	205	205	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					725	727		10.1038/nature01380	http://dx.doi.org/10.1038/nature01380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	644UP	12610620				2022-12-28	WOS:000180938000038
J	Fuller, LC; Child, FJ; Midgley, G; Higgins, EM				Fuller, LC; Child, FJ; Midgley, G; Higgins, EM			Diagnosis and management of scalp ringworm	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SOUTH-EAST LONDON; TINEA-CAPITIS; INFECTION; CHILDREN; GRISEOFULVIN; PERSPECTIVE	Scalp ringworm is reaching epidemic proportions in parts of Britain's cities. Prompt diagnosis is needed to stop it spreading from child to child, but the varied presentation makes it easy to miss.	Kings Coll Hosp London, London SE5 9RS, England; St Thomas Hosp, St Johns Inst Dermatol, Med Mycol Dept, London SE1 7EH, England	King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Fuller, LC (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	claire.fuller@kcl.ac.uk	Fuller, Lucinda Claire/AAB-1897-2021					ALLEN HB, 1982, PEDIATRICS, V69, P81; BRONSON DM, 1983, J AM ACAD DERMATOL, V8, P322, DOI 10.1016/S0190-9622(83)70034-4; BUCKLEY DA, 1996, BR J DERMATOL S47, V135, P21; Elewski BE, 1996, BRIT J DERMATOL, V134, P7, DOI 10.1111/j.1365-2133.1996.tb15651.x; Elewski BE, 2000, J AM ACAD DERMATOL, V42, P1, DOI 10.1016/S0190-9622(00)90001-X; Fuller LC, 1997, BRIT J DERMATOL, V136, P139, DOI 10.1111/j.1365-2133.1997.tb08771.x; Fuller LC, 2001, BRIT J DERMATOL, V144, P321, DOI 10.1046/j.1365-2133.2001.04022.x; FULLER LC, 1997, J EUR ACAD DERM V S1, V9, P209; Gibbon KL, 2000, BRIT MED J, V320, P696, DOI 10.1136/bmj.320.7236.696; Hay RJ, 1996, BRIT J DERMATOL, V135, P955, DOI 10.1046/j.1365-2133.1996.d01-1101.x; Hay RJ, 2001, J EUR ACAD DERMATOL, V15, P229, DOI 10.1046/j.1468-3083.2001.00214.x; HAY RJ, 1998, TXB DERMATOLOGY, V2, P1151; Higgins EM, 2000, BRIT J DERMATOL, V143, P53, DOI 10.1046/j.1365-2133.2000.03530.x; JONES TC, 1995, BRIT J DERMATOL, V132, P683, DOI 10.1111/j.1365-2133.1995.tb00711.x; Leeming JG, 1995, BRIT J DERMATOL, V133, P929, DOI 10.1111/j.1365-2133.1995.tb06928.x; WILLIAMS DI, 1958, LANCET, V2, P1212	16	26	26	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2003	326	7388					539	541		10.1136/bmj.326.7388.539	http://dx.doi.org/10.1136/bmj.326.7388.539			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623917	Green Published			2022-12-28	WOS:000181548400023
J	Rorth, P				Rorth, P			Communication by touch: Role of cellular extensions in complex animals	CELL			English	Review							DROSOPHILA IMAGINAL DISCS; MIGRATION; GROWTH; FORCE; CHEMOATTRACTANT; ADHESION; FGF	Neurons make networks of intercellular connections. Many other cells also send out long cellular extensions and "touch" other cells far away. The extensions are intriguing, but what do they do? Possible rationales for this cell behavior include: (1) forming precise binary connections with the possibility of forming more complex networks, and (2) coupling of signaling with physical force.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Rorth, P (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Rørth, Pernille/H-3020-2011					Chou YH, 2002, DEV CELL, V3, P839, DOI 10.1016/S1534-5807(02)00362-3; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Gibson MC, 2000, CELL, V103, P343, DOI 10.1016/S0092-8674(00)00125-2; GUSTAFSON T, 1967, BIOL REV, V42, P422; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	15	53	53	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					595	598		10.1016/S0092-8674(03)00156-9	http://dx.doi.org/10.1016/S0092-8674(03)00156-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628180	Bronze			2022-12-28	WOS:000181443600003
J	Ruse, M				Ruse, M			Is evolution a secular religion?	SCIENCE			English	Editorial Material									Florida State Univ, Dept Philosophy, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Ruse, M (corresponding author), Florida State Univ, Dept Philosophy, Tallahassee, FL 32306 USA.	mruse@mailer.fsu.edu						DARWIN E, 2003, TEMPLE NATURE, V1, P309; Ruse M., 1996, MONAD MAN CONCEPT PR, DOI DOI 10.4159/9780674042995; WILSON E O, 1992; Wilson E. O., 1984, HARV U PRESS, DOI DOI 10.2307/J.CTVK12S6H; Wilson E. O., 1978, HUMAN NATURE, P192	5	8	9	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1523	1524		10.1126/science.1082968	http://dx.doi.org/10.1126/science.1082968			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624249				2022-12-28	WOS:000181367900019
J	Vaida, V; Kjaergaard, HG; Hintze, PE; Donaldson, DJ				Vaida, V; Kjaergaard, HG; Hintze, PE; Donaldson, DJ			Photolysis of sulfuric acid vapor by visible solar radiation	SCIENCE			English	Article							GAS-PHASE REACTION; CONDENSATION NUCLEI; NITRIC-ACID; OVERTONE SPECTRA; WATER; PHOTODISSOCIATION; INTENSITIES; STRATOSPHERE; ABSORPTION; EXCITATION	Atmospheric field measurements and models of the stratospheric sulfate aerosol layer led to the suggestion that sulfuric acid (H2SO4) must photolyze at high attitudes. We propose that excitation of vibrational overtones of H2SO4 and its hydrate in the near-infrared and visible leads to photolysis, forming sulfur trioxide (SO3) and water. On the basis of absorption cross sections calculated with ab initio methods calibrated to experimental measurements, we estimated j values that are sufficient to explain stratospheric and mesospheric sulfur dioxide (SO2) concentrations and the observation of the sulfate layer.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Colorado, CIRES, Boulder, CO 80309 USA; Univ Otago, Dept Chem, Dunedin, New Zealand; Dept Chem, Toronto, ON M5S 3H6, Canada; Univ Toronto Scarborough, Toronto, ON M5S 3H6, Canada	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Otago; University of Toronto; University Toronto Scarborough	Vaida, V (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA.		Donaldson, James/G-7120-2012; Vaida, Veronica/N-6069-2014; Kjaergaard, Henrik G/H-4333-2014	Donaldson, James/0000-0002-5090-3318; Vaida, Veronica/0000-0001-5863-8056; Kjaergaard, Henrik G/0000-0002-7275-8297; Hintze, Paul/0000-0002-9962-2955				Bingemann D, 1997, J CHEM PHYS, V107, P661, DOI 10.1063/1.474443; Burkholder JB, 2000, GEOPHYS RES LETT, V27, P2493, DOI 10.1029/1999GL011271; BUTLER LJ, 1986, J CHEM PHYS, V85, P2331, DOI 10.1063/1.451081; CRIM FF, 1984, ANNU REV PHYS CHEM, V35, P657; Crim FF, 1996, J PHYS CHEM-US, V100, P12725, DOI 10.1021/jp9604812; DAUBERT TE, 1993, PHYSICAL THERMODYNAM; Donaldson DJ, 1998, J PHYS CHEM A, V102, P5171, DOI 10.1021/jp980811d; Donaldson DJ, 2000, PHYS CHEM EARTH PT C, V25, P223, DOI 10.1016/S1464-1917(00)00009-X; Donaldson DJ, 1997, GEOPHYS RES LETT, V24, P2651, DOI 10.1029/97GL02663; FRISCH MJ, 1995, GAUSSIAN 94; Hintze PE, 2003, J PHYS CHEM A, V107, P1112, DOI 10.1021/jp0263626; HOFMANN DJ, 1985, GEOPHYS RES LETT, V12, P13, DOI 10.1029/GL012i001p00013; HOFMANN DJ, 1981, J ATMOS SCI, V38, P168, DOI 10.1175/1520-0469(1981)038<0168:OTBSAL>2.0.CO;2; JUNGE CE, 1961, J METEOROL, V18, P81, DOI 10.1175/1520-0469(1961)018<0081:SA>2.0.CO;2; Kjaergaard HG, 2002, J PHYS CHEM A, V106, P2979, DOI 10.1021/jp014018n; KJAERGAARD HG, 1990, J CHEM PHYS, V93, P6239, DOI 10.1063/1.458993; KOLB CE, 1994, J AM CHEM SOC, V116, P10314, DOI 10.1021/ja00101a067; Larson LJ, 2000, J CHEM PHYS, V112, P8830, DOI 10.1063/1.481532; Lovejoy ER, 1996, J PHYS CHEM-US, V100, P19911, DOI 10.1021/jp962414d; Low GR, 1999, J CHEM PHYS, V110, P9104, DOI 10.1063/1.478832; Mills MJ, 1999, GEOPHYS RES LETT, V26, P1133, DOI 10.1029/1999GL900187; MOROKUMA K, 1994, J AM CHEM SOC, V116, P10316, DOI 10.1021/ja00101a068; MORTENSEN OS, 1981, J CHEM PHYS, V75, P4800, DOI 10.1063/1.441916; RINSLAND CP, 1995, GEOPHYS RES LETT, V22, P1109, DOI 10.1029/95GL00917; ROBINSON TW, IN PRESS J CHEM PHYS; Roehl CM, 2002, J PHYS CHEM A, V106, P3766, DOI 10.1021/jp013536v; ROSEN JM, 1983, J GEOPHYS RES-OCEANS, V88, P3725, DOI 10.1029/JC088iC06p03725; SINHA A, 1990, J CHEM PHYS, V92, P401, DOI 10.1063/1.458442; Staikova M, 2002, J PHYS CHEM A, V106, P3023, DOI 10.1021/jp0143746; Weisenstein DK, 1997, J GEOPHYS RES-ATMOS, V102, P13019, DOI 10.1029/97JD00901; Wennberg PO, 1999, GEOPHYS RES LETT, V26, P1373, DOI 10.1029/1999GL900255; Wrenn SJ, 1999, J PHOTOCH PHOTOBIO A, V129, P101, DOI 10.1016/S1010-6030(99)00170-7; ZHAO JX, 1995, J GEOPHYS RES-ATMOS, V100, P5215, DOI 10.1029/94JD03110	33	151	152	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1566	1568		10.1126/science.1079297	http://dx.doi.org/10.1126/science.1079297			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624265				2022-12-28	WOS:000181367900035
J	Cowan, F; Rutherford, M; Groenendaal, F; Eken, P; Mercuri, E; Bydder, GM; Meiners, LC; Dubowitz, LMS; de Vries, LS				Cowan, F; Rutherford, M; Groenendaal, F; Eken, P; Mercuri, E; Bydder, GM; Meiners, LC; Dubowitz, LMS; de Vries, LS			Origin and timing of brain lesions in term infants with neonatal encephalopathy	LANCET			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; CEREBRAL INFARCTION; ASPHYXIA; CHILDREN; PALSY	Background The role of intrapartum asphyxia in neonatal encephalopathy and seizures in term infants is not clear, and antenatal factors are being implicated in the causal pathway for these disorders. However, there is no evidence that brain damage occurs before birth. We aimed to test the hypothesis that neonatal encephalopathy, early neonatal seizures, or both result from early antenatal insults. Methods We used brain MRI or post-mortem examination in 351 fullterm infants with neonatal encephalopathy, early seizures, or both to distinguish between lesions acquired antenatally and those that developed in the intrapartum and early post-partum period. We excluded infants with major congenital malformations or obvious chromosomal disorders. Infants were divided into two groups: those with neonatal encephalopathy (with or without seizures), and evidence of perinatal asphyxia (group 1); and those without other evidence of encephalopathy, but who presented with seizures within 3 days of birth (group 2). Findings Brain images showed evidence of an acute insult without established injury or atrophy in 197 (80%) of infants in group 1, MRI showed evidence of established injury in only 2 infants (<1%), although tiny foci of established white matter gliosis, in addition to acute injury, were seen in three of 21 on post-mortem examination. In group 2, acute focal damage was noted in 62 (69%) of infants. Two (3%) also had evidence of antenatal injury. Interpretation Although our results cannot exclude the possibility that antenatal or genetic factors might predispose some infants to perinatal brain injury, our data strongly suggest that events in the immediate perinatal period are most important in neonatal brain injury.	Hammersmith Hosp, Imperial Coll, Fac Med, Dept Paediat, London W12 0NN, England; Hammersmith Hosp, Imperial Coll, Fac Med, Dept Neonatal Med, London W12 0NN, England; Univ Med Ctr, Wilhelmina Childrens Hosp, Utrecht, Netherlands; Catholic Univ, Dept Paediat Neurol, Rome, Italy	Imperial College London; Imperial College London; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Cowan, F (corresponding author), Hammersmith Hosp, Imperial Coll, Fac Med, Dept Paediat, London W12 0NN, England.	f.cowan@imperial.ac.uk	Groenendaal, Floris/P-6872-2019; de Vries, Linda S/AAB-6454-2021	Groenendaal, Floris/0000-0002-9284-1637; 				ALNAKEB L, 1999, EUR J PAED NEUROL, V29, P124; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; BADAWI N, 1998, ANTEPARTUM RISK FACT, P1549; BADAWI N, 1998, INTRAPARTUM RISK FAC, P1554; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P427; BLAIR E, 1988, J PEDIATR-US, V112, P515, DOI 10.1016/S0022-3476(88)80161-6; *CHILD GROWTH FDN, 1996, BOYS GIRLS 4 IN ON G; COWAN EM, 1994, NEUROPEDIATRICS, V25, P172, DOI 10.1055/s-2008-1073018; Cowan F, 2000, Semin Neonatol, V5, P127, DOI 10.1053/siny.2000.0011; COWAN F, 2003, DEV MED CHILD NE S93, V45, P24; Draper ES, 2002, ARCH DIS CHILD-FETAL, V87, P176; EKEN P, 1994, NEUROPEDIATRICS, V25, P301, DOI 10.1055/s-2008-1073044; Felix JF, 2000, DEV MED CHILD NEUROL, V42, P803; GAFFNEY G, 1994, ARCH DIS CHILD-FETAL, V70, pF195, DOI 10.1136/fn.70.3.F195; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; HELLER G, 2000, EARLY NEONATAL MORTA, P274; HOPE PL, 1984, LANCET, V2, P366; Jouvet P, 1999, AM J NEURORADIOL, V20, P1343; LOW JA, 1989, AM J OBSTET GYNECOL, V160, P608, DOI 10.1016/S0002-9378(89)80040-7; MERCURI E, 1995, ARCH DIS CHILD-FETAL, V73, pF67, DOI 10.1136/fn.73.2.F67; Mercuri E, 1999, PEDIATRICS, V103, P39, DOI 10.1542/peds.103.1.39; Mercuri E, 2002, NEUROPEDIATRICS, V33, P150, DOI 10.1055/s-2002-33412; Mercuri E, 2001, PEDIATRICS, V107, P1400, DOI 10.1542/peds.107.6.1400; NELSON KB, 1991, AM J DIS CHILD, V145, P1325, DOI 10.1001/archpedi.1991.02160110117034; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; Roland EP, 1998, ANN NEUROL, V44, P161, DOI 10.1002/ana.410440205; Rutherford M, 1996, ARCH DIS CHILD-FETAL, V75, pF145, DOI 10.1136/fn.75.3.F145; RUTHERFORD MA, 1995, NEUROPEDIATRICS, V26, P183, DOI 10.1055/s-2007-979751; Rutherford MA, 1998, PEDIATRICS, V102, P323, DOI 10.1542/peds.102.2.323; Sie LTL, 2000, NEUROPEDIATRICS, V31, P128, DOI 10.1055/s-2000-7496; SQUIER M, 1991, NEUROPATH APPL NEURO, V17, P29, DOI 10.1111/j.1365-2990.1991.tb00691.x; YUDKIN PL, 1994, BRIT J OBSTET GYNAEC, V101, P774, DOI 10.1111/j.1471-0528.1994.tb11945.x	33	406	418	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					736	742		10.1016/S0140-6736(03)12658-X	http://dx.doi.org/10.1016/S0140-6736(03)12658-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620738				2022-12-28	WOS:000181232000009
J	Degen, M				Degen, M			Europe draws up plans for funding agency	NATURE			English	News Item																		Schiermeier Q, 2002, NATURE, V419, P108, DOI 10.1038/419108a	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					881	881		10.1038/421881b	http://dx.doi.org/10.1038/421881b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606965	Bronze			2022-12-28	WOS:000181186900011
J	Ashraf, H				Ashraf, H			Iraq's refugees and internally displaced people will face hardship wherever they go	LANCET			English	Editorial Material																			0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					630	631		10.1016/S0140-6736(03)12623-2	http://dx.doi.org/10.1016/S0140-6736(03)12623-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12611390				2022-12-28	WOS:000181129500007
J	Ratjen, F; Doring, G				Ratjen, F; Doring, G			Cystic fibrosis	LANCET			English	Review							AERUGINOSA LUNG INFECTION; TRANSMEMBRANE CONDUCTANCE REGULATOR; SECRETORY LEUKOPROTEASE INHIBITOR; CHRONIC PSEUDOMONAS INFECTION; AIRWAY-SURFACE LIQUID; ALTERNATE-DAY; PULMONARY-FUNCTION; DELTA-F508 CFTR; CHLORIDE CONDUCTANCE; INHALED TOBRAMYCIN	Cystic fibrosis is the most common autosomal recessive disorder in white people, with a frequency of about 1 in 2500 livebirths. Discovery of the mutated gene encoding a defective chloride channel in epithelial cells-named cystic fibrosis transmembrane conductance regulator (CFTR)-has improved our understanding of the disorder's pathophysiology and has aided diagnosis, but has shown the disease's complexity. Gene replacement therapy is still far from being used in patients with cystic fibrosis, mostly because of difficulties of targeting the appropriate cells. Life expectancy of patients with the disorder has been greatly increased over past decades because of better notions of symptomatic treatment strategies. Here, we summarise advances in understanding and treatment of cystic fibrosis, focusing on pulmonary disease, which accounts for most morbidity and deaths.	Univ Essen Gesamthsch, Dept Paediat, Essen, Germany; Univ Tubingen, Inst Gen & Environm Hyg, Tubingen, Germany	University of Duisburg Essen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ratjen, F (corresponding author), Univ Essen Gesamthsch, Dept Paediat, Essen, Germany.			Ratjen, Felix/0000-0003-4057-6592				Alton EWFW, 1999, LANCET, V353, P947, DOI 10.1016/S0140-6736(98)06532-5; Andersson C, 2000, EUR RESPIR J, V15, P937, DOI 10.1034/j.1399-3003.2000.15e21.x; Aris RM, 2001, AM J RESP CRIT CARE, V164, P2102, DOI 10.1164/ajrccm.164.11.2107022; Armstrong DS, 1997, AM J RESP CRIT CARE, V156, P1197, DOI 10.1164/ajrccm.156.4.96-11058; Aron Y, 1999, AM J RESP CRIT CARE, V159, P1464, DOI 10.1164/ajrccm.159.5.9807046; AUERBACH HS, 1985, LANCET, V2, P686; Aurora P, 1999, LANCET, V354, P1591, DOI 10.1016/S0140-6736(99)03031-7; Bals R, 1999, J CLIN INVEST, V103, P1113, DOI 10.1172/JCI6570; BARBERO GJ, 1966, AM J DIS CHILD, V112, P536, DOI 10.1001/archpedi.1966.02090150080005; Barclay ML, 1996, J ANTIMICROB CHEMOTH, V37, P1155, DOI 10.1093/jac/37.6.1155; BENNET LE, 2000, CLIN TRANSPL, V1, P31; BONFIELD TL, 1995, AM J RESP CELL MOL, V13, P257, DOI 10.1165/ajrcmb.13.3.7544594; BOUCHER R, 1988, J PHYSL, V404, P77; Breen L, 2001, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002767; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Buscher R, 2002, PHARMACOGENETICS, V12, P347, DOI 10.1097/00008571-200207000-00002; Bush A, 2000, PEDIATR PULM, V30, P139; Cantin AM, 1999, AM J RESP CRIT CARE, V160, P1130, DOI 10.1164/ajrccm.160.4.9807166; Cheng K, 2000, COCHRANE DB SYST REV, V2, pCD000222; Cheng K, 2000, COCHRANE DB SYST REV, V2; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chmiel JF, 1999, AM J RESP CRIT CARE, V160, P2040, DOI 10.1164/ajrccm.160.6.9901043; Cohen RG, 2001, WORLD J SURG, V25, P244; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; CONWAY SP, 2000, COCHRANE DB SYST REV, V2, P1198; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; *CYST FIBR FDN, 2001, CYST FIBR FDN PAT RE; *CYST FIBR GEN AN, CYST FIBR MUT DAT BA; Dezateux C, 2000, COCHRANE DB SYST REV, V2; DODGE JA, 1995, LANCET, V346, P587, DOI 10.1016/S0140-6736(95)91431-5; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; DORING G, 1994, PEDIATR PULM, V18, P3, DOI 10.1002/ppul.1950180104; Doring G, 2000, CYSTIC FIBROSIS, P109; DORING G, 2002, HOSP PHARM, V5, P65; Dork T, 1997, HUM GENET, V100, P365, DOI 10.1007/s004390050518; EIGEN H, 1995, J PEDIATR-US, V126, P515, DOI 10.1016/S0022-3476(95)70343-8; Elborn JS, 1996, THORAX, V51, P971, DOI 10.1136/thx.51.10.971; Elborn JS, 2000, THORAX, V55, P355, DOI 10.1136/thorax.55.5.355; Equi A, 2002, LANCET, V360, P978, DOI 10.1016/S0140-6736(02)11081-6; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.5.e2; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Flotte TR, 2001, CHEST, V120, p124S, DOI 10.1378/chest.120.3_suppl.124S; Fogarty A, 2000, CHEST, V117, P1656, DOI 10.1378/chest.117.6.1656; Frederiksen B, 1996, PEDIATR PULM, V21, P153, DOI 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R; FRIED MD, 1991, J PEDIATR-US, V119, P913, DOI 10.1016/S0022-3476(05)83042-2; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Garred P, 1999, J CLIN INVEST, V104, P431, DOI 10.1172/JCI6861; GASKIN K, 1982, J PEDIATR-US, V100, P857, DOI 10.1016/S0022-3476(82)80501-5; GHARIB R, 1964, AM J DIS CHILD, V108, P499, DOI 10.1001/archpedi.1964.02090010501009; Grasemann H, 2000, AM J RESP CRIT CARE, V162, P2172, DOI 10.1164/ajrccm.162.6.2003106; Hamilton JW, 2001, LANCET, V358, P2014, DOI 10.1016/S0140-6736(01)07138-0; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; HOIBY N, 1990, THORAX, V45, P881, DOI 10.1136/thx.45.11.881; Holl RW, 1997, J PEDIATR GASTR NUTR, V25, P188, DOI 10.1097/00005176-199708000-00010; IMUNDO L, 1995, P NATL ACAD SCI USA, V92, P3019, DOI 10.1073/pnas.92.7.3019; Jaffe A, 1998, LANCET, V351, P420, DOI 10.1016/S0140-6736(05)78360-4; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; JENSEN T, 1987, J ANTIMICROB CHEMOTH, V19, P831, DOI 10.1093/jac/19.6.831; Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Kearney CE, 2000, COCHRANE DB SYST REV, V2; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; KNOWLES MR, 1995, NEW ENGL J MED, V333, P823, DOI 10.1056/NEJM199509283331302; KNOWLES MR, 1990, NEW ENGL J MED, V322, P1189, DOI 10.1056/NEJM199004263221704; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; KONSTAN MW, 1995, NEW ENGL J MED, V332, P848, DOI 10.1056/NEJM199503303321303; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; KOPELMAN H, 1985, NEW ENGL J MED, V312, P329, DOI 10.1056/NEJM198502073120601; KOPITO LE, 1973, FERTIL STERIL, V24, P512; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; Lai HC, 2000, NEW ENGL J MED, V342, P851, DOI 10.1056/NEJM200003233421204; LANNG S, 1994, ACTA PAEDIATR, V83, P72, DOI 10.1111/j.1651-2227.1994.tb12956.x; LESTER LA, 1994, PEDIATRICS, V93, P114; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; LITTLEWOOD JM, 1985, LANCET, V1, P865, DOI 10.1016/S0140-6736(85)92222-6; Mahadeva R, 2001, THORAX, V56, P53, DOI 10.1136/thorax.56.1.53; MAHADEVA R, 1998, CLIN OUTCOME RELATIO, P1771; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; McCarty NA, 2002, PEDIATR PULM, V33, P90, DOI 10.1002/ppul.10041; MCELVANEY NG, 1993, AM REV RESPIR DIS, V148, P1056, DOI 10.1164/ajrccm/148.4_Pt_1.1056; MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994; MCELVANEY NG, 1991, LANCET, V337, P392, DOI 10.1016/0140-6736(91)91167-S; Merelle M.E., 2001, COCHRANE DB SYST REV, V3; Milkiewicz P, 2002, J GASTROEN HEPATOL, V17, P208, DOI 10.1046/j.1440-1746.2002.02671.x; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Noone PG, 2001, PEDIATR PULM, V32, P122, DOI 10.1002/ppul.1098.abs; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Penque D, 2000, LAB INVEST, V80, P857, DOI 10.1038/labinvest.3780090; Phillips IJ, 1999, ANN CLIN BIOCHEM, V36, P739, DOI 10.1177/000456329903600606; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; Poschet JF, 2001, P NATL ACAD SCI USA, V98, P13972, DOI 10.1073/pnas.241182598; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Ratjen F, 2001, LANCET, V358, P983, DOI 10.1016/S0140-6736(01)06124-4; Ratjen F, 2001, PEDIATR PULM, V31, P13, DOI 10.1002/1099-0496(200101)31:1<13::AID-PPUL1001>3.3.CO;2-E; RATJEN F, 1985, EUR J PEDIATR, V144, P374, DOI 10.1007/BF00441781; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rodgers HC, 1999, EUR RESPIR J, V14, P693, DOI 10.1034/j.1399-3003.1999.14c32.x; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; RYAN C, 2000, GENET PROGR SER, V2, P1; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; Scotet V, 2000, LANCET, V356, P789, DOI 10.1016/S0140-6736(00)02652-0; Sinaasappel M, 2002, J Cyst Fibros, V1, P51, DOI 10.1016/S1569-1993(02)00032-2; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; SMYTH A, 2000, COCHRANE DATABASE SY, V2, DOI UNSP CD001021; SMYTH R, 2000, COCHRANE DATABASE SY, V2, DOI UNSP CD000406; SOUTHERN KW, 2000, COCHRANE DATABASE SY, V3, DOI UNSP CD002203; STEINKAMP G, 1989, PEDIATR PULM, V6, P91, DOI 10.1002/ppul.1950060207; Stern RC, 1997, NEW ENGL J MED, V336, P487, DOI 10.1056/NEJM199702133360707; Stutman HR, 2002, J PEDIATR-US, V140, P299, DOI 10.1067/mpd.2002.121930; Suri R, 2001, LANCET, V358, P1316, DOI 10.1016/S0140-6736(01)06412-1; SZAFF M, 1982, ACTA PAEDIATR SCAND, V71, P21; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; Vankeerberghen Anne, 2002, J Cyst Fibros, V1, P13, DOI 10.1016/S1569-1993(01)00003-0; VEEZE HJ, 1991, GASTROENTEROLOGY, V101, P398, DOI 10.1016/0016-5085(91)90017-F; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Wark PA, 2000, COCHRANE DB SYST REV, V2; WEAVER LT, 1994, ARCH DIS CHILD, V70, P84, DOI 10.1136/adc.70.2.84; Widdicombe JH, 2001, PFLUG ARCH EUR J PHY, V443, pS8; Wiesemann HG, 1998, PEDIATR PULM, V25, P88, DOI 10.1002/(SICI)1099-0496(199802)25:2<88::AID-PPUL3>3.3.CO;2-9; Wilmott RW, 1998, J PEDIATR-US, V132, P563, DOI 10.1016/S0022-3476(98)70337-3; Wolter J, 2002, THORAX, V57, P212, DOI 10.1136/thorax.57.3.212; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Zabner J, 1996, J CLIN INVEST, V97, P1504, DOI 10.1172/JCI118573; Zahm JM, 1997, AM J PHYSIOL-CELL PH, V272, pC853, DOI 10.1152/ajpcell.1997.272.3.C853; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180; Zielenski J, 1999, NAT GENET, V22, P128, DOI 10.1038/9635; ZIELINSKI J, 1991, GENOMICS, V10, P241	139	755	804	0	193	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					681	689		10.1016/S0140-6736(03)12567-6	http://dx.doi.org/10.1016/S0140-6736(03)12567-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606185				2022-12-28	WOS:000181129500023
J	Tobias, PV				Tobias, PV			Encore olduvai	SCIENCE			English	Editorial Material							HOMO-RUDOLFENSIS		Univ Witwatersrand, Sch Anat Sci, Sterkfontein Res Unit, ZA-2193 Johannesburg, South Africa	University of Witwatersrand	Tobias, PV (corresponding author), Univ Witwatersrand, Sch Anat Sci, Sterkfontein Res Unit, ZA-2193 Johannesburg, South Africa.							Alexeev V.P., 1986, ORIGIN HUMAN RACE; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Delson E, 1997, NATURE, V389, P445, DOI 10.1038/38912; GROVES CP, 1991, THEORY HUMAN PRIMATE; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; ISAAC GL, 1978, EARLY HOMINIDS AFRIC, P219; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Kennedy GE, 1999, J HUM EVOL, V36, P119, DOI 10.1006/jhev.1999.0247; Leakey L. S. B., 1965, OLDUVAI GORGE 1951 1; LEAKEY MD, 1971, GORGE EXCAVATIONS BE; Tobias P.V., 1991, OLDUVAI GORGE, V4; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; [No title captured]	14	15	15	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1193	1194						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595682				2022-12-28	WOS:000181065500028
J	Lincoff, AM; Bittl, JA; Harrington, RA; Feit, F; Kleiman, NS; Jackman, JD; Sarembock, IJ; Cohen, DJ; Spriggs, D; Ebrahimi, R; Keren, G; Carr, J; Cohen, EA; Betriu, A; Desmet, W; Kereiakes, DJ; Rutsch, W; Wilcox, RG; de Feyter, PJ; Vahanian, A; Topol, EJ				Lincoff, AM; Bittl, JA; Harrington, RA; Feit, F; Kleiman, NS; Jackman, JD; Sarembock, IJ; Cohen, DJ; Spriggs, D; Ebrahimi, R; Keren, G; Carr, J; Cohen, EA; Betriu, A; Desmet, W; Kereiakes, DJ; Rutsch, W; Wilcox, RG; de Feyter, PJ; Vahanian, A; Topol, EJ		REPLACE 2 Investigators	Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention - REPLACE-2 Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISCHEMIC EVENTS; MYOCARDIAL-INFARCTION; ABCIXIMAB; THROMBIN; THROMBOCYTOPENIA; COMPLICATIONS; ANGIOPLASTY; INHIBITION; MORTALITY; PLACEBO	Context The direct thrombin inhibitor bivalirudin has been associated with better efficacy and less bleeding than heparin during coronary balloon angioplasty but has not been widely tested during contemporary percutaneous coronary intervention (PCI). Objective To determine the efficacy of bivalirudin, with glycoprotein Ilb/IIIa (Gp IIb/IIia) inhibition on a provisional basis for complications during PCI, compared with heparin plus planned Gp IIb/IIIa blockade with regard to protection from periprocedural ischemic and hemorrhagic complications. Design Setting, and Participants The Randomized Evaluation in PCI Linking Angiomax Reduced Clinical Events (REPLACE)72 trial, a randomized, double-blind, active-controlled trial conducted among 6010 patients undergoing urgent or elective PCI at 233 community or referral hospitals in 9 countries from October 2001 through August 2002. Interventions Patients were randomly assigned to receive intravenous bivalirudin (0.75-mg/kg bolus plus 1.75 mg/kg per hour for the duration of PCI), with provisional Gp IIb/IIIa inhibition (n=2999), or heparin (65-U/kg bolus) with planned Gp IIb/IIIa inhibition (abciximab or eptifibatide) (n=3011). Both groups received daily aspirin and a thienopyridine for at least 30 days after PCI. Main Outcome Measures The primary composite end point was 30-day incidence of death, myocardial infarction, urgent repeat revascularization, or in-hospital major bleeding; the secondary composite end point was 30-day incidence of death, myocardial infarction, or urgent repeat revascularization. Results Provisional Gp IIb/IIIa blockade was administered to 7.2%of patients in the bivalirudin group. By 30 days, the primary composite end point had occurred among 9.2% of patients in the bivalirudin group vs 10.0% of patients in the Neparin-plus-Gp IIb/IIIa group (odds ratio, 0.92; 95% confidence interval, 0.77-1.09; P=32). The secondary composite end point occurred in 7.6% of patients in the bivalirudin vs 7.1% of patients in the heparin-plus-Gp IIb/IIIa groups (odds ratio, 1.09; 95% confidence interval 0.90-1.32; P=.40). Prespecified statistical criteria for noninferiority to heparin plus Gp IIb/IIIa were satisfied for both end points. In-hospital major bleeding rates were significantly reduced by bivalirudin (2.4% vs 4.1%; P<.001). Conclusions Bivalirudin with provisional Gp IIb/IIIa blockade is statistically not inferior to heparin plus planned Go IIb/IIIa blockade during contemporary PCI with regard to suppression of acute ischemic end points and is associated with less bleeding.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Munroe Reg Med Ctr, Ocala Heart Inst, Ocala, FL USA; Duke Clin Res Inst, Durham, NC USA; NYU, Sch Med, New York, NY USA; Baylor Coll Med, Houston, TX 77030 USA; Methodist Hosp, Houston, TX 77030 USA; Trinity Mother Frances Hosp, Tyler Cardiovasc Consultants, Tyler, TX USA; Univ Virginia Hlth Syst, Charlottesville, VA USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Clearwater Cardiovasc Consultants, Clearwater, FL USA; W Los Angeles VA, Los Angeles, CA USA; Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; E Texas Med Ctr, Tyler, TX USA; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; Univ Barcelona, Hosp Clin, Barcelona, Spain; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; Ohio Heart Hlth Ctr, Lindner Ctr, Cincinnati, OH USA; Univ Clin Charite Berlin, Berlin, Germany; Univ Nottingham Hosp, Nottingham NG7 2UH, England; Univ Hosp Dijkzigt, NL-3015 GD Rotterdam, Netherlands; Hop Bichat Claude Bernard, F-75877 Paris, France	Cleveland Clinic Foundation; Duke University; New York University; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; University of Virginia; Harvard University; Beth Israel Deaconess Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Barcelona; Hospital Clinic de Barcelona; KU Leuven; University Hospital Leuven; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Nottingham; Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Lincoff, AM (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	lincofa@ccf.org	Carr, John/A-1938-2012	Carr, John/0000-0002-4398-8237; Topol, Eric/0000-0002-1478-4729				Anderson KM, 2001, J AM COLL CARDIOL, V37, P2059, DOI 10.1016/S0735-1097(01)01290-6; Berkowitz SD, 1998, J AM COLL CARDIOL, V32, P311, DOI 10.1016/S0735-1097(98)00252-6; BITTL JA, 1995, NEW ENGL J MED, V333, P764, DOI 10.1056/NEJM199509213331204; Bittl JA, 2001, AM HEART J, V142, P952, DOI 10.1067/mhj.2001.119374; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Chew DP, 2001, CIRCULATION, V103, P961; Cohen H, 2002, REDBOOK DRUG TOPICS; EITZMAN DT, 1994, CIRCULATION, V89, P1523, DOI 10.1161/01.CIR.89.4.1523; Hasselblad V, 2001, DRUG INF J, V35, P435, DOI 10.1177/009286150103500212; *INT JOINT EFF COM, 1995, LANCET, V346, P329; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Kereiakes DJ, 2002, AM J CARDIOL, V90, P628, DOI 10.1016/S0002-9149(02)02568-7; Kereiakes DJ, 2000, AM HEART J, V140, P74, DOI 10.1067/mhj.2000.106615; KOERBER JM, 2001, J THROMBOSIS HAEMO S, V86; LANDEFELD CS, 1987, AM J MED, V82, P703, DOI 10.1016/0002-9343(87)90004-0; LEFKOVITS J, 1994, CIRCULATION, V90, P1522, DOI 10.1161/01.CIR.90.3.1522; Lincoff A. Michael, 2002, Journal of the American College of Cardiology, V39, p16A; Lincoff AM, 1999, CIRCULATION, V99, P1951, DOI 10.1161/01.CIR.99.15.1951; Lincoff AM, 2002, JAMA-J AM MED ASSOC, V288, P2130, DOI 10.1001/jama.288.17.2130; Lincoff AM, 2002, AM HEART J, V143, P847, DOI 10.1067/mhj.2002.122173; Lincoff AM, 2000, J AM COLL CARDIOL, V35, P1103, DOI 10.1016/S0735-1097(00)00554-4; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; ROTHMANN M, 2000, IN PRESS STAT MED, V139, pS166; Siegel JP, 2000, AM HEART J, V139, pS166, DOI 10.1016/S0002-8703(00)90066-8; Sobel M, 2001, J VASC SURG, V33, P587, DOI 10.1067/mva.2001.112696; Tcheng JE, 2000, LANCET, V356, P2037; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Topol EJ, 1997, JAMA-J AM MED ASSOC, V278, P479, DOI 10.1001/jama.278.6.479; Topol EJ, 2002, AM J MED, V113, P1, DOI 10.1016/S0002-9343(02)01145-2; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; *US FDA, 2001, 20896 NDA US FOOD DR; Weitz Jeffrey I, 2002, J Invasive Cardiol, V14 Suppl B, p2B; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251	37	934	971	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					853	863		10.1001/jama.289.7.853	http://dx.doi.org/10.1001/jama.289.7.853			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588269				2022-12-28	WOS:000181072200029
J	Miller, FH; Greaney, TL				Miller, FH; Greaney, TL			The National Resident Matching Program and antitrust law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								In May 2002, a group of physicians filed a class action lawsuit alleging that the National Resident Matching Program (NRMP) violates antitrust laws. The plaintiffs contend that NRMP practices have stabilized lower-than-competitive wages and imposed exhausting working conditions on residents. They also maintain that NRMP procedures virtually force applicants for house officer positions to forfeit their right to negotiate for better wages and conditions. The plaintiffs also allege that the defendants have collectively fostered anticompetitive accreditation standards through the Accreditation Council for Graduate Medical Education. Jung v Association of American Medical Colleges could present antitrust law with some difficult challenges. Although the matching program on its face appears to limit competition in a manner that previous cases have found illegal, it operates in the context of important professional activities (medical education and quality improvement) that may generate some judicial deference. At this early stage, no confident prediction can be made about the outcome of the case if it goes to trial; however, the plaintiffs appear to have a plausible case under existing antitrust doctrine, and lengthy litigation is possible. Given the important questions that the litigation will not address, such as the potential costs of a finding of illegality to the government and other payers, and the impact of such a finding on the health care system as a whole, a legislative solution seems highly desirable.	Boston Univ, Sch Law, Boston, MA 02215 USA; St Louis Univ, Sch Law, St Louis, MO 63103 USA	Boston University; Saint Louis University	Miller, FH (corresponding author), Boston Univ, Sch Law, 765 Commonwealth Ave, Boston, MA 02215 USA.	fmiller@bu.edu						*AM MED ASS, 2002, NAT RES MATCH PROGR; Avery C, 2001, U CHICAGO LAW REV, V68, P793, DOI 10.2307/1600403; FURROW BR, 2000, HLTH LAW, V2; GREANEY TL, 2002, LOY CONSUMER L REV, V14, P481; HONAN WH, 1993, NY TIMES        1223, pA13; LIPTAK A, 2002, NY TIMES        0826, pA1; MORRISON R, 1992, U CHICAGO LAW REV, V59, P807, DOI 10.2307/1599922; Robertson Elbert L., 2002, YALE LAW POLICY REV, V20, P400; SHEPHERD GB, 1998, CARDOZO L REV, V19, P2091	9	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					913	918		10.1001/jama.289.7.913	http://dx.doi.org/10.1001/jama.289.7.913			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588279				2022-12-28	WOS:000181072200039
J	Gunturkun, O				Gunturkun, O			Adult persistence of head-turning asymmetry	NATURE			English	Article							FUNCTIONAL LATERALITIES; PRETERM INFANTS; POSITION		Ruhr Univ Bochum, Fak Psychol, D-44780 Bochum, Germany	Ruhr University Bochum	Gunturkun, O (corresponding author), Ruhr Univ Bochum, Fak Psychol, D-44780 Bochum, Germany.			Gunturkun, Onur/0000-0003-4173-5233				Casey MB, 2000, DEV PSYCHOBIOL, V37, P13, DOI 10.1002/1098-2302(200007)37:1<13::AID-DEV3>3.0.CO;2-M; Corballis MC, 1997, PSYCHOL REV, V104, P714, DOI 10.1037/0033-295X.104.4.714; Coryell J. F., 1978, INFANT BEHAV DEV, V1, P245, DOI [DOI 10.1016/S0163-6383(78)80036-8, 10.1016/S0163-6383(78)80036-8]; GENTRY V, 1995, J GEN PSYCHOL, V122, P37, DOI 10.1080/00221309.1995.9921220; KONISHI Y, 1986, DEV MED CHILD NEUROL, V28, P450; KONISHI Y, 1987, DEV MED CHILD NEUROL, V29, P751; Michel GF, 2002, DEV PSYCHOBIOL, V40, P1; Nicholls MER, 1999, P ROY SOC B-BIOL SCI, V266, P1517, DOI 10.1098/rspb.1999.0809; Reiss M, 1997, PERCEPT MOTOR SKILL, V85, P569, DOI 10.2466/PMS.85.6.569-574; Rogers LJ, 2002, COMP VERTEBRATE LATE; Skiba M, 2002, BEHAV BRAIN RES, V134, P149, DOI 10.1016/S0166-4328(01)00463-6; VERVERS IAP, 1994, EARLY HUM DEV, V39, P83, DOI 10.1016/0378-3782(94)90157-0	12	89	89	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					711	711		10.1038/421711a	http://dx.doi.org/10.1038/421711a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	644UP	12610611	Bronze			2022-12-28	WOS:000180938000029
J	Wisdom, J				Wisdom, J			Swimming in spacetime: Motion by cyclic changes in body shape	SCIENCE			English	Article								Cyclic changes in the shape of a quasi-rigid body on a curved manifold can lead to net translation and/or rotation of the body. The amount of translation depends on the intrinsic curvature of the manifold. Presuming spacetime is a curved manifold as portrayed by general relativity, translation in space can be accomplished simply by cyclic changes in the shape of a body, without any external forces.	MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wisdom, J (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							GUICHARDET A, 1984, ANN I H POINCARE-PHY, V40, P329; Misner C. W., 1970, GRAVITATION; Montgomery R., 1991, GEOMETRY HAMILTONIAN; SHAPERE A, 1989, J FLUID MECH, V198, P557, DOI 10.1017/S002211208900025X; SHAPERE A, 1989, GEOMETRIC PHASES PHY, P449; Sussman G. J., 2001, STRUCTURE INTERPRETA	6	24	26	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1865	1869		10.1126/science.1081406	http://dx.doi.org/10.1126/science.1081406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12610230				2022-12-28	WOS:000181669700037
J	Kushiro, T; Nambara, E; McCourt, P				Kushiro, T; Nambara, E; McCourt, P			The key to signalling	NATURE			English	Article									RIKEN, Plant Sci Ctr, Lab Reprod Growth Regulat, Wako, Saitama 35101, Japan; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada	RIKEN; University of Toronto	Kushiro, T (corresponding author), RIKEN, Plant Sci Ctr, Lab Reprod Growth Regulat, 2-1 Hirosawa, Wako, Saitama 35101, Japan.		Nambara, Eiji/E-5533-2012	Kushiro, Tetsuo/0000-0002-7598-4791				Bogan AA, 1998, NAT STRUCT BIOL, V5, P679, DOI 10.1038/1372; McCourt P, 2001, MOL CELL, V8, P1157, DOI 10.1016/S1097-2765(01)00420-8; Mussig C, 2001, TRENDS ENDOCRIN MET, V12, P398, DOI 10.1016/S1043-2760(01)00477-5; Ourisson G, 1994, CHEM BIOL, V1, P11, DOI 10.1016/1074-5521(94)90036-1; Szostak JW, 2002, NATURE, V419, P890, DOI 10.1038/419890a	5	35	35	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					122	122		10.1038/422122a	http://dx.doi.org/10.1038/422122a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634761	Bronze			2022-12-28	WOS:000181488900022
J	Loconto, J; Papes, F; Chang, E; Stowers, L; Jones, EP; Takada, T; Kumanovics, A; Lindahl, KF; Dulac, C				Loconto, J; Papes, F; Chang, E; Stowers, L; Jones, EP; Takada, T; Kumanovics, A; Lindahl, KF; Dulac, C			Functional expression of murine V213 pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules	CELL			English	Article							MULTIGENE FAMILY; AXONAL PROJECTIONS; VOMERONASAL SYSTEM; ODORANT RECEPTORS; CRYSTAL-STRUCTURE; SENSORY NEURONS; H2-M REGION; FC RECEPTOR; MAMMALS; GENES	The vomeronasal organ (VNO) of the mouse has two neuronal compartments expressing distinct families of pheromone receptors, the V1Rs and the V2Rs. We report here that two families of major histocompatibility complex (MHC) class Ib molecules, the M10 and the M1 families, show restricted expression in V2R-expressing neurons. Our data suggest that neurons expressing a given V2R specifically co-express one or a few members of the M10 family. Biochemical and immunocytochemical analysis demonstrates that in VNO sensory dendrites M10s belong to large multi-molecular complexes that include pheromone receptors and beta2-microglobulin (beta2m). In cultured cells, M10s appear to function as escort molecules in transport of V2Rs to the cell surface. Accordingly, beta2m-deficient mice exhibit mislocalization of V2Rs in the VNO and a specific defect in male-male aggressive behavior. The functional characterization of M10 highlights an unexpected role for MHC molecules in pheromone detection by mammalian VNO neurons.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Texas, Ctr Immunol, SW Med Ctr, Dallas, TX 75390 USA; Univ Texas, Howard Hughes Med Inst, SW Med Ctr, Dallas, TX 75390 USA	Harvard University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Papes, Fabio/E-3774-2013; Stowers, Lisa/K-6137-2015; Takada, Toyoyuki/U-3206-2018	Papes, Fabio/0000-0001-5034-4088; Stowers, Lisa/0000-0002-4403-1269; Dulac, Catherine/0000-0001-5024-5418	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037818] Funding Source: NIH RePORTER; NIAID NIH HHS [AI37818] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arepalli SR, 1998, IMMUNOGENETICS, V47, P264, DOI 10.1007/s002510050356; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Halpern M, 1998, MICROSC RES TECHNIQ, V41, P519, DOI 10.1002/(SICI)1097-0029(19980615)41:6<519::AID-JEMT7>3.3.CO;2-C; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hotta C, 2000, IMMUNOGENETICS, V51, P624, DOI 10.1007/s002510000195; Houimel M, 2001, INT J CANCER, V92, P748, DOI 10.1002/1097-0215(20010601)92:5<748::AID-IJC1258>3.0.CO;2-1; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jones EP, 1999, IMMUNOGENETICS, V49, P183, DOI 10.1007/s002510050479; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Maenaka K, 1999, CURR OPIN STRUC BIOL, V9, P745, DOI 10.1016/S0959-440X(99)00039-1; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Praetor A, 2002, J CELL SCI, V115, P2389; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TAKADA T, 2003, IN PRESS GENOME RES; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilson IA, 1998, CURR OPIN IMMUNOL, V10, P67, DOI 10.1016/S0952-7915(98)80034-4; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859	42	217	225	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					607	618		10.1016/S0092-8674(03)00153-3	http://dx.doi.org/10.1016/S0092-8674(03)00153-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628182	Bronze			2022-12-28	WOS:000181443600005
J	Cox, H; Hargreaves, S				Cox, H; Hargreaves, S			To treat or not to treat? Implementation of DOTS in Central Asia	LANCET			English	Editorial Material							TUBERCULOSIS		Med Sans Frontieres, Tashkent 700000, Uzbekistan		Cox, H (corresponding author), Med Sans Frontieres, POB 333, Tashkent 700000, Uzbekistan.	hom@msfh-tashkent.uz		Cox, Helen/0000-0002-6538-7192; Hargreaves, Sally/0000-0003-2974-4348				Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; ILKHAMOV FA, 2001, EUROPEAN OBSERVATORY, P179; RAVIGLIONE MC, 2002, 33 IUATLD WORLD C LU; Small I, 2001, ENVIRON HEALTH PERSP, V109, P547, DOI 10.2307/3455025; Trebucq A, 1999, INT J TUBERC LUNG D, V3, P466; *WHO, 1996, WHO REP TUB EP 1996; World Health Organization, 1998, TUB HDB; World Health Organization, 2002, WHOCDSTB2002295	9	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					714	715		10.1016/S0140-6736(03)12667-0	http://dx.doi.org/10.1016/S0140-6736(03)12667-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620733				2022-12-28	WOS:000181232000004
J	Simon, AF; Shih, C; Mack, A; Benzer, S				Simon, AF; Shih, C; Mack, A; Benzer, S			Steroid control of longevity in Drosophila melanogaster	SCIENCE			English	Article							ECDYSONE; RECEPTOR; METAMORPHOSIS; MECHANISMS; L(3)3DTS; DEATH; FLIES	Ecdysone, the major steroid hormone of Drosophila melanogaster, is known for its role in development and reproduction. Flies that are heterozygous for mutations of the ecdysone receptor exhibit increases in life-span and resistance to various stresses, with no apparent deficit in fertility or activity. A mutant involved in the biosynthesis of ecdysone displays similar effects, which are suppressed by feeding ecdysone to the flies. These observations demonstrate the importance of the ecdysone hormonal pathway, a new player in regulating longevity.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Benzer, S (corresponding author), CALTECH, Div Biol 156 29, 1201 Calif Blvd, Pasadena, CA 91125 USA.	benzer@caltech.edu	Simon, Anne/J-9199-2015	Simon, Anne/0000-0002-6509-4541	NIA NIH HHS [AG16630] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG016630] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Carney GE, 2000, GENETICS, V154, P1203; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; HOLDEN JJA, 1986, DEV GENET, V6, P153; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; LUO Y, 1991, MOL CELL BIOL, V11, P3660, DOI 10.1128/MCB.11.7.3660; MAROY P, COMMUNICATION; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Perry HM, 1999, CLIN CHEM, V45, P1369; Radyuk SN, 2000, ARCH INSECT BIOCHEM, V45, P79, DOI 10.1002/1520-6327(200010)45:2&lt;79::AID-ARCH4&gt;3.0.CO;2-Y; Riddiford LM, 2001, VITAM HORM, V60, P1; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; WALKER VK, 1987, J INSECT PHYSIOL, V33, P137, DOI 10.1016/0022-1910(87)90139-9	21	189	201	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1407	1410		10.1126/science.1080539	http://dx.doi.org/10.1126/science.1080539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610309				2022-12-28	WOS:000181192300056
J	Tatar, M; Bartke, A; Antebi, A				Tatar, M; Bartke, A; Antebi, A			The endocrine regulation of aging by insulin-like signals	SCIENCE			English	Review							LIFE-SPAN; GROWTH-HORMONE; CALORIC RESTRICTION; EXTENDED LONGEVITY; THYROID-HORMONES; OXIDATIVE DAMAGE; RECEPTOR; ELEGANS; MUTANT; TRANSCRIPTION	Reduced signaling of insulin-like peptides increases the life-span of nematodes, flies, and rodents. In the nematode and the fly, secondary hormones downstream of insulin-like signaling appear to regulate aging. In mammals, the order in which the hormones act is unresolved because insulin, insulin-like growth factor-1, growth hormone, and thyroid hormones are interdependent. In all species examined to date, endocrine manipulations can slow aging without concurrent costs in reproduction, but with inevitable increases in stress resistance. Despite the similarities among mammals and invertebrates in insulin-like peptides and their signal cascade, more research is needed to determine whether these signals control aging in the same way in all the species by the same mechanism.	Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; So Illinois Univ, Dept Med, Springfield, IL 62794 USA; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Brown University; Southern Illinois University System; Southern Illinois University; Max Planck Society	Tatar, M (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Box G-W, Providence, RI 02912 USA.	marc_tatar@brown.edu	Gimenez, Luis E Diaz/D-9291-2011; Bartke, Andzej/D-6640-2017	Bartke, Andzej/0000-0002-2569-557X; Tatar, Marc/0000-0003-3232-6884				Antebi A, 2000, GENE DEV, V14, P1512; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Carter CS, 2002, J GERONTOL A-BIOL, V57, pB177, DOI 10.1093/gerona/57.5.B177; Chan SJ, 2000, AM ZOOL, V40, P213; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; DAVENPORT RJ, 2002, SCI SAGE KE     1211; DAVENPORT RJ, 2003, SCI SAGE KE     0226; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Force A, 1999, GENETICS, V151, P1531; Furlong RF, 2002, PHILOS T R SOC B, V357, P531, DOI 10.1098/rstb.2001.1035; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gems D, 2002, AGING CELL, V1, P1, DOI 10.1046/j.1474-9728.2002.00003.x; Gems D, 1998, GENETICS, V150, P129; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Hauck SJ, 2001, EXP BIOL MED, V226, P552; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Jia KL, 2002, DEVELOPMENT, V129, P221; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Kelley KM, 2002, J ENDOCRINOL, V175, P3, DOI 10.1677/joe.0.1750003; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kozlova T, 2000, TRENDS ENDOCRIN MET, V11, P276, DOI 10.1016/S1043-2760(00)00282-4; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Torres M, 2000, MOL CELL ENDOCRINOL, V168, P127, DOI 10.1016/S0303-7207(00)00302-6; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mobbs CV, 2001, J GERONTOL A-BIOL, V56, P34, DOI 10.1093/gerona/56.suppl_1.34; MULLER F, 2001, SCI SAGE KE     1003, pTG11; Navarro I, 1999, COMP BIOCHEM PHYS B, V122, P137, DOI 10.1016/S0305-0491(98)10163-3; OOKA H, 1983, MECH AGEING DEV, V22, P113, DOI 10.1016/0047-6374(83)90104-5; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Ramsey MM, 2002, ENDOCRINOLOGY, V143, P4139, DOI 10.1210/en.2002-220717; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; ROGINA B, 2002, SCIENCE, V29, P298; Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Soller M, 1999, DEV BIOL, V208, P337, DOI 10.1006/dbio.1999.9210; Sonntag WE, 2000, J ANAT, V197, P575, DOI 10.1017/S002187829900713X; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; TOBE SS, 2000, ANN NY ACAD SCI, V897, P300; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Xu Y, 2002, EUR J BIOCHEM, V269, P6026, DOI 10.1046/j.1432-1033.2002.03293.x; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; C ELEGANS DAF12 SCI; C ELEGANS DAF16 SCI; D MELANOGASTER CHICO; D MELANOGASTER INR S	75	945	1002	4	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1346	1351		10.1126/science.1081447	http://dx.doi.org/10.1126/science.1081447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610294				2022-12-28	WOS:000181192300039
J	Sieber, OM; Lipton, L; Crabtree, M; Heinimann, K; Fidalgo, P; Phillips, RKS; Bisgaard, M; Orntoft, TF; Aaltonen, LA; Hodgson, SV; Thomas, HJW; Tomlinson, IPM				Sieber, OM; Lipton, L; Crabtree, M; Heinimann, K; Fidalgo, P; Phillips, RKS; Bisgaard, M; Orntoft, TF; Aaltonen, LA; Hodgson, SV; Thomas, HJW; Tomlinson, IPM			Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OXIDATIVE DNA-DAMAGE; MUTY HOMOLOG HMYH; ESCHERICHIA-COLI; LUNG-CANCER; 8-HYDROXYGUANINE 7,8-DIHYDRO-8-OXOGUANINE; INTRACELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; REPAIR ENZYME; HOGG1	BACKGROUND Germ-line mutations in the base-excision-repair gene MYH have been associated with recessive inheritance of multiple colorectal adenomas. Tumors from affected persons displayed excess somatic transversions of a guanine-cytosine pair to a thymine-adenine pair (G:C(rightarrow)T:A) in the APC gene. METHODS We screened for germ-line MYH mutations in 152 patients with multiple (3 to 100) colorectal adenomas and 107 APC-mutation-negative probands with classic familial adenomatous polyposis (>100 adenomas). Subgroups were analyzed for changes in the related genes MTH1 and OGG1. Adenomas were tested for somatic APC mutations. RESULTS Six patients with multiple adenomas and eight patients with polyposis had biallelic germline MYH variants. Missense and protein-truncating mutations were found, and the spectrums of mutations were very similar in the two groups of patients. In the tumors of carriers of biallelic mutations, all somatic APC mutations were G:C(rightarrow)T:A transversions. In the group with multiple adenomas, about one third of patients with more than 15 adenomas had biallelic MYH mutations. In the polyposis group, no patient with biallelic MYH mutations had severe disease (>1000 adenomas), but three had extracolonic disease. No clearly pathogenic MTH1 or OGG1 mutations were identified. CONCLUSIONS Germ-line MYH mutations predispose persons to a recessive phenotype, multiple adenomas, or polyposis coli. For patients with about 15 or more colorectal adenomas -- especially if no germ-line APC mutation has been identified and the family history is compatible with recessive inheritance - genetic testing of MYH is indicated for diagnosis and calculation of the level of risk in relatives. Clinical care of patients with biallelic MYH mutations should be similar to that of patients with classic or attenuated familial adenomatous polyposis.	Canc Res UK, Mol & Populat Genet Lab, London Res Inst, London WC2A 3PX, England; St Marks Hosp, Canc Res UK Colorectal Unit, Harrow, Middx, England; St Marks Hosp, Polyposis Registry, Harrow, Middx, England; Guys Hosp, Dept Clin Genet, London, England; Univ Clin, Div Med Genet, Res Grp Human Genet, Basel, Switzerland; Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal; Hvidovre Univ Hosp, Dept Gastroenterol, Danish Polyposis Register, DK-2650 Hvidovre, Denmark; Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, Helsinki, Finland	Cancer Research UK; Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Portuguese Institute of Oncology; University of Copenhagen; Aarhus University; University of Helsinki	Tomlinson, IPM (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Sieber, Oliver/ABA-9211-2021; Aaltonen, Lauri/A-5375-2010; Sieber, Oliver/M-9473-2015	Sieber, Oliver/0000-0001-9480-0786; Aaltonen, Lauri/0000-0001-6839-4286; Sieber, Oliver/0000-0001-9480-0786; Fidalgo, Paulo/0000-0001-7199-3810				Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Halliwell B, 1996, PATHOL BIOL, V44, P6; Hanaoka T, 2001, CANCER LETT, V170, P53, DOI 10.1016/S0304-3835(01)00565-1; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Lamlum H, 2000, HUM MOL GENET, V9, P2215, DOI 10.1093/oxfordjournals.hmg.a018912; LOTHE RA, 1995, GENE CHROMOSOME CANC, V14, P182, DOI 10.1002/gcc.2870140305; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; LYNCH HT, 1995, SEMIN SURG ONCOL, V11, P406, DOI 10.1002/ssu.2980110607; MALINS DC, 1991, CANCER RES, V51, P5430; McLennan AG, 1999, INT J MOL MED, V4, P79; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; *NAT CANC I, 2003, SURV EP END RES; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Oda H, 1997, J BIOL CHEM, V272, P17843, DOI 10.1074/jbc.272.28.17843; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; OKAMOTO K, 1994, INT J CANCER, V58, P825, DOI 10.1002/ijc.2910580613; OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2; PRAML C, 1995, ONCOGENE, V11, P1357; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Shinmura K, 1997, MUTAT RES-DNA REPAIR, V385, P75, DOI 10.1016/S0921-8777(97)00041-4; Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996; Slupska MM, 1999, J BACTERIOL, V181, P6210, DOI 10.1128/JB.181.19.6210-6213.1999; Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638; TANAKA K, 1993, ONCOGENE, V8, P2253; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Wikman H, 2000, INT J CANCER, V88, P932, DOI 10.1002/1097-0215(20001215)88:6<932::AID-IJC15>3.0.CO;2-P	36	613	647	0	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					791	799		10.1056/NEJMoa025283	http://dx.doi.org/10.1056/NEJMoa025283			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606733	Bronze			2022-12-28	WOS:000181173300005
J	Horak, E; Lanigan, A; Roberts, M; Welsh, L; Wilson, J; Carlin, JB; Olinsky, A; Robertson, CF				Horak, E; Lanigan, A; Roberts, M; Welsh, L; Wilson, J; Carlin, JB; Olinsky, A; Robertson, CF			Longitudinal study of childhood wheezy bronchitis and asthma: outcome at age 42	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; CAFFEINE INTAKE; FETAL GROWTH; ADULT LIFE; PREGNANCY; RISK; BIRTH; REPRODUCTION; CONSUMPTION; POPULATION	Longitudinal studies have reported that asthma in childhood has a good prognosis. However, most of these studies have not taken into account the severity of childhood symptoms.' The Melbourne Epidemiological Study of Childhood Asthma recruited children at age 7 years and followed them up through adolescence to adulthood.(2-5) This report describes outcome at age 42 years in relation to symptoms in childhood.	Royal Childrens Hosp, Dept Resp Med, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic 3052, Australia; Alfred Hosp, Dept Resp Med, Melbourne, Vic, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Florey Institute of Neuroscience & Mental Health	Robertson, CF (corresponding author), Royal Childrens Hosp, Dept Resp Med, Flemington Rd, Parkville, Vic 3052, Australia.		Carlin, John B/B-3492-2012; Carlin, John/AAG-4332-2020	Carlin, John B/0000-0002-2694-9463; Carlin, John/0000-0002-2694-9463				Ahmed IH, 1999, LUNG BIOL HEALTH DIS, V126, P41; Andersen K V, 1991, Ugeskr Laeger, V153, P1494; BUNKER ML, 1979, J AM DIET ASSOC, V74, P28; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; DOMINGUEZROJAS V, 1994, EUR J EPIDEMIOL, V10, P665, DOI 10.1007/BF01719278; Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; GILBERT SG, 1988, J PHARMACOL EXP THER, V245, P1048; GOLDING J, 1995, EARLY HUM DEV, V43, P1, DOI 10.1016/0378-3782(95)01660-U; Juel K, 1999, DAN MED BULL, V46, P354; KELLY WJW, 1987, BRIT MED J, V294, P1059, DOI 10.1136/bmj.294.6579.1059; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; KNUDSEN LB, 1986, COMMUNITY MED, V8, P29; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; MCNICOL KN, 1973, BRIT MED J, V4, P7, DOI 10.1136/bmj.4.5883.7; Muhajarine N, 1997, CAN J PUBLIC HEALTH, V88, P375, DOI 10.1007/BF03403909; OSWALD H, 1994, BRIT MED J, V309, P95, DOI 10.1136/bmj.309.6947.95; RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0; WATKINSON B, 1985, NEUROBEH TOXICOL TER, V7, P9; WEATHERSBEE PS, 1977, J REPROD MED, V19, P55; WILLIAMS H, 1969, BRIT MED J, V4, P321, DOI 10.1136/bmj.4.5679.321; Wisborg K, 2001, AM J EPIDEMIOL, V154, P322, DOI 10.1093/aje/154.4.322	23	83	83	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					422	+		10.1136/bmj.326.7386.422	http://dx.doi.org/10.1136/bmj.326.7386.422			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595380	Bronze, Green Published			2022-12-28	WOS:000181318000017
J	Leslie, P; Carding, PN; Wilson, JA				Leslie, P; Carding, PN; Wilson, JA			Investigation and management of chronic dysphagia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE STROKE; ESOPHAGEAL MOTILITY; ASPIRATION; DISORDERS; MANOMETRY; SWALLOW	Timely intervention by a multidisciplinary team can prevent or ameliorate the complications of chronic dysphagia, reducing the burden of this common and diverse condition.	Newcastle Univ, Sch Surg & Reprod Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Leslie, P (corresponding author), Newcastle Univ, Sch Surg & Reprod Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	paula.leslie@ncl.ac.uk	Leslie, Paula/G-9623-2013	Leslie, Paula/0000-0002-0379-9044; wilson, janet/0000-0002-6416-5870; Carding, Paul/0000-0002-4206-1827				Bastian Robert W., 1993, Dysphagia, V8, P359, DOI 10.1007/BF01321780; Broniatowski M, 1999, OTOLARYNG HEAD NECK, V120, P464, DOI 10.1053/hn.1999.v120.a93228; Calcagno P, 2002, ACTA NEUROL SCAND, V105, P40, DOI 10.1034/j.1600-0404.2002.10062.x; Daniels SK, 1998, ARCH PHYS MED REHAB, V79, P14, DOI 10.1016/S0003-9993(98)90200-3; DEARY IJ, 1995, J PSYCHOSOM RES, V39, P203, DOI 10.1016/0022-3999(94)00104-D; Dent J, 1996, GASTROENTEROL CLIN N, V25, P51, DOI 10.1016/S0889-8553(05)70365-4; *DEP HLTH, 2002, HOSP IN PAT DAT; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; *DYSPH RES SOC, 2001, SAL SEN SWALL 1 FAC; Ekberg O, 1999, ABDOM IMAGING, V24, P444, DOI 10.1007/s002619900535; Ergun GA, 1996, AM J GASTROENTEROL, V91, P1077; Finestone HM, 1996, ARCH PHYS MED REHAB, V77, P340, DOI 10.1016/S0003-9993(96)90081-7; Gore RM, 1997, RADIOL CLIN N AM, V35, P243; HENNESSY TPJ, 1992, SURG OESOPHAGUS; Hughes TAT, 1996, QJM-MON J ASSOC PHYS, V89, P109; Kahrilas PJ, 2000, CAN J GASTROENTEROL, V14, P221, DOI 10.1155/2000/389709; Lee A., 1999, Annals Academy of Medicine Singapore, V28, P371; Lin LC, 2002, J AM GERIATR SOC, V50, P1118, DOI 10.1046/j.1532-5415.2002.50270.x; Logemann J, 1993, MANUAL VIDEOFLUOROGR; LOUIS LP, 1995, DIGEST DIS, V13, P145, DOI 10.1159/000171497; Lundy DS, 1999, OTOLARYNG HEAD NECK, V120, P474, DOI 10.1053/hn.1999.v120.a91765; Mari F, 1997, J NEUROL NEUROSUR PS, V63, P456, DOI 10.1136/jnnp.63.4.456; McManus M, 2001, J Psychosoc Nurs Ment Health Serv, V39, P24; Mujica VR, 1999, POSTGRAD MED, V105, P131; Murray J., 1999, CENGAGE LEARNING; ODDERSON IR, 1995, ARCH PHYS MED REHAB, V76, P1130, DOI 10.1016/S0003-9993(95)80121-9; Paterson WG, 1996, CAN FAM PHYSICIAN, V42, P925; PENNINGTON CR, 1996, CURRENT PERSPECTIVES; Perie S, 1998, LARYNGOSCOPE, V108, P1712, DOI 10.1097/00005537-199811000-00022; Perry L, 2001, DYSPHAGIA, V16, P7, DOI 10.1007/PL00021290; QUINE MA, 1995, BRIT J SURG, V82, P530, DOI 10.1002/bjs.1800820430; RICHTER J, 2002, LANCET, V359, P169; Schmidt John, 1994, Dysphagia, V9, P7; Schurr MJ, 1999, J TRAUMA, V46, P817, DOI 10.1097/00005373-199905000-00009; Selley WG, 1998, DYSPHAGIA, V13, P228; Smith CH, 1999, DYSPHAGIA, V14, P1, DOI 10.1007/PL00009579; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Smout A. J. P. M., 2001, Scandinavian Journal of Gastroenterology, V36, P22, DOI 10.1080/003655201753265415; VELDEE M S, 1992, Dysphagia, V7, P86, DOI 10.1007/BF02493439; WILCOX CM, 1995, DIGEST DIS SCI, V40, P2192	40	38	42	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					433	436		10.1136/bmj.326.7386.433	http://dx.doi.org/10.1136/bmj.326.7386.433			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595385	Green Published			2022-12-28	WOS:000181318000024
J	Luo, MM; Fee, MS; Katz, LC				Luo, MM; Fee, MS; Katz, LC			Encoding pheromonal signats in the accessory olfactory bulb of behaving mice	SCIENCE			English	Article							VOMERONASAL NEURONS; URINARY PROTEINS; RECEPTOR NEURONS; SEXUAL-BEHAVIOR; MALE HAMSTER; ORGANIZATION; PROJECTIONS; ORGAN; RAT; ACTIVATION	Many mammalian species rely on pheromones-semiochemicals produced by other members of the same species-to communicate social status and reproductive readiness. To assess how the central nervous system integrates the complex repertoire of pheromones, we recorded from single neurons in the accessory olfactory bulb, a nucleus that processes pheromonal signals, of mate mice engaged in natural behaviors. Neuronal firing was robustly modulated by physical contact with mate and female conspecifics, with individual neurons activated selectively by specific combinations of the sex and strain of conspecifics. We infer that mammals encode social and reproductive information by integrating vomeronasal sensory activity specific to sex and genetic makeup.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA	Duke University; Howard Hughes Medical Institute; Duke University; Alcatel-Lucent; Lucent Technologies; AT&T	Luo, MM (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	luo@neuro.duke.edu		Fee, Michale/0000-0001-7539-1745; Luo, Minmin/0000-0003-3535-6624				Albone ES, 1984, MAMMALIAN SEMIOCHEMI; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; BOOTH WD, 1972, J ENDOCRINOL, V55, P119, DOI 10.1677/joe.0.0550119; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; IMAMURA K, 1985, BRAIN RES, V328, P362, DOI 10.1016/0006-8993(85)91050-9; Inamura I, 1999, J PHYSIOL-LONDON, V517, P731, DOI 10.1111/j.1469-7793.1999.0731s.x; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Jia CP, 1999, J NEUROPHYSIOL, V81, P345, DOI 10.1152/jn.1999.81.1.345; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; Lazar J, 2002, BIOCHEMISTRY-US, V41, P11786, DOI 10.1021/bi0256734; LEHMAN MN, 1980, SCIENCE, V210, P557, DOI 10.1126/science.7423209; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MEREDITH M, 1994, PHYSIOL BEHAV, V56, P345, DOI 10.1016/0031-9384(94)90205-4; MEREDITH M, 1979, J PHYSIOL-LONDON, V286, P301, DOI 10.1113/jphysiol.1979.sp012620; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; MORI K, 1987, PROG NEUROBIOL, V29, P275, DOI 10.1016/0301-0082(87)90024-4; MURPHY MR, 1970, SCIENCE, V167, P302, DOI 10.1126/science.167.3916.302; POWERS JB, 1975, SCIENCE, V187, P961, DOI 10.1126/science.1145182; POWERS JB, 1973, PHYSIOL BEHAV, V10, P361; Rasmussen LEL, 1998, ANIM REPROD SCI, V53, P19, DOI 10.1016/S0378-4320(98)00124-9; REINHARDT W, 1983, NEUROSCIENCE, V10, P131, DOI 10.1016/0306-4522(83)90087-8; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; THIESSEN D, 1976, PSYCHOL BULL, V83, P505, DOI 10.1037/0033-2909.83.4.505; WYSOCKI CJ, 1980, SCIENCE, V207, P781, DOI 10.1126/science.7352288; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	48	287	293	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2003	299	5610					1196	1201		10.1126/science.1082133	http://dx.doi.org/10.1126/science.1082133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595684				2022-12-28	WOS:000181065500030
J	Pasha, O; Del Rosso, J; Mukaka, M; Marsh, D				Pasha, O; Del Rosso, J; Mukaka, M; Marsh, D			The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi	LANCET			English	Article							MALARIA	Malaria is a major cause of death in school-age (5-18 years) children in Malawi. Save the Children Federation helped schools in Mangochi District, Malawi, to obtain pupil-treatment kits, which enabled teachers to dispense sulfadoxine-pyrimethamine tablets according to national guidelines. The overall and malaria-specific mortality rates were calculated for the 3 years before and 2 years after the intervention was introduced; rates dropped from 2.2 to 1.44 deaths/1000 student-years and from 1.28 to 0.44 deaths/1000 student-years, respectively. School-based interventions could play a part in mitigating malaria.	Save Children Federat, Int Program, Off Hlth, Westport, CT 06881 USA; Save Children Malawi, Malawi Field Off, Mangochi, Malawi	Save the Children; Save the Children	Del Rosso, J (corresponding author), Save Children Federat, Int Program, Off Hlth, Westport, CT 06881 USA.			Pasha, Omrana/0000-0003-4046-3918				Brooker S, 2000, PARASITOL TODAY, V16, P183, DOI 10.1016/S0169-4758(00)01663-X; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; Magnussen P, 2001, TROP MED INT HEALTH, V6, P273, DOI 10.1046/j.1365-3156.2001.00720.x; MURRAY CJL, 1996, GLOBAL HLTH STAT, P137; OGUTU RO, 1992, E AFR MED J, V69, P298	5	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					577	578		10.1016/S0140-6736(03)12511-1	http://dx.doi.org/10.1016/S0140-6736(03)12511-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598146				2022-12-28	WOS:000181033400014
J	Ridker, PM; Goldhaber, SZ; Danielson, E; Rosenberg, Y; Eby, CS; Deitcher, SR; Cushman, M; Moll, S; Kessler, CM; Elliott, CG; Paulson, R; Wong, T; Bauer, KA; Schwartz, BA; Miletich, JP; Bounameaux, H; Glynn, RJ; Ridker, PM; Glynn, RJ; Danielson, EM; Bates, D; Christen, W; DeFonce, P; Griffin, W; Jackson, F; Murray, A; Taylor, K; Johnson, K; McKenna, K; Pierre, J; Holman, B; Dessources, F; Quinn, P; Laurinaitis, T; MacFadyen, J; Eby, C; Miletich, JP; Porche-Sorbet, R; Goldhaber, SZ; Morrison, RB; MacDougall, RC; Morrison, RM; Lamas, G; Bailey, K; Gersh, B; Pellegrino, E; Rick, M; Vaughan, D; Rosenberg, Y; Goldhaber, SZ; Morrison, RB; MacDougall, RC; Morrison, RM; Deitcher, SR; Olin, J; Sulzer, S; Cushman, M; Cohen, R; Moll, S; Jones, S; Kessler, CM; Lee, A; Elliott, CG; Kitterman, N; Jafri, S; Wulbrecht, N; Bauer, K; Mahony, M; Paulson, R; Vold, D; Wong, T; Erickson-Nesmith, S; Bounameaux, H; de Lucia, S; Chagnon, I; Schwartz, B; Thackery, R; Gates, N; Nguyen, P; Paris, S; LeCours, B; Oliver, M; Hodapp, K; Grad, G; Bank, B; Rindels, J; Leano, C; Haire, W; O'Grady, D; Schneider, J; Key, N; Christie, B; Blostein, M; Strulovitch, C; Usedom, J; Oskins, D; Eby, C; Lee, V; Heuerman, S; Kerins, D; Roberts, B; White, R; Castro, E; Riddle, E; Ingram, M; Becker, RC; Emery, C; Wong, L; Dent, S; Comp, P; Havarda, D; Galichia, JP; Terry, L; Waldren, S; Hambleton, J; Pineo, G; Hull, R; Sheldon, J; Tsapatsaris, N; Woodhead, G; Mann, M; Welsh, C; Schoch, T; Goldsmith, J; Anthony, T; Walters, J; Caprini, J; Maher, ML; Medica, K; Rabbitt, S; Finocchio, J; Keaton, K; Lee, H; McLean, S; Barban, K; Mohler, E; Medenilla, E; Wolfe, M; deLemos, A; Rubenfire, M; McDevitt, S; Housholder, S; Siegel, JE; Bradley, B; Brophy, M; Reilly, C; Brown, E; Valeria, A; Rodriguez, L; Kumar, A; Pekron, J; Wagner, J; Richart, J; Jones, J; Weber, V; Fellin, C; Sim, J; Graham, M; Sutton, D; Tezcan, H; Herbst, S; Waldrum, M; Meadows, T; Carlson, W; Welch-Costantino, M; Gosset, J; Nonnweiler, J; Kumar, A; Green, K; Tapson, V; Krichman, A; Yeo, E; Boross-Harmer, S				Ridker, PM; Goldhaber, SZ; Danielson, E; Rosenberg, Y; Eby, CS; Deitcher, SR; Cushman, M; Moll, S; Kessler, CM; Elliott, CG; Paulson, R; Wong, T; Bauer, KA; Schwartz, BA; Miletich, JP; Bounameaux, H; Glynn, RJ; Ridker, PM; Glynn, RJ; Danielson, EM; Bates, D; Christen, W; DeFonce, P; Griffin, W; Jackson, F; Murray, A; Taylor, K; Johnson, K; McKenna, K; Pierre, J; Holman, B; Dessources, F; Quinn, P; Laurinaitis, T; MacFadyen, J; Eby, C; Miletich, JP; Porche-Sorbet, R; Goldhaber, SZ; Morrison, RB; MacDougall, RC; Morrison, RM; Lamas, G; Bailey, K; Gersh, B; Pellegrino, E; Rick, M; Vaughan, D; Rosenberg, Y; Goldhaber, SZ; Morrison, RB; MacDougall, RC; Morrison, RM; Deitcher, SR; Olin, J; Sulzer, S; Cushman, M; Cohen, R; Moll, S; Jones, S; Kessler, CM; Lee, A; Elliott, CG; Kitterman, N; Jafri, S; Wulbrecht, N; Bauer, K; Mahony, M; Paulson, R; Vold, D; Wong, T; Erickson-Nesmith, S; Bounameaux, H; de Lucia, S; Chagnon, I; Schwartz, B; Thackery, R; Gates, N; Nguyen, P; Paris, S; LeCours, B; Oliver, M; Hodapp, K; Grad, G; Bank, B; Rindels, J; Leano, C; Haire, W; O'Grady, D; Schneider, J; Key, N; Christie, B; Blostein, M; Strulovitch, C; Usedom, J; Oskins, D; Eby, C; Lee, V; Heuerman, S; Kerins, D; Roberts, B; White, R; Castro, E; Riddle, E; Ingram, M; Becker, RC; Emery, C; Wong, L; Dent, S; Comp, P; Havarda, D; Galichia, JP; Terry, L; Waldren, S; Hambleton, J; Pineo, G; Hull, R; Sheldon, J; Tsapatsaris, N; Woodhead, G; Mann, M; Welsh, C; Schoch, T; Goldsmith, J; Anthony, T; Walters, J; Caprini, J; Maher, ML; Medica, K; Rabbitt, S; Finocchio, J; Keaton, K; Lee, H; McLean, S; Barban, K; Mohler, E; Medenilla, E; Wolfe, M; deLemos, A; Rubenfire, M; McDevitt, S; Housholder, S; Siegel, JE; Bradley, B; Brophy, M; Reilly, C; Brown, E; Valeria, A; Rodriguez, L; Kumar, A; Pekron, J; Wagner, J; Richart, J; Jones, J; Weber, V; Fellin, C; Sim, J; Graham, M; Sutton, D; Tezcan, H; Herbst, S; Waldrum, M; Meadows, T; Carlson, W; Welch-Costantino, M; Gosset, J; Nonnweiler, J; Kumar, A; Green, K; Tapson, V; Krichman, A; Yeo, E; Boross-Harmer, S		PREVENT Investigators	Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR-V-LEIDEN; ORAL ANTICOAGULANT-THERAPY; COAGULATION-FACTOR-V; ACTIVATED PROTEIN-C; PROTHROMBIN GENE; DOSE WARFARIN; FIRST EPISODE; RISK FACTOR; THROMBOSIS; MUTATION	BACKGROUND: Standard therapy to prevent recurrent venous thromboembolism includes 3 to 12 months of treatment with full-dose warfarin with a target international normalized ratio (INR) between 2.0 and 3.0. However, for long-term management, no therapeutic agent has shown an acceptable benefit-to-risk ratio. METHODS: Patients with idiopathic venous thromboembolism who had received full-dose anticoagulation therapy for a median of 6.5 months were randomly assigned to placebo or low-intensity warfarin (target INR, 1.5 to 2.0). Participants were followed for recurrent venous thromboembolism, major hemorrhage, and death. RESULTS: The trial was terminated early after 508 patients had undergone randomization and had been followed for up to 4.3 years (mean, 2.1). Of 253 patients assigned to placebo, 37 had recurrent venous thromboembolism (7.2 per 100 person-years), as compared with 14 of 255 patients assigned to low-intensity warfarin (2.6 per 100 person-years), a risk reduction of 64 percent (hazard ratio, 0.36 [95 percent confidence interval, 0.19 to 0.67]; P<0.001). Risk reductions were similar for all subgroups, including those with and those without inherited thrombophilia. Major hemorrhage occurred in two patients assigned to placebo and five assigned to low-intensity warfarin (P=0.25). Eight patients in the placebo group and four in the group assigned to low-intensity warfarin died (P=0.26). Low-intensity warfarin was thus associated with a 48 percent reduction in the composite end point of recurrent venous thromboembolism, major hemorrhage, or death. According to per-protocol and as-treated analyses, the reduction in the risk of recurrent venous thromboembolism was between 76 and 81 percent. CONCLUSIONS: Long-term, low-intensity warfarin therapy is a highly effective method of preventing recurrent venous thromboembolism.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; NIH, Bethesda, MD 20892 USA; Washington Univ, St Louis, MO USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Vermont, Burlington, VT USA; Univ N Carolina, Chapel Hill, NC USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; LDS Hosp, Salt Lake City, UT USA; Altru Res Clin, Grand Forks, ND USA; St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Modwest Pulm Consultants, Kansas City, MO USA; Univ Hosp Geneva, Geneva, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; Washington University (WUSTL); Cleveland Clinic Foundation; University of Vermont; University of North Carolina; University of North Carolina Chapel Hill; Georgetown University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Harvard University; Beth Israel Deaconess Medical Center; University of Geneva	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org	Kerins, David/AAE-5692-2020; Jafri, Wasim/AAE-5085-2020; caprini, joseph/AAH-4750-2019					Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; BERN MM, 1990, ANN INTERN MED, V112, P423, DOI 10.7326/0003-4819-76-3-112-6-423; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624; Eriksson H, 2002, BLOOD, V100, p81A; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; Hillarp A, 1997, THROMB HAEMOSTASIS, V78, P990; HIRSH J, 1995, NEW ENGL J MED, V332, P1710, DOI 10.1056/NEJM199506223322510; Kearon C, 1999, NEW ENGL J MED, V341, P298; Kearon C, 2002, BLOOD, V100, p150A; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LEVINE M, 1994, LANCET, V343, P886, DOI 10.1016/S0140-6736(94)90008-6; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; McMahan DA, 1998, J GEN INTERN MED, V13, P311, DOI 10.1046/j.1525-1497.1998.00096.x; Miles JS, 2001, J AM COLL CARDIOL, V37, P215, DOI 10.1016/S0735-1097(00)01080-9; MILLENSON MM, 1992, BLOOD, V79, P2034; POLLER L, 1990, BRIT HEART J, V63, P231; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Price DT, 1997, ANN INTERN MED, V127, P895, DOI 10.7326/0003-4819-127-10-199711150-00007; Ridker P M, 1998, Vasc Med, V3, P67; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; RIDKER PM, 1995, CIRCULATION, V92, P2800, DOI 10.1161/01.CIR.92.10.2800; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801	30	622	644	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 10	2003	348	15					1425	1434		10.1056/NEJMoa035029	http://dx.doi.org/10.1056/NEJMoa035029			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665CU	12601075	Bronze			2022-12-28	WOS:000182102700002
J	Aligne, CA; Moss, ME; Auinger, P; Weitzman, M				Aligne, CA; Moss, ME; Auinger, P; Weitzman, M			Association of pediatric dental caries with passive smoking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; ENVIRONMENTAL TOBACCO-SMOKE; 3RD NATIONAL-HEALTH; CHILDRENS ORAL HEALTH; BLOOD LEAD LEVELS; UNITED-STATES; PRESCHOOL-CHILDREN; PARENTAL SMOKING; COTININE LEVELS; US POPULATION	Context Dental decay is the most common chronic disease of children and it disproportionately affects those living in poverty, but the reasons for this are not clear. Passive smoking may be a modifiable, risk factor for dental caries. Objective To examine the relationship between dental caries and serum cotinine levels. Design, Setting, and Participants Cross-sectional data from the Third National Health and Nutrition Examination Survey (1988-1994) of 3531 children aged 4 to 11 years, who had had both dental examinations and a serum cotinine level measurement. Main Outcome Measures Passive smoking defined as serum cotinine levels of 0.2 to 10 ng/mL and caries defined as decayed (unfilled) or filled tooth surfaces. Results Twenty-five percent of the children had at least 1 unfilled decayed tooth surface and 33% had at least 1 filled surface. Fifty-three percent had cotinine levels consistent with passive smoking. Elevated cotinine level was significantly associated with both decayed (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.5-2.9) and filled (OR, 1.4; 95% CI, 1.1-1.8) tooth surfaces in deciduous but not in permanent teeth. This relationship persisted after adjusting forage, sex, race, family income, geographic region, frequency of dental visits, and blood lead level. For dental caries in deciduous teeth, the adjusted OR was 1.8 (95% CI, 1.2-2.7) for the risk of decayed surfaces and 1.4 (95% CI, 1.1-2.0) for filled surfaces. We estimated the population attributable risk-from passive smoking to be 27% for decayed and 14% for filled tooth surfaces. Conclusions There is an association between environmental tobacco smoke and risk of caries among children. Reduction of passive smoking is important not only for the prevention of many medical problems, but also for the promotion of children's dental health.	Pediathink, Rochester, NY USA; Eastman Sch Dent, Rochester, NY USA; Amer Acad Pediat, Ctr Child Hlth Res, Elk Grove Village, IL 60007 USA; Univ Rochester, Sch Med, Dept Community & Prevent Med, Rochester, NY USA; Univ Rochester, Sch Med, Dept Pediat, Rochester, NY 14642 USA	University of Rochester; American Academy of Pediatrics; University of Rochester; University of Rochester	Aligne, CA (corresponding author), 620 Pk Ave,Box 135, Rochester, NY 14607 USA.		Moss, Mark E/Q-3014-2019; Moss, Mark E/AAF-1697-2020	Moss, Mark E/0000-0003-0105-0416				ADAIR SM, 1999, PEDIAT DENT; Aligne CA, 1997, ARCH PEDIAT ADOL MED, V151, P648, DOI 10.1001/archpedi.1997.02170440010002; Arbes SJ, 2001, AM J PUBLIC HEALTH, V91, P253, DOI 10.2105/AJPH.91.2.253; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; Brown LJ, 2000, J AM DENT ASSOC, V131, P223, DOI 10.14219/jada.archive.2000.0151; Brunelle J A, 1990, J Dent Res, V69 Spec No, P723; BRUNELLE JA, 1982, J DENT RES, V61, P1346; *CDC, 1992, MMWR-MORBID MORTAL W, V41, P372; CDC (Centers for Disease Control and Prevention), 2001, NAT REP HUM EXP ENV; CHARLTON A, 1994, J FAM PRACTICE, V38, P267; DiFranza JR, 1996, PEDIATRICS, V97, P560; DOLL R, 1992, BMJ-BRIT MED J, V305, P1521, DOI 10.1136/bmj.305.6868.1521; Drury TF, 1996, J DENT RES, V75, P620, DOI 10.1177/002203459607502S02; EDELSTEIN BL, 1995, PUBLIC HEALTH REP, V110, P522; Edelstein BL, 2002, AMBUL PEDIATR, V2, P141, DOI 10.1367/1539-4409(2002)002<0141:DIOHAA>2.0.CO;2; Edwards K, 1999, HUM EXP TOXICOL, V18, P233, DOI 10.1191/096032799678839978; Ettinger R L, 1999, Dent Clin North Am, V43, P679; Hopper JA, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e47; Kaste LM, 1996, J DENT RES, V75, P631, DOI 10.1177/002203459607502S03; KIDD EAM, 1997, ESSENTIALS DENT CARI; LINDEMEYER RG, 1981, J AM DENT ASSOC, V103, P719, DOI 10.14219/jada.archive.1981.0372; MANDEL ID, 1987, J DENT RES, V66, P623, DOI 10.1177/00220345870660S203; Mannino DM, 2002, CHEST, V122, P409, DOI 10.1378/chest.122.2.409; Mannino DM, 2001, CHEST, V120, P718, DOI 10.1378/chest.120.3.718; Moss ME, 1999, JAMA-J AM MED ASSOC, V281, P2294, DOI 10.1001/jama.281.24.2294; Mouradian WE, 2000, JAMA-J AM MED ASSOC, V284, P2625, DOI 10.1001/jama.284.20.2625; Nelson E, 1999, HUM EXP TOXICOL, V18, P252, DOI 10.1191/096032799678840002; *NIH, 1999, SMOK TOB CONTR MON N, V10; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; RONCHETTI R, 1994, EUR RESPIR J, V7, P472, DOI 10.1183/09031936.94.07030472; Schafer TE, 2000, PEDIATR CLIN N AM, V47, P1021, DOI 10.1016/S0031-3955(05)70256-X; SCHYDLOWER M, 1994, PEDIATRICS, V93, P866; Seow WK, 1998, COMMUNITY DENT ORAL, V26, P8, DOI 10.1111/j.1600-0528.1998.tb02090.x; Shah BV, 1997, SOFTWARE STAT ANAL C; Stamm J. W., 1991, RISK MARKERS ORAL DI, V1, P132; Strauss RS, 2001, PEDIATRICS, V107, P540, DOI 10.1542/peds.107.3.540; Tinanoff N, 2000, J PUBLIC HEALTH DENT, V60, P197, DOI 10.1111/j.1752-7325.2000.tb03328.x; Tinanoff Norman, 1997, Pediatric Dentistry, V19, P12; VAANANEN MK, 1994, SCAND J DENT RES, V102, P103; Vargas CM, 1998, J AM DENT ASSOC, V129, P1229, DOI 10.14219/jada.archive.1998.0420; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Weaver VM, 1996, CANCER EPIDEM BIOMAR, V5, P135; Weitzman M, 2001, AMBUL PEDIATR, V1, P162, DOI 10.1367/1539-4409(2001)001<0162:ACSOHN>2.0.CO;2; Williams SA, 2000, CARIES RES, V34, P117, DOI 10.1159/000016578; Winn DM, 1996, J DENT RES, V75, P642, DOI 10.1177/002203459607502S04; WOOD RA, 2001, PRIMARY PEDIAT CARE, P1318; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; CENSUS 2000 SUPPLEME; ORAL HLTH AM REPORT; 1997, MMWR MORB MORTAL WKL, V46, P1038	50	155	160	2	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1258	1264		10.1001/jama.289.10.1258	http://dx.doi.org/10.1001/jama.289.10.1258			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633187	Bronze			2022-12-28	WOS:000181466500027
J	Chilcott, J; McCabe, C; Tappenden, P; O'Hagan, A; Cooper, NJ; Abrams, K; Claxton, K				Chilcott, J; McCabe, C; Tappenden, P; O'Hagan, A; Cooper, NJ; Abrams, K; Claxton, K		Cost Effectiveness Multiple Sclero	Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. Design Modelling cost effectiveness. Setting UK NHS. Participants Patients with relapsing remitting multiple sclerosis and secondary progressive multiple sclerosis. Main outcome measures Cost per quality adjusted life year gained. Results The base case cost per quality adjusted life year gained by using any of the four treatments ranged from pound42 000 ($66 469; (sic) 61 630) to pound98 000 based on efficacy information in the public domain. Uncertainty analysis suggests that the probability of any of these therapies having a cost effectiveness better than pound20 000 is below 20%. The key determinants of cost effectiveness were the time horizon, the progression of patients after stopping treatment, differential discount rates, and the price of the treatments. Conclusions Cost effectiveness varied markedly between the interventions. Uncertainty around point estimates was substantial. This uncertainty could be reduced by conducting research on the true magnitude of the effect of these drugs, the progression of patients after stopping treatment, the costs of care, and the quality of life of the patients. Price was the key modifiable determinant of the cost effectiveness of these treatments.	Univ Sheffield, Sch Hlth & Related Res Rapid Rev Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Dept Probabil & Stat, Ctr Bayesian Stat Hlth Econ, Sheffield S3 7RH, S Yorkshire, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Univ York, Dept Econ & Related Studies, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England	University of Sheffield; University of Sheffield; University of Leicester; University of York - UK	McCabe, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res Rapid Rev Grp, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.		Tappenden, Paul/B-4557-2009; McCabe, Christopher/E-2051-2016; O'Hagan, Anthony/B-2992-2016; Abrams, Keith/AAA-2557-2020; Chilcott, Jim/B-4474-2009	O'Hagan, Anthony/0000-0002-7994-0702; Abrams, Keith/0000-0002-7557-1567	Multiple Sclerosis Society [491] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		*ASS BRIT NEUR, 2001, GUID TREATM INT BET; *ASS BRIT NEUR, 2001, GUID US BET INT GLAT; *BRIT MED ASS, 2001, BRIT NAT FORM, P422; Brown MG, 2000, INT J TECHNOL ASSESS, V16, P751, DOI 10.1017/S026646230010203X; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EBERS G, 2001, LONDON ONTARIO COHOR; Forbes RB, 1999, BMJ-BRIT MED J, V319, P1529, DOI 10.1136/bmj.319.7224.1529; Kendrick M, 2000, PHARMACOECONOMICS, V18, P45, DOI 10.2165/00019053-200018010-00005; Kobelt G, 2000, SCANDINAVIAN WORKING; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; *MULT SCL RES TRUS, 2001, QUAL LIF PEOPL MULT; *NAT I CLIN EXC, 2002, BET INT GLAT AC TREA; *NAT I CLIN EXC, TECHN APPR COMM M 13; National Grid, 2002, FULL GUID US BET INT, P1; Noseworthy J, 2003, LANCET, V361, P350, DOI 10.1016/S0140-6736(03)12354-9; PARKIN D, 1998, HLTH TECHNOL ASSESS, V4, pR1; PATZOLD U, 1982, ACTA NEUROL SCAND, V65, P248, DOI 10.1111/j.1600-0404.1982.tb03084.x; PROSSER L, 2000, COST EFFECTIVENESS T; RICE GPA, 2001, COCHRANE LIB; RICHARDS RG, 2002, HLTH TECHNOL ASSESS, V6, pR1; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133	21	108	108	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					522	525		10.1136/bmj.326.7388.522	http://dx.doi.org/10.1136/bmj.326.7388.522			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623909	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000181548400014
J	Alward, WLM				Alward, WLM			A new angle on ocular development	SCIENCE			English	Editorial Material							GLAUCOMA		Univ Iowa, Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA	University of Iowa	Alward, WLM (corresponding author), Univ Iowa, Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.		Alward, Wallace/AAY-4149-2020	Alward, Wallace/0000-0001-6368-9018				Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Bruesch SR, 1942, J COMP NEUROL, V77, P631, DOI 10.1002/cne.900770310; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; Panicker SG, 2002, INVEST OPHTH VIS SCI, V43, P1358; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; WEIN FB, 2001, CURR OPIN OPHTHALMOL, V13, P61	6	16	18	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1527	1528		10.1126/science.1082933	http://dx.doi.org/10.1126/science.1082933			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624251				2022-12-28	WOS:000181367900021
J	Lim, LP; Glasner, ME; Yekta, S; Burge, CB; Bartel, DP				Lim, LP; Glasner, ME; Yekta, S; Burge, CB; Bartel, DP			Vertebrate MicroRNA genes	SCIENCE			English	Article							IDENTIFICATION; RNAS		MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Lim, LP (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Burge, Christopher B./AAH-2177-2020	Glasner, Margaret/0000-0003-1818-1965				Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LIM LP, IN PRESS GENES DEV; Moss EG, 2002, CURR BIOL, V12, pR688, DOI 10.1016/S0960-9822(02)01206-X	6	941	1238	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1540	1540		10.1126/science.1080372	http://dx.doi.org/10.1126/science.1080372			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624257				2022-12-28	WOS:000181367900027
J	Seitz, AR; Watanabe, T				Seitz, AR; Watanabe, T			Is subliminal learning really passive?	NATURE			English	Article							TASK; ATTENTION		Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Boston Univ, Dept Psychol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Boston University	Seitz, AR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.							AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Herzog MH, 1999, VISION RES, V39, P4232, DOI 10.1016/S0042-6989(99)00138-8; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KARNI A, 1995, SFI STUDIES SCI COMP, P1; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P591, DOI 10.1080/14640748508400921; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	10	220	225	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					36	36		10.1038/422036a	http://dx.doi.org/10.1038/422036a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621425	Bronze			2022-12-28	WOS:000181343100028
J	Juengst, ET; Binstock, RH; Mehlman, MJ; Post, SG				Juengst, ET; Binstock, RH; Mehlman, MJ; Post, SG			Aging - Antiaging research and the need for public dialogue	SCIENCE			English	Editorial Material							POLICY		Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA	Case Western Reserve University	Juengst, ET (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.			Juengst, Eric/0000-0002-8374-5774	NATIONAL INSTITUTE ON AGING [R01AG020916] Funding Source: NIH RePORTER; NIA NIH HHS [1R01-AGHG20916-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], QUEST IMMORTALITY SC; [Anonymous], 2000, MORAL CHALLENGE ALZH; BINSTOCK RH, IN PRESS GERONTOLOGI; BONNICKSEN AL, 2002, CRAFTING CLONING POL; Butler R, 2001, GENERATIONS, V25, P63; Butler RN, 2002, J GERONTOL A-BIOL, V57, pB333, DOI 10.1093/gerona/57.9.B333; Cohen Gene., 2000, CREATIVE AGE AWAKENI; De Grey ADNJ, 2002, ANN NY ACAD SCI, V959, P452, DOI 10.1111/j.1749-6632.2002.tb02115.x; de Grey ADNJ, 2002, BIOESSAYS, V24, P667, DOI 10.1002/bies.10113; de Grey ADNJ, 2000, BIOGERONTOLOGY, V1, P369, DOI 10.1023/A:1026547023576; Fisher A, 2002, J GERONTOL A-BIOL, V57, pM636, DOI 10.1093/gerona/57.10.M636; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Garland MJ, 1999, PUBLIC UNDERST SCI, V8, P241, DOI 10.1088/0963-6625/8/3/308; GRUMAN G, 1966, T AM PHILOS SOC, V56; Hackler C, 2001, GENERATIONS, V25, P15; Hayflick L, 2001, GENERATIONS, V25, P20; Juengst ET, 2002, J ANTI-AGING MED, V5, P73, DOI 10.1089/109454502317629318; Kass L R, 2001, First Things, P17; Kirkland JL, 2002, CLIN GERIATR MED, V18, P383, DOI 10.1016/S0749-0690(02)00023-X; Lane MA, 2002, SCI AM, V287, P36, DOI 10.1038/scientificamerican0802-36; MASORO EJ, 2001, J GERONTOL A, V56; Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006; Moody H. R., 1995, WORLD GROWING OLD CO, P9; Moody HR, 2001, GENERATIONS, V25, P33; *NAT I AG, 2001, ACT PLAN AG RES STRA; Olshansky SJ, 2002, SCI AM, V286, P92, DOI 10.1038/scientificamerican0602-92; Olshansky SJ, 2002, J GERONTOL A-BIOL, V57, pB292, DOI 10.1093/gerona/57.8.B292; SELTZER M, 1995, IMPACT INCREASED LIF; WALTERS L, 1991, HUM GENE THER, V2, P115, DOI 10.1089/hum.1991.2.2-115; WATSON J, 1992, GENE MAPPING USING L, pR15	30	38	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1323	1323		10.1126/science.1083135	http://dx.doi.org/10.1126/science.1083135			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610284				2022-12-28	WOS:000181192300029
J	Krause, TG; Hviid, A; Koch, A; Friborg, J; Hjuler, T; Wohlfahrt, J; Olsen, OR; Kristensen, B; Melbye, M				Krause, TG; Hviid, A; Koch, A; Friborg, J; Hjuler, T; Wohlfahrt, J; Olsen, OR; Kristensen, B; Melbye, M			BCG vaccination and risk of atopy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN; SENSITIZATION; CHILDHOOD	Context It has been suggested that BCG vaccination may protect against development of allergic diseases, particularly when given just after birth. BCG vaccination was given routinely to all infants in Greenland until 1990, when it was withdrawn from the vaccination program.,Whether this resulted in an increased prevalence of atopy in children born after the stop of BCG vaccination is unknown. Objective To determine whether BCG vaccination and age at BCG vaccination are associated with development of atopy. Design, Setting, and Participants Cross-sectional study among schoolchildren aged 8 to 16 years in 4 towns on the northwest coast of Greenland. Participants had a blood sample drawn and information on BCG vaccination was obtained during 2 periods, November 1998 and November 2001. A total of 1686 children (79% of available children) participated, 1575 of whom had complete information on vaccination status. Atopy was defined as a positive test result in an assay that tests for IgE specific against the most common inhalant allergens in serum. Main Outcome Measures Odds ratio (OR) of atopy in BCG-vaccinated compared with unvaccinated children and OR according to age at vaccination. Results The risk of atopy was the same in BCG-vaccinated compared with unvaccinated children after adjustment for confounders (OR, 1.03; 95% confidence interval, 0.72-1.48). The risk of atopy in BCG-vaccinated children was not associated with age at vaccination (P=.17). Conclusions BCG vaccination administered to infants is not associated with reduced risk of development of atopy.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; Sisimiut Hosp, Sisimiut, Greenland; Pharmacia, Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Pfizer	Krause, TG (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	tgv@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127; Koch, Anders/0000-0001-9205-1048; melbye, mads/0000-0001-8264-6785; Friborg, Jeppe/0000-0001-5423-0627; Hjuler, Thomas/0000-0002-3860-0306				Aaby P, 2000, CLIN EXP ALLERGY, V30, P644, DOI 10.1046/j.1365-2222.2000.00803.x; Alm JS, 1997, LANCET, V350, P400, DOI 10.1016/S0140-6736(97)02207-1; Alm JS, 2002, GENES IMMUN, V3, P71, DOI 10.1038/sj.gene.6363834; *AT, 1991, STAT HLTH GREENL REP; Gruber C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e36; Gruber C, 2002, PEDIAT ALLERG IMM-UK, V13, P177, DOI 10.1034/j.1399-3038.2002.01006.x; Gruber C, 2001, PEDIAT ALLERG IMM-UK, V12, P296, DOI 10.1034/j.1399-3038.2001.1r046.x; Krause TG, 2002, CLIN EXP ALLERGY, V32, P367, DOI 10.1046/j.1365-2222.2002.01316.x; Marchant A, 1999, J IMMUNOL, V163, P2249; MARTINEZ FD, 1994, THORAX, V49, P1189, DOI 10.1136/thx.49.12.1189; Pershagen G, 2000, PEDIATR ALLERGY IMMU, V11, P26, DOI 10.1034/j.1399-3038.2000.00507.x; ROMANUS V, 1992, TUBERCLE LUNG DIS, V73, P150, DOI 10.1016/0962-8479(92)90149-E; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Strannegard IL, 1998, ALLERGY, V53, P249, DOI 10.1111/j.1398-9995.1998.tb03884.x	14	44	45	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1012	1015		10.1001/jama.289.8.1012	http://dx.doi.org/10.1001/jama.289.8.1012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597754	Bronze			2022-12-28	WOS:000181129800028
J	Tucker, P; Folkard, S; Macdonald, I				Tucker, P; Folkard, S; Macdonald, I			Rest breaks and accident risk	LANCET			English	Article								Regular rest breaks are recommended to prevent accumulation of accident risk during sustained activities. We examined the effect of rest breaks on temporal trends in industrial accident risk, by assessment of accident records from a large engineering company, obtained over 3 years. In 2 h of continuous work, relative risk of an accident in the last half-hour of a shift was 2.08 (95% CI 1.73-2.43) higher than in the first half-hour. Trends in risk did not seem to differ between three 2-h work periods. Regular rest breaks seem to be an effective way to control accumulation of risk during industrial shift-work.	Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales; Univ Loughborough, Loughborough, Leics, England	Swansea University; Loughborough University	Tucker, P (corresponding author), Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales.			Tucker, Philip/0000-0002-8105-0901				BHATIA N, 1969, HUM FACTORS, V11, P167, DOI 10.1177/001872086901100210; Dababneh AJ, 2001, ERGONOMICS, V44, P164, DOI 10.1080/001401301750048196; Horne J, 1999, OCCUP ENVIRON MED, V56, P289, DOI 10.1136/oem.56.5.289; KOPARDEKAR P, 1994, ERGONOMICS, V37, P1697, DOI 10.1080/00140139408964946	4	111	112	0	19	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					680	680		10.1016/S0140-6736(03)12566-4	http://dx.doi.org/10.1016/S0140-6736(03)12566-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	648BG	12606184				2022-12-28	WOS:000181129500022
J	Bray, D				Bray, D			Molecular prodigality	SCIENCE			English	Editorial Material									Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Bray, D (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Nakada K, 2002, DIFFERENTIATION, V70, P92, DOI 10.1046/j.1432-0436.2002.700204.x; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Wolfram S., 2002, NEW KIND SCI	11	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1189	1190		10.1126/science.1080010	http://dx.doi.org/10.1126/science.1080010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595679				2022-12-28	WOS:000181065500025
J	Cleveland, DW; Mao, YH; Sullivan, KF				Cleveland, DW; Mao, YH; Sullivan, KF			Centromeres and kinetochores: From epigenetics to mitotic checkpoint signaling	CELL			English	Review							METAPHASE CHROMOSOME ALIGNMENT; SPINDLE ASSEMBLY CHECKPOINT; SISTER-CHROMATID SEPARATION; FISSION YEAST CENTROMERES; VERTEBRATE SOMATIC-CELLS; KINESIN-RELATED PROTEIN; POLYPOSIS-COLI PROTEIN; NEWT LUNG-CELLS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST	The centromere is a chromosomal locus that ensures delivery of one copy of each chromosome to each daughter at cell division. Efforts to understand the nature and specification of the centromere have demonstrated that this central element for ensuring inheritance is itself epigenetically determined. The kinetochore, the protein complex assembled at each centromere, serves as the attachment site for spindle microtubules and the site at which motors generate forces to power chromosome movement. Unattached kinetochores are also the signal generators for the mitotic checkpoint, which arrests mitosis until all kinetochores have correctly attached to spindle microtubules, thereby representing the major cell cycle control mechanism protecting against loss of a chromosome (aneuploidy).	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Mao, Yinghui/0000-0002-4078-129X; Sullivan, Kevin/0000-0002-5374-8245; Cleveland, Don/0000-0002-1934-3682				Abrieu A, 2000, CELL, V102, P817, DOI 10.1016/S0092-8674(00)00070-2; Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; AULT JG, 1989, CHROMOSOMA, V98, P33, DOI 10.1007/BF00293332; BABU JR, 2003, IN PRESS J CELL BIOL, V160; Barry AE, 1999, HUM MOL GENET, V8, P217, DOI 10.1093/hmg/8.2.217; Bast RC, 2000, INT J GYNECOL CANCER, V10, P2, DOI 10.1046/j.1525-1438.2000.99502.x; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; BROWN KE, 1994, HUM MOL GENET, V3, P1227, DOI 10.1093/hmg/3.8.1227; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2002, J CELL BIOL, V157, P199, DOI 10.1083/jcb.200201052; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Clarke L, 1998, CURR OPIN GENET DEV, V8, P212, DOI 10.1016/S0959-437X(98)80143-3; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; DAWSON IA, 1993, DEVELOPMENT, V117, P359; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Espelin CW, 1997, J CELL BIOL, V139, P1383, DOI 10.1083/jcb.139.6.1383; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gardner RD, 2001, GENETICS, V157, P1493; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; GORBSKY GJ, 1987, J CELL BIOL, V104, P9, DOI 10.1083/jcb.104.1.9; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HAYS TS, 1982, J CELL BIOL, V93, P374, DOI 10.1083/jcb.93.2.374; He DC, 1998, CHROMOSOMA, V107, P189, DOI 10.1007/s004120050296; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hemmerich P, 2000, P NATL ACAD SCI USA, V97, P12583, DOI 10.1073/pnas.97.23.12583; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Keith KC, 2000, GENETICS, V156, P973; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Lee S, 1999, MOL BIOL CELL, V10, P771, DOI 10.1091/mbc.10.3.771; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Lo AWI, 2001, GENOME RES, V11, P448, DOI 10.1101/gr.GR-1676R; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maddox P, 2002, CURR BIOL, V12, P1670, DOI 10.1016/S0960-9822(02)01183-1; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; MCINTOSH JR, 1991, COLD SH Q B, V56, P613; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; MITCHISON TJ, 1992, J CELL BIOL, V119, P569, DOI 10.1083/jcb.119.3.569; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Ngan VK, 1997, MOL CELL BIOL, V17, P3305, DOI 10.1128/MCB.17.6.3305; NICKLAS RB, 1988, ANNU REV BIOPHYS BIO, V17, P431, DOI 10.1146/annurev.bb.17.060188.002243; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; OSTERGREN G, 1951, HEREDITAS, V37, P85; Partridge JF, 2000, GENE DEV, V14, P783; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rieder CL, 1997, P NATL ACAD SCI USA, V94, P5107, DOI 10.1073/pnas.94.10.5107; ROBERTS BT, 1994, MOL CELL BIOL, V14, P8282, DOI 10.1128/MCB.14.12.8282; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Savoian MS, 2000, NAT CELL BIOL, V2, P948, DOI 10.1038/35046605; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SU LK, 1995, CANCER RES, V55, P2972; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Sullivan B, 2001, J CELL BIOL, V154, P683, DOI 10.1083/jcb.200103001; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor TE, 1998, TROP MED INT HEALTH, V3, P3, DOI 10.1046/j.1365-3156.1998.00166.x; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALTERS JC, 1996, MOL BIOL CELL, V7, P1547; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30; Williams BC, 1996, J CELL BIOL, V134, P1127, DOI 10.1083/jcb.134.5.1127; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Wu HY, 2000, ONCOGENE, V19, P4557, DOI 10.1038/sj.onc.1203803; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Yu HG, 1999, J CELL BIOL, V145, P425, DOI 10.1083/jcb.145.3.425; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	153	807	830	1	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 21	2003	112	4					407	421		10.1016/S0092-8674(03)00115-6	http://dx.doi.org/10.1016/S0092-8674(03)00115-6			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600307	Bronze			2022-12-28	WOS:000181252600002
J	Rahmstorf, S				Rahmstorf, S			The current climate	NATURE			English	Editorial Material									Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung	Rahmstorf, S (corresponding author), Potsdam Inst Climate Impact Res, Box 601203, D-14412 Potsdam, Germany.		Rahmstorf, Stefan/A-8465-2010	Rahmstorf, Stefan/0000-0001-6786-7723				Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Seager R, 2002, Q J ROY METEOR SOC, V128, P2563, DOI 10.1256/qj.01.128; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Wunsch C, 2000, NATURE, V405, P743, DOI 10.1038/35015639	4	102	110	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					699	699		10.1038/421699a	http://dx.doi.org/10.1038/421699a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610602	Bronze			2022-12-28	WOS:000180938000022
J	Chiorescu, I; Nakamura, Y; Harmans, CJPM; Mooij, JE				Chiorescu, I; Nakamura, Y; Harmans, CJPM; Mooij, JE			Coherent quantum dynamics of a superconducting flux qubit	SCIENCE			English	Article							JOSEPHSON-JUNCTION; STATES; SUPERPOSITION	We have observed coherent time evolution between two quantum states of a superconducting flux qubit comprising three Josephson junctions in a loop. The superposition of the two states carrying opposite macroscopic persistent currents is manipulated by resonant microwave pulses. Readout by means of switching-event measurement with an attached superconducting quantum interference device revealed quantum-state oscillations with high fidelity. Under strong microwave driving, it was possible to induce hundreds of coherent oscillations. Pulsed operations on this first sample yielded a relaxation time of 900 nanoseconds and a free-induction dephasing time of 20 nanoseconds. These results are promising for future solid-state quantum computing.	Delft Univ Technol, Dept Nanosci, Quantum Transport Grp, NL-2628 CJ Delft, Netherlands; Delft Univ Technol, Delft Inst Microelect & Submicron Technol, NL-2628 CJ Delft, Netherlands; NEC Fundamental Res Labs, Tsukuba, Ibaraki 3058501, Japan	Delft University of Technology; Delft University of Technology; NEC Corporation	Chiorescu, I (corresponding author), Delft Univ Technol, Dept Nanosci, Quantum Transport Grp, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	chiorescu@qt.tn.tudelft.nl	Mooij, Johan/B-1371-2012; Nakamura, Yasunobu/H-1300-2012	Nakamura, Yasunobu/0000-0003-0424-630X				Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; Grifoni M, 1998, PHYS REP, V304, P229, DOI 10.1016/S0370-1573(98)00022-2; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; LEGGETT AJ, 1985, PHYS REV LETT, V54, P857, DOI 10.1103/PhysRevLett.54.857; Makhlin Y, 2001, REV MOD PHYS, V73, P357, DOI 10.1103/RevModPhys.73.357; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Rabi II, 1937, PHYS REV, V51, P0652, DOI 10.1103/PhysRev.51.652; Tian L, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144516; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; van der Wal CH, 2003, EUR PHYS J B, V31, P111, DOI 10.1140/epjb/e2003-00015-9; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Yu Y, 2002, SCIENCE, V296, P889, DOI 10.1126/science.1069452	16	1003	1034	5	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1869	1871		10.1126/science.1081045	http://dx.doi.org/10.1126/science.1081045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12589004	Green Submitted			2022-12-28	WOS:000181669700038
J	Sung, NS; Crowley, WF; Genel, M; Salber, P; Sandy, L; Sherwood, LM; Johnson, SB; Catanese, V; Tilson, H; Getz, K; Larson, EL; Scheinberg, D; Reece, EA; Slavkin, H; Dobs, A; Grebb, J; Martinez, RA; Korn, A; Rimoin, D				Sung, NS; Crowley, WF; Genel, M; Salber, P; Sandy, L; Sherwood, LM; Johnson, SB; Catanese, V; Tilson, H; Getz, K; Larson, EL; Scheinberg, D; Reece, EA; Slavkin, H; Dobs, A; Grebb, J; Martinez, RA; Korn, A; Rimoin, D			Central challenges facing the national clinical research enterprise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACADEMIC MEDICAL-CENTERS; INFORMATION TECHNOLOGY; INFORMED CONSENT; HEALTH-CARE; BIOMEDICAL-RESEARCH; FUTURE CHALLENGES; TRIALS; PRIVACY; PARTICIPATION; INVESTIGATORS	Medical scientists and public health policy makers are increasingly concerned that the scientific discoveries of the past generation are failing to be translated efficiently into tangible human benefit. This concern has generated several initiatives, including the Clinical Research Roundtable at the Institute of Medicine, which first convened in June 2000. Representatives from a diverse group of stakeholders in the nation's clinical research enterprise have collaborated to address the issues it faces. The context of clinical research is increasingly encumbered by high costs, slow results, lack of funding, regulatory burdens, fragmented infrastructure, incompatible databases, and a shortage of qualified investigators and willing participants. These factors have contributed to 2 major obstacles, or translational blocks: impeding the translation of basic science discoveries into clinical studies and of clinical studies into medical practice and health decision making in systems of care. Considering data from across the entire health care system, it has become clear that these 2 translational blocks can be removed only by the collaborative efforts of multiple system stakeholders. The goal of this article is to articulate the 4 central challenges facing clinical research at present-public participation, information systems, workforce training, and funding; to make recommendations about how they might be addressed by particular stakeholders; and to invite a broader, participatory dialogue with a view to improving the overall performance of the US clinical research enterprise.	Burroughs Wellcome Fund, Res Triangle Pk, NC 27709 USA; Harvard Univ, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Clin Res Program, Boston, MA 02114 USA; Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; Ctr Watch, Boston, MA USA; Yale Univ, Sch Med, New Haven, CT USA; Blue Shield Calif, Calif Publ Employees Retirement Syst, San Francisco, CA USA; Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; Univ Penn, MEDSA, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Columbia Univ, Dept Med Informat, New York, NY USA; Columbia Univ, Sch Nursing, New York, NY USA; NYU, Sch Med, New York, NY USA; Amer Federat Med Res Fdn, New York, NY USA; Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY USA; Sloan Kettering Inst, Leukemia Serv, New York, NY USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; Univ Arkansas, Coll Med, Little Rock, AR 72205 USA; Univ So Calif, Sch Dent, Los Angeles, CA 90089 USA; Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Ctr Med Genet Birth Defects, Los Angeles, CA 90048 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Clin Res Unit, Baltimore, MD USA; Johnson & Johnson, Janssen Res Fdn, Global CNS Analgesia Clin Res & Dev, Titusville, NJ USA; Johnson & Johnson, Corp & Community Relat, Med Affairs, New Brunswick, NJ USA; Blue Cross Blue Shield Assoc, Chicago, IL USA	Burroughs Wellcome Fund; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Yale University; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; University of Pennsylvania; Columbia University; Columbia University; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Southern California; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins University; Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Johnson & Johnson USA	Sung, NS (corresponding author), Burroughs Wellcome Fund, POB 13901,21 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	nsung@bwfund.org	Tao, Youyou/D-2367-2014	Johnson, Stephen/0000-0002-6079-8419				Annas GJ, 2002, NEW ENGL J MED, V346, P216, DOI 10.1056/NEJM200201173460320; *ASS AM MED COLL, 1999, HLTH PUBL ENS FUT CL; Beauchamp T, 1996, PRINCIPLES BIOMEDICA; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; *BIOT IND ORG, 2000, COMM PROP STAND PRIV; BRESCIA BA, 2001, GUIDE PATIENT RECRUI; Brittain J M, 2000, Health Libr Rev, V17, P117, DOI 10.1046/j.1365-2532.2000.00279.x; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell EG, 2001, JAMA-J AM MED ASSOC, V286, P800, DOI 10.1001/jama.286.7.800; Cech TR, 2001, SCIENCE, V293, P573, DOI 10.1126/science.293.5530.573; Centers for Disease Control and Prevention Agency for Toxic Substances and Disease Registry Committee on Community Engagement, 1997, PRINC COMM ENG; *CENTRW, 2001, IND EV, P49; Chalmers I, 2002, EVAL HEALTH PROF, V25, P12, DOI 10.1177/0163278702025001003; Christian MC, 2002, NEW ENGL J MED, V346, P1405, DOI 10.1056/NEJM200205023461814; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Cox K, 2002, PATIENT EDUC COUNS, V46, P31, DOI 10.1016/S0738-3991(01)00147-1; EDGAR H, 1995, MILBANK Q, V73, P489, DOI 10.2307/3350283; EGAN L, 2002, NEW ENGL J MED, V436, P2013; Entwistle VA, 1998, BRIT MED J, V316, P463, DOI 10.1136/bmj.316.7129.463; FIELD MJ, 1995, HLTH SERVICES RES WO; Frist WH, 2002, JAMA-J AM MED ASSOC, V287, P1722, DOI 10.1001/jama.287.13.1722; Gelijns AC, 2002, JAMA-J AM MED ASSOC, V287, P72, DOI 10.1001/jama.287.1.72; Gifford AL, 2002, NEW ENGL J MED, V346, P1373, DOI 10.1056/NEJMsa011565; Giuliano AR, 2000, ANN EPIDEMIOL, V10, pS22, DOI 10.1016/S1047-2797(00)00195-2; Goldman E, 2002, SCIENCE, V298, P40, DOI 10.1126/science.298.5591.40; Gorkin L, 1996, CONTROL CLIN TRIALS, V17, P46, DOI 10.1016/0197-2456(95)00089-5; Gostin LO, 2001, HEALTH CARE ANAL, V9, P321, DOI 10.1023/A:1012905932744; *GRANTM HLTH, 2002, ASS HLTH FIND 2001 S; Green LW, 2001, AM J PUBLIC HEALTH, V91, P1926, DOI 10.2105/AJPH.91.12.1926; Griner PF, 1998, ACAD MED, V73, P818, DOI 10.1097/00001888-199807000-00025; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; HELMS D, 2002, NAT AC SCI CLIN RES; HENINIG S, 1999, CHANGING LANDSCAPE C; HENRY D, 1999, EMERGING DIGITAL EC, V2; hhs, 1979, BELM REP ETH PRINC G; *I MED CLIN RES RO, 2001, CLIN RES ROUNDTABLE, V3; *I MED CLIN RES RO, 2001, CLIN RES ROUNDTABLE, V2; Institute of Medicine Clinical Research Roundtable, 2001, CLIN INV WORKF CLIN; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Johnson KB, 2001, ARCH PEDIAT ADOL MED, V155, P1374, DOI 10.1001/archpedi.155.12.1374; Kaiser J, 2001, SCIENCE, V294, P2070, DOI 10.1126/science.294.5549.2070; Kaushal R, 2001, ARCH PEDIAT ADOL MED, V155, P1002, DOI 10.1001/archpedi.155.9.1002; KELLEY WN, 1994, CAREERS CLIN RES OBS, V240, P260; Kian L A, 1995, Healthc Financ Manage, V49, P58; Killien M, 2000, J WOMEN HEALTH GEN-B, V9, P1061, DOI 10.1089/152460900445974; Kroll J., 2001, IND EVOLUTION; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Lemonick M.D., 2002, TIME            0422, P46; Ley TJ, 2002, NEW ENGL J MED, V346, P368, DOI 10.1056/NEJM200201313460515; Lovato LC, 1997, CONTROL CLIN TRIALS, V18, P328, DOI 10.1016/S0197-2456(96)00236-X; MARGHERIO L, 2001, EMERGING DIGITAL EC; Marks RG, 2001, STAT MED, V20, P2683, DOI 10.1002/sim.736; Marwick C, 2002, J NATL CANCER I, V94, P478; McDonald CJ, 2001, ANN EMERG MED, V38, P303, DOI 10.1067/mem.2001.117947; Moskowitz J, 2001, ACAD MED, V76, P307, DOI 10.1097/00001888-200104000-00004; Nathan DG, 2000, NAT MED, V6, P1201, DOI 10.1038/81282; Nathan DG, 2002, NEW ENGL J MED, V346, P372, DOI 10.1056/NEJM200201313460516; Nathan DG, 2002, JAMA-J AM MED ASSOC, V287, P2424, DOI 10.1001/jama.287.18.2424; National Institutes of Health, 1994, FED REGISTER, V59, P1408; Nelson AF, 1998, HEALTH AFFAIR, V17, P128, DOI 10.1377/hlthaff.17.1.128; *NIH, 2002, INF NIH CAR DEV AW; *NIH, 1998, N01OD22109 NIH OFF E; *NIH, NIH LOAN REP PROGR; *NIH RES TRAIN OPP, K30 CLIN RES CURR AW; OCHS N, 2002, FINAL NIH DOUBLING I; Office of Civil Rights Department of Health and Human Services, 2002, FED REGISTER, V67, P53182; Oinonen MJ, 2001, ACAD MED, V76, P700, DOI 10.1097/00001888-200107000-00010; Olson L A, 1998, Healthc Inf Manage, V12, P27; Phillips DF, 2000, JAMA-J AM MED ASSOC, V283, P729, DOI 10.1001/jama.283.6.729; *PHYS CONS PERF IM, 2002, COR PHYS PERF MEAS S; Pober JS, 2001, FASEB J, V15, P2303, DOI 10.1096/fj.01-0540lsf; Randal J, 2001, J NATL CANCER I, V93, P1440, DOI 10.1093/jnci/93.19.1440; RAYMOND B, 2002, CLIN INFORMATION SYS; Sable JH, 2000, J AM MED INFORM ASSN, P744; Saiber PR, 2002, J INVEST MED, V50, P170, DOI 10.2310/6650.2002.33429; Schiff GD, 2000, AM J MED, V109, P494, DOI 10.1016/S0002-9343(00)00546-5; Schiff GD, 1998, JAMA-J AM MED ASSOC, V279, P1024, DOI 10.1001/jama.279.13.1024; Schrier RW, 1997, ACAD MED, V72, P589, DOI 10.1097/00001888-199707000-00010; Shahar Y, 2002, METHOD INFORM MED, V41, P8; SHERWOOD LM, 2002, EVIDENCE BASED MED C, P46; Shine KI, 2002, ACAD MED, V77, P92, DOI 10.1097/00001888-200201000-00021; SHOICHET CE, 2002, CHRONICLE HIGHE 0802; SILVERMAN DC, 2001, J CLIN OUTCOMES MANA, V8, P39; Solovy A, 2001, HOSP HEALTH NETWORK, V75, P40; Tait AR, 2002, PAEDIATR ANAESTH, V12, P332, DOI 10.1046/j.1460-9592.2002.00851.x; *TASK FORC FIN INT, 2001, PROT SUBJ PRES TRUST; *TASK FORC RES ACC, REP IND I FIN CONFL; Tunis SKA., 2002, ROLE PURCHASERS PAYE; *US DEP HHS, 1998, OEI019700194 DHHS OF; *US DEP HHS, 2001, INF HLTH STRAT BUILD; *US DEP HHS, 1998, OEI019700193 DHHS OF; *US PUBL HLTH SERV, MAK POW CONN HLTH PU; *WAK FOR U SCH MED, 1999, CLIN RES NAT CALL AC; Wan TTH, 2002, J MED SYST, V26, P127, DOI 10.1023/A:1014805909707; WENNBERG J, 2002, NAT AC SCI CLIN RES; WILSON D, 2001, SEATTLE TIMES   0311, pA1; WOOD A, CRISIS HUMAN PARTICI; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221; ZISSON S, 2001, CENTERWATCH, V8, P1; [No title captured]; 1996, JAMA, V276, P1691	101	833	856	3	102	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1278	1287		10.1001/jama.289.10.1278	http://dx.doi.org/10.1001/jama.289.10.1278			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633190				2022-12-28	WOS:000181466500030
J	Weber, DJ; Sickbert-Bennett, E; Gergen, MF; Rutala, WA				Weber, DJ; Sickbert-Bennett, E; Gergen, MF; Rutala, WA			Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECOGNITION; MANAGEMENT	Context The intentional use of Bacillus anthracis transmitted via the US mail in October-November 2001 resulted in 22 people developing inhalation or cutaneous anthrax. Glove use with handwashing prior to and after contact with potential contaminated environmental surfaces and cutaneous lesions has been recommended. However, only limited data are available on the susceptibility of B anthracis to antiseptics. Objective To evaluate the efficacy of several hand antiseptics (interventions) and soap and water (control) against Bacillus atrophaeus, a surrogate of B anthracis. Design, Setting, and Participants Challenge study conducted among healthy adult volunteers, using the Standard Test Method for Evaluation of the Effectiveness of Health Care Professional Handwash Formulations (American Society for Testing and Mate-m rials E 1174-94) to determine the efficacy of various hand hygiene products at wash times of 10, 30, and 60 seconds. Volunteers were excluded if they had eczema, psoriasis, or other chronic skin conditions; nonintact skin; or allergies to any study agent. Study agents were a waterless rub containing 61% ethyl alcohol, a 2% chlorhexidine gluconate preparation, and an antibacterial microfiber towel that releases hypochlorite. A nonantimicrobial soap was used as a control. Main Outcome Measure Reduction of B atrophaeus spores (log(10) CFU/mL) on contaminated hands. Results Washes of 10, 30, and 60 seconds with either soap and water or 2% chlorhexidine gluconate eliminated 1.5 to 2.0 log(10) CFUs/mL of B atrophaeus spores at wash 3. Mean reductions (95% confidence intervals) with 10-, 30-, and 60-second washes with soap and water were 2.4 (2.2-2.5), 2.3 (2.2-2.4), and 2.1 (1.9-2.4) log(10) CFUs/mL, respectively; and with 2% chlorhexidine gluconate, 2.1 (2.0-2.3), 1.8 (1.5-2.0), and 1.7 (1.5-1.9) log(10) CFUs/mL, respectively. Handwashing with chlorine-containing towels was increasingly effective as the wipe time increased; reductions at 10, 30, and 60 seconds were 1.3 (1.1-1.5), 1.6 (1.2-2.0), and 2.2 (2.1-2.2) log(10) CFUs/mL, respectively. A waterless rub containing 61% ethyl alcohol was ineffective in eliminating B atrophaeus spores at all times tested (0 [-0.1 to 0.1], -0.2 [-0.3 to -0.1], and 0 [-0.2 to 0.2] log(10) CFUs/mL). Conclusions In this evaluation of hand hygiene agents, handwashing with soap and water, 2% chlorhexidine gluconate, or chlorine-containing towels reduced the amount of B atrophaeus spore contamination, whereas use of a waterless rub containing ethyl alcohol was not effective in removing spores.	Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; Univ N Carolina Hlth Care Syst, Dept Hosp Epidemiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University North Carolina Hospital	Weber, DJ (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, CB 7030,130 Mason Farm Rd, Chapel Hill, NC 27599 USA.	dweber@unch.unc.edu						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; *ASTM, 1994, E117494 ASTM; Babb J R, 1980, J Hosp Infect, V1, P63, DOI 10.1016/0195-6701(80)90033-X; BRAZIS AR, 1958, APPL MICROBIOL, V6, P338, DOI 10.1128/AEM.6.5.338-342.1958; *BUR COMM DIS, 2000, MED TREATM RESP SUSP; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1129; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P482; DYER DL, INFECT CONTROL TODAY, V4, P34; English J.F., 1999, BIOTERRORISM READINE; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Friedlander AM, 2000, CURR CLIN TOPICS INF, V20, P335; Hsu VP, 2002, EMERG INFECT DIS, V8, P1039, DOI 10.3201/eid0810.020332; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Kortepeter M., 2001, USAMRIIDS MED MANAGE; LENSING HH, 1985, ZBL HYG UMWELTMED, V181, P487; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Russell AD, 1999, J HOSP INFECT, V43, pS57, DOI 10.1016/S0195-6701(99)90066-X; RUSSELL AD, 1990, CLIN MICROBIOL REV, V3, P99, DOI 10.1128/CMR.3.2.99-119.1990; RUTALA WA, IN PRESS AM J INFECT; Sanderson WT, 2002, EMERG INFECT DIS, V8, P1145, DOI 10.3201/eid0810.020382; Small D, 2002, JAMA-J AM MED ASSOC, V287, P445; SPAULDING EH, 1939, SURG GYNECOL OBSTET, V69, P738; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Weber DJ, 2002, NEW ENGL J MED, V346, P944; Weber DJ, 2001, CLIN INFECT DIS, V32, P446, DOI 10.1086/318509; WILLIAMS ND, 1991, J APPL BACTERIOL, V70, P427, DOI 10.1111/j.1365-2672.1991.tb02960.x	27	79	80	1	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1274	1277		10.1001/jama.289.10.1274	http://dx.doi.org/10.1001/jama.289.10.1274			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633189				2022-12-28	WOS:000181466500029
J	Ammal, SC; Yamataka, H; Aida, M; Dupuis, M				Ammal, SC; Yamataka, H; Aida, M; Dupuis, M			Dynamics-driven reaction pathway in an intramolecular rearrangement	SCIENCE			English	Article								A critical role is traditionally assigned to transition states (TSs) and minimum energy pathways, or intrinsic reaction coordinates (IRCs), in interpreting organic reactivity. Such an interpretation, however, ignores vibrational and kinetic energy effects of finite temperature. Recently it has been shown that reactions do not necessarily follow the intermediates along the IRC. We report here molecular dynamics (MD) simulations that show that dynamics effects may alter chemical reactions even more. In the heterolysis rearrangement of protonated pinacolyl alcohol Me3C-CHMe-OH2+ (Me, methyl), the MD pathway involves a stepwise route with C-O bond cleavage followed by methyl group migration, whereas the IRC pathway suggests a concerted mechanism. Dynamics effects may lead to new interpretations of organic reactivity.	Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan; Pacific NW Natl Lab, Richland, WA 99352 USA	Osaka University; Hiroshima University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Yamataka, H (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.		Aida, Misako/D-1670-2010	Aida, Misako/0000-0001-8788-1071				ANDO T, 1979, TETRAHEDRON LETT, V20, P121; Bolton K, 1999, J PHYS CHEM B, V103, P3691, DOI 10.1021/jp982988d; CARPENTER BK, 1992, ACCOUNTS CHEM RES, V25, P520, DOI 10.1021/ar00023a006; CARPENTER BK, 1995, J AM CHEM SOC, V117, P6336, DOI 10.1021/ja00128a024; Frisch M. J., 1998, GAUSSIAN 98; Hammett, 1940, PHYS ORGANIC CHEM RE; HASE WL, 1983, ACCOUNTS CHEM RES, V16, P258, DOI 10.1021/ar00091a004; Lewis ES, 1974, INVESTIGATION RATES; March J., 1992, ADV ORG CHEM, V4th; Robinson P. J., 1972, UNIMOLECULAR REACTIO; Sun LP, 2002, SCIENCE, V296, P875, DOI 10.1126/science.1068053; WILGIS FP, 1990, J AM CHEM SOC, V112, P4435, DOI 10.1021/ja00167a048; Yamataka H, 2002, B CHEM SOC JPN, V75, P2555, DOI 10.1246/bcsj.75.2555; Yamataka H, 2002, CHEM PHYS LETT, V353, P310, DOI 10.1016/S0009-2614(02)00041-6	14	129	129	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1555	1557		10.1126/science.1079491	http://dx.doi.org/10.1126/science.1079491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624261				2022-12-28	WOS:000181367900031
J	Zimetbaum, PJ; Josephson, ME				Zimetbaum, PJ; Josephson, ME			Current concepts - Use of the electrocardiogram in acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BUNDLE-BRANCH BLOCK; ST SEGMENT DEPRESSION; CORONARY-ARTERY; ATRIOVENTRICULAR-BLOCK; CLINICAL CHARACTERISTICS; VENTRICULAR-TACHYCARDIA; THROMBOLYTIC THERAPY; HOSPITAL MORTALITY; LEFT CIRCUMFLEX; FIBRILLATION		Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Zimetbaum, PJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, 1 Deaconess Rd, Boston, MA 02215 USA.							Angeja BG, 2002, CIRCULATION, V105, P282, DOI 10.1161/hc0302.103588; ANTMAN EM, 1992, CIRCULATION, V86, P764, DOI 10.1161/01.CIR.86.3.764; BAIREY CN, 1987, AM J CARDIOL, V60, P456, DOI 10.1016/0002-9149(87)90285-2; BERGER PB, 1993, J AM COLL CARDIOL, V22, P1773, DOI 10.1016/0735-1097(93)90756-Q; BERTOLET BD, 1995, ANN INTERN MED, V123, P509, DOI 10.7326/0003-4819-123-7-199510010-00006; Eldar M, 1998, CIRCULATION, V97, P965; Engelen DJ, 1999, J AM COLL CARDIOL, V34, P389, DOI 10.1016/S0735-1097(99)00197-7; FEIGL D, 1984, J AM COLL CARDIOL, V4, P35, DOI 10.1016/S0735-1097(84)80315-0; Go AS, 1998, ANN INTERN MED, V129, P690, DOI 10.7326/0003-4819-129-9-199811010-00003; GORGELS APM, 1988, AM J CARDIOL, V61, P231, DOI 10.1016/0002-9149(88)90921-6; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; GRESSIN V, 1992, AM J CARDIOL, V69, P152, DOI 10.1016/0002-9149(92)91295-F; Harpaz D, 1999, J AM COLL CARDIOL, V34, P1721, DOI 10.1016/S0735-1097(99)00431-3; Hasdai D, 1995, EUR HEART J, V16, P1549, DOI 10.1093/oxfordjournals.eurheartj.a060776; Herz I, 1997, AM J CARDIOL, V80, P1343, DOI 10.1016/S0002-9149(97)00678-4; HINDMAN MC, 1978, CIRCULATION, V58, P689, DOI 10.1161/01.CIR.58.4.689; HINDMAN MC, 1978, CIRCULATION, V58, P679, DOI 10.1161/01.CIR.58.4.679; Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223; LOPEZSENDON J, 1985, J AM COLL CARDIOL, V6, P1273, DOI 10.1016/S0735-1097(85)80213-8; Matetzky S, 1999, J AM COLL CARDIOL, V34, P1932, DOI 10.1016/S0735-1097(99)00466-0; Mont L, 1996, J AM COLL CARDIOL, V28, P1670, DOI 10.1016/S0735-1097(96)00383-X; Newby KH, 1996, CIRCULATION, V94, P2424, DOI 10.1161/01.CIR.94.10.2424; Poli A, 2002, CIRCULATION, V106, P313, DOI 10.1161/01.CIR.0000022691.71708.94; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Schroder K, 2001, LANCET, V358, P1479, DOI 10.1016/S0140-6736(01)06577-1; Sgarbossa EB, 1996, NEW ENGL J MED, V334, P931; Sgarbossa EB, 1996, NEW ENGL J MED, V334, P481, DOI 10.1056/NEJM199602223340801; Sgarbossa EB, 1998, J AM COLL CARDIOL, V31, P105, DOI 10.1016/S0735-1097(97)00446-4; Tamura A, 1995, EUR HEART J, V16, P1795, DOI 10.1093/oxfordjournals.eurheartj.a060830; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; Wehrens XHT, 2000, AM HEART J, V139, P430, DOI 10.1067/mhj.2000.103222; Zimetbaum PJ, 1998, AM J CARDIOL, V81, P918, DOI 10.1016/S0002-9149(98)00013-7	32	206	225	1	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					933	940		10.1056/NEJMra022700	http://dx.doi.org/10.1056/NEJMra022700			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621138				2022-12-28	WOS:000181341100009
J	Clark, CM; Karlawish, JHT				Clark, CM; Karlawish, JHT			Alzheimer disease: Current concepts and emerging diagnostic and therapeutic strategies	ANNALS OF INTERNAL MEDICINE			English	Review							CEREBROSPINAL-FLUID TAU; ESTROGEN-REPLACEMENT THERAPY; MILD COGNITIVE IMPAIRMENT; PLACEBO-CONTROLLED TRIAL; QUALITY STANDARDS SUBCOMMITTEE; RANDOMIZED CONTROLLED-TRIAL; APOLIPOPROTEIN-E GENOTYPE; ACADEMY-OF-NEUROLOGY; CEREBRAL-BLOOD-FLOW; E ALLELE EPSILON-4	Alzheimer disease is a complex neurodegenerative dementing illness. It has become a major public health problem because of its increasing prevalence, long duration, high cost of care, and lack of disease-modifying therapy. Over the past few years, however, remarkable advances have taken place in understanding both the genetic and molecular biology associated with the intracellular processing of amyloid and tau and the changes leading to the pathologic formation of extracellular amyloid plaques and the intraneuronal aggregation of hyperphosphorylated tau into neurofibrillary tangles. The identification of disease-causing autosomal dominant mutations as well as gene polymorphisms that alter the risk for pathology indicate that Alzheimer disease is a genetically complex disorder. This progress in our understanding of the molecular pathology has set the stage for clinically meaningful advances in diagnosis and treatment. Emerging diagnostic methods that are based on biochemical and imaging biomarkers of disease-specific pathology hold the potential for accurately diagnosing Alzheimer disease at the earliest stage of the illness-the time when disease-modifying treatment will be most effective. Currently available cholinesterase inhibition therapy targets the cognitive symptoms. However, the goal of new therapies under development is halting the pathologic cascade and potentially reversing the course of the disease. If these new therapies are successful, they will represent a remarkable medical advance for patients and the families who care for them.	Univ Penn, Memory Disorders Clin, Penn Ralston Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Clark, CM (corresponding author), Univ Penn, Memory Disorders Clin, Penn Ralston Ctr, 3615 Chestnut St, Philadelphia, PA 19104 USA.				NIA NIH HHS [AG09215, AG10124, K01-AG00931, P01-AG10124] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG000931, P01AG009215, P30AG010124] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aisen PS, 2000, NEUROLOGY, V54, P588, DOI 10.1212/WNL.54.3.588; Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Andersson LM, 1999, J NEUROL SCI, V171, P92, DOI 10.1016/S0022-510X(99)00253-1; Andreasen N, 1999, NEUROSCI LETT, V273, P5, DOI 10.1016/S0304-3940(99)00617-5; Andreasen N, 1998, J NEUROL NEUROSUR PS, V64, P298, DOI 10.1136/jnnp.64.3.298; Andreasen N, 1999, NEUROLOGY, V53, P1488, DOI 10.1212/WNL.53.7.1488; Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373; Arai H, 2000, EXP NEUROL, V166, P201, DOI 10.1006/exnr.2000.7501; Arai H, 1998, NEUROBIOL AGING, V19, P125, DOI 10.1016/S0197-4580(98)00018-9; Arai H, 1997, BIOCHEM BIOPH RES CO, V236, P262, DOI 10.1006/bbrc.1997.6908; ARAI H, 1997, ALZHEIMERS RES, V3, P211; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Baldereschi M, 1998, NEUROLOGY, V50, P996, DOI 10.1212/WNL.50.4.996; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Bayer TA, 2001, BRAIN PATHOL, V11, P1; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Blacker D, 1998, ARCH NEUROL-CHICAGO, V55, P294, DOI 10.1001/archneur.55.3.294; Blennow K, 2001, MOL NEUROBIOL, V24, P87, DOI 10.1385/MN:24:1-3:087; BONTE FJ, 1993, RADIOLOGY, V186, P361, DOI 10.1148/radiology.186.2.8421735; Borson S, 1997, NEUROLOGY, V48, pS17, DOI 10.1212/WNL.48.5_Suppl_6.17S; BRENNER DE, 1994, AM J EPIDEMIOL, V140, P262, DOI 10.1093/oxfordjournals.aje.a117245; Brodaty H, 1995, ALZ DIS ASSOC DIS, V9, P182; CARMEL R, 1988, ARCH INTERN MED, V148, P1715, DOI 10.1001/archinte.148.8.1715; Chui H, 1997, NEUROLOGY, V49, P925, DOI 10.1212/WNL.49.4.925; Clark Christopher M., 1997, P217; Collie A, 2001, NEUROLOGY, V56, P1533, DOI 10.1212/WNL.56.11.1533; Cummings JL, 2000, AM J PSYCHIAT, V157, P4, DOI 10.1176/ajp.157.1.4; CUNHA UGV, 1990, ACTA PSYCHIAT SCAND, V82, P261, DOI 10.1111/j.1600-0447.1990.tb03063.x; DAVIS KL, 1992, NEW ENGL J MED, V327, P1253, DOI 10.1056/NEJM199210293271801; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; DeCarli C, 2001, CLIN GERIATR MED, V17, P255, DOI 10.1016/S0749-0690(05)70068-9; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Doody RS, 2001, DEMENT GERIATR COGN, V12, P295, DOI 10.1159/000051272; Doody RS, 2001, ARCH NEUROL-CHICAGO, V58, P427, DOI 10.1001/archneur.58.3.427; Eastley R, 2000, INT J GERIATR PSYCH, V15, P226, DOI 10.1002/(SICI)1099-1166(200003)15:3<226::AID-GPS98>3.0.CO;2-K; Ernst RL, 1997, ARCH NEUROL-CHICAGO, V54, P687, DOI 10.1001/archneur.1997.00550180013006; EVANS DA, 1990, MILBANK Q, V68, P267, DOI 10.2307/3350099; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Ewbank DC, 1999, AM J PUBLIC HEALTH, V89, P90, DOI 10.2105/AJPH.89.1.90; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Fox NC, 1999, NEUROLOGY, V52, P1687, DOI 10.1212/WNL.52.8.1687; Galasko D, 1998, NEUROBIOL AGING, V19, P117, DOI 10.1016/S0197-4580(98)00021-9; Galasko D, 1997, NEUROLOGY, V48, P632, DOI 10.1212/WNL.48.3.632; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; GEANEY DP, 1990, BRIT J PSYCHIAT, V157, P66, DOI 10.1192/S0007125000291861; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goebels N, 2000, J NEUROPSYCH CLIN N, V12, P389, DOI 10.1176/appi.neuropsych.12.3.389; GOTMAN CW, 2000, NEURODEGENERATIVE DE, P127; Green AJE, 1999, NEUROSCI LETT, V259, P133, DOI 10.1016/S0304-3940(98)00904-5; Growdon JH, 1999, ARCH NEUROL-CHICAGO, V56, P281, DOI 10.1001/archneur.56.3.281; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.3.CO;2-X; Henderson VW, 2000, NEUROLOGY, V54, P295, DOI 10.1212/WNL.54.2.295; HENDERSON VW, 1994, ARCH NEUROL-CHICAGO, V51, P896, DOI 10.1001/archneur.1994.00540210068014; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hogan DB, 2001, NEUROLOGY, V56, P1131, DOI 10.1212/WNL.56.9.1131; HONG M, 2000, TAU BASED NEUROFIBRI, P161; IWATSUBO T, 2000, NEURODEGENERATIVE DE, P147; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; JACKSON JH, 1985, SELECTED WRITINGS JH, P411; Jagust W, 2001, NEUROLOGY, V56, P950, DOI 10.1212/WNL.56.7.950; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JOBST KA, 1992, J NEUROL NEUROSUR PS, V55, P190, DOI 10.1136/jnnp.55.3.190; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Kanai M, 1998, ANN NEUROL, V44, P17, DOI 10.1002/ana.410440108; Kapaki E, 2000, EUR NEUROL, V43, P228, DOI 10.1159/000008181; Kawas C, 2000, NEUROLOGY, V54, P2072, DOI 10.1212/WNL.54.11.2072; Kaye JA, 1997, NEUROLOGY, V48, P1297, DOI 10.1212/WNL.48.5.1297; Knopman D, 2001, ARCH NEUROL-CHICAGO, V58, P349, DOI 10.1001/archneur.58.3.349; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Knopman DS, 2000, DM-DIS MON, V46, P761, DOI 10.1016/S0011-5029(00)90008-7; Kurz A, 1998, ALZ DIS ASSOC DIS, V12, P372, DOI 10.1097/00002093-199812000-00020; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Levy-Lahad E, 1998, J GERIATR PSYCH NEUR, V11, P42, DOI 10.1177/089198879801100202; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lovell MA, 2001, ARCH NEUROL-CHICAGO, V58, P392, DOI 10.1001/archneur.58.3.392; Manly JJ, 2000, NEUROLOGY, V54, P833, DOI 10.1212/WNL.54.4.833; Marder K, 2000, NEUROLOGY, V54, P2035, DOI 10.1212/WNL.54.11.2035; Mayeux R, 1999, NEW ENGL J MED, V341, P1670, DOI 10.1056/NEJM199911253412207; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; MOLINOFF PB, 2000, NEUROBIOL AGING, V21, pS136; Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; Otto M, 1997, NEUROSCI LETT, V225, P210, DOI 10.1016/S0304-3940(97)00215-2; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Post SG, 1998, J AM GERIATR SOC, V46, P784, DOI 10.1111/j.1532-5415.1998.tb03819.x; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Raskind MA, 1999, J CLIN PSYCHIAT, V60, P45; Raskind MA, 2000, NEUROLOGY, V54, P2261, DOI 10.1212/WNL.54.12.2261; REED BR, 1989, NEUROLOGY, V39, P1537, DOI 10.1212/WNL.39.11.1537; Relkin NR, 1996, LANCET, V347, P1091, DOI 10.1016/S0140-6736(96)90284-6; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Roses AD, 1998, AM J MED GENET, V81, P49, DOI 10.1002/(SICI)1096-8628(19980207)81:1<49::AID-AJMG10>3.0.CO;2-W; Rosler M, 1999, BMJ-BRIT MED J, V318, P633, DOI 10.1136/bmj.318.7184.633; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk DB, 2000, ARCH NEUROL-CHICAGO, V57, P934, DOI 10.1001/archneur.57.7.934; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Seshadri S, 2001, ARCH NEUROL-CHICAGO, V58, P435, DOI 10.1001/archneur.58.3.435; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sisodia SS, 2000, SCIENCE, V289, P2296, DOI 10.1126/science.289.5488.2296; Small SA, 2001, ARCH NEUROL-CHICAGO, V58, P360, DOI 10.1001/archneur.58.3.360; SOBEL E, 1995, NEUROLOGY, V45, P903, DOI 10.1212/WNL.45.5.903; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sutor B, 2001, MAYO CLIN PROC, V76, P540, DOI 10.4065/76.5.540; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Teri Linda, 2000, Comprehensive Therapy, V26, P169, DOI 10.1007/s12019-000-0005-x; Tol J, 1999, Rev Neurol (Paris), V155 Suppl 4, pS10; *US GEN ACC OFF, 1998, AZDC06782 US GEN ACC, P1; VANGOOL WA, 1994, LANCET, V344, P275, DOI 10.1016/S0140-6736(94)93044-9; Wang PN, 2000, NEUROLOGY, V54, P2061, DOI 10.1212/WNL.54.11.2061; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x	129	102	123	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					400	410		10.7326/0003-4819-138-5-200303040-00010	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614093				2022-12-28	WOS:000181257300006
J	Longo, VD; Finch, CE				Longo, VD; Finch, CE			Evolutionary medicine: From dwarf model systems to healthy centenarians?	SCIENCE			English	Review							HUMAN GROWTH-HORMONE; GENE-EXPRESSION PROFILE; LIFE-SPAN EXTENSION; CALORIC RESTRICTION; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; DIETARY RESTRICTION; OXIDATIVE STRESS; FAMILY MEMBER; LONG-TERM	Restriction of the number of calories consumed extends longevity in many organisms. In rodents, caloric restriction decreases the levels of plasma glucose and insulin-like growth factor 1 (IGF-1) and postpones or attenuates cancer, immunosenescence, and inflammation without irreversible side effects. In organisms ranging from yeast to mice, mutations in glucose or IGF-1-like signaling pathways extend life-span but also cause glycogen or fat accumulation and dwarfism. This information suggests a new category of drugs that could prevent or postpone diseases of aging with few adverse effects.	Univ So Calif, Andrus Gerontol Ctr, Div Biogerontol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Longo, VD (corresponding author), Univ So Calif, Andrus Gerontol Ctr, Div Biogerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA.				NIA NIH HHS [AG 01028] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abdu TAM, 2001, CLIN ENDOCRINOL, V55, P209, DOI 10.1046/j.1365-2265.2001.01320.x; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bartke A, 2001, J ANTI-AGING MED, V4, P197, DOI 10.1089/109454501753249966; Bengtsson BA, 2000, J CLIN ENDOCR METAB, V85, P933, DOI 10.1210/jc.85.3.933; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; BREM G, 1989, MOL BIOL MED, V6, P531; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dunn SE, 1997, CANCER RES, V57, P4667; EFFROS RB, 1991, J GERONTOL, V46, pB142, DOI 10.1093/geronj/46.4.B142; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Finch Caleb E., 2002, P275; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Finch CE, 1990, LONGEVITY SENESCENCE; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; FLURKEY K, COMMUNICATION; Gems D, 1998, GENETICS, V150, P129; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HOPKIN K, 2003, SCI SAGE KE     0226; Jazwinski SM, 1996, SCIENCE, V273, P54, DOI 10.1126/science.273.5271.54; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kirwan JP, 2001, AM J PHYSIOL-ENDOC M, V281, pE1137, DOI 10.1152/ajpendo.2001.281.6.E1137; Krzisnik C., 1999, J ENDOCR GENET, V1, P9, DOI DOI 10.1515/IJDHD.1999.1.1.9; Laron Z, 1999, J CLIN ENDOCR METAB, V84, P4397, DOI 10.1210/jc.84.12.4397; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1997, THESIS U CALIFORNIA; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Markowska AL, 1998, NEUROSCIENCE, V87, P559, DOI 10.1016/S0306-4522(98)00143-2; MASORO EJ, SCI SAGE KE     0226; Mattison JA, 2000, J AM AGING ASSOC, V23, P9, DOI 10.1007/s11357-000-0002-0; MCCAY CM, 1947, AM J PUBLIC HEALTH, V37, P527; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller RA, 1997, MECH AGEING DEV, V96, P181, DOI 10.1016/S0047-6374(97)01893-9; MILLER RE, COMMUNICATION; Moran Edgar M., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P193; Morohoshi M, 1996, DIABETES, V45, P954, DOI 10.2337/diabetes.45.7.954; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MULLER F, 2000, SCI SAGE KE     0227, pTG1; MULLER F, 2001, SCI SAGE KE     1003, pTG11; MULLER F, 2001, SCI SAGE KE     1017, pTG13; Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730; Pahlavani MA, 2000, FRONT BIOSCI-LANDMRK, V5, pD580, DOI 10.2741/Pahlavani; Patel NV, 2002, NEUROBIOL AGING, V23, P707, DOI 10.1016/S0197-4580(02)00017-9; Powell LA, 2001, FREE RADICAL BIO MED, V31, P1149, DOI 10.1016/S0891-5849(01)00648-7; RITCHIE DG, 1990, AM J PHYSIOL, V258, pE57, DOI 10.1152/ajpendo.1990.258.1.E57; Roth GS, 2001, ANN NY ACAD SCI, V928, P305; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; Saito H, 1996, HORM RES, V45, P50, DOI 10.1159/000184759; Sampson MJ, 2002, ARTERIOSCL THROM VAS, V22, P1187, DOI 10.1161/01.ATV.0000021759.08060.63; Segev Y, 1999, J AM SOC NEPHROL, V10, P2374; SILBERBERG R, 1972, PATHOL MICROBIOL, V38, P417, DOI 10.1159/000162458; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Utiger RD, 2000, NEW ENGL J MED, V342, P1210, DOI 10.1056/NEJM200004203421611; Walford RL, 2002, J GERONTOL A-BIOL, V57, pB211, DOI 10.1093/gerona/57.6.B211; WARD WF, 1988, J GERONTOL B-PSYCHOL, V43, P50; WEINDRUCH R, 1982, P NATL ACAD SCI-BIOL, V79, P898, DOI 10.1073/pnas.79.3.898; WEINDRUCH R, 1988, RETARDATION AGING DI; WOLF E, 1993, MECH AGEING DEV, V68, P71, DOI 10.1016/0047-6374(93)90141-D; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; S CEREVISIAE CYR1 SC; S CEREVISIAE SCH9 SC	82	441	470	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1342	1346		10.1126/science.1077991	http://dx.doi.org/10.1126/science.1077991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610293				2022-12-28	WOS:000181192300038
J	Viculis, LM; Mack, JJ; Kaner, RB				Viculis, LM; Mack, JJ; Kaner, RB			A chemical route to carbon nanoscrolls	SCIENCE			English	Article							NANOTUBES		Univ Calif Los Angeles, Dept Chem & Biochem, Exot Mat Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kaner, RB (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Exot Mat Inst, Los Angeles, CA 90095 USA.		Kaner, Richard B./K-1594-2019	Kaner, Richard B./0000-0003-0345-4924				AMELINCKX S, 1995, SCIENCE, V267, P1334, DOI 10.1126/science.267.5202.1334; [Anonymous], 1982, INTERCALATION CHEM, V19, P821, DOI 10.1016/j.cardfail.2013.11.003; Ding ZF, 2001, ADV MATER, V13, P797, DOI 10.1002/1521-4095(200106)13:11<797::AID-ADMA797>3.0.CO;2-U; Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X; Schaak RE, 2000, CHEM MATER, V12, P3427, DOI 10.1021/cm000495r; ZHOU O, 1994, SCIENCE, V263, P1744, DOI 10.1126/science.263.5154.1744	6	624	666	2	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1361	1361		10.1126/science.1078842	http://dx.doi.org/10.1126/science.1078842			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610297				2022-12-28	WOS:000181192300042
J	Hassall, O; Bedu-Addo, G; Adarkwa, M; Danso, K; Bates, I				Hassall, O; Bedu-Addo, G; Adarkwa, M; Danso, K; Bates, I			Umbilical-cord blood for transfusion in children with severe anaemia in under-resourced countries	LANCET			English	Article								Shortage of blood for transfusion contributes substantially to mortality of children with severe anaemia in sub-Saharan Africa. Umbilical-cord blood could be an additional and readily available source of blood. We aimed to show whether it is possible to gather cord blood in a busy Ghanaian labour ward. Mean volume of each blood sample obtained from the umbilical cord was 85 mL (SID 28.0). This amount of blood is sufficient to raise the haemoglobin concentrations of 28 (21%) of 131 children needing transfusions in the same hospital, by 30 g/L. Further work is needed to improve the sterility of cord blood and to establish the resource and logistical implications of scaling-up for sub-Saharan Africa transfusion services.	Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Komfo Anokye Teaching Hosp, Kumasi, Ghana	Liverpool School of Tropical Medicine; University of Liverpool; Kwame Nkrumah University Science & Technology	Bates, I (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.			bates, imelda/0000-0002-0862-8199				English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; INSLEY J, 1996, PAEDIAT VADE MECUM; Lackritz EM, 1997, AIDS, V11, P1487, DOI 10.1097/00002030-199712000-00013; *WHO, 1999, CLIN US BLOOD HDB	4	29	32	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					678	679		10.1016/S0140-6736(03)12565-2	http://dx.doi.org/10.1016/S0140-6736(03)12565-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606183				2022-12-28	WOS:000181129500021
J	Kamali, A; Quigley, M; Nakiyingi, J; Kinsman, J; Kengeya-Kayondo, J; Gopal, R; Ojwiya, A; Hughes, P; Carpenter, LM; Whitworth, J				Kamali, A; Quigley, M; Nakiyingi, J; Kinsman, J; Kengeya-Kayondo, J; Gopal, R; Ojwiya, A; Hughes, P; Carpenter, LM; Whitworth, J			Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial	LANCET			English	Article							PREVENTION; DISEASES; POPULATION; PREVALENCE	Background Treatment of sexually-transmitted infections (STIs) and behavioural interventions are the main methods to prevent HIV in developing countries. We aimed to assess the effect of these interventions on incidence of HIV-1 and other sexually-transmitted infections. Methods We randomly allocated all adults living in 18 communities in rural Uganda to receive behavioural interventions alone (group A), behavioural and STI interventions (group B), or routine government health services and community development activities (group C). The primary outcome was HIV-1 incidence. Secondary outcomes were incidence of herpes simplex virus type 2 (HSV2) and active syphilis and prevalence of gonorrhoea, chlamydia, reported genital ulcers, reported genital discharge, and markers of behavioural change. Analysis was per protocol. Findings Compared with group C, the incidence rate ratio of HIV-1 was 0.94 (0.60-1.45, p=0.72) in group A and 1.00 (0.63-1.58, p=0.98) in group B, and the prevalence ratio of use of condoms with last casual partner was 1.12 (95% CI 0.99-1.25) in group A and 1.27 (1.02-1.56) in group B. Incidence of HSV2 was lower in group A than in group C (incidence rate ratio 0.65, 0.53-0.80) and incidence of active syphilis for high rapid plasma reagent test titre and prevalence of gonorrhoea were both lower in group B than in group C (active syphilis incidence rate ratio, 0.52, 0.27-0.98; gonorrhoea prevalence ratio, 0.25, 0.10-0.64). Interpretation The interventions we used were insufficient to reduce HIV-1 incidence in rural Uganda, where secular changes are occurring. More effective STI and behavioural interventions need to be developed for HIV control in mature epidemics.	Uganda Virus Res Inst, MRC, Programme AIDS, Entebbe, Uganda; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Univ Oxford, Inst Hlth Sci, Dept Publ Hlth, Oxford OX1 2JD, England; WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; PHLS Cent Publ Hlth Lab, Colindale, England	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; World Health Organization	Kamali, A (corresponding author), Uganda Virus Res Inst, MRC, Programme AIDS, POB 49, Entebbe, Uganda.	anatoli.kamali@mrcuganda.mimcom.net		Quigley, Maria/0000-0002-8058-6181				Carpenter LM, 2002, J ACQ IMMUN DEF SYND, V29, P174, DOI 10.1097/00042560-200202010-00011; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Gopal R, 2000, J VIROL METHODS, V87, P71, DOI 10.1016/S0166-0934(00)00149-X; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hayes R, 1997, GENITOURIN MED, V73, P432; Huber P. H., 1981, ROBUST STAT; Kamali A., 2001, International Journal of STD and AIDS, V12, P46; Kamali A, 2002, TROP MED INT HEALTH, V7, P1053, DOI 10.1046/j.1365-3156.2002.00963.x; KATZENSTEIN D, 1998, 12 WORLD AIDS C GEN; KING A, 1993, AIDS YOUTH ANAL FACT; Kinsman J, 2002, HEALTH EDUC RES, V17, P253, DOI 10.1093/her/17.2.253; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Manfrin V, 2001, LANCET, V357, P1364, DOI 10.1016/S0140-6736(00)04489-5; Mbulaiteye SM, 2002, LANCET, V360, P41, DOI 10.1016/S0140-6736(02)09331-5; MERTENS T, 1994, AIDS, V8, P1359, DOI 10.1097/00002030-199410000-00002; Mitchell K, 2002, SOC SCI MED, V54, P1081, DOI 10.1016/S0277-9536(01)00082-X; MOEMA S, 1998, 12 WORLD AIDS C GEN; NUNN AJ, 1994, METHOD INFORM MED, V33, P170; NUNN AJ, 1993, AIDS, V7, P1057, DOI 10.1097/00002030-199308000-00005; OAKLEY A, 1995, AIDS, V9, P479, DOI 10.1097/00002030-199509050-00010; Purswani MU, 2002, J ANTIMICROB CHEMOTH, V50, P51, DOI 10.1093/jac/dkf091; RISBERK K, 2002, J CHEMOTHER, V14, P3; Stephenson JM, 2000, AIDS, V14, pS115; WATTERS JK, 1994, LANCET, V344, P1312, DOI 10.1016/S0140-6736(94)90688-2; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	27	225	233	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2003	361	9358					645	652		10.1016/S0140-6736(03)12598-6	http://dx.doi.org/10.1016/S0140-6736(03)12598-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606175				2022-12-28	WOS:000181129500013
J	Chubb, JR; Bickmore, WA				Chubb, JR; Bickmore, WA			Considering nuclear compartmentalization in the light of nuclear dynamics	CELL			English	Review							CHROMOSOME TERRITORIES; INTERPHASE NUCLEI; GENE; ARCHITECTURE; HETEROCHROMATIN; ORGANIZATION; ASSOCIATION; MOTION; CELLS	Many proteins are concentrated in compartments within the nucleus. Chromatin is also compartmentalized at different nuclear sites. However, nuclear proteins have now been shown to be highly mobile. This review considers the formation and function of nuclear compartments in a situation in which proteins are rapidly moving through the nuclear volume.	MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Bickmore, WA (corresponding author), MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.		Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735				ANDERSSON K, 1984, J CELL BIOL, V98, P1296, DOI 10.1083/jcb.98.4.1296; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; MANY NL, 2002, J CELL BIOL, V159, P753; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Volpi EV, 2000, J CELL SCI, V113, P1565; Wang ZG, 1998, SCIENCE, V279, P1547	20	100	104	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					403	406		10.1016/S0092-8674(03)00078-3	http://dx.doi.org/10.1016/S0092-8674(03)00078-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600306	Bronze, Green Published			2022-12-28	WOS:000181252600001
J	Ungar, G; Liu, YS; Zeng, XB; Percec, V; Cho, WD				Ungar, G; Liu, YS; Zeng, XB; Percec, V; Cho, WD			Giant supramolecular liquid crystal lattice	SCIENCE			English	Article							PHASE-BEHAVIOR; DENDRIMERS; SHAPE; COPOLYMERS; MICELLES; SURFACES; DESIGN; AREA	Self-organized supramolecular organic nanostructures have potential applications that include molecular electronics, photonics, and precursors for nanoporous catalysts. Accordingly, understanding how self-assembly is controlled by molecular architecture will enable the design of increasingly complex structures. We report a liquid crystal (LC) phase with a tetragonal three-dimensional unit cell containing 30 globular supramolecular dendrimers, each of which is self-assembled from 12 dendron (tree-like) molecules, for the compounds described here. The present structure is one of the most complex LC phases yet discovered. A model explaining how spatial arrangement of self-assembled dendritic aggregates depends on molecular architecture and temperature is proposed.	Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England; Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA	University of Sheffield; University of Pennsylvania	Ungar, G (corresponding author), Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England.		Hudson, Steven/AAB-2909-2019; Liu, Yongsong/G-9203-2011; Percec, Virgil/H-6316-2014	Hudson, Steven/0000-0002-3203-4833; Percec, Virgil/0000-0001-5926-0489; Ungar, Goran/0000-0002-9743-2656				Attard GS, 1997, ANGEW CHEM INT EDIT, V36, P1315, DOI 10.1002/anie.199713151; Balagurusamy VSK, 1997, J AM CHEM SOC, V119, P1539, DOI 10.1021/ja963295i; Berne C, 1999, PHYS REV LETT, V83, P1621, DOI 10.1103/PhysRevLett.83.1621; CHARVOLIN J, 1988, J PHYS-PARIS, V49, P521, DOI 10.1051/jphys:01988004903052100; Duan H, 2001, CHEM-EUR J, V7, P4134, DOI 10.1002/1521-3765(20011001)7:19<4134::AID-CHEM4134>3.0.CO;2-W; FRANK FC, 1959, ACTA CRYSTALLOGR, V12, P483, DOI 10.1107/S0365110X59001499; Hahn T., 1996, INT TABLES CRYSTALLO, VA; HAMLEY IW, 1998, PHYSICS BLOCK COPOLY; Hillmyer MA, 1996, SCIENCE, V271, P976, DOI 10.1126/science.271.5251.976; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Hudson SD, 1997, SCIENCE, V278, P449, DOI 10.1126/science.278.5337.449; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; LAWSON AC, 1988, ACTA CRYSTALLOGR B, V44, P89, DOI 10.1107/S0108768187009406; Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063; Levelut AM, 1998, LIQ CRYST, V24, P105, DOI 10.1080/026782998207631; Lopes WA, 2001, NATURE, V414, P735, DOI 10.1038/414735a; LUZZATI V, 1992, BIOCHEMISTRY-US, V31, P279, DOI 10.1021/bi00116a038; Percec V, 1998, NATURE, V391, P161, DOI 10.1038/34384; Percec V, 2002, CHEM-EUR J, V8, P1106, DOI 10.1002/1521-3765(20020301)8:5<1106::AID-CHEM1106>3.0.CO;2-G; Percec V, 2001, J AM CHEM SOC, V123, P1302, DOI 10.1021/ja0037771; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; Seddon JM, 1996, BER BUNSEN PHYS CHEM, V100, P380, DOI 10.1002/bbpc.19961000324; SHOEMAKER DP, 1986, ACTA CRYSTALLOGR B, V42, P3, DOI 10.1107/S0108768186098671; Sinha A. K., 1972, TOPOLOGICALLY CLOSE; THOMAS EL, 1987, MACROMOLECULES, V20, P2934, DOI 10.1021/ma00177a049; THOMAS EL, 1988, NATURE, V334, P598, DOI 10.1038/334598a0; Tomalia D. A., 2001, DENDRIMERS OTHER DEN; Tschierske C, 2001, J MATER CHEM, V11, P2647, DOI 10.1039/b102914m; Ungar G, 2000, CHEM-EUR J, V6, P1258, DOI 10.1002/(SICI)1521-3765(20000403)6:7<1258::AID-CHEM1258>3.0.CO;2-O; WEAIRE D, 1994, PHIL MAG LETT, V69, P107, DOI 10.1080/09500839408241577; Weaire D., 1997, KELVIN PROBLEM FOAM; Williams R., 1979, GEOMETRICAL FDN NATU; Yeardley DJP, 2000, J AM CHEM SOC, V122, P1684, DOI 10.1021/ja993915q; Ziherl P, 2001, J PHYS CHEM B, V105, P10147, DOI 10.1021/jp010944q	34	358	360	5	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1208	1211		10.1126/science.1078849	http://dx.doi.org/10.1126/science.1078849			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595686				2022-12-28	WOS:000181065500033
J	[Anonymous]				[Anonymous]			How to publish in Nature	NATURE			English	Editorial Material																			0	0	0	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					769	769		10.1038/421769a	http://dx.doi.org/10.1038/421769a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594461	Bronze			2022-12-28	WOS:000181044700001
J	Burgess, SA; Walker, ML; Sakakibara, H; Knight, PJ; Oiwa, K				Burgess, SA; Walker, ML; Sakakibara, H; Knight, PJ; Oiwa, K			Dynein structure and power stroke	NATURE			English	Article							HEAVY-CHAIN; ADENOSINE-TRIPHOSPHATASE; CYTOPLASMIC DYNEIN; NUCLEOTIDE-BINDING; MYOSIN; ATP; ACTIVATION; PROTEINS; FLAGELLA; FAMILY	Dynein ATPases are microtubule motors that are critical to diverse processes such as vesicle transport and the beating of sperm tails; however, their mechanism of force generation is unknown. Each dynein comprises a head, from which a stalk and a stem emerge. Here we use electron microscopy and image processing to reveal new structural details of dynein c, an isoform from Chlamydomonas reinhardtii flagella, at the start and end of its power stroke. Both stem and stalk are flexible, and the stem connects to the head by means of a linker approximately 10 nm long that we propose lies across the head. With both ADP and vanadate bound, the stem and stalk emerge from the head 10 nm apart. However, without nucleotide they emerge much closer together owing to a change in linker orientation, and the coiled-coil stalk becomes stiffer. The net result is a shortening of the molecule coupled to an approximately 15-nm displacement of the tip of the stalk. These changes indicate a mechanism for the dynein power stroke.	Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; Commun Res Labs, Kansai Adv Res Ctr, Kobe, Hyogo 6512492, Japan	University of Leeds; University of Leeds; National Institute of Information & Communications Technology (NICT) - Japan	Burgess, SA (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.a.burgess@leeds.ac.uk	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X				Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; BURGESS SA, 1995, J MOL BIOL, V250, P52, DOI 10.1006/jmbi.1995.0357; Burgess SA, 1997, J CELL BIOL, V139, P675, DOI 10.1083/jcb.139.3.675; DiBella LM, 2001, INT REV CYTOL, V210, P227; ELLIOTT A, 1976, PROC R SOC SER B-BIO, V193, P45, DOI 10.1098/rspb.1976.0030; Fan J, 2001, J MOL BIOL, V307, P1317, DOI 10.1006/jmbi.2001.4566; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Gee M, 1998, EUR BIOPHYS J BIOPHY, V27, P466, DOI 10.1007/s002490050157; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GIBBONS IR, 1991, METHOD ENZYMOL, V196, P428; GIBBONS IR, 1987, J BIOL CHEM, V262, P2780; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; GOODENOUGH U, 1984, J MOL BIOL, V180, P1083, DOI 10.1016/0022-2836(84)90272-9; Goodenough U.W., 1989, CELL MOVEMENT, V1, P121; GOODENOUGH UW, 1982, J CELL BIOL, V95, P798, DOI 10.1083/jcb.95.3.798; GOODENOUGH UW, 1987, J MOL BIOL, V194, P481, DOI 10.1016/0022-2836(87)90676-0; JOHNSON JG, 1988, CANADIAN SOC PETROLE, V14, P161; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 2000, J CELL SCI, V113, P2521; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Mocz G, 1996, BIOCHEMISTRY-US, V35, P9204, DOI 10.1021/bi960662u; Neuwald AF, 1999, GENOME RES, V9, P27; OGAWA K, 1991, NATURE, V352, P643, DOI 10.1038/352643a0; OKUNO M, 1980, J CELL BIOL, V85, P712, DOI 10.1083/jcb.85.3.712; OMOTO CK, 1986, BIOCHEMISTRY-US, V25, P419, DOI 10.1021/bi00350a022; Sakakibara H, 1999, NATURE, V400, P586, DOI 10.1038/23066; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Shiroguchi K, 2001, CELL MOTIL CYTOSKEL, V49, P189, DOI 10.1002/cm.1032; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Vallee RB, 1998, TRENDS CELL BIOL, V8, P490, DOI 10.1016/S0962-8924(98)01379-8; VERNON GG, 1995, EXP CELL RES, V220, P482, DOI 10.1006/excr.1995.1340; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Woolley D, 2000, Essays Biochem, V35, P103; Yagi T, 2000, CELL STRUCT FUNCT, V25, P263, DOI 10.1247/csf.25.263	41	390	395	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					715	718		10.1038/nature01377	http://dx.doi.org/10.1038/nature01377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610617	Green Accepted			2022-12-28	WOS:000180938000035
J	Mamdouh, Z; Chen, X; Pierini, LM; Maxfield, FR; Muller, WA				Mamdouh, Z; Chen, X; Pierini, LM; Maxfield, FR; Muller, WA			Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis	NATURE			English	Article							VESICULO-VACUOLAR ORGANELLES; TRANSENDOTHELIAL MIGRATION; CELL-ADHESION; TRANSMIGRATION; MONOCYTES; CADHERIN; LEUKOCYTES	Leukocytes enter sites of inflammation by squeezing through the borders between endothelial cells that line postcapillary venules at that site. This rapid process, called transendothelial migration (TEM) or diapedesis, is completed within 90 s after a leukocyte arrests on the endothelial surface(1-4). In this time, the leukocyte moves in ameboid fashion across the endothelial borders, which remain tightly apposed to it during transit. It is not known how the endothelial cell changes its borders rapidly and reversibly to accommodate the migrating leukocyte. Here we show that there is a membrane network just below the plasmalemma at the cell borders that is connected at intervals to the junctional surface. PECAM-1, an integral membrane protein with an essential role in TEM5-7, is found in this compartment and constitutively recycles evenly along endothelial cell borders. During TEM, however, recycling PECAM is targeted to segments of the junction across which monocytes are in the act of migration. In addition, blockade of TEM with antibodies against PECAM specifically blocks the recruitment of this membrane to the zones of leukocyte migration, without affecting the constitutive membrane trafficking.	Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University; Cornell University	Muller, WA (corresponding author), Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10021 USA.		Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866				Ali J, 1997, MICROCIRCULATION-LON, V4, P267, DOI 10.3109/10739689709146790; Allport JR, 2000, J CELL BIOL, V148, P203, DOI 10.1083/jcb.148.1.203; Bamforth SD, 1997, INVEST OPHTH VIS SCI, V38, P25; Berman ME, 1996, J IMMUNOL, V156, P1515; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Feng D, 1996, J EXP MED, V183, P1981, DOI 10.1084/jem.183.5.1981; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; HAMMERSEN F, 1987, PROG APPL MICROCIRC, V12, P1; LIAO F, 1995, J EXP MED, V182, P1337, DOI 10.1084/jem.182.5.1337; Liao F, 1997, J EXP MED, V185, P1349, DOI 10.1084/jem.185.7.1349; MULLER WA, 1992, J EXP MED, V176, P819, DOI 10.1084/jem.176.3.819; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Muller WA, 1999, J LEUKOCYTE BIOL, V66, P698, DOI 10.1002/jlb.66.5.698; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Vasile E, 1999, J HISTOCHEM CYTOCHEM, V47, P159, DOI 10.1177/002215549904700205; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713	21	248	255	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					748	753		10.1038/nature01300	http://dx.doi.org/10.1038/nature01300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610627				2022-12-28	WOS:000180938000045
J	Meyzen, CM; Toplis, MJ; Humler, E; Ludden, JN; Mevel, C				Meyzen, CM; Toplis, MJ; Humler, E; Ludden, JN; Mevel, C			A discontinuity in mantle composition beneath the southwest Indian ridge	NATURE			English	Article							GLOBAL CORRELATIONS; BASALT CHEMISTRY; OCEAN; GEOCHEMISTRY; SEGMENTATION	The composition of mid-ocean-ridge basalt is known to correlate with attributes such as ridge topography(1,2) and seismic velocity in the underlying mantle(3), and these correlations have been interpreted to reflect variations in the average extent and mean pressures of melting during mantle upwelling. In this respect, the eastern extremity of the southwest Indian ridge is of special interest, as its mean depth of 4.7 km (ref. 4), high upper-mantle seismic wave velocities(5) and thin oceanic crust of 4-5 km (ref. 6) suggest the presence of unusually cold mantle beneath the region. Here we show that basaltic glasses dredged in this zone, when compared to other sections of the global mid-ocean-ridge system, have higher Na-8.0, Sr and Al2O3 compositions, very low CaO/Al2O3 ratios relative to TiO2 and depleted heavy rare-earth element distributions. This signature cannot simply be ascribed to low-degree melting of a typical mid-ocean-ridge source mantle, as different geochemical indicators of the extent of melting(1) are mutually inconsistent. Instead, we propose that the mantle beneath similar to1,000 km of the southwest Indian ridge axis has a complex history involving extensive earlier melting events and interaction with partial melts of a more fertile source.	Ctr Rech Petrog & Geochim, UPR 2300, F-54501 Vandoeuvre Les Nancy, France; Inst Phys Globe, Lab Geosci Marines, F-75251 Paris 05, France	Universite de Lorraine; UDICE-French Research Universities; Universite Paris Cite	Mevel, C (corresponding author), Danish Lithosphere Ctr, Oster Voldgade 10, DK-1350 Copenhagen, Denmark.		Meyzen, Christine/L-1941-2015; lgm, ipgp/F-8820-2010	Meyzen, Christine/0000-0002-7529-5347; 				BRYAN WB, 1994, J GEOPHYS RES-SOL EA, V99, P2973, DOI 10.1029/93JB02157; Cannat M, 1999, J GEOPHYS RES-SOL EA, V104, P22825, DOI 10.1029/1999JB900195; Debayle E, 1997, GEOPHYS RES LETT, V24, P245, DOI 10.1029/96GL03954; Elthon D, 1996, J GEOPHYS RES-SOL EA, V101, P17577, DOI 10.1029/96JB00657; ELTHON D, 1995, J GEOPHYS RES-SOL EA, V100, P12497, DOI 10.1029/94JB02777; Falloon TJ, 2000, J PETROL, V41, P257, DOI 10.1093/petrology/41.2.257; HUMLER E, 1993, NATURE, V364, P225, DOI 10.1038/364225a0; KLEIN EM, 1991, J GEOPHYS RES-SOLID, V96, P2089, DOI 10.1029/90JB01384; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; Muller MR, 1999, GEOLOGY, V27, P867, DOI 10.1130/0091-7613(1999)027<0867:SAMSAT>2.3.CO;2; NATLAND JH, 1991, OCEANIC BASALTS, P288; Patriat P, 1997, MAR GEOPHYS RES, V19, P457, DOI 10.1023/A:1004312623534; Pickering-Witter J, 2000, CONTRIB MINERAL PETR, V140, P190, DOI 10.1007/s004100000183; PLANK T, 1992, J GEOPHYS RES-SOL EA, V97, P19749, DOI 10.1029/92JB01769; PYLE DG, 1995, J GEOPHYS RES-SOL EA, V100, P22261, DOI 10.1029/95JB01424; PYLE DG, 1994, THESIS OREGON STATE; Robinson CJ, 2001, EARTH PLANET SC LETT, V188, P383, DOI 10.1016/S0012-821X(01)00329-6; SCHILLING JG, 1995, J GEOPHYS RES-SOL EA, V100, P10057, DOI 10.1029/95JB00668; SEYLER M, IN PRESS GEOCHEM GEO; SHU D, 1999, NATURE, V398, P64; Smith W. H. F., 1997, Science, V277, P1956, DOI 10.1126/science.277.5334.1956; White RS, 2001, J PETROL, V42, P1171, DOI 10.1093/petrology/42.6.1171	23	90	101	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					731	733		10.1038/nature01424	http://dx.doi.org/10.1038/nature01424			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610622				2022-12-28	WOS:000180938000040
J	Nicastro, F; Zezas, A; Elvis, M; Mathur, S; Fiore, F; Cecchi-Pestellini, C; Burke, D; Drake, J; Casella, P				Nicastro, F; Zezas, A; Elvis, M; Mathur, S; Fiore, F; Cecchi-Pestellini, C; Burke, D; Drake, J; Casella, P			The far-ultraviolet signature of the 'missing' baryons in the Local Group of galaxies	NATURE			English	Article							HIGH-VELOCITY CLOUDS; SPECTROSCOPIC EXPLORER OBSERVATIONS; O-VI	The number of baryons detected in the low-redshift (z < 1) Universe is far smaller than the number detected in corresponding volumes at higher redshifts. Simulations(1-3) of the formation of structure in the Universe show that up to two-thirds of the 'missing' baryons may have escaped detection because of their high temperature and low density. One of the few ways to detect this matter directly is to look for its signature in the form of ultraviolet absorption lines in the spectra of background sources such as quasars. Here we show that the amplitude of the average velocity vector of 'high velocity' OVI (O5+) absorption clouds detected in a survey(4) of ultraviolet emission from active galactic nuclei decreases significantly when the vector is transformed to the frames of the Galactic Standard of Rest and the Local Group of galaxies. At least 82 per cent of these absorbers are not associated with any 'high velocity' atomic hydrogen complex in our Galaxy, and are therefore likely to result from a primordial warm-hot intergalactic medium pervading an extended corona around the Milky Way or the Local Group. The total mass of baryons in this medium is estimated to be up to &SIM;10(12) solar masses, which is of the order of the mass required(5) to dynamically stabilize the Local Group.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; Osservatorio Astron Monteporzio, I-00040 Monte Porzio Catone, RM, Italy	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University System of Ohio; Ohio State University	Nicastro, F (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.		Zezas, Andreas/C-7543-2011	Zezas, Andreas/0000-0001-8952-676X; Fiore, Fabrizio/0000-0002-4031-4157; Nicastro, Fabrizio/0000-0002-6896-1364; Cecchi Pestellini, Cesare/0000-0001-7480-0324; Burke, Douglas/0000-0003-4428-7835; Casella, Piergiorgio/0000-0002-0752-3301				Blitz L, 1999, ASTROPHYS J, V514, P818, DOI 10.1086/306963; Braun R, 1999, ASTRON ASTROPHYS, V341, P437; Braun R, 2001, ASTRON ASTROPHYS, V375, P219, DOI 10.1051/0004-6361:20010810; Canizares C. R., 1986, P SOC PHOTO-OPT INS, V597, P253; CECCHIPESTELLIN.C, UNPUB ASTROPHYS J; Cen RY, 1999, ASTROPHYS J, V514, P1, DOI 10.1086/306949; Dave R, 2001, ASTROPHYS J, V552, P473, DOI 10.1086/320548; DEHEIJ V, IN PRESS ASTRON ASTR; DEHEIJ V, 2002, ASTROPH0206306; Draine BT, 1996, ASTROPHYS J, V468, P269, DOI 10.1086/177689; Freeman PE, 2001, PROC SPIE, V4477, P76, DOI 10.1117/12.447161; GREVESSE N, 1989, AIP C P, V183, P1; HECKMAN TM, 2002, ASTROPH020556; HECKMAN TM, IN PRESS ASTROPHYS J; Hellsten U, 1998, ASTROPHYS J, V509, P56, DOI 10.1086/306499; Hoopes CG, 2002, ASTROPHYS J, V569, P233, DOI 10.1086/339323; Howk JC, 2002, ASTROPHYS J, V572, P264, DOI 10.1086/340231; KAHN FD, 1959, ASTROPHYS J, V130, P705, DOI 10.1086/146762; KLYPIN A, 2001, ASTROPH0107104; KLYPIN A, 2001, UNPUB ASTROPHYS J; KRAVTSOV AV, IN PRESS ASTROPHYS J; KRAVTSOV AV, 2001, ASTROPH0109077; Moos HW, 2000, ASTROPHYS J, V538, pL1, DOI 10.1086/312795; Nicastro F, 2002, ASTROPHYS J, V573, P157, DOI 10.1086/340489; Oort J H, 1926, OBSERVATORY, V49, P302; SANKRIT R, 2001, FUSE DATA ANAL COOKB; SAVAGE, 2001, AM ASTRON SOC, V199, P6504; Savage BD, 2000, ASTROPHYS J, V538, pL27, DOI 10.1086/312792; Sembach KR, 2000, ASTROPHYS J, V538, pL31, DOI 10.1086/312785; SEMBACH KR, 2002, UNPUB ASTROPHYS J SU; SEMBACH KR, 2001, AM ASTRON SOC, V199, P11301; SEMBACH KR, 2002, ASTROPH0207562; STARK AA, 1992, ASTROPHYS J SUPPL S, V79, P77, DOI 10.1086/191645; STERNBERG A, 2002, IN PRESS ASTROPHY J; STERNBERG A, 2002, ASTROPH0207040; WAKKER BP, 2001, AM ASTRON SOC, V199, P6508	37	79	79	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					719	721		10.1038/nature01369	http://dx.doi.org/10.1038/nature01369			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610618				2022-12-28	WOS:000180938000036
J	Dalton, R				Dalton, R			Auction of DNA archive cancelled	NATURE			English	News Item																		KLUG A, 2003, NATURE, V421, P564	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					102	102		10.1038/422102b	http://dx.doi.org/10.1038/422102b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634743	Bronze			2022-12-28	WOS:000181488900006
J	Walsh, JME; Terdiman, JP				Walsh, JME; Terdiman, JP			Colorectal cancer screening - Scientific review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							OCCULT-BLOOD-TESTS; BARIUM ENEMA EXAMINATION; COLONOSCOPIC MISS-RATE; FLEXIBLE SIGMOIDOSCOPY; CT COLONOGRAPHY; VIRTUAL COLONOSCOPY; PERFORMANCE-CHARACTERISTICS; CONVENTIONAL COLONOSCOPY; SURVEILLANCE INTERVALS; ASYMPTOMATIC ADULTS	Context Screening for colorectal cancer clearly reduces colorectal cancer mortality, vet many eligible adults remain unscreened Several screening tests are available and various professional organizations have differing recommendations on which screening test to use. Clinicians are challenged to ensure that eligible patients undergo colorectal cancer screening and to guide patients in choosing what tests to receive. Objective To critically assess the evidence for use of the available colorectal cancer screening tests, including fecal occult blood tests, sigmoidoscopy, colonoscopy, double-contrast barium enema, and newer tests, such as virtual colonoscopy and stool-based molecular screening. Data Sources All relevant English-language articles were identified using PubMed (January 1966-August 2002), published meta-analyses, reference lists of key articles, and expert consultation. Data Extraction Studies that evaluated colorectal cancer screening in healthy individuals and assessed clinical outcomes were included. Evidence from randomized controlled trials was considered to be of highest quality, followed by observational evidence. Diagnostic accuracy studies were evaluated when randomized controlled trials and observational studies were not available or did not provide adequate evidence. Studies were excluded if they did not evaluate colorectal screening tests and if they did not evaluate average-risk individuals. Data Synthesis Randomized controlled trials have shown that fecal occult blood testing can reduce colorectal cancer incidence and mortality. Case-control studies have shown that sigmoidoscopy is associated with a reduction in mortality, and observational studies suggest colonoscopy is effective as well. Combining fecal occult blood testing and sigmoidoscopy may decrease mortality and can increase diagnostic yield. Conclusion The recommendation that all men and women aged 50 years or older undergo screening for colorectal cancer is supported by a large body of direct and indirect evidence. At present, the available evidence does not currently support choosing one test over another.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Womens Hlth Clin Res Ctr, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Walsh, JME (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Womens Hlth Clin Res Ctr, Campus Box 1793,1635 Divisadero Suite 600, San Francisco, CA 94115 USA.	Jwalsh@medicine.ucsf.edu						Ahlquist DA, 2000, GASTROENTEROLOGY, V119, P1219, DOI 10.1053/gast.2000.19580; AHLQUIST DA, 1993, JAMA-J AM MED ASSOC, V269, P1262, DOI 10.1001/jama.269.10.1262; Akerkar GA, 2001, GASTROINTEST ENDOSC, V54, P310, DOI 10.1067/mge.2001.117595; ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Anderson ML, 2000, AM J GASTROENTEROL, V95, P3418, DOI 10.1111/j.1572-0241.2000.03356.x; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2000, GASTROENTEROLOGY, V118, pA187, DOI 10.1016/S0016-5085(00)82822-X; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Bensen S, 1999, AM J GASTROENTEROL, V94, P194; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Berry DP, 1997, BRIT J SURG, V84, P1274; Blakeborough A, 1997, CLIN RADIOL, V52, P142, DOI 10.1016/S0009-9260(97)80108-0; Bond J H, 2000, Semin Gastrointest Dis, V11, P176; Bond JH, 1999, NEW ENGL J MED, V341, P1540, DOI 10.1056/NEJM199911113412010; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Cash BD, 1999, GASTROINTEST ENDOSC, V49, P163, DOI 10.1016/S0016-5107(99)70481-5; Church TR, 1997, JNCI-J NATL CANCER I, V89, P1440, DOI 10.1093/jnci/89.19.1440; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Cotton PB, 2002, GASTROINTEST ENDOSC, V55, pAB98; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fenlon HM, 1999, NEW ENGL J MED, V341, P1496, DOI 10.1056/NEJM199911113412003; Fletcher JG, 2000, RADIOLOGY, V216, P704, DOI 10.1148/radiology.216.3.r00au41704; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Gross GWW, 2000, GASTROINTEST ENDOSC, V51, P783, DOI 10.1053/ge.2000.v51.age516783; Hara AK, 1997, RADIOLOGY, V205, P59, DOI 10.1148/radiology.205.1.9314963; Hara AK, 2001, RADIOLOGY, V219, P461, DOI 10.1148/radiology.219.2.r01ma28461; HIXSON LJ, 1991, GASTROINTEST ENDOSC, V37, P125, DOI 10.1016/S0016-5107(91)70668-8; Hoff G, 2001, EUR J CANCER PREV, V10, P131, DOI 10.1097/00008469-200104000-00003; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Johnson CD, 1996, AM J ROENTGENOL, V167, P39, DOI 10.2214/ajr.167.1.8659417; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Kavanagh AM, 1998, CANCER CAUSE CONTROL, V9, P455; Kewenter J, 1996, DIS COLON RECTUM, V39, P676, DOI 10.1007/BF02056949; Kim LS, 2001, GASTROINTEST ENDOSC, V54, P67, DOI 10.1067/mge.2001.114064; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LANG CA, 1994, JAMA-J AM MED ASSOC, V271, P1011, DOI 10.1001/jama.271.13.1011; Law RL, 1999, CLIN RADIOL, V54, P80, DOI 10.1016/S0009-9260(99)91063-2; Lemmel GT, 1996, GASTROINTEST ENDOSC, V44, P109, DOI 10.1016/S0016-5107(96)70125-6; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; Levin TR, 2000, GASTROENTEROLOGY, V118, pA441, DOI 10.1016/S0016-5085(00)83876-7; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; MARSHALL JB, 1995, GASTROINTEST ENDOSC, V42, P287, DOI 10.1016/S0016-5107(95)70123-0; Miao YM, 2000, GUT, V47, P832, DOI 10.1136/gut.47.6.832; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; MORSON BC, 1984, CLIN RADIOL, V35, P425, DOI 10.1016/S0009-9260(84)80033-1; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Pescatore P, 2000, GUT, V47, P126, DOI 10.1136/gut.47.1.126; Pignone M, 2001, Eff Clin Pract, V4, P150; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; Ransohoff DF, 1997, ANN INTERN MED, V126, P808, DOI 10.7326/0003-4819-126-10-199705150-00014; Rasmussen M, 1999, SCAND J GASTROENTERO, V34, P73; Read TE, 1997, NEW ENGL J MED, V336, P8, DOI 10.1056/NEJM199701023360102; Rembacken BJ, 2000, LANCET, V355, P1211, DOI 10.1016/S0140-6736(00)02086-9; REX DK, 1994, GASTROENTEROLOGY, V106, P593, DOI 10.1016/0016-5085(94)90690-4; Rex DK, 1996, GASTROENTEROLOGY, V111, P1178, DOI 10.1053/gast.1996.v111.pm8898630; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1999, GASTROINTEST ENDOSC, V50, P309, DOI 10.1053/ge.1999.v50.97776; REX DK, 1990, GASTROINTEST ENDOSC, V36, P486, DOI 10.1016/S0016-5107(90)71121-2; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Saitoh Y, 2001, GASTROENTEROLOGY, V120, P1657, DOI 10.1053/gast.2001.24886; SCHERTZ RD, 1989, GASTROINTEST ENDOSC, V35, P316, DOI 10.1016/S0016-5107(89)72800-5; Schoen RE, 2002, GASTROENTEROLOGY, V122, pA40; Schoen RE, 1998, GASTROENTEROLOGY, V115, P533, DOI 10.1016/S0016-5085(98)70132-5; Schoenfeld P, 1999, GASTROENTEROLOGY, V117, P312, DOI 10.1053/gast.1999.0029900312; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SIDRANSKY D, 1992, SCIENCE, V256, P102, DOI 10.1126/science.1566048; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Sonnenberg A, 1999, AM J GASTROENTEROL, V94, P2268; Spinzi G, 2001, AM J GASTROENTEROL, V96, P394; Strom E, 1999, RADIOLOGY, V211, P211, DOI 10.1148/radiology.211.1.r99ap37211; Thiis-Evensen E, 1999, SCAND J GASTROENTERO, V34, P414; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Traverso G, 2002, LANCET, V359, P403, DOI 10.1016/S0140-6736(02)07591-8; Verne JECW, 1998, BRIT MED J, V317, P182, DOI 10.1136/bmj.317.7152.182; Wallace MB, 1998, ANN INTERN MED, V129, P273, DOI 10.7326/0003-4819-129-4-199808150-00002; Wallace MB, 1999, AM J MED, V107, P214, DOI 10.1016/S0002-9343(99)00225-9; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, J NATL CANCER I, V85, P1311, DOI 10.1093/jnci/85.16.1311; Winawer SJ, 2002, GASTROENTEROLOGY, V122, pA480; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; Yee J, 2001, RADIOLOGY, V219, P685, DOI 10.1148/radiology.219.3.r01jn40685; Young GP, 2002, AM J GASTROENTEROL, V97, P2499, DOI 10.1111/j.1572-0241.2002.06046.x; Zalis ME, 2001, AM J ROENTGENOL, V176, P646, DOI 10.2214/ajr.176.3.1760646; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0; Zauber AG, 1997, GASTROENTEROLOGY, V112, pA50; Zubarik R, 1999, GASTROINTEST ENDOSC, V50, P322, DOI 10.1053/ge.1999.v50.97111	104	326	336	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1288	1296		10.1001/jama.289.10.1288	http://dx.doi.org/10.1001/jama.289.10.1288			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633191	Bronze			2022-12-28	WOS:000181466500031
J	Koot, VCM; Peeters, PHM; Granath, F; Grobbee, DE; Nyren, O				Koot, VCM; Peeters, PHM; Granath, F; Grobbee, DE; Nyren, O			Total and cause specific mortality among Swedish women with cosmetic breast implants: prospective study	BRITISH MEDICAL JOURNAL			English	Article							SURGERY; SWEDEN		Univ Med, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Koot, VCM (corresponding author), Comprehens Canc Ctr Middle Netherlands, POB 19079, NL-3501 DB Utrecht, Netherlands.		Grobbee, Diederick/C-7651-2014	Grobbee, Diederick/0000-0003-4472-4468				Angell M, 1996, NEW ENGL J MED, V334, P1513, DOI 10.1056/NEJM199606063342306; Brinton LA, 2001, EPIDEMIOLOGY, V12, P321, DOI 10.1097/00001648-200105000-00012; Fryzek JP, 2000, ANN PLAS SURG, V45, P349, DOI 10.1097/00000637-200045040-00001; Hasan JS, 2000, ANN PLAS SURG, V44, P89, DOI 10.1097/00000637-200044010-00017; Nyren O, 1998, BRIT MED J, V316, P417, DOI 10.1136/bmj.316.7129.417	5	50	51	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					527	528		10.1136/bmj.326.7388.527	http://dx.doi.org/10.1136/bmj.326.7388.527			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623911	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000181548400017
J	Allen, JF				Allen, JF			State transitions - a question of balance	SCIENCE			English	Editorial Material									Lund Univ, Ctr Chem & Chem Engn, Dept Plant Biochem, SE-22100 Lund, Sweden	Lund University	Allen, JF (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Dept Plant Biochem, Box 124, SE-22100 Lund, Sweden.			Allen, John/0000-0002-0950-0429				Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; ALLEN JF, 2002, SCI STKE, pPE43; [Anonymous], 2002, PHOTOSYNTHETICA; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Kaftan D, 2002, EMBO J, V21, P6146, DOI 10.1093/emboj/cdf624; Kruse O, 2001, NATURWISSENSCHAFTEN, V88, P284, DOI 10.1007/s001140100232; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623	10	195	211	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1530	1532		10.1126/science.1082833	http://dx.doi.org/10.1126/science.1082833			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624254				2022-12-28	WOS:000181367900024
J	Cramer, T; Yamanishi, Y; Clausen, BE; Forster, I; Pawlinski, R; Mackman, N; Haase, VH; Jaenisch, R; Corr, M; Nizet, V; Firestein, GS; Gerber, HP; Ferrara, N; Johnson, RS				Cramer, T; Yamanishi, Y; Clausen, BE; Forster, I; Pawlinski, R; Mackman, N; Haase, VH; Jaenisch, R; Corr, M; Nizet, V; Firestein, GS; Gerber, HP; Ferrara, N; Johnson, RS			HIF-1 alpha is essential for myeloid cell-mediated inflammation	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; CUTANEOUS INFLAMMATION; ALVEOLAR MACROPHAGES; OXYGEN HOMEOSTASIS; ENERGY-METABOLISM; HUMAN-NEUTROPHILS; OXIDATIVE STRESS; TUMOR HYPOXIA; T-CELL; EXPRESSION	Granulocytes and monocytes/macrophages of the myeloid lineage are the chief cellular agents of innate immunity. Here, we have examined the inflammatory response in mice with conditional knockouts of the hypoxia responsive transcription factor HIF-1alpha, its negative regulator VHL, and a known downstream target, VEGF. We find that activation of HIF-1alpha is essential for myeloid cell infiltration and activation in vivo through a mechanism independent of VEGF. Loss of VHL leads to a large increase in acute inflammatory responses. Our results show that HIF-1alpha is essential for the regulation of glycolytic capacity in myeloid cells: when HIF-1alpha is absent, the cellular ATP pool is drastically reduced. The metabolic defect results in profound impairment of myeloid cell aggregation, motility, invasiveness, and bacterial killing. This role for HIF-1alpha demonstrates its direct regulation of survival and function in the inflammatory microenvironment.	Univ Calif San Diego, Sch Med, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Div Rheumatol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; Univ Amsterdam, Dept Cell Biol & Histol, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; Scripps Res Inst, Dept Immunol, San Diego, CA 92037 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Genentech Inc, San Francisco, CA 94080 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam; Technical University of Munich; Scripps Research Institute; University of Pennsylvania; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Roche Holding; Genentech	Johnson, RS (corresponding author), Univ Calif San Diego, Sch Med, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.		Nizet, Victor/AAF-3190-2019; Haase, Volker Hans/AAJ-5061-2021; Johnson, Randall/AAM-1189-2021; Förster, Irmgard/P-8545-2016; PAwlinski, Rafal/AAD-6090-2022; CLAUSEN, Björn Erik/A-8229-2010; Haase, Volker Hans/A-6758-2013; Cramer, Thorsten/S-2479-2016	Johnson, Randall/0000-0002-4084-6639; Förster, Irmgard/0000-0002-7644-5642; CLAUSEN, Björn Erik/0000-0002-2484-7842; Haase, Volker Hans/0000-0002-7051-8994; Cramer, Thorsten/0000-0002-6462-239X; Nizet, Victor/0000-0003-3847-0422	NATIONAL CANCER INSTITUTE [R01CA082515, R01CA100787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002668] Funding Source: NIH RePORTER; NCI NIH HHS [CA82515, R01 CA100787, R01 CA082515] Funding Source: Medline; NIDDK NIH HHS [K08 DK002668] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNOLD F, 1987, BRIT J EXP PATHOL, V68, P569; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; BAKKER A., 1927, KLIN WOCHENSCHR, V6, P252, DOI 10.1007/BF01710710; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; BOXER LA, 1977, J CELL PHYSIOL, V91, P89, DOI 10.1002/jcp.1040910110; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Buttgereit F, 2000, IMMUNOL TODAY, V21, P192; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Denko NC, 2001, CANCER RES, V61, P795; Dvorak HF, 2000, SEMIN PERINATOL, V24, P75, DOI 10.1016/S0146-0005(00)80061-0; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Fleischmann W, 1927, BIOCHEM Z, V181, P395; Grunstein J, 1999, CANCER RES, V59, P1592; Haji-Michael PG, 1999, METABOLISM, V48, P779, DOI 10.1016/S0026-0495(99)90179-8; Hempel SL, 1996, AM J RESP CELL MOL, V14, P170, DOI 10.1165/ajrcmb.14.2.8630267; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; KALBHEN DA, 1967, MED PHARMACOL EXP, V16, P425; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KAY NE, 1980, J RETICULOENDOTH SOC, V28, P367; KELLETT DN, 1965, J PHARM PHARMACOL, V18, P199; Kempner W, 1939, J CLIN INVEST, V18, P291, DOI 10.1172/JCI101045; KITTLICK PD, 1986, EXP PATHOL-JENA, V30, P1; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Korhonen K, 2000, ANN CHIR GYNAECOL, V89, P7; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Levene PA, 1912, J BIOL CHEM, V11, P361; Levene PA, 1912, J BIOL CHEM, V12, P265; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; MANJUNATH N, 1993, J IMMUNOL, V151, P1528; MANNS G, 1967, EXP INT J EXP MED, V17, P557; MAPP PI, 1995, BRIT MED BULL, V51, P419, DOI 10.1093/oxfordjournals.bmb.a072970; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MICHL J, 1976, J EXP MED, V144, P1484, DOI 10.1084/jem.144.6.1484; NAJAFIPOUR H, 1995, EXP PHYSIOL, V80, P209, DOI 10.1113/expphysiol.1995.sp003841; NAKADATE T, 1985, JPN J PHARMACOL, V38, P161, DOI 10.1254/jjp.38.161; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; OFLAHERTY JT, 1977, J IMMUNOL, V119, P1751; Ott A, 1987, Adv Exp Med Biol, V220, P79; RAICK AN, 1973, CANCER RES, V33, P269; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; Roos D, 1979, Adv Exp Med Biol, V121, P29; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saadi S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0690hyp; SAWYER RG, 1991, ANN SURG, V213, P253, DOI 10.1097/00000658-199103000-00013; SBARRA AJ, 1959, J BIOL CHEM, V234, P1355; Schor H, 2000, Dev Immunol, V7, P227, DOI 10.1155/2000/51902; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; SIMCHOWITZ L, 1979, ARTHRITIS RHEUM, V22, P755, DOI 10.1002/art.1780220711; SIMMEN HP, 1994, INFECTION, V22, P386, DOI 10.1007/BF01715494; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thepen T, 2000, NAT BIOTECHNOL, V18, P48, DOI 10.1038/71908; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; VANOTTEREN GM, 1995, AM J RESP CELL MOL, V13, P399, DOI 10.1165/ajrcmb.13.4.7546769; WEISDORF DJ, 1982, BLOOD, V60, P888; WEISDORF DJ, 1982, INFLAMMATION, V6, P245, DOI 10.1007/BF00916406	65	1523	1611	7	150	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					645	657		10.1016/S0092-8674(03)00154-5	http://dx.doi.org/10.1016/S0092-8674(03)00154-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628185	Green Accepted, Bronze			2022-12-28	WOS:000181443600008
J	Dalal, HM; Evans, PH				Dalal, HM; Evans, PH			Achieving national service framework standards for cardiac rehabilitation and secondary prevention	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PRIMARY-CARE	Problem Integrated care for patients who survive a myocardial infarction is lacking. Many patients are not offered cardiac rehabilitation, and secondary prevention is not optimal. Design 12 month audit of 106 patients who survived an acute myocardial infarction. Background and setting Carrick Primary Care Trust in Cornwall (population 98 500) and one district general hospital. Key measures for improvement Proportion of patients who complete a cardiac rehabilitation programme after a myocardial infarction. Proportion of patients with optimal secondary prevention, as measured by smoking status, body mass index, cholesterol < 5.0 mmol/l, and blood pressure < 140/85 mm Hg. Strategies for change We set up a novel, integrated, and seamless system for cardiac rehabilitation. We employed a cardiac liaison nurse to identify and assess in hospital all patients with suspected acute myocardial infarction. The nurse offered patients the choice of home based rehabilitation with the Heart Manual or hospital based rehabilitation. The nurse gave discharge details to the patient's general practice; these were to be included on a practice based register of coronary heart disease. Effects of change All 106 eligible patients were offered cardiac rehabilitation and were included in a practice based register of coronary heart disease to facilitate long term follow up in primary care. 47 (44%) patients chose home based rehabilitation with the Heart Manual, and 41 (87%) of these completed the programme; 35 (33%) patients chose hospital based rehabilitation, and 17 (49%) of these completed the programme. The numbers of patients achieving secondary prevention targets improved significantly: those with serum cholesterol < 5.0 mmol/l at discharge increased from 28% at baseline to 75% at 12 months. Optimal care (at least 80-90% uptake of an intervention) was seen with antiplatelet and statin treatments and with smoking cessation. Significantly more patients were prescribed statins at follow up than at baseline (77/106 v 80/91, P=0.005). Lessons learnt National service framework targets for cardiac rehabilitation and secondary prevention can be achieved in patients who survive a myocardial infarction by integrating rehabilitation services (home and hospital) with secondary prevention clinics in primary care. Nurse led clinics in primary care facilitate long term structured care and optimal secondary prevention.	Royal Cornwall Hosp, Truro TR1 3LJ, Cornwall, England; Postgrad Med Ctr, Peninsula Med Sch, Somerset & N & E Devon Primary Care Res Network, Exeter EX2 5DW, Devon, England	Royal Cornwall Hospital; University of Exeter	Dalal, HM (corresponding author), Lower Lemon St Surg, Truro TR1 2LZ, Cornwall, England.			Evans, Philip/0000-0002-5277-3545				Ades PA, 2001, NEW ENGL J MED, V345, P892, DOI 10.1056/NEJMra001529; Bethell H J, 2001, J Cardiopulm Rehabil, V21, P111, DOI 10.1097/00008483-200103000-00008; Campbell NC, 1998, HEART, V80, P447, DOI 10.1136/hrt.80.5.447; *CORNW ISL SCILL H, 1998, HLTH POP 1998 ANN RE; Dalal HM, 1999, BRIT MED J, V319, P853, DOI 10.1136/bmj.319.7213.853a; de Bono DP, 1998, BRIT MED J, V316, P1329, DOI 10.1136/bmj.316.7141.1329; *DEP HLTH, 2000, NAT SERV FRAM COR HE; JOLLIFFE JA, 2002, COCHRANE LIB, V2, DOI UNSP AB001800; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G; Lewin RJP, 1998, BRIT MED J, V316, P1354, DOI 10.1136/bmj.316.7141.1354; Mayou R, 1996, BRIT MED J, V313, P1498, DOI 10.1136/bmj.313.7071.1498; Scottish Intercollegiate Guidelines Network 57, 2002, CARD REH NAT CLIN GU; Wood D, 1998, HEART, V80, pS1; 1998, EFFECTIVE HLTH CARE, V4	15	51	51	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					481	484		10.1136/bmj.326.7387.481	http://dx.doi.org/10.1136/bmj.326.7387.481			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609946	Green Published			2022-12-28	WOS:000181421400020
J	Filippone, M; Sartor, M; Zacchello, F; Baraldi, E				Filippone, M; Sartor, M; Zacchello, F; Baraldi, E			Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age	LANCET			English	Article							SEQUELAE	Bronchopulmonary dysplasia is associated with abnormalities in lung function during infancy, yet many infants recover with no respiratory problems in the long term. We therefore did a longitudinal study of pulmonary function in 18 children with moderate to severe bronchopulmonary dysplasia. Forced expiratory volume in 1 s (FEV1) and forced mid-expiratory flow (FEF25-75) at school age were lower than normal in 15 of IS children, and both showed a significant positive correlation with the maximal flow at functional residual capacity (Vmax(FRC)) at 24 months of age (r=0.68 and 0.85, respectively). Our results suggest that assessment of respiratory function during infancy can help to identify children with bronchopulmonary dysplasia at risk of incomplete recovery of respiratory function during childhood.	Univ Padua, Sch Med, Dept Paediat, I-35128 Padua, Italy	University of Padua	Baraldi, E (corresponding author), Univ Padua, Sch Med, Dept Paediat, Via Giustiniani 3, I-35128 Padua, Italy.		baraldi, eugenio/AAC-5233-2022	BARALDI, EUGENIO/0000-0002-1829-3652				Baraldi E, 1997, AM J RESP CRIT CARE, V155, P149, DOI 10.1164/ajrccm.155.1.9001304; Eber E, 2001, THORAX, V56, P317, DOI 10.1136/thorax.56.4.317; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603	5	95	100	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 1	2003	361	9359					753	754		10.1016/S0140-6736(03)12633-5	http://dx.doi.org/10.1016/S0140-6736(03)12633-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620742				2022-12-28	WOS:000181232000013
J	Makino, K; Oshima, K; Kurokawa, K; Yokoyama, K; Uda, T; Tagomori, K; Iijima, Y; Najima, M; Nakano, M; Yamashita, A; Kubota, Y; Kimura, S; Yasunaga, T; Honda, T; Shinagawa, H; Hattori, M; Iida, T				Makino, K; Oshima, K; Kurokawa, K; Yokoyama, K; Uda, T; Tagomori, K; Iijima, Y; Najima, M; Nakano, M; Yamashita, A; Kubota, Y; Kimura, S; Yasunaga, T; Honda, T; Shinagawa, H; Hattori, M; Iida, T			Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae	LANCET			English	Article							CHROMOSOMES; BACTERIA; SYSTEM; GENES	Background Vibrio parahaemolyticus, a gram-negative marine bacterium, is a worldwide cause of food-borne gastroenteritis. V parahaemolyticus strains of a few specific serotypes, probably derived from a common clonal ancestor, have lately caused a pandemic of gastroenteritis. The organism is phylogenetically close to V cholerae, the causative agent of cholera. Methods The whole genome sequence of a clinical V parahaemolyticus strain RIMD2210633 was established by shotgun sequencing. The coding sequences were identified by use of Gambler and Glimmer programs. Comparative analysis with the V cholerae genome was undertaken with MUMmer. Findings The genome consisted of two circular chromosomes of 3 288 558 bp and 1877 212 bp; it contained 4832 genes. Comparison of the V parahaemolyticus genome with that of V cholerae showed many rearrangements within and between the two chromosomes. Genes for the type III secretion system (TTSS) were identified in the genome of V parahaemolyticus; V cholerae does not have these genes. Interpretation The TTSS is a central virulence factor of diarrhoea-causing bacteria such as shigella, salmonella, and enteropathogenic Escherichia coli, which cause gastroenteritis by invading or intimately interacting with intestinal epithelial cells. Our results suggest that V parahaemolyticus and V cholerae use distinct mechanisms to establish infection. This finding explains clinical features of V parahaemolyticus infections, which commonly include inflammatory diarrhoea and in some cases systemic manifestations such as septicaemia, distinct from those of V cholerae infections, which are generally associated with non-inflammatory diarrhoea.	Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Suita, Osaka 5650871, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Mol Microbiol, Suita, Osaka 5650871, Japan; Osaka Univ, Genome Informat Res Ctr, Suita, Osaka 5650871, Japan; Kitasato Univ, Sch Sci, Kanagawa, Japan; Hitachi Instruments Serv Co, Tokyo, Japan; Kobe Inst Hlth, Kobe, Hyogo, Japan; RIKEN Yokohama Inst, Genom Sci Ctr, Human Genome Res Grp, Kanagawa, Japan	Osaka University; Osaka University; Osaka University; Kitasato University; Hitachi Limited; RIKEN	Iida, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	iida@biken.osaka-u.ac.jp	Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019	Hattori, Masahira/0000-0001-9467-0344; 				BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; CDC (Centers for Disease Control and Prevention), 2008, MMWR-MORBID MORTAL W, V47, P457; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P48; Choi SW, 1996, J CLIN MICROBIOL, V34, P928, DOI 10.1128/JCM.34.4.928-932.1996; Chowdhury NR, 2000, EMERG INFECT DIS, V6, P631, DOI 10.3201/eid0606.000612; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Eisen JA, 2000, GENOME BIOL, V1; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FUJINO T., 1953, MED JOUR OSAKA UNIV, V4, P299; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; JOSEPH SW, 1982, CRC CR REV MICROBIOL, V10, P77, DOI 10.3109/10408418209113506; Kachlany SC, 2000, J BACTERIOL, V182, P6169, DOI 10.1128/JB.182.21.6169-6176.2000; Kim YK, 2000, J BACTERIOL, V182, P3693, DOI 10.1128/JB.182.13.3693-3704.2000; McCarter Linda, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P51; Mintz Eric D., 1994, P345; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; Park KS, 2000, INFECT IMMUN, V68, P5742, DOI 10.1128/IAI.68.10.5742-5748.2000; Rowe-Magnus DA, 2001, P NATL ACAD SCI USA, V98, P652, DOI 10.1073/pnas.98.2.652; Sakiyama T, 2000, BIOSCI BIOTECH BIOCH, V64, P670, DOI 10.1271/bbb.64.670; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Tagomori K, 2002, J BACTERIOL, V184, P4351, DOI 10.1128/JB.184.16.4351-4358.2002; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Yamaichi Y, 1999, MOL MICROBIOL, V31, P1513, DOI 10.1046/j.1365-2958.1999.01296.x; YAMAZAKI K, 2001, GENOME INFORMATICS, V12, P409	30	738	1600	10	146	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					743	749		10.1016/S0140-6736(03)12659-1	http://dx.doi.org/10.1016/S0140-6736(03)12659-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620739				2022-12-28	WOS:000181232000010
J	Hartley, RR; Behringer, RP				Hartley, RR; Behringer, RP			Logarithmic rate dependence of force networks in sheared granular materials	NATURE			English	Article							PHYSICAL ANALYSIS; FRICTION LAW; STICK-SLIP; FLUCTUATIONS; DYNAMICS	Many models of slow, dense granular flows(1-5) assume that the internal stresses are independent of the shearing rate. In contrast, logarithmic rate dependence is found in solid-on-solid friction(6-8), geological settings(9-11) and elsewhere(12-15). Here we investigate the rate dependence of stress in a slowly sheared two-dimensional system of photoelastic disks, in which we are able to determine forces on the granular scale. We find that the mean (time-averaged) stress displays a logarithmic dependence on the shear rate for plastic (irreversible) deformations. However, there is no perceivable dependence on the driving rate for elastic (reversible) deformations, such as those that occur under moderate repetitive compression. Increasing the shearing rate leads to an increase in the strength of the force network and stress fluctuations. Qualitatively, this behaviour resembles the changes associated with an increase in density. Increases in the shearing rate also lead to qualitative changes in the distributions of stress build-up and relaxation events. If shearing is suddenly stopped, stress relaxations occur with a logarithmic functional form over long timescales. This slow collective relaxation of the stress network provides a mechanism for rate-dependent strengthening.	Duke Univ, Dept Phys, Durham, NC 27708 USA; Duke Univ, Ctr Nonlinear & Complex Syst, Durham, NC 27708 USA	Duke University; Duke University	Behringer, RP (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.							Baumberger T, 1999, PHYS REV B, V60, P3928, DOI 10.1103/PhysRevB.60.3928; BEHRINGER RP, 1997, POWDERS GRAINS 97; Berthoud P, 1999, PHYS REV B, V59, P14313, DOI 10.1103/PhysRevB.59.14313; Carlson JM, 1996, PHYS REV E, V53, P4153, DOI 10.1103/PhysRevE.53.4153; COULOMB A, 1776, MEMOIRES MATH PHYSIQ; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Geng JF, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.035506; Gnecco E, 2000, PHYS REV LETT, V84, P1172, DOI 10.1103/PhysRevLett.84.1172; HERMANN HJ, 1997, NATO ASI SERIES; HESLOT F, 1994, PHYS REV E, V49, P4973, DOI 10.1103/PhysRevE.49.4973; Heywood R.B., 1952, DESIGNING PHOTOELAST; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; Howell DW, 1999, CHAOS, V9, P559, DOI 10.1063/1.166430; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Karner SL, 1998, GEOPHYS RES LETT, V25, P4561, DOI 10.1029/1998GL900182; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Losert W, 2000, PHYS REV E, V61, P4060, DOI 10.1103/PhysRevE.61.4060; Meyer E., 1998, FRICTION RHEOLOGY NA; Nasuno S, 1998, PHYS REV E, V58, P2161, DOI 10.1103/PhysRevE.58.2161; Neddermann R. M., 1992, STATICS KINEMATICS G; Nowak ER, 1998, PHYS REV E, V57, P1971, DOI 10.1103/PhysRevE.57.1971; Ovarlez G, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.060302; PEARSSON BNJ, 1998, SLIDING FRICTION PHY; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Wood D. M., 1990, SOIL BEHAV CRITICAL	25	154	157	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					928	931		10.1038/nature01394	http://dx.doi.org/10.1038/nature01394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606996	Green Submitted			2022-12-28	WOS:000181186900044
J	Schaffner, A; Schneemann, M				Schaffner, A; Schneemann, M			Whipple's disease - from enigma to genomics	LANCET			English	Editorial Material							TROPHERYMA-WHIPPELII; BACTERIUM; BACILLUS		Univ Zurich, Dept Med, CH-8091 Zurich, Switzerland	University of Zurich	Schaffner, A (corresponding author), Univ Zurich, Dept Med, CH-8091 Zurich, Switzerland.							Dobbins 3rd WO, 1987, WHIPPLES DIS; Maibach RC, 2002, J CLIN MICROBIOL, V40, P2466, DOI 10.1128/JCM.40.7.2466-2471.2002; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; Marth T, 2002, GASTROENTEROLOGY, V123, P1468, DOI 10.1053/gast.2002.36583; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Schoedon G, 1997, J INFECT DIS, V176, P672, DOI 10.1086/514089; Street S, 1999, LANCET, V354, P1178, DOI 10.1016/S0140-6736(99)03065-2; *WELLC TRUST SANG, 2002, TROPH WHIPP; Whipple GH, 1907, B JOHNS HOPKINS HOSP, V18, P382; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z; ZINKERNAGEL AS, IN PRESS INFECTION	12	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					632	632		10.1016/S0140-6736(03)12616-5	http://dx.doi.org/10.1016/S0140-6736(03)12616-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606170				2022-12-28	WOS:000181129500008
J	Stephenson, JM; Cowan, FM				Stephenson, JM; Cowan, FM			Evaluating interventions for HIV prevention in Africa	LANCET			English	Editorial Material							SEXUALLY-TRANSMITTED-DISEASES; INFECTION; BEHAVIOR; TRIALS		UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AK, England	University of London; University College London; UCL Medical School	Stephenson, JM (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AK, England.	jstephen@gum.ucl.ac.uk		Cowan, Frances/0000-0003-3087-4422				Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Carpenter LM, 2002, J ACQ IMMUN DEF SYND, V29, P174, DOI 10.1097/00042560-200202010-00011; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hayes R. J., 2001, International Journal of STD and AIDS, V12, P62; Kamali A, 2002, TROP MED INT HEALTH, V7, P1053, DOI 10.1046/j.1365-3156.2002.00963.x; Kinsman J, 2002, HEALTH EDUC RES, V17, P253, DOI 10.1093/her/17.2.253; Richens J, 2000, LANCET, V355, P400, DOI 10.1016/S0140-6736(99)09109-6; Stephenson J, 1998, BMJ-BRIT MED J, V316, P611, DOI 10.1136/bmj.316.7131.611; Stephenson JM, 2000, AIDS, V14, pS115; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	13	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2003	361	9358					633	634		10.1016/S0140-6736(03)12613-X	http://dx.doi.org/10.1016/S0140-6736(03)12613-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606171				2022-12-28	WOS:000181129500009
J	Blumenschine, RJ; Peters, CR; Masao, FT; Clarke, RJ; Deino, AL; Hay, RL; Swisher, CC; Stanistreet, IG; Ashley, GM; McHenry, LJ; Sikes, NE; van der Merwe, NJ; Tactikos, JC; Cushing, AE; Deocampo, DM; Njau, JK; Ebert, JI				Blumenschine, RJ; Peters, CR; Masao, FT; Clarke, RJ; Deino, AL; Hay, RL; Swisher, CC; Stanistreet, IG; Ashley, GM; McHenry, LJ; Sikes, NE; van der Merwe, NJ; Tactikos, JC; Cushing, AE; Deocampo, DM; Njau, JK; Ebert, JI			Late pliocene Homo and hominid land use from western Olduvai Gorge, Tanzania	SCIENCE			English	Article							PLEISTOCENE HOMINIDS; ZINJANTHROPUS; BASIN	Excavation in the previously little-explored western portion of Olduvai Gorge indicates that hominid land use of the eastern pateobasin extended at least episodically to the west. Finds included a dentally complete Homo maxilla (OH 65) with lower face, Oldowan stone artifacts, and butchery-marked bones dated to be between 1.84 and 1.79 million years old. The hominid shows strong affinities to the KNM ER 1470 cranium from Kenya (Homo rudolfensis), a morphotype previously unrecognized at Olduvai. ER 1470 and OH 65 can be accommodated in the H. habilis holotype, casting doubt on H. rudolfensis as a biologically valid taxon.	Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, New Brunswick, NJ 08901 USA; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Paleocultural & Environm Res, Dar Es Salaam, Tanzania; Univ Witwatersrand, Sch Med, Sch Anat Sci, ZA-2193 Johannesburg, South Africa; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85718 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; Univ Liverpool, Dept Earth Sci, Liverpool L69 3BX, Merseyside, England; Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Univ Cape Town, Dept Archaeol, ZA-7700 Rondebosch, Cape Town, South Africa; Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, MRC 119, Washington, DC 20560 USA; Ebert & Associates, Albuquerque, NM 87107 USA	Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Witwatersrand; Berkeley Geochronolgy Center; University of Arizona; Rutgers State University New Brunswick; University of Liverpool; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Cape Town; Smithsonian Institution; Smithsonian National Museum of Natural History	Blumenschine, RJ (corresponding author), Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, 131 George St, New Brunswick, NJ 08901 USA.		McHenry, Lindsay Jean/ABP-7150-2022	McHenry, Lindsay Jean/0000-0003-1805-1941				Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 1998, J HUM EVOL, V34, P565, DOI 10.1006/jhev.1998.0216; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; CURTIS GH, 1972, CALIBRATION HOMINOID, P289; Groves C., 1989, THEORY HUMAN PRIMATE; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Leakey L. S. B., 1965, OLDUVAI GORGE 1951 1; LEAKEY LSB, 1964, NATURE, V202, P5, DOI 10.1038/202005a0; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; LEETHORP JA, 1987, S AFR J SCI, V83, P712; McMahon R.F., 1983, P505; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; PETERS CR, 1996, 4000000 YEARS HOMINI, P175; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; Stringer C.B., 1986, P266; Tobias P.V., 1991, OLDUVAI GORGE, V4; TOBIAS PV, 1966, NATURE, V209, P953, DOI 10.1038/209953a0; Walker A., 1981, HOMO ERECTUS PAPERS, P193; Walter R.C., 1992, QUATERN INT, V14, P37, DOI DOI 10.1016/1040-6182(92)90008-P; WALTER RC, 1991, NATURE, V354, P145, DOI 10.1038/354145a0; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wood Bernard, 1993, P485; [No title captured]	29	174	178	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1217	1221		10.1126/science.1075374	http://dx.doi.org/10.1126/science.1075374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	646YY	12595689				2022-12-28	WOS:000181065500036
J	Bastian, LA; Smith, CM; Nanda, K				Bastian, LA; Smith, CM; Nanda, K			Is this woman perimenopausal?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE-REPLACEMENT THERAPY; MENOPAUSAL HOT FLASHES; HUMAN MENSTRUAL-CYCLE; CIGARETTE-SMOKING; CLIMACTERIC COMPLAINTS; URINARY-INCONTINENCE; MULTIETHNIC SAMPLE; NATURAL MENOPAUSE; RISK-FACTORS; THAI WOMEN	Context Perimenopause is a time of transition for women at midlife. Women want to know whether they are starting this change and physicians need to know the accuracy of a clinical examination in identifying perimenopausal women. These women should be counseled about alleviating climacteric symptoms, using contraception, and preventing diseases such as osteoporosis. Objective To systematically review the accuracy of self-assessment, symptoms, signs, and laboratory tests in diagnosing women in perimenopause. Data Sources English-language articles that presented data relevant to diagnosis of perimenopause were identified in a MEDLINE search from 1966 to 2001. References of these articles and other publications also were reviewed. Study Selection Cross-sectional or longitudinal studies of women aged 40 years or older that used the definition of perimenopause as 3 to 11 months of amenorrhea or irregular periods, included a premenopausal control group, and reported a clinical examination finding. Of 1246 articles identified, 16 studies were included in the analysis. Data Extraction Two authors independently reviewed articles for quality (L.A.B. and C.M.S.). Discrepancies were resolved by a third author (K.N.). Data Synthesis The prior probability of perimenopause is directly related to a woman's age. After considering age, the following yielded the greatest positive likelihood ratios (LRs+): self assessment of going through the transition (LR+ range, 1.53-2.13), symptoms of hot flashes (LR+ range, 2.15-4.06), night sweats (LR+ 1.90; 95% confidence interval [CI], 1.63-2.21), vaginal dryness (LR+ range, 1.48-3.79), high follicle-stimulating hormone levels (LR+ 3.06; 95% CI, 2.06-4.54), and low inhibin B levels (LR+ 2.05; 95% CI, 0.96-4.39). Self-assessment of perimenopausal status had the smallest negative LR (range, 0.18-0.36). Conclusions No one symptom or test is accurate enough by itself to rule in or rule out perimenopause. Clinicians should diagnose perimenopause based on menstrual history and age without relying on laboratory test results.	Vet Affairs Med Ctr, Hlth Serv Res, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; Duke Univ, Dept Internal Med, Durham, NC USA; Duke Univ, Dept Obstet & Gynecol, Durham, NC USA; Family Hlth Int, Res Triangle Pk, NC 27709 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University	Bastian, LA (corresponding author), Vet Affairs Med Ctr, Hlth Serv Res, Ctr Hlth Serv Res Primary Care, Mail Code 152,508 Fulton St, Durham, NC 27705 USA.	basti001@mc.duke.edu		Nanda, Kavita/0000-0001-7650-2929				ADENA MA, 1982, ANN HUM BIOL, V9, P121, DOI 10.1080/03014468200005591; Al-Azzawi F, 1999, OBSTET GYNECOL, V93, P258, DOI 10.1016/S0029-7844(98)00403-7; *AM COLL OBST GYN, 2001, ACOG PRACT B, V28; *AM COLL OBST GYN, 2000, ACOG PRACT B, V18; Avis Nancy E., 1994, Annals of Epidemiology, V4, P214; Avis NE, 2000, MENOPAUSE, V7, P297, DOI 10.1097/00042192-200007050-00004; BARBIERI RL, 1986, FERTIL STERIL, V46, P232; Berg JA, 1999, MENOPAUSE, V6, P105; Bergen AW, 1999, JNCI-J NATL CANCER I, V91, P1365, DOI 10.1093/jnci/91.16.1365; Bosworth HB, 2001, PSYCHOSOM MED, V63, P603, DOI 10.1097/00006842-200107000-00013; BRAMBILLA DJ, 1989, J CLIN EPIDEMIOL, V42, P1031, DOI 10.1016/0895-4356(89)90044-9; BRAMBILLA DJ, 1994, AM J EPIDEMIOL, V140, P1091, DOI 10.1093/oxfordjournals.aje.a117209; Bromberger JT, 1997, AM J EPIDEMIOL, V145, P124; Bromberger JT, 2001, AM J PUBLIC HEALTH, V91, P1435, DOI 10.2105/AJPH.91.9.1435; Burger HG, 1998, CLIN ENDOCRINOL, V48, P809; Caillouette JC, 1997, AM J OBSTET GYNECOL, V176, P1270, DOI 10.1016/S0002-9378(97)70345-4; CHOMPOOTWEEP S, 1993, MATURITAS, V17, P63, DOI 10.1016/0378-5122(93)90124-Z; CRAMER DW, 1995, MATURITAS, V22, P79, DOI 10.1016/0378-5122(95)00928-E; DENNERSTEIN L, 1994, J PSYCHOSOM OBST GYN, V15, P59, DOI 10.3109/01674829409025630; Dennerstein L, 1999, J NERV MENT DIS, V187, P685, DOI 10.1097/00005053-199911000-00006; Dennerstein L, 2000, OBSTET GYNECOL, V96, P351, DOI 10.1016/S0029-7844(00)00930-3; DENNERSTEIN L, 1987, OBSTET GYN CLIN N AM, V14, P33; DENNERSTEIN L, 1993, MED J AUSTRALIA, V159, P232, DOI 10.5694/j.1326-5377.1993.tb137821.x; DEUTSH H, 1945, PSYCHOL WOMEN PSYCHO; Dudley E C, 1998, Climacteric, V1, P18, DOI 10.3109/13697139809080677; EDDY D, 1992, FAST STAR PRO VERSIO; EDINGTON RF, 1980, CAN MED ASSOC J, V123, P23; FELDMAN BM, 1985, RES NURS HEALTH, V8, P261, DOI 10.1002/nur.4770080308; FLINT M, 1990, ANN NY ACAD SCI, V592, P134; Freedman RR, 2001, AM J HUM BIOL, V13, P453, DOI 10.1002/ajhb.1077; FRIEDMAN AJ, 1987, FERTIL STERIL, V47, P398; Garamszegi C, 1998, J PSYCHOSOM OBST GYN, V19, P165, DOI 10.3109/01674829809025694; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Greendale GA, 1999, LANCET, V353, P571, DOI 10.1016/S0140-6736(98)05352-5; Hammar M, 1998, BRIT J OBSTET GYNAEC, V105, P904, DOI 10.1111/j.1471-0528.1998.tb10237.x; Hardy R, 2000, INT J EPIDEMIOL, V29, P845, DOI 10.1093/ije/29.5.845; Harlow SD, 2000, MATURITAS, V36, P93, DOI 10.1016/S0378-5122(00)00145-6; Harper AJ, 2001, FERTIL STERIL, V76, pS108, DOI 10.1016/S0015-0282(01)02318-4; HARTMANN BW, 1995, GYNECOL ENDOCRINOL, V9, P247, DOI 10.3109/09513599509160453; HEE J, 1993, MATURITAS, V18, P9, DOI 10.1016/0378-5122(93)90026-E; HIATT RA, 1986, JNCI-J NATL CANCER I, V76, P833; Ho SC, 1999, MATURITAS, V33, P219, DOI 10.1016/S0378-5122(99)00056-0; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; HUNTER MS, 1990, PSYCHOSOM MED, V52, P357, DOI 10.1097/00006842-199005000-00009; ILLINGWORTH PJ, 1991, J CLIN ENDOCR METAB, V73, P667, DOI 10.1210/jcem-73-3-667; JASZMANN L, 1969, INT J FERTIL, V14, P106; JENSEN J, 1985, NEW ENGL J MED, V313, P973, DOI 10.1056/NEJM198510173131602; JOHNSON SR, 1987, CLIN OBSTET GYNECOL, V30, P367, DOI 10.1097/00003081-198706000-00017; Kato I, 1998, J CLIN EPIDEMIOL, V51, P1271, DOI 10.1016/S0895-4356(98)00119-X; KAUFERT PA, 1992, MATURITAS, V14, P143, DOI 10.1016/0378-5122(92)90006-P; KAUFMAN DW, 1980, AM J PUBLIC HEALTH, V70, P420, DOI 10.2105/AJPH.70.4.420; Klein J, 2001, AM J OBSTET GYNECOL, V185, P758, DOI 10.1067/mob.2001.114689; KOSTER A, 1993, MATURITAS, V16, P49; KRONENBERG F, 1987, CAN J PHYSIOL PHARM, V65, P1312, DOI 10.1139/y87-208; KRONENBERG F, 1990, ANN NY ACAD SCI, V592, P52; Kuh D, 1999, J EPIDEMIOL COMMUN H, V53, P453, DOI 10.1136/jech.53.8.453; Leidy LE, 1997, MENOPAUSE, V4, P154; Lobo RA., 2000, MENOPAUSE BIOL PATHO; Maartens LW, 2001, FAM PRACT, V18, P189, DOI 10.1093/fampra/18.2.189; MACMAHON B, 1982, NEW ENGL J MED, V307, P1062, DOI 10.1056/NEJM198210213071707; MATTHEWS KA, 1994, ARCH INTERN MED, V154, P2349, DOI 10.1001/archinte.154.20.2349; McKinlay SM, 1996, MATURITAS, V23, P137, DOI 10.1016/0378-5122(95)00985-X; MCKINLAY SM, 1974, BRIT J PREV SOC MED, V28, P108; MCKINLAY SM, 1992, MATURITAS, V14, P103, DOI 10.1016/0378-5122(92)90003-M; MICHNOVICZ JJ, 1986, NEW ENGL J MED, V315, P1305, DOI 10.1056/NEJM198611203152101; MILSOM I, 1993, J UROLOGY, V149, P1459, DOI 10.1016/S0022-5347(17)36415-7; NAGAMANI M, 1987, AM J OBSTET GYNECOL, V156, P561, DOI 10.1016/0002-9378(87)90050-0; NILSSON K, 1995, MATURITAS, V21, P51, DOI 10.1016/0378-5122(94)00863-3; O'Connor KA, 2001, AM J HUM BIOL, V13, P465, DOI 10.1002/ajhb.1078; OLDENHAVE A, 1993, AM J OBSTET GYNECOL, V168, P765, DOI 10.1016/S0002-9378(12)90816-9; Panyakhamlerd Krasean, 1999, Journal of the Medical Association of Thailand, V82, P352; Pearlstein T, 1997, ENDOCRIN METAB CLIN, V26, P279, DOI 10.1016/S0889-8529(05)70247-4; Pokras R, 1989, Stat Bull Metrop Insur Co, V70, P12; Punyahotra S, 1997, MATURITAS, V26, P1, DOI 10.1016/S0378-5122(96)01058-4; REKERS H, 1992, MATURITAS, V15, P101, DOI 10.1016/0378-5122(92)90244-X; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sherburn M, 2001, OBSTET GYNECOL, V98, P628, DOI 10.1016/S0029-7844(01)01508-3; SHERMAN BM, 1975, J CLIN INVEST, V55, P699, DOI 10.1172/JCI107979; Stellato R K, 1998, Endocr Pract, V4, P137; TANG GWK, 1994, MATURITAS, V19, P177, DOI 10.1016/0378-5122(94)90069-8; Torgerson DJ, 1997, EUR J OBSTET GYN R B, V74, P63, DOI 10.1016/S0301-2115(97)00085-7; TORGERSON DJ, 1994, MATURITAS, V19, P83, DOI 10.1016/0378-5122(94)90057-4; TRELOAR AE, 1967, INT J FERTIL, V12, P77; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WINOKUR G, 1973, AM J PSYCHIAT, V130, P92, DOI 10.1176/ajp.130.1.92; World Health Organisation [WHO, 1996, WHO TECHN REP SER, V866	87	71	73	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2003	289	7					895	902		10.1001/jama.289.7.895	http://dx.doi.org/10.1001/jama.289.7.895			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647BW	12588275				2022-12-28	WOS:000181072200035
J	Schulz, HU; Mantke, R; Freitag, J; Lippert, H				Schulz, HU; Mantke, R; Freitag, J; Lippert, H			Persistent left superior vena cava	LANCET			English	Editorial Material									Magdeburg Univ Hosp, Dept Surg, D-39120 Magdeburg, Germany; Schoenebeck Cty Hosp, Dept Radiol, D-39218 Schoenebeck, Germany	University Hospital Magdeburg	Schulz, HU (corresponding author), Magdeburg Univ Hosp, Dept Surg, D-39120 Magdeburg, Germany.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					560	560		10.1016/S0140-6736(03)12514-7	http://dx.doi.org/10.1016/S0140-6736(03)12514-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598140	Bronze			2022-12-28	WOS:000181033400008
J	Vagnucci, AH; Li, WW				Vagnucci, AH; Li, WW			Alzheimer's disease and angiogenesis	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELLS; TUMOR; MICROVESSELS; INHIBITION; DEMENTIA; DRUGS; BRAIN; RISK	Despite enormous investigative efforts, the pathological basis for Alzheimer's disease remains unclear. Suggested mechanisms for the disorder include cerebral hypoperfusion, inflammation, gene polymorphisms, and molecular lesions in the brain. In this Hypothesis, we argue that the vascular endothelial cell has a central role in the progressive destruction of cortical neurons in Alzheimer's disease. In Alzheimer's disease, the brain endothelium secretes the precursor substrate for the beta-amyloid plaque and a neurotoxic peptide that selectively kills cortical neurons. Large populations of endothelial cells are activated by angiogenesis due to brain hypoxia and inflammation. Results of epidemiological studies have shown that long-term use of non-steroidal anti-inflammatory drugs, statins, histamine H2-receptor blockers, or calcium-channel blockers seems to prevent Alzheimer's disease. We think this benefit is largely due to these drugs' ability to inhibit angiogenesis. If Alzheimer's disease is an angiogenesis-dependent disorder, then development of antiangiogenic drugs targeting the abnormal brain endothelial cell might be able to prevent and treat this disease. We suggest several laboratory and clinical approaches for testing our hypothesis.	Angiogenesis Fdn, Inst Adv Studies, Cambridge, MA 02238 USA; Cambridge Hosp, Dept Psychiat, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; Harvard Medical School	Li, WW (corresponding author), Angiogenesis Fdn, Inst Adv Studies, POB 382111, Cambridge, MA 02238 USA.	wli@angio.org						BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; BUEE L, 1992, AM J PATHOL, V141, P783; Buee L, 1997, ANN NY ACAD SCI, V826, P7, DOI 10.1111/j.1749-6632.1997.tb48457.x; Ciallella JR, 1999, THROMB HAEMOSTASIS, V81, P630; Feleszko W, 1999, INT J CANCER, V81, P560, DOI 10.1002/(SICI)1097-0215(19990517)81:4<560::AID-IJC10>3.0.CO;2-7; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7; Grammas P, 1999, AM J PATHOL, V154, P337, DOI 10.1016/S0002-9440(10)65280-7; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jones MK, 1999, NAT MED, V5, P1418; Kalaria RN, 1998, MOL BRAIN RES, V62, P101, DOI 10.1016/S0169-328X(98)00190-9; Li WW, 2000, ACAD RADIOL, V7, P800, DOI 10.1016/S1076-6332(00)80629-7; Liu FJ, 2000, BIOL PHARM BULL, V23, P735, DOI 10.1248/bpb.23.735; Matsuoka Y, 2001, AM J PATHOL, V158, P1345, DOI 10.1016/S0002-9440(10)64085-0; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Miyakawa T, 1997, ANN NY ACAD SCI, V826, P25, DOI 10.1111/j.1749-6632.1997.tb48458.x; PERLMUTTER LS, 1990, BRAIN RES, V508, P13, DOI 10.1016/0006-8993(90)91111-S; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SIEDLAK SL, 1991, J HISTOCHEM CYTOCHEM, V39, P899, DOI 10.1177/39.7.1865106; St Croix B, 2000, SCIENCE, V289, P1197; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Sundberg C, 2001, AM J PATHOL, V158, P1145, DOI 10.1016/S0002-9440(10)64062-X; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; TSUCHIDA T, 1990, DIGESTION, V47, P8, DOI 10.1159/000200469; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439	28	204	231	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					605	608		10.1016/S0140-6736(03)12521-4	http://dx.doi.org/10.1016/S0140-6736(03)12521-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598159				2022-12-28	WOS:000181033400026
J	Horowitz, HW				Horowitz, HW			Dumbing down	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2003	289	11					1349	1350		10.1001/jama.289.11.1349	http://dx.doi.org/10.1001/jama.289.11.1349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	656PM	12636437				2022-12-28	WOS:000181616200001
J	Igakura, T; Stinchcombe, JC; Goon, PKC; Taylor, GP; Weber, JN; Griffiths, GM; Tanaka, Y; Osame, M; Bangham, CRM				Igakura, T; Stinchcombe, JC; Goon, PKC; Taylor, GP; Weber, JN; Griffiths, GM; Tanaka, Y; Osame, M; Bangham, CRM			Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton	SCIENCE			English	Article							T-CELL LEUKEMIA; HUMAN-IMMUNODEFICIENCY-VIRUS; ADHESION MOLECULE-1; SYNCYTIUM FORMATION; TYPE-1 INFECTION; TRANSMISSION; ANTIBODIES; ACTIVATION; EXPRESSION; ADENOVIRUS	Cell contact is required for efficient transmission of human T cell leukemia virus-type 1 (HTLV-1) between cells and between individuals, because naturally infected lymphocytes produce virtually no cell-free infectious HTLV-I particles. However, the mechanism of cell-to-cell spread of HTLV-I is not understood. We show here that cell contact rapidly induces polarization of the cytoskeleton of the infected cell to the cell-cell junction. HTLV-I core (Gag protein) complexes and the HTLV-I genome accumulate at the cell-cell junction and are then transferred to the uninfected cell. Other lymphotropic viruses, such as HIV-1, may similarly subvert normal T cell physiology to allow efficient propagation between cells.	Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Dept Genitourinary Med & Communicable Dis, London W2 1PG, England; Kagoshima Univ, Fac Med, Dept Internal Med 3, Kagoshima 8908520, Japan; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Ryukyus, Fac Med, Okinawa Asia Res Ctr Med Sci, Dept Immunol & Infect Dis, Okinawa 9030215, Japan	Imperial College London; Imperial College London; Kagoshima University; University of Oxford; University of the Ryukyus	Bangham, CRM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, St Marys Campus,Norfolk Pl, London W2 1PG, England.		Goon, Peter/AAF-2508-2021	stinchcombe, jane/0000-0003-1459-9299; Griffiths, Gillian/0000-0003-0434-5842; Bangham, Charles/0000-0003-2624-3599				Cullen BR, 2001, CELL, V105, P697, DOI 10.1016/S0092-8674(01)00392-0; Daenke S, 1999, J GEN VIROL, V80, P1429, DOI 10.1099/0022-1317-80-6-1429; Delamarre L, 1997, J VIROL, V71, P259, DOI 10.1128/JVI.71.1.259-266.1997; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; FAN N, 1992, J CLIN MICROBIOL, V30, P905, DOI 10.1128/JCM.30.4.905-910.1992; GESSAIN A, 1985, LANCET, V2, P407; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; Hildreth JEK, 1997, J VIROL, V71, P1173, DOI 10.1128/JVI.71.2.1173-1180.1997; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; Jassal SR, 2001, VIRUS RES, V78, P17, DOI 10.1016/S0168-1702(01)00279-9; Le Blanc I, 2002, J VIROL, V76, P905, DOI 10.1128/JVI.76.2.905-911.2002; Mabit H, 2002, J VIROL, V76, P9962, DOI 10.1128/JVI.76.19.9962-9971.2002; MERIC C, 1986, J VIROL, V60, P450; MEULLER NE, 1997, VIRAL INFECT HUMANS, P785; NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310; NAGY K, 1984, HUMAN T CELL LEUKEMI, P121; OKOCHI K, 1984, VOX SANG, V46, P245, DOI 10.1111/j.1423-0410.1984.tb00083.x; OSAME M, 1986, LANCET, V1, P1031; PEARCEPRATT R, 1994, J VIROL, V68, P2898, DOI 10.1128/JVI.68.5.2898-2905.1994; POPOVIC M, 1983, SCIENCE, V219, P856, DOI 10.1126/science.6600519; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; SOMMERFELT MA, 1988, SCIENCE, V242, P1557, DOI 10.1126/science.3201246; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Valentin H, 1997, J VIROL, V71, P8522, DOI 10.1128/JVI.71.11.8522-8530.1997; Yamamoto A, 1997, J NEUROL SCI, V151, P121, DOI 10.1016/S0022-510X(97)00121-4; YAMAMOTO N, 1982, SCIENCE, V217, P737, DOI 10.1126/science.6980467	29	527	540	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 14	2003	299	5613					1713	1716		10.1126/science.1080115	http://dx.doi.org/10.1126/science.1080115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654WM	12589003				2022-12-28	WOS:000181519500039
J	Itoh, Y; Kawamata, Y; Harada, M; Kobayashi, M; Fujii, R; Fukusumi, S; Ogi, K; Hosoya, M; Tanaka, Y; Uejima, H; Tanaka, H; Maruyama, M; Satoh, R; Okubo, S; Kizawa, H; Komatsu, H; Matsumura, F; Noguchi, Y; Shinobara, T; Hinuma, S; Fujisawa, Y; Fujino, M				Itoh, Y; Kawamata, Y; Harada, M; Kobayashi, M; Fujii, R; Fukusumi, S; Ogi, K; Hosoya, M; Tanaka, Y; Uejima, H; Tanaka, H; Maruyama, M; Satoh, R; Okubo, S; Kizawa, H; Komatsu, H; Matsumura, F; Noguchi, Y; Shinobara, T; Hinuma, S; Fujisawa, Y; Fujino, M			Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40	NATURE			English	Article							SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; RECEPTOR; GLUCOSE; RAT; EXPRESSION; SUBTYPE	Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue(1,2). Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion(3). Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion(4,5). Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood(6). Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.	Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Tsukuba, Ibaraki 3004293, Japan	Takeda Chemical Industries	Hinuma, S (corresponding author), Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.			Komatsu, Hidetoshi/0000-0003-1630-0537; Maruyama, Minoru/0000-0002-1478-9415; Kawamata, Yuji/0000-0001-5652-4899				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; BRAUN T, 1987, BIOCHEM BIOPH RES CO, V149, P125, DOI 10.1016/0006-291X(87)91613-5; BRISCOE CP, 2002, J BIOL CHEM     1219; BRUNO JF, 1993, ENDOCRINOLOGY, V133, P2561, DOI 10.1210/en.133.6.2561; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Gadsby R, 2002, ADV DRUG DELIVER REV, V54, P1165, DOI 10.1016/S0169-409X(02)00094-7; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hinuma S, 1999, J MOL MED, V77, P495, DOI 10.1007/s001090050403; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Jovanovic L, 1999, ANN CLIN LAB SCI, V29, P33; KAWAMATA Y, 2003, J BIOL CHEM     0110; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LANKATBUTTGEREIT B, 1994, EXP CLIN ENDOCRINOL, V102, P341, DOI 10.1055/s-0029-1211301; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Nunez EA, 1997, PROSTAG LEUKOTR ESS, V57, P107, DOI 10.1016/S0952-3278(97)90500-7; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; SPECTOR AA, 1975, SCIENCE, V190, P490, DOI 10.1126/science.1166323; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; WANK SA, 1992, P NATL ACAD SCI USA, V89, P3125, DOI 10.1073/pnas.89.7.3125; WOLHEIM CB, 1986, ANN NY ACAD SCI, V488, P317	26	1180	1299	7	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					173	176		10.1038/nature01478	http://dx.doi.org/10.1038/nature01478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12629551				2022-12-28	WOS:000181488900047
J	Milner-Gulland, EJ; Bukreevea, OM; Coulson, T; Lushchekina, AA; Kholodova, MV; Bekenov, AB; Grachev, IA				Milner-Gulland, EJ; Bukreevea, OM; Coulson, T; Lushchekina, AA; Kholodova, MV; Bekenov, AB; Grachev, IA			Conservation - Reproductive collapse in saiga antelope harems	NATURE			English	Article							POPULATIONS; DYNAMICS		Univ London Imperial Coll Sci Technol & Med, Dept Environm Sci & Technol, London SW7 2AZ, England; Dept Hunting Management, Elista 358000, Republic Kalmyk, Russia; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; AN Severtsov Inst Ecol & Evolut, Moscow 119071, Russia; Minist Educ, Inst Zool, Almaty 480032, Kazakhstan	Imperial College London; University of Cambridge; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Institute of Zoology in Kazakhstan	Milner-Gulland, EJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Environm Sci & Technol, S Kensington Campus, London SW7 2AZ, England.		Coulson, Tim/AAL-8148-2021; Lushchekina, Anna/C-3945-2014; Grachev, Yuriy/AAY-9102-2020; Kholodova, Marina/V-3628-2019	Coulson, Tim/0000-0001-9371-9003; Lushchekina, Anna/0000-0003-1915-7430; Milner-Gulland, E.J./0000-0003-0324-2710; grachev, yuriy/0000-0003-3311-2079				Bekenov AB, 1998, MAMMAL REV, V28, P1, DOI 10.1046/j.1365-2907.1998.281024.x; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Hudson RJ., 1993, FARMING WAPITI RED D; Milner-Gulland EJ, 2001, ORYX, V35, P340, DOI 10.1017/S0030605300032105; MILNERGULLAND EJ, 1995, NATURE, V377, P488, DOI 10.1038/377488a0; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Robinson Sarah., 2000, PASTORALISM LAND DEG; Sharp R, 2002, ORYX, V36, P323, DOI 10.1017/S0030605302000625; Sokolov V. E., 1998, SAIGA FILOGENY TAXON; [No title captured]	10	177	189	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					135	135		10.1038/422135a	http://dx.doi.org/10.1038/422135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634775				2022-12-28	WOS:000181488900034
J	Parish, WL; Laumann, EO; Cohen, MS; Pan, SM; Zheng, HY; Hoffman, I; Wang, TF; Ng, KH				Parish, WL; Laumann, EO; Cohen, MS; Pan, SM; Zheng, HY; Hoffman, I; Wang, TF; Ng, KH			Population-based study of chlamydial infection in China - A hidden epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED DISEASES; REPUBLIC-OF-CHINA; TRACHOMATIS INFECTIONS; UNITED-STATES; RISK-FACTORS; SEX WORKERS; PREVALENCE; HIV; AIDS; WOMEN	Context Sexually transmitted diseases are increasing rapidly in China. Surveillance data imperfectly indicate current prevalence and risk factors, Objectives To estimate the prevalence of genital chlamydial and gonococcal infections and to describe patterns of infection by subgroup and behavioral patterns. Design, Setting, and Participants A national stratified probability sample of 3426 Chinese individuals (1738 women and 1688 men) aged 20 to 64 years, who were interviewed between August 1999 and August 2000, completed a computer-administered survey, and provided a urine specimen (69% total participation rate). Main Outcome Measure Positive-test result for chlamydial or gonococcal infections. Results The overall prevalence per 100 population of chlamydial infection was 2.6 (95% confidence interval [CI], 1.6-4.1) for women and 2.1 (95% CI, 1.3-3.3) for men. For gonococcal infection, the overall prevalence per 100 population was 0.08 (95% CI, 0.02-0.4) for women and 0.02 (95% CI, 0.005-0.1) for men. Risk factors for chlamydial infection among men aged 20 to 44 years were unprotected sex with a commercial sex worker (odds ratio [OR], 8.24; 95% CI, 3.51-19.35), less education (OR, 7.20; 95% CI, 2.31-22.37), and recent sex with their spouse or other steady partner (OR, 7.73; 95% CI, 2.70-22.10). Among women aged 20 to 44 years, risk factors for chlamydial infection were having less education (OR, 2.82; 95% CI, 1.01-7.91) and living in a city (OR, 3.46; 95% CI, 1.67-7.18) or along the southern coast (OR, 2.16; 95% CI, 1.29-3.63) and having a spouse or other steady sexual partner who earned a high income (OR, 2.85; 95% CI, 1.11-7.29), who socialized often (OR, 2.79; 95% CI, 1.08-7.19), or who traveled less than 1 week per year (OR, 5.40; 95% CI, 1.44-20.3). Conclusions The prevalence of chlamydial infection in China is substantial. The patterns of infection suggest potential avenues for intervention.	Univ Chicago, Natl Opin Res Ctr, Populat Res Ctr, Chicago, IL 60637 USA; Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; Renmin Univ, Sociol Sexual Inst, Beijing, Peoples R China; Peking Union Med Coll, Dermatol Venerol Div, Beijing, Peoples R China	University of Chicago; University of North Carolina; University of North Carolina Chapel Hill; Renmin University of China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Parish, WL (corresponding author), 1126 E 59th St, Chicago, IL 60637 USA.				FIC NIH HHS [D43 TW01039] Funding Source: Medline; NIAID NIH HHS [U19 AI31496, P30 AI50410] Funding Source: Medline; NICHD NIH HHS [P30 HD18288, R01 HD34157] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034157, P30HD018288] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031496, P30AI050410] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALI MM, 2001, AIDS BEHAV, V5, P343, DOI DOI 10.1023/A:1013186806939; CARAEL M, 1995, SEXUAL BEHAV AIDS DE; *CDCP, 2003, CHLM US; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Cheng YM, 2002, CONTRACEPTION, V66, P179, DOI 10.1016/S0010-7824(02)00350-5; *CHIN CTR DIS CONT, YEAR 2001 NAT SEX TR; *CHIN NAT CENS OFF, 1997, 1995 NAT 1 PERC POP; Chinese Population Census Office under the State Council and Department of Population Social Science and Technology Statistics of the National Bureau of Statistics of China, 2002, TAB 2000 POP CENS PE; Cohen MS, 2000, SEX TRANSM DIS, V27, P143, DOI 10.1097/00007435-200003000-00004; Cohen MS, 1996, J INFECT DIS, V174, pS223, DOI 10.1093/infdis/174.Supplement_2.S223; DOLCINI MM, 2000, AIDS BEHAV, V4, P297; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Fonck K, 2000, SEX TRANSM DIS, V27, P417, DOI 10.1097/00007435-200008000-00007; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Gielen A, 2001, AIDS BEHAV, V5, P193; Groseclose SL, 1999, SEX TRANSM DIS, V26, P339, DOI 10.1097/00007435-199907000-00006; Hanenberg R, 1998, AIDS CARE, V10, P69, DOI 10.1080/713612352; Hee Choi Kyung, 2000, AIDS BEHAV, V4, P111; Hershatter Gail, 1997, DANGEROUS PLEASURES; Howell MR, 1998, ANN INTERN MED, V128, P277, DOI 10.7326/0003-4819-128-4-199802150-00005; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; KISH L, 1974, J ROY STAT SOC B MET, V36, P1; Klouman E, 2002, INT J STD AIDS, V13, P234, DOI 10.1258/0956462021925027; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lim L. L., 1998, SEX SECTOR EC SOCIAL; Long JS, 1997, REGRESSION MODELS CA; Morre SA, 1999, J CLIN MICROBIOL, V37, P3092; PARISH WL, 2003, CHINESE HLTH FAMILY; Paxton LA, 1998, SEX TRANSM INFECT, V74, P421, DOI 10.1136/sti.74.6.421; Pierpoint T, 2000, SEX TRANSM INFECT, V76, P273, DOI 10.1136/sti.76.4.273; Plafker T, 2001, BRIT MED J, V323, P714, DOI 10.1136/bmj.323.7315.714; Pulerwitz J, 2001, AM J PUBLIC HEALTH, V91, P1650, DOI 10.2105/AJPH.91.10.1650; Radcliffe KW, 2001, SEX TRANSM INFECT, V77, P265, DOI 10.1136/sti.77.4.265; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; Solomon S, 1998, INT J STD AIDS, V9, P98, DOI 10.1258/0956462981921756; *STAT STAT BUR, 1999, CHIN POP STAT YB 199; *STATA CORP, 2001, STATA REF MAN REL 7, V4; SUN S, 2002, CHINA DAILY     0309; Tarantola DJM, 2001, AIDS PATIENT CARE ST, V15, P439, DOI 10.1089/108729101316914476; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; *UNAIDS CHIN OFF, OBS CHIN YEAR 2000 A; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Van Duynhoven YTHP, 1997, INT J EPIDEMIOL, V26, P1373, DOI 10.1093/ije/26.6.1373; van Valkengoed IGM, 2000, SEX TRANSM INFECT, V76, P375, DOI 10.1136/sti.76.5.375; Wang JC, 2001, SEX TRANSM DIS, V28, P171, DOI 10.1097/00007435-200103000-00009; Welsch R, 1980, REGRESSION DIAGNOSTI; WEN C, NO CONDOMS PLEASE CH; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; ZHANG L, 2000, REDRAWING BOUNDARIES, P171; [No title captured]	52	214	226	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1265	1273		10.1001/jama.289.10.1265	http://dx.doi.org/10.1001/jama.289.10.1265			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633188	Bronze			2022-12-28	WOS:000181466500028
J	Chakravarti, D; Hong, R				Chakravarti, D; Hong, R			SET-ting the stage for life and death	CELL			English	Editorial Material							ONCOPROTEIN; ONCOGENE; PROTEIN	Cytotoxic T lymphocytes release granzymes (Gzm) A and B to induce apoptosis or programmed cell death of virally infected or tumor cells. In this issue of Cell, Fan et al. identify the tumor metastasis suppressor NM23-H1 as a GzmA-activated, apoptosis-inducing DNase and the oncoprotein SET as its inhibitor. Work from the Lieberman and Wang groups indicates a surprising role for a group of acidic nucleo-cytoplasmic proteins in regulating apoptosis.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Chakravarti, D (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.			Chakravarti, Debabrata/0000-0001-8446-8599				ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Orre RS, 2001, J BIOL CHEM, V276, P1794, DOI 10.1074/jbc.M008560200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113	10	36	40	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					589	591		10.1016/S0092-8674(03)00151-X	http://dx.doi.org/10.1016/S0092-8674(03)00151-X			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628178	Bronze			2022-12-28	WOS:000181443600001
J	Foster, SE; Vaughan, RD; Foster, WH; Califano, JA				Foster, SE; Vaughan, RD; Foster, WH; Califano, JA			Alcohol consumption and expenditures for underage drinking and adult excessive drinking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RELATIVE RISK; DRIVER AGE; PREVALENCE; YOUTH; IMPACT	Context Although estimates of the amount and proportion of alcohol consumed by underage and adult drinkers have been reported, more accurate estimates are possible and the economic impact has not been explored. Objectives To provide accurate estimates of underage and adult excessive drinking and to describe consumer expenditures linked to underage and adult excessive drinking. Design and Setting Information was obtained from national data sets, including 1999 versions of the National Household Survey of Drug Abuse, the Youth Risk Behavior Survey (YRBS), the Behavior Risk Factor Surveillance System (BRFSS), 2000 US Census, and national data on consumption and consumer expenditures for alcohol, published by Adams Business Research. Participants A total of 217192 persons aged 12 years or older across 3 data sources. Main Outcome Measures Amount as a proportion of total alcohol consumed and proportion of consumer expenditures on alcohol among underage (12-20 years) and adult excessive (greater than or equal to21 years) drinkers. Results The proportion of 12- to 20-year-olds who drink was estimated to be 50.0% using data from the YRBS; the proportion of adults aged 21 or older who drink was estimated to be 52.8% using data from the BRFSS. The estimated total number of drinks consumed per month was 4.21 billion; underage drinkers consumed 19.7% of this total. The amount of adult drinking that was excessive (>2 drinks per day) was 30.4%. Consumer expenditure on alcohol in the United States in 1999 was $116.2 billion; of that, $22.5 billion was attributed to underage drinking and $34.4 billion was attributed to adult excessive drinking. Conclusion These data Suggest that underage drinkers and adult excessive drinkers are responsible for 50.1% of alcohol consumption and, 48.9% of consumer expenditure.	Columbia Univ, Natl Ctr Addict & Subst Abuse, New York, NY 10017 USA; Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY USA; Columbia Univ, Dept Biostat, New York, NY USA	Columbia University; Columbia University; Columbia University	Foster, SE (corresponding author), Columbia Univ, Natl Ctr Addict & Subst Abuse, 633 3rd Ave, New York, NY 10017 USA.							*AD BUS RES, 2001, AD BEER HDB; *AD BUS RES, 2001, AD LIQ HDB; *AD BUS RES, 2001, AD WIN HDB; [Anonymous], 2000, ALCOHOL RES HEALTH, V24, P5; *CDCP, 1999, BEH RISK FACT SURV S; *CDCP, 1993, MMWR-MORBID MORTAL W, V41, P969; Center for Disease Control and Prevention, 1999, YOUTH RISK BEH SURV; Center on Alcohol Marketing and Youth, 2002, OV YOUTH TARG ALC AD; COOK PJ, 1984, ALCOHOLISM RELATED P, P56; Cowan CD, 2001, J DRUG ISSUES, V31, P599, DOI 10.1177/002204260103100302; *CTR SCI PUBL INT, 1996, STAT ALC TAX HLTH CI; *CTR SCI PUBL INT, 1996, AD RESP TEL BEER ADV; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5; EIGEN LD, 1996, DRINK AG 21 PROBL SO; EMBREE BG, 1993, J STUD ALCOHOL, V54, P334, DOI 10.15288/jsa.1993.54.334; Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901; Fendrich M, 2001, J DRUG ISSUES, V31, P615, DOI 10.1177/002204260103100303; Fowler FJ, 2001, J DRUG ISSUES, V31, P643, DOI 10.1177/002204260103100304; Gerstein D, 1981, ALCOHOL PUBLIC POLIC, P182; Gfroerer J, 1997, DRUG ALCOHOL DEPEN, V47, P19, DOI 10.1016/S0376-8716(97)00063-X; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Greenfield TK, 1999, J STUD ALCOHOL, V60, P78, DOI 10.15288/jsa.1999.60.78; GRUNBAUM JA, 2002, MMWR-MORBID MORTAL W, V51, P62; Harrison LD, 2001, J DRUG ISSUES, V31, P665, DOI 10.1177/002204260103100305; Hingson RW, 1999, ALCOHOL RES HEALTH, V23, P31; Jacobson JL, 1999, ALCOHOL RES HEALTH, V23, P25; JOHNSTON LD, 2000, MONITORING FUTURE CO; LAIXUTHAI A, 1993, CONTEMP POLICY ISSUE, V11, P70, DOI 10.1111/j.1465-7287.1993.tb00402.x; LEVY DT, 1999, COSTS UNDERAGE DRINK; *NAT CTR ADD SUBST, 2002, TEEN TIPPL AM UND DR; *NAT CTR ADD SUBST, 1998, BARS SUBST AB AM PRI; *NAT I ALC AB ALC, 2002, FAQS ALC AB ALC; *NAT I ALC AB ALC, 2000, C ALC HLTH HIGHL CUR; *OFF APPL STUD, 2001, NAT HOUS SURV DRUG A; *PAC I RES EV, 1999, REG STRAT PREV YOUTH; *PAC I RES EV, 1999, STRAT RED UND ALC US; Rogers JD, 1999, J STUD ALCOHOL, V60, P732, DOI 10.15288/jsa.1999.60.732; Schuman H., 1981, QUESTIONS ANSWERS AT; *SUBST AB MENT HLT, 1999, NAT HOUS SURV DRUG A; *SUBST AB MENT HLT, 2002, STAT SUBST AB MENT H; *US DEP COMM, 2002, PROF GEN DEM CHAR; *US DEP HHS, 2002, RES 2001 NAT HOUS SU, V1; *USDA, 2000, NUTR YOUR HLTH DIET; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387; ZADOR PL, 1991, J STUD ALCOHOL, V52, P302, DOI 10.15288/jsa.1991.52.302	46	67	69	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					989	995		10.1001/jama.289.8.989	http://dx.doi.org/10.1001/jama.289.8.989			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597750	Bronze			2022-12-28	WOS:000181129800024
J	Jahn, R; Lang, T; Sudhof, TC				Jahn, R; Lang, T; Sudhof, TC			Membrane fusion	CELL			English	Review							HOMOTYPIC VACUOLE FUSION; SNARE COMPLEX-FORMATION; GTP-BINDING PROTEIN; INFLUENZA HEMAGGLUTININ; TRANSMITTER RELEASE; CA2+ BINDING; NEUROTRANSMITTER RELEASE; 3-DIMENSIONAL STRUCTURE; PHOSPHOLIPID-BINDING; SYNAPTIC EXOCYTOSIS	Membrane fusion, one of the most fundamental processes in life, occurs when two separate lipid membranes merge into a single continuous bilayer. Fusion reactions share common features, but are catalyzed by diverse proteins. These proteins mediate the initial recognition of the membranes that are destined for fusion and pull the membranes close together to destabilize the lipid/water interface and to initiate mixing of the lipids. A single fusion protein may do everything or assemblies of protein complexes may be required for intracellular fusion reactions to guarantee rigorous regulation in space and time. Cellular fusion machines are adapted to fit the needs of different reactions but operate by similar principles in order to achieve merging of the bilayers.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet,Ctr Basic Neurosci, Dallas, TX 75390 USA	Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.			Jahn, Reinhard/0000-0003-1542-3498				Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; ARAKI S, 1990, J BIOL CHEM, V265, P13007; Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Arkin AP, 2001, CURR OPIN BIOTECH, V12, P638, DOI 10.1016/S0958-1669(01)00273-7; Atluri PP, 1998, J NEUROSCI, V18, P8214; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Brickner JH, 2001, J CELL BIOL, V155, P969, DOI 10.1083/jcb.200104093; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Cevc G, 1999, ADV DRUG DELIVER REV, V38, P207, DOI 10.1016/S0169-409X(99)00030-7; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Chanturiya A, 1997, P NATL ACAD SCI USA, V94, P14423, DOI 10.1073/pnas.94.26.14423; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V906, P309, DOI 10.1016/0304-4157(87)90016-5; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Dobrunz LE, 2002, NATURE, V415, P277, DOI 10.1038/415277a; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Epand RM, 2000, BIOPOLYMERS, V55, P358, DOI 10.1002/1097-0282(2000)55:5<358::AID-BIP1009>3.0.CO;2-8; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fernandez-Chacon R, 2002, J NEUROSCI, V22, P8438; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Garoff H, 2001, TRENDS MICROBIOL, V9, P408, DOI 10.1016/S0966-842X(01)02162-X; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Graham ME, 2000, J NEUROSCI, V20, P1281; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hay JC, 2001, EXP CELL RES, V271, P10, DOI 10.1006/excr.2001.5368; Heinz FX, 2001, CURR OPIN MICROBIOL, V4, P450, DOI 10.1016/S1369-5274(00)00234-4; Hsu SC, 1999, TRENDS CELL BIOL, V9, P150, DOI 10.1016/S0962-8924(99)01516-0; Hung CH, 1996, P NATL ACAD SCI USA, V93, P10797, DOI 10.1073/pnas.93.20.10797; Jahn R, 2002, CURR OPIN CELL BIOL, V14, P488, DOI 10.1016/S0955-0674(02)00356-3; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; KOZLOV GV, 1983, PHYS REV B, V28, P255, DOI 10.1103/PhysRevB.28.255; Kozlov MM, 1998, BIOPHYS J, V75, P1384, DOI 10.1016/S0006-3495(98)74056-1; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lentz BR, 2000, CURR OPIN STRUC BIOL, V10, P607, DOI 10.1016/S0959-440X(00)00138-X; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Lewis MJ, 2002, TRAFFIC, V3, P922, DOI 10.1034/j.1600-0854.2002.31207.x; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Liu J, 2002, J BIOL CHEM, V277, P12891, DOI 10.1074/jbc.M110315200; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Luo ZL, 1999, J VIROL, V73, P8152, DOI 10.1128/JVI.73.10.8152-8159.1999; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Markin VS, 2002, BIOPHYS J, V82, P693, DOI 10.1016/S0006-3495(02)75432-5; Martin I, 2000, BIOSCIENCE REP, V20, P483, DOI 10.1023/A:1010454803579; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; MELIKYAN GB, 1995, J CELL BIOL, V131, P679, DOI 10.1083/jcb.131.3.679; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Noguchi H, 2001, J CHEM PHYS, V115, P9547, DOI 10.1063/1.1414314; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Price A, 2000, J CELL BIOL, V148, P1223, DOI 10.1083/jcb.148.6.1223; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Shin OH, 2002, NAT NEUROSCI, V5, P649, DOI 10.1038/nn869; SIEGEL DP, 1993, BIOPHYS J, V65, P2124, DOI 10.1016/S0006-3495(93)81256-6; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tamm LK, 2000, BIOSCIENCE REP, V20, P501, DOI 10.1023/A:1010406920417; Titorenko VI, 2000, J CELL BIOL, V150, P881, DOI 10.1083/jcb.150.4.881; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; VONMOLLARD GF, 1991, NATURE, V349, P79, DOI 10.1038/349079a0; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wang XL, 2001, J BIOL CHEM, V276, P32480, DOI 10.1074/jbc.M103337200; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WEBER T, 1994, J BIOL CHEM, V269, P18353; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6	143	1137	1172	3	298	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					519	533		10.1016/S0092-8674(03)00112-0	http://dx.doi.org/10.1016/S0092-8674(03)00112-0			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600315	Bronze			2022-12-28	WOS:000181252600010
J	Kim, UK; Jorgenson, E; Coon, H; Leppert, M; Risch, N; Drayna, D				Kim, UK; Jorgenson, E; Coon, H; Leppert, M; Risch, N; Drayna, D			Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide	SCIENCE			English	Article							RECEPTOR; FAMILY; LOCALIZATION; PERCEPTION; GENES	The ability to taste the substance phenylthiocarbamide (PTC) has been widely used for genetic and anthropological studies, but genetic studies have produced conflicting results and demonstrated complex inheritance for this trait. We have identified a small region on chromosome 7q that shows strong linkage disequilibrium between single-nucleotide polymorphism (SNP) markers and PTC taste sensitivity in unrelated subjects. This region contains a single gene that encodes a member of the TAS2R bitter taste receptor family. We identified three coding SNPs giving rise to five haplotypes in this gene worldwide. These haplotypes completely explain the bimodal distribution of PTC taste sensitivity, thus accounting for the inheritance of the classically defined taste insensitivity and for 55 to 85% of the variance in PTC sensitivity. Distinct phenotypes were associated with specific haplotypes, which demonstrates that this gene has a direct influence on PTC taste sensitivity and that sequence variants at different sites interact with each other within the encoded gene product.	Natl Inst Deafness & Other Commun Disorders, NIH, Rockville, MD 20850 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Utah, Med Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Med Ctr, Red Butte Hlth Ctr, Dept Psychiat, Salt Lake City, UT 84112 USA; Kaiser Permanente, Div Res, Oakland, CA 94612 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Stanford University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Kaiser Permanente	Drayna, D (corresponding author), Natl Inst Deafness & Other Commun Disorders, NIH, 5 Res Court, Rockville, MD 20850 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000046, Z01DC000046] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [T32 HG00044] Funding Source: Medline; PHS HHS [Z01-000046-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Blakeslee AF, 1932, P NATL ACAD SCI USA, V18, P120, DOI 10.1073/pnas.18.1.120; Blakfslee AF, 1935, P NATL ACAD SCI USA, V21, P84, DOI 10.1073/pnas.21.2.84; BOYD WC, 1950, GENETICS RACES MAN I, P276; BRANDTZAEG MERTON B, 1958, Acta Genet Stat Med, V8, P114; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHAUTARD.EA, 1974, ANN HUM GENET, V38, P191, DOI 10.1111/j.1469-1809.1974.tb01950.x; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DRAYNA D, IN PRESS HUM GENET; Enoch MA, 2001, ADDICT BEHAV, V26, P399, DOI 10.1016/S0306-4603(00)00117-9; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FALCONER DS, 1946, ANN EUGEN, V13, P211; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guo SW, 2001, ANN HUM BIOL, V28, P111; GUYER M, 1992, SCIENCE, V258, P67; HARRIS H, 1950, ANN EUGENIC, V15, P24, DOI 10.1111/j.1469-1809.1949.tb02419.x; KALMUS H, 1958, ANN HUM GENET, V22, P222, DOI 10.1111/j.1469-1809.1958.tb01416.x; LEE B. F., 1934, OHIO JOUR SCI, V34, P337; Levit SG, 1935, J GENET, V30, P389, DOI 10.1007/BF02982247; NABHAN C, 1995, BIOCHEM BIOPH RES CO, V212, P1015, DOI 10.1006/bbrc.1995.2071; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; OLSON JM, 1989, GENET EPIDEMIOL, V6, P423, DOI 10.1002/gepi.1370060305; Prodi DA, 2002, AM J HUM GENET, V71, P464; REDDY BM, 1989, GENET EPIDEMIOL, V6, P413, DOI 10.1002/gepi.1370060304; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; SPENCE MA, 1984, HUM GENET, V67, P183; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; TILLS D, 1983, DISTRIBUTION HUMAN B; Ueda T, 2001, BIOCHEM BIOPH RES CO, V285, P147, DOI 10.1006/bbrc.2001.5136; 1931, SCIENCE S, V73, P14	33	626	649	2	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1221	1225		10.1126/science.1080190	http://dx.doi.org/10.1126/science.1080190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595690				2022-12-28	WOS:000181065500037
J	Smith, MM; Johanson, Z				Smith, MM; Johanson, Z			Separate evolutionary origins of teeth from evidence in fossil jawed vertebrates	SCIENCE			English	Article								Placoderms are extinct jawed fishes of the class Placodermi and are basal among jawed vertebrates. It is generally thought that teeth are absent in placoderms and that the phylogenetic origin of teeth occurred after the evolution of jaws. However, we now report the presence of tooth rows in more derived placoderms, the arthrodires. New teeth are composed of gnathostome-type dentine and develop at specific locations. Hence, it appears that these placoderm teeth develop and are regulated as in other jawed vertebrates. Because tooth development occurs only in derived forms of placoderms, we suggest that teeth evolved at least twice, through a mechanism of convergent evolution.	Kings Coll London, Inst Dent, London SE1 9RT, England; Australian Museum, Sydney, NSW 2010, Australia	University of London; King's College London; Australian Museum	Smith, MM (corresponding author), Kings Coll London, Inst Dent, Guys Campus,London Bridge, London SE1 9RT, England.	moya.smith@kcl.ac.uk	Self, Casey J/B-6871-2011	Meredith Smith, Moya/0000-0002-3397-873X; Johanson, Zerina/0000-0002-8444-6776				Denison R., 1978, HDB PALEOICHTHYOLOGY; DENNERLINE J, 1995, INT HIST REV, V17, P127; Goujet D, 2001, SYST ASSOC SPEC VOL, V61, P209; Janvier P, 2001, SYST ASSOC SPEC VOL, V61, P172; McCollum M, 2001, J ANAT, V199, P153, DOI 10.1046/j.1469-7580.2001.19910153.x; ORVIG T, 1980, ZOOL SCR, V9, P141, DOI 10.1111/j.1463-6409.1980.tb00660.x; REIF WE, 1982, EVOL BIOL, V15, P287; Reisz RR, 2001, NATURE, V411, P548, DOI 10.1038/35079187; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; SMITH MM, 1993, EVOL BIOL, V27, P387; Smith MM, 2001, J ANAT, V199, P161; SMITH MM, IN PRESS EVOL DEV; Williams ME, 2001, J VERTEBR PALEONTOL, V21, P214, DOI 10.1671/0272-4634(2001)021[0214:TRICSW]2.0.CO;2; Wilson Mark V. H., 1999, Journal of Vertebrate Paleontology, V19, p85A; Young GC, 2001, J VERTEBR PALEONTOL, V21, P670, DOI 10.1671/0272-4634(2001)021[0670:PJSIAA]2.0.CO;2	15	79	86	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1235	1236		10.1126/science.1079623	http://dx.doi.org/10.1126/science.1079623			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595693				2022-12-28	WOS:000181065500041
J	Zubieta, JK; Heitzeg, MM; Smith, YR; Bueller, JA; Xu, K; Xu, YJ; Koeppe, RA; Stohler, CS; Goldman, D				Zubieta, JK; Heitzeg, MM; Smith, YR; Bueller, JA; Xu, K; Xu, YJ; Koeppe, RA; Stohler, CS; Goldman, D			COMT val(158)met genotype affects mu-opioid neurotransmitter responses to a pain stressor	SCIENCE			English	Article							CATECHOL-O-METHYLTRANSFERASE; AFFECTIVE DIMENSIONS; ANTERIOR CINGULATE; NOREPINEPHRINE; MODULATION; RECEPTORS; STRIATUM; BEHAVIOR; AMYGDALA; ORGANIZATION	Responses to pain and other stressors are regulated by interactions between multiple brain areas and neurochemical systems. We examined the influence of a common functional genetic polymorphism affecting the metabolism of catecholamines on the modulation of responses to sustained pain in humans. Individuals homozygous for the met(158) allele of the catechol-O-methyttransferase (COMT) polymorphism (val(158)met) showed diminished regional mu-opioid system responses to pain compared with heterozygotes. These effects were accompanied by higher sensory and affective ratings of pain and a more negative internal affective state. Opposite effects were observed in val(158) homozygotes. The COMT val(158)met polymorphism thus influences the human experience of pain and may underlie interindividual differences in the adaptation and responses to pain and other stressful stimuli.	Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Mental Hlth Res Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Natl Inst Alcohol & Alcoholism, Neurogenet Lab, Rockville, MD 20852 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Zubieta, JK (corresponding author), Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA.		Heitzeg, Mary/M-7154-2017; Goldman, David/F-9772-2010; Xu, Ke/V-5941-2019; Zubieta, Jon-Kar/AAB-5565-2022; STOHLER, CHRISTIAN/AAQ-7539-2020; Majid, Salma/AAT-2616-2020	Goldman, David/0000-0002-1724-5405; Xu, Ke/0000-0002-6472-7052; Majid, Salma/0000-0002-1724-5405; Stohler, Christian S/0000-0003-0443-6146; Heitzeg, Mary/0000-0002-6737-2971	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012743, R01DE012059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000302, Z01AA000298, Z01AA000303] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 12743, R01 DE 12059] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; CUMMING P, 1992, J NEUROCHEM, V59, P1905, DOI 10.1111/j.1471-4159.1992.tb11026.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; ENOCH MA, IN PRESS PSYCHOL GEN; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; GEORGE SR, 1987, PEPTIDES, V8, P487, DOI 10.1016/0196-9781(87)90014-3; HELMSTETTER FJ, 1995, J PHARMACOL EXP THER, V275, P381; Johnson PI, 1997, NEUROSCIENCE, V77, P187, DOI 10.1016/S0306-4522(96)00482-4; KALIN NH, 1988, BRAIN RES, V440, P285, DOI 10.1016/0006-8993(88)90997-3; Kalivas PW, 1999, ANN NY ACAD SCI, V877, P64, DOI 10.1111/j.1749-6632.1999.tb09261.x; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; KOPIN IJ, 1985, PHARMACOL REV, V37, P333; LI PP, 1984, J NEUROCHEM, V43, P1425, DOI 10.1111/j.1471-4159.1984.tb05404.x; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; MCALONAN GM, 1993, NEUROSCIENCE, V52, P605, DOI 10.1016/0306-4522(93)90410-H; Melzack R, 2000, HDB PAIN ASSESSMENT, P152; MOGENSON GJ, 1991, ADV EXP MED BIOL, V295, P267; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Napier TC, 1999, ANN NY ACAD SCI, V877, P176, DOI 10.1111/j.1749-6632.1999.tb09268.x; Nestler EJ, 2001, J NEUROSCI, V21, P8324, DOI 10.1523/JNEUROSCI.21-21-08324.2001; Oke AF, 1997, BRAIN RES, V763, P69, DOI 10.1016/S0006-8993(97)00404-6; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Quirarte GL, 1998, BRAIN RES, V808, P134, DOI 10.1016/S0006-8993(98)00795-1; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; Stohler CS, 1999, PAIN, V79, P165, DOI 10.1016/S0304-3959(98)00171-7; Tiihonen J, 1999, MOL PSYCHIATR, V4, P286, DOI 10.1038/sj.mp.4000509; UNTERWALD EM, 1994, NEUROREPORT, V5, P1613, DOI 10.1097/00001756-199408150-00018; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; VOGT BA, 1995, EXP NEUROL, V135, P83, DOI 10.1006/exnr.1995.1069; WATKINS LR, 1982, SCIENCE, V216, P1185, DOI 10.1126/science.6281891; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Zubieta JK, 2002, J NEUROSCI, V22, P5100, DOI 10.1523/JNEUROSCI.22-12-05100.2002; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	39	842	872	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1240	1243		10.1126/science.1078546	http://dx.doi.org/10.1126/science.1078546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595695				2022-12-28	WOS:000181065500043
J	West, GB; Savage, VM; Gillooly, J; Enquist, BJ; Woodruff, WH; Brown, JH				West, GB; Savage, VM; Gillooly, J; Enquist, BJ; Woodruff, WH; Brown, JH			Why does metabolic rate scale with body size?	NATURE			English	Article									Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; University of New Mexico; University of Arizona	West, GB (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	gbw@lanl.gov	Woodruff, William/AAH-6890-2021; Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096				Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799; Westerhoff H., 1987, THERMODYNAMICS CONTR	6	95	99	5	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					713	713		10.1038/421713a	http://dx.doi.org/10.1038/421713a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610614				2022-12-28	WOS:000180938000032
J	Yoder, AD; Burns, MM; Zehr, S; Delefosse, T; Veron, G; Goodman, SM; Flynn, JJ				Yoder, AD; Burns, MM; Zehr, S; Delefosse, T; Veron, G; Goodman, SM; Flynn, JJ			Single origin of Malagasy Carnivora from an African ancestor	NATURE			English	Article							MADAGASCAR; PHYLOGENY; RADIATION; DISPERSAL; ANCIENT; LEMURS; INDIA	The Carnivora are one of only four orders of terrestrial mammals living in Madagascar today. All four (carnivorans, primates, rodents and lipotyphlan insectivores) are placental mammals with limited means for dispersal, yet they occur on a large island that has been surrounded by a formidable oceanic barrier for at least(88) million years(1,2), predating the age of origin for any of these groups(3,4). Even so, as many as four colonizations of Madagascar have been proposed for the Carnivora alone(5). The mystery of the island's mammalian origins is confounded by its poor Tertiary fossil record, which leaves us with no direct means for estimating dates of initial diversification. Here we use a multi-gene phylogenetic analysis to show that Malagasy carnivorans are monophyletic and thus the product of a single colonization of Madagascar by an African ancestor. Furthermore, a bayesian analysis(6) of divergence ages for Malagasy carnivorans and lemuriforms indicates that their respective colonizations were temporally separated by tens of millions of years. We therefore conclude that a single event, such as vicariance or common dispersal, cannot explain the presence of both groups in Madagascar.	Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06551 USA; Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Museum Natl Hist Nat, Lab Zool Mammiferes & Oiseaux, F-75231 Paris, France; WWF, Antananarivo 101, Madagascar	Yale University; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Museum National d'Histoire Naturelle (MNHN); World Wildlife Fund	Yoder, AD (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 165 Prospect St, New Haven, CT 06551 USA.	anne.yoder@yale.edu	Veron, Geraldine/P-8163-2019	Veron, Geraldine/0000-0003-4247-3976				ALBIGNAC R, 1973, FAUNE MADAGASCAR, V36, P206; Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x; COFFIN MF, 1992, AAPG MEMOIR, V53, P207; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; GOODMAN SM, IN PRESS NATURAL HIS; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Krause David W., 1997, P3; Krause DW, 2001, NATURE, V412, P497, DOI 10.1038/35087649; KRAUSE DW, 1999, GSA TODAY, V9, P1; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Novacek MJ, 2001, CURR BIOL, V11, pR573, DOI 10.1016/S0960-9822(01)00347-5; OLSON LE, 1999, THESIS U CHICAGO, P349; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Rogers RR, 2000, J GEOL, V108, P275, DOI 10.1086/314403; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; SCHMID J, IN PRESS NATURAL HIS; SIMPSON GG, 1952, B AM MUS NAT HIST, V99, P163; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Veron G, 1995, MAMMALIA, V59, P551, DOI 10.1515/mamm.1995.59.4.551; Veron Geraldine, 1993, Journal of Mammalian Evolution, V1, P169, DOI 10.1007/BF01024706; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoder AD, 1996, COLLOQ SEMI, P245	30	224	257	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 13	2003	421	6924					734	737		10.1038/nature01303	http://dx.doi.org/10.1038/nature01303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610623				2022-12-28	WOS:000180938000041
J	Lai, ZP; Bonilla, G; Diaz, I; Nery, JG; Sujaoti, K; Amat, MA; Kokkoli, E; Terasaki, O; Thompson, RW; Tsapatsis, M; Vlachos, DG				Lai, ZP; Bonilla, G; Diaz, I; Nery, JG; Sujaoti, K; Amat, MA; Kokkoli, E; Terasaki, O; Thompson, RW; Tsapatsis, M; Vlachos, DG			Microstructural optimization of a zeolite membrane for organic vapor separation	SCIENCE			English	Article							MOLECULAR-SIEVE; MFI MEMBRANES; SILICALITE MEMBRANES; HIGH-SELECTIVITY; GAS SEPARATION; THIN-FILMS; PERMEATION; GROWTH; ORIENTATION	A seeded growth method for the fabrication of high-permeance, high-separation-factor zeolite (siliceous ZSM-5, [Si96O192]-MFI) membranes is reported. The method consists of growing the crystals of an oriented seed layer to a well-intergrown film by avoiding events that lead to a loss of preferred orientation, such as twin overgrowths and random nucleation. Organic polycations are used as zeolite crystal shape modifiers to enhance relative growth rates along the desirable out-of-plane direction. The polycrystalline films are thin (similar to1 micrometer) with single grains extending along the film thickness and with large in-plane grain size (similar to1 micrometer). The preferred orientation is such that straight channels with an open diameter of similar to5.5 angstroms run down the membrane thickness. Comparison with previously reported membranes shows that these microstructurally optimized films have superior performance for the separation of organic mixtures with components that have small differences in size and shape, such as xylene isomers.	Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; Tohoku Univ, Grad Sch Sci, Dept Phys, Sendai, Miyagi 9808578, Japan; Worcester Polytech Inst, Dept Chem Engn, Worcester, MA 01609 USA; Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA	University of Massachusetts System; University of Massachusetts Amherst; Tohoku University; Worcester Polytechnic Institute; University of Delaware	Tsapatsis, M (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.		Kokkoli, Efrosini/J-1656-2015; Diaz, Isabel/H-2071-2018; Lai, Zhiping/M-6756-2013; Terasaki, Osamu/Y-1137-2018; Tsapatsis, Michael/AAA-2527-2019; Vlachos, Dionisios/ABH-6064-2020; Nery, Jose Geraldo/ABA-2884-2020; Lai, Zhiping/E-3072-2012	Kokkoli, Efrosini/0000-0001-7783-0158; Diaz, Isabel/0000-0002-3602-9812; Lai, Zhiping/0000-0001-9555-6009; Terasaki, Osamu/0000-0001-5803-0817; Vlachos, Dionisios/0000-0002-6795-8403				Au LTY, 2001, MICROPOR MESOPOR MAT, V47, P203, DOI 10.1016/S1387-1811(01)00380-8; Beck LW, 1998, MICROPOR MESOPOR MAT, V22, P107, DOI 10.1016/S1387-1811(98)00096-1; Bein T, 1996, CHEM MATER, V8, P1636, DOI 10.1021/cm960148a; Boudreau LC, 1997, CHEM MATER, V9, P1705, DOI 10.1021/cm970151+; BURKETT SL, 1994, J PHYS CHEM-US, V98, P4647, DOI 10.1021/j100068a027; Caro J, 2000, MICROPOR MESOPOR MAT, V38, P3, DOI 10.1016/S1387-1811(99)00295-4; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; de Vos Burchart E., 1993, ZEOLITES, V13, P216; de Vos RM, 1998, SCIENCE, V279, P1710, DOI 10.1126/science.279.5357.1710; Dong JH, 2000, MICROPOR MESOPOR MAT, V34, P241, DOI 10.1016/S1387-1811(99)00175-4; FLANIGEN EM, 1978, NATURE, V271, P512, DOI 10.1038/271512a0; Gouzinis A, 1998, CHEM MATER, V10, P2497, DOI 10.1021/cm9802402; Gump CJ, 2001, IND ENG CHEM RES, V40, P565, DOI 10.1021/ie000553i; Ha K, 2000, ADV MATER, V12, P1114, DOI 10.1002/1521-4095(200008)12:15<1114::AID-ADMA1114>3.0.CO;2-5; Hedlund J, 2002, MICROPOR MESOPOR MAT, V52, P179, DOI 10.1016/S1387-1811(02)00316-5; Keizer K, 1998, J MEMBRANE SCI, V147, P159, DOI 10.1016/S0376-7388(98)00133-1; Kondo M, 1997, J MEMBRANE SCI, V133, P133, DOI 10.1016/S0376-7388(97)00087-2; Koros WJ, 2000, J MEMBRANE SCI, V175, P181, DOI 10.1016/S0376-7388(00)00418-X; KUHL GH, 1986, Patent No. 4585638; LOK BM, 1983, ZEOLITES, V3, P282, DOI 10.1016/0144-2449(83)90169-0; Lovallo MC, 1996, AICHE J, V42, P3020, DOI 10.1002/aic.690421104; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Meier W. M., 1996, ATLAS ZEOLITE FRAMEW; Merkel TC, 2002, SCIENCE, V296, P519, DOI 10.1126/science.1069580; Mintova S, 1997, MICROPOROUS MATER, V11, P149, DOI 10.1016/S0927-6513(97)00037-0; Noack M, 2001, MICROPOR MESOPOR MAT, V49, P25, DOI 10.1016/S1387-1811(01)00396-1; Nomura M, 1997, IND ENG CHEM RES, V36, P4217, DOI 10.1021/ie970338a; OZIN GA, 1989, ANGEW CHEM INT EDIT, V28, P359, DOI 10.1002/anie.198903591; SCHOEMAN BJ, 1993, J CHEM SOC CHEM COMM, P994, DOI 10.1039/c39930000994; Shiflett MB, 1999, SCIENCE, V285, P1902, DOI 10.1126/science.285.5435.1902; Song LJ, 2002, MICROPOR MESOPOR MAT, V55, P31, DOI 10.1016/S1387-1811(02)00394-3; TSAPATSIS M, 2000, CATTECH, V3, P148; Wang ZB, 2001, CHEM MATER, V13, P1101, DOI 10.1021/cm000849e; Wang ZB, 2001, ADV MATER, V13, P746, DOI 10.1002/1521-4095(200105)13:10<746::AID-ADMA746>3.0.CO;2-J; Xomeritakis G, 2001, IND ENG CHEM RES, V40, P544, DOI 10.1021/ie000613k; Yan YS, 1997, J MEMBRANE SCI, V123, P95, DOI 10.1016/S0376-7388(96)00206-2	36	905	969	28	831	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 18	2003	300	5618					456	460		10.1126/science.1082169	http://dx.doi.org/10.1126/science.1082169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668LR	12624179				2022-12-28	WOS:000182295900030
J	Hsu, RT; Lambert, PC; Dixon-Woods, M; Kurinczuk, JJ				Hsu, RT; Lambert, PC; Dixon-Woods, M; Kurinczuk, JJ			Effect of NHS walk-in centre on local primary healthcare services: before and after observational study	BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the effect of an NHS walk-in centre on local primary and emergency healthcare services. Design Before and after observational study. Setting Loughborough, which had an NHS walk-in centre, and Market Harborough, the control town. Participants 12 general practices. Main outcome measures Mean daily rate of emergency general practitioner consultations, mean number of half days to the sixth bookable routine appointment, and attendance rates at out of hours services, minor injuries units, and accident and emergency departments. Results The change between the before and after study periods was not significantly different in the two towns for daily rate of emergency general practice consultations (mean difference -0.02/1000 population, 95% confidence interval -0.75 to 0.71), the time to the sixth bookable routine appointment (-0.24 half-days, -1.85 to 1.37), and daily rate of attendances at out of hours services (0.07/1000 population, -0.06 to 0.19). However, attendance at the local minor injuries unit was significantly higher in Loughborough than Market Harborough (rate ratio 1.22,1.12 to 1.33). Non-ambulance attendances at accident and emergency departments fell less in Loughborough than Market Harborough (rate ratio 1.17, 1.03 to 1.33). Conclusions The NHS walk-in centre did not greatly affect the workload of local general practitioners. However, the workload of the local minor injuries unit increased significantly, probably because it was in the same building as the walk-in centre.	Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England	University of Leicester	Hsu, RT (corresponding author), Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England.			Dixon-Woods, Mary/0000-0002-5915-0041; Lambert, Paul/0000-0002-5337-663X				Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Jones M, 2000, BMJ-BRIT MED J, V321, P928, DOI 10.1136/bmj.321.7266.928; *NHS EX, 1999, NHS PRIM CAR WALK IN; Oldham J, 2001, ADV ACCESS PRIMARY C; ROGERS A, 1999, DEMANDING PATIENTS A, P39; *ROYAL COLL GEN PR, 1999, DISC PAP IMPL GEN PR; *TEAM NAT EV NHS W, 2000, NAT EV NHS WALK IN C	7	27	27	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2003	326	7388					530	532		10.1136/bmj.326.7388.530	http://dx.doi.org/10.1136/bmj.326.7388.530			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655JR	12623913	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000181548400019
J	Mercer, JM; Roth, VL				Mercer, JM; Roth, VL			The effects of Cenozoic global change on squirrel phylogeny	SCIENCE			English	Article							FLYING SQUIRRELS; EVOLUTION	By modifying habitats and creating bridges and barriers between landmasses, climate change and tectonic events are believed to have important consequences for diversification of terrestrial organisms. Such consequences should be most evident in phylogenetic histories of groups that are ancient, widespread, and diverse. The squirrel family (Sciuridae) is one of very few mammalian families endemic to Eurasia, Africa, and North and South America and is idea[ for examining these issues. Through phylogenetic and molecular-clock analyses, we infer that arrival and diversification of squirrels in Africa, on Sunda Shelf islands, across Beringea, and across the Panamanian isthmus coincide in timing and location with multiple well-documented sea-level, tectonic, and paleontological events. These precise correspondences point to an important role for global change in the diversification of a major group of mammals.	Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Mercer, JM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.							Berggren WA, 1992, EOCENE OLIGOCENE CLI, P1; Butlin R. K., 1998, P355; Coates Anthony G., 1996, P21; Corbet GB, 1992, MAMMALS INDO MALAYAN; de Bruijn Hans, 1999, P271; DEBRUIJN H, 1989, PAPERS FOSSIL RODENT, P139; DEGRACIANSKY PC, 1998, SOC EC PALEONTOL MIN, V60; Emry R.J., 1984, P23; Emry RJ, 1996, J VERTEBR PALEONTOL, V16, P775, DOI 10.1080/02724634.1996.10011366; Emry RJ, 2001, J VERTEBR PALEONTOL, V21, P400, DOI 10.1671/0272-4634(2001)021[0400:DNNFDE]2.0.CO;2; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hoffman Robert S., 1993, P419; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Lavocat R., 1978, P69; Marincovich L, 1999, NATURE, V397, P149, DOI 10.1038/16446; MARSHALL LG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P329; MERCER JL, UNPUB; MILLER JR. G. S., 1901, P BIOL SOC WASH, V14, P23; MOORE JOSEPH CURTIS, 1959, BULL AMER MUS NAT HIST, V118, P153; Moss Steve J., 1998, P133; Musser G G, 1993, MAMMAL SPECIES WORLD; Nowack R.M., 1999, WALKERS MAMMALS WORL; Sanders WJ, 2002, J VERTEBR PALEONTOL, V22, P388, DOI 10.1671/0272-4634(2002)022[0388:NPFTEM]2.0.CO;2; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; THORINGTON RW, 1984, SCIENCE, V225, P1048, DOI 10.1126/science.225.4666.1048; Thorington RW, 1996, J MAMMAL, V77, P69, DOI 10.2307/1382710; VIANEYLIAUD M, 1984, EVOLUTIONARY RELATIO, P277; Welcomme JL, 2001, GEOL MAG, V138, P397, DOI 10.1017/S0016756801005428; Wing Scott L., 1998, P37	30	225	243	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 7	2003	299	5612					1568	1572		10.1126/science.1079705	http://dx.doi.org/10.1126/science.1079705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12595609				2022-12-28	WOS:000181367900036
J	Min, JR; Feng, Q; Li, ZZ; Zhang, Y; Xu, RM				Min, JR; Feng, Q; Li, ZZ; Zhang, Y; Xu, RM			Structure of the catalytic domain of human DOT1L, a Non-SET domain nucleosomal histone methyltransferase	CELL			English	Article							CRYSTAL-STRUCTURE; LYSINE METHYLTRANSFERASE; SILENCING PROTEIN; DIFFRACTION DATA; CORE PARTICLE; METHYLATION; H3; CHROMATIN; UBIQUITINATION; YEAST	Dot1 is an evolutionarily conserved histone methyltransferase that methylates lysine-79 of histone H3 in the core domain. Unlike other histone methyltransferases, Dot1 does not contain a SET domain, and it specifically methylates nucleosomal histone H3. We have solved a 2.5 Angstrom resolution structure of the catalytic domain of human Dot1, hDOT1L, in complex with S-adenosyl-L-methionine (SAM). The structure reveals a unique organization of a mainly alpha-helical N-terminal domain and a central open alpha/beta structure, an active site consisting of a SAM binding pocket, and a potential lysine binding channel. We also show that a flexible, positively charged region at the C terminus of the catalytic domain is critical for nucleosome binding and enzymatic activity. These structural and biochemical analyses, combined with molecular modeling, provide mechanistic insights into the catalytic mechanism and nucleosomal specificity of Dot1 proteins.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Cold Spring Harbor Laboratory; University of North Carolina; University of North Carolina Chapel Hill	Xu, RM (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		xu, rui/GRX-5734-2022; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Zhang, Yi/0000-0002-2789-0811	NIGMS NIH HHS [GM63070, GM63716] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063716] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Dlakic M, 2001, TRENDS BIOCHEM SCI, V26, P405, DOI 10.1016/S0968-0004(01)01856-4; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Singer MS, 1998, GENETICS, V150, P613; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	45	290	311	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					711	723		10.1016/S0092-8674(03)00114-4	http://dx.doi.org/10.1016/S0092-8674(03)00114-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628190	Bronze			2022-12-28	WOS:000181443600013
J	Imperiale, TF				Imperiale, TF			Aspirin and the prevention of colorectal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Indiana Univ, Sch Med, Indianapolis, IN 46202 USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Imperiale, TF (corresponding author), Indiana Univ, Sch Med, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073					0	64	67	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					879	880		10.1056/NEJMp030005	http://dx.doi.org/10.1056/NEJMp030005			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621130				2022-12-28	WOS:000181341100001
J	Niemeier, M; Crawford, JD; Tweed, DB				Niemeier, M; Crawford, JD; Tweed, DB			Optimal transsaccadic integration explains distorted spatial perception	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; APPARENT POSITION; DISPLACEMENT; SUPPRESSION; MOTION; COMPRESSION; SIGNALS; VISION; SPACE	We scan our surroundings with quick eye movements called saccades, and from the resulting sequence of images we build a unified percept by a process known as transsaccadic integration. This integration is often said to be flawed, because around the time of saccades, our perception is distorted(1-6) and we show saccadic suppression of displacement (SSD): we fail to notice if objects change location during the eye movement(7,8). Here we show that transsaccadic integration works by optimal inference. We simulated a visuomotor system with realistic saccades, retinal acuity, motion detectors and eye-position sense, and programmed it to make optimal use of these imperfect data when interpreting scenes. This optimized model showed human-like SSD and distortions of spatial perception. It made new predictions, including tight correlations between perception and motor action (for example, more SSD in people with less-precise eye control) and a graded contraction of perceived jumps; we verified these predictions experimentally. Our results suggest that the brain constructs its evolving picture of the world by optimally integrating each new piece of sensory or motor information.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Canadian Inst Hlth Res, Grp Act & Percept, Ottawa, ON, Canada; York Univ, Ctr Vis Res, Toronto, ON M3J 1P3, Canada	University of Toronto; University of Toronto; Institute for Work & Health; York University - Canada	Tweed, DB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.			Crawford, Doug/0000-0003-2288-1286				BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; CARPENTER RHS, 1991, VISION VISUAL DYSFUN, P1; CHOUDHURY BP, 1981, PHYSIOL BEHAV, V26, P125, DOI 10.1016/0031-9384(81)90087-1; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Gysen V, 2002, VISION RES, V42, P379, DOI 10.1016/S0042-6989(01)00296-6; Honda H, 1997, EXP BRAIN RES, V113, P327, DOI 10.1007/BF02450330; HONDA H, 1993, VISION RES, V33, P709, DOI 10.1016/0042-6989(93)90190-8; ILG UJ, 1993, VISION RES, V33, P211, DOI 10.1016/0042-6989(93)90159-T; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; LI WX, 1990, PERCEPT PSYCHOPHYS, V48, P453, DOI 10.3758/BF03211589; Li WX, 1997, VISION RES, V37, P1779, DOI 10.1016/S0042-6989(96)00301-X; MACK A, 1970, PERCEPT PSYCHOPHYS, V8, P291, DOI 10.3758/BF03212596; MACKAY DM, 1973, HDB SENSORY PHYSIOLO, V7, P307; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; Morrone MC, 1997, J NEUROSCI, V17, P7941; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; SHIOIRI S, 1989, VISION RES, V29, P915, DOI 10.1016/0042-6989(89)90106-5; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; TYNAN PD, 1982, VISION RES, V22, P61, DOI 10.1016/0042-6989(82)90167-5; VANOPSTAL AJ, 1989, VISION RES, V29, P1183, DOI 10.1016/0042-6989(89)90064-3; vonHelmholtz HL, 1910, HDB PHYSL OPTIK; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WESTHEIMER G, 1984, ANNU REV PSYCHOL, V35, P201, DOI 10.1146/annurev.psych.35.1.201	30	134	135	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					76	80		10.1038/nature01439	http://dx.doi.org/10.1038/nature01439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621435				2022-12-28	WOS:000181343100040
J	Johnston, MV				Johnston, MV			MRI for neonatal encephalopathy in full-term infants	LANCET			English	Editorial Material							NEWBORN ENCEPHALOPATHY; RISK-FACTORS		Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Dept Neurol & Dev Med, Baltimore, MD 21205 USA	Johns Hopkins University; Kennedy Krieger Institute	Johnston, MV (corresponding author), Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Dept Neurol & Dev Med, Baltimore, MD 21205 USA.							Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Biagioni E, 2001, PEDIATRICS, V107, P461, DOI 10.1542/peds.107.3.461; ELLENBERG JH, 1988, J PEDIATR-US, V113, P546; Ellis M, 2000, BMJ-BRIT MED J, V320, P1229, DOI 10.1136/bmj.320.7244.1229; Felix JF, 2000, DEV MED CHILD NEUROL, V42, P803; Geerdink N, 2002, NEUROPEDIATRICS, V33, P33, DOI 10.1055/s-2002-23598; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; LEVENE MI, 1986, LANCET, V1, P67, DOI 10.1016/S0140-6736(86)90718-X; Richer LP, 2001, PEDIATR NEUROL, V25, P32, DOI 10.1016/S0887-8994(01)00277-6; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Smith A, 1996, J MED GENET, V33, P107, DOI 10.1136/jmg.33.2.107	11	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 1	2003	361	9359					713	714		10.1016/S0140-6736(03)12666-9	http://dx.doi.org/10.1016/S0140-6736(03)12666-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620732				2022-12-28	WOS:000181232000003
J	Bizzarro, M; Baker, JA; Haack, H; Ulfbeck, D; Rosing, M				Bizzarro, M; Baker, JA; Haack, H; Ulfbeck, D; Rosing, M			Early history of Earth's crust-mantle system inferred from hafnium isotopes in chondrites	NATURE			English	Article							LU-HF; DETRITAL ZIRCONS; DEPLETED MANTLE; SOLAR-SYSTEM; EVOLUTION; DIFFERENTIATION; TRANSIENT; LU-176	The Lu-176 to Hf-176 decay series has been widely used to understand the nature of Earth's early crust-mantle system(1-6). The interpretation, however, of Lu-Hf isotope data requires accurate knowledge of the radioactive decay constant of Lu-176 (lambda(176Lu)), as well as bulk-Earth reference parameters. A recent calibration of the lambda(176Lu) value calls for the presence of highly unradiogenic hafnium in terrestrial zircons with ages greater than 3.9 Gyr, implying widespread continental crust extraction from an isotopically enriched mantle source more than 4.3 Gyr ago(7), but does not provide evidence for a complementary depleted mantle reservoir. Here we report Lu-Hf isotope measurements of different Solar System objects including chondrites and basaltic eucrites. The chondrites define a Lu-Hf isochron with an initial Hf-176/Hf-177 ratio of 0.279628+/-0.000047, corresponding to lambda(176Lu)=1.983+/-0.033x10(-11) yr(-1) using an age of 4.56 Gyr for the chondrite-forming event. This lambda(176Lu) value indicates that Earth's oldest minerals were derived from melts of a mantle source with a time-integrated history of depletion rather than enrichment(7). The depletion event must have occurred no later than 320 Myr after planetary accretion, consistent with timing inferred from extinct radionuclides(8-10).	Geol Museum, DK-1350 Copenhagen, Denmark; Danish Lithosphere, DK-1350 Copenhagen, Denmark		Bizzarro, M (corresponding author), Geol Museum, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.		Bizzarro, Martin/M-7474-2019; Bizzarro, Martin/I-8701-2012; Baker, Joel/A-3477-2008; Haack, Henning/A-4807-2013; Rosing, Minik/A-9977-2013	Bizzarro, Martin/0000-0001-9966-2124; Bizzarro, Martin/0000-0001-9966-2124; Haack, Henning/0000-0002-4618-3178; Baker, Joel/0000-0001-6371-5060; Rosing, Minik/0000-0001-7559-661X				Albarede F, 2000, NATURE, V404, P488, DOI 10.1038/35006621; Alexander CMO, 2001, SCIENCE, V293, P64; Amelin Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4205, DOI 10.1016/S0016-7037(00)00493-2; Amelin Y, 1999, NATURE, V399, P252, DOI 10.1038/20426; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; BARFOD GH, 2002, THESIS U COPENHAGEN; BENNETT VC, 1993, EARTH PLANET SC LETT, V119, P299, DOI 10.1016/0012-821X(93)90140-5; Bizzarro M, 2002, GEOLOGY, V30, P771, DOI 10.1130/0091-7613(2002)030<0771:HIEFAH>2.0.CO;2; Blichert-Toft J, 1999, EARTH PLANET SC LETT, V171, P439, DOI 10.1016/S0012-821X(99)00151-X; Blichert-Toft J, 2002, EARTH PLANET SC LETT, V204, P167, DOI 10.1016/S0012-821X(02)00976-7; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; BOYET M, 2002, GEOCHIM COSMOCHIM AC, V66; CARO G, 2002, GEOCHIM COSMOCHIM AC, V66; CHASE CG, 1988, EARTH PLANET SC LETT, V91, P66, DOI 10.1016/0012-821X(88)90151-3; DALMASSO J, 1992, APPL RADIAT ISOTOPES, V43, P69, DOI 10.1016/0883-2889(92)90078-S; DIXON D, 1954, PHILOS MAG, V45, P683; GOPEL C, 1994, EARTH PLANET SC LETT, V121, P153, DOI 10.1016/0012-821X(94)90038-8; HARPER CL, 1992, NATURE, V360, P728, DOI 10.1038/360728a0; JACOBSEN SB, 1980, EARTH PLANET SC LETT, V50, P139, DOI 10.1016/0012-821X(80)90125-9; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; LUGMAIR GW, 1975, METEORITICS, V10, P447; Lugmair GW, 1974, METEORITICS, V9, P369; Nir-El Y, 1998, APPL RADIAT ISOTOPES, V49, P1653, DOI 10.1016/S0969-8043(97)10007-0; PATCHETT PJ, 1980, NATURE, V288, P571, DOI 10.1038/288571a0; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; STEVENSON RK, 1990, GEOCHIM COSMOCHIM AC, V54, P1683, DOI 10.1016/0016-7037(90)90400-F; TATSUMOTO M, 1981, MEM NATL I POLAR RES, V20, P237; Vervoort JD, 1999, GEOCHIM COSMOCHIM AC, V63, P533, DOI 10.1016/S0016-7037(98)00274-9; Vervoort JD, 1996, NATURE, V379, P624, DOI 10.1038/379624a0; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	31	168	169	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					931	933		10.1038/nature01421	http://dx.doi.org/10.1038/nature01421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606997				2022-12-28	WOS:000181186900045
J	Frolkis, JP; Pothier, CE; Blackstone, EH; Lauer, MS				Frolkis, JP; Pothier, CE; Blackstone, EH; Lauer, MS			Frequent ventricular ectopy after exercise as a predictor of death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-RATE RECOVERY; CORONARY-ARTERY DISEASE; ALL-CAUSE MORTALITY; TREADMILL EXERCISE; PROGNOSTIC-SIGNIFICANCE; VITAL STATUS; ARRHYTHMIAS; MEN; DEPOLARIZATIONS; PREVALENCE	BACKGROUND Exercise-induced ventricular ectopy predicts an increased risk of death in population-based cohorts. We sought to examine in a clinical cohort the prognostic importance of ventricular ectopy immediately after exercise, when reactivation of parasympathetic activity occurs. We hypothesized that ventricular ectopy after exercise (i.e., during the recovery phase) would predict an increased risk of death better than ventricular ectopy during exercise. METHODS We studied 29,244 patients (mean [+/-SD] age, 56+/-11 years; 70 percent men) who had been referred for symptom-limited exercise testing without a history of heart failure, valve disease, or arrhythmia. Frequent ventricular ectopy was defined by the presence of seven or more ventricular premature beats per minute, ventricular bigeminy or trigeminy, ventricular couplets or triplets, ventricular tachycardia, ventricular flutter, torsade de pointes, or ventricular fibrillation. RESULTS Frequent ventricular ectopy occurred only during exercise in 945 patients (3 percent), only during recovery in 589 (2 percent), and during both exercise and recovery in 491 (2 percent). There were 1862 deaths during a mean of 5.3 years of follow-up. Frequent ventricular ectopy during exercise predicted an increased risk of death (five-year death rate, 9 percent, vs. 5 percent among patients without frequent ventricular ectopy during exercise; hazard ratio, 1.8; 95 percent confidence interval, 1.5 to 2.1; P<0.001), but frequent ventricular ectopy during recovery was a stronger predictor (11 percent vs. 5 percent; hazard ratio, 2.4; 95 percent confidence interval, 2.0 to 2.9; P<0.001). After propensity matching for confounding variables, frequent ventricular ectopy during recovery predicted an increased risk of death (adjusted hazard ratio, 1.5; 95 percent confidence interval, 1.1 to 1.9; P=0.003), but frequent ventricular ectopy during exercise did not (adjusted hazard ratio, 1.1; 95 percent confidence interval, 0.9 to 1.3; P=0.53). CONCLUSIONS Frequent ventricular ectopy during recovery after exercise is a better predictor of an increased risk of death than ventricular ectopy occurring only during exercise.	Cleveland Clin Fdn, Dept Gen Internal Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiothorac Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Epidemiol & Biostat, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Gen Internal Med, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177	NHLBI NIH HHS [HL 66004] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066004] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2002.120329; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; CALIFF RM, 1983, J AM COLL CARDIOL, V2, P1060, DOI 10.1016/S0735-1097(83)80330-1; Calkins H, 2000, NEW ENGL J MED, V343, P879, DOI 10.1056/NEJM200009213431209; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; COX DR, 1972, J R STAT SOC B, V34, P187; CURB JD, 1985, AM J EPIDEMIOL, V121, P754, DOI 10.1093/aje/121.5.754; DEMARIA AN, 1974, AM J CARDIOL, V33, P732, DOI 10.1016/0002-9149(74)90213-6; Elhendy A, 2002, AM J CARDIOL, V90, P95, DOI 10.1016/S0002-9149(02)02428-1; FARIS JV, 1976, AM J CARDIOL, V37, P617, DOI 10.1016/0002-9149(76)90404-5; FLEG JL, 1984, AM J CARDIOL, V54, P762, DOI 10.1016/S0002-9149(84)80204-0; GOLDSCHLAGER N, 1973, AM J CARDIOL, V31, P434, DOI 10.1016/0002-9149(73)90291-9; Gottlieb SS, 1997, LANCET, V349, P662, DOI 10.1016/S0140-6736(97)22010-6; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; HOSMER DW, 1989, APPL LOGISTIC REGRES; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; LOWN B, 1977, AM J CARDIOL, V39, P910, DOI 10.1016/S0002-9149(77)80046-5; NAIR CK, 1983, J AM COLL CARDIOL, V1, P1201, DOI 10.1016/S0735-1097(83)80130-2; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schweikert RA, 1999, AM J CARDIOL, V83, P530, DOI 10.1016/S0002-9149(98)00908-4; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Snader CE, 1997, J AM COLL CARDIOL, V30, P641, DOI 10.1016/S0735-1097(97)00217-9; UDALL JA, 1977, CIRCULATION, V56, P985, DOI 10.1161/01.CIR.56.6.985; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; WEINER DA, 1984, AM J CARDIOL, V53, P1553, DOI 10.1016/0002-9149(84)90578-2; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]	33	192	205	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					781	790		10.1056/NEJMoa022353	http://dx.doi.org/10.1056/NEJMoa022353			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606732				2022-12-28	WOS:000181173300004
J	Goldberg, M; Stucki, M; Falck, J; D'Amours, D; Rahman, D; Pappin, D; Bartek, J; Jackson, SP				Goldberg, M; Stucki, M; Falck, J; D'Amours, D; Rahman, D; Pappin, D; Bartek, J; Jackson, SP			MDC1 is required for the intra-S-phase DNA damage checkpoint	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; CELLULAR-RESPONSE; HISTONE H2AX; NUCLEAR FOCI; REPAIR; GENE; ATM; DISORDERS	MRE11, RAD50 and NBS1 form a highly conserved protein complex (the MRE11 complex) that is involved in the detection, signalling and repair of DNA damage(1). We identify MDC1 (KIAA0170/NFBD1), a protein that contains a forkhead-associated (FHA) domain and two BRCA1 carboxy-terminal (BRCT) domains, as a binding partner for the MRE11 complex. We show that, in response to ionizing radiation, MDC1 is hyperphosphorylated in an ATM-dependent manner, and rapidly relocalizes to nuclear foci that also contain the MRE11 complex, phosphorylated histone H2AX and 53BP1. Downregulation of MDC1 expression by small interfering RNA yields a radioresistant DNA synthesis (RDS) phenotype and prevents ionizing radiation-induced focus formation by the MRE11 complex. However, downregulation of MDC1 does not abolish the ionizing radiation-induced phosphorylation of NBS1, CHK2 and SMC1, or the degradation of CDC25A. Furthermore, we show that overexpression of the MDC1 FHA domain interferes with focus formation by MDC1 itself and by the MRE11 complex, and induces an RDS phenotype. These findings reveal that MDC1-mediated focus formation by the MRE11 complex at sites of DNA damage is crucial for the efficient activation of the intra-S-phase checkpoint.	Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Imperial Coll Sch Med, Dept Proteom, London W12 0NN, England	University of Cambridge; University of Cambridge; Danish Cancer Society; Imperial College London	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst Canc & Dev Biol, Cambridge CB2 1QR, England.		Dry, Kate/I-2328-2014; Stucki, Manuel/H-4739-2017; Bartek, Jiri/G-5870-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Goldberg, Michal/0000-0001-9397-2383; Pappin, Darryl/0000-0002-8981-8401				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Michelson RJ, 2000, BIOESSAYS, V22, P966, DOI 10.1002/1521-1878(200011)22:11<966::AID-BIES2>3.3.CO;2-C; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	30	402	433	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					952	956		10.1038/nature01445	http://dx.doi.org/10.1038/nature01445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607003				2022-12-28	WOS:000181186900051
J	Mora, C; Chittaro, PM; Sale, PF; Kritzer, JP; Ludsin, SA				Mora, C; Chittaro, PM; Sale, PF; Kritzer, JP; Ludsin, SA			Patterns and processes in reef fish diversity	NATURE			English	Article							BIODIVERSITY HOTSPOTS; CORAL; CONSERVATION; DURATION; PACIFIC	A central aim of ecology is to explain the heterogeneous distribution of biodiversity on earth. As expectations of diversity loss grow(1-5), this understanding is also critical for effective management and conservation. Although explanations for biodiversity patterns are still a matter for intense debate(5), they have often been considered to be scale-dependent(6,7). At large geographical scales, biogeographers have suggested that variation in species richness results from factors such as area, temperature, environmental stability, and geological processes, among many others(5,7-14). From the species pools generated by these large-scale processes, community ecologists have suggested that local-scale assembly of communities is achieved through processes such as competition, predation, recruitment, disturbances and immigration(5-8,15,16). Here we analyse hypotheses on speciation and dispersal for reef fish from the Indian and Pacific oceans and show how dispersal from a major centre of origination can simultaneously account for both large-scale gradients in species richness and the structure of local communities.	Univ Windsor, Dept Biol, Windsor, ON N9B 3P4, Canada	University of Windsor	Mora, C (corresponding author), Univ Windsor, Dept Biol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	moracamilo@hotmail.com	Ludsin, Stuart/F-2925-2010	Ludsin, Stuart/0000-0002-3866-2216; Chittaro, Paul/0000-0001-9310-7314				Allen G.R., 1994, Atoll Research Bulletin, V412, P1; [Anonymous], 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237.001; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonhomme F, 2000, ENVIRON BIOL FISH, V59, P365, DOI 10.1023/A:1026508715631; Caley MJ, 1997, ECOLOGY, V78, P70; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Cornell HV, 2000, CORAL REEFS, V19, P37, DOI 10.1007/s003380050224; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Grove J.S., 1997, FISHES GALAPAGOS ISL; Harmelin-Vivien Mireille L., 2002, P265, DOI 10.1016/B978-012615185-5/50016-5; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Karlson RH, 1998, ECOL MONOGR, V68, P259, DOI 10.1890/0012-9615(1998)068[0259:SDVILV]2.0.CO;2; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SPRINGER VG, 1982, SMITHSON CONTRIB ZOO, V177, P1; THOMSON DA, 1999, REEF FISHES SEA CORT; VERON JEN, 1995, CORALS SPACE TIME BI; Victor BC, 2000, MAR ECOL PROG SER, V205, P241, DOI 10.3354/meps205241; VICTOR BC, 1986, MAR BIOL, V90, P317, DOI 10.1007/BF00428555; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; ZAPATA F, 1998, P 8 INT COR REEF S, V1, P1029	27	248	259	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					933	936		10.1038/nature01393	http://dx.doi.org/10.1038/nature01393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606998				2022-12-28	WOS:000181186900046
J	Rees, WE				Rees, WE			A blot on the land	NATURE			English	Article									Univ British Columbia, Sch Community & Reg Planning, Vancouver, BC V6T 1Z2, Canada	University of British Columbia	Rees, WE (corresponding author), Univ British Columbia, Sch Community & Reg Planning, 6333 Mem Rd, Vancouver, BC V6T 1Z2, Canada.							Rees W.E, 1992, ENVIRON URBAN, V4, P120, DOI 10.1177/095624789200400212; Rees WE, 2002, B SCI TECHNOL SOC, V22, P249, DOI DOI 10.1177/0270467602022004001; TAINTER JA, 1995, FUTURES, V27, P397, DOI 10.1016/0016-3287(95)00016-P; *WORLDW FUND NAT, 2002, LIV PLAN REP 2002	4	24	26	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					898	898		10.1038/421898a	http://dx.doi.org/10.1038/421898a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649BK	12606978	Bronze			2022-12-28	WOS:000181186900023
J	Wu, LZ; de Bruin, A; Saavedra, HI; Starovic, M; Trimboli, A; Yang, Y; Opavska, J; Wilson, P; Thompson, JC; Ostrowski, MC; Rosol, TJ; Woollett, LA; Weinstein, M; Cross, JC; Robinson, ML; Leone, G				Wu, LZ; de Bruin, A; Saavedra, HI; Starovic, M; Trimboli, A; Yang, Y; Opavska, J; Wilson, P; Thompson, JC; Ostrowski, MC; Rosol, TJ; Woollett, LA; Weinstein, M; Cross, JC; Robinson, ML; Leone, G			Extra-embryonic function of Rb is essential for embryonic development and viability	NATURE			English	Article							RETINOBLASTOMA GENE; MOUSE PLACENTA; CHIMERIC MICE; CELLS; PROLIFERATION; MUTATION; PROTEIN; DIFFERENTIATION; EXPRESSION; APOPTOSIS	The retinoblastoma (Rb) gene was the first tumour suppressor identified(1). Inactivation of Rb in mice results in unscheduled cell proliferation, apoptosis and widespread developmental defects, leading to embryonic death by day 14.5 (refs 2-4). However, the actual cause of the embryonic lethality has not been fully investigated. Here we show that loss of Rb leads to excessive proliferation of trophoblast cells and a severe disruption of the normal labyrinth architecture in the placenta. This is accompanied by a decrease in vascularization and a reduction in placental transport function. We used two complementary techniques-tetraploid aggregation and conditional knockout strategies-to demonstrate that Rb-deficient embryos supplied with a wild-type placenta can be carried to term, but die soon after birth. Most of the neurological and erythroid abnormalities thought to be responsible for the embryonic lethality of Rb-null animals were virtually absent in rescued Rb-null pups. These findings identify and define a key function of Rb in extra-embryonic cell lineages that is required for embryonic development and viability, and provide a mechanism for the cell autonomous versus non-cell autonomous roles of Rb in development.	Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; Childrens Res Inst, Div Mol & Human Genet, Columbus, OH 43205 USA; Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Calgary; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; University of Cincinnati	Leone, G (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA.		Rosol, Thomas/G-9585-2011; Cross, James/AAU-2973-2020; Wenzel, Pamela/AAJ-1944-2021; de Bruin, Alain/AAL-9195-2020; Thompson, Jessica/GXW-0323-2022; Cross, James/F-4814-2011; Wenzel, Pamela/A-2992-2010; Ostrowski, Michael/H-3108-2011	Rosol, Thomas/0000-0003-3737-1190; Cross, James/0000-0003-0956-9378; Wenzel, Pamela/0000-0002-4530-015X; Cross, James/0000-0003-0956-9378; Ostrowski, Michael/0000-0003-2948-6297; de Bruin, Alain/0000-0001-8579-2649				Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; FARIA TN, 1991, BIOL REPROD, V44, P327, DOI 10.1095/biolreprod44.2.327; Hogan B, 1994, MANIPULATING MOUSE E; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; Kurz H, 1999, ANAT EMBRYOL, V200, P335, DOI 10.1007/s004290050284; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; LINZER DIH, 1985, P NATL ACAD SCI USA, V82, P4356, DOI 10.1073/pnas.82.13.4356; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Marino S, 2000, GENE DEV, V14, P994; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	29	305	311	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 27	2003	421	6926					942	947		10.1038/nature01417	http://dx.doi.org/10.1038/nature01417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607001				2022-12-28	WOS:000181186900049
J	Smith, GCS; Pell, JP; Walsh, D				Smith, GCS; Pell, JP; Walsh, D			Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FACTOR-V-LEIDEN		Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh EH5 3SE, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Box 223, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Walsh, David/0000-0002-3390-5039; Pell, Jill/0000-0002-8898-7035				NESS RB, 1993, NEW ENGL J MED, V328, P1528, DOI 10.1056/NEJM199305273282104; Rosendaal FR, 1997, BLOOD, V89, P2817, DOI 10.1182/blood.V89.8.2817; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Souza SS, 1999, HUM REPROD, V14, P2448, DOI 10.1093/humrep/14.10.2448; Vaarala O, 1998, LUPUS, V7, pS132, DOI 10.1177/096120339800700229	5	45	45	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					423	424		10.1136/bmj.326.7386.423	http://dx.doi.org/10.1136/bmj.326.7386.423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595381	Bronze, Green Published			2022-12-28	WOS:000181318000018
J	Douglas, T				Douglas, T			A bright bio-inspired future	SCIENCE			English	Editorial Material							PROTEINS; NUCLEATION; MONOLAYERS; CRYSTALS; CALCITE		Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Douglas, T (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.		Douglas, Trevor/GRS-0012-2022; Douglas, Trevor/F-2748-2011	Douglas, Trevor/0000-0002-7882-2704; 				ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Aizenberg J, 2003, SCIENCE, V299, P1205, DOI 10.1126/science.1079204; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; Lowenstam HA, 1989, BIOMINERALIZATION; MANN S, 1988, NATURE, V334, P692, DOI 10.1038/334692a0; MANN S, 1990, ADV MATER, V2, P257; Mann S., 1989, BIOMINERALIZATION CH; Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108	13	64	72	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1192	1193		10.1126/science.1081791	http://dx.doi.org/10.1126/science.1081791			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595681				2022-12-28	WOS:000181065500027
J	Sillje, HHW; Nigg, EA				Sillje, HHW; Nigg, EA			Capturing polo kinase	SCIENCE			English	Editorial Material							MITOSIS; DOMAINS; PLX1		Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Sillje, HHW (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.			nigg, erich/0000-0003-4835-5719				Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7	11	11	11	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1190	1191						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595680				2022-12-28	WOS:000181065500026
J	Tanaka, K; Tengeiji, A; Kato, T; Toyama, N; Shionoya, M				Tanaka, K; Tengeiji, A; Kato, T; Toyama, N; Shionoya, M			A discrete self-assembled metal array in artificial DNA	SCIENCE			English	Article							BASE-PAIR; COMPLEXES	DNA has a structural basis to array functionalized building blocks. Here we report the synthesis of a series of artificial oligonucleotides, d(5'-GH(n)C-3') (n = 1 to 5), with hydroxypyridone nucleobases (H) as flat bidentate ligands. Right-handed double helices of the oligonucleotides, nCu(2+).d(5'-GHnC-3'), (n = 1 to 5), were quantitatively formed through copper ion (Cu2+)-mediated alternative base pairing (H-Cu2+-H), where the Cu2+ ions incorporated into each complex were aligned along the helix axes inside the duplexes with the Cu2+-Cu2+ distance of 3.7 +/- 0.1 angstroms. The Cu2+ ions were coupled ferromagnetically with one another through unpaired d electrons to form magnetic chains.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Inst Mol Sci, Okazaki, Aichi 4448585, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Shionoya, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.		Tanaka, Kentaro/I-7056-2014	Tanaka, Kentaro/0000-0002-6395-4536				Atwell S, 2001, J AM CHEM SOC, V123, P12364, DOI 10.1021/ja011822e; BERGSTROM DE, 2001, CURRENT PROTOCOLS NU; Finniss GM, 1996, ANGEW CHEM INT EDIT, V35, P2772, DOI 10.1002/anie.199627721; Kool ET, 2002, ACCOUNTS CHEM RES, V35, P936, DOI 10.1021/ar000183u; Lai SY, 1999, J AM CHEM SOC, V121, P250, DOI 10.1021/ja982065w; Meggers E, 2000, J AM CHEM SOC, V122, P10714, DOI 10.1021/ja0025806; Palmans R, 1996, J AM CHEM SOC, V118, P12647, DOI 10.1021/ja962491m; Tanaka K, 1999, J ORG CHEM, V64, P5002, DOI 10.1021/jo990326u; Tanaka K, 2002, J AM CHEM SOC, V124, P8802, DOI 10.1021/ja020510o; Tanaka K, 2002, J AM CHEM SOC, V124, P12494, DOI 10.1021/ja027175o; Weizman H, 2001, J AM CHEM SOC, V123, P3375, DOI 10.1021/ja005785n	11	454	458	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 21	2003	299	5610					1212	1213		10.1126/science.1080587	http://dx.doi.org/10.1126/science.1080587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646YY	12595687				2022-12-28	WOS:000181065500034
J	Butler, D				Butler, D			Ministers back gene-crop advisers	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					775	775		10.1038/421775b	http://dx.doi.org/10.1038/421775b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594469	Bronze			2022-12-28	WOS:000181044700009
J	Fauci, AS				Fauci, AS			Biodefence on the research agenda	NATURE			English	Editorial Material									NIAID, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, Dept Hlth & Human Serv, 9000 Rockville Pike, Bethesda, MD 20892 USA.							Frey SE, 2002, NEW ENGL J MED, V346, P1265, DOI 10.1056/NEJMoa020534; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Lane HC, 2001, NAT MED, V7, P1271, DOI 10.1038/nm1201-1271	3	16	16	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					787	787		10.1038/nature01480	http://dx.doi.org/10.1038/nature01480			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594484	Bronze			2022-12-28	WOS:000181044700023
J	Zhou, ZH; Barrett, PM; Hilton, J				Zhou, ZH; Barrett, PM; Hilton, J			An exceptionally preserved Lower Cretaceous ecosystem	NATURE			English	Review							YIXIAN FORMATION; INTEGUMENTARY STRUCTURES; EARLY DIVERSIFICATION; FEATHERED DINOSAURS; JURASSIC ANGIOSPERM; LIAONING PROVINCE; EARLY EVOLUTION; INNER-MONGOLIA; CHINA; BIRD	Fieldwork in the Early Cretaceous Jehol Group, northeastern China has revealed a plethora of extraordinarily well-preserved fossils that are shaping some of the most contentious debates in palaeontology and evolutionary biology. These discoveries include feathered theropod dinosaurs and early birds, which provide additional, indisputable support for the dinosaurian ancestry of birds, and much new evidence on the evolution of feathers and flight. Specimens of putative basal angiosperms and primitive mammals are clarifying details of the early radiations of these major clades. Detailed soft-tissue preservation of the organisms from the Jehol Biota is providing palaeobiological insights that would not normally be accessible from the fossil record.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Natl Museums Scotland, Dept Geol & Zool, Edinburgh EH1 1JF, Midlothian, Scotland	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Oxford	Zhou, ZH (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhonghe@yeah.net	Barrett, Paul M/A-2648-2010; Hilton, Jason/F-5830-2012	Barrett, Paul M/0000-0003-0412-3000; Hilton, Jason/0000-0003-0286-8236				Allison P.A., 1991, TAPHONOMY RELEASING; [Anonymous], 1964, YORKSHIRE JURASSIC F; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Barrett PM, 2002, PALAEONTOLOGY, V45, P1197, DOI 10.1111/1475-4983.00282; Chen P, 1999, PALAEOWORLD, P1; Chen P., 1980, B NANJING I GEOL PAL, V1, P22; Chen P.-j., 1988, Acta Palaeontologica Sinica, V27, P659; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chiappe LM, 1999, B AM MUS NAT HIST, P3; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; Dalton R, 2000, NATURE, V406, P930, DOI 10.1038/35023182; Dalton R, 2000, NATURE, V403, P689, DOI 10.1038/35001723; Dalton R, 2001, NATURE, V414, P571, DOI 10.1038/414571a; Deng S., 1995, EARLY CRETACEOUS FLO; Deng S.-H., 1997, EARLY CRETACEOUS FLO; EBERTH DA, 1993, CAN J EARTH SCI, V30, P2101, DOI 10.1139/e93-182; ENDO RUIJI, 1942, BULL CENTRAL NATION MUS MANCHOUKUO, V3, P1; ENKIN RJ, 1992, J GEOPHYS RES-SOL EA, V97, P13953, DOI 10.1029/92JB00648; Evans Susan E., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P183; Friis EM, 2001, NATURE, V410, P357, DOI 10.1038/35066557; Gao KQ, 2000, J VERTEBR PALEONTOL, V20, P417, DOI 10.1671/0272-4634(2000)020[0417:EFMOAS]2.0.CO;2; Gao KQ, 2001, NATURE, V410, P574, DOI 10.1038/35069051; Grabau A.W., 1928, STRATIGRAPHY CHINA 2; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande L, 2002, J VERTEBR PALEONTOL, V22, P209, DOI 10.1671/0272-4634(2002)022[0209:PLAWPP]2.0.CO;2; Hirayama Ren, 2000, Russian Journal of Herpetology, V7, P181; HOU LH, 1995, CHINESE SCI BULL, V40, P1545; HOU LH, 1995, NATURE, V377, P616, DOI 10.1038/377616a0; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hu YM, 2002, CHINESE SCI BULL, V47, P933, DOI 10.1360/02tb9209; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; Ji Q., 1996, CHINESE GEOL, V233, P30; JI Q, 1997, CHIN GEOL, V3, P38; Jiang Fu-Xing, 2000, Acta Palaeontologica Sinica, V39, P307; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Li JL, 2001, CHINESE SCI BULL, V46, P782, DOI 10.1007/BF03187223; LI PX, 1994, ACTA GEOL SINICA, V7, P329; LO CH, 1999, PALAEOWORLD, V11, P329; Luo ZX, 1999, NATURE, V400, P23, DOI 10.1038/21790; Manabe M, 1999, J PALEONTOL, V73, P1176, DOI 10.1017/S002233600003105X; Manabe M, 2000, NATURE, V404, P953, DOI 10.1038/35010199; Martill DM., 1993, PALAEONTOLOGICAL ASS; Martin LD, 2000, AM ZOOL, V40, P687, DOI 10.1668/0003-1569(2000)040[0687:TFROFE]2.0.CO;2; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; Padian K, 2001, AM ZOOL, V41, P598, DOI 10.1668/0003-1569(2001)041[0598:CTAHPA]2.0.CO;2; Padian Kevin, 2001, P117; Ren D, 1998, SCIENCE, V280, P85, DOI 10.1126/science.280.5360.85; Ren D, 1995, FAUNAE STRATIGRAPHY, P47; ROTHWELL GW, 1994, SYST BOT, V19, P443, DOI 10.2307/2419767; Rowe T, 2001, NATURE, V410, P539, DOI 10.1038/35069145; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; Rydin C, 2002, INT J PLANT SCI, V163, P197, DOI 10.1086/338321; Setoguchi T., 1999, P 7 ANN M CHIN SOC V, P117; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Smith JB, 2001, J VERTEBR PALEONTOL, V21, P389, DOI 10.1671/0272-4634(2001)021[0389:ATPCTD]2.0.CO;2; Smith JB, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P549; SMITH PE, 1995, CAN J EARTH SCI, V32, P1426, DOI 10.1139/e95-115; Stokstad E, 2002, SCIENCE, V296, P821; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Sun G, 2001, EARLY ANGIOSPERMS TH; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Taylor Rod S., 1999, Paleontological Research, V3, P121; Unwin David M., 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P181; Upchurch P, 2002, P ROY SOC B-BIOL SCI, V269, P613, DOI 10.1098/rspb.2001.1921; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; WANG DF, 1984, SCI PAPERS GEOLOGY I, V1, P1; WANG HZ, 1983, ACTA GEOL SIN-ENGL, V57, P213; Wang SS, 2001, ACTA PETROL SIN, V17, P663; Wang X., 2000, VERTEBRATA PALASIA S, V38, P41; Wang Xiaolin, 1998, Vertebrata Palasiatica, V36, P81; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Wang XL, 2001, CHINESE SCI BULL, V46, P1112; Wang XL, 2001, CHINESE SCI BULL, V46, P1669, DOI 10.1007/BF02900633; WANG XL, GEOL REV S, V45, P458; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2002, NATURE, V419, P291, DOI 10.1038/nature00966; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; Xu X, 2001, NATURWISSENSCHAFTEN, V88, P297, DOI 10.1007/s001140100233; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu Xing, 1998, Vertebrata Palasiatica, V36, P147; Xu Xing, 2000, Vertebrata Palasiatica, V38, P318; Yuan W, 2000, NATURWISSENSCHAFTEN, V87, P417, DOI 10.1007/s001140050753; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhang M.M., 2001, JEHOL BIOTA; Zheng S., 1989, MESOZOIC STRATIGRAPH; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930; Zhou ZH, 2001, CHINESE SCI BULL, V46, P1258, DOI 10.1007/BF03184320; Zhou ZH, 2002, NATURWISSENSCHAFTEN, V89, P34, DOI 10.1007/s00114-001-0276-9	100	518	584	6	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					807	814		10.1038/nature01420	http://dx.doi.org/10.1038/nature01420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594504				2022-12-28	WOS:000181044700039
J	Scorrano, L; Oakes, SA; Opferman, JT; Cheng, EH; Sorcinelli, MD; Pozzan, T; Korsmeyer, SJ				Scorrano, L; Oakes, SA; Opferman, JT; Cheng, EH; Sorcinelli, MD; Pozzan, T; Korsmeyer, SJ			BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis	SCIENCE			English	Article							CYTOCHROME-C; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; PERMEABILITY TRANSITION; BCL-2; CALCIUM; EXPRESSION; ACTIVATION; MOLECULES; CHANNELS	BAX and BAK are "multidomain" proapoptotic proteins that initiate mitochondrial dysfunction but also localize to the endoplasmic reticulum (ER). Mouse embryonic. broblasts deficient for BAX and BAK (DKO cells) were found to have a reduced resting concentration of calcium in the ER ([Ca2+](er)) that results in decreased uptake of Ca2+ by mitochondria after Ca2+ release from the ER. Expression of SERCA (sarcoplasmic-endoplasmic reticulum Ca2+ adenosine triphosphatase) corrected [Ca2+](er) and mitochondrial Ca2+ uptake in DKO cells, restoring apoptotic death in response to agents that release Ca2+ from intracellular stores (such as arachidonic acid, C-2-ceramide, and oxidative stress). In contrast, targeting of BAX to mitochondria selectively restored apoptosis to "BH3-only" signals. A third set of stimuli, including many intrinsic signals, required both ER-released Ca2+ and the presence of mitochondrial BAX or BAK to fully restore apoptosis. Thus, BAX and BAK operate in both the ER and mitochondria as an essential gateway for selected apoptotic signals.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA; Venetian Inst Mol Med, I-35121 Padua, Italy; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Veneto Institute Molecular Medicine; University of Padua	Korsmeyer, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu	Scorrano, Luca/K-3967-2019; Opferman, Joseph T/M-5331-2018; Scorrano, Luca/A-6652-2008	Scorrano, Luca/0000-0002-8515-8928; Opferman, Joseph T/0000-0002-1147-5621; Scorrano, Luca/0000-0002-8515-8928	NATIONAL CANCER INSTITUTE [R37CA050239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NCI NIH HHS [R37CA50239] Funding Source: Medline; NHLBI NIH HHS [T32HL07627] Funding Source: Medline; Telethon [TCP02016] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon)		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Decaudin D, 1997, CANCER RES, V57, P62; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; Gajkowska B, 2001, CELL BIOL INT, V25, P725, DOI 10.1006/cbir.2001.0768; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; OAKES SA, UNPUB; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2	31	1155	1209	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2003	300	5616					135	139		10.1126/science.1081208	http://dx.doi.org/10.1126/science.1081208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663CP	12624178				2022-12-28	WOS:000181988900050
J	Ma, DDD; Lee, CS; Au, FCK; Tong, SY; Lee, ST				Ma, DDD; Lee, CS; Au, FCK; Tong, SY; Lee, ST			Small-diameter silicon nanowire surfaces	SCIENCE			English	Article							SCANNING-TUNNELING MICROSCOPY; LASER-ABLATION; QUANTUM WIRES; SPECTROSCOPY; DEPENDENCE	Small-diameter (11 to 7 nanometers) silicon nanowires (SiNWs) were prepared, and their surfaces were removed of oxide and terminated with hydrogen by a hydrofluoric acid dip. Scanning tunneling microscopy (STM) of these SiNWs, performed both in air and in ultrahigh vacuum, revealed atomically resolved images that can be interpreted as hydrogen-terminated Si (1111)-(1 x 1) and Si (001)-(l x 1) surfaces corresponding to SiH3 on Si (1111) and SiH2 on Si (001), respectively. These hydrogen-terminated SiNW surfaces seem to be more oxidation-resistant than regular silicon wafer surfaces, because atomically resolved STM images of SiNWs were obtained in air after several days' exposure to the ambient environment. Scanning tunneling spectroscopy measurements were performed on the oxide-removed SiNWs and were used to evaluate the electronic energy gaps. The energy gaps were found to increase with decreasing SiNW diameter from 1.1 electron volts for 7 nanometers to 3.5 electron volts for 1.3 nanometers, in agreement with previous theoretical predictions.	City Univ Hong Kong, Ctr Super Diamond & Adv Films, Hong Kong, Hong Kong, Peoples R China; City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong	Lee, ST (corresponding author), City Univ Hong Kong, Ctr Super Diamond & Adv Films, Hong Kong, Hong Kong, Peoples R China.		LEE, Chun-Sing/B-6254-2013; Lee, Shuit-Tong/Q-7552-2018; Tong, SY/AAE-1711-2020	LEE, Chun-Sing/0000-0001-6557-453X; 				Cui Y, 2001, APPL PHYS LETT, V78, P2214, DOI 10.1063/1.1363692; DELERUE C, 1993, PHYS REV B, V48, P11024, DOI 10.1103/PhysRevB.48.11024; DELLEY B, 1995, APPL PHYS LETT, V67, P2370, DOI 10.1063/1.114348; Gole JL, 2000, APPL PHYS LETT, V76, P2346, DOI 10.1063/1.126341; HAMERS RJ, 1993, SCANNING TUNNELING M, P51; HIGASHI GS, 1991, APPL PHYS LETT, V58, P1656, DOI 10.1063/1.105155; HIGASHI GS, 1990, APPL PHYS LETT, V56, P656, DOI 10.1063/1.102728; Holmes JD, 2000, SCIENCE, V287, P1471, DOI 10.1126/science.287.5457.1471; LANG ND, 1986, PHYS REV B, V34, P5947, DOI 10.1103/PhysRevB.34.5947; LEE ST, 1999, J MATER RES, V14, P4053; Ma DDD, 2001, APPL PHYS LETT, V79, P2468, DOI 10.1063/1.1409276; Marsen B, 1999, PHYS REV B, V60, P11593, DOI 10.1103/PhysRevB.60.11593; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; MORITA Y, 1991, APPL PHYS LETT, V59, P1347, DOI 10.1063/1.105304; NIWANO M, 1994, J APPL PHYS, V76, P2157, DOI 10.1063/1.357627; NORTHRUP JE, 1991, PHYS REV B, V44, P1419, DOI 10.1103/PhysRevB.44.1419; PANDEY KC, 1975, PHYS REV LETT, V35, P1728, DOI 10.1103/PhysRevLett.35.1728; Pavesi L, 2000, NATURE, V408, P440, DOI 10.1038/35044012; READ AJ, 1992, PHYS REV LETT, V69, P1232, DOI 10.1103/PhysRevLett.69.1232; STROSCIO JA, 1986, PHYS REV LETT, V57, P2579, DOI 10.1103/PhysRevLett.57.2579; SUN XH, IN PRESS INORG CHEM; Wang N, 1999, CHEM PHYS LETT, V299, P237, DOI 10.1016/S0009-2614(98)01228-7; Xia JB, 1997, PHYS REV B, V55, P15688, DOI 10.1103/PhysRevB.55.15688; Zhang R., UNPUB; Zhang YF, 1998, APPL PHYS LETT, V72, P1835, DOI 10.1063/1.121199	25	1037	1073	6	383	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 21	2003	299	5614					1874	1877		10.1126/science.1080313	http://dx.doi.org/10.1126/science.1080313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657LY	12595610				2022-12-28	WOS:000181669700040
J	Boguski, MS; McIntosh, MW				Boguski, MS; McIntosh, MW			Biomedical informatics for proteomics	NATURE			English	Review							LASER CAPTURE MICRODISSECTION; PROTEIN IDENTIFICATION; FUNCTIONAL GENOMICS; PROSTATE-CANCER; SERUM; DISCOVERY; STANDARDS; PATTERNS; HISTORY; BIND		Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Boguski, MS (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.	mboguski@fhcrc.org; mmcintos@fhcrc.org						Abiteboul S., 1999, DATA WEB RELATIONS S; Adam BL, 2002, CANCER RES, V62, P3609; Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Anderson NG, 2001, PROTEOMICS, V1, P3, DOI 10.1002/1615-9861(200101)1:1<3::AID-PROT3>3.0.CO;2-T; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; *ASS BIOM RES FAC, 2002, DELT MASS DAT PROT P; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Bafna V, 2001, Bioinformatics, V17 Suppl 1, pS13; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2247, DOI 10.1093/nar/19.suppl.2247; Ball CA, 2002, SCIENCE, V298, P539; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOGUSKI MS, 1994, CURR OPIN GENET DEV, V4, P383, DOI 10.1016/0959-437X(94)90025-6; BOGUSKI MS, 1995, TRENDS BIOCHEM SCI, V20, P295, DOI 10.1016/S0968-0004(00)89051-9; Bonini P, 2002, CLIN CHEM, V48, P691; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; *CAMBR HEALTHT I, 2001, CAMBR HEALTHT I C HU; CHAKRAVARTI DN, 2002, BIOTECHNIQUES, V32, pS4; Chou SC, 2000, AUSTRALAS J AGEING, V19, P7; Choudhary JS, 2001, PROTEOMICS, V1, P651, DOI 10.1002/1615-9861(200104)1:5<651::AID-PROT651>3.0.CO;2-N; COYLE FP, 2002, XML WEB SERVICES DAT; Craven RA, 2002, METHOD ENZYMOL, V356, P33; Craven RA, 2001, PROTEOMICS, V1, P1200; Creasy DM, 2002, PROTEOMICS, V2, P1426, DOI 10.1002/1615-9861(200210)2:10<1426::AID-PROT1426>3.0.CO;2-5; DAYHOFF M O, 1970, Computers in Biology and Medicine, V1, P5, DOI 10.1016/0010-4825(70)90013-2; DAYHOFF MO, 1965, J THEOR BIOL, V8, P97, DOI 10.1016/0022-5193(65)90096-2; Doolittle RF, 1997, J MOL MED-JMM, V75, P239; Duyk GM, 2002, NAT GENET, V32, P465, DOI 10.1038/ng1027; Eck Richard V., 1966, ATLAS PROTEIN SEQ ST; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fenyo D, 2000, CURR OPIN BIOTECH, V11, P391, DOI 10.1016/S0958-1669(00)00115-4; Field HI, 2002, PROTEOMICS, V2, P36, DOI 10.1002/1615-9861(200201)2:1<36::AID-PROT36>3.0.CO;2-W; Hayles K., 1999, WE BECAME POSTHUMAN, DOI 10.7208/chicago/9780226321394.001.0001; Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601; Huang J, 2001, J SURG RES, V99, P222, DOI 10.1006/jsre.2001.6195; Judson Horace F., 1996, 8 DAY CREATION MAKER, Vsecond; Jung E, 2001, PROTEOMICS, V1, P262, DOI 10.1002/1615-9861(200102)1:2<262::AID-PROT262>3.0.CO;2-#; Keegan LP, 2001, NAT REV GENET, V2, P869, DOI 10.1038/35098584; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kohane I. S., 2002, MICROARRAYS INTEGRAT; Kratz A, 1998, NEW ENGL J MED, V339, P1063, DOI 10.1056/NEJM199810083391508; KRISHNA RG, 1993, ADV ENZYMOL RAMB, V67, P265; LIEBLER D, 2002, INTRO PROTEOMICS; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Margolin J, 2001, GENOME RES, V11, P923, DOI 10.1101/gr.192201; McClatchey KD, 2002, CLIN LAB MED; Narayanan S, 2000, AM J CLIN PATHOL, V113, P429, DOI 10.1309/C0NM-Q7R0-LL2E-B3UY; Orchard S, 2003, COMP FUNCT GENOM, V4, P16, DOI 10.1002/cfg.232; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; PEPE MS, IN PRESS BIOMETRICS; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petricoin EF, 2002, J NATL CANCER I, V94, P1576; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Potter JD, 2001, NAT REV GENET, V2, P142, DOI 10.1038/35052575; Qu YS, 2002, CLIN CHEM, V48, P1835; SHORTLIFFE E, 2000, MED INFORMATICS COMP; SMITH TF, 1990, GENOMICS, V6, P701, DOI 10.1016/0888-7543(90)90509-S; Spellman PT, 2002, GENOME BIOL, V3; Wilkins MR, 1999, J MOL BIOL, V289, P645, DOI 10.1006/jmbi.1999.2794; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4; 2002, NATURE GENET, V32, P333	64	150	207	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					233	237		10.1038/nature01515	http://dx.doi.org/10.1038/nature01515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634797				2022-12-28	WOS:000181488900058
J	Fehr, E; Rockenbach, B				Fehr, E; Rockenbach, B			Detrimental effects of sanctions on human altruism	NATURE			English	Article							INDIRECT RECIPROCITY; EVOLUTION; COOPERATION; FAIRNESS; TRUST	The existence of cooperation and social order among genetically unrelated individuals is a fundamental problem in the behavioural sciences. The prevailing approaches in biology and economics view cooperation exclusively as self-interested behaviour-unrelated individuals cooperate only if they face economic rewards or sanctions rendering cooperation a self-interested choice. Whether economic incentives are perceived as just or legitimate does not matter in these theories. Fairness-based altruism is, however, a powerful source of human cooperation. Here we show experimentally that the prevailing self-interest approach has serious shortcomings because it overlooks negative effects of sanctions on human altruism. Sanctions revealing selfish or greedy intentions destroy altruistic cooperation almost completely, whereas sanctions perceived as fair leave altruism intact. These findings challenge proximate and ultimate theories of human cooperation that neglect the distinction between fair and unfair sanctions, and they are probably relevant in all domains in which voluntary compliance matters-in relations between spouses, in the education of children, in business relations and organizations as well as in markets.	Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Univ Erfurt, D-99089 Erfurt, Germany	University of Zurich; University of Erfurt	Fehr, E (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.		Rockenbach, Bettina/AAI-8072-2021; van Lent, Laurence/G-5298-2010; Rockenbach, Bettina/B-5447-2016	Rockenbach, Bettina/0000-0003-2624-1964; van Lent, Laurence/0000-0002-9354-0932; Rockenbach, Bettina/0000-0003-2624-1964				ANDREONI J, 1995, AM ECON REV, V85, P891; ARROW KJ, 1972, PHILOS PUBLIC AFF, V1, P343; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bewley T. F., 1999, WHY WAGES DONT FALL; Bohnet I, 2001, AM POLIT SCI REV, V95, P131, DOI 10.1017/S0003055401000211; BOWLES S, IN PRESS EC I BEHAV; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; DUKHEIM E, 1902, DIVISION TRAVAIL SOC; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, EUR ECON REV, V46, P687, DOI 10.1016/S0014-2921(01)00208-2; FEHR E, 1993, Q J ECON, V108, P437, DOI 10.2307/2118338; Frey B., 1997, NOT JUST MONEY EC TH; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Laffont J.-J., 2002, THEORY INCENTIVES PR; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Mas-Colell A., 1995, MICROECONOMIC THEORY; Milgrom P., 1992, EC ORG MANAGEMENT; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; RABIN M, 1993, AM ECON REV, V83, P1281; Smith Adam, 1976, WEALTH NATIONS; Titmuss R. M., 1970, GIFT RELATIONSHIP; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3	27	445	459	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					137	140		10.1038/nature01474	http://dx.doi.org/10.1038/nature01474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654HG	12634778				2022-12-28	WOS:000181488900037
J	MacWilliams, B				MacWilliams, B			Russia pulls out of Antarctic station	NATURE			English	News Item																		LUKIN V, 2002, NATURE, V415, P828	1	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					104	104		10.1038/422104b	http://dx.doi.org/10.1038/422104b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634747				2022-12-28	WOS:000181488900010
J	Phizicky, E; Bastiaens, PIH; Zhu, H; Snyder, M; Fields, S				Phizicky, E; Bastiaens, PIH; Zhu, H; Snyder, M; Fields, S			Protein analysis on a proteomic scale	NATURE			English	Review							BIOCHEMICAL GENOMICS APPROACH; LIGATION-INDEPENDENT CLONING; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; CHEMICAL STRATEGIES; BINDING PROTEIN; GLOBAL ANALYSIS; YEAST; MICROARRAYS; CELLS		Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Rochester; European Molecular Biology Laboratory (EMBL); Yale University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Phizicky, E (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, Box 712,601 Elmwood Ave, Rochester, NY 14642 USA.	eric_phizicky@urmc.rochester.edu; philippe.bastiaens@embl-heidelberg.de; heng.zhu@yale.edu; michael.snyder@yale.edu; fields@u.washington.edu		Snyder, Michael/0000-0003-0784-7987				Adam GC, 2002, NAT BIOTECHNOL, V20, P805, DOI 10.1038/nbt714; Adam GC, 2002, MOL CELL PROTEOMICS, V1, P781, DOI 10.1074/mcp.R200006-MCP200; Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; ASLANIDIS C, 1994, PCR METH APPL, V4, P172; Belov L, 2001, CANCER RES, V61, P4483; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Cravatt BF, 2000, CURR OPIN CHEM BIOL, V4, P663, DOI 10.1016/S1367-5931(00)00147-2; Day RN, 1998, MOL ENDOCRINOL, V12, P1410, DOI 10.1210/me.12.9.1410; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602; Ding DQ, 2000, GENES CELLS, V5, P169, DOI 10.1046/j.1365-2443.2000.00317.x; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Fashena SJ, 2000, GENE, V250, P1, DOI 10.1016/S0378-1119(00)00182-7; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Grayhack EJ, 2001, CURR OPIN CHEM BIOL, V5, P34, DOI 10.1016/S1367-5931(00)00169-1; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Haab BB, 2001, GENOME BIOL, V2; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Hazbun TR, 2002, MOL CELL PROTEOMICS, V1, P538, DOI 10.1074/mcp.T200002-MCP200; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Houseman BT, 2002, NAT BIOTECHNOL, V20, P270, DOI 10.1038/nbt0302-270; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Joos TO, 2000, ELECTROPHORESIS, V21, P2641, DOI 10.1002/1522-2683(20000701)21:13<2641::AID-ELPS2641>3.3.CO;2-X; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Kenyon GL, 2002, MOL CELL PROTEOMICS, V1, P763; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kumar A, 2002, NAT BIOTECHNOL, V20, P58, DOI 10.1038/nbt0102-58; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LeProust E, 2000, J COMB CHEM, V2, P349, DOI 10.1021/cc000009x; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; MacBeath G, 2000, SCIENCE, V289, P1760; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; Martins LM, 1997, J BIOL CHEM, V272, P7421, DOI 10.1074/jbc.272.11.7421; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; Myszka, 2000, Pharm Sci Technol Today, V3, P310; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; Phizicky EM, 2002, METHOD ENZYMOL, V350, P546; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Reboul J, 2001, NAT GENET, V27, P332, DOI 10.1038/85913; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Sawin KE, 1996, P NATL ACAD SCI USA, V93, P15146, DOI 10.1073/pnas.93.26.15146; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Sreekumar A, 2001, CANCER RES, V61, P7585; Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Weng S, 2002, PROTEOMICS, V2, P48, DOI 10.1002/1615-9861(200201)2:1<48::AID-PROT48>3.0.CO;2-I; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Xing F, 2002, RNA, V8, P370, DOI 10.1017/S1355838202029825; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu H, 2001, CURR OPIN CHEM BIOL, V5, P40, DOI 10.1016/S1367-5931(00)00170-8; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	75	477	543	4	106	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 13	2003	422	6928					208	215		10.1038/nature01512	http://dx.doi.org/10.1038/nature01512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634794				2022-12-28	WOS:000181488900055
J	Kilpatrick, AM; Ives, AR				Kilpatrick, AM; Ives, AR			Species interactions can explain Taylor's power law for ecological time series	NATURE			English	Article							SYNOPTIC DYNAMICS; VARIABILITY; POPULATION; STABILITY; COMPETITION; MODELS; COMMUNITIES; DIVERSITY; MIGRATION; BEHAVIOR	One of the few generalities in ecology, Taylor's power law(1-3), describes the species-specific relationship between the temporal or spatial variance of populations and their mean abundances. For populations experiencing constant per capita environmental variability, the regression of log variance versus log mean abundance gives a line with a slope of 2. Despite this expectation, most species have slopes of less than 2 (refs 2-4), indicating that more abundant populations of a species are relatively less variable than expected on the basis of simple statistical grounds. What causes abundant populations to be less variable has received considerable attention(5-12), but an explanation for the generality of this pattern is still lacking. Here we suggest a novel explanation for the scaling of temporal variability in population abundances. Using stochastic simulation and analytical models, we demonstrate how negative interactions among species in a community can produce slopes of Taylor's power law of less than 2, like those observed in real data sets. This result provides an example in which the population dynamics of single species can be understood only in the context of interactions within an ecological community.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kilpatrick, AM (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.		Ives, Anthony/A-5698-2008	Ives, Anthony/0000-0001-9375-9523				ANDERSON RM, 1982, NATURE, V296, P245, DOI 10.1038/296245a0; Beissinger S. R., 2002, POPULATION VIABILITY; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Gianoli E, 2000, ENVIRON ENTOMOL, V29, P213, DOI 10.1603/0046-225X(2000)029[0213:CICAHA]2.0.CO;2; GILLIS DM, 1986, J THEOR BIOL, V123, P281, DOI 10.1016/S0022-5193(86)80243-0; GREEN RH, 1989, ENVIRON RES, V50, P195, DOI 10.1016/S0013-9351(89)80058-1; HANSKI I, 1980, OIKOS, V34, P293, DOI 10.2307/3544289; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Ives AR, 2002, AM NAT, V159, P388, DOI 10.1086/338994; IVES AR, IN PRESS ECOL MONOGR; Keeling M, 1999, PHILOS T R SOC B, V354, P769, DOI 10.1098/rstb.1999.0429; Keeling MJ, 2000, THEOR POPUL BIOL, V58, P21, DOI 10.1006/tpbi.2000.1475; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Muller CB, 1997, J ANIM ECOL, V66, P57, DOI 10.2307/5964; PERRY JN, 1988, OIKOS, V51, P124, DOI 10.2307/3565634; PERRY JN, 1994, P ROY SOC B-BIOL SCI, V257, P221, DOI 10.1098/rspb.1994.0118; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; TAYLOR LR, 1986, J ANIM ECOL, V55, P1, DOI 10.2307/4690; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1982, J ANIM ECOL, V51, P879, DOI 10.2307/4012; TAYLOR LR, 1978, J ANIM ECOL, V47, P383, DOI 10.2307/3790; TAYLOR LR, 1977, NATURE, V265, P415, DOI 10.1038/265415a0; TAYLOR MG, 1987, IMMUNOLOGY IMMUNOPRO, V2, P50; TAYLOR RAJ, 1981, J ANIM ECOL, V50, P573, DOI 10.2307/4075; THORARINSSON K, 1986, OIKOS, V46, P70, DOI 10.2307/3565382; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TITMUS G, 1983, OIKOS, V40, P64, DOI 10.2307/3544199	29	145	148	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 6	2003	422	6927					65	68		10.1038/nature01471	http://dx.doi.org/10.1038/nature01471			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651VP	12621433				2022-12-28	WOS:000181343100037
J	Gregg, EW; Gerzoff, RB; Thompson, TJ; Williamson, DF				Gregg, EW; Gerzoff, RB; Thompson, TJ; Williamson, DF			Intentional weight loss and death in overweight and obese US adults 35 years of age and older	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ALL-CAUSE MORTALITY; BODY-WEIGHT; LIFE-STYLE; WOMEN; DIET; MEN; INTERVENTION; VARIABILITY; TRIAL	Background: Although weight loss improves risk factors for cardiovascular and metabolic disease, it is unclear whether intentional weight loss reduces mortality rates. Objective: To examine the relationships among intention to lose weight, weight loss, and all-cause mortality. Design: Prospective cohort study using a probability sample of the U.S. population. Setting: Interviewer-administered survey. Participants: 6391 overweight and obese persons (body mass index greater than or equal to 25 kg/m(2)) who were at least 35 years of age. Measurements: Intention to lose weight and weight change during the past year were assessed by self-report in 1989. Vital status was followed for 9 years. Hazard rate ratios (HRRs) were adjusted for age, sex, ethnicity, education, smoking, health status, health care utilization, and initial body mass index. Results: Compared with persons not trying to lose weight and reporting no weight change, those reporting intentional weight loss had a 24% lower mortality rate (HRR, 0.76 [95% CI, 0.60 to 0.97]) and those with unintentional weight loss had a 31% higher mortality rate (HRR, 1.31 [CI, 1.01 to 1.70]). However, mortality rates were lower in persons who reported trying to lose weight than those in not trying to lose weight, independent of actual weight change. Compared with persons not trying to lose weight and reporting no weight change, persons trying to lose weight had the following HRRs: no weight change, 0.80 (CI, 0.65 to 0.99); gained weight, 0.94 (CI, 0.65 to 1.37); and lost weight, 0.76 (CI, 0.60 to 0.97). Conclusions: Attempted weight loss is associated with lower all-cause mortality, independent of weight change. Self-reported intentional weight loss is associated with lower mortality rates, and weight loss is associated with higher mortality rates only if it is unintentional.	Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE,Mailstop K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov		Gregg, Edward/0000-0003-2381-6822				ANDRES R, 1993, ANN INTERN MED, V119, P737, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00022; BLAIR SN, 1993, ANN INTERN MED, V119, P749, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00024; Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; FRENCH SA, 1995, INT J OBESITY, V19, P22; French SA, 1999, AM J EPIDEMIOL, V149, P504, DOI 10.1093/oxfordjournals.aje.a009844; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Lee IM, 1996, NUTR REV, V54, pS116; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; MELTZER AA, 1995, AM J EPIDEMIOL, V142, P1039, DOI 10.1093/oxfordjournals.aje.a117557; Meltzer AA, 1996, OBES RES, V4, P479, DOI 10.1002/j.1550-8528.1996.tb00257.x; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; *NAT CTR HLTH STAT, 1993, NAT CTR HLTH STAT 10, V3; *NAT CTR HLTH STAT, 1999, NAT HLTH INT SURV MU; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; PISUNYER FX, 1993, ANN INTERN MED, V119, P722, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00019; SINGH RB, 1992, BRIT MED J, V304, P1015, DOI 10.1136/bmj.304.6833.1015; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Wannamethee SG, 2000, AM J EPIDEMIOL, V151, P667, DOI 10.1093/oxfordjournals.aje.a010261; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P731, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00021; Williamson DF, 1999, AM J EPIDEMIOL, V149, P491, DOI 10.1093/oxfordjournals.aje.a009843; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; Yaari S, 1998, AM J EPIDEMIOL, V148, P546, DOI 10.1093/oxfordjournals.aje.a009680	29	169	175	5	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					383	389		10.7326/0003-4819-138-5-200303040-00007	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650HJ	12614090				2022-12-28	WOS:000181257300003
J	Chopdar, A; Chakravarthy, U; Verma, D				Chopdar, A; Chakravarthy, U; Verma, D			Age related macular degeneration	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED TRIAL	An epidemic of "ageing" is impending in the Western world. According to the latest predictions released by the United Nations, the number of people aged over 60 will triple from 606 million worldwide in 2000 to nearly 2 billion by 2050. The increase in the population aged over 80 is expected to be more than fivefold, from 69 million in 2000 to 379 million by 2050. People aged over 60 constitute about 20% of the population in more developed regions of the world; by 2050 they will probably account for 33%.(1) The United Kingdom is predicted to have about 16 million people over the age of 60 by 2040.(2) One major implication of this demographic change is the emergence of conditions that are directly related to ageing. Age related macular degeneration is already the leading cause of blindness in the Western world. Between 20 and 25 million people are affected worldwide, a figure that will triple with the increase in the ageing population in the next 30-40 years.(2) According to the World Health Organization, 8 million people have severe blindness due to age related macular degeneration, excluding the countries where data are scare.(3) in a recent systematic review Fletcher et al estimate that somewhere between 182 000 and 300 000 people in the United Kingdom are blind or partially sighted as a result of age related macular degeneration(4).	E Surrey Hosp, Surrey RH1 5RH, England; Queens Univ Belfast, Belfast, Antrim, North Ireland; Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland; Univ So Calif, Keck Sch Med, Doheny Retina Inst, Los Angeles, CA USA	East Surrey Hospital; Queens University Belfast; University of Southern California	Chopdar, A (corresponding author), E Surrey Hosp, Surrey RH1 5RH, England.			Chakravarthy, Usha/0000-0002-2606-3734				Arnold JJ, 2000, BRIT MED J, V321, P741, DOI 10.1136/bmj.321.7263.741; Blumenkranz MS, 2001, ARCH OPHTHALMOL-CHIC, V119, P198; Bressler NM, 2000, BRIT MED J, V321, P1425, DOI 10.1136/bmj.321.7274.1425; CHOPDAR A, 1996, FUNDUS FLUORESCEIN A, P4; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; EVANS JR, 2000, COCHRANE DB SYST REV; Fletcher A, 2001, LOW VISION SERVICES; FLINN ED, 2002, AEROSPACE AM, V4, P18; Hart PM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1029; HAWKINS BS, 1991, ARCH OPHTHALMOL-CHIC, V109, P1109; Humayun M S, 2001, Trans Am Ophthalmol Soc, V99, P271; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Maguire MG, 1997, ARCH OPHTHALMOL-CHIC, V115, P741; MAGUIRE MG, 1994, ARCH OPHTHALMOL-CHIC, V112, P489; Marcus DM, 2001, ARCH OPHTHALMOL-CHIC, V119, P171; MOISSEIEV J, 1995, ARCH OPHTHALMOL-CHIC, V113, P185, DOI 10.1001/archopht.1995.01100020069031; National Statistics Office, NAT POP PROJ; Pieramici D J, 1998, Curr Opin Ophthalmol, V9, P38, DOI 10.1097/00055735-199806000-00007; Rasmussen H, 2001, Hum Gene Ther, V12, P2029; Taylor HR, 2002, BMJ-BRIT MED J, V325, P11, DOI 10.1136/bmj.325.7354.11; United Nations, WORLD POP PROSP 2000; World Health Organization, 144 WHO	22	125	139	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2003	326	7387					485	488		10.1136/bmj.326.7387.485	http://dx.doi.org/10.1136/bmj.326.7387.485			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609947	Green Published			2022-12-28	WOS:000181421400021
J	Horton, R				Horton, R			Medical journals: evidence of bias against the diseases of poverty	LANCET			English	Editorial Material							RACISM		Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							Bhopal R, 2001, BRIT MED J, V322, P1503, DOI 10.1136/bmj.322.7301.1503; Davidoff F, 2001, LANCET, V358, P854, DOI 10.1016/S0140-6736(01)06035-4; DONNELLY J, 2003, BOSTON GLOBE    0126; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; *GLOB FOR HLTH RES, 2002, 1090 GLOB FOR HLTH R; HODGSON J, I RACISM PRINT; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; McKenzie K, 2003, BRIT MED J, V326, P65, DOI 10.1136/bmj.326.7380.65; OBUAYA CC, 2002, EURO SCI EDIT, V28, P72; Saxena S, 2003, LANCET, V361, P609, DOI 10.1016/S0140-6736(03)12528-7; SMITH R, 1994, BRIT MED J, V309, P1247, DOI 10.1136/bmj.309.6964.1247	11	132	136	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2003	361	9359					712	713		10.1016/S0140-6736(03)12665-7	http://dx.doi.org/10.1016/S0140-6736(03)12665-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620731				2022-12-28	WOS:000181232000002
J	Molinari, M; Calanca, V; Galli, C; Lucca, P; Paganetti, P				Molinari, M; Calanca, V; Galli, C; Lucca, P; Paganetti, P			Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle	SCIENCE			English	Article							MANNOSIDASE-LIKE PROTEIN; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; QUALITY-CONTROL; DEGRADATION; DEFICIENT; YEAST	The mechanisms that determine how folding attempts are interrupted to target folding-incompetent proteins for endoplasmic reticulum-associated degradation (ERAD) are poorly defined. Here the alpha-mannosidase I-like protein EDEM was shown to extract misfolded glycoproteins, but not glycoproteins undergoing productive folding, from the calnexin cycle. EDEM overexpression resulted in faster release of folding-incompetent proteins from the calnexin cycle and earlier onset of degradation, whereas EDEM down-regulation prolonged folding attempts and delayed ERAD. Up-regulation of EDEM during ER stress may promote cell recovery by clearing the calnexin cycle and by accelerating ERAD of terminally misfolded polypeptides.	Inst Res Biomed, CH-6500 Bellinzona, Switzerland; Novartis Pharma AG, Nervous Syst, CH-4002 Basel, Switzerland	Universita della Svizzera Italiana; Novartis	Molinari, M (corresponding author), Inst Res Biomed, CH-6500 Bellinzona, Switzerland.		Molinari, Maurizio/N-2587-2019; Paganetti, Paolo/AAF-8039-2020	Molinari, Maurizio/0000-0002-7636-5829; Paganetti, Paolo/0000-0003-1896-6324				Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 2001, EMBO REP, V2, P423; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; ORA A, 1995, J BIOL CHEM, V270, P26060, DOI 10.1074/jbc.270.44.26060; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; RAY MK, 1991, J BIOL CHEM, V266, P22818	13	359	380	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1397	1400		10.1126/science.1079474	http://dx.doi.org/10.1126/science.1079474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610306				2022-12-28	WOS:000181192300053
J	Burns, RB; Hartman, EE				Burns, RB; Hartman, EE			A 44-year-old woman with borderline personality disorder, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Oldham JM, 2002, JAMA-J AM MED ASSOC, V287, P1029, DOI 10.1001/jama.287.8.1029	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1026	1026		10.1001/jama.289.8.1026	http://dx.doi.org/10.1001/jama.289.8.1026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597756				2022-12-28	WOS:000181129800030
J	Bachmann, LM; Kolb, E; Koller, MT; Steurer, J; ter Riet, G				Bachmann, LM; Kolb, E; Koller, MT; Steurer, J; ter Riet, G			Accuracy of Ottawa ankle rules to exclude fractures of the ankle and mid-foot: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL DECISION RULES; INVERSION INJURIES; RADIOGRAPHY; VALIDATION; EMERGENCY; IMPLEMENTATION; NEED; GUIDELINES; CHILDREN; SENSITIVITY	Objective To summarise the evidence on accuracy of the Ottawa ankle rules, a decision aid for excluding fractures of the ankle and mid-foot. Design Systematic review. Data sources Electronic databases, reference lists of included studies, and experts. Review methods Data were extracted on the study population, the type of Ottawa ankle rules used, and methods. Sensitivities, but not specificities, were pooled using the bootstrap after inspection of the receiver operating characteristics plot. Negative likelihood ratios were pooled for several subgroups, correcting for four main methodological threats to validity. Results 32 studies met the inclusion criteria and 27 studies reporting on 15 581 patients were used for meta-analysis. The pooled negative likelihood ratios for the ankle and mid-foot were 0.08 (95% confidence interval 0.03 to 0.18) and 0.08 (0.03 to 0.20), respectively. The pooled negative likelihood ratio for both regions in children was 0.07 (0.03 to 0.18). Applying these ratios-to a 15% prevalence of fracture gave a less than 1.4% probability of actual fracture in these subgroups. Conclusion Evidence supports the Ottawa ankle rules as an accurate instrument for excluding fractures of the ankle and mid-foot. The instrument has a sensitivity of almost 100% and a modest specificity, and its use should reduce the number of unnecessary radiographs by 30-40%.	Univ Zurich, Horten Ctr, CH-8091 Zurich, Switzerland; Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands	University of Zurich; University of Amsterdam; Academic Medical Center Amsterdam	Bachmann, LM (corresponding author), Univ Zurich, Horten Ctr, Postfach Nord, CH-8091 Zurich, Switzerland.	lucas.bachmann@evimed.ch	Koller, Michael/AEN-1656-2022; Riet, Gerben ter/A-6943-2011; Bachmann, Lucas M/C-9686-2011	Koller, Michael/0000-0001-5574-2341; Riet, Gerben ter/0000-0002-2231-7637; 				AGINAGA B, 1999, ATENCION PRIMARIA, V24, P203; Allerston J, 2000, Accid Emerg Nurs, V8, P110, DOI 10.1054/aaen.2000.0103; Auleley GR, 1998, ANN EMERG MED, V32, P14, DOI 10.1016/S0196-0644(98)70093-9; Boutis K, 2001, LANCET, V358, P2118, DOI 10.1016/S0140-6736(01)07218-X; BRAND DA, 1982, NEW ENGL J MED, V306, P333, DOI 10.1056/NEJM198202113060604; BROOKS SC, 1981, BRIT MED J, V282, P607, DOI 10.1136/bmj.282.6264.607; Cameron C, 1999, CAN MED ASSOC J, V160, P1165; CHANDE VT, 1995, ARCH PEDIAT ADOL MED, V149, P255, DOI 10.1001/archpedi.1995.02170150035005; Chandra A, 2001, UNFALLCHIRURG, V104, P617, DOI 10.1007/s001130170092; Deeks JJ., 2001, SYSTEMATIC REV HLTH, P248, DOI DOI 10.1002/9780470693926.CH14; DUNLOP MG, 1986, BRIT MED J, V293, P603, DOI 10.1136/bmj.293.6547.603; Garces P, 2001, Aten Primaria, V28, P129; Glas AS, 2002, CAN MED ASSOC J, V166, P727; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Karpas A, 2002, ACAD EMERG MED, V9, P130, DOI 10.1111/j.1553-2712.2002.tb00229.x; Keogh SP, 1998, J ROY COLL SURG EDIN, V43, P341; KERR L, 1994, NEW ZEAL MED J, V107, P294; Khan K. S., 2001, 4 CRD U YORK; Leddy JJ, 2002, MED SCI SPORT EXER, V34, P57, DOI 10.1097/00005768-200201000-00010; Leddy JJ, 1998, AM J SPORT MED, V26, P158, DOI 10.1177/03635465980260020201; Libetta C, 1999, J ACCID EMERG MED, V16, P342; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LLOYD S, 1986, CAN MED ASSOC J, V135, P973; LUCCHESI GM, 1995, ANN EMERG MED, V26, P1, DOI 10.1016/S0196-0644(95)70229-6; Mann CJ, 1998, J ACCID EMERG MED, V15, P315; McAlister FA, 1999, LANCET, V354, P1721, DOI 10.1016/S0140-6736(99)01174-5; McBride KL, 1997, CAN FAM PHYSICIAN, V43, P459; Papacostas E, 2001, BRIT J SPORT MED, V35, P445, DOI 10.1136/bjsm.35.6.445; PERRY S, 1999, EMERG MED J, V16, P258; PIGMAN EC, 1994, ANN EMERG MED, V24, P41, DOI 10.1016/S0196-0644(94)70160-1; Plint AC, 1999, ACAD EMERG MED, V6, P1005, DOI 10.1111/j.1553-2712.1999.tb01183.x; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Rosin A, 1999, MIL MED, V164, P793, DOI 10.1093/milmed/164.11.793; Salt P, 1997, J ACCID EMERG MED, V14, P363; Singh-Ranger G, 1999, Accid Emerg Nurs, V7, P201, DOI 10.1016/S0965-2302(99)80051-4; SMITH GF, 1993, J FAM PRACTICE, V37, P345; SOLOMITO AL, 1994, ACAD EMERG MED, V193, pA64; Springer BA, 2000, AM J SPORT MED, V28, P864, DOI 10.1177/03635465000280061501; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; SUJITKUMAR P, 1986, ARCH EMERG MED, V3, P101; Tay SY, 1999, J EMERG MED, V17, P945, DOI 10.1016/S0736-4679(99)00120-1; Verma S, 1997, AM J ROENTGENOL, V169, P825, DOI 10.2214/ajr.169.3.9275906; Yuen MC, 2001, AM J EMERG MED, V19, P429, DOI 10.1053/ajem.2001.24474	45	235	243	1	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					417	419		10.1136/bmj.326.7386.417	http://dx.doi.org/10.1136/bmj.326.7386.417			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595378	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000181318000015
J	Horrobin, DF				Horrobin, DF			Are large clinical trials in rapidly lethal diseases usually unethical?	LANCET			English	Editorial Material							MANTLE CELL LYMPHOMA; TRANSLATION INITIATION; INHIBITION		Laxdale Ltd, Stirling FK7 9JQ, Scotland		Horrobin, DF (corresponding author), Laxdale Ltd, Kings Pk House,Laurethill Business Pk, Stirling FK7 9JQ, Scotland.							Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; Dreyling MH, 1997, CANCER RES, V57, P4608; Edwards SJL, 1997, LANCET, V350, P804, DOI 10.1016/S0140-6736(97)02290-3; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; HORROBIN DF, 2002, BRIT MED J, V325, pA491; HORROBIN DF, IN PRESS MED HYPOTH; Hughes JR, 2002, JAMA-J AM MED ASSOC, V288, P2118; Janosky JE, 2002, JAMA-J AM MED ASSOC, V288, P2118, DOI 10.1001/jama.288.17.2118; Lilford RJ, 2002, JAMA-J AM MED ASSOC, V288, P2118; Oka K, 1996, LEUKEMIA LYMPHOMA, V21, P37, DOI 10.3109/10428199609067577; Palakurthi SS, 2000, CANCER RES, V60, P2919; Palakurthi SS, 2001, CANCER RES, V61, P6213; RIMOKH R, 1994, BLOOD, V83, P3689	14	41	42	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					695	697		10.1016/S0140-6736(03)12571-8	http://dx.doi.org/10.1016/S0140-6736(03)12571-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12611394				2022-12-28	WOS:000181129500026
J	van Buiren, M; Uhl, M				van Buiren, M; Uhl, M			Bilateral striatal necrosis associated with Mycoplasma pneumoniae infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Childrens Hosp, D-79106 Freiburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	van Buiren, M (corresponding author), Univ Childrens Hosp, D-79106 Freiburg, Germany.								0	10	10	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2003	348	8					720	720		10.1056/NEJMicm010723	http://dx.doi.org/10.1056/NEJMicm010723			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646BF	12594316				2022-12-28	WOS:000181014400007
J	Buckley, RH				Buckley, RH			Treatment options for genetically determined immunodeficiency	LANCET			English	Editorial Material							BONE-MARROW TRANSPLANTATION; CELLS; DISEASE		Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Buckley, RH (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.		Buckley, Rebecca/AAB-1578-2019					BACH FH, 1968, LANCET, V2, P1364; BORTIN MM, 1977, JAMA-J AM MED ASSOC, V238, P591, DOI 10.1001/jama.238.7.591; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; BUCKLEY RH, 1996, IMMUNOLOGIC DISORDER, P1014; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; GATTI RA, 1968, LANCET, V2, P1366; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Haddad E, 1999, BLOOD, V94, P2923, DOI 10.1182/blood.V94.8.2923.420k44_2923_2930; Haddad E, 1998, BLOOD, V91, P3646; Handgretinger R, 2001, BONE MARROW TRANSPL, V27, P777, DOI 10.1038/sj.bmt.1702996; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; REISNER Y, 1983, BLOOD, V61, P341; Smogorzewska Elzbieta M., 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P111	14	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					541	542		10.1016/S0140-6736(03)12562-7	http://dx.doi.org/10.1016/S0140-6736(03)12562-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598135				2022-12-28	WOS:000181033400003
J	Schellenberg, JA; Victora, CG; Mushi, A; de Savigny, D; Schellenberg, D; Mshinda, H; Bryce, J				Schellenberg, JA; Victora, CG; Mushi, A; de Savigny, D; Schellenberg, D; Mshinda, H; Bryce, J		Tanzania IMCI MCE Baseline Househo	Inequities among the very poor: health care for children in rural southern Tanzania	LANCET			English	Article								Background Few studies have been done to assess socioeconomic inequities in health in African countries. We sought evidence of inequities in health care by sex and socioeconomic status for young children living in a poor rural area of southern Tanzania. Methods In a baseline household survey in Tanzania early in the implementation phase of integrated management of childhood illness (IMCI), we included cluster samples of 2006 children younger than 5 years in four rural districts. Questions focused on the extent to which carers' knowledge of illness, care-seeking outside the home, and care in health facilities were consistent with IMCI guidelines and messages. We used principal components analysis to develop a relative index of household socioeconomic status, with weighted scores of information on income sources, education of the household head, and household assets. Findings 1026 (52%) of 1968 children reported having been ill in the 2 weeks before the survey. Carers of 415 (41%) of 1014 of these children had sought care first from an appropriate provider. 71 (26%) carers from families in the wealthiest quintile knew greater than or equal to2 danger signs compared with 48 (20%) of those from the poorest (p=0.03 for linear trend across quintiles) and wealthier families were more likely to bring their sick children to a health facility (p=0.02). Their children were more likely than poorer children to have received antimalarials, and antibiotics for pneumonia (p=0.0001 and 0.0048, respectively). Interpretation Care-seeking behaviour is worse in poorer than in relatively rich families, even within a rural society that might easily be assumed to be uniformly poor.	Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania; Swiss Trop Inst, CH-4002 Basel, Switzerland; Fed Univ Pelotas, Pelotas, Brazil; Minist Hlth, Tanzania Essential Hlth Intervent Project, Dar Es Salaam, Tanzania; Int Dev Res Ctr, Ottawa, ON, Canada; Hosp Clin Barcelona, Barcelona, Spain; WHO, CH-1211 Geneva, Switzerland	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; Universidade Federal de Pelotas; University of Barcelona; Hospital Clinic de Barcelona; World Health Organization	Schellenberg, JA (corresponding author), London Sch Hyg & Trop Med, Gates Malaria Partnership, 50 Bedford Sq, London WC1B 3DP, England.		Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Schellenberg, Joanna/0000-0002-0708-3676; Schellenberg, David/0000-0001-8222-0186				BENNETT S, 1994, INT J EPIDEMIOL, V23, P1282, DOI 10.1093/ije/23.6.1282; ETLINGE JL, 1996, STAT TECH B, V31, P3; ETLINGE JL, 1996, STATA TECH B, V31, P26; ETLINGE JL, 1996, STATA TECH B, V31, P6; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; *INDEPTH, 2002, POP HLTH DEV COUNTR, V1; *MIN HLTH TANZ, 1999, TANZ AD WHO UNICEF I; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; SCHELLENBERG JRM, 2002, INDEPTH POPULATION H, V1; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; United Nations Children's Fund, 2000, STAT WORLDS CHILDR 2; United Nations Children's Fund World Health Organization World Bank Group, 2021, LEVELS TRENDS CHILD; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; WHITEHEAD M, 1992, INT J HLTH SERV, V22, P430; *WHO EXP COMM NUTR, 1995, WHO TECHN REP SER, V854; World Bank, 1997, WORLD DEV REP STAT C	17	298	301	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					561	566		10.1016/S0140-6736(03)12515-9	http://dx.doi.org/10.1016/S0140-6736(03)12515-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598141				2022-12-28	WOS:000181033400009
J	Brumfiel, G				Brumfiel, G			Bush seeks to beef up US nuclear-weapons arsenal	NATURE			English	News Item																		2002, NATURE, V415, P945	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 13	2003	422	6928					101	101		10.1038/422101b	http://dx.doi.org/10.1038/422101b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654HG	12634741	Bronze			2022-12-28	WOS:000181488900004
J	Lee, HK; Takamiya, K; Han, JS; Man, HY; Kim, CH; Rumbaugh, G; Yu, S; Ding, L; He, C; Petralia, RS; Wenthold, RJ; Gallagher, M; Huganir, RL				Lee, HK; Takamiya, K; Han, JS; Man, HY; Kim, CH; Rumbaugh, G; Yu, S; Ding, L; He, C; Petralia, RS; Wenthold, RJ; Gallagher, M; Huganir, RL			Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory	CELL			English	Article							GLUTAMATE RECEPTORS; REGULATORY PHOSPHORYLATION; SITES; POTENTIATION; SYNAPSES; REDISTRIBUTION; IDENTIFICATION; TRANSMISSION; TRAFFICKING; CONDUCTANCE	Plasticity of the nervous system is dependent on mechanisms that regulate the strength of synaptic transmission. Excitatory synapses in the brain undergo long-term potentiation (LTP) and long-term depression (LTD), cellular models of learning and memory. Protein phosphorylation is required for the induction of many forms of synaptic plasticity, including LTP and LTD. However, the critical kinase substrates that mediate plasticity have not been identified. We previously reported that phosphorylation of the GluR1 subunit of AMPA receptors, which mediate rapid excitatory transmission in the brain, is modulated during LTP and LTD. To test if GluR1 phosphorylation is necessary for plasticity and learning and memory, we generated mice with knockin mutations in the GluR1 phosphorylation sites. The phosphomutant mice show deficits in LTD and LTP and have memory defects in spatial learning tasks. These results demonstrate that phosphorylation of GluR1 is critical for LTD and LTP expression and the retention of memories.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA; NIDCD, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Han, Jung-Soo/0000-0001-8447-4518; Takamiya, Kogo/0000-0001-7240-6307; Lee, Hey-Kyoung/0000-0002-5554-983X; Man, Hengye/0000-0002-3530-3066	NIMH NIH HHS [R01 MH61108-02] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003, ZIADC000003] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carvalho AL, 1999, J NEUROSCI, V19, P4748; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Luscher C, 2001, TRENDS NEUROSCI, V24, P665, DOI 10.1016/S0166-2236(00)01959-7; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; McDonald BJ, 2001, NEUROPHARMACOLOGY, V41, P672, DOI 10.1016/S0028-3908(01)00129-0; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; PERTRALLA RS, 1999, METHODS MOL BIOL NMD, P73; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	48	589	621	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					631	643		10.1016/S0092-8674(03)00122-3	http://dx.doi.org/10.1016/S0092-8674(03)00122-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628184	Bronze			2022-12-28	WOS:000181443600007
J	Spratt, BG				Spratt, BG			Stomachs out of Africa	SCIENCE			English	Editorial Material							HELICOBACTER-PYLORI; CHILD TRANSMISSION		St Marys Hosp, Imperial Coll, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Spratt, BG (corresponding author), St Marys Hosp, Imperial Coll, Dept Infect Dis Epidemiol, Praed St, London W2 1PG, England.	b.spratt@imperial.ac.uk	Spratt, Brian G/A-1676-2009					Cavalli-Sforza LL, 1986, AFRICAN PYGMIES; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Funk DJ, 2000, P ROY SOC B-BIOL SCI, V267, P2517, DOI 10.1098/rspb.2000.1314; Ghose C, 2002, P NATL ACAD SCI USA, V99, P15107, DOI 10.1073/pnas.242574599; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rothenbacher D, 1999, J INFECT DIS, V179, P398, DOI 10.1086/314595; Tindberg Y, 2001, GASTROENTEROLOGY, V121, P310, DOI 10.1053/gast.2001.26282	8	3	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2003	299	5612					1528	1529		10.1126/science.1082950	http://dx.doi.org/10.1126/science.1082950			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652EY	12624252				2022-12-28	WOS:000181367900022
J	Kilbridge, P				Kilbridge, P			Computer crash - Lessons from a system failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Kilbridge Associates, Cambridge, MA USA		Kilbridge, P (corresponding author), Kilbridge Associates, Cambridge, MA USA.								0	36	38	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					881	882		10.1056/NEJMp030010	http://dx.doi.org/10.1056/NEJMp030010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621131				2022-12-28	WOS:000181341100002
J	Andrews, NJ; Farrington, CP; Ward, HJT; Cousens, SN; Smith, PG; Molesworth, AM; Knight, RSG; Ironside, JW; Will, RG				Andrews, NJ; Farrington, CP; Ward, HJT; Cousens, SN; Smith, PG; Molesworth, AM; Knight, RSG; Ironside, JW; Will, RG			Deaths from variant Creutzfeldt-Jakob disease in the UK	LANCET			English	Article								In 2002, 17 people died. from variant CJD (vCJD) in the UK, compared with 20 in 2001 and 28 in 2000. We analysed data for deaths from vCJD since 1995 and estimated the underlying trend in mortality. The trend had a quadratic component (p=0.005), suggesting that the Increase was not exponential, and that the previously increasing trend is slowing down. The death rate peaked in 2000. These findings are encouraging, but mortality might increase again in the future.	Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Open Univ, Dept Stat, Milton Keynes MK7 6AA, Bucks, England; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Edinburgh; Public Health England; Open University - UK; University of London; London School of Hygiene & Tropical Medicine	Will, RG (corresponding author), Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland.		smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560; Ironside, James/0000-0001-5869-2108; Farrington, Conor Patrick/0000-0002-7148-2612				Andrews NJ, 2000, LANCET, V356, P481, DOI 10.1016/S0140-6736(00)02559-9; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; d'Aignaux JH, 1999, NEUROLOGY, V53, P1197, DOI 10.1212/WNL.53.6.1197; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Will RG, 2000, ANN NEUROL, V47, P575	5	51	52	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 1	2003	361	9359					751	752		10.1016/S0140-6736(03)12632-3	http://dx.doi.org/10.1016/S0140-6736(03)12632-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649WY	12620741				2022-12-28	WOS:000181232000012
J	Sifers, RN				Sifers, RN			Protein degradation unlocked	SCIENCE			English	Editorial Material							MISFOLDED GLYCOPROTEINS; EDEM		Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Sifers, RN (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.	rsifers@bcm.tmc.edu	Sifers, Richard Norman/AGQ-7262-2022					Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 2001, EMBO REP, V2, P423; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; SIFERS RN, 1989, MOL BIOL MED, V6, P127; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890	11	29	33	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2003	299	5611					1330	1331		10.1126/science.1082718	http://dx.doi.org/10.1126/science.1082718			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610289				2022-12-28	WOS:000181192300034
J	Stappers, BW; Gaensler, BM; Kaspi, VM; van der Klis, M; Lewin, WHG				Stappers, BW; Gaensler, BM; Kaspi, VM; van der Klis, M; Lewin, WHG			An x-ray nebula associated with the millisecond pulsar B1957+20	SCIENCE			English	Article							CRAB-NEBULA; PARTICLE-ACCELERATION; SYNCHROTRON NEBULA; RADIO PULSARS; HIGH-ENERGY; BINARY; PSR1957+20; DISCOVERY; EMISSION; HST	We have detected an x-ray nebula around the binary millisecond pulsar B1957+20. A narrow tail, corresponding to the shocked pulsar wind, is seen interior to the known Halpha bow shock and proves the long-held assumption that the rotational energy of millisecond pulsars is dissipated through relativistic winds. Unresolved x-ray emission likely represents the shock where the winds of the pulsar and its companion collide. This emission indicates that the efficiency with which relativistic particles are accelerated in the postshock flow is similar to that for young pulsars, despite the shock proximity and much weaker surface magnetic field of this millisecond pulsar.	Stichting ASTRON, NL-7990 Dwingeloo, Netherlands; Sterrenkundig Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; McGill Univ, Dept Phys, Montreal, PQ H3A 278, Canada; MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Space Res Ctr, Cambridge, MA 02139 USA	University of Amsterdam; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; McGill University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Stappers, BW (corresponding author), Stichting ASTRON, NL-7990 Dwingeloo, Netherlands.		Gaensler, Bryan M/F-8655-2010	Gaensler, Bryan/0000-0002-3382-9558				ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; ARONS J, 1994, ASTROPHYS J SUPPL S, V90, P797, DOI 10.1086/191905; Arons J, 2002, ASTR SOC P, V271, P71; ARONS J, 1993, ASTROPHYS J, V403, P249, DOI 10.1086/172198; ARZOUMANIAN Z, 1994, ASTROPHYS J, V426, pL85, DOI 10.1086/187346; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Bucciantini N, 2002, ASTRON ASTROPHYS, V387, P1066, DOI 10.1051/0004-6361:20020495; Chatterjee S, 2002, ASTROPHYS J, V575, P407, DOI 10.1086/341139; DEJAGER OC, 1992, ASTROPHYS J, V396, P161, DOI 10.1086/171706; FRUCHTER AS, 1995, ASTROPHYS J, V443, pL21, DOI 10.1086/187826; FRUCHTER AS, 1988, NATURE, V333, P237, DOI 10.1038/333237a0; Gaensler BM, 2002, ASTROPHYS J, V569, P878, DOI 10.1086/339354; GINZBURG VL, 1965, ANNU REV ASTRON ASTR, V3, P297, DOI 10.1146/annurev.aa.03.090165.001501; Helfand DJ, 2001, ASTROPHYS J, V556, P380, DOI 10.1086/321533; HESTER JJ, 1995, ASTROPHYS J, V448, P240, DOI 10.1086/175956; Hog E, 2000, ASTRON ASTROPHYS, V355, pL27; HOSHINO M, 1992, ASTROPHYS J, V390, P454, DOI 10.1086/171296; KENNEL CF, 1984, ASTROPHYS J, V283, P694, DOI 10.1086/162356; KULKARNI SR, 1992, NATURE, V359, P300, DOI 10.1038/359300a0; KULKARNI SR, 1988, NATURE, V335, P801, DOI 10.1038/335801a0; MICHEL FC, 1994, ASTROPHYS J, V431, P397, DOI 10.1086/174493; NICE DJ, COMMUNICATION; TAYLOR JH, 1993, ASTROPHYS J SUPPL S, V88, P529, DOI 10.1086/191832; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Toscano M, 1999, MON NOT R ASTRON SOC, V307, P925, DOI 10.1046/j.1365-8711.1999.02685.x; WANG QD, 1993, NATURE, V364, P127, DOI 10.1038/364127a0; Weisskopf MC, 2000, ASTROPHYS J, V536, pL81, DOI 10.1086/312733	28	116	116	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1372	1374		10.1126/science.1079841	http://dx.doi.org/10.1126/science.1079841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610299	Green Submitted			2022-12-28	WOS:000181192300045
J	Trombetta, ES; Ebersold, M; Garrett, W; Pypaert, M; Mellman, I				Trombetta, ES; Ebersold, M; Garrett, W; Pypaert, M; Mellman, I			Activation of lysosomal function during dendritic cell maturation	SCIENCE			English	Article							II ANTIGEN PRESENTATION; IN-VIVO; INFLAMMATORY STIMULI; PLASMA-MEMBRANE; ATPASE ACTIVITY; HLA-DM; PROTEOLYSIS; COMPLEXES; ACIDIFICATION; DISSOCIATION	In response to a variety of stimuli, dendritic cells (DCs) transform from immature cells specialized for antigen capture into mature cells specialized for T cell stimulation. During maturation, the DCs acquire an enhanced capacity to form and accumulate peptide-MHC (major histocompatibility complex) class II complexes. Here we show that a key mechanism responsible for this alteration was the generalized activation of lysosomal function. In immature DCs, internalized antigens were slowly degraded and inefficiently used for peptide loading. Maturation induced activation of the vacuolar proton pump that enhanced lysosomal acidification and antigen proteolysis, facilitating efficient formation of peptide-MHC class II complexes. Lysosomal function in DCs thus appears to be specialized for the developmentally regulated processing of internalized antigens.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.			Garrett, Wendy/0000-0002-5092-0150	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034098] Funding Source: NIH RePORTER; NIAID NIH HHS [R37-AI34098] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; COHN ZA, 1969, J EXP MED, V129, P201, DOI 10.1084/jem.129.1.201; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Drakesmith H, 1998, P NATL ACAD SCI USA, V95, P14903, DOI 10.1073/pnas.95.25.14903; EHRENREICH BA, 1969, J EXP MED, V129, P227, DOI 10.1084/jem.129.1.227; FAGOTTO F, 1994, J CELL SCI, V107, P3325; Fiebiger E, 2001, J EXP MED, V193, P881, DOI 10.1084/jem.193.8.881; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; MALLYA SK, 1992, J CELL BIOL, V117, P1211, DOI 10.1083/jcb.117.6.1211; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Vogt AB, 1999, TRENDS BIOCHEM SCI, V24, P150, DOI 10.1016/S0968-0004(99)01364-X; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	39	545	558	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1400	1403		10.1126/science.1080106	http://dx.doi.org/10.1126/science.1080106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610307				2022-12-28	WOS:000181192300054
J	McCulloh, KA; Sperry, JS; Adler, FR				McCulloh, KA; Sperry, JS; Adler, FR			Water transport in plants obeys Murray's law	NATURE			English	Article							HYDRAULIC CONDUCTANCE; STOMATAL CONDUCTANCE; GENERAL-MODEL; TRANSPIRATION	The optimal water transport system in plants should maximize hydraulic conductance (which is proportional to photosynthesis(1-5)) for a given investment in transport tissue. To investigate how this optimum may be achieved, we have performed computer simulations of the hydraulic conductance of a branched transport system. Here we show that the optimum network is not achieved by the commonly assumed pipe model of plant form(6-8), or its antecedent, da Vinci's rule(9,10). In these representations, the number and area of xylem conduits is constant at every branch rank. Instead, the optimum network has a minimum number of wide conduits at the base that feed an increasing number of narrower conduits distally. This follows from the application of Murray's law, which predicts the optimal taper of blood vessels in the cardiovascular system(11). Our measurements of plant xylem indicate that these conduits conform to the Murray's law optimum as long as they do not function additionally as supports for the plant body.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	McCulloh, KA (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mcculloh@biology.utah.edu						CANNY MJ, 1993, PHILOS T R SOC B, V341, P87, DOI 10.1098/rstb.1993.0094; da Vinci Leonardo, 1970, COURIER CORPORATION, P2; Enquist BJ, 2000, SFI S SCI C, P167; Givnish T. J., 1986, EC PLANT FORM FUNCTI, P3; GOULD SJ, 1979, P ROY SOC LOND B BIO, V205, P581, DOI DOI 10.1098/RSPB.1979.0086; Grafen A., 2002, MODERN STAT LIFE SCI; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; HORN H S, 1971, P144; Horn HS, 2000, SFI S SCI C, P199; Hubbard RM, 2001, PLANT CELL ENVIRON, V24, P113, DOI 10.1046/j.1365-3040.2001.00660.x; KELLER JB, 1966, J MATH MECH, V16, P433; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; Mark R, 1996, AM SCI, V84, P383; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MEINZER FC, 1995, OECOLOGIA, V101, P514, DOI 10.1007/BF00329432; MEINZER FC, 1990, PLANT CELL ENVIRON, V13, P383, DOI 10.1111/j.1365-3040.1990.tb02142.x; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Raven JA., 1977, ADV BOTANICAL RESEAR, V5, P153, DOI DOI 10.1016/S0065-2296(08)60361-4; SALIENDRA NZ, 1995, PLANTA, V196, P357, DOI 10.1007/BF00201396; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Sokal R.R., 2012, BIOMETRY; SPERRY JS, 1993, J EXP BOT, V44, P1075, DOI 10.1093/jxb/44.6.1075; Vogel S., 1994, LIFE MOVING FLUIDS P; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; ZIMMERMANN MH, 1983, XYLEM STRUCTURE ASCE, P15	27	300	316	8	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					939	942		10.1038/nature01444	http://dx.doi.org/10.1038/nature01444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12607000				2022-12-28	WOS:000181186900048
J	Vance, ML				Vance, ML			Retrospective - Can growth hormone prevent aging?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEN		Univ Virginia, Med Ctr, Dept Med, Charlottesville, VA 22903 USA	University of Virginia	Vance, ML (corresponding author), Univ Virginia, Med Ctr, Dept Med, Charlottesville, VA 22903 USA.							Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; TAAFFE DR, 1994, J CLIN ENDOCR METAB, V79, P1361, DOI 10.1210/jc.79.5.1361; VANCE ML, 1990, NEW ENGL J MED, V323, P52	6	51	55	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					779	780		10.1056/NEJMp020186	http://dx.doi.org/10.1056/NEJMp020186			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606731				2022-12-28	WOS:000181173300003
J	Ferguson, E; James, D; O'Hehir, F; Sanders, A				Ferguson, E; James, D; O'Hehir, F; Sanders, A			Pilot study of the roles of personality, references, and personal statements in relation to performance over the five years of a medical degree	BRITISH MEDICAL JOURNAL			English	Article							SCHOOL; MODEL	Objectives To compare the power of three traditional selection procedures (A levels, personal statements, and references) and one non-traditional selection procedure (personality) to predict performance over the five years of a medical degree. Design Cohort study over five years. Setting Nottingham medical school. Participants Entrants in 1995. Main outcome measures A level grades, amounts of information contained in teacher's reference and the student's personal statement, and personality scores examined in relation to 18 different assessments. Results Information in the teacher's reference did not consistently predict performance. Information in the personal statement was predictive of clinical aspects of training, whereas A level grades primarily predicted preclinical performance. The personality domain of conscientiousness was consistently the best predictor across the course. A structural model indicated that conscientiousness was positively related to A level grades and preclinical performance but was negatively related to clinical grades. Conclusion A teacher's reference is of no practical use in predicting clinical performance of medical students, in contrast to the amount of information contained in the personal statement. Therefore, simple quantification of the personal statement should aid selection. Personality factors, in particular conscientiousness, need to be considered and integrated into selection procedure.	Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; Queens Med Ctr, Fac Med, Sch Human Dev, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Ferguson, E (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.			Ferguson, Eamonn/0000-0002-7678-1451				Anderson N., 1993, SUCCESSFUL SELECTION; Cohen J., 1983, APPL MULTIPLE REGRES; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Ferguson E, 2000, J OCCUP ORGAN PSYCH, V73, P321, DOI 10.1348/096317900167056; Goldberg LR., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; HALL ML, 1995, ACAD MED, V70, P230, DOI 10.1097/00001888-199503000-00015; IEVENS F, 2002, MED EDUC, V36, P1050; JONES BJ, 1991, ACAD MED, V66, pS22, DOI 10.1097/00001888-199109000-00029; MCMANUS IC, 1986, MED EDUC, V20, P181, DOI 10.1111/j.1365-2923.1986.tb01165.x; McManus IC, 1999, BRIT MED J, V319, P542, DOI 10.1136/bmj.319.7209.542; MCMANUS IC, 1989, MED EDUC, V23, P136, DOI 10.1111/j.1365-2923.1989.tb00877.x; PATTERSON F, 2001, 10 INT C INT SOC STU; TETT RP, 1991, PERS PSYCHOL, V44, P703	13	127	130	0	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2003	326	7386					429	431		10.1136/bmj.326.7386.429	http://dx.doi.org/10.1136/bmj.326.7386.429			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595384	Bronze, Green Published			2022-12-28	WOS:000181318000021
J	Lopansri, BK; Anstey, NM; Weinberg, JB; Stoddard, GJ; Hobbs, MR; Levesque, MC; Mwaikambo, ED; Granger, DL				Lopansri, BK; Anstey, NM; Weinberg, JB; Stoddard, GJ; Hobbs, MR; Levesque, MC; Mwaikambo, ED; Granger, DL			Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production	LANCET			English	Article								Nitric oxide (NO) production and mononuclear cell NO synthase 2 (NOS2) expression are high in healthy Tanzanian children but low in those with cerebral malaria. Factors that downregulate NOS2 also diminish factors involved in cellular uptake and biosynthesis of L-arginine, the substrate for NO synthesis. We therefore postulated that L-arginine concentrations would be low in individuals with cerebral malaria. We measured concentrations of L-arginine in cryopreserved plasma samples from Tanzanian children with and without malaria. L-arginine concentrations were low in individuals with cerebral malaria (mean 46 mumol/L, SD 14), intermediate in those with uncomplicated malaria (70 mumol/L, 20), and within the normal range in healthy controls (122 mumol/L, 22; p<0.0001). Analysis by logistic regression showed that hypoargininaemia was significantly associated with cerebral malaria case-fatality. Hypoargininaemia may contribute to limited NO production in children with cerebral malaria and to severe disease.	Vet Affairs Med Ctr, Div Infect Dis, Salt Lake City, UT 84132 USA; Univ Utah, Med Ctr, Salt Lake City, UT USA; Flinders Univ No Terr Clin Sch, Darwin, NT, Australia; Menzies Sch Hlth Res, Div Infect Dis, Darwin, NT, Australia; Duke Univ, Med Ctr, Durham, NC USA; Vet Affairs Med Ctr, Div Hematol, Durham, NC USA; Univ Utah, Sch Med, Div Clin Epidemiol, Salt Lake City, UT USA; Hubert Kairuki Mem Univ, Dept Paediat, Dar Es Salaam, Tanzania	US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; Flinders University South Australia; Charles Darwin University; Menzies School of Health Research; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Granger, DL (corresponding author), Vet Affairs Med Ctr, Div Infect Dis, 30 N 1900 E,Room 4B319, Salt Lake City, UT 84132 USA.				NIAID NIH HHS [R01 AI041764] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041764] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Kamada Y, 2001, J CLIN INVEST, V108, P717, DOI 10.1172/JCI11260; Meyer J, 1997, ANAL BIOCHEM, V247, P11, DOI 10.1006/abio.1997.2008; Planche T, 2002, QJM-INT J MED, V95, P89, DOI 10.1093/qjmed/95.2.89; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001	5	133	137	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					676	678		10.1016/S0140-6736(03)12564-0	http://dx.doi.org/10.1016/S0140-6736(03)12564-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606182				2022-12-28	WOS:000181129500020
J	Perez-Moreno, M; Jamora, C; Fuchs, E				Perez-Moreno, M; Jamora, C; Fuchs, E			Sticky business: Orchestrating cellular signals at adherens junctions	CELL			English	Review							RHO-FAMILY GTPASES; CAENORHABDITIS-ELEGANS EMBRYO; ADHESION MOLECULE JAM; ACTIN CABLE DYNAMICS; E-CADHERIN; BETA-CATENIN; ALPHA-CATENIN; P120 CATENIN; SACCHAROMYCES-CEREVISIAE; INTERMEDIATE FILAMENTS	Cohesive sheets of epithelial cells are a fundamental feature of multicellular organisms and are largely a product of the varied functions of adherens junctions. These junctions and their cytoskeletal associations contribute heavily to the distinct shapes, polarity, spatially oriented mitotic spindle planes, and cellular movements of developing tissues. Deciphering the underlying mechanisms that govern these conserved cellular rearrangements is a prerequisite to understanding vertebrate morphogenesis.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10021 USA.		Fuchs, Elaine/G-1565-2016; Perez-Moreno, Mirna/I-3687-2015	Perez-Moreno, Mirna/0000-0002-0170-6406	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR027883-28] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Bierkamp C, 1999, DEVELOPMENT, V126, P371; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bloor JW, 2002, DEVELOPMENT, V129, P3173; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chan SK, 2002, CELL, V111, P265, DOI 10.1016/S0092-8674(02)01037-1; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Dumstrei K, 2002, DEVELOPMENT, V129, P3983; EATON S, 1995, J CELL BIOL, V131, P151, DOI 10.1083/jcb.131.1.151; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Gundersen GG, 2002, CURR BIOL, V12, pR645, DOI 10.1016/S0960-9822(02)01156-9; Heil-Chapdelaine RA, 2000, MOL BIOL CELL, V11, P863, DOI 10.1091/mbc.11.3.863; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; Le Borgne R, 2002, CURR BIOL, V12, P95, DOI 10.1016/S0960-9822(01)00648-0; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Orsulic S, 2000, J CELL SCI, V113, P1793; Pokutta S, 2002, CURR OPIN STRUC BIOL, V12, P255, DOI 10.1016/S0959-440X(02)00318-4; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Rath P, 2002, EMBO REP, V3, P660, DOI 10.1093/embo-reports/kvf134; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Sun DM, 2001, J CELL SCI, V114, P161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024; YONEMURA S, 1995, J CELL SCI, V108, P127	104	590	615	1	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					535	548		10.1016/S0092-8674(03)00108-9	http://dx.doi.org/10.1016/S0092-8674(03)00108-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600316	Bronze			2022-12-28	WOS:000181252600011
J	Weis, K				Weis, K			Regulating access to the genome: Nucleocytoplasmic transport throughout the cell cycle	CELL			English	Review							NUCLEAR-PORE COMPLEX; XENOPUS EGG EXTRACTS; SMALL GTPASE RAN; IMPORTIN-BETA; PROTEIN IMPORT; MITOTIC-SPINDLE; RNA EXPORT; PROTEOMIC ANALYSIS; MULTIPLE PATHWAYS; BOUND RAN	Macromolecular transport between the cytoplasm and the nucleus occurs through the nuclear pore complex (NPC) and is mediated by multiple families of soluble transport factors. All these transport factors share the ability to translocate across the NPC through specific interactions with components of the nuclear pore. This review highlights advances in our understanding of the structure and function of the NPC and the shuttling transport receptors involved in nuclear transport. It discusses recently proposed models for the translocation of receptor-cargo complexes through the NPC channel and reviews how the small GTPase Ran functions as a positional marker of the genome to regulate multiple important aspects of the eukaryotic cell cycle.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Weis, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA.		Weis, Karsten/F-5719-2011	Weis, Karsten/0000-0001-7224-925X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058065] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58065] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Bilbao-Cortes D, 2002, CURR BIOL, V12, P1151, DOI 10.1016/S0960-9822(02)00927-2; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cole CN, 2001, NAT GENET, V29, P6, DOI 10.1038/ng0901-6; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; DASSO M, 1992, MOL CELL BIOL, V12, P3337, DOI 10.1128/MCB.12.8.3337; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; Fahrenkrog B, 2001, CURR TOP MICROBIOL, V259, P95; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fleig U, 2000, J CELL BIOL, V151, P1101, DOI 10.1083/jcb.151.5.1101; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hinkle B, 2002, J CELL SCI, V115, P4685, DOI 10.1242/jcs.00136; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Lee SJ, 2000, J MOL BIOL, V302, P251, DOI 10.1006/jmbi.2000.4055; Lei EP, 2002, DEV CELL, V2, P261, DOI 10.1016/S1534-5807(02)00134-X; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Lindsay ME, 2001, J CELL BIOL, V153, P1391, DOI 10.1083/jcb.153.7.1391; Lyman SK, 2002, J CELL BIOL, V159, P55, DOI 10.1083/jcb.200204163; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Moore JD, 2001, BIOESSAYS, V23, P77, DOI 10.1002/1521-1878(200101)23:1<77::AID-BIES1010>3.3.CO;2-5; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakielny S, 1998, CURR BIOL, V8, P89, DOI 10.1016/S0960-9822(98)70039-9; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Reed R, 2001, NAT CELL BIOL, V3, pE201, DOI 10.1038/ncb0901-e201; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; SCHMITZ N, 1999, P ASCO S, V5, P18; Schwoebel ED, 1998, J BIOL CHEM, V273, P35170, DOI 10.1074/jbc.273.52.35170; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; STROM AC, 2001, GENOME BIOL, V2; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yoshida K, 2001, J CELL BIOL, V152, P729, DOI 10.1083/jcb.152.4.729; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 1999, J CELL SCI, V112, P2453; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5; Zhang CM, 2001, CURR BIOL, V11, P208, DOI 10.1016/S0960-9822(01)00053-7	85	556	581	0	53	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 21	2003	112	4					441	451		10.1016/S0092-8674(03)00082-5	http://dx.doi.org/10.1016/S0092-8674(03)00082-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600309	Bronze			2022-12-28	WOS:000181252600004
J	Aas, PA; Otterlei, M; Falnes, PO; Vagbo, CB; Skorpen, F; Akbari, M; Sundheim, O; Bjoras, M; Slupphaug, G; Seeberg, E; Krokan, HE				Aas, PA; Otterlei, M; Falnes, PO; Vagbo, CB; Skorpen, F; Akbari, M; Sundheim, O; Bjoras, M; Slupphaug, G; Seeberg, E; Krokan, HE			Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA	NATURE			English	Article							ESCHERICHIA-COLI; CLONING; CONSTRUCTION; EXPRESSION; NUCLEOTIDE; VECTORS; GENE	Repair of DNA damage is essential for maintaining genome integrity, and repair deficiencies in mammals are associated with cancer, neurological disease and developmental defects(1). Alkylation damage in DNA is repaired by at least three different mechanisms, including damage reversal by oxidative demethylation of 1-methyladenine and 3-methylcytosine by Escherichia coli AlkB(2,3). By contrast, little is known about consequences and cellular handling of alkylation damage to RNA(4). Here we show that two human AlkB homologues, hABH2 and hABH3, also are oxidative DNA demethylases and that AlkB and hABH3, but not hABH2, also repair RNA. Whereas AlkB and hABH3 prefer single-stranded nucleic acids, hABH2 acts more efficiently on double-stranded DNA. In addition, AlkB and hABH3 expressed in E. coli reactivate methylated RNA bacteriophage MS2 in vivo, illustrating the biological relevance of this repair activity and establishing RNA repair as a potentially important defence mechanism in living cells. The different catalytic properties and the different subnuclear localization patterns shown by the human homologues indicate that hABH2 and hABH3 have distinct roles in the cellular response to alkylation damage.	Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, N-7489 Trondheim, Norway; Univ Oslo, Natl Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway; Univ Oslo, Natl Hosp, Inst Med Microbiol, N-0027 Oslo, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Krokan, HE (corresponding author), Norwegian Univ Sci & Technol, Inst Canc Res & Mol Biol, N-7489 Trondheim, Norway.		Bjørås, Magnar/N-9286-2017; Falnes, Pål Ø./AAA-4581-2020; Vågbø, Cathrine Broberg/N-3226-2017; Slupphaug, Geir/AAN-3794-2020	Vågbø, Cathrine Broberg/0000-0003-3959-7409; Skorpen, Frank/0000-0001-7093-8000; Akbari, Mansour/0000-0002-6490-7766; Falnes, Pal/0000-0001-8114-6025; Slupphaug, Geir/0000-0002-7498-3500; Otterlei, Marit/0000-0002-5232-1186				Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; ARAVIND L, 2001, GENOME BIOL, V2; BJELLAND S, 1993, NUCLEIC ACIDS RES, V21, P2045, DOI 10.1093/nar/21.9.2045; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; BOITEUX S, 1982, BIOCHIMIE, V64, P637, DOI 10.1016/S0300-9084(82)80103-X; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Dinglay S, 2000, GENE DEV, V14, P2097; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haug T, 1996, GENOMICS, V36, P408, DOI 10.1006/geno.1996.0485; Huang X, 2001, FREE RADICAL BIO MED, V31, P1341, DOI 10.1016/S0891-5849(01)00681-5; KAASEN I, 1986, J BACTERIOL, V168, P642, DOI 10.1128/jb.168.2.642-647.1986; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Matsugi J, 2001, BBA-GENE STRUCT EXPR, V1521, P81, DOI 10.1016/S0167-4781(01)00293-7; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; SAFFHILL R, 1984, CARCINOGENESIS, V5, P691; Sambrook J., 2002, MOL CLONING LAB MANU; Singer B., 1983, MOL BIOL MUTAGENS CA; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Valegard K, 1998, NATURE, V394, P805, DOI 10.1038/29575; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Wei YF, 1996, NUCLEIC ACIDS RES, V24, P931, DOI 10.1093/nar/24.5.931; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	27	487	505	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					859	863		10.1038/nature01363	http://dx.doi.org/10.1038/nature01363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594517				2022-12-28	WOS:000181044700052
J	Langkjaer, RB; Cliften, PF; Johnston, M; Piskur, J				Langkjaer, RB; Cliften, PF; Johnston, M; Piskur, J			Yeast genome duplication was followed by asynchronous differentiation of duplicated genes	NATURE			English	Article							HEMIASCOMYCETOUS YEASTS; SACCHAROMYCES; EVOLUTION; EXPLORATION; CHROMOSOMES; REGIONS; GROWTH	Gene redundancy has been observed in yeast, plant and human genomes, and is thought to be a consequence of whole-genome duplications(1-3). Baker's yeast, Saccharomyces cerevisiae, contains several hundred duplicated genes(1). Duplication(s) could have occurred before or after a given speciation. To understand the evolution of the yeast genome, we analysed orthologues of some of these genes in several related yeast species. On the basis of the inferred phylogeny of each set of genes, we were able to deduce whether the gene duplicated and/or specialized before or after the divergence of two yeast lineages. Here we show that the gene duplications might have occurred as a single event, and that it probably took place before the Saccharomyces and Kluyveromyces lineages diverged from each other. Further evolution of each duplicated gene pair-such as specialization or differentiation of the two copies, or deletion of a single copy-has taken place independently throughout the evolution of these species.	Tech Univ Denmark, Bioctr DTU, DK-2800 Lyngby, Denmark; Washington Univ, Sch Med, Dept Genet & Genome Sequencing Ctr, St Louis, MO 63110 USA	Technical University of Denmark; Washington University (WUSTL)	Piskur, J (corresponding author), Tech Univ Denmark, Bioctr DTU, Bldg 301, DK-2800 Lyngby, Denmark.	jp@biocentrum.dtu.dk	Johnston, Mark/K-3543-2019; Johnston, Mark/R-6156-2019	Johnston, Mark/0000-0002-4932-7229; 	NIGMS NIH HHS [R01 GM063803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063803] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berbee ML, 2001, MYCOTA, V7, P229; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Koonin EV, 1997, CURR OPIN GENET DEV, V7, P757, DOI 10.1016/S0959-437X(97)80037-8; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; LALO D, 1993, CR ACAD SCI III-VIE, V316, P367; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langkjaer RB, 2000, J MOL BIOL, V304, P271, DOI 10.1006/jmbi.2000.4209; LANGKJAER RB, 2002, THESIS DTU; Llorente B, 2000, FEBS LETT, V487, P122, DOI 10.1016/S0014-5793(00)02291-2; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; MELNICK L, 1993, J MOL BIOL, V233, P372, DOI 10.1006/jmbi.1993.1518; Moller K, 2002, BIOTECHNOL BIOENG, V77, P186, DOI 10.1002/bit.10122; Moller K, 2001, J BACTERIOL, V183, P2485, DOI 10.1128/JB.183.8.2485-2489.2001; Ohno S., 1970, EVOLUTION GENE DUPLI; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Piskur J, 2001, TRENDS GENET, V17, P302, DOI 10.1016/S0168-9525(01)02308-3; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vaughan-Martini Ann, 1998, P358, DOI 10.1016/B978-044481312-1/50048-4; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WESOLOWSKILOUVE.M, 1906, NONCONVENTIONAL YEAS, P139; WICKSTEED BL, 1994, YEAST, V10, P39, DOI 10.1002/yea.320100105; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099	30	114	155	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2003	421	6925					848	852		10.1038/nature01419	http://dx.doi.org/10.1038/nature01419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594514				2022-12-28	WOS:000181044700049
J	Niikura, H; Legare, F; Hasbani, R; Ivanov, MY; Villeneuve, DM; Corkum, PB				Niikura, H; Legare, F; Hasbani, R; Ivanov, MY; Villeneuve, DM; Corkum, PB			Probing molecular dynamics with attosecond resolution using correlated wave packet pairs	NATURE			English	Article							INTENSE LASER FIELDS; HIGH-HARMONIC-GENERATION; ENHANCED IONIZATION; IONS; PULSES; ATOMS	Spectroscopic measurements with increasingly higher time resolution are generally thought to require increasingly shorter laser pulses, as illustrated by the recent monitoring of the decay of core-excited krypton(1) using attosecond photon pulses(2),(3). However, an alternative approach to probing ultrafast dynamic processes might be provided by entanglement, which has improved the precision(4,5) of quantum optical measurements. Here we use this approach to observe the motion of a D(2)(+) vibrational wave packet formed during the multiphoton ionization of D(2) over several femtoseconds with a precision of about 200 attoseconds and 0.05 angstroms, by exploiting the correlation between the electronic and nuclear wave packets formed during the ionization event. An intense infrared laser field drives the electron wave packet, and electron recollision(6-11) probes the nuclear motion. Our results show that laser pulse duration need not limit the time resolution of a spectroscopic measurement, provided the process studied involves the formation of correlated wave packets, one of which can be controlled; spatial resolution is likewise not limited to the focal spot size or laser wavelength.	Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	National Research Council Canada; University of Sherbrooke	Corkum, PB (corresponding author), Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	Paul.Corkum@nrc.ca	NUTER, Rachel/ABC-3536-2020; Villeneuve, David M/I-4140-2012; NUTER, Rachel/L-7818-2017; NIIKURA, HIROMICHI/C-3838-2012; Ivanov, Mikhail/AAG-1727-2021	Villeneuve, David M/0000-0002-2810-3648; NUTER, Rachel/0000-0001-9543-3164; Corkum, Paul/0000-0003-3394-5572				Bhardwaj VR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.253003; CODLING K, 1993, J PHYS B-AT MOL OPT, V26, P783, DOI 10.1088/0953-4075/26/5/005; Constant E, 1996, PHYS REV LETT, V76, P4140, DOI 10.1103/PhysRevLett.76.4140; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; D'Ariano GM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.270404; DIETRICH P, 1994, PHYS REV A, V50, pR3585, DOI 10.1103/PhysRevA.50.R3585; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Hargittai I., 1998, STEREOCHEMICAL APPL; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Itatani J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173903; IVANOV M, 1995, PHYS REV LETT, V74, P2933, DOI 10.1103/PhysRevLett.74.2933; KRAUSE JL, 1992, PHYS REV LETT, V68, P3535, DOI 10.1103/PhysRevLett.68.3535; LAMBROPOULOS P, 1985, PHYS REV LETT, V55, P2141, DOI 10.1103/PhysRevLett.55.2141; Lein M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.183903; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; PAULUS GG, 1994, PHYS REV LETT, V72, P2851, DOI 10.1103/PhysRevLett.72.2851; PEEK JM, 1964, PHYS REV A, V134, P877; RESCH KJ, 2000, PHYS REV A, V63; SCHINKE R, 1993, PHOTODISSOCIATION DY, P114; SEIDEMAN T, 1995, PHYS REV LETT, V75, P2819, DOI 10.1103/PhysRevLett.75.2819; Weber T, 2000, NATURE, V405, P658, DOI 10.1038/35015033; Yudin GL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.019902; Yudin GL, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.033404; ZAVRIYEV A, 1990, PHYS REV A, V42, P5500, DOI 10.1103/PhysRevA.42.5500; ZEWAIL AH, 1988, SCIENCE, V242, P1645, DOI 10.1126/science.242.4886.1645; ZUO T, 1995, PHYS REV A, V52, pR2511, DOI 10.1103/PhysRevA.52.R2511	28	363	368	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 20	2003	421	6925					826	829		10.1038/nature01430	http://dx.doi.org/10.1038/nature01430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	646QA	12594508	Green Submitted			2022-12-28	WOS:000181044700043
J	Vinicor, F; Bowman, B; Engelgau, M				Vinicor, F; Bowman, B; Engelgau, M			Diabetes: prevention needed	LANCET			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; HEALTH; PREVALENCE; MELLITUS; OBESITY; CARE; RISK		Ctr Dis Control & Prevent, Div Diabet Translat K10, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Vinicor, F (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat K10, Atlanta, GA 30341 USA.	fxv1@cdc.gov						Bagust A, 2002, DIABETIC MED, V19, P1, DOI 10.1046/j.1464-5491.19.s4.2.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Gavin JR, 1997, DIABETES CARE, V20, P1183; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; NARAYAN V, 2002, BRIT MED J, V325, P403; Saydah SH, 2001, DIABETES CARE, V24, P447, DOI 10.2337/diacare.24.3.447; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Wylie G, 2002, BMJ-BRIT MED J, V324, P1190, DOI 10.1136/bmj.324.7347.1190	16	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					544	544		10.1016/S0140-6736(03)12561-5	http://dx.doi.org/10.1016/S0140-6736(03)12561-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598137				2022-12-28	WOS:000181033400005
J	Minkoff, H; Chervenak, FA				Minkoff, H; Chervenak, FA			Elective primary cesarean delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MATERNAL MORTALITY; URINARY-INCONTINENCE; VAGINAL DELIVERY; FETAL MACROSOMIA; SECTION; TERM; MODE; PRIMIPARAS; DISORDERS; RISK		Maimonides Hosp, Dept Obstet & Gynecol, Brooklyn, NY 11219 USA; SUNY Downstate Med Ctr, Dept Obstet & Gynecol, Brooklyn, NY 11203 USA; Cornell Univ, Weill Med Coll, Dept Obstet & Gynecol, New York, NY USA; New York Presbyterian Hosp, New York, NY USA	Maimonides Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Cornell University; NewYork-Presbyterian Hospital	Minkoff, H (corresponding author), Maimonides Hosp, Dept Obstet & Gynecol, 967 48th St, Brooklyn, NY 11219 USA.	hminkoff@maimonidesmed.org	Chervenak, Frank/P-3555-2017; Sampiev, Abdulmutalip/O-9577-2017	Chervenak, Frank/0000-0002-4600-0853; Sampiev, Abdulmutalip/0000-0002-5100-2239				Alberman E, 1997, BRIT J OBSTET GYNAEC, V104, P1043, DOI 10.1111/j.1471-0528.1997.tb12064.x; Bewley S, 2002, LANCET, V359, P2128, DOI 10.1016/S0140-6736(02)09113-4; Bewley S, 2002, BJOG-INT J OBSTET GY, V109, P597, DOI 10.1016/S1470-0328(02)07106-9; CORKE BC, 1982, ANAESTHESIA, V37, P658, DOI 10.1111/j.1365-2044.1982.tb01278.x; Farrell SA, 2001, OBSTET GYNECOL, V97, P350, DOI 10.1016/S0029-7844(00)01164-9; FELDMAN GB, 1992, OBSTET GYNECOL, V79, P547; FELDMAN GB, 1985, NEW ENGL J MED, V312, P1264, DOI 10.1056/NEJM198505093121926; Gilliam M, 2002, OBSTET GYNECOL, V99, P976, DOI 10.1016/S0029-7844(02)02002-1; Gonen R, 2002, OBSTET GYNECOL, V99, P577, DOI 10.1016/S0029-7844(01)01766-5; Graham WJ, 1999, BRIT J OBSTET GYNAEC, V106, P213, DOI 10.1111/j.1471-0528.1999.tb08233.x; Grether JK, 1998, JAMA-J AM MED ASSOC, V279, P118; Haas D M, 2002, J Matern Fetal Neonatal Med, V11, P196; Hall MH, 1999, LANCET, V354, P776, DOI 10.1016/S0140-6736(05)76016-5; Hannah ME, 2002, JAMA-J AM MED ASSOC, V287, P1822, DOI 10.1001/jama.287.14.1822; HANNAH P, 1992, BRIT J PSYCHIAT, V160, P777, DOI 10.1192/bjp.160.6.777; Hemminki E, 1996, AM J OBSTET GYNECOL, V174, P1569, DOI 10.1016/S0002-9378(96)70608-7; HOFMEYR GJ, 2001, COCHRANE DB SYST REV, V12; Land R, 2001, AUST NZ J OBSTET GYN, V41, P249, DOI 10.1111/j.1479-828X.2001.tb01224.x; LASALA AP, 1987, AM J OBSTET GYNECOL, V157, P379; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; Lydon-Rochelle M, 2000, JAMA-J AM MED ASSOC, V283, P2411, DOI 10.1001/jama.283.18.2411; MacLennan AH, 2000, BRIT J OBSTET GYNAEC, V107, P1460, DOI 10.1111/j.1471-0528.2000.tb11669.x; McCullogh LB., 1994, ETHICS OBSTET GYNECO; MCFARLAND LV, 1986, OBSTET GYNECOL, V68, P784; Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0; MINKOFF HL, 1980, OBSTET GYNECOL, V56, P135; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; *NAT I CLIN EXC SC, 2001, WHY MOTH DIE 1997 19; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; PARILLA BV, 1993, OBSTET GYNECOL, V81, P392; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Rouse DJ, 1999, AM J OBSTET GYNECOL, V181, P332, DOI 10.1016/S0002-9378(99)70557-0; SACHS BP, 1988, OBSTET GYNECOL, V71, P385; SAUNDERS N, 1991, LANCET, V338, P1190, DOI 10.1016/0140-6736(91)92044-3; Schenker JG, 1999, INT J GYNECOL OBSTET, V64, P317; Schuitemaker N, 1997, ACTA OBSTET GYN SCAN, V76, P332, DOI 10.1111/j.1600-0412.1997.tb07987.x; Smaill F, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858. CD000933, DOI 10.1002/14651858]; SULTAN AH, 1993, NEW ENGL J MED, V329, P1905, DOI 10.1056/NEJM199312233292601; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Tucker J, 2002, LANCET, V359, P99; VIKTRUP L, 1992, OBSTET GYNECOL, V79, P945; Yoles I., 1998, American Journal of Obstetrics and Gynecology, V178, pS78	43	236	242	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2003	348	10					946	950		10.1056/NEJMsb022734	http://dx.doi.org/10.1056/NEJMsb022734			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651UU	12621140				2022-12-28	WOS:000181341100012
J	McConnell, JR; Barton, MK				McConnell, JR; Barton, MK			Leaf development takes shape	SCIENCE			English	Editorial Material									Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	McConnell, JR (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.							Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Kosugi S, 1997, PLANT CELL, V9, P1607, DOI 10.1105/tpc.9.9.1607; Kosugi S, 2002, PLANT J, V30, P337, DOI 10.1046/j.1365-313X.2002.01294.x; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P37, DOI 10.1093/pcp/pce011	8	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1328	1329		10.1126/science.1082433	http://dx.doi.org/10.1126/science.1082433			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610287				2022-12-28	WOS:000181192300032
J	Gerberding, JL				Gerberding, JL			Occupational exposure to HIV in health care settings	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; POSTEXPOSURE PROPHYLAXIS; ZIDOVUDINE TREATMENT; VIRAL LOAD; INFECTION; TRANSMISSION; PREVENTION; SEROCONVERSION; NEVIRAPINE; INITIATION	While obtaining a peripheral venous blood sample from a patient with the acquired immunodeficiency syndrome (AIDS), a 35-year-old phlebotomist is injured by a bloody 18-gauge needle attached to a syringe. The patient has been taking didanosine and stavudine for more than six months, but her quantitative plasma human immunodeficiency virus (HIV) RNA titer and CD4 T-lymphocyte count have not been measured for many weeks. What is the appropriate postexposure treatment for the phlebotomist?.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Gerberding, JL (corresponding author), Ctr Dis Control & Prevent, Mailstop D14,1600 Clifton Rd, Atlanta, GA 30333 USA.	jgerberding@cdc.gov						Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], GAO0160R; BELTRAMI EM, 2000, 4 DEC INT C NOS HEAL, P125; BELTRAMI EM, 2000, 4 DEC INT C NOS HEAL, P128; Bottiger D, 1997, AIDS, V11, P157, DOI 10.1097/00002030-199702000-00004; BUSCH MP, 1995, TRANSFUSION, V35, P91, DOI 10.1046/j.1537-2995.1995.35295125745.x; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Henry K, 1996, ANN INTERN MED, V124, P855, DOI 10.7326/0003-4819-124-9-199605010-00014; *HIV AIDS, 2000, HIV AIDS SURV REP, V12, P24; *HIV AIDS CLIN TRI, 2002, GUID US ANT AG HIV I; Jochimsen Elise M., 1997, American Journal of Medicine, V102, P52, DOI 10.1016/S0002-9343(97)00062-4; Kallenborn JC, 2001, INFECT CONT HOSP EP, V22, P289, DOI 10.1086/501902; LOT F, 1995, B EPIDEMIOL HEBD, V44, P193; MARTIN LN, 1993, J INFECT DIS, V168, P825, DOI 10.1093/infdis/168.4.825; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; *NIOSH, 1999, DHHS PUBL; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Perdue B, 1999, 6 C RETR OPP INF CHI, P107; Pinto Ligia A., 1997, American Journal of Medicine, V102, P21, DOI 10.1016/S0002-9343(97)00056-9; PRATT RD, 1995, J INFECT DIS, V172, P851, DOI 10.1093/infdis/172.3.851; *PUBL HLTH SERV TA, 2001, HIV CLIN TRIALS, V2, P56; Rich JD, 1999, ANN INTERN MED, V130, P37, DOI 10.7326/0003-4819-130-1-199901050-00007; ROLAND ME, 2000, 7 C RETR OPP INF SAN, P220; Salgado CD, 2002, INFECT CONT HOSP EP, V23, P335, DOI 10.1086/502061; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Struble Kimberly A., 1997, American Journal of Medicine, V102, P65, DOI 10.1016/S0002-9343(97)00065-X; Trape M, 2001, INFECT CONT HOSP EP, V22, P333, DOI 10.1086/503403; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; Wang SA, 2000, INFECT CONT HOSP EP, V21, P780, DOI 10.1086/501736; Weisburd Guillermo, 1996, P460; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; 2000, JAMA, V284, P2722; 2001, MMWR MORB MORTAL WKL, V49, P1153	37	90	101	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2003	348	9					826	833		10.1056/NEJMcp020892	http://dx.doi.org/10.1056/NEJMcp020892			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648WE	12606738				2022-12-28	WOS:000181173300010
J	Gallagher, TH; Waterman, AD; Ebers, AG; Fraser, VJ; Levinson, W				Gallagher, TH; Waterman, AD; Ebers, AG; Fraser, VJ; Levinson, W			Patients' physicians' attitudes regarding the disclosure of medical errors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-MANAGEMENT; PATIENTS WANT; MISTAKES; MALPRACTICE; DOCTORS; TRUTH; LEGAL; PREVENTION; SAFETY; IMPACT	Context Despite the best efforts of health care practitioners, medical errors are inevitable. Disclosure of errors,to patients is desired by patients and recommended by ethicists and professional organizations, but little is known about how patients and physicians think medical errors should be discussed. Objective To determine patients' and physicians' attitudes about error disclosure. Design, Setting, and Participants Thirteen focus groups were organized, including 6 groups of adult patients, 4 groups of academic and community physicians, and 3 groups of both physicians and patients. A total of 52 patients and 46 physicians participated. Main Outcome Measures Qualitative analysis of focus group transcripts to determine the attitudes of patients and physicians about medical error disclosure; whether physicians disclose the information patients desire; and patients' and physicians' emotional needs when an error occurs and whether these needs are met. Results Both patients and physicians had unmet needs following errors. Patients wanted disclosure of all harmful errors and sought information about what happened, why the error happened, how the error's consequences will be mitigated, and how recurrences will be prevented. Physicians agreed that harmful errors should be disclosed but "choose their words carefully" when telling patients about errors. Although physicians disclosed the adverse event, they often avoided stating that an error occurred, why the error happened, or how recurrences would be prevented. Patients also desired emotional support from physicians following errors, including an apology. However, physicians worried that an apology might create legal liability. Physicians were also upset when errors happen but were unsure where to seek emotional support. Conclusions Physicians may not be providing the information or emotional support that patients seek following harmful medical errors. Physicians should strive to meet patients' desires for an,apology and for information on the nature, cause, and prevention of errors. Institutions should also address the emotional needs of practitioners who are involved in medical errors.	Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med Hist & Eth, Seattle, WA 98195 USA; Washington Univ, St Louis Sch Med, Dept Med, St Louis, MO USA; Univ Toronto, Dept Med, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Saint Louis University; Washington University (WUSTL); University of Toronto	Gallagher, TH (corresponding author), Univ Washington, Sch Med, Dept Med, 1959 NE Pacific St,Box 356178, Seattle, WA 98195 USA.	thomasg@u.washington.edu		Waterman, Amy/0000-0002-7799-0060; Fraser, Victoria/0000-0001-6251-0733	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011898] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM HOSP ASS, 1992, ETH COND HLTH CAR I; *AM MED ASS COUNC, 1998, COD MED ETH CURR OP; *AMA NAT PAT SAF F, PUBL OP PAT SAF ISS; APPLEGATE WB, 1986, ARCH INTERN MED, V146, P2249, DOI 10.1001/archinte.146.11.2249; *AUSTR COUNC SAF Q, 2002, DRAFT OP DISCL STAND; Banja J, 2001, Bioethics Forum, V17, P7; Berwick DM, 1999, QUAL HEALTH CARE, V8, P145, DOI 10.1136/qshc.8.3.145; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; Bosk CL, 1979, FORGIVE REMEMBER MAN, DOI DOI 10.7208/CHICAGO/9780226924687.001.0001; Boyte WR, 2001, HEALTH AFFAIR, V20, P250, DOI 10.1377/hlthaff.20.2.250; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Brazeau C, 1999, AM FAM PHYSICIAN, V60, P1013; Calman NS, 2001, HEALTH AFFAIR, V20, P243, DOI 10.1377/hlthaff.20.2.243; Cantor MD, 2002, QUAL SAF HEALTH CARE, V11, P7, DOI 10.1136/qhc.11.1.7-a; CHRISTENSEN JF, 1992, J GEN INTERN MED, V7, P424, DOI 10.1007/BF02599161; COMDEN S, 2002, STATEWIDE PATIENT SA; Downing L, 2001, Bioethics Forum, V17, P12; Eads Judy, 2002, Tenn Med, V95, P239; Finkelstein D, 1997, J CLIN ETHIC, V8, P330; FLYNN E, 2002, SHINING LIGHT ERRORS; Goldberg RM, 2002, ANN EMERG MED, V39, P287, DOI 10.1067/mem.2002.121995; Hebert PC, 2001, CAN MED ASSOC J, V164, P509; HICKSON GB, 1992, JAMA-J AM MED ASSOC, V267, P1359, DOI 10.1001/jama.267.10.1359; HIGGINBOTHAM JB, 1979, FOCUS GROUP INTERVIE; HILFIKER D, 1984, NEW ENGL J MED, V310, P118, DOI 10.1056/NEJM198401123100211; Hingorani M, 1999, BRIT MED J, V318, P640, DOI 10.1136/bmj.318.7184.640; Hobgood C, 2002, ACAD EMERG MED, V9, P1156, DOI 10.1111/j.1553-2712.2002.tb01570.x; HUYCKE LI, 1994, ANN INTERN MED, V120, P792, DOI 10.7326/0003-4819-120-9-199405010-00011; *I MED COMM QUAL H, 2001, NEW HLTH SYSTEM 21 C; *JOINT COMM ACCR H, 2001, REV JOINT COMM STAND; *KAIS FAM FDN, NAT SURV AM HLTH CAR; Kitchens LW, 1998, ANN INTERN MED, V128, P576, DOI 10.7326/0003-4819-128-7-199804010-00012; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Kraman SS, 1999, ANN INTERN MED, V131, P963, DOI 10.7326/0003-4819-131-12-199912210-00010; KRITZER HM, 1991, J LAW SOC, V18, P400, DOI 10.2307/1410316; Leape LL, 2002, NEW ENGL J MED, V347, P1633, DOI 10.1056/NEJMNEJMhpr011493; LEBLANG TR, 1984, DICKINSON LAW REV, V89, P1; LEVINSON W, 1989, JAMA-J AM MED ASSOC, V261, P2252, DOI 10.1001/jama.261.15.2252; Liang BA, 2002, QUAL SAF HEALTH CARE, V11, P64, DOI 10.1136/qhc.11.1.64; Lo B.., 2020, RESOLVING ETHICAL DI; MAY ML, 1990, LAW SOC REV, V24, P105, DOI 10.2307/3053788; May T, 2001, KENNEDY INST ETHIC J, V11, P135, DOI 10.1353/ken.2001.0014; *MN HOSP HEALTHC P, 2001, SUGG LANG COMM OUTC; Morgan D.L., 1997, FOCUS GROUPS QUALITA, V2nd ed., DOI [10.4135/9781412984287, DOI 10.4135/9781412984287]; Newman MC, 1996, ARCH FAM MED, V5, P71, DOI 10.1001/archfami.5.2.71; NOVACK DH, 1989, JAMA-J AM MED ASSOC, V261, P2980, DOI 10.1001/jama.261.20.2980; PENCHANSKY R, 1994, MED CARE, V32, P813, DOI 10.1097/00005650-199408000-00005; Pinkus RL, 2000, MARGIN ERROR ETHICS; Quality Interagency Coordination Task Force, DOING WHAT COUNTS PA; Robinson AR, 2002, ARCH INTERN MED, V162, P2186, DOI 10.1001/archinte.162.19.2186; Rosner F, 2000, ARCH INTERN MED, V160, P2089, DOI 10.1001/archinte.160.14.2089; SHAPIRO RS, 1989, ARCH INTERN MED, V149, P2190, DOI 10.1001/archinte.149.10.2190; Smith ML, 2000, CAMB Q HEALTHC ETHIC, V9, P38, DOI 10.1017/S0963180100901051; Stewart D.W., 2014, FOCUS GROUPS THEORY; Sweet MP, 1997, J CLIN ETHIC, V8, P341; Thurman AE, 2001, KENNEDY INST ETHIC J, V11, P147, DOI 10.1353/ken.2001.0018; UPMC Presbyterian Policy Procedu, 2001, KENNEDY INST ETHIC J, V11, P165; VINCENT C, 1994, LANCET, V343, P1609, DOI 10.1016/S0140-6736(94)93062-7; Vincent C A, 1993, Qual Health Care, V2, P77, DOI 10.1136/qshc.2.2.77; Vincent CA, 2002, QUAL SAF HEALTH CARE, V11, P76, DOI 10.1136/qhc.11.1.76; Wears RL, 2002, ANN EMERG MED, V39, P344, DOI 10.1067/mem.2002.121996; Witman AB, 1996, ARCH INTERN MED, V156, P2565, DOI 10.1001/archinte.156.22.2565; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; Wu AW, 1999, ANN INTERN MED, V131, P970, DOI 10.7326/0003-4819-131-12-199912210-00012; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726; Wu AW, 1997, J GEN INTERN MED, V12, P770, DOI 10.1046/j.1525-1497.1997.07163.x	66	588	600	0	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2003	289	8					1001	1007		10.1001/jama.289.8.1001	http://dx.doi.org/10.1001/jama.289.8.1001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BK	12597752	Bronze			2022-12-28	WOS:000181129800026
J	Cantillon, P				Cantillon, P			ABC of learning and teaching in medicine - Teaching large groups	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Natl Univ Ireland Univ Coll Galway, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Cantillon, P (corresponding author), Natl Univ Ireland Univ Coll Galway, Galway, Ireland.							Bligh D. A, 2000, WHATS USE LECT; Brown G, 2001, MED TEACH, V23, P231, DOI 10.1080/01421590120043000; Gibbs G., 1989, PREPARING TEACH; Newble DI, 2001, HDB MED TEACHERS	4	71	78	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2003	326	7386					437	440		10.1136/bmj.326.7386.437	http://dx.doi.org/10.1136/bmj.326.7386.437			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	651KA	12595386	Green Published			2022-12-28	WOS:000181318000025
J	Petronczki, M; Siomos, MF; Nasmyth, K				Petronczki, M; Siomos, MF; Nasmyth, K			Un menage a quatre: The molecular biology of chromosome segregation in meiosis	CELL			English	Review							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; SYNAPTONEMAL COMPLEX PROTEIN; ANAPHASE-PROMOTING COMPLEX; MEIOTIC GENE CONVERSION; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; XENOPUS-OOCYTES; TOPOISOMERASE-II	Sexually reproducing organisms rely on the precise reduction of chromosome number during a specialized cell division called meiosis. Whereas mitosis produces diploid daughter cells from diploid cells, meiosis generates haploid gametes from diploid precursors. The molecular mechanisms controlling chromosome transmission during both divisions have started to be delineated. This review focuses on the four fundamental differences between mitotic and meiotic chromosome segregation that allow the ordered reduction of chromosome number in meiosis: (1) reciprocal recombination and formation of chiasmata between homologous chromosomes, (2) suppression of sister kinetochore biorientation, (3) protection of centromeric cohesion, and (4) inhibition of DNA replication between the two meiotic divisions.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	nasmyth@nt.imp.univie.ac.at		Petronczki, Mark/0000-0003-0139-5692; Nasmyth, Kim/0000-0001-7030-4403				Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; AULT JG, 1989, CHROMOSOMA, V98, P33, DOI 10.1007/BF00293332; AVRAVIND L, 2002, PROTEINS, V46, P355; BAHLER J, 1993, J CELL BIOL, V121, P241, DOI 10.1083/jcb.121.2.241; BARNES TM, 1995, GENETICS, V141, P159; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; BOVERI T, 2004, ERGEBNISSE KONSTITUT; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Cavalier-Smith T, 2002, HEREDITY, V88, P125, DOI 10.1038/sj.hdy.6800034; CHAN CSM, 1993, GENETICS, V135, P677; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; COLLINS I, 1994, CELL, V76, P65, DOI 10.1016/0092-8674(94)90173-2; Darwiche N, 1999, GENE, V233, P39, DOI 10.1016/S0378-1119(99)00160-2; Davis ES, 2002, GENETICS, V160, P805; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Diffley JFX, 2002, J CELL SCI, V115, P869; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; DOWNES CS, 1991, P NATL ACAD SCI USA, V88, P8895, DOI 10.1073/pnas.88.20.8895; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Gimenez-Abian JF, 2000, CHROMOSOMA, V109, P235, DOI 10.1007/s004120000065; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; HAIG D, 1991, J THEOR BIOL, V153, P531, DOI 10.1016/S0022-5193(05)80155-9; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD T, 1995, AM J HUM GENET, V57, P867; Hawley RS, 2002, CURR BIOL, V12, pR660, DOI 10.1016/S0960-9822(02)01161-2; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Hoque MT, 2002, J BIOL CHEM, V277, P42306, DOI 10.1074/jbc.M206836200; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; JANSSENS FA, 1909, CELLULE, V25, P387; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; LAMBIE EJ, 1988, CELL, V52, P863, DOI 10.1016/0092-8674(88)90428-X; Lee BH, 2002, GENE DEV, V16, P1672, DOI 10.1101/gad.989302; Lemaitre JM, 2002, NATURE, V419, P718, DOI 10.1038/nature01046; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Moore DP, 1998, J CELL BIOL, V140, P1003, DOI 10.1083/jcb.140.5.1003; MOSES MJ, 1958, J BIOPHYS BIOCHEM CY, V4, P633, DOI 10.1083/jcb.4.5.633; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Muller HJ, 1916, AM NAT, V50, P350, DOI 10.1086/279547; Muller HJ, 1916, AM NAT, V50, P284, DOI 10.1086/279541; Muller HJ, 1916, AM NAT, V50, P421, DOI 10.1086/279553; MURRAY AW, 1985, ANNU REV CELL BIOL, V1, P289, DOI 10.1146/annurev.cellbio.1.1.289; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Paliulis LV, 2000, J CELL BIOL, V150, P1223, DOI 10.1083/jcb.150.6.1223; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Perez LH, 2002, NAT CELL BIOL, V4, P737, DOI 10.1038/ncb850; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Prieto I, 2002, EMBO REP, V3, P543, DOI 10.1093/embo-reports/kvf108; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; ROCKMILL B, 1990, GENETICS, V126, P563; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; ROWLEY JD, 1975, P NATL ACAD SCI USA, V72, P152, DOI 10.1073/pnas.72.1.152; Schalk JAC, 1998, CHROMOSOMA, V107, P540, DOI 10.1007/s004120050340; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Walker MY, 2000, CHROMOSOMA, V109, P3, DOI 10.1007/s004120050407; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; Whitmire E, 2002, NATURE, V419, P722, DOI 10.1038/nature01032; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zachariae W, 1999, CURR OPIN CELL BIOL, V11, P708, DOI 10.1016/S0955-0674(99)00041-1; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	133	546	559	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 21	2003	112	4					423	440		10.1016/S0092-8674(03)00083-7	http://dx.doi.org/10.1016/S0092-8674(03)00083-7			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650FP	12600308	Bronze			2022-12-28	WOS:000181252600003
J	Cardon, LR; Palmer, LJ				Cardon, LR; Palmer, LJ			Population stratification and spurious allelic association	LANCET			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; COMPLEX HUMAN-DISEASES; CASE-CONTROL DESIGNS; LINKAGE DISEQUILIBRIUM; DIABETES-MELLITUS; TRANSMISSION DISEQUILIBRIUM; ADMIXED POPULATIONS; ETHNIC-DIFFERENCES; GENOMIC CONTROL; RELATIVE POWER	Great efforts and expense have been expended in attempts to detect genetic polymorphisms contributing to susceptibility to complex human disease. Concomitantly, technology for detection and scoring of single nucleotide polymorphisms (SNPs) has undergone rapid development, extensive catalogues of SNPs across the genome have been constructed, and SNPs have been increasingly used as a means for investigation of the genetic causes of complex human diseases. For many diseases, population-based studies of unrelated individuals-in which case-control and cohort studies serve as standard designs for genetic association analysis-can be the most practical and powerful approach. However, extensive debate has arisen about optimum study design, and considerable concern has been expressed that these approaches are prone to population stratification, which can-lead to biased or spurious results. Over the past decade, a great shift has been noted, away from case-control and cohort studies, towards family-based association designs. These designs have fewer problems with population stratification but have greater genotyping and sampling requirements, and data can be difficult or impossible to gather. We discuss past evidence for population stratification on genotype-phenotype association studies, review methods to detect and account for it, and present suggestions for future study design and analysis.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk	Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019; Peng, Bo/A-6920-2009	Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Peng, Bo/0000-0001-8225-2284	NHLBI NIH HHS [U01 HL65899] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065899] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; [Anonymous], 1999, NAT GENET, V22, P1; [Anonymous], 1986, LANCET, V2, P57; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Ball S, 1997, NAT BIOTECHNOL, V15, P925, DOI 10.1038/nbt1097-925; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CARDON LR, 2002, FUTURE BEHAV GENETIC; Carvajal-Carmona LG, 2001, AM J HUM GENET, V69, P418; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Clayton D, 2001, LANCET, V358, P1356, DOI 10.1016/S0140-6736(01)06418-2; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Cutler DJ, 2001, AM J HUM GENET, V69, P181; Deng HW, 2001, GENETICS, V159, P1319; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Drews J, 1997, NAT BIOTECHNOL, V15, P1318, DOI 10.1038/nbt1297-1318; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Gauderman W. James, 1999, Journal of the National Cancer Institute Monographs, P31; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Hill L, 2001, AM J HUM GENET, V69, P423; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jiang R, 2001, AM J HUM GENET, V69, P409; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kirk KM, 2002, EUR J HUM GENET, V10, P616, DOI 10.1038/sj.ejhg.5200855; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; March R, 2000, YEAST, V17, P16, DOI 10.1002/(SICI)1097-0061(200004)17:1<16::AID-YEA6>3.0.CO;2-E; Martin NC, 2001, AM J HUM GENET, V69, P419; McCarthy JJ, 2000, NAT BIOTECHNOL, V18, P505, DOI 10.1038/75360; McCarthy MI, 2002, J MOL ENDOCRINOL, V28, P1, DOI 10.1677/jme.0.0280001; McGinnis R, 2002, BEHAV GENET, V32, P135, DOI 10.1023/A:1015205924326; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; McLeod HL, 2001, NAT GENET, V29, P247, DOI 10.1038/ng1101-247; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Nielsen DM, 2001, THEOR POPUL BIOL, V60, P253, DOI 10.1006/tpbi.2001.1539; Overall ADJ, 2001, MOL BIOL EVOL, V18, P2048, DOI 10.1093/oxfordjournals.molbev.a003746; Palmer LJ, 2002, AM J RESP CRIT CARE, V165, P861, DOI 10.1164/ajrccm.165.7.2109096; Palmer LJ, 2000, GENOME RES, V10, P1280, DOI 10.1101/gr.143400; PALMER LJ, 2000, GENETIC ANAL MULTIFA, P215; Pankow JS, 2001, AM J HUM GENET, V69, P412; PATO CN, 1993, AM J MED GENET, V48, P78, DOI 10.1002/ajmg.1320480204; Pettipher R, 2002, PHARMACOGENOMICS, V3, P257, DOI 10.1517/14622416.3.2.257; Poolsup N, 2000, J CLIN PHARM THER, V25, P197; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Radda G, 2002, LANCET, V359, P2282, DOI 10.1016/S0140-6736(02)09289-9; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; RIBOLI E, 1992, ANN ONCOL, V3, P783, DOI 10.1093/oxfordjournals.annonc.a058097; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Roses AD, 2000, LANCET, V355, P1358, DOI 10.1016/S0140-6736(00)02126-7; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Schulze TG, 2002, AM J MED GENET, V114, P1, DOI 10.1002/ajmg.10042; Silverman EK, 2000, AM J RESP CELL MOL, V22, P645, DOI 10.1165/ajrcmb.22.6.f191; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Teng J, 1999, GENOME RES, V9, P234; Terwilliger JD, 2000, HUM BIOL, V72, P63; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; WACHOLDER S, 2002, BIOSTATISTICAL GENET; Walker J, 2001, EUR J CANCER, V37, pS163; Wallace H, 2002, LANCET, V359, P2282; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wilson PWF, 2001, ENDOCRIN METAB CLIN, V30, P857, DOI 10.1016/S0889-8529(05)70219-X; Witte JS, 1999, AM J EPIDEMIOL, V149, P693; Wright A. F., 2002, Pharmacogenomics Journal, V2, P75, DOI 10.1038/sj.tpj.6500085; Yamada R, 2001, AM J HUM GENET, V69, P423; Zondervan KT, 2002, HUM REPROD, V17, P1415, DOI 10.1093/humrep/17.6.1415	92	898	933	2	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					598	604		10.1016/S0140-6736(03)12520-2	http://dx.doi.org/10.1016/S0140-6736(03)12520-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598158				2022-12-28	WOS:000181033400025
J	Gwatkin, DR				Gwatkin, DR			How well do health programmes reach the poor?	LANCET			English	Editorial Material							WEALTH		World Bank, Washington, DC 20433 USA	The World Bank	Gwatkin, DR (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.							Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FILMER D, 2002, 2789 WORLD BANK DEV; Gwatkin DR, 2001, INT J EPIDEMIOL, V30, P720, DOI 10.1093/ije/30.4.720; GWATKIN DR, 2002, M FOG INT CTR NIH BE; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; RUTSTEIN S, 1999, M HLTH IN CHALL FUT; Sahn D., 2001, 97 CORN FOOD NUTR PO	7	27	27	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 15	2003	361	9357					540	541		10.1016/S0140-6736(03)12558-5	http://dx.doi.org/10.1016/S0140-6736(03)12558-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598134				2022-12-28	WOS:000181033400002
J	Taylor, SE; Garalda, ME; Tudor-Williams, G; Martinez-Alier, N				Taylor, SE; Garalda, ME; Tudor-Williams, G; Martinez-Alier, N			An organic cause of neuropsychiatric illness in adolescence	LANCET			English	Editorial Material							HASHIMOTO ENCEPHALOPATHY		St Marys Hosp, Acad Dept Child & Adolescent Psychiat, London W2 1PG, England; St Marys Hosp, Dept Paediat, London W2 1PG, England	Imperial College London; Imperial College London	Taylor, SE (corresponding author), St Marys Hosp, Acad Dept Child & Adolescent Psychiat, Praed St, London W2 1PG, England.	sharontaylor_2000@yahoo.com						KothbauerMargreiter I, 1996, J NEUROL, V243, P585, DOI 10.1007/BF00900946; SHAW PJ, 1991, NEUROLOGY, V41, P228, DOI 10.1212/WNL.41.2_Part_1.228; Sybesma CA, 1999, EUR J PEDIATR, V158, P867, DOI 10.1007/s004310051226; Vasconcellos E, 1999, PEDIATR NEUROL, V20, P394, DOI 10.1016/S0887-8994(99)00006-5; Watemberg N, 2000, J CHILD NEUROL, V15, P66, DOI 10.1177/088307380001500116	5	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2003	361	9357					572	572		10.1016/S0140-6736(03)12517-2	http://dx.doi.org/10.1016/S0140-6736(03)12517-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646KD	12598143				2022-12-28	WOS:000181033400011
J	Fu, XD; Harberd, NP				Fu, XD; Harberd, NP			Auxin promotes Arabidopsis root growth by modulating gibberellin response	NATURE			English	Article							GAI; DEGRADATION; TRANSPORT; GENE; DEREPRESSION; EXPRESSION; REDUCTION; REGULATOR; DEFINES; PROTEIN	The growth of plant organs is influenced by a stream of the phytohormone auxin that flows from the shoot apex to the tip of the root(1). However, until now it has not been known how auxin regulates the cell proliferation and enlargement that characterizes organ growth. Here we show that auxin controls the growth of roots by modulating cellular responses to the phytohormone gibberellin (GA). GA promotes the growth of plants by opposing the effects of nuclear DELLA protein growth repressors(2-8), one of which is Arabidopsis RGA (for repressor of gal-3)(9,10). GA opposes the action of several DELLA proteins by destabilizing them, reducing both the concentration of detectable DELLA proteins and their growth-restraining effects(9-14). We also show that auxin is necessary for GA-mediated control of root growth, and that attenuation of auxin transport or signalling delays the GA-induced disappearance of RGA from root cell nuclei. Our observations indicate that the shoot apex exerts long-distance control on the growth of plant organs through the effect of auxin on GA-mediated DELLA protein destabilization.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Harberd, NP (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England.	nicholas.harberd@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council [BBS/E/J/00000583] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 1995, PLANT HORMONES PHYSL, DOI DOI 10.1007/978-94-011-0473-9; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BRIAN P. W., 1958, Annals of Botany, V22, P1; Chansang H., 1982, Proceedings of the International Coral Reef Symposium, P129; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dill A, 2001, GENETICS, V159, P777; EVANS ML, 1994, PLANTA, V194, P215, DOI 10.1007/BF01101680; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Fu XD, 2001, PLANT CELL, V13, P1791, DOI 10.1105/tpc.13.8.1791; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; King KE, 2001, GENETICS, V159, P767; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Lomax Terri L., 1995, P509; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Richards DE, 2001, ANNU REV PLANT PHYS, V52, P67, DOI 10.1146/annurev.arplant.52.1.67; Rogg LE, 2001, DEV CELL, V1, P595, DOI 10.1016/S1534-5807(01)00077-6; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368	30	558	641	4	213	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					740	743		10.1038/nature01387	http://dx.doi.org/10.1038/nature01387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610625				2022-12-28	WOS:000180938000043
J	Walsh, JME; Terdiman, JP				Walsh, JME; Terdiman, JP			Colorectal cancer screening - Clinical applications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS ANALYSIS; OCCULT BLOOD-TEST; COLON-CANCER; FLEXIBLE SIGMOIDOSCOPY; AVERAGE-RISK; CONTROLLED-TRIAL; COLONOSCOPY; PARTICIPATION; GUIDELINES; ADHERENCE	Screening for colorectal cancer reduces mortality in individuals aged 50 years or older. A number of screening tests, including fecal occult blood tests, sigmoidoscopy, double-contrast barium enema, and colonoscopy, are recommended by professional organizations for colorectal cancer screening, yet the rates of colorectal cancer screening remain low. Questions regarding the quality of evidence for each screening test, whether screening for individuals at higher risk should be modified, the availability of the tests, and cost-effectiveness are addressed. Many potential barriers to colorectal cancer screening exist for the patient and the physician. Strategies to increase compliance for colorectal cancer screening are proposed.	Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Womens Hlth Clin Res Ctr, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94115 USA; Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Walsh, JME (corresponding author), Univ Calif San Francisco, Dept Med, Div Gen Internal Med, Womens Hlth Clin Res Ctr, Campus Box 1793,1635 Divisadero Suite 600, San Francisco, CA 94115 USA.	Jwalsh@medicine.ucsf.edu						Anderson ML, 2000, AM J GASTROENTEROL, V95, P3418, DOI 10.1111/j.1572-0241.2000.03356.x; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2000, GASTROENTEROLOGY, V118, pA187, DOI 10.1016/S0016-5085(00)82822-X; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Beeker C, 2000, J COMMUN HEALTH, V25, P263, DOI 10.1023/A:1005104406934; Bejes C, 1992, Fam Pract Res J, V12, P83; Bell CM, 1998, JAMA-J AM MED ASSOC, V279, P1015, DOI 10.1001/jama.279.13.1015; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Bini EJ, 1999, ARCH INTERN MED, V159, P2022, DOI 10.1001/archinte.159.17.2022; Brenes GA, 2000, PREV MED, V31, P410, DOI 10.1006/pmed.2000.0729; Burke CA, 2001, AM J GASTROENTEROL, V96, P3175; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; DiPalma AM, 1998, SOUTHERN MED J, V91, P342, DOI 10.1097/00007611-199804000-00005; Dominitz JA, 1997, AM J GASTROENTEROL, V92, P2171; EISNER MS, 1991, ARCH INTERN MED, V151, P2180, DOI 10.1001/archinte.151.11.2180; Ellerbeck EF, 2001, J GEN INTERN MED, V16, P697, DOI 10.1111/j.1525-1497.2001.01224.x; ELWOOD TW, 1978, AM J PUBLIC HEALTH, V68, P135, DOI 10.2105/AJPH.68.2.135; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; HARDCASTLE JD, 1986, CANCER-AM CANCER SOC, V58, P397, DOI 10.1002/1097-0142(19860715)58:2<397::AID-CNCR2820580235>3.0.CO;2-X; HARDCASTLE JD, 1983, LANCET, V2, P1; HERRINTON LJ, 1995, AM J EPIDEMIOL, V142, P961, DOI 10.1093/oxfordjournals.aje.a117744; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; KELLY RB, 1992, MED CARE, V30, P1029, DOI 10.1097/00005650-199211000-00006; Khandker RK, 2000, INT J TECHNOL ASSESS, V16, P799, DOI 10.1017/S0266462300102077; KING J, 1992, AUST NZ J SURG, V62, P714, DOI 10.1111/j.1445-2197.1992.tb07068.x; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LALLEMAND RC, 1984, BRIT MED J, V288, P31, DOI 10.1136/bmj.288.6410.31; LEE C Y, 1991, Yonsei Medical Journal, V32, P131; LEE FI, 1983, BRIT J CANCER, V48, P843, DOI 10.1038/bjc.1983.275; Lemon S, 2001, AM J PUBLIC HEALTH, V91, P1264, DOI 10.2105/AJPH.91.8.1264; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Ling BS, 2001, J GEN INTERN MED, V16, P822, DOI 10.1046/j.1525-1497.2001.10337.x; Lipkus IM, 1996, J COMMUN HEALTH, V21, P409, DOI 10.1007/BF01702602; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANT D, 1992, BRIT J GEN PRACT, V42, P18; MYERS RE, 1994, PREV MED, V23, P142, DOI 10.1006/pmed.1994.1020; MYERS RE, 1991, MED CARE, V29, P1039, DOI 10.1097/00005650-199110000-00009; NEALE AV, 1989, J OCCUP ENVIRON MED, V31, P1007, DOI 10.1097/00043764-198912000-00015; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Ness RM, 2000, AM J GASTROENTEROL, V95, P1800; NICHOLS S, 1986, BRIT MED J, V293, P107, DOI 10.1136/bmj.293.6539.107; Olynyk JK, 1996, MED J AUSTRALIA, V165, P74, DOI 10.5694/j.1326-5377.1996.tb124851.x; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; PLASKON PP, 1995, SOC WORK HEALTH CARE, V21, P59, DOI 10.1300/J010v21n04_04; PYE G, 1988, J EPIDEMIOL COMMUN H, V42, P66, DOI 10.1136/jech.42.1.66; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; Ransohoff DF, 1997, ANN INTERN MED, V126, P808, DOI 10.7326/0003-4819-126-10-199705150-00014; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Schroy PC, 1999, GASTROENTEROLOGY, V117, P304, DOI 10.1053/gast.1999.0029900304; SLATER PE, 1985, J CLIN GASTROENTEROL, V7, P51, DOI 10.1097/00004836-198502000-00007; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; Sonnenberg A, 2002, ARCH INTERN MED, V162, P163, DOI 10.1001/archinte.162.2.163; SONTAG SJ, 1983, AM J SURG, V145, P89, DOI 10.1016/0002-9610(83)90172-1; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; STRUEWING JP, 1991, AM J PREV MED, V7, P75, DOI 10.1016/S0749-3797(18)30941-3; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; THOMPSON RS, 1986, MED CARE, V24, P904, DOI 10.1097/00005650-198610000-00004; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VERNON SW, 1990, J OCCUP ENVIRON MED, V32, P46, DOI 10.1097/00043764-199001000-00013; Vernon SW, 1992, HEALTH VALUES, V16, P3; Vijan S, 2001, AM J MED, V111, P593, DOI 10.1016/S0002-9343(01)00977-9; Wagner JL, 1996, PREVENTION EARLY DET, P321; Walsh JME, 2002, PREV MED, V35, P209, DOI 10.1006/pmed.2002.1059; WEINRICH SP, 1993, GERONTOLOGIST, V33, P491, DOI 10.1093/geront/33.4.491; Weitzman ER, 2001, PREV MED, V32, P502, DOI 10.1006/pmed.2001.0838; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yamamoto M, 2000, HEPATO-GASTROENTEROL, V47, P396; 2000, MMWR MORB MORTAL WKL, V50, P162	78	95	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2003	289	10					1297	1302		10.1001/jama.289.10.1297	http://dx.doi.org/10.1001/jama.289.10.1297			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653ZG	12633192	Bronze			2022-12-28	WOS:000181466500032
J	Orlando, V				Orlando, V			Polycomb, epigenomes, and control of cell identity	CELL			English	Review							HISTONE METHYLTRANSFERASE ACTIVITY; CONVEYS EPIGENETIC INHERITANCE; GROUP PROTEINS; DROSOPHILA TRITHORAX; BITHORAX COMPLEX; INTERGENIC TRANSCRIPTION; REPRESSES TRANSCRIPTION; RETINOBLASTOMA PROTEIN; SET DOMAINS; LYSINE 9	In development, cell identity is maintained by epigenetic functions that prevent changes in cell type-specific transcription programs. Recent insights into gene silencing mechanisms by Polycomb group (PcG) and trithorax group (trxG) proteins reveal that the memory system involves a concerted process of chromatin modification, blocking of RNA polymerase II, and synthesis of noncoding RNA. Remarkably, cell memory is regulated by a balance between repressors and activators that maintains both transcription status and at the same time the possibility of switching to a different state.	CNR, Dulbecco Telethon Inst, Inst Genet & Biophys, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI)	Orlando, V (corresponding author), CNR, Dulbecco Telethon Inst, Inst Genet & Biophys, Via Pietro Castellino 111, I-80131 Naples, Italy.	orlando@iigb.na.cnr.it			Telethon [TCP00094] Funding Source: Medline	Telethon(Fondazione Telethon)		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Armstrong JA, 2002, EMBO J, V21, P5245, DOI 10.1093/emboj/cdf517; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bea S, 2001, CANCER RES, V61, P2409; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bender W, 2002, DEVELOPMENT, V129, P4923; Beuchle D, 2001, DEVELOPMENT, V128, P993; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; CUMBERLEDGE S, 1990, P NATL ACAD SCI USA, V87, P3259, DOI 10.1073/pnas.87.9.3259; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Dernburg AF, 2002, CELL, V111, P159, DOI 10.1016/S0092-8674(02)01039-5; Drewell RA, 2002, P NATL ACAD SCI USA, V99, P16853, DOI 10.1073/pnas.222671199; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; FAUVARQUE MO, 1995, MECH DEVELOP, V52, P343, DOI 10.1016/0925-4773(95)00412-T; Fitzgerald DP, 2001, MOL CELL BIOL, V21, P6585, DOI 10.1128/MCB.21.19.6585-6597.2001; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Hogga I, 2002, DEVELOPMENT, V129, P4915; JACOBS JJ, 2002, BIOCHIM BIOPHYS ACTA, V21, P151; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; JONES RS, 1990, GENETICS, V126, P185; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Kodjabachian L, 1998, EMBO J, V17, P1063, DOI 10.1093/emboj/17.4.1063; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li C, 1998, MOL CELL BIOL, V18, P3771, DOI 10.1128/MCB.18.7.3771; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; Lyko F, 1999, BIOESSAYS, V21, P824; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; PARO R, 1990, TRENDS GENET, V6, P416, DOI 10.1016/0168-9525(90)90303-N; Plant KE, 2001, MOL CELL BIOL, V21, P6507, DOI 10.1128/MCB.21.19.6507-6514.2001; Poux S, 2002, DEVELOPMENT, V129, P2483; Poux S, 2001, DEVELOPMENT, V128, P75; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Rego EM, 2002, TRENDS MOL MED, V8, P396, DOI 10.1016/S1471-4914(02)02384-5; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Rozovskaia T, 2000, ONCOGENE, V19, P351, DOI 10.1038/sj.onc.1203307; RUDERT F, 1995, MAMM GENOME, V6, P76, DOI 10.1007/BF00303248; Satijn DPE, 1999, BBA-GENE STRUCT EXPR, V1447, P1, DOI 10.1016/S0167-4781(99)00130-X; SAUER F, 1995, NATURE, V375, P162, DOI 10.1038/375162a0; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; SCHLOSSHERR J, 1994, MOL GEN GENET, V243, P453; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	78	280	295	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2003	112	5					599	606		10.1016/S0092-8674(03)00157-0	http://dx.doi.org/10.1016/S0092-8674(03)00157-0			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628181	Bronze			2022-12-28	WOS:000181443600004
J	Shen, K; Bargmann, CI				Shen, K; Bargmann, CI			The immunoglobulin superfamily protein SYG-1 determines the location of specific synapses in C-elegans	CELL			English	Article							EGG-LAYING SYSTEM; CAENORHABDITIS-ELEGANS; MYOBLAST FUSION; ADHESION MOLECULE; VULVAL INDUCTION; SEX MYOBLASTS; MOTOR NEURONS; CELL LINEAGE; GENE; DROSOPHILA	During nervous system development, neurons form reproducible synapses onto specific targets. Here, we analyze the development of stereotyped synapses of the C. elegans HSNL neuron in vivo. Postsynaptic neurons and muscles were not required for accurate synaptic vesicle clustering in HSNL. Instead, vulval epithelial cells that contact HSNL act as synaptic guidepost cells that direct HSNL presynaptic vesicles to adjacent regions. The mutant syg-1(ky652) has defects in synapse formation that resemble those in animals that lack vulval epithelial cells: HSNL synaptic vesicles fail to accumulate at normal synaptic locations and form ectopic anterior clusters. syg-1 encodes an immunoglobulin superfamily protein that acts in the presynaptic HSNL axon. SYG-1 protein is localized to the site of future synapses, where it initiates synapse formation and localizes synaptic connections in response to the epithelial signal. SYG-1 is related to Drosophila IrreC and vertebrate NEPH1 proteins, which mediate cell-cell recognition in diverse developmental contexts.	Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, Box 0452, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618				Artero RD, 2001, DEVELOPMENT, V128, P4251; Baumeister R, 1996, GENE DEV, V10, P1395, DOI 10.1101/gad.10.11.1395; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bour BA, 2000, GENE DEV, V14, P1498; BRENNER S, 1974, GENETICS, V77, P71; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; CASH S, 1992, J NEUROSCI, V12, P2051; CLARK SG, 1993, CELL, V74, P43, DOI 10.1016/0092-8674(93)90293-Y; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Fournier-Thibault C, 1999, J NEUROSCI, V19, P1382; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HENRIKSON CK, 1974, J NEUROCYTOL, V6, P659; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Hobert O, 1998, J NEUROSCI, V18, P2084; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; LI C, 1990, NEURON, V4, P681, DOI 10.1016/0896-6273(90)90195-L; Mello C, 1995, METHOD CELL BIOL, V48, P451; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; O'Connor TP, 1999, CELL MOL LIFE SCI, V55, P1358, DOI 10.1007/s000180050376; POURQUIE O, 1992, J NEUROSCI, V12, P1548; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Wang MQ, 2001, CURR TOP DEV BIOL, V51, P189, DOI 10.1016/S0070-2153(01)51006-6; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	56	218	224	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					619	630		10.1016/S0092-8674(03)00113-2	http://dx.doi.org/10.1016/S0092-8674(03)00113-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628183	Bronze			2022-12-28	WOS:000181443600006
J	van Leeuwen, F; Gottschling, DE				van Leeuwen, F; Gottschling, DE			The histone minority report: the variant shall not be silenced	CELL			English	Editorial Material							NUCLEOSOME CORE; H2A.Z; ACETYLATION; CHROMATIN; SAS2P; SIR2P; YEAST	In this issue of Cell, Meneghini et al. demonstrate that replacement of canonical histone H2A with the histone variant H2A.Z within euchromatin prevents silent chromatin proteins from migrating into regions of the chromosome that normally are transcriptionally active. Thus, this highly conserved histone variant is critical for defining chromatin domains.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	van Leeuwen, F (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.		van Leeuwen, Fred/A-7698-2010	van Leeuwen, Fred/0000-0002-7267-7251				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Dhillon N, 2000, MOL CELL, V6, P769, DOI 10.1016/S1097-2765(00)00076-9; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Formosa T, 2002, GENETICS, V162, P1557; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6	10	16	16	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 7	2003	112	5					591	593		10.1016/S0092-8674(03)00152-1	http://dx.doi.org/10.1016/S0092-8674(03)00152-1			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	653NW	12628179	Bronze			2022-12-28	WOS:000181443600002
J	Harrison, B				Harrison, B			A historical survey of national health movements and public opinion in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Harrison, B (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V268, P3371, DOI 10.1001/jama.268.23.3371; Blendon RJ, 2001, HEALTH AFFAIR, V20, P33, DOI 10.1377/hlthaff.20.2.33; BLENDON RJ, 1997, HLTH POLITICS POLICY; BODENHEIMER T, 2002, HLTH POLICY CLIN APP; CAMPION FD, 1984, AMA US HLTH POLICY 1; Jacobs Lawrence R., 1993, HLTH NATIONS PUBLIC; KOTELCHUCK R, 1994, CRISIS CONFRONTING H; SKOCPOL T, 1995, HEALTH AFFAIR, V14, P66, DOI 10.1377/hlthaff.14.1.66; Starr P, 1982, SOCIAL TRANSFORMATIO; STARR P, 1993, AM PROSPECT, P4; STEINMO S, 1995, J HEALTH POLIT POLIC, V20, P329, DOI 10.1215/03616878-20-2-329	11	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2003	289	9					1163	1164		10.1001/jama.289.9.1163	http://dx.doi.org/10.1001/jama.289.9.1163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650XM	12622591				2022-12-28	WOS:000181289400036
J	Saitz, R; Horton, NJ; Sullivan, LM; Moskowitz, MA; Samet, JH				Saitz, R; Horton, NJ; Sullivan, LM; Moskowitz, MA; Samet, JH			Addressing alcohol problems in primary care: A cluster randomized, controlled trial of a systems intervention - The screening and intervention in primary care (SIP) study	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	24th Annual Meeting of the Research-Society-on-Alcoholism	JUN 23-28, 2001	MONTREAL, CANADA	Res Soc Alcoholism			BRIEF PHYSICIAN ADVICE; CONTINUING MEDICAL-EDUCATION; BENEFIT-COST-ANALYSIS; PREVENTIVE CARE; SUBSTANCE-ABUSE; PROBLEM DRINKING; LONG-TERM; FOLLOW-UP; HAZARDOUS DRINKERS; MENTAL-DISORDERS	Background: screening and intervention for alcohol problems can reduce drinking and its consequences but are often not implemented. Objective: To test whether providing physicians with patients' alcohol screening results and simple individualized recommendations would affect the likelihood of a physician's having a discussion with patients about alcohol during a primary care visit and would affect subsequent alcohol use. Design: Cluster randomized, controlled trial. Setting: Urban academic primary care practice. Participants: 41 faculty and resident primary care physicians and 312 patients with hazardous drinking. Interventions: Providing physicians with alcohol screening results (CAGE questionnaire responses, alcohol consumption, and readiness to change) and recommendations for their patients at a visit. Measurements: Patient self-report of discussions about alcohol use immediately after the physician visit and alcohol use 6 months later. Results: Of 312 patients, 240 visited faculty physicians, 301 (97%) completed the outcome assessment after the office visit, and 236 (76%) were followed for 6 months. Faculty physicians in the intervention group tended to be more likely than faculty physicians in the control group to give patients advice about drinking (adjusted proportion, 64% [95% CI, 47% to 79%] vs. 42% [CI, 33% to 53%]) and to discuss problems associated with alcohol use (74% [CI, 59% to 85%] vs. 51% [CI, 39% to 62%]). Resident physicians' advice and discussions did not differ between groups. Six months later, patients who saw resident physicians in the intervention group had fewer drinks per drinking day (adjusted mean number of drinks, 3.8 [CI, 1.9 to 5.71 versus 11.6 [CI, 5.4 to 17.7]). Conclusions: Although effects seem to differ by physician level of training, prompting physicians with alcohol screening results and recommendations for action can modestly increase discussions about alcohol use and advice to patients and may decrease alcohol consumption.	Boston Med Ctr, Clin Addict Res & Educ Unit, Gen Internal Med Sect, Boston, MA 02118 USA; Boston Univ, Boston, MA 02215 USA	Boston Medical Center; Boston University	Saitz, R (corresponding author), Boston Med Ctr, Clin Addict Res & Educ Unit, Gen Internal Med Sect, 91 E Concord St,Suite 200, Boston, MA 02118 USA.	rsaitz@bu.edu	Horton, Nicholas/A-2493-2008	Horton, Nicholas/0000-0003-3332-4311; Sullivan, Lisa/0000-0003-0726-7149; Samet, Jeffrey/0000-0002-0897-3400; /0000-0002-2535-1427	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K30HL004124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013216, R01AA010870, R01AA012617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010019] Funding Source: NIH RePORTER; NHLBI NIH HHS [1 K30 HL04124] Funding Source: Medline; NIAAA NIH HHS [AA13216, R01 AA10870, AA12617] Funding Source: Medline; NIDA NIH HHS [R01 DA10019] Funding Source: Medline; CSAP SAMHSA HHS [T26-SP08355] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CSAP SAMHSA HHS		Aalto M, 2002, DRUG ALCOHOL DEPEN, V66, P39, DOI 10.1016/S0376-8716(01)00179-X; Adams A, 1998, J GEN INTERN MED, V13, P692, DOI 10.1046/j.1525-1497.1998.00206.x; Aertgeerts B, 2000, ALCOHOL CLIN EXP RES, V24, P733, DOI 10.1097/00000374-200005000-00020; Ahluwalia LS, 1999, J GEN INTERN MED, V14, P402, DOI 10.1046/j.1525-1497.1999.09078.x; ALLEN JP, 1995, ARCH INTERN MED, V155, P1726, DOI 10.1001/archinte.155.16.1726; Allen JP, 2001, ALCOHOL CLIN EXP RES, V25, P1119; Babor T., 2001, BRIEF INTERVENTION H; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Babor TF, 2000, ADDICTION, V95, P677, DOI 10.1046/j.1360-0443.2000.9556773.x; BABOR TF, 1987, J STUD ALCOHOL, V48, P410, DOI 10.15288/jsa.1987.48.410; Baker AM, 1998, J GEN INTERN MED, V13, P469, DOI 10.1046/j.1525-1497.1998.00136.x; Balas EA, 1998, MED CARE, V36, P79, DOI 10.1097/00005650-199801000-00009; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Barzilai DA, 2001, PREV MED, V33, P595, DOI 10.1006/pmed.2001.0931; Bean P, 2001, ALCOHOL CLIN EXP RES, V25, P309; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Bradley KA, 1998, J GEN INTERN MED, V13, P379, DOI 10.1046/j.1525-1497.1998.00118.x; Bray GA, 1999, DIABETES CARE, V22, P623; BUCHSBAUM DG, 1992, J GEN INTERN MED, V7, P517, DOI 10.1007/BF02599456; BUCHSBAUM DG, 1991, ANN INTERN MED, V115, P774, DOI 10.7326/0003-4819-115-10-774; BUCHSBAUM DG, 1993, ARCH INTERN MED, V153, P1573, DOI 10.1001/archinte.153.13.1573; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CASA Columbia University, 2000, MISS OPP NAT SURV PR; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7; Conigrave KM, 2002, ALCOHOL CLIN EXP RES, V26, P332, DOI 10.1097/00000374-200203000-00005; COULEHAN JL, 1987, ARCH INTERN MED, V147, P349, DOI 10.1001/archinte.147.2.349; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; DELBOCA FK, 1980, ADDICTION S, V95, pS347; Dennis ML, 2000, ADDICTION, V95, pS281; Eckstrom E, 1999, J GEN INTERN MED, V14, P376, DOI 10.1046/j.1525-1497.1999.00356.x; ELVY GA, 1988, BRIT J ADDICT, V83, P83; Etter JF, 2000, J GEN INTERN MED, V15, P421, DOI 10.1046/j.1525-1497.2000.04119.x; EWING JA, 1970, 29 INT C ALC DRUG DE; FEIN R, 1984, ALCOHOL AM PRICE WE; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Fiellin DA, 2000, ANN INTERN MED, V133, P815, DOI 10.7326/0003-4819-133-10-200011210-00015; Figueredo AJ, 2000, ADDICTION, V95, pS361; Fleming MF, 2002, ALCOHOL CLIN EXP RES, V26, P36, DOI 10.1111/j.1530-0277.2002.tb02429.x; Fleming MF, 1997, ALCOHOL HEALTH RES W, V21, P340; Fleming MF, 2000, MED CARE, V38, P7, DOI 10.1097/00005650-200001000-00003; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; Frayne SM, 1996, J GEN INTERN MED, V11, P39, DOI 10.1007/BF02603484; Friedmann PD, 2000, J GEN INTERN MED, V15, P84, DOI 10.1046/j.1525-1497.2000.03379.x; Friedmann PD, 2001, J STUD ALCOHOL, V62, P234, DOI 10.15288/jsa.2001.62.234; Gerbert B, 1999, MED CARE, V37, P104, DOI 10.1097/00005650-199901000-00014; GOLDBERG HI, 1991, MED CARE, V29, pJS49; GOLDMAN L, 1990, NEW ENGL J MED, V322, P1524, DOI 10.1056/NEJM199005243222110; Gomel M, 1994, HLTH PROM J AUST, V4, P65; Gomel MK, 1998, SOC SCI MED, V47, P203, DOI 10.1016/S0277-9536(98)00063-X; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Goodwin MA, 2001, AM J PREV MED, V21, P20, DOI 10.1016/S0749-3797(01)00310-5; Halbert RJ, 1999, DIABETES CARE, V22, P752, DOI 10.2337/diacare.22.5.752; Hansten ML, 2000, ADDICTION, V95, P1403, DOI 10.1046/j.1360-0443.2000.959140310.x; HEATHER N, 1993, 19 U NEW S WAL NAT D; HERMAN CJ, 1994, J AM GERIATR SOC, V42, P1154, DOI 10.1111/j.1532-5415.1994.tb06981.x; KAMEROW DB, 1986, JAMA-J AM MED ASSOC, V255, P2054, DOI 10.1001/jama.255.15.2054; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; KRISTENSON H, 1983, ALCOHOL CLIN EXP RES, V7, P203, DOI 10.1111/j.1530-0277.1983.tb05441.x; Kroenke K, 2000, MED CARE, V38, P4, DOI 10.1097/00005650-200001000-00002; Krumholz HM, 2000, AM J MED, V109, P501, DOI 10.1016/S0002-9343(00)00593-3; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LITZELMAN DK, 1993, J GEN INTERN MED, V8, P311, DOI 10.1007/BF02600144; Litzelman DK, 1996, J GEN INTERN MED, V11, P497, DOI 10.1007/BF02599049; Maisto SA, 2001, J STUD ALCOHOL, V62, P605, DOI 10.15288/jsa.2001.62.605; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; MCILVAIN HE, 1992, J FAM PRACTICE, V34, P745; MCPHEE SJ, 1991, JAMA-J AM MED ASSOC, V266, P538, DOI 10.1001/jama.266.4.538; Miller W.R., 1995, NIH PUBLICATION, V95-3911; Moore AA, 1997, AM J MED, V102, P371, DOI 10.1016/S0002-9343(97)00089-2; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Murray CJL, 1996, COMPREHENSIVE ASSESS; *NAT HEART LUNG BL, 2000, NHLBI MORB MORT CHAR; National Institutes of Health, 1992, NIH PUBL; Naylor CD, 2002, AM J MED, V113, P161, DOI 10.1016/S0002-9343(02)01215-9; *NIH, 1998, NIH PUBL; Ockene JK, 1999, ARCH INTERN MED, V159, P2198, DOI 10.1001/archinte.159.18.2198; Ockene JK, 1997, ARCH INTERN MED, V157, P2334, DOI 10.1001/archinte.157.20.2334; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; ROBINSON MD, 1995, J FAM PRACTICE, V40, P556; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; Rollnick S, 1997, ADDICT RES, V5, P331, DOI 10.3109/16066359709004347; Rubin HR, 2000, J GEN INTERN MED, V15, P434, DOI 10.1046/j.1525-1497.2000.115600.x; RYDON P, 1992, J STUD ALCOHOL, V53, P197, DOI 10.15288/jsa.1992.53.197; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Saitz R, 1997, AM J DRUG ALCOHOL AB, V23, P343, DOI 10.3109/00952999709016881; Saitz R, 2002, J GEN INTERN MED, V17, P373, DOI 10.1007/s11606-002-0043-4; Saitz R, 1999, ARCH INTERN MED, V159, P718, DOI 10.1001/archinte.159.7.718; Samet JH, 1996, ARCH INTERN MED, V156, P2287, DOI 10.1001/archinte.156.20.2287; Saunders JB, 2000, COMPR PSYCHIAT, V41, P95, DOI 10.1016/S0010-440X(00)80015-2; SAUNDERS JB, 1992, IMPLEMENTING EARLY I; Senft RA, 1997, AM J PREV MED, V13, P464, DOI 10.1016/S0749-3797(18)30143-0; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; SOBELL L, 1990, BEHAV ASSESSMENT, P77; Sobell L. C., 1995, ALCOHOL TIMELINE FOL; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Sobell LC, 1996, DRUG ALCOHOL DEPEN, V42, P49, DOI 10.1016/0376-8716(96)01263-X; Solberg LI, 1998, PREV MED, V27, P623, DOI 10.1006/pmed.1998.0337; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WENRICH MD, 1995, J GEN INTERN MED, V10, P631, DOI 10.1007/BF02602748; *WHO, COLL PROJ ID MAN ALC; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Whooley MA, 2000, J GEN INTERN MED, V15, P293, DOI 10.1046/j.1525-1497.2000.04319.x; Wutzke SE, 2002, ADDICTION, V97, P665, DOI 10.1046/j.1360-0443.2002.00080.x; Wutzke SE, 2001, SOC SCI MED, V52, P863, DOI 10.1016/S0277-9536(00)00189-1	109	97	97	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 4	2003	138	5					372	382		10.7326/0003-4819-138-5-200303040-00006	http://dx.doi.org/10.7326/0003-4819-138-5-200303040-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	650HJ	12614089				2022-12-28	WOS:000181257300002
J	Trivedi, DP; Doll, R; Khaw, KT				Trivedi, DP; Doll, R; Khaw, KT			Effect of four monthly oral vitamin D-3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARATHYROID-HORMONE; HIP-FRACTURES; BONE-DENSITY; SELF-REPORT; CALCIUM; RISK; ALENDRONATE	Objective To determine,the effect of four monthly vitamin D supplementation on the rate of fractures in men and women aged 65 years and over living in the community. Design Randomised double blind controlled trial of 100 000 IU oral vitamin D, (cholecalciferol) supplementation or matching Placebo every four months over five years. Setting and participants. 2686 people (2037 men and 649 women) aged 65785 years living in the general community, recruited from the British, doctors register and a general practice register in Suffolk. Main outcome measures Fracture. incidence and total mortality by cause. Results After five years 268 men and women had incident fractures, of whom 147 had fractures in common osteoporotic sites (hip, wrist or forearm, or vertebrae). Relative risks in the vitamin. D group compared with the placebo group were 0.78 (95% confidence interval 0.61 to 0.99, P=0.04) for any first fracture and 0.67 (0.48 to 0.0, P=0.02) for first hip, wrist or forearm, or vertebral fracture. 471 participants died. The relative risk for total mortality in the vitamin D group compared with the placebo group was 0.88 (0.74 to 1.06, P=0.48). Findings were consistent in men and women and in, doctors and the general practice population. Conclusion Four monthly supplementation with 160 000 IU oral vitamin D may prevent fractures without adverse effects in men and women living in the general community.	Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Cambridge CB2 2QQ, England; Univ Oxford, Clin Trial Serv Unit, Oxford OX1 2JD, England; Univ Oxford, Epidemiol Studies Unit, Oxford OX1 2JD, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; University of Oxford	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Cambridge CB2 2QQ, England.	kk101@medschl.cam.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021	Trivedi, Daksha/0000-0002-7572-4113				Barrett-Connor E, 1998, OSTEOPOROSIS INT, V8, pS2; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; COX DR, 1972, J R STAT SOC B, V34, P187; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Garland CF, 1999, ANN NY ACAD SCI, V889, P107, DOI 10.1111/j.1749-6632.1999.tb08728.x; GILLESPIE WJ, 2002, COCHRANE DB SYST REV; HEIKINHEIMO RJ, 1992, CALCIFIED TISSUE INT, V51, P105, DOI 10.1007/BF00298497; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; KHAW KT, 1992, BRIT MED J, V305, P273, DOI 10.1136/bmj.305.6848.273; KHAW KT, 1994, AM J CLIN NUTR, V59, P1040, DOI 10.1093/ajcn/59.5.1040; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; PARFITT AM, 1982, AM J CLIN NUTR, V36, P1014, DOI 10.1093/ajcn/36.5.1014; ROSE G, 1992, STRATEGY PREVENTION; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559	23	875	912	2	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2003	326	7387					469	472		10.1136/bmj.326.7387.469	http://dx.doi.org/10.1136/bmj.326.7387.469			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653EC	12609940	Green Published, Green Submitted			2022-12-28	WOS:000181421400014
J	Oda, Y; Hosokawa, N; Wada, I; Nagata, K				Oda, Y; Hosokawa, N; Wada, I; Nagata, K			EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin	SCIENCE			English	Article							MANNOSIDASE-LIKE PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; QUALITY-CONTROL; CALRETICULIN; YEAST	Terminally misfolded proteins in the endoplasmic reticulum (ER) are retro-translocated to the cytoplasm and degraded by proteasomes through a mechanism known as ER-associated degradation (ERAD). EDEM, a postulated Man8B-binding protein, accelerates the degradation of misfolded proteins in the ER. Here, EDEM was shown to interact with calnexin, but not with calreticulin, through its transmembrane region. Both binding of substrates to calnexin and their release from calnexin were required for ERAD to occur. Overexpression of EDEM accelerated ERAD by promoting the release of terminally misfolded proteins from calnexin. Thus, EDEM appeared to function in the ERAD pathway by accepting substrates from calnexin.	Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068397, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan; Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608556, Japan	Kyoto University; Japan Science & Technology Agency (JST); Sapporo Medical University	Nagata, K (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068397, Japan.			Wada, Ikuo/0000-0001-5668-6994				Braakman I, 2001, EMBO REP, V2, P666, DOI 10.1093/embo-reports/kve162; Cannon KS, 1999, J BIOL CHEM, V274, P7537, DOI 10.1074/jbc.274.11.7537; CARBRAL CM, 2002, MOL BIOL CELL, V13, P2639; CARBRAL CM, 2001, TRENDS BIOCHEM SCI, V26, P619; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Danilczyk UG, 2000, J BIOL CHEM, V275, P13089, DOI 10.1074/jbc.275.17.13089; ELLGARD L, 2001, CURR OPIN CELL BIOL, V11, P120; Fagioli C, 2001, J BIOL CHEM, V276, P12885, DOI 10.1074/jbc.M009603200; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; ODA Y, UNPUB; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Tokunaga F, 2000, J BIOL CHEM, V275, P40757, DOI 10.1074/jbc.M001073200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; Wilson CM, 2000, J BIOL CHEM, V275, P21224, DOI 10.1074/jbc.M000567200; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	27	360	375	3	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 28	2003	299	5611					1394	1397		10.1126/science.1079181	http://dx.doi.org/10.1126/science.1079181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649DU	12610305				2022-12-28	WOS:000181192300052
J	Long, JC; Chan, HW; Churnside, AB; Gulbis, EA; Varney, MCM; Price, JC				Long, JC; Chan, HW; Churnside, AB; Gulbis, EA; Varney, MCM; Price, JC			Upper limits to submillimetre-range forces from extra space-time dimensions	NATURE			English	Article							INVERSE-SQUARE LAW	String theory is the most promising approach to the long-sought unified description of the four forces of nature and the elementary particles(1), but direct evidence supporting it is lacking. The theory requires six extra spatial dimensions beyond the three that we observe; it is usually supposed that these extra dimensions are curled up into small spaces. This 'compactification' induces 'moduli' fields, which describe the size and shape of the compact dimensions at each point in space-time. These moduli fields generate forces with strengths comparable to gravity, which according to some recent predictions(2-7) might be detected on length scales of about 100 mum. Here we report a search for gravitational-strength forces using planar oscillators separated by a gap of 108 mum. No new forces are observed, ruling out a substantial portion of the previously allowed parameter space(4) for the strange and gluon moduli forces, and setting a new upper limit on the range of the string dilaton(2,3) and radion(5-7) forces.	Univ Colorado, Dept Phys, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Price, JC (corresponding author), Univ Colorado, Dept Phys, UCB 390, Boulder, CO 80309 USA.	john.price@colorado.edu						ADELBERGER E, 2002, HEPEX0202008; Arkani-Hamed N, 1998, PHYS LETT B, V429, P263, DOI 10.1016/S0370-2693(98)00466-3; Beane SR, 1997, GEN RELAT GRAVIT, V29, P945, DOI 10.1023/A:1018843607120; Bordag M, 2001, PHYS REP, V353, P1, DOI 10.1016/S0370-1573(01)00015-1; CHACKO Z, 2002, EXTRA DIMENSIONS WEA; Chan HW, 1999, REV SCI INSTRUM, V70, P2742, DOI 10.1063/1.1149839; CHIAVERINI J, 2002, HEPPH0209325; Dimopoulos S, 1996, PHYS LETT B, V379, P105, DOI 10.1016/0370-2693(96)00390-5; Fischbach E, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.075010; FISCHBACH E, 1999, SEARCH NONEWTONIAN G; Floratos EG, 1999, PHYS LETT B, V465, P95, DOI 10.1016/S0370-2693(99)01019-9; Greene B., 2003, ELEGANT UNIVERSE SUP; HOSKINS JK, 1985, PHYS REV D, V32, P3084, DOI 10.1103/PhysRevD.32.3084; Hoyle CD, 2001, PHYS REV LETT, V86, P1418, DOI 10.1103/PhysRevLett.86.1418; Kaplan DB, 2000, J HIGH ENERGY PHYS; Kehagias A, 2000, PHYS LETT B, V472, P39, DOI 10.1016/S0370-2693(99)01421-5; KLEIMAN RN, 1985, REV SCI INSTRUM, V56, P2088, DOI 10.1063/1.1138425; Lamoreaux SK, 1997, PHYS REV LETT, V78, P5, DOI 10.1103/PhysRevLett.78.5; Long JC, 1999, NUCL PHYS B, V539, P23, DOI 10.1016/S0550-3213(98)00711-1; LONG JC, 2002, HEPPH0210004; MOODY JE, 1984, PHYS REV D, V30, P130, DOI 10.1103/PhysRevD.30.130; PRICE JC, 1988, P INT S EXP GRAV PHY, P436; Rosenberg LJ, 2000, PHYS REP, V325, P1, DOI 10.1016/S0370-1573(99)00045-9; SCHMIDHUBER C, 2002, HEPTH0207203; Sundrum R, 1999, J HIGH ENERGY PHYS; TAYLOR TR, 1988, PHYS LETT B, V213, P450, DOI 10.1016/0370-2693(88)91290-7	28	264	269	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2003	421	6926					922	925		10.1038/nature01432	http://dx.doi.org/10.1038/nature01432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649BK	12606994	Green Submitted			2022-12-28	WOS:000181186900042
J	Kakko, J; Svanborg, KD; Kreek, MJ; Heilig, M				Kakko, J; Svanborg, KD; Kreek, MJ; Heilig, M			1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial	LANCET			English	Article							CONTROLLED CLINICAL-TRIAL; OPIOID DEPENDENCE; METHADONE-MAINTENANCE; COMPARING BUPRENORPHINE; OPIATE DEPENDENCE; ADDICTION; AGONIST; HUMANS; MODEL	Background The partial opiate-receptor agonist buprenorphine has been suggested for treatment of heroin dependence, but there are few long-term and placebo-controlled studies of its effectiveness. We aimed to assess the 1-year efficacy of buprenorphine in combination with intensive psychosocial therapy for treatment of heroin dependence. Methods 40 individuals aged older than 20 years, who met DSM-IV criteria for opiate dependence for at least 1 year, but did not fulfil Swedish legal criteria for methadone maintenance treatment were randomly allocated either to daily buprenorphine (fixed dose 16 mg sublingually for 12 months; supervised daily administration for a least 6 months, possible take-home doses thereafter) or a tapered 6 day regimen of buprenorphine, thereafter followed by placebo. All patients participated in cognitive-behavioural group therapy to prevent relapse, received weekly individual counselling sessions, and submitted thrice weekly supervised urine samples for analysis to detect illicit drug use. Our primary endpoint was 1-year retention in treatment and analysis was by intention to treat. Findings 1-year retention in treatment was 75% and 0% in the buprenorphine and placebo groups, respectively (p=0.0001; risk ratio 58.7 [95% CI 7.4-467.4]). Urine screens were about 75% negative for illicit opiates, central stimulants, cannabinoids, and benzodiazepines in the patients remaining in treatment. Interpretation The combination of buprenorphine and intensive psychosocial treatment is safe and highly efficacious, and should be added to the treatment options available for individuals who are dependent on heroin.	Huddinge Univ Hosp, Karolinska Inst, NEUROTEC, Div Psychiat, S-14186 Huddinge, Sweden; Rockefeller Univ, Lab Biol Addict Dis, New York, NY USA	Karolinska Institutet; Rockefeller University	Heilig, M (corresponding author), Huddinge Univ Hosp, Karolinska Inst, NEUROTEC, Div Psychiat, S-14186 Huddinge, Sweden.			Heilig, Markus/0000-0003-2706-2482	PHS HHS [P50-05130, K0500049] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Auriacombe M, 2001, JAMA-J AM MED ASSOC, V285, P45, DOI 10.1001/jama.285.1.45; Barnett PG, 2001, ADDICTION, V96, P683, DOI 10.1046/j.1360-0443.2001.9656834.x; CAPLEHORN JRM, 1993, INT J ADDICT, V28, P73, DOI 10.3109/10826089309038923; COMPTON P, 1994, NIDA RES MONOGR, V153, P138; DOLE VP, 1966, ARCH INTERN MED, V118, P304, DOI 10.1001/archinte.118.4.304; GRONBLADH L, 1990, ACTA PSYCHIAT SCAND, V82, P223, DOI 10.1111/j.1600-0447.1990.tb03057.x; Gunne L., 2002, HEROIN ADDICT RELAT, V4, P37; GUNNE LM, 1981, DRUG ALCOHOL DEPEN, V7, P249, DOI 10.1016/0376-8716(81)90096-X; JOHNSON RE, 1992, JAMA-J AM MED ASSOC, V267, P2750, DOI 10.1001/jama.267.20.2750; JOHNSON RE, 1995, DRUG ALCOHOL DEPEN, V40, P17, DOI 10.1016/0376-8716(95)01186-2; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; JOHNSON RE, 1995, DRUG ALCOHOL DEPEN, V40, P27, DOI 10.1016/0376-8716(95)01189-7; Judd LL, 1998, JAMA-J AM MED ASSOC, V280, P1936; KADDEN R, 1992, NIAAA PROJECT MATCH; Kreek MJ, 2000, ANN NY ACAD SCI, V909, P186; Krook AL, 2002, ADDICTION, V97, P533, DOI 10.1046/j.1360-0443.2002.00090.x; Larimer ME, 1999, ALCOHOL RES HEALTH, V23, P151; Ling W, 1996, ARCH GEN PSYCHIAT, V53, P401; Ling W, 1998, ADDICTION, V93, P475, DOI 10.1046/j.1360-0443.1998.9344753.x; MARLATT GA, 1984, BRIT J ADDICT, V79, P261; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Nath RP, 1999, J CLIN PHARMACOL, V39, P619, DOI 10.1177/00912709922008236; Pani PP, 2000, DRUG ALCOHOL DEPEN, V60, P39, DOI 10.1016/S0376-8716(99)00140-4; PRESTON KL, 1992, J PHARMACOL EXP THER, V261, P62; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; STRAIN EC, 1994, AM J PSYCHIAT, V151, P1025; WALSH SL, 1995, J PHARMACOL EXP THER, V274, P361; West SL, 2000, J SUBST ABUSE, V12, P405, DOI 10.1016/S0899-3289(01)00054-2; WOODY GE, 1995, AM J PSYCHIAT, V152, P1302	30	304	304	1	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 22	2003	361	9358					662	668		10.1016/S0140-6736(03)12600-1	http://dx.doi.org/10.1016/S0140-6736(03)12600-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	648BG	12606177				2022-12-28	WOS:000181129500015
J	McCulloch, M; Fallon, S; Wyndham, T; Hendy, E; Lough, J; Barnes, D				McCulloch, M; Fallon, S; Wyndham, T; Hendy, E; Lough, J; Barnes, D			Coral record of increased sediment flux to the inner Great Barrier Reef since European settlement	NATURE			English	Article							PHASE-SHIFTS; MASSIVE CORALS; PERSPECTIVES; IMPACTS; ISSUES; BANDS; WATER	The effect of European settlement on water quality in the Great Barrier Reef of Australia is a long-standing and controversial issue(1-6). Erosion and sediment transport in river catchments in this region have increased substantially since European settlement(6-10), but the magnitude of these changes remains uncertain(1-10). Here we report analyses of Ba/Ca ratios in long-lived Porites coral from Havannah Reef-a site on the inner Great Barrier Reef that is influenced by flood plumes from the Burdekin river-to establish a record of sediment fluxes from about 1750 to 1998. We find that, in the early part of the record, suspended sediment from river floods reached the inner reef area only occasionally, whereas after about 1870-following the beginning of European settlement-a five- to tenfold increase in the delivery of sediments is recorded with the highest fluxes occurring during the drought-breaking floods. We conclude that, since European settlement, land-use practices such as clearing and overstocking have led to major degradation of the semi-arid river catchments, resulting in substantially increased sediment loads entering the inner Great Barrier Reef.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian National University; Australian Institute of Marine Science	McCulloch, M (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	Malcom.McCulloch@anu.edu.au	McCulloch, Malcolm T/C-3651-2009; Hendy, Erica J/H-4488-2016; Fallon, Stewart J/G-6645-2011; Lough, Janice M/L-1682-2013	McCulloch, Malcolm T/0000-0003-1538-1558; Hendy, Erica J/0000-0001-5949-4349; Fallon, Stewart J/0000-0002-8064-5903; Lough, Janice M/0000-0002-3789-1009				ALIBERT C, IN PRESS GEOCHIM COS; Ash A. J., 1997, Rangeland Journal, V19, P123, DOI 10.1071/RJ9970123; Barnes DJ, 2001, CORAL REEFS, V19, P221, DOI 10.1007/PL00006958; BELL PR, 1991, MAR POLLUT BULL, V23, P89, DOI 10.1016/0025-326X(91)90655-C; BELPERIO AP, 1983, BMR J AUST GEOL GEOP, V8, P179; Devlin M., 2001, GREAT BARRIER REEF M; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Fallon SJ, 2002, GEOCHIM COSMOCHIM AC, V66, P45, DOI 10.1016/S0016-7037(01)00715-3; Furnas M, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P37; Haynes D, 2000, MAR POLLUT BULL, V41, P428, DOI 10.1016/S0025-326X(00)00150-8; Hendy EJ, 2002, SCIENCE, V295, P1511, DOI 10.1126/science.1067693; HOLMES JM, 1963, AUSTR OPEN N; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; ISDALE P, 1984, NATURE, V310, P578, DOI 10.1038/310578a0; King B, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P145; Larcombe P, 1999, CORAL REEFS, V18, P163, DOI 10.1007/s003380050174; LEA DW, 1989, NATURE, V340, P373, DOI 10.1038/340373a0; LI YH, 1979, EARTH PLANET SC LETT, V43, P343, DOI 10.1016/0012-821X(79)90089-X; LOUGH JM, IN PRESS HOLOCENE RE; McCook LJ, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P113; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P2747, DOI 10.1016/0016-7037(94)90142-2; Moore WS, 1999, MAR CHEM, V65, P111, DOI 10.1016/S0304-4203(99)00014-6; Moss AJ, 1993, PRELIMINARY ASSESSME; Neil DT, 2002, MAR FRESHWATER RES, V53, P733, DOI 10.1071/MF00151; Prosser IP, 2001, MAR FRESHWATER RES, V52, P81, DOI 10.1071/MF00033; SHEN GT, 1990, GLOBAL ECOLOGICAL CO, P255, DOI DOI 10.1016/S0422-9894(08)70038-2; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; SMITH SV, 1981, PAC SCI, V35, P279; Tudhope AW, 1996, PALAIOS, V11, P347, DOI 10.2307/3515245	30	529	548	3	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 13	2003	421	6924					727	730		10.1038/nature01361	http://dx.doi.org/10.1038/nature01361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	644UP	12610621				2022-12-28	WOS:000180938000039
